data_1omt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1omt _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.302 0.572 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -87.93 122.92 32.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.99 19.61 10.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.696 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -19.55 60.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -106.06 42.02 1.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.593 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 42.8 m-85 -137.38 164.37 42.19 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 36.8 Cg_endo -86.89 145.9 31.59 Favored 'Cis proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.08 -1.633 . . . . 0.0 110.646 1.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.6 mttp -98.51 134.57 21.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.98 15.11 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.422 2.082 . . . . 0.0 111.022 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.89 124.47 7.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.387 -0.821 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.5 m -119.38 131.96 55.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 2.6 p -63.79 -169.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 108.61 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -115.35 -13.86 11.66 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.279 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 5.8 pm0 -46.15 127.74 8.89 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -87.33 125.3 34.15 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.68 1.228 . . . . 0.0 112.276 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -162.57 82.26 1.65 Allowed Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.8 Cg_endo -65.92 132.78 31.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.071 2.514 . . . . 0.0 113.67 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.9 mp -118.77 141.1 48.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -99.26 129.84 45.51 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.716 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -67.17 -167.74 3.27 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.7 t -82.56 -27.81 31.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.096 -1.238 . . . . 0.0 109.101 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.3 p30 -75.09 0.17 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.7 m-20 79.89 37.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 110.187 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 30' ' ' THR . 3.1 tttm -108.11 144.1 35.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 108.573 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.47 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 32.0 m -90.36 146.26 24.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.738 -1.227 . . . . 0.0 109.514 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.34 -49.27 3.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 7.2 p-10 -163.83 -166.64 1.21 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.274 -1.133 . . . . 0.0 110.217 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.607 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.32 -48.7 73.76 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.435 -0.79 . . . . 0.0 111.213 -177.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.455 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 16.0 t -54.44 -60.97 2.64 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.821 -1.175 . . . . 0.0 111.375 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.427 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 19.5 m-80 -62.43 -26.63 68.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.779 -1.2 . . . . 0.0 110.652 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 7.9 t80 -65.94 -59.84 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.856 -1.153 . . . . 0.0 109.863 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -59.86 -44.07 94.34 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.583 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' A' ' 42' ' ' VAL . 3.4 m-80 -43.25 -28.98 0.36 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.666 -1.271 . . . . 0.0 107.882 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -74.98 -49.78 18.79 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' CYS . 90.1 t -53.65 -56.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.584 0.707 . . . . 0.0 109.43 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 23.4 m -59.78 -26.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.543 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -88.0 -13.83 40.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.028 -1.045 . . . . 0.0 108.801 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 47' ' ' THR . 27.9 p -110.4 29.83 7.34 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.448 -0.782 . . . . 0.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 44.85 55.32 6.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.979 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 36.38 45.54 0.95 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 44' ' ' SER . 12.0 t -110.04 -7.4 14.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.5 tp -83.0 -71.45 0.5 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.51 0.671 . . . . 0.0 109.313 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.609 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 14.2 p 60.78 138.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.541 0.686 . . . . 0.0 109.37 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.66 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -93.57 165.59 12.66 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.697 0.76 . . . . 0.0 111.135 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.94 -34.5 6.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.6 p80 -156.08 165.21 37.11 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.583 0.706 . . . . 0.0 109.88 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CD2' HD22 ' A' ' 23' ' ' LEU . 6.0 m-85 -83.15 -168.9 2.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.692 -0.63 . . . . 0.0 109.641 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 60.07 -166.95 9.81 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 mtmt -90.41 164.96 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.992 . . . . 0.0 108.657 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.146 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.86 118.06 23.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.408 -0.807 . . . . 0.0 109.784 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.2 m -97.91 50.45 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.241 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -79.36 -23.79 43.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.858 . . . . 0.0 109.635 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.94 43.18 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.038 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 34.0 m-85 -131.31 165.51 34.75 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -87.51 169.42 39.49 Favored 'Cis proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.237 -1.568 . . . . 0.0 110.887 -0.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 2.6 mtpt -125.25 142.99 43.05 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.81 14.86 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.719 2.28 . . . . 0.0 111.308 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.57 151.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -126.54 160.31 30.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.448 ' OG1' ' OE1' ' A' ' 19' ' ' GLU . 5.2 p -64.62 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.406 ' N ' ' OG1' ' A' ' 17' ' ' THR . 4.1 pp -132.17 -13.9 3.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.963 -1.086 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 15.2 pm0 -55.42 126.51 25.42 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 120.448 -1.408 . . . . 0.0 108.25 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 6.0 t80 -81.83 118.98 23.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.555 1.169 . . . . 0.0 110.906 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.9 69.08 10.89 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.595 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.5 Cg_endo -65.34 132.4 31.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.227 2.618 . . . . 0.0 113.389 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -125.21 132.99 52.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.198 178.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.698 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 32.8 t -78.09 118.67 20.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -64.01 -163.62 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 C-N-CA 118.648 -1.739 . . . . 0.0 109.481 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 49' ' ' THR . 8.5 t -85.25 -30.03 24.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -1.231 . . . . 0.0 108.766 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -71.07 -4.69 26.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.4 t30 84.83 16.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 110.095 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.63 126.54 44.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 108.375 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 55' ' ' LYS . 51.8 m -64.71 144.8 56.98 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.047 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 31.7 m-85 -121.74 120.97 36.19 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.96 -50.23 0.21 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.6 p30 -162.41 -162.87 0.85 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.825 -1.397 . . . . 0.0 109.989 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.22 -47.28 65.76 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.48 -0.763 . . . . 0.0 111.829 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.3 m -62.79 -61.23 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.515 -1.366 . . . . 0.0 110.152 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.8 m-80 -50.04 -22.09 1.48 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.2 t80 -80.93 -52.87 6.97 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.797 1.284 . . . . 0.0 109.486 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.598 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 7.3 m -58.84 -30.15 67.45 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.314 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.614 ' HA ' HG23 ' A' ' 42' ' ' VAL . 4.1 m-80 -61.06 -29.85 69.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.584 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -76.61 -31.29 57.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.501 ' CG2' HD21 ' A' ' 48' ' ' LEU . 53.5 t -77.1 -24.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.5 0.667 . . . . 0.0 110.205 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.614 HG23 ' HA ' ' A' ' 39' ' ' ASN . 4.9 m -90.8 -25.71 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.898 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.51 ' N ' HG21 ' A' ' 42' ' ' VAL . 2.6 tt0 -90.96 -5.43 55.44 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.256 -0.903 . . . . 0.0 108.832 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 22.6 p -111.6 -0.65 16.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.1 t-20 77.43 15.18 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 108.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 81.29 2.51 90.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 t -80.12 0.43 32.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 108.662 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.563 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -82.41 -78.37 0.21 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.563 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 77.69 172.85 0.2 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.616 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -120.38 170.12 9.66 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.677 -1.264 . . . . 0.0 111.688 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.616 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 1.6 p -92.1 -42.09 10.12 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.476 1.131 . . . . 0.0 108.544 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.698 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -171.99 172.36 4.74 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.174 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -77.21 -174.63 3.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 108.763 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 64.75 -167.27 30.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.98 154.94 19.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.963 . . . . 0.0 109.305 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 55' ' ' LYS . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.5 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 37' ' ' PHE . 5.4 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.367 0.603 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.63 177.79 6.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -156.2 39.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.211 -0.93 . . . . 0.0 109.715 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 -38.32 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -88.14 -4.76 58.7 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 61.0 m-85 -88.05 161.52 43.51 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.211 -0.931 . . . . 0.0 109.269 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HB3' HG22 ' A' ' 42' ' ' VAL . 33.1 Cg_endo -87.27 144.44 27.29 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.424 1.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -101.07 142.21 24.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.291 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.57 13.63 2.04 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.517 2.144 . . . . 0.0 110.478 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.12 128.25 12.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' THR . 66.7 m -123.12 138.94 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.113 -0.992 . . . . 0.0 109.959 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -52.51 -176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.263 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.9 mt -117.89 -31.45 5.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.739 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.3 pm0 -44.26 135.93 4.24 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 5.4 t80 -87.27 126.88 35.1 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.789 1.28 . . . . 0.0 111.135 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.3 mtm180 -160.54 71.24 2.89 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.65 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 20.6 Cg_endo -62.97 132.76 38.24 Favored 'Trans proline' 0 C--O 1.196 -1.592 0 C-N-CA 123.844 3.029 . . . . 0.0 114.339 -176.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.658 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 4.3 mp -111.38 161.08 16.45 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 30.3 t -119.09 137.13 53.78 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.677 -1.89 . . . . 0.0 110.858 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.608 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -96.51 164.37 23.14 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.258 -0.901 . . . . 0.0 111.651 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 23.9 t -67.68 -29.31 68.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.8 p30 -59.51 -14.5 13.1 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.3 t30 88.97 10.15 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.299 0.571 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -99.38 126.52 45.27 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 55' ' ' LYS . 20.9 m -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.829 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.73 136.65 36.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -39.52 -42.75 2.0 Favored Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.477 -0.765 . . . . 0.0 111.889 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 30.0 p30 -172.47 -149.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.684 -1.48 . . . . 0.0 109.813 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.38 -63.0 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.843 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 16.8 t -53.71 -57.07 12.16 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.88 -1.137 . . . . 0.0 109.378 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -52.4 -24.26 7.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 108.842 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.829 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.7 t80 -78.09 -66.5 0.84 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.51 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 43.6 t -50.62 -44.92 57.35 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.587 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.526 ' HA ' HG23 ' A' ' 42' ' ' VAL . 8.1 m-20 -48.77 -35.28 13.95 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 37' ' ' PHE . . . -62.07 -45.37 93.84 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.572 ' CG2' HD22 ' A' ' 48' ' ' LEU . 56.6 t -62.73 -59.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.713 0.768 . . . . 0.0 109.662 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 12' ' ' PRO . 2.9 m -51.55 -28.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.325 -0.859 . . . . 0.0 110.356 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.402 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -91.64 -20.41 21.66 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.793 -1.192 . . . . 0.0 109.464 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 43.8 t -97.11 9.94 40.75 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.642 -0.662 . . . . 0.0 109.906 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.0 m120 62.62 25.61 15.23 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.265 -0.897 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 20.3 73.44 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 44' ' ' SER . 1.5 p -103.72 16.92 25.23 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -94.4 -48.41 6.15 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.602 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 39.2 p 52.28 125.21 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.347 1.07 . . . . 0.0 111.547 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 51' ' ' SER . 7.9 tp -68.66 157.19 36.74 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.516 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.91 -20.21 10.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.687 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 173.68 162.04 0.16 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -75.17 150.18 38.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.663 0.744 . . . . 0.0 109.131 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.65 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 96.94 -166.74 23.68 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 2.0 mtmt -90.07 158.65 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -1.156 . . . . 0.0 109.104 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.45 160.68 25.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.138 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -134.17 57.75 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.084 -1.01 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.13 -29.64 20.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.69 30.16 2.12 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 40.5 m-85 -120.84 166.83 14.47 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -89.42 169.13 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.56 -1.433 . . . . 0.0 111.528 0.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -122.08 136.98 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.17 14.76 1.86 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.349 2.033 . . . . 0.0 110.859 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 126.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 109.525 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.0 t -110.37 159.84 17.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 82.5 p -64.7 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.95 -12.4 9.56 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.808 -1.183 . . . . 0.0 110.088 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.08 120.45 2.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.104 -0.997 . . . . 0.0 108.729 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.4 t80 -89.77 118.01 29.05 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.657 1.218 . . . . 0.0 110.294 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -151.41 74.54 8.1 Favored Pre-proline 0 C--N 1.287 -2.147 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.5 Cg_endo -63.35 126.13 17.1 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.09 2.526 . . . . 0.0 112.415 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.627 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.09 128.61 55.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.36 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 53.2 t -79.77 161.39 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.5 169.97 21.68 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.136 -1.507 . . . . 0.0 112.078 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.26 -20.8 66.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.016 -0.696 . . . . 0.0 109.969 -178.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.3 p30 -65.35 -12.14 49.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 109.153 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.2 t-20 85.29 30.4 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.535 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -132.56 -166.84 1.8 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.97 . . . . 0.0 109.416 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 31' ' ' TYR . 8.2 m -126.2 156.48 40.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 27.0 m-85 -126.54 126.45 43.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.3 -52.68 0.42 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.8 p30 -162.5 -166.08 1.29 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.802 -1.41 . . . . 0.0 111.152 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.11 -42.08 38.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.799 -0.563 . . . . 0.0 111.958 -177.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.521 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 m -68.72 -54.53 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.623 -1.298 . . . . 0.0 110.165 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.2 m-80 -59.02 -20.38 52.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.051 -1.031 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 35.6 t80 -80.18 -51.1 9.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.554 1.168 . . . . 0.0 109.285 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.551 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m -60.58 -29.18 69.02 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.593 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.591 ' HA ' HG23 ' A' ' 42' ' ' VAL . 16.4 m-20 -67.1 -31.13 71.4 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.707 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.74 -23.21 49.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.455 ' CG2' HD21 ' A' ' 48' ' ' LEU . 48.6 t -84.16 -25.57 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 39' ' ' ASN . 3.6 m -88.07 -19.3 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.707 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.25 -32.21 15.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 t -84.09 8.88 14.06 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.539 -0.726 . . . . 0.0 109.838 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 69.1 m-20 61.72 27.08 16.56 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.155 -0.965 . . . . 0.0 108.96 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.51 27.3 73.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.0 p -105.19 -1.47 25.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.605 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.74 -79.77 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.605 ' CG2' ' O ' ' A' ' 48' ' ' LEU . 7.3 p 95.57 136.52 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.108 0.956 . . . . 0.0 110.185 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 15.1 tp -67.28 158.64 31.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 4.7 p -109.22 -43.24 4.19 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.695 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 167.01 1.74 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.3 m-85 -74.69 171.24 14.27 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.128 -0.983 . . . . 0.0 108.53 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -176.7 46.71 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.34 155.58 18.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.24 . . . . 0.0 109.077 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.454 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.469 HG11 ' SG ' ' A' ' 8' ' ' CYS . 4.1 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.29 0.567 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -87.3 134.0 33.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' HG11 ' A' ' 6' ' ' VAL . 12.8 m -144.7 42.06 1.34 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.221 -0.924 . . . . 0.0 109.869 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 27.3 t -90.83 -8.82 48.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -0.949 . . . . 0.0 109.685 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.3 mm-40 -97.9 -1.74 42.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.973 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 41.2 m-85 -82.88 158.16 65.41 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.131 -0.981 . . . . 0.0 109.526 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 37.1 Cg_endo -75.76 165.46 85.54 Favored 'Cis proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.589 1.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 6.0 mtmt -120.03 143.83 36.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.54 14.57 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.506 2.137 . . . . 0.0 111.1 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.83 128.37 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.355 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -105.51 144.21 32.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.743 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -61.71 -177.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 108.667 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -111.1 -20.77 12.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.052 -1.03 . . . . 0.0 109.738 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mt-10 -44.89 122.63 3.34 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.121 -0.987 . . . . 0.0 108.751 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.479 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 32.8 t80 -86.93 108.81 18.97 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 122.497 1.141 . . . . 0.0 110.177 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.9 mtm180 -144.26 90.62 6.63 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -67.23 109.21 1.7 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.105 1.87 . . . . 0.0 112.239 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.641 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -105.45 118.49 36.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -79.33 176.93 9.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 110.542 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -139.91 172.91 23.18 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.425 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.5 t -65.65 -31.27 72.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.746 -0.856 . . . . 0.0 109.678 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.4 p30 -65.77 -8.74 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 83.15 19.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -103.22 154.37 19.4 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.458 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 53.6 m -106.54 143.73 34.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 94.5 m-85 -118.37 116.07 25.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 108.949 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.64 -54.43 0.63 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p-10 -144.11 -170.35 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.656 -1.496 . . . . 0.0 110.706 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.0 -28.22 67.53 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.978 -0.451 . . . . 0.0 111.634 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.5 t -70.98 -51.14 27.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.55 -1.344 . . . . 0.0 109.278 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.539 -0.725 . . . . 0.0 109.914 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.2 t80 -69.12 -53.31 20.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.442 1.115 . . . . 0.0 109.715 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.603 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.6 m -56.28 -47.84 77.81 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.334 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 6.0 m-20 -48.72 -33.3 9.93 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -72.36 -39.67 67.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.295 -0.878 . . . . 0.0 108.664 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.467 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 77.6 t -60.43 -57.2 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.626 -0.672 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -64.59 -22.34 31.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.473 -0.767 . . . . 0.0 110.612 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.13 -10.96 36.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.92 -1.113 . . . . 0.0 109.138 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 47' ' ' THR . 6.2 p -115.05 25.66 10.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 110.438 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' C ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 43.71 53.55 5.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.905 -1.122 . . . . 0.0 109.527 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.09 43.55 8.94 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 44' ' ' SER . 6.1 t -117.12 2.13 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -1.083 . . . . 0.0 108.483 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.655 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.61 -50.79 7.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.076 0.941 . . . . 0.0 108.536 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.655 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 62.0 p 57.66 126.34 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.302 1.049 . . . . 0.0 110.32 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.7 tp -61.65 131.15 49.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.44 -23.24 43.28 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 108.656 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 51' ' ' SER . 11.0 p80 154.46 163.47 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.15 151.82 44.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.824 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 90.73 -176.4 41.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.64 169.28 15.5 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.047 -1.266 . . . . 0.0 108.373 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.581 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 30.4 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.217 0.532 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -73.19 147.12 45.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 m -134.49 43.24 2.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -90.21 -11.45 40.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -125.03 49.61 1.85 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 m-85 -135.23 162.61 56.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.313 -0.867 . . . . 0.0 109.076 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.35 157.69 54.38 Favored 'Cis proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.852 -1.728 . . . . 0.0 110.749 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.581 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.39 140.24 25.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 108.688 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.37 14.97 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.679 2.253 . . . . 0.0 111.731 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.83 154.25 0.71 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.155 -0.965 . . . . 0.0 110.056 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 t -148.63 171.05 16.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.57 2.12 8.28 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.751 -1.218 . . . . 0.0 110.289 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.41 127.42 31.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 6.0 t80 -80.04 110.59 15.57 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.553 1.168 . . . . 0.0 111.272 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.22 73.29 37.75 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.5 Cg_endo -64.29 123.16 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.553 2.169 . . . . 0.0 112.721 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.4 mt -112.74 122.99 49.29 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -82.92 112.2 19.49 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.126 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.535 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.6 -166.13 0.06 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -78.1 -32.49 50.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -1.16 . . . . 0.0 109.137 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 37.1 p-10 -73.08 0.01 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.825 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 m120 77.27 30.32 0.53 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -98.87 137.5 37.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 m -86.97 122.61 31.06 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 82.0 m-85 -99.17 139.45 34.8 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -54.03 -39.03 62.02 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.111 -1.043 . . . . 0.0 112.021 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.4 p30 -162.58 -157.06 0.43 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.725 -1.456 . . . . 0.0 109.304 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.37 -47.5 85.78 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 111.263 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.516 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 89.3 m -68.07 -43.13 79.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.535 -1.353 . . . . 0.0 109.965 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -59.38 -24.08 63.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.825 -1.172 . . . . 0.0 108.449 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 10.3 t80 -83.15 -63.03 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.05 0.929 . . . . 0.0 111.004 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 t -56.92 -47.0 81.62 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.781 -0.574 . . . . 0.0 110.041 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' HA ' HG23 ' A' ' 42' ' ' VAL . 25.7 m-20 -42.43 -29.45 0.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.17 . . . . 0.0 108.307 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -73.86 -49.8 23.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 48' ' ' LEU . 92.8 t -53.53 -54.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.573 0.702 . . . . 0.0 109.732 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.536 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 27.6 m -60.17 -30.06 45.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.289 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -85.78 -13.35 48.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 108.729 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.4 p -106.19 -2.75 22.14 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.473 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.565 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER 74.66 13.28 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 109.323 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 88.95 7.46 70.58 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.887 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.565 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 70.8 p -82.71 0.19 44.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.637 -1.507 . . . . 0.0 108.609 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.62 ' HG ' ' N ' ' A' ' 49' ' ' THR . 7.5 tp -80.15 -75.48 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.491 0.662 . . . . 0.0 110.117 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.62 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 p 62.56 147.0 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.06 171.69 7.21 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.858 -177.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.652 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.07 -29.43 8.97 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.57 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -167.92 159.84 11.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.6 -0.688 . . . . 0.0 110.082 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.49 -166.32 0.52 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.2 -167.1 18.25 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.512 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.34 -179.04 4.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 109.838 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 7' ' ' ASP . 9.2 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 6' ' ' VAL . 25.4 t70 -105.1 108.95 20.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 17.8 m -128.95 52.86 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 t -90.29 -13.16 35.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -103.54 17.08 24.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 109.31 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 38' ' ' CYS . 73.9 m-85 -96.72 163.68 19.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.8 Cg_endo -83.09 135.63 26.65 Favored 'Cis proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.308 -1.538 . . . . 0.0 111.258 1.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -100.79 138.38 20.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.82 14.04 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.401 2.068 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.21 19.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 94.2 m -103.67 146.46 28.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.261 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.461 HG23 ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -55.73 -166.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.459 -0.775 . . . . 0.0 108.91 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 pp -126.55 -37.34 2.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.49 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 5.1 pm0 -50.57 137.57 19.27 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.572 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.5 t80 -79.5 121.37 25.12 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.32 1.057 . . . . 0.0 110.382 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmm180 -148.61 72.38 10.67 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 28.3 Cg_endo -65.51 114.43 2.89 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.046 1.831 . . . . 0.0 111.743 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -109.42 138.56 45.6 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.675 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -89.15 165.13 14.68 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -127.42 168.55 19.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 35.4 t -66.81 -25.98 66.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -1.047 . . . . 0.0 108.856 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.8 p30 -65.52 -10.88 38.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 t-20 85.38 29.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 110.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.47 ' CG ' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -120.85 -179.37 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.968 -1.082 . . . . 0.0 109.261 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 31' ' ' TYR . 53.1 m -118.95 166.13 13.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.656 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 72.0 m-85 -138.49 110.9 7.46 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.48 -55.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -177.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.5 p30 -146.87 -172.54 4.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.771 -1.429 . . . . 0.0 110.787 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -53.26 -36.29 60.95 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.849 -0.532 . . . . 0.0 110.355 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.2 t -62.33 -69.47 0.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.63 -1.294 . . . . 0.0 108.937 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.567 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.6 m-80 -43.22 -38.7 2.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 110.765 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 72.9 t80 -70.59 -40.14 73.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.688 1.233 . . . . 0.0 110.483 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 91.7 m -68.53 -34.94 76.74 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.519 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 9.8 m-80 -69.08 -23.77 64.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.89 -1.131 . . . . 0.0 108.226 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.753 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.64 -24.9 33.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 48' ' ' LEU . 72.9 t -80.99 -27.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 30.9 m -89.52 -21.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.746 . . . . 0.0 109.127 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.753 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -91.04 -31.15 16.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 86.4 p -86.93 -0.09 55.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.585 -0.697 . . . . 0.0 109.806 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 77.97 12.74 1.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.247 -0.908 . . . . 0.0 108.813 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 84.1 16.57 66.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.459 HG21 ' HB2' ' A' ' 44' ' ' SER . 7.4 t -98.02 10.1 41.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -1.123 . . . . 0.0 108.95 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.68 -53.3 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.6 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 81.1 p 53.65 124.97 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.644 1.211 . . . . 0.0 111.703 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 51' ' ' SER . 2.2 tp -71.6 152.75 42.64 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.74 -25.27 11.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.2 p80 -173.3 157.92 3.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -79.51 164.31 24.01 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.05 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 92.78 -167.27 29.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.81 129.39 36.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.083 -1.245 . . . . 0.0 109.645 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.508 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 7' ' ' ASP . 25.1 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.423 ' N ' HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -94.35 159.24 15.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.42 36.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 0.0 109.246 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -85.57 -28.65 24.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.788 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.64 46.09 1.03 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.469 -0.769 . . . . 0.0 109.048 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 59.9 m-85 -139.77 161.25 57.4 Favored Pre-proline 0 C--N 1.306 -1.293 0 O-C-N 121.316 -0.865 . . . . 0.0 109.141 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -83.51 148.95 61.97 Favored 'Cis proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.882 -1.716 . . . . 0.0 110.793 2.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -102.94 137.78 19.37 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.94 14.66 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.658 2.239 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.26 158.04 2.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 30.3 t -146.54 163.04 37.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.694 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -56.91 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -122.81 -7.72 8.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.505 -1.372 . . . . 0.0 110.789 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.526 ' N ' HD11 ' A' ' 18' ' ' LEU . 12.1 pm0 -55.93 -173.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.6 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 3.4 t80 -128.93 121.32 27.83 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.622 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.9 mmt180 -151.22 66.17 7.02 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 54' ' ' GLY . 23.4 Cg_endo -63.28 137.17 59.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.494 2.796 . . . . 0.0 112.551 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 2.1 mp -127.49 143.49 51.18 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.202 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.63 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.0 t -101.53 162.3 13.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.236 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.536 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -106.95 178.55 22.17 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.1 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 27.4 t -70.65 -18.79 62.85 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -78.9 -10.98 59.98 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 85.06 33.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.315 0.579 . . . . 0.0 109.662 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -111.94 139.82 47.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.248 -0.908 . . . . 0.0 109.019 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.505 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 18.5 m -90.04 161.97 15.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.147 . . . . 0.0 110.018 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 63.9 m-85 -138.39 137.92 37.74 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.55 -50.23 3.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -164.37 -166.21 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.152 -1.204 . . . . 0.0 111.123 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.567 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -47.72 -48.48 29.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.717 -0.614 . . . . 0.0 112.374 -177.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.0 m -65.86 -52.64 48.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.473 -1.392 . . . . 0.0 110.457 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.1 m-80 -60.06 -17.45 39.54 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.847 -1.158 . . . . 0.0 109.347 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.6 t80 -82.59 -50.31 8.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.588 1.185 . . . . 0.0 109.762 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.619 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -66.51 -24.02 66.33 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.786 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -64.43 -26.22 68.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.28 -26.8 26.4 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 48' ' ' LEU . 93.1 t -80.97 -23.72 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 27.7 m -90.82 -25.65 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.6 pp20? -90.42 -28.23 18.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 48.2 t -89.11 3.54 51.48 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.5 t30 77.11 9.77 2.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 108.958 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 82.89 3.21 90.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.5 HG21 ' OG ' ' A' ' 44' ' ' SER . 14.1 t -79.85 2.68 22.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.041 -1.27 . . . . 0.0 108.974 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.41 -50.02 11.45 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.805 0.812 . . . . 0.0 109.088 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.6 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 25.2 p 54.86 122.13 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.293 1.044 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.615 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.9 tp -60.61 152.99 24.84 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.15 -20.26 11.01 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.63 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 171.23 158.46 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.462 ' CD2' HD22 ' A' ' 23' ' ' LEU . 5.1 m-85 -71.18 -169.23 0.36 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 109.002 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.11 -168.76 5.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.585 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.41 146.41 23.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.429 -1.042 . . . . 0.0 109.452 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.599 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.397 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -67.55 116.75 8.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 m -99.15 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 m -90.48 -8.67 49.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.49 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 3.9 pm0 -112.97 -7.55 13.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.973 -1.079 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.88 158.9 46.87 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 108.938 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.0 Cg_endo -79.89 134.99 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.841 -1.733 . . . . 0.0 110.631 3.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.63 138.98 19.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.638 -0.664 . . . . 0.0 110.215 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.76 15.05 2.02 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.512 2.141 . . . . 0.0 110.237 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.42 133.42 20.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.806 . . . . 0.0 109.243 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.3 m -112.23 150.31 31.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 p -56.75 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 108.942 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -123.6 -28.3 3.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.998 -1.064 . . . . 0.0 109.725 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.463 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 9.5 pm0 -58.57 -166.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.5 t80 -132.83 124.75 28.57 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.258 1.028 . . . . 0.0 110.62 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -154.78 75.83 5.5 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.2 Cg_endo -64.59 123.67 12.08 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.701 2.267 . . . . 0.0 112.557 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.589 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.39 126.78 53.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 49.5 t -79.4 161.78 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.301 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.91 166.54 23.6 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.545 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.475 ' N ' HD13 ' A' ' 48' ' ' LEU . 13.2 t -53.15 -48.46 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.945 . . . . 0.0 110.781 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -41.63 -26.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.202 -179.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 p-10 97.93 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.273 0.559 . . . . 0.0 109.899 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -125.81 173.64 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 109.583 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -108.9 150.02 28.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 74.0 m-85 -117.36 124.75 49.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.94 -52.32 1.19 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.5 p-10 -158.51 -168.34 2.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.746 -1.444 . . . . 0.0 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 7.8 pttt -46.86 -49.95 19.37 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.995 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 43.9 t -56.1 -64.88 0.72 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.696 -1.252 . . . . 0.0 110.07 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.4 m-80 -53.64 -18.9 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 6.8 t80 -79.41 -65.06 1.05 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.677 -1.265 . . . . 0.0 110.216 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.566 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.6 t -56.48 -48.71 76.55 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.033 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.0 m-20 -43.91 -28.0 0.41 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.614 -1.304 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 31' ' ' TYR . . . -74.43 -48.03 30.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.591 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 79.7 t -57.08 -54.64 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.646 0.736 . . . . 0.0 109.649 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 20.3 m -58.25 -30.28 39.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -91.27 -10.59 40.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.154 -0.966 . . . . 0.0 109.36 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 13.7 t -102.96 12.68 35.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 110.398 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.2 m-80 62.44 23.89 14.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.059 -1.026 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 62.88 25.11 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.5 p -95.13 -4.16 46.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.395 -1.062 . . . . 0.0 108.209 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.591 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -88.94 -76.51 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.081 0.943 . . . . 0.0 109.306 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.7 p 80.94 152.0 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.871 0.843 . . . . 0.0 108.955 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 68.2 tp -68.92 158.21 35.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p -111.96 -42.38 3.79 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.708 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.01 169.94 1.9 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -82.12 176.37 9.57 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.001 -1.062 . . . . 0.0 108.655 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -168.13 54.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 153.14 20.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 109.145 178.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 26.9 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 61.2 t0 -125.78 130.27 51.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.964 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 15.6 m -129.71 69.51 1.42 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -91.21 -18.79 23.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.65 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.3 mp0 -106.22 27.5 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.134 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 97.7 m-85 -109.3 158.26 34.98 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.087 -1.008 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 33.5 Cg_endo -80.86 143.97 64.25 Favored 'Cis proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.823 2.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 7.1 mttt -103.5 136.03 19.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.858 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.6 14.71 1.77 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.757 2.305 . . . . 0.0 110.58 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.12 136.84 11.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.6 m -128.55 136.89 51.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 109.841 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.9 p -55.99 -165.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.3 pp -131.87 1.36 3.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.844 -1.16 . . . . 0.0 110.326 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 4.9 mm-40 -57.4 -165.99 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.1 t80 -139.73 115.08 9.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.448 -1.301 . . . . 0.0 111.38 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.77 74.3 8.64 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 27.9 Cg_endo -65.35 121.9 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.894 -176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.623 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.34 137.53 50.35 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.67 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER -86.67 167.58 14.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.376 -0.827 . . . . 0.0 109.11 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.38 159.73 23.47 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.497 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -68.62 -19.68 64.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -1.164 . . . . 0.0 108.915 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -66.74 -9.16 33.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.4 t-20 87.48 22.87 0.05 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.85 -0.531 . . . . 0.0 110.669 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.14 177.44 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.82 -1.175 . . . . 0.0 109.627 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 29.9 m -118.24 166.5 12.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.233 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 73.7 m-85 -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.94 -51.28 7.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.955 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.3 p-10 -149.4 -165.29 2.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.763 -1.433 . . . . 0.0 110.828 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.623 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.22 -24.61 67.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.642 -0.661 . . . . 0.0 111.537 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.6 t -76.27 -39.55 54.05 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.574 -1.328 . . . . 0.0 108.898 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.3 m-80 -72.1 -34.48 68.67 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.506 -0.746 . . . . 0.0 109.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 24' ' ' CYS . 63.2 t80 -75.65 -44.18 43.92 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.393 1.092 . . . . 0.0 109.896 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.587 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 20.9 m -66.51 -38.45 87.25 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.568 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 6.9 m-80 -63.74 -21.37 66.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -85.15 -27.91 25.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' HA2' ' A' ' 46' ' ' GLY . 86.4 t -76.45 -26.89 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.553 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 21.0 m -91.07 -26.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.372 0.606 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -90.7 -15.36 30.46 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 20.0 t -101.29 12.6 37.18 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.157 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER 68.64 7.72 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.066 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 87.3 13.16 66.32 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.554 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p -79.6 -11.11 59.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.289 . . . . 0.0 108.746 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.5 OUTLIER -78.38 159.34 28.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 48' ' ' LEU . 81.2 p -157.64 126.46 5.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.095 0.95 . . . . 0.0 110.061 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -63.43 145.51 55.47 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.503 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.84 -25.04 11.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.67 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -171.42 160.73 6.14 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -79.35 174.06 11.95 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.197 -0.939 . . . . 0.0 108.768 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.31 -166.64 42.31 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.96 131.06 37.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.047 -1.266 . . . . 0.0 109.048 178.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.579 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.532 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.251 0.548 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -64.27 119.07 9.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 108.962 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 6' ' ' VAL . 15.9 m -132.38 40.17 3.32 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.093 -1.004 . . . . 0.0 110.044 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.05 4.95 48.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -126.81 2.72 6.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.069 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 46.1 m-85 -84.71 162.07 51.46 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.13 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -71.68 148.04 89.51 Favored 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.891 2.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -91.5 144.44 29.62 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.92 13.57 1.93 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.53 2.153 . . . . 0.0 110.822 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.35 117.83 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.7 m -102.77 135.14 44.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.469 ' OG1' ' HD3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -55.88 142.92 33.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 19' ' ' GLU . 5.2 mt -75.88 -36.58 59.48 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.97 . . . . 0.0 109.51 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -42.84 122.28 2.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.356 -0.84 . . . . 0.0 108.782 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 11.5 t80 -80.82 104.27 11.22 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.672 1.225 . . . . 0.0 110.543 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 mmt180 -137.55 80.91 31.17 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -66.97 128.83 19.45 Favored 'Trans proline' 0 C--O 1.202 -1.323 0 C-N-CA 123.994 3.129 . . . . 0.0 114.771 -176.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.619 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 2.0 mp -107.83 158.34 17.4 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -116.48 137.3 52.27 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.285 -1.509 . . . . 0.0 110.394 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.577 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -102.07 157.71 18.45 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.221 -0.925 . . . . 0.0 112.969 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.414 ' N ' HD13 ' A' ' 48' ' ' LEU . 41.1 t -55.4 -18.64 7.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.192 -0.593 . . . . 0.0 110.382 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -84.57 20.29 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.998 -1.064 . . . . 0.0 109.398 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 27.4 t30 56.83 15.34 2.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -99.69 127.54 45.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -89.03 126.55 35.47 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.55 -0.719 . . . . 0.0 109.794 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 126.45 43.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -24.8 -42.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -178.73 -154.85 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 109.745 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.39 -60.13 3.59 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 110.658 -177.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 49.2 t -52.44 -65.75 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.606 -1.309 . . . . 0.0 110.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.501 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 10.2 m-80 -49.28 -21.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.8 t80 -78.8 -71.31 0.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.012 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.601 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -39.72 -40.62 0.96 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.413 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.92 -44.91 94.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.474 -1.391 . . . . 0.0 108.016 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.684 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -54.17 -21.64 9.33 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 48' ' ' LEU . 56.7 t -85.64 -63.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -59.0 -9.21 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 110.279 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.684 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.02 -32.02 16.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.551 -1.343 . . . . 0.0 107.78 178.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -92.22 7.89 40.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 80.93 3.71 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.331 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.23 79.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -79.79 2.25 23.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -1.188 . . . . 0.0 108.758 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -89.12 -78.91 0.34 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.364 -0.835 . . . . 0.0 109.339 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.567 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 83.57 148.13 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.047 0.927 . . . . 0.0 109.276 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 51' ' ' SER . 13.1 tp -67.29 166.47 14.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.584 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -122.6 -44.62 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -160.28 159.37 31.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -77.21 143.43 39.0 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.714 0.768 . . . . 0.0 110.057 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 101.91 -167.42 18.45 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.48 137.63 32.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.438 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.516 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.441 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.43 104.73 5.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.999 . . . . 0.0 109.601 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 59.8 m -103.59 52.72 0.77 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -21.53 38.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.0 109.859 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.75 -7.53 59.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.576 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 74.7 m-85 -79.87 163.86 56.01 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.8 Cg_endo -82.38 143.0 51.26 Favored 'Cis proline' 0 C--N 1.306 -1.664 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.088 2.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.2 mttt -97.35 141.11 22.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.033 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.42 15.13 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.755 2.303 . . . . 0.0 110.477 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.27 116.29 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 109.028 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.6 m -82.24 145.59 29.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -52.35 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -114.91 -19.29 11.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.822 -1.174 . . . . 0.0 110.262 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 18' ' ' LEU . 16.5 pm0 -57.9 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.788 -1.195 . . . . 0.0 107.827 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.2 t80 -139.15 126.85 21.95 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.893 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.2 mtm180 -161.52 81.03 1.99 Allowed Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -63.83 107.24 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.192 1.928 . . . . 0.0 111.739 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -100.6 126.09 47.05 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.198 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.494 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 43.3 t -77.97 168.1 20.43 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -145.46 161.19 28.19 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.102 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -59.45 -35.18 73.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.728 -0.866 . . . . 0.0 109.441 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.635 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -45.18 -27.43 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 109.036 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 101.11 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.063 0.458 . . . . 0.0 109.961 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 175.24 8.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.105 -0.997 . . . . 0.0 109.616 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.507 HG21 ' N ' ' A' ' 31' ' ' TYR . 38.0 m -106.18 162.08 13.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.7 m-85 -133.26 102.66 5.65 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.188 -0.945 . . . . 0.0 108.618 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.14 -60.29 0.02 OUTLIER Glycine 0 N--CA 1.499 2.856 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.1 p30 -143.42 -170.37 3.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.968 -1.313 . . . . 0.0 110.627 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.19 -48.32 45.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.853 -0.529 . . . . 0.0 110.816 -178.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 18.2 t -53.32 -71.59 0.07 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.741 -1.225 . . . . 0.0 109.432 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.2 m-80 -40.28 -39.77 1.01 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.839 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 35.9 t80 -61.73 -51.51 68.05 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.862 1.315 . . . . 0.0 109.833 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 90.1 m -57.77 -50.89 71.72 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.575 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -44.37 -29.29 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.833 -1.167 . . . . 0.0 108.66 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.589 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.42 -49.41 49.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.529 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 38.4 t -57.62 -56.84 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.667 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 39' ' ' ASN . 13.2 m -58.7 -23.07 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 0.0 110.642 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.1 tt0 -91.43 -17.48 25.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.391 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 11.9 t -105.69 22.95 14.67 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.342 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 44' ' ' SER . 21.6 m120 64.74 9.61 5.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 109.524 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 80.92 17.93 71.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.1 p -89.97 -9.43 48.78 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.373 -1.075 . . . . 0.0 108.239 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -81.47 149.76 28.6 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.561 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 5.1 p -122.41 151.52 41.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.6 tp -65.52 124.28 21.89 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.3 t -78.55 -24.75 45.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.62 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CB ' ' O ' ' A' ' 51' ' ' SER . 15.9 p80 151.02 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.299 0.571 . . . . 0.0 110.056 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 154.91 22.54 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 85.54 178.5 50.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -79.85 161.37 25.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.892 -1.358 . . . . 0.0 107.947 178.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 87.1 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.437 0.637 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 50.2 t0 63.77 147.42 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 40.8 t -160.49 20.89 0.15 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.027 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -90.8 -4.01 56.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -108.56 34.82 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.667 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.1 m-85 -133.23 159.67 71.7 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -73.42 159.6 97.14 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.859 -1.725 . . . . 0.0 111.994 2.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttt -117.72 144.78 35.05 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.26 14.48 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.44 2.093 . . . . 0.0 111.411 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 166.21 134.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.2 t -112.03 157.62 20.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.516 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.486 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 10.6 p -59.3 -162.53 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -120.53 -15.92 8.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.524 -1.36 . . . . 0.0 109.976 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.9 pt-20 -46.62 130.55 11.37 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.1 t80 -89.28 130.02 35.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.391 1.091 . . . . 0.0 111.107 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mtt180 -160.63 74.26 2.79 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.0 Cg_endo -64.59 129.7 24.42 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.145 2.563 . . . . 0.0 112.794 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.646 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.93 135.72 53.94 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.515 -1.274 . . . . 0.0 108.212 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 8.7 t -77.37 133.44 38.72 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -79.94 -162.68 26.03 Favored Glycine 0 C--N 1.292 -1.867 0 C-N-CA 117.67 -2.205 . . . . 0.0 109.218 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -85.85 -33.87 21.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -1.2 . . . . 0.0 108.331 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -57.3 -17.29 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t30 96.31 22.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 120.982 0.42 . . . . 0.0 110.707 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -107.49 -158.5 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 0.0 109.163 178.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 20.9 m -129.74 158.9 38.12 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.484 -0.76 . . . . 0.0 110.031 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -132.74 135.02 45.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.95 -50.3 1.5 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -163.73 -157.42 0.4 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.945 -1.327 . . . . 0.0 110.369 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.646 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 112.146 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -64.9 -57.01 9.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.585 -1.322 . . . . 0.0 110.43 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.06 -32.21 71.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.025 -1.047 . . . . 0.0 110.129 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 7.0 t80 -62.38 -60.06 4.1 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.793 -1.192 . . . . 0.0 109.511 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.8 t -56.79 -49.68 74.61 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.033 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 7.1 m-20 -40.97 -30.82 0.14 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.807 -1.183 . . . . 0.0 108.084 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.38 -49.45 18.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.1 t -60.36 -63.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 7.1 p -55.89 -26.36 20.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 111.785 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.43 -16.17 27.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.08 -1.637 . . . . 0.0 108.737 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 10.7 t -98.85 21.94 10.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 110.097 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' SER . 78.4 m-20 65.22 8.27 4.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.862 . . . . 0.0 109.927 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.32 85.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.2 p -79.3 -4.24 49.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.025 -1.28 . . . . 0.0 108.194 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.9 tp -79.94 -86.03 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.642 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p 80.36 168.69 0.16 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -119.82 178.89 4.42 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.639 -1.288 . . . . 0.0 110.565 -178.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.614 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.07 -38.36 3.89 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.3 p80 -163.93 151.67 12.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.752 0.787 . . . . 0.0 110.139 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.586 ' CD2' HD22 ' A' ' 23' ' ' LEU . 15.6 m-85 -62.41 -174.97 0.07 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.69 -0.631 . . . . 0.0 109.413 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 66.15 -169.27 32.15 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 1.2 mtmm -92.51 134.99 34.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.691 -0.888 . . . . 0.0 109.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.539 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.954 -1.091 . . . . 0.0 109.402 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.9 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.195 0.522 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 11.5 p-10 -80.62 -176.37 5.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 7.1 m -157.81 49.77 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.792 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -90.96 -4.27 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.965 . . . . 0.0 110.07 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 4.6 mp0 -134.11 49.4 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.004 -1.06 . . . . 0.0 110.422 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 99.1 m-85 -141.66 153.48 65.05 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 120.922 -1.111 . . . . 0.0 109.241 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.28 136.44 44.95 Favored 'Cis proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.396 -1.918 . . . . 0.0 111.439 2.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.0 tttt -85.4 145.0 41.42 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.662 -0.649 . . . . 0.0 109.62 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.09 13.73 1.92 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.801 2.334 . . . . 0.0 110.742 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.65 128.07 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.387 -0.821 . . . . 0.0 109.111 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' THR . 71.7 m -91.64 139.08 31.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.85 . . . . 0.0 110.054 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -49.14 174.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.55 -16.83 12.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.96 -1.088 . . . . 0.0 109.928 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -56.53 -168.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.551 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.8 t80 -140.22 123.15 16.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.422 1.106 . . . . 0.0 110.576 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.15 80.92 2.37 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -65.59 125.23 14.02 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.694 2.262 . . . . 0.0 112.466 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.38 128.4 55.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.8 t -78.7 135.34 37.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.571 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -82.6 -165.47 36.93 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 118.511 -1.804 . . . . 0.0 108.613 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 45.8 t -87.45 -29.6 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.664 -1.492 . . . . 0.0 108.728 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -63.06 -14.02 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 109.082 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.1 t-20 96.28 19.26 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 120.929 0.395 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.655 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.97 -165.54 1.25 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.879 -1.138 . . . . 0.0 108.54 178.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.508 HG21 ' N ' ' A' ' 31' ' ' TYR . 7.7 m -135.4 157.43 46.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.333 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 70.6 m-85 -129.63 121.69 27.55 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -29.07 -51.94 0.13 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 44.7 p30 -158.28 -162.96 1.2 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.111 -1.229 . . . . 0.0 109.488 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -57.71 -48.12 80.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.43 -0.794 . . . . 0.0 111.051 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.518 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 50.7 t -52.8 -52.71 55.81 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 109.962 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.6 m-80 -63.26 -31.5 72.66 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.488 -0.758 . . . . 0.0 110.942 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 19.2 t80 -74.02 -61.65 1.78 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.689 -1.257 . . . . 0.0 110.766 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 30.5 t -57.56 -49.4 76.51 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.927 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 13.3 m-20 -42.34 -30.89 0.35 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.67 -1.269 . . . . 0.0 108.18 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.6 ' CB ' ' CD2' ' A' ' 48' ' ' LEU . . . -80.12 -43.4 21.76 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 38' ' ' CYS . 87.5 t -66.78 -65.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.426 -0.796 . . . . 0.0 108.928 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 43' ' ' GLU . 9.8 p -50.67 -30.57 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 111.423 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.519 ' N ' HG11 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -92.72 -16.96 24.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.056 -1.652 . . . . 0.0 109.137 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 65.8 p -101.1 19.8 16.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 110.391 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 44' ' ' SER . 1.8 p-10 53.85 29.66 10.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.81 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.21 28.92 73.13 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.258 -0.901 . . . . 0.0 110.861 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 44' ' ' SER . 10.1 t -95.72 -10.62 28.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.55 -53.7 6.33 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER 50.99 172.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.302 0.572 . . . . 0.0 109.586 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.589 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -132.49 163.49 28.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 109.099 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.586 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.49 -30.97 8.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -168.93 163.52 11.52 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.429 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.2 -166.48 0.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 57.67 -173.51 2.56 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HB3' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.13 138.47 31.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.285 -1.126 . . . . 0.0 109.142 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.554 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.07 122.97 42.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.586 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 12.1 m -125.72 43.04 3.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.003 -1.061 . . . . 0.0 110.652 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 10.47 25.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -131.73 6.1 4.33 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.939 -1.101 . . . . 0.0 110.868 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -84.19 156.97 63.05 Favored Pre-proline 0 C--N 1.307 -1.282 0 O-C-N 120.827 -1.17 . . . . 0.0 109.019 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.7 144.98 82.5 Favored 'Cis proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.011 2.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -92.45 147.68 34.88 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -77.4 13.6 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 111.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.7 112.45 0.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.024 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.8 m -87.86 144.55 26.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.44 ' OG1' ' HG3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -45.37 157.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.83 -33.57 7.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.853 -1.155 . . . . 0.0 110.107 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -62.09 -176.51 0.1 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.579 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -115.83 129.32 56.38 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.411 1.101 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 16.2 mtp-105 -159.86 70.73 3.17 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 54' ' ' GLY . 19.4 Cg_endo -60.27 121.79 10.32 Favored 'Trans proline' 0 C--O 1.192 -1.795 0 C-N-CA 123.295 2.664 . . . . 0.0 112.831 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.648 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 1.7 mp -103.97 158.73 16.22 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.618 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -116.7 132.05 56.79 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 119.795 -1.816 . . . . 0.0 111.949 -178.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.598 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -87.46 160.87 32.04 Favored Glycine 0 N--CA 1.503 3.101 0 CA-C-O 121.758 0.643 . . . . 0.0 111.909 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.501 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -64.44 -34.41 78.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -61.49 -11.84 12.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.397 -0.814 . . . . 0.0 109.309 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.3 m-20 88.27 18.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.815 -0.553 . . . . 0.0 110.942 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 1.3 pttm -107.78 122.28 46.44 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 55' ' ' LYS . 51.1 m -80.7 132.97 35.62 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 140.98 31.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.306 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.549 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -49.38 -41.51 32.37 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.216 -0.927 . . . . 0.0 112.069 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.9 p30 -164.88 -158.39 0.4 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.448 -1.619 . . . . 0.0 110.363 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -57.75 -45.6 85.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.404 -177.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.519 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 36.4 t -68.43 -57.27 6.11 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.703 -1.248 . . . . 0.0 108.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -49.97 -22.23 1.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.3 t80 -83.04 -63.67 1.32 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.266 1.032 . . . . 0.0 110.918 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 13.5 m -47.87 -51.4 23.17 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.257 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 9.8 m-20 -48.3 -36.24 13.82 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 37' ' ' PHE . . . -60.12 -46.27 90.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 48' ' ' LEU . 58.0 t -64.93 -65.17 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.56 0.695 . . . . 0.0 110.246 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' TYR . 7.4 p -58.97 -19.58 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.842 . . . . 0.0 112.011 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -93.42 -16.27 24.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.093 -1.629 . . . . 0.0 109.22 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 4.4 p -98.66 18.39 16.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t30 74.54 4.61 4.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.135 -0.978 . . . . 0.0 108.415 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.81 20.08 69.03 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.0 t -87.53 -1.77 58.16 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -1.03 . . . . 0.0 108.642 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.52 HD22 ' CE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -89.45 161.76 16.1 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 75.8 p -147.9 130.21 15.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.1 tp -68.83 141.16 55.2 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.04 -17.91 12.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.802 -1.186 . . . . 0.0 108.065 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.618 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 173.88 154.22 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.54 0.686 . . . . 0.0 109.701 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -70.31 176.77 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.049 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.14 -172.09 44.85 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.68 156.23 17.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -1.211 . . . . 0.0 108.811 178.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 5.6 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.029 -1.044 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.497 HG13 ' CE2' ' A' ' 37' ' ' PHE . 2.6 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -114.87 132.64 56.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.488 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 79.9 m -130.62 53.58 1.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.3 -16.31 29.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.866 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.51 37.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.159 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.9 m-85 -125.91 161.09 53.37 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -86.29 153.88 50.35 Favored 'Cis proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.281 -1.55 . . . . 0.0 110.999 1.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.0 140.67 25.85 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.85 14.4 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.58 2.186 . . . . 0.0 111.141 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 167.95 135.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 108.871 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -133.2 165.44 24.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.933 -1.104 . . . . 0.0 110.737 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -54.99 -165.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 0.0 109.39 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -122.86 3.68 9.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.008 -1.057 . . . . 0.0 110.273 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.7 pt-20 -47.63 118.44 2.26 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -79.37 126.91 31.42 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.757 1.265 . . . . 0.0 111.759 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.2 ptm180 -161.45 75.12 2.45 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.7 Cg_endo -64.31 118.99 5.91 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.662 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -113.05 128.84 56.61 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.507 179.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -88.87 112.09 22.84 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.604 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.67 -169.73 0.05 OUTLIER Glycine 0 N--CA 1.484 1.855 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.7 t -75.5 -34.63 60.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -1.173 . . . . 0.0 109.173 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.9 p30 -68.51 -6.64 26.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.882 . . . . 0.0 109.261 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.1 t-20 83.92 30.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.932 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.18 137.77 37.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.222 -0.924 . . . . 0.0 108.536 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 91.1 m -85.12 135.22 34.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.028 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 6.9 m-85 -113.83 142.68 45.79 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -55.98 -39.13 78.08 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.151 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 23.1 p-10 -160.05 -164.25 1.26 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.689 -1.477 . . . . 0.0 109.632 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -29.0 69.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.598 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 62.5 m -77.18 -57.1 4.03 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.041 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 m120 -48.61 -36.85 16.63 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.782 -1.199 . . . . 0.0 108.528 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.0 t80 -68.38 -56.52 8.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.359 1.076 . . . . 0.0 110.247 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CE2' ' A' ' 11' ' ' TYR . 64.0 m -52.65 -56.6 14.29 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.317 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' HA ' HG23 ' A' ' 42' ' ' VAL . 14.1 m-20 -38.7 -29.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.31 -51.03 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . 89.8 t -52.24 -53.79 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.646 0.736 . . . . 0.0 109.474 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 32.8 m -59.96 -34.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -91.83 -2.33 56.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 28.9 t -106.28 -8.26 17.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.8 t-20 80.32 30.41 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.802 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.62 31.93 57.99 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.47 HG21 ' OG ' ' A' ' 44' ' ' SER . 10.5 t -114.13 8.31 16.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.616 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.0 tp -89.76 -71.03 0.63 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.538 0.685 . . . . 0.0 109.292 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.616 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.9 p 60.5 143.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -102.55 171.83 7.21 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.213 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.613 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.23 -30.54 8.31 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.576 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -162.53 158.04 23.01 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.391 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 6.4 m-85 -75.81 -164.45 0.36 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 60.43 -169.49 8.12 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -92.45 168.64 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.494 -1.003 . . . . 0.0 108.773 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.8 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.591 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.0 152.19 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 m -135.01 57.04 1.82 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.273 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -89.1 -15.59 33.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -95.94 4.13 52.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 109.305 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 96.0 m-85 -96.5 159.52 31.66 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.401 -0.812 . . . . 0.0 109.079 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 33.0 Cg_endo -81.68 140.29 45.92 Favored 'Cis proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.531 2.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -99.78 139.05 20.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.61 14.2 2.08 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.55 2.167 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.92 126.25 7.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.5 m -116.57 139.63 50.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 16' ' ' CYS . 7.1 p -55.4 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 108.729 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -121.84 -25.74 4.96 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.497 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mt-10 -45.37 123.62 4.24 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.537 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.8 t80 -83.97 105.42 14.84 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.694 1.235 . . . . 0.0 110.693 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.668 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.6 mtp180 -136.89 75.33 49.02 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 18.4 Cg_endo -61.15 119.35 6.46 Favored 'Trans proline' 0 C--O 1.193 -1.747 0 C-N-CA 123.523 2.815 . . . . 0.0 114.195 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.647 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 2.7 mp -101.77 154.47 18.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.79 140.35 48.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 119.897 -1.752 . . . . 0.0 109.637 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.624 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.44 161.88 17.96 Favored Glycine 0 N--CA 1.497 2.743 0 CA-C-O 122.4 1.0 . . . . 0.0 113.747 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -37.44 86.15 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.802 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p-10 -58.69 -13.82 6.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.962 . . . . 0.0 109.267 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.8 m-20 91.61 12.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.313 0.578 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 30.5 ttpt -99.28 128.8 45.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 55' ' ' LYS . 96.7 m -88.29 129.54 35.35 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.849 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.07 132.02 43.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -45.0 -39.74 6.61 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 121.476 -0.765 . . . . 0.0 112.045 -176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -165.57 -157.26 0.31 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.528 -1.572 . . . . 0.0 110.279 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -57.83 -51.2 70.55 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.475 -178.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.3 t -61.3 -60.01 4.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.68 -1.263 . . . . 0.0 109.214 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -48.9 -23.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 108.858 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.1 t80 -80.78 -65.62 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.125 0.964 . . . . 0.0 110.618 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.638 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 m -50.26 -22.8 1.91 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' O ' HG21 ' A' ' 42' ' ' VAL . 11.1 m-80 -76.83 -40.28 48.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -58.32 -23.38 56.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.595 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -84.04 -53.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -65.71 -12.36 13.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.684 -0.635 . . . . 0.0 109.649 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -93.55 -18.91 21.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 2.5 t -108.41 22.99 15.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.895 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 79.26 -3.82 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 109.057 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 86.54 11.06 72.26 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.3 t -85.42 -5.94 59.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -1.187 . . . . 0.0 108.838 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.595 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.93 150.91 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.58 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.8 p -123.68 142.99 50.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.11 0.957 . . . . 0.0 109.465 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.6 tp -57.73 121.1 9.63 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.0 t -76.76 -24.26 52.94 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.238 -0.913 . . . . 0.0 109.366 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p80 155.72 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.477 0.656 . . . . 0.0 109.362 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 19.3 m-85 -93.83 156.36 16.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.408 -0.808 . . . . 0.0 109.625 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 86.12 -167.94 40.28 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.28 -176.56 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -1.071 . . . . 0.0 108.443 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 41.1 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 7' ' ' ASP . 17.9 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 6' ' ' VAL . 18.5 t0 21.57 99.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.152 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 7.8 m -121.55 64.62 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.42 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -91.27 -14.71 30.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.391 -0.818 . . . . 0.0 109.33 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.42 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 5.4 mm-40 -105.56 34.93 3.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 110.047 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 41.7 m-85 -113.73 161.44 27.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.023 -1.048 . . . . 0.0 108.929 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -73.28 175.99 43.21 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.633 -1.82 . . . . 0.0 111.377 2.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -125.78 144.01 47.0 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.582 -0.698 . . . . 0.0 109.559 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.89 14.22 1.76 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.788 2.326 . . . . 0.0 111.204 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.63 141.13 16.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.583 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -116.01 2.56 13.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.825 -1.172 . . . . 0.0 110.981 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 67.43 -17.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 178.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 72.21 -9.04 1.06 Allowed 'General case' 0 C--N 1.275 -2.635 0 O-C-N 121.697 -0.627 . . . . 0.0 111.448 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -59.45 129.07 40.19 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.594 -1.316 . . . . 0.0 107.899 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.3 123.18 33.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.527 1.155 . . . . 0.0 111.701 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -162.19 81.94 1.76 Allowed Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -64.83 117.25 4.35 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.615 2.21 . . . . 0.0 113.344 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.12 136.08 47.58 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -98.83 112.39 24.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.878 -1.139 . . . . 0.0 111.672 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.522 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -51.13 176.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.0 t -72.73 -22.66 60.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -1.176 . . . . 0.0 107.829 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.6 p30 -76.42 -5.73 48.6 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.6 m-20 82.04 30.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 110.363 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -102.74 146.44 28.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.522 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 95.8 m -98.3 143.52 28.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 0.0 110.409 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.62 ' CE2' ' CB ' ' A' ' 40' ' ' ALA . 1.9 m-85 -124.81 125.08 43.45 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.59 -46.88 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.363 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 35.9 p-10 -156.61 -168.17 2.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.445 -1.62 . . . . 0.0 111.492 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.07 -37.09 71.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.867 -0.521 . . . . 0.0 112.313 -177.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.8 p -77.41 -54.39 6.5 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.655 -1.278 . . . . 0.0 108.662 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.551 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 8.9 m-80 -50.36 -26.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.017 -1.052 . . . . 0.0 108.888 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 76.5 t80 -87.02 -35.69 18.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 123.069 1.414 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.2 m -67.34 -29.17 68.65 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.551 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -70.39 -36.09 73.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.733 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.97 -25.35 63.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 48' ' ' LEU . 54.4 t -77.64 -40.05 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.333 0.587 . . . . 0.0 110.186 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.574 HG13 ' CB ' ' A' ' 11' ' ' TYR . 1.9 p -84.7 -13.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.915 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.733 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -91.73 -33.21 15.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 9.8 t -89.98 20.31 4.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.5 m-80 64.99 10.24 6.1 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.424 -0.797 . . . . 0.0 109.911 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.99 15.69 64.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.7 p -92.26 7.25 43.54 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.9 tp -79.5 -66.58 0.85 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.568 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.6 p 50.02 118.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 122.456 1.122 . . . . 0.0 111.904 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -77.89 170.89 15.83 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.72 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.99 -22.85 9.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.55 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 2.2 p80 -164.53 144.53 7.6 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.494 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.11 164.17 13.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 85.81 -170.0 43.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 8.9 mtmm -90.76 165.67 13.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -1.105 . . . . 0.0 109.395 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 37.3 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.932 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' A' ' 37' ' ' PHE . 7.2 p . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.325 0.583 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.73 139.91 51.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.153 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.6 m -143.29 46.54 1.52 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.36 -6.38 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.128 -0.982 . . . . 0.0 109.872 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -100.86 13.55 34.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.48 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 87.5 m-85 -100.4 159.72 28.95 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -76.68 162.94 90.77 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.568 -1.846 . . . . 0.0 111.247 1.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.58 141.0 26.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.47 13.83 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 109.84 0.49 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -94.28 144.96 25.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.473 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 25.1 p -50.92 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -122.27 -16.81 7.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.058 -1.026 . . . . 0.0 109.904 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' LEU . 13.7 pm0 -55.8 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.59 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.8 t80 -134.74 130.86 36.86 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.25 80.55 2.09 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.8 Cg_endo -63.15 117.76 4.68 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.026 1.817 . . . . 0.0 111.966 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -108.44 132.53 53.69 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.699 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -80.7 120.72 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.584 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.43 -162.98 5.43 Favored Glycine 0 C--N 1.294 -1.757 0 C-N-CA 118.593 -1.765 . . . . 0.0 108.861 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.7 t -85.24 -49.83 7.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.893 -1.357 . . . . 0.0 109.963 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.8 p-10 -57.39 -14.83 5.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.3 t30 98.12 45.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.084 0.468 . . . . 0.0 110.069 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.07 114.17 20.0 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.353 1.073 . . . . 0.0 109.006 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 20.6 m -60.32 158.23 12.15 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.127 -0.983 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.6 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 1.2 m-85 -129.96 147.53 51.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -53.35 -37.68 55.86 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.555 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.6 p30 -166.59 -163.86 0.61 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.697 -1.472 . . . . 0.0 109.557 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.49 -36.67 78.87 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.665 -178.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' O ' ' C ' ' A' ' 36' ' ' ASN . 11.8 t -70.11 -64.35 0.91 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.497 -1.377 . . . . 0.0 108.391 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.6 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -40.8 -37.55 0.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.9 t80 -72.47 -59.65 2.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.511 1.148 . . . . 0.0 110.349 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.607 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 20.6 m -53.17 -58.54 6.7 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.093 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' CYS . 15.8 m-20 -38.98 -30.43 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.283 -0.886 . . . . 0.0 109.056 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' CB ' HD21 ' A' ' 48' ' ' LEU . . . -74.55 -50.71 17.01 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.39 -59.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.665 -0.647 . . . . 0.0 110.202 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.592 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 11.3 p -61.49 -26.0 38.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.209 -0.932 . . . . 0.0 111.353 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.91 -8.92 44.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.517 -1.364 . . . . 0.0 109.398 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.5 p -109.13 18.19 20.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 110.307 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.4 m-20 63.46 15.26 8.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 0.0 109.717 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 19.73 76.6 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 44' ' ' SER . 24.2 p -88.99 -2.86 58.79 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.307 -1.113 . . . . 0.0 108.061 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.64 ' HG ' ' N ' ' A' ' 49' ' ' THR . 8.3 tp -85.28 -80.31 0.22 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.64 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER 68.41 171.55 0.28 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.11 167.66 14.48 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.376 -0.827 . . . . 0.0 109.697 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.9 -35.09 7.03 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -162.18 165.24 27.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.611 0.719 . . . . 0.0 109.129 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -80.07 175.25 10.81 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 108.968 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.66 -169.25 53.26 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -90.71 129.33 36.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.264 . . . . 0.0 109.787 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.534 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.395 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -93.11 147.23 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.808 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 71.5 m -133.04 30.24 3.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -0.859 . . . . 0.0 109.284 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -75.2 -23.68 57.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.589 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -90.73 19.91 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.61 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 86.8 m-85 -117.58 161.76 32.11 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.0 Cg_endo -82.34 132.96 22.05 Favored 'Cis proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.042 -1.649 . . . . 0.0 110.966 2.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -80.25 143.19 55.9 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.668 -0.645 . . . . 0.0 109.659 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.22 14.18 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.564 2.176 . . . . 0.0 110.27 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 144.82 2.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.7 m -133.94 144.37 48.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.467 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 80.5 p -56.32 -168.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.0 109.02 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.05 -16.56 6.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 109.74 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -50.69 132.87 26.2 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.589 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 t80 -86.45 125.5 33.75 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 122.824 1.297 . . . . 0.0 111.36 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.2 mtt-85 -160.59 70.64 2.85 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.635 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -62.87 131.07 31.48 Favored 'Trans proline' 0 C--O 1.198 -1.522 0 C-N-CA 124.044 3.163 . . . . 0.0 114.767 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.619 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 3.1 mp -111.22 159.76 17.6 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 176.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.624 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -120.05 141.16 50.0 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.819 -1.801 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.612 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.51 158.95 18.62 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 122.701 1.167 . . . . 0.0 114.473 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -57.73 -17.79 17.36 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.549 -0.825 . . . . 0.0 109.858 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' HD11 ' A' ' 48' ' ' LEU . 4.1 p30 -89.62 21.8 3.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 109.007 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.82 16.96 3.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.526 -0.734 . . . . 0.0 109.867 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -99.26 120.54 39.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.242 -0.912 . . . . 0.0 108.592 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.491 ' CG2' ' HD3' ' A' ' 55' ' ' LYS . 42.6 m -84.5 126.49 33.33 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.462 -0.773 . . . . 0.0 109.648 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.82 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.66 136.79 36.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -41.77 -40.51 3.07 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.296 -0.878 . . . . 0.0 111.545 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.1 p30 -171.02 -153.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.677 -1.484 . . . . 0.0 110.318 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -58.89 -52.31 66.3 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.014 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 7.8 t -64.02 -57.83 8.52 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.737 -1.227 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -49.92 -23.14 1.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.82 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 5.3 t80 -78.25 -67.32 0.75 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.424 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 6.4 m -45.25 -25.73 0.41 Allowed 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.554 ' HA ' HG23 ' A' ' 42' ' ' VAL . 6.7 m-80 -70.06 -46.7 64.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -60.67 -19.97 59.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.579 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 53.1 t -90.91 -29.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.134 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 39' ' ' ASN . 3.8 m -83.98 -19.37 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.11 -16.78 25.88 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.916 . . . . 0.0 108.703 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -100.15 9.29 43.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.64 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.7 t30 76.45 6.29 3.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 79.85 7.73 88.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.466 HG21 ' OG ' ' A' ' 44' ' ' SER . 11.1 t -87.76 9.55 21.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.264 -1.139 . . . . 0.0 108.885 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.66 -77.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.355 -0.841 . . . . 0.0 109.14 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.648 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.2 p 92.27 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.084 0.945 . . . . 0.0 110.203 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.5 tp -72.68 157.71 37.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.08 -18.95 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.655 -1.278 . . . . 0.0 108.385 179.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.624 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 174.03 161.17 0.17 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.24 164.78 25.28 Favored 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.635 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.96 -168.5 52.25 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -91.1 171.72 9.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.651 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 3.0 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.616 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.05 112.2 21.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 38.7 m -108.15 64.53 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -89.49 -23.18 22.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -5.26 59.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 78.0 m-85 -79.83 162.24 63.28 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.181 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.2 Cg_endo -82.08 144.2 57.53 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.201 -1.583 . . . . 0.0 110.933 2.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -99.46 141.63 23.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 109.934 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.67 14.26 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.522 2.148 . . . . 0.0 110.27 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 119.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.538 -0.726 . . . . 0.0 109.052 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 64.8 m -93.8 148.9 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 66.2 p -56.67 -164.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.7 -7.58 5.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.94 -1.1 . . . . 0.0 110.654 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.478 ' OE1' ' HG3' ' A' ' 21' ' ' ARG . 1.3 pp20? -65.94 -176.3 0.38 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.55 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 9.4 t80 -122.49 129.43 51.99 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 120.862 -1.149 . . . . 0.0 111.239 -178.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 17.1 mtm180 -160.31 73.31 2.97 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.9 Cg_endo -64.73 112.85 2.1 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.909 1.739 . . . . 0.0 110.87 -178.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.555 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.78 138.61 49.35 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.325 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 9.2 t -96.24 165.75 12.06 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.912 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -132.81 176.71 19.35 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.493 -177.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.4 t -58.56 -49.24 78.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.667 -0.902 . . . . 0.0 109.049 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.602 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.2 p-10 -47.97 -24.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 108.985 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.3 t-20 91.08 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.22 0.533 . . . . 0.0 109.844 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -127.89 153.5 46.57 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 36.8 m -92.82 160.98 14.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 87.5 m-85 -140.11 100.26 3.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 108.679 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -17.43 -61.43 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.113 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.3 p30 -139.34 -169.82 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.923 -1.339 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 28.5 pttt -53.11 -39.47 63.44 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.821 -0.549 . . . . 0.0 110.533 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -63.03 -66.31 0.56 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.996 -1.065 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.8 m-80 -41.43 -34.74 0.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 109.871 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 59.0 t80 -71.72 -44.89 63.36 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.914 1.34 . . . . 0.0 109.69 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 71.5 m -61.73 -55.7 27.49 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.534 ' HA ' HG23 ' A' ' 42' ' ' VAL . 4.4 m-80 -44.23 -27.61 0.43 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.757 -1.214 . . . . 0.0 108.667 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -72.56 -47.51 47.57 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 32.8 t -60.19 -56.71 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.823 0.82 . . . . 0.0 109.335 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.534 HG23 ' HA ' ' A' ' 39' ' ' ASN . 15.9 m -56.22 -29.08 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 110.553 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.27 -15.73 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.025 -1.047 . . . . 0.0 108.81 179.536 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 89.5 p -106.33 11.25 31.21 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.414 -0.804 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER 50.65 39.05 20.67 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.69 0.757 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.56 32.15 82.39 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.749 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.521 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 70.1 p -104.93 -6.11 20.43 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.324 -1.104 . . . . 0.0 108.573 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.631 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 -57.11 3.83 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.104 0.954 . . . . 0.0 108.501 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.59 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 32.1 p 63.7 129.47 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.955 -177.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -58.21 152.73 16.52 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.1 p -107.38 -42.86 4.7 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.664 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -174.45 160.49 3.19 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.723 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -77.72 139.07 39.36 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.115 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.82 -170.33 16.9 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -89.41 159.17 17.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.884 -1.362 . . . . 0.0 108.007 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.587 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.444 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 7' ' ' ASP . 77.0 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.267 0.556 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 6' ' ' VAL . 9.9 t0 -77.94 137.81 38.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 60.1 m -146.6 49.17 1.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.823 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -90.55 -10.83 42.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.971 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.82 21.09 11.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.736 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 90.3 m-85 -106.75 159.69 28.97 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -75.61 175.96 45.71 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.711 -1.787 . . . . 0.0 111.364 2.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 50.5 mttt -135.4 139.07 30.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.82 13.96 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.346 2.031 . . . . 0.0 110.58 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.78 114.72 1.57 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -91.81 150.46 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.55 167.39 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 109.124 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -101.09 -33.79 9.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.026 . . . . 0.0 109.625 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -46.0 125.05 5.94 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.042 -1.036 . . . . 0.0 108.797 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -79.69 116.74 20.05 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.393 1.092 . . . . 0.0 109.915 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.68 76.68 10.68 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -64.01 120.98 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.983 2.455 . . . . 0.0 112.614 -177.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.626 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -114.01 127.61 56.02 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.63 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.702 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 37.5 t -79.91 115.97 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -64.75 -170.97 2.5 Favored Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.299 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -80.91 -33.62 34.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.945 -1.327 . . . . 0.0 108.75 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.4 p-10 -60.05 -16.41 31.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 92.9 17.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 109.891 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.54 130.44 45.78 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.169 -0.957 . . . . 0.0 108.725 179.169 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 m -70.88 147.24 49.01 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.57 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 71.7 m-85 -120.69 116.18 24.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -26.85 -47.78 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 -177.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.4 p30 -160.7 -163.47 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.616 -1.52 . . . . 0.0 109.694 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.626 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.31 -41.73 80.45 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.397 -179.069 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 42.4 t -61.59 -66.46 0.53 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.734 -1.229 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 12.8 m-80 -43.71 -34.23 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 0.0 110.708 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 25.9 t80 -72.25 -52.57 15.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.179 . . . . 0.0 109.982 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 32.9 m -53.83 -53.18 56.1 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 4.3 m-20 -41.43 -34.29 0.52 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.154 -0.967 . . . . 0.0 108.864 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' CB ' HD23 ' A' ' 48' ' ' LEU . . . -71.74 -47.24 55.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.468 HG11 ' HA2' ' A' ' 46' ' ' GLY . 97.4 t -58.06 -62.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.433 0.635 . . . . 0.0 110.06 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.593 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 11.8 p -58.96 -22.84 22.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 111.869 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.07 -16.42 27.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.377 -1.452 . . . . 0.0 108.702 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.539 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 18.9 p -102.63 -2.24 28.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.59 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 78.63 12.83 1.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 109.305 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 88.63 5.86 74.14 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 44' ' ' SER . 14.3 t -79.61 -4.0 49.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.258 -1.143 . . . . 0.0 108.15 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.633 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.7 tp -80.4 -82.89 0.11 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.633 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 75.27 179.88 0.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.544 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -130.88 -179.79 5.52 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.582 -1.324 . . . . 0.0 110.22 -179.472 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.596 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -111.61 -21.91 11.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.018 -1.051 . . . . 0.0 108.465 -179.82 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.702 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 179.74 155.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.504 -0.748 . . . . 0.0 109.835 -179.211 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -73.65 148.35 42.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.39 -166.97 14.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.74 157.67 16.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -1.103 . . . . 0.0 108.219 178.855 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.09 -1.006 . . . . 0.0 109.627 -179.885 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' HD23 ' A' ' 23' ' ' LEU . 40.3 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.343 0.592 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -101.26 131.17 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.542 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 29.0 m -122.23 58.69 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 t -82.65 -16.85 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -1.92 40.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.117 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 36.4 m-85 -84.53 165.46 37.85 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.9 Cg_endo -84.5 153.43 62.92 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.338 -1.526 . . . . 0.0 110.913 1.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.9 141.28 22.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.759 . . . . 0.0 109.694 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.19 13.57 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.561 2.174 . . . . 0.0 110.278 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.02 112.58 1.0 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.5 m -83.89 143.16 30.06 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.62 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.196 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -125.61 -31.88 2.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.897 -1.127 . . . . 0.0 109.928 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.431 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 2.8 pm0 -49.03 142.08 7.13 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 7.9 t80 -90.23 126.15 35.73 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 122.731 1.253 . . . . 0.0 111.2 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.655 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.68 71.87 2.83 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 20' ' ' TYR . 22.7 Cg_endo -61.16 130.9 34.17 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.531 2.821 . . . . 0.0 113.159 -176.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.586 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -115.29 126.44 54.49 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.171 178.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.747 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.4 t -78.07 133.66 37.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -75.72 -157.26 6.62 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 118.534 -1.793 . . . . 0.0 108.784 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -92.99 -66.55 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 110.171 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.629 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -40.16 -40.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.605 -0.684 . . . . 0.0 109.401 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.6 p30 133.38 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 11.3 pttp -108.46 107.27 17.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 109.636 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 46.6 m -66.37 152.13 45.69 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.531 -0.731 . . . . 0.0 109.101 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 37' ' ' PHE . 1.5 m-85 -129.62 142.74 50.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.555 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -47.52 -35.06 10.35 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.708 -176.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.655 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p30 -173.18 -155.55 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.725 -1.456 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.96 -42.39 97.29 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.436 -0.79 . . . . 0.0 110.786 -178.227 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.8 t -66.55 -57.36 7.45 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.579 -1.326 . . . . 0.0 108.512 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -48.93 -37.0 18.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.82 . . . . 0.0 109.478 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 31.9 t80 -70.22 -51.91 27.23 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.492 1.139 . . . . 0.0 110.247 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.574 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 61.2 m -55.21 -61.03 2.59 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.289 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.545 ' HA ' HG23 ' A' ' 42' ' ' VAL . 3.9 m-20 -37.47 -29.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.302 -0.874 . . . . 0.0 109.657 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -74.33 -52.3 12.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 68.9 t -52.06 -54.72 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.585 0.707 . . . . 0.0 109.738 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 39' ' ' ASN . 6.1 m -61.89 -26.48 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 111.183 -178.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 6.9 tt0 -90.63 -6.43 54.6 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.962 -1.087 . . . . 0.0 109.792 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 p -112.57 18.42 18.39 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.118 -0.989 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.562 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.61 -1.58 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 0.0 109.304 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.88 17.24 61.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.562 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 3.1 p -87.0 -10.41 53.21 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.248 . . . . 0.0 108.486 178.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -78.26 148.47 33.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.712 0.768 . . . . 0.0 109.467 -179.573 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' SER . 1.3 p -137.77 167.17 22.25 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -109.63 170.31 8.15 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.57 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -108.41 -35.77 6.41 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.829 -1.17 . . . . 0.0 107.896 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -167.86 164.73 14.07 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.568 0.699 . . . . 0.0 109.505 -178.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.65 -167.16 0.33 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.577 -0.702 . . . . 0.0 109.306 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.81 -167.31 4.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -85.55 165.4 17.11 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.598 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.584 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.53 131.6 35.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.165 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.573 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 54.9 m -139.08 49.61 1.84 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -90.91 -10.18 43.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.689 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.67 23.76 9.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 46.9 m-85 -117.63 158.28 45.69 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.066 -1.021 . . . . 0.0 108.385 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.24 164.86 84.19 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.003 3.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -119.91 146.85 42.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.478 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -78.53 13.67 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.5 2.133 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 150.94 1.29 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.9 m -119.83 138.25 53.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.023 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.3 p -54.04 -171.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 108.817 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.472 ' N ' HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -119.51 -22.87 6.81 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.362 179.577 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -49.95 118.42 2.88 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 12.4 t80 -78.42 126.55 30.93 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.536 1.16 . . . . 0.0 110.501 -178.164 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.0 ptm180 -160.66 77.91 2.5 Favored Pre-proline 0 C--N 1.293 -1.89 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HG3' ' CZ ' ' A' ' 20' ' ' TYR . 27.6 Cg_endo -66.11 127.68 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.707 2.271 . . . . 0.0 112.853 -176.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -116.88 135.15 53.95 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.881 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.653 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 19.1 t -92.88 161.48 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.424 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -117.56 168.18 12.9 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 35.3 t -69.47 -17.97 63.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.64 -0.917 . . . . 0.0 108.636 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 35.7 p30 -73.85 -7.97 54.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.068 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.6 t30 82.33 31.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.756 -0.59 . . . . 0.0 110.044 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -123.94 139.68 53.72 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.143 179.719 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 23.2 m -85.22 159.91 20.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.816 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 40' ' ' ALA . 48.1 m-85 -130.98 124.85 31.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -38.41 -53.62 2.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.967 -178.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -155.06 -164.45 1.79 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.783 -1.422 . . . . 0.0 110.529 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.15 -25.28 68.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 111.533 -178.253 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -70.78 -53.23 16.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.598 -1.314 . . . . 0.0 109.197 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.13 -37.5 87.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.715 -0.616 . . . . 0.0 110.018 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 58.9 t80 -70.51 -47.61 59.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.942 -1.099 . . . . 0.0 109.791 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 17.3 m -64.02 -29.56 70.7 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 95.1 m-20 -72.64 -39.24 67.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.72 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -72.41 -17.3 61.81 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 54.2 t -84.54 -50.75 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.001 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 11' ' ' TYR . 6.8 p -68.54 -17.8 22.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.661 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.72 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.08 -31.3 15.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.05 -1.031 . . . . 0.0 108.371 178.548 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 46.5 t -88.15 15.11 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.633 -0.667 . . . . 0.0 110.53 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 64.04 12.79 7.22 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.203 -0.935 . . . . 0.0 109.511 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 80.04 20.74 66.96 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.8 p -93.75 3.61 55.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -1.137 . . . . 0.0 108.72 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.56 -52.73 7.63 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.047 0.927 . . . . 0.0 108.745 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.623 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 29.5 p 53.38 119.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.442 1.115 . . . . 0.0 111.323 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.2 tp -65.36 152.46 43.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -112.52 -16.87 12.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.653 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 175.86 163.52 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.92 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -80.22 177.66 8.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.159 -0.963 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.88 -167.45 54.88 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.432 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.09 173.46 7.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.775 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.846 -1.159 . . . . 0.0 109.681 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.3 152.51 22.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -122.98 49.88 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.671 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -90.01 -36.57 14.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.35 43.16 1.07 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.321 -0.862 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 47.2 m-85 -132.38 164.98 39.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.8 Cg_endo -89.48 173.94 24.77 Favored 'Cis proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.399 -1.5 . . . . 0.0 111.293 0.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.4 mtpt -136.53 136.41 21.98 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 109.14 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.95 15.6 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.561 2.174 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.44 14.2 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.49 -0.756 . . . . 0.0 109.064 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.68 160.09 40.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.43 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 1.3 p -60.86 -164.23 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.09 -7.67 10.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 110.417 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HG3' ' HD3' ' A' ' 21' ' ' ARG . 3.7 pm0 -56.59 119.32 5.91 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -79.6 128.96 34.03 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.505 1.145 . . . . 0.0 111.049 -178.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.56 80.03 2.05 Favored Pre-proline 0 C--N 1.294 -1.809 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.758 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.557 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -65.02 124.87 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.973 2.449 . . . . 0.0 112.975 -176.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.5 mp -112.25 139.93 47.38 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -102.52 129.32 49.01 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.983 -178.303 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.482 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -70.11 -170.16 8.21 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' THR . 29.5 t -82.03 -22.02 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.938 -1.331 . . . . 0.0 108.416 178.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -76.15 -3.42 36.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.836 . . . . 0.0 109.44 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 17.6 t30 80.18 30.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.382 -0.824 . . . . 0.0 110.308 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 10.2 ttmt -105.32 137.1 43.65 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.103 -0.998 . . . . 0.0 108.781 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.9 m -85.66 146.5 26.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 0.0 109.998 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.6 m-85 -125.51 132.23 52.66 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.98 -51.03 0.65 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p30 -165.54 -168.32 1.32 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.036 -1.273 . . . . 0.0 111.086 178.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.579 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 6.3 ptmt -45.76 -45.98 14.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.88 -0.512 . . . . 0.0 111.868 -177.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.563 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 10.3 m -64.76 -62.73 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.555 -1.341 . . . . 0.0 109.698 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.3 m-80 -50.56 -20.12 1.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 21.3 t80 -82.84 -57.93 3.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.954 -1.091 . . . . 0.0 110.889 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.5 t -58.01 -47.35 83.3 Favored 'General case' 0 C--N 1.286 -2.156 0 O-C-N 121.698 -0.626 . . . . 0.0 110.911 -178.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -46.29 -28.75 1.39 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.341 -1.475 . . . . 0.0 107.997 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -70.2 -48.31 57.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' CYS . 87.2 t -55.86 -56.14 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.408 0.623 . . . . 0.0 110.031 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -53.48 -33.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.075 -1.015 . . . . 0.0 111.062 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.531 ' N ' HG21 ' A' ' 42' ' ' VAL . 5.0 tt0 -92.57 -11.27 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.629 -1.295 . . . . 0.0 109.697 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 8.5 t -100.65 -5.35 26.76 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.035 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 77.37 27.58 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.0 -179.649 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 64.79 11.69 50.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 44' ' ' SER . 14.7 t -87.09 -2.44 58.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.293 -1.122 . . . . 0.0 108.666 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.02 -59.87 2.61 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 26' ' ' SER . 37.6 p 52.58 127.6 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.114 0.959 . . . . 0.0 111.305 178.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -85.94 160.67 19.32 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.563 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.1 -29.13 9.57 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.568 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.8 p80 -160.04 163.1 34.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.89 177.72 8.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 73.63 -167.11 54.52 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -91.4 164.78 13.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -1.031 . . . . 0.0 109.072 179.041 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.7 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.922 -179.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.172 0.51 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.83 156.57 39.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.0 109.243 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 19.5 t -160.98 24.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.947 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.18 -4.83 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -112.06 36.95 3.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.906 -1.121 . . . . 0.0 110.217 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 97.0 m-85 -136.51 157.81 74.52 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.994 -1.066 . . . . 0.0 108.817 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -72.08 145.04 82.12 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.631 -1.821 . . . . 0.0 111.544 3.149 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -108.1 144.95 30.44 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 -179.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -78.72 14.62 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.781 2.321 . . . . 0.0 110.956 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.03 117.49 2.25 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 109.127 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' THR . 94.3 m -102.21 139.71 37.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.877 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.443 ' HB ' ' CD ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -45.16 142.88 1.81 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.425 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -92.28 -23.08 19.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.947 -1.096 . . . . 0.0 109.851 -179.484 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 14.5 pm0 -57.44 -166.8 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.6 t80 -134.03 116.4 15.46 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.352 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.4 mmt180 -147.92 74.71 11.07 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.5 Cg_endo -65.91 132.07 29.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.114 2.543 . . . . 0.0 113.144 -176.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -118.78 136.71 53.84 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.583 178.334 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.705 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 51.8 t -79.05 117.98 20.61 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.28 -165.56 1.32 Allowed Glycine 0 C--N 1.296 -1.663 0 C-N-CA 118.299 -1.905 . . . . 0.0 108.589 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.1 t -85.89 -31.78 22.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.27 . . . . 0.0 109.144 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -69.24 -4.92 19.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 179.57 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.3 t-20 86.11 15.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.742 -0.599 . . . . 0.0 109.881 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -99.56 117.54 34.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.812 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.483 HG21 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -54.5 158.05 2.62 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.592 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 4.2 m-85 -129.2 133.13 47.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.07 -51.51 3.46 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -161.43 -158.5 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.336 -1.096 . . . . 0.0 109.547 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.53 -57.03 10.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.096 -178.099 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.9 t -42.85 -57.44 2.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.838 -1.164 . . . . 0.0 110.41 -179.264 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.34 -43.22 99.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.277 -0.889 . . . . 0.0 111.129 -178.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.7 t80 -56.07 -60.55 3.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.905 -1.122 . . . . 0.0 110.521 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -55.58 -51.96 65.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.32 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.9 m-20 -41.6 -29.19 0.16 Allowed 'General case' 0 C--N 1.308 -1.196 0 O-C-N 120.567 -1.333 . . . . 0.0 108.773 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.532 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . . . -75.1 -49.34 19.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -58.26 -62.45 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.591 0.71 . . . . 0.0 109.8 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.443 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 3.3 p -57.47 -26.56 26.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.262 -0.899 . . . . 0.0 111.627 -178.627 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -91.71 -13.44 31.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.283 -1.511 . . . . 0.0 109.059 179.203 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.6 t -104.59 22.85 14.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.509 -0.744 . . . . 0.0 110.082 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.6 p30 65.08 6.25 3.39 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.463 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.59 87.14 Favored Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.291 -0.881 . . . . 0.0 110.912 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.6 t -79.45 -4.37 50.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.803 -1.41 . . . . 0.0 108.188 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.7 tp -79.95 -80.29 0.13 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p 70.92 169.07 0.32 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.14 173.33 7.16 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.425 -0.797 . . . . 0.0 110.486 -178.143 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.648 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.73 -36.38 7.07 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.714 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.705 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -162.54 165.58 25.86 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.456 0.646 . . . . 0.0 109.383 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 15.7 m-85 -75.61 -164.5 0.35 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.595 -0.691 . . . . 0.0 109.184 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 59.06 -168.99 6.16 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.4 143.2 26.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -1.02 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.543 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 32.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.693 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.18 0.514 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.13 143.29 55.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 7.3 m -139.32 61.37 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -90.83 -1.24 57.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.4 41.59 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.427 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 38' ' ' CYS . 70.8 m-85 -122.83 161.35 44.73 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.247 -0.908 . . . . 0.0 108.934 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.15 -179.77 28.24 Favored 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.698 -1.793 . . . . 0.0 111.41 1.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 tttp -123.04 141.34 35.48 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.0 Cg_endo -77.18 13.99 1.43 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.656 2.238 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 14' ' ' PRO . . . 170.5 144.37 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 34.6 t -124.08 159.47 29.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.4 p -59.37 -157.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.55 -11.06 8.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.731 -1.231 . . . . 0.0 109.685 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.506 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.3 pt-20 -56.6 124.86 19.75 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 19.3 t80 -86.04 132.41 34.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.323 1.059 . . . . 0.0 111.537 -177.532 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.73 80.32 2.26 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.769 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.6 Cg_endo -65.42 122.0 9.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.668 2.245 . . . . 0.0 112.415 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 37' ' ' PHE . 2.0 mt -107.18 128.4 54.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.713 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -79.06 102.28 8.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.384 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.53 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.27 -170.89 0.12 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 118.579 -1.772 . . . . 0.0 109.113 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.9 t -74.32 -45.0 50.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.008 -1.289 . . . . 0.0 109.306 179.409 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -54.99 -16.39 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.817 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER 92.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.375 0.607 . . . . 0.0 109.73 179.754 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -99.41 127.89 45.48 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -69.61 152.79 44.33 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 8.2 m-85 -126.54 125.2 41.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -28.89 -50.5 0.1 Allowed Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -176.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -163.04 -159.94 0.58 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.704 -1.468 . . . . 0.0 110.317 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.05 -46.12 79.02 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.307 -0.871 . . . . 0.0 112.213 -177.413 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 5.3 m -66.23 -52.61 46.17 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.477 -1.389 . . . . 0.0 110.17 -178.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.0 m-80 -56.42 -23.43 38.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.685 -1.259 . . . . 0.0 110.395 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 16.6 t80 -82.72 -54.59 5.01 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.037 1.399 . . . . 0.0 110.007 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 1.1 m -55.55 -35.99 66.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.324 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 3.5 m-20 -57.48 -36.51 71.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.588 -1.32 . . . . 0.0 108.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.668 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.0 -28.67 66.81 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 48' ' ' LEU . 79.4 t -72.97 -62.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.512 -0.742 . . . . 0.0 109.119 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.584 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 4.4 p -59.58 -15.15 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 111.299 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.668 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.93 -30.72 15.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.573 -1.329 . . . . 0.0 108.659 179.308 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.1 t -93.22 22.38 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.678 -0.638 . . . . 0.0 110.31 -179.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 44' ' ' SER . 17.4 m-80 65.62 8.85 5.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.175 -0.953 . . . . 0.0 109.802 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.33 17.82 63.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 p -95.74 5.79 50.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 108.734 179.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.3 tp -79.49 -78.28 0.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.668 0.747 . . . . 0.0 109.394 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.579 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.9 p 68.12 153.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.655 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -110.63 179.64 4.01 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.525 -0.734 . . . . 0.0 111.223 -177.733 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.655 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -109.06 -32.4 7.25 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.783 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.713 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.3 p80 -170.56 159.51 6.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.401 0.619 . . . . 0.0 109.626 -178.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 33.6 m-85 -70.55 -169.17 0.3 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 63.11 -169.29 17.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 138.83 31.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.131 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.523 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.499 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.62 148.1 34.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 108.857 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 10.1 t -158.03 24.09 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.944 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.6 0.23 57.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.396 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 11.5 mp0 -122.37 43.18 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.917 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.7 m-85 -139.02 158.77 69.06 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.07 -1.019 . . . . 0.0 108.571 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.04 159.68 95.04 Favored 'Cis proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.096 3.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 5.0 tttm -110.42 145.9 33.18 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.3 14.09 1.66 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.536 2.157 . . . . 0.0 110.731 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.69 124.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -79.74 156.08 27.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.745 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -72.66 -172.05 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -115.27 -20.01 10.53 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.101 -0.999 . . . . 0.0 110.19 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.553 ' N ' HD21 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -57.87 123.17 14.85 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.855 -1.153 . . . . 0.0 108.758 179.324 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.6 t80 -83.96 124.83 31.43 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.248 1.023 . . . . 0.0 109.818 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.2 mtp180 -161.11 87.33 1.68 Allowed Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -65.46 120.54 7.75 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.147 1.898 . . . . 0.0 112.225 -177.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -112.15 139.83 47.35 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.482 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -104.24 124.07 48.48 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.964 -178.307 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -69.34 -171.81 8.22 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 49' ' ' THR . 30.6 t -82.84 -17.69 43.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.696 -1.473 . . . . 0.0 108.045 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -76.68 -8.03 56.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.549 -0.72 . . . . 0.0 109.321 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.6 t30 81.75 36.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 9.6 tttt -111.99 138.83 48.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.814 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -88.73 145.14 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.917 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.592 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 66.8 m-85 -121.35 124.29 44.2 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.446 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.17 -52.63 0.71 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -177.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.4 p30 -152.63 -163.79 1.8 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.138 -1.213 . . . . 0.0 110.052 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 ptmt -58.27 -68.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 111.297 -178.217 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.8 p -41.28 -45.43 2.95 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.875 -1.141 . . . . 0.0 110.694 -178.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 12.1 m-80 -63.61 -40.59 97.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.549 -1.345 . . . . 0.0 109.871 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 20.5 t80 -65.35 -60.15 3.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.194 -0.941 . . . . 0.0 110.941 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.662 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.05 -41.57 71.6 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.893 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.625 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.4 m-20 -49.42 -37.41 25.45 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.425 -1.422 . . . . 0.0 107.971 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -72.66 -32.25 65.69 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 48' ' ' LEU . 88.1 t -70.62 -67.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.296 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.474 HG13 ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -54.05 -17.61 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.705 -0.622 . . . . 0.0 111.551 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.663 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.75 -31.07 15.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.183 -1.573 . . . . 0.0 107.763 178.346 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 10.7 t -88.28 -1.29 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.829 -0.544 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 84.44 4.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.362 -179.513 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 91.12 8.94 64.18 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.554 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 18.0 p -85.03 1.1 49.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.915 -1.344 . . . . 0.0 108.868 178.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -78.82 -50.61 10.99 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.923 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' SER . 73.9 p 45.84 121.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.282 1.039 . . . . 0.0 112.574 178.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -82.38 159.4 23.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.513 0.673 . . . . 0.0 109.218 178.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.68 -26.39 10.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.552 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.571 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.8 p80 -164.2 160.21 21.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.573 0.701 . . . . 0.0 109.682 -178.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.96 -170.11 1.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.67 -171.67 20.72 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -90.75 166.58 13.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 108.774 179.3 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.0 m . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.667 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.6 128.37 34.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.998 . . . . 0.0 109.504 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 m -138.0 45.89 2.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 8.43 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.893 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 21.9 mp0 -118.08 3.39 12.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 109.833 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 32.2 m-85 -85.34 160.4 54.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.202 -0.936 . . . . 0.0 109.421 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -73.91 156.43 99.69 Favored 'Cis proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.775 -1.76 . . . . 0.0 111.939 2.042 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -100.34 142.75 25.21 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 14.85 1.71 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.588 2.192 . . . . 0.0 110.757 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 173.3 133.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 108.994 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.7 m -99.44 149.42 23.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 0.0 109.922 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -49.19 -24.28 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.291 1.043 . . . . 0.0 110.037 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 76.22 2.21 3.52 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.239 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG2' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -78.03 -164.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.779 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 5.2 t80 -130.69 126.46 36.58 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.098 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 45.0 mtm180 -159.88 77.02 2.85 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -64.28 120.3 7.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.44 2.093 . . . . 0.0 112.552 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.38 127.44 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.106 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.681 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.5 t -79.78 126.57 31.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 109.75 -179.37 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.36 169.99 54.96 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 t -64.88 -35.27 80.59 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.133 -1.216 . . . . 0.0 109.916 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -76.53 4.52 9.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.4 t30 80.33 41.41 0.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.0 110.36 179.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.8 109.64 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.39 1.09 . . . . 0.0 109.495 179.38 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -63.72 144.24 57.19 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.006 -1.059 . . . . 0.0 108.221 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.245 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -49.7 -45.42 39.11 Favored Glycine 0 N--CA 1.486 1.977 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.066 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.2 p-10 -159.04 -164.4 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.011 -1.288 . . . . 0.0 110.329 -179.567 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.2 -26.36 62.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 110.397 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 29.0 t -69.15 -63.36 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.968 -1.083 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.551 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 37.1 m-80 -59.53 -39.44 83.91 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.439 -0.788 . . . . 0.0 110.201 -179.328 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 61.3 t80 -60.38 -47.21 87.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.621 -1.3 . . . . 0.0 108.752 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.618 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.5 m -64.08 -28.54 69.85 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.356 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.5 m-20 -67.08 -32.6 73.88 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -22.86 41.25 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.072 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 39.9 t -77.67 -33.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.651 -0.656 . . . . 0.0 109.265 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -90.98 -17.57 7.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.237 -0.914 . . . . 0.0 109.768 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.0 tt0 -91.9 -11.92 34.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.068 -1.02 . . . . 0.0 109.104 179.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.1 t -109.49 26.06 11.08 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.249 -0.907 . . . . 0.0 110.223 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 44' ' ' SER . 30.5 m-20 62.14 35.89 15.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.144 -0.972 . . . . 0.0 108.734 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 49.33 25.06 5.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.2 p -88.18 -14.56 38.32 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -1.092 . . . . 0.0 108.688 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 1.1 tp -80.3 133.24 35.94 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.9 p -135.08 123.5 23.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 108.997 178.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -64.42 165.29 10.01 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.429 -0.794 . . . . 0.0 109.644 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.567 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.01 -22.77 10.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.718 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -174.2 152.41 1.83 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.537 -0.727 . . . . 0.0 109.548 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.07 170.77 6.37 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.354 -0.841 . . . . 0.0 108.871 178.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.06 -170.82 47.83 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.519 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.39 134.28 35.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.097 -1.237 . . . . 0.0 108.272 178.619 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.575 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.005 -1.06 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.229 0.537 . . . . 0.0 109.614 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.53 141.33 29.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.573 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 7.1 m -142.87 65.61 1.34 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -90.37 14.94 11.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.068 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 4.9 pm0 -122.17 -10.35 8.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.979 -1.075 . . . . 0.0 109.723 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 87.6 m-85 -80.37 158.94 71.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -73.98 178.8 31.85 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.74 -1.775 . . . . 0.0 111.437 3.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 145.92 57.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.636 -0.665 . . . . 0.0 109.461 -179.001 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.27 14.14 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.436 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.47 115.95 0.25 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.1 m -81.09 158.24 25.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 110.174 -179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -50.06 -25.36 3.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.396 1.093 . . . . 0.0 109.778 -179.777 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER 74.57 -12.14 0.95 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.453 179.192 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.423 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -75.33 -167.94 0.72 Allowed 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.466 -1.396 . . . . 0.0 107.855 178.761 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.1 t80 -123.28 122.19 37.74 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.274 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -155.22 77.36 4.94 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.754 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -65.35 112.42 2.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.164 1.91 . . . . 0.0 112.033 -177.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.605 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -108.86 122.02 46.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.758 179.655 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 1.3 m -79.41 103.36 9.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 108.633 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.54 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.21 -174.55 0.08 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -178.18 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.3 t -72.67 -33.4 66.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -1.202 . . . . 0.0 108.876 178.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -66.27 -12.34 55.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.42 -0.8 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 88.66 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.803 -0.561 . . . . 0.0 110.161 179.715 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 ttpt -100.6 143.87 30.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 108.956 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.524 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 33.9 m -87.59 128.59 35.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.018 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 38.2 m-85 -103.8 118.46 36.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.17 -44.95 0.11 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.972 -0.455 . . . . 0.0 112.476 -176.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 32.2 p-10 -156.12 -161.8 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.702 -1.47 . . . . 0.0 109.472 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.6 pttt -70.59 -28.38 64.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.398 -0.814 . . . . 0.0 110.377 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 16.8 t -69.52 -59.86 2.7 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.86 -1.15 . . . . 0.0 109.051 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -52.88 -40.9 63.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.621 -0.674 . . . . 0.0 109.811 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 35.7 t80 -64.17 -50.1 69.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.658 1.218 . . . . 0.0 109.225 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -59.37 -26.05 64.76 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.009 -178.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -69.13 -35.51 76.47 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.202 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.743 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.15 -23.51 59.27 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.208 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' GLY . 55.1 t -80.36 -35.58 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.651 -0.656 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.513 HG13 ' CB ' ' A' ' 11' ' ' TYR . 5.5 p -88.56 -13.24 9.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.743 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.74 -33.83 14.86 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.005 -1.06 . . . . 0.0 108.148 178.54 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -85.96 7.44 24.33 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.567 -0.708 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.0 t-20 77.02 6.56 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.117 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 88.84 10.46 66.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 t -90.88 7.8 38.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.119 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.3 tp -79.42 -73.16 0.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.308 -0.87 . . . . 0.0 109.136 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.59 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.0 p 64.71 142.66 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.68 172.66 6.68 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 122.125 0.964 . . . . 0.0 111.522 -177.876 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.56 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -97.59 -46.63 5.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.028 0.918 . . . . 0.0 108.591 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 3.8 p80 -154.82 157.32 37.73 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.646 0.736 . . . . 0.0 110.507 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -77.84 175.49 9.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.53 -171.82 52.89 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -90.39 158.75 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.293 . . . . 0.0 109.619 179.294 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 57.5 m . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.956 -178.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.488 HG11 ' N ' ' A' ' 7' ' ' ASP . 90.6 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.488 ' N ' HG11 ' A' ' 6' ' ' VAL . 12.8 t0 -84.26 116.58 23.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.9 m -119.46 60.1 0.84 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.356 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -90.97 -17.23 26.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.44 31.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.099 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 90.3 m-85 -117.81 162.2 30.35 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.4 Cg_endo -85.91 163.85 56.08 Favored 'Cis proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.213 -1.578 . . . . 0.0 110.581 1.947 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -122.91 140.61 33.7 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.658 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.66 13.36 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.462 2.108 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.36 116.4 4.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' THR . 76.8 m -92.77 138.18 31.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.839 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.7 p -52.51 -175.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pt? -114.21 -26.88 7.84 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.041 -1.037 . . . . 0.0 109.636 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.0 pm0 -48.68 162.97 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.588 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.5 t80 -113.95 131.49 56.29 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.209 1.004 . . . . 0.0 110.935 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.0 mtp180 -161.21 84.84 1.79 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.445 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -67.94 113.27 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.088 1.859 . . . . 0.0 111.586 -177.878 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -107.84 126.53 52.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.513 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 51' ' ' SER . 49.0 t -79.29 164.42 24.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.016 . . . . 0.0 108.761 -179.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -136.25 168.03 24.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -178.572 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 30.5 t -66.21 -23.27 66.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -1.02 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -61.08 -13.75 19.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 109.121 179.282 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.7 m-20 86.77 22.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.862 -0.524 . . . . 0.0 110.089 179.625 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -126.53 171.88 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.512 179.406 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 31' ' ' TYR . 28.7 m -104.94 163.69 12.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 65.1 m-85 -126.12 118.86 26.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.357 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.27 -52.58 0.41 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.655 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.2 p-10 -154.31 -167.96 2.79 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.78 -1.423 . . . . 0.0 109.909 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.56 -36.1 71.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.621 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 34.7 t -60.9 -61.57 2.49 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 109.72 -179.329 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -56.05 -41.99 75.88 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 74.3 t80 -61.92 -43.85 97.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.768 -1.207 . . . . 0.0 109.607 -179.514 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 88.4 m -69.49 -24.19 63.74 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.139 -179.697 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 3.6 m120 -74.93 -26.14 59.41 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.178 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -78.19 -33.53 50.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 37' ' ' PHE . 42.2 t -69.02 -48.45 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 35.0 m -64.16 -31.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.572 -0.705 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.79 -8.33 43.97 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 109.521 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 46.6 t -111.52 14.03 21.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.104 -0.997 . . . . 0.0 110.958 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.15 48.57 21.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.842 -1.162 . . . . 0.0 109.399 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.52 35.06 5.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 44' ' ' SER . 30.2 p -110.86 5.5 20.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -1.072 . . . . 0.0 108.391 178.229 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.649 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.7 -51.76 6.99 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.993 0.901 . . . . 0.0 109.143 -179.931 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.649 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 77.5 p 56.24 124.39 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.281 1.038 . . . . 0.0 110.48 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.8 tp -62.05 129.6 41.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.101 179.798 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.564 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 10.9 t -79.47 -21.91 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.865 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.564 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.3 p80 156.23 154.63 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.787 179.416 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -63.48 165.48 7.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.089 . . . . 0.0 108.663 179.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.08 -168.76 45.28 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -178.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.01 161.68 14.35 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.891 -1.359 . . . . 0.0 108.074 178.052 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 7.8 m . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.767 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -88.15 145.89 25.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.207 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 35.9 m -134.41 70.69 1.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.275 -0.891 . . . . 0.0 110.009 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -19.46 23.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.867 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 32.77 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 60.6 m-85 -113.34 164.82 14.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.6 Cg_endo -84.91 152.31 58.0 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.433 -1.486 . . . . 0.0 111.274 2.073 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.5 mtpm? -112.34 138.25 21.83 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.7 Cg_endo -80.39 14.78 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.728 2.285 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.19 160.51 21.36 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.112 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -147.5 159.84 43.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 110.002 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.57 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -117.18 -23.29 7.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.775 -1.203 . . . . 0.0 110.02 179.965 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -45.5 115.94 1.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.519 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.8 t80 -79.19 127.24 31.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.466 1.127 . . . . 0.0 111.354 -177.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 ptm180 -161.65 78.05 2.18 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.15 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.0 Cg_endo -66.16 128.14 18.94 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 123.208 2.605 . . . . 0.0 113.069 -177.135 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -112.34 130.34 55.99 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.606 178.402 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.1 t -83.56 122.75 28.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.5 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -68.53 -165.95 3.84 Favored Glycine 0 C--N 1.296 -1.665 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 49' ' ' THR . 7.1 t -89.2 -36.99 15.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.238 . . . . 0.0 107.972 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.624 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.4 p-10 -58.61 -17.37 21.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.532 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 97.17 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.128 0.49 . . . . 0.0 110.01 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.75 119.85 38.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.217 179.592 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.434 HG22 ' HB3' ' A' ' 55' ' ' LYS . 16.2 m -69.9 152.85 44.03 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.412 -0.805 . . . . 0.0 109.171 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 19.4 m-85 -132.7 124.43 28.17 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.793 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.78 -51.96 0.07 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -163.63 -162.32 0.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -1.232 . . . . 0.0 110.289 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.51 -40.76 60.22 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 112.6 -177.408 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -69.12 -65.15 0.74 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.209 -1.557 . . . . 0.0 108.911 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.7 m-80 -42.93 -30.5 0.41 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 27.5 t80 -74.85 -48.25 26.01 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.897 1.332 . . . . 0.0 109.406 179.545 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 87.4 m -55.92 -53.67 53.97 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.735 -178.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.546 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -42.23 -26.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.951 -1.093 . . . . 0.0 108.931 -179.475 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.97 -47.75 17.83 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.592 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 61.6 t -60.5 -28.12 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.715 -0.616 . . . . 0.0 110.422 179.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 33.2 m -90.93 -26.28 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.88 -1.137 . . . . 0.0 109.897 -179.033 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.3 tt0 -90.47 0.77 57.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.406 -0.808 . . . . 0.0 108.868 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.496 ' O ' ' OG ' ' A' ' 44' ' ' SER . 1.4 t -119.18 22.47 11.82 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.543 ' O ' ' CG2' ' A' ' 47' ' ' THR . 0.8 OUTLIER 64.11 46.47 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.905 1.336 . . . . 0.0 108.082 179.951 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 32.31 37.33 0.04 OUTLIER Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.513 -0.742 . . . . 0.0 111.874 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 45' ' ' ASN . 43.2 p -111.01 0.45 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.265 . . . . 0.0 108.231 177.868 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.493 HD21 ' N ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.36 152.92 30.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.759 0.79 . . . . 0.0 109.016 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' CB ' ' A' ' 26' ' ' SER . 41.2 p -141.45 149.89 41.56 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.926 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.624 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.22 175.96 6.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.713 -1.242 . . . . 0.0 109.214 -179.544 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.624 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.5 -23.04 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.756 -1.215 . . . . 0.0 108.607 -179.439 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 177.14 155.03 0.27 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 -178.816 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -62.04 -168.0 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.561 -0.712 . . . . 0.0 109.133 178.87 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.6 -167.45 6.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.49 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.8 175.68 6.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -1.073 . . . . 0.0 108.471 178.571 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.568 -179.807 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.611 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 78.1 m -137.3 47.98 2.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.309 179.81 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 64.6 p -86.96 -30.21 21.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.464 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 12.0 mm-40 -73.19 -8.92 57.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 80.3 m-85 -79.97 161.44 65.87 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.416 -0.802 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.2 Cg_endo -84.51 143.36 40.08 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 123.156 -1.602 . . . . 0.0 110.846 1.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.0 mtpt -116.09 137.85 23.72 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.484 -0.76 . . . . 0.0 109.369 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -80.49 14.08 2.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.349 2.033 . . . . 0.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.14 126.74 15.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.2 m -112.78 138.75 49.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.78 -179.548 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -56.9 -170.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.734 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.14 -25.48 9.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.099 -1.001 . . . . 0.0 109.603 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.8 mt-10 -41.47 122.51 1.93 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.349 -0.844 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.474 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 15.6 t80 -83.14 107.37 15.66 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.432 1.11 . . . . 0.0 110.357 -179.007 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -141.27 77.7 19.75 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.197 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.542 ' O ' ' O ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -64.25 115.24 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.228 1.952 . . . . 0.0 111.688 -177.933 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.76 135.7 53.89 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.539 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.69 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 47.4 t -89.99 160.47 16.36 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.536 -179.67 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -133.2 161.21 24.14 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.515 -177.659 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t -45.36 -21.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.817 -0.813 . . . . 0.0 111.177 -178.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' CD1' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -86.14 25.23 1.19 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.094 -179.654 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 m120 49.48 20.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.63 141.23 36.79 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.008 -1.058 . . . . 0.0 109.999 -179.84 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 m -86.87 157.54 19.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.427 -0.796 . . . . 0.0 108.932 179.53 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.606 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 82.1 m-85 -135.74 99.49 4.2 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.31 -59.28 0.02 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -178.166 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p-10 -137.77 -170.27 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.739 -1.448 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -54.22 -35.37 62.34 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.9 -0.5 . . . . 0.0 110.743 -178.639 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.7 t -64.57 -67.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.902 -1.124 . . . . 0.0 109.569 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.6 m-80 -44.84 -30.27 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.82 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 24.1 t80 -71.79 -54.31 10.58 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.535 1.16 . . . . 0.0 109.78 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 72.7 m -54.59 -58.9 5.69 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.109 -179.684 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' HG23 ' A' ' 42' ' ' VAL . 9.1 m-20 -42.68 -27.78 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.878 -1.139 . . . . 0.0 109.394 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . . . -73.57 -48.1 35.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.489 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 66.9 t -60.69 -54.11 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.378 0.609 . . . . 0.0 109.57 179.347 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 39' ' ' ASN . 10.2 m -56.3 -31.31 32.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.237 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -92.2 -12.31 33.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.915 -1.116 . . . . 0.0 109.638 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 17.6 t -98.06 8.19 45.15 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.101 -0.999 . . . . 0.0 110.309 -179.089 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t-20 75.33 12.12 3.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.984 -1.073 . . . . 0.0 108.484 -179.24 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 67.29 8.39 50.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.3 t -86.45 5.51 34.82 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.203 -1.175 . . . . 0.0 108.469 178.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.525 ' CD1' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -87.94 -71.81 0.56 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.993 0.901 . . . . 0.0 108.888 -179.666 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.525 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.6 p 81.69 152.11 0.1 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.965 0.888 . . . . 0.0 109.081 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.5 tp -67.69 156.76 36.17 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.52 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.3 p -106.28 -40.85 5.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.69 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 168.5 1.71 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.132 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -81.61 166.21 20.4 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.262 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 82.84 -175.11 53.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.96 156.49 19.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.949 -1.324 . . . . 0.0 109.132 179.081 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -92.35 128.87 38.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.136 179.712 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.1 m -123.05 63.56 0.99 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 109.831 -179.674 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.471 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.2 t -90.68 -19.5 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.325 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.9 mm-40 -97.46 26.3 5.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.092 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 68.9 m-85 -114.71 161.99 26.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.548 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.7 Cg_endo -85.84 156.03 56.88 Favored 'Cis proline' 0 C--N 1.305 -1.752 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.698 1.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 20.3 mtpt -118.31 140.15 27.74 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.869 . . . . 0.0 109.192 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.86 14.33 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.658 2.239 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.99 119.88 5.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.741 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -101.07 139.37 36.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.275 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -172.07 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.647 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.36 -14.31 11.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.887 -1.133 . . . . 0.0 110.379 -179.461 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.536 ' N ' HD21 ' A' ' 18' ' ' LEU . 3.0 pm0 -49.35 120.96 4.47 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.379 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -79.57 126.62 31.12 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.45 1.119 . . . . 0.0 110.902 -178.273 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.81 80.05 1.99 Allowed Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.408 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -65.72 119.54 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.286 1.991 . . . . 0.0 112.135 -177.366 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.621 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -110.79 123.13 49.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.151 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.1 t -79.26 127.65 32.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 0.0 109.101 -179.193 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.462 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -74.3 -173.31 29.28 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.573 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 5.2 t -76.14 -33.47 59.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.695 -1.474 . . . . 0.0 108.902 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.593 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -62.08 -12.18 17.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 109.653 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 59.3 t30 92.23 20.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.956 -0.465 . . . . 0.0 111.041 179.229 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.516 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.68 175.03 5.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.799 -1.188 . . . . 0.0 108.017 178.235 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -119.89 148.16 43.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 109.887 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.573 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 46.2 m-85 -120.67 120.72 36.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -30.27 -51.24 0.19 Allowed Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -177.768 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -153.04 -166.4 2.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.738 -1.448 . . . . 0.0 110.252 179.737 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -66.7 -22.54 66.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.569 -0.707 . . . . 0.0 111.323 -178.32 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 49.2 t -74.1 -50.55 19.0 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.612 -1.305 . . . . 0.0 108.859 179.578 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -62.9 -38.47 91.09 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 48.4 t80 -68.87 -47.8 65.02 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.37 1.081 . . . . 0.0 109.635 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 29.2 m -62.23 -29.34 70.32 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.908 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.529 ' HA ' HG23 ' A' ' 42' ' ' VAL . 19.9 m-20 -71.67 -23.61 61.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.077 -1.015 . . . . 0.0 108.638 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -85.78 -22.82 27.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.472 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 48' ' ' LEU . 86.7 t -83.2 -26.68 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.272 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 39' ' ' ASN . 33.8 m -86.49 -31.0 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.443 -0.786 . . . . 0.0 109.294 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.92 -15.4 28.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 27.9 t -96.97 9.63 41.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.957 . . . . 0.0 110.299 -179.385 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.3 m120 62.59 28.31 16.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.155 -0.965 . . . . 0.0 109.355 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.85 63.83 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.3 p -96.28 5.76 50.26 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -1.098 . . . . 0.0 108.584 178.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.82 -63.82 1.28 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.437 -0.789 . . . . 0.0 109.042 -179.712 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.607 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 65.5 p 56.27 124.72 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.96 0.886 . . . . 0.0 110.446 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -85.83 172.08 11.04 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.524 0.678 . . . . 0.0 110.733 -178.709 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.04 -28.72 9.38 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -174.44 162.7 3.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.766 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 m-85 -71.45 -170.77 0.54 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.51 -174.01 8.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.701 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -85.6 164.82 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -1.103 . . . . 0.0 108.868 179.396 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 3.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.393 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 7' ' ' ASP . 51.8 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.218 0.533 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.455 ' O ' HG11 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -76.72 172.89 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.185 179.952 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.4 t -161.15 26.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -90.56 -0.21 57.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.93 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -119.58 38.55 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 110.267 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.3 m-85 -139.83 154.17 70.56 Favored Pre-proline 0 C--N 1.305 -1.334 0 O-C-N 121.057 -1.027 . . . . 0.0 108.369 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -72.13 149.07 92.47 Favored 'Cis proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.597 -1.835 . . . . 0.0 111.622 2.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -110.6 148.03 37.65 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.981 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.5 Cg_endo -77.44 13.32 1.63 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.509 2.139 . . . . 0.0 110.968 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 115.26 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.2 m -88.69 149.66 23.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 109.749 -179.612 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -47.92 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.393 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.95 -23.21 9.2 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.869 -1.145 . . . . 0.0 110.228 -179.521 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pm0 -59.18 -168.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.885 -1.134 . . . . 0.0 108.134 179.358 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 20.0 t80 -127.55 129.1 46.75 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.32 81.61 2.0 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.262 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -66.4 111.33 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.177 1.918 . . . . 0.0 111.27 -178.268 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -105.95 136.78 45.0 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.266 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.678 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 12.1 t -98.22 159.04 15.2 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.251 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -116.53 174.06 15.04 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.441 -177.895 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.1 t -70.33 -13.47 62.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.45 -1.029 . . . . 0.0 108.547 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.7 p-10 -81.92 -8.99 59.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.41 -0.806 . . . . 0.0 109.318 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.6 t-20 82.74 34.78 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.649 -0.657 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 tttp -123.2 147.3 47.02 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.15 -0.969 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 78.0 m -93.35 162.18 14.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.071 -1.018 . . . . 0.0 109.898 -179.87 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.6 m-85 -138.18 108.22 6.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.69 -57.44 0.12 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -177.252 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.1 p30 -141.66 -169.88 2.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.817 -1.402 . . . . 0.0 110.535 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.0 ptmt -54.7 -47.06 74.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.794 -0.566 . . . . 0.0 110.708 -178.514 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.7 t -53.79 -52.69 59.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.802 -1.187 . . . . 0.0 109.541 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.1 m-80 -61.64 -29.39 70.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.549 -0.72 . . . . 0.0 110.547 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 11.5 t80 -73.86 -62.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.76 -1.212 . . . . 0.0 110.813 -179.167 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.2 -48.75 73.39 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.81 -0.556 . . . . 0.0 109.523 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.6 m-80 -41.88 -31.13 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.179 . . . . 0.0 108.321 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -72.99 -49.08 31.08 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.569 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.551 ' CG2' HD22 ' A' ' 48' ' ' LEU . 71.4 t -55.78 -59.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.401 0.62 . . . . 0.0 110.373 179.207 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -60.62 -23.97 30.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.204 -0.935 . . . . 0.0 110.599 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.8 tm-20 -89.35 -15.39 33.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.611 -1.306 . . . . 0.0 107.994 178.276 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -105.6 0.27 26.34 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 44' ' ' SER . 2.4 p30 60.64 22.85 12.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 0.0 109.447 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.45 16.11 57.55 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.488 ' OG1' ' OG ' ' A' ' 44' ' ' SER . 74.1 p -85.52 -12.04 52.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.26 . . . . 0.0 108.268 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.644 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -78.41 -52.13 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.713 0.768 . . . . 0.0 109.177 -179.967 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.644 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 20.9 p 55.17 123.73 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.312 1.053 . . . . 0.0 109.839 -178.045 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 24.8 tp -56.45 160.22 3.26 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -115.91 -41.57 3.18 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.54 1.162 . . . . 0.0 107.928 179.545 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.678 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.04 159.64 1.34 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.726 -179.568 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.84 133.8 36.99 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.408 178.792 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 112.91 -172.13 14.33 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.43 134.36 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.042 -1.269 . . . . 0.0 109.295 179.211 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.53 ' CG2' HD21 ' A' ' 23' ' ' LEU . 99.1 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.202 0.525 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' N ' HG11 ' A' ' 6' ' ' VAL . 4.2 t70 -69.42 148.23 49.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.46 30.38 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -13.85 43.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.651 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.49 -2.19 25.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.629 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 54.5 m-85 -93.56 163.37 24.71 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.1 Cg_endo -83.27 157.7 74.04 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.247 -1.564 . . . . 0.0 110.989 2.114 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.61 142.54 25.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.627 -179.735 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.7 Cg_endo -79.75 15.27 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.753 2.302 . . . . 0.0 110.861 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 164.35 137.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.478 -0.763 . . . . 0.0 109.025 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 17' ' ' THR . 49.0 t -109.86 157.57 19.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.065 -1.022 . . . . 0.0 110.842 -179.258 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.474 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -64.19 -157.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.058 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -116.69 -8.26 11.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.269 -1.519 . . . . 0.0 110.856 -179.708 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -49.62 136.32 17.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.585 -1.322 . . . . 0.0 107.811 179.276 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.0 t80 -98.29 130.2 44.98 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 122.282 1.039 . . . . 0.0 110.618 -178.602 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.86 77.58 2.46 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.536 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -62.59 121.35 9.27 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.741 2.294 . . . . 0.0 112.55 -177.084 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.574 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -110.03 133.88 52.73 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.563 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.704 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -80.31 111.07 16.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.492 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.59 -169.04 3.28 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.665 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -80.85 -32.38 35.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.839 -1.389 . . . . 0.0 108.812 178.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -65.23 -8.15 16.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.836 . . . . 0.0 109.616 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 46.1 t30 86.05 16.37 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.695 -0.628 . . . . 0.0 110.489 179.033 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -109.41 119.98 41.1 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.5 178.856 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 55' ' ' LYS . 27.0 m -58.64 161.93 4.3 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.494 0.664 . . . . 0.0 109.771 -179.354 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -130.54 133.36 46.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.772 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.611 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.3 -50.3 0.25 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -177.313 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.6 p30 -165.31 -164.02 0.72 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.921 -1.34 . . . . 0.0 110.75 178.896 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 pttt -52.82 -40.31 63.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.688 -0.633 . . . . 0.0 111.676 -177.674 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.629 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -72.69 -50.86 22.1 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.628 -1.295 . . . . 0.0 110.173 -178.427 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.1 m-80 -61.65 -18.58 60.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.713 -1.242 . . . . 0.0 108.931 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 9.4 t80 -80.74 -60.85 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.303 1.049 . . . . 0.0 109.636 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 46.8 t -57.78 -49.65 75.89 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.321 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HA ' HG23 ' A' ' 42' ' ' VAL . 8.0 m-20 -42.17 -28.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.721 -1.237 . . . . 0.0 108.343 179.357 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -74.32 -49.65 22.05 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 38' ' ' CYS . 97.2 t -55.53 -56.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 178.796 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 39' ' ' ASN . 19.4 m -58.21 -29.67 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -0.974 . . . . 0.0 110.27 -179.544 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.0 tt0 -90.78 -10.46 42.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.01 -1.056 . . . . 0.0 109.426 -179.616 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -105.86 16.14 25.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -179.559 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 10.5 m120 63.16 16.21 9.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.016 -1.053 . . . . 0.0 109.644 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 72.44 21.94 79.19 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -96.2 6.55 48.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 107.99 178.155 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 49' ' ' THR . 5.3 tp -87.78 -76.19 0.39 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.547 0.689 . . . . 0.0 109.841 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.567 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.1 p 66.22 152.86 0.07 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -178.586 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.659 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.87 173.14 6.45 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.635 -0.666 . . . . 0.0 110.198 -178.056 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.659 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.93 -33.53 7.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.659 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.704 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -167.27 163.32 15.32 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.533 0.682 . . . . 0.0 109.667 -178.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' CD2' HD22 ' A' ' 23' ' ' LEU . 16.1 m-85 -76.03 -177.72 4.05 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.524 -0.735 . . . . 0.0 109.359 179.15 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.38 -170.48 52.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.11 125.86 36.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -1.082 . . . . 0.0 109.609 179.326 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.454 179.775 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.15 98.28 7.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.957 -179.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 34.6 m -93.08 65.55 4.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 108.939 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -88.98 -10.11 48.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.122 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mp0 -116.04 36.98 3.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 87.1 m-85 -117.87 160.95 36.69 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.644 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.4 Cg_endo -83.63 159.66 72.3 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.964 -1.682 . . . . 0.0 110.819 2.364 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLU . 17.0 mtpp -131.35 137.84 31.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.391 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.66 14.04 2.13 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.492 2.128 . . . . 0.0 110.687 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.1 115.32 10.35 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.72 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.9 m -98.84 139.57 34.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 -179.353 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.509 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 36.0 p -47.13 169.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.16 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -110.12 -1.79 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.775 -1.203 . . . . 0.0 110.365 -179.869 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' N ' HD21 ' A' ' 18' ' ' LEU . 3.3 pm0 -76.26 -170.83 1.56 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.584 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.8 t80 -133.57 125.5 28.95 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.889 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 53.8 mtt180 -161.16 80.75 2.1 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.241 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -65.75 122.65 10.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.5 2.134 . . . . 0.0 112.045 -177.188 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.603 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.67 135.58 49.67 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.286 -0.966 . . . . 0.0 108.583 179.17 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.673 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 4.1 t -85.21 162.29 19.24 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 -179.298 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.98 161.49 15.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.479 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -69.23 -19.16 63.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -1.149 . . . . 0.0 109.109 -179.721 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 29.9 p-10 -78.12 -0.16 27.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.073 179.19 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER 79.62 42.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.508 -0.745 . . . . 0.0 109.752 179.857 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -134.18 139.41 45.82 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.944 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 5.5 m -92.23 165.86 12.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.009 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 57.9 m-85 -137.83 123.61 19.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.57 -53.69 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.804 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -157.35 -168.23 2.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.973 -1.31 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.603 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -53.15 -37.9 62.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 111.358 -178.29 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.7 t -63.0 -61.15 2.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.635 -1.29 . . . . 0.0 109.964 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.2 m-80 -55.75 -31.29 62.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.456 -0.777 . . . . 0.0 110.837 -179.017 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 69.6 t80 -73.58 -44.23 57.79 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.818 -1.177 . . . . 0.0 109.682 -179.526 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.594 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 63.3 m -66.23 -30.1 70.49 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.43 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 11.4 m-20 -68.42 -24.85 64.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.44 -26.35 32.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.531 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' GLY . 92.1 t -80.08 -26.48 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 33.4 m -90.68 -21.02 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.353 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.756 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.54 -31.59 16.66 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.277 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 96.6 p -88.63 23.16 2.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.541 -0.725 . . . . 0.0 109.744 -179.66 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.2 m120 64.97 11.59 7.18 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.377 -0.827 . . . . 0.0 109.319 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 78.1 22.63 67.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.9 p -93.1 -5.34 50.54 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.322 -1.104 . . . . 0.0 109.093 179.418 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -78.96 157.57 28.14 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.567 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 70.9 p -149.0 126.22 11.44 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.281 1.039 . . . . 0.0 110.496 179.714 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.2 tp -67.05 150.24 49.49 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.802 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.502 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.15 -22.58 12.32 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.116 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.4 p80 -175.92 163.29 2.72 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.497 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -78.51 178.58 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 178.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 75.73 -172.19 54.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.44 131.42 36.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.081 -1.246 . . . . 0.0 109.429 179.127 . . . . . . . . 3 3 . 1 . 037 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.596 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.562 179.915 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.502 HG11 ' N ' ' A' ' 7' ' ' ASP . 90.0 t . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.502 ' N ' HG11 ' A' ' 6' ' ' VAL . 10.6 t0 -99.27 153.68 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 109.199 179.868 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 t -151.87 17.63 0.68 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.08 -1.012 . . . . 0.0 109.945 -179.875 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -90.8 13.02 17.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.149 -0.969 . . . . 0.0 109.748 179.616 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -130.74 -18.39 3.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.008 -1.057 . . . . 0.0 110.972 -179.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 96.4 m-85 -79.76 161.59 65.88 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.933 -1.104 . . . . 0.0 109.175 -179.304 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.7 Cg_endo -69.43 167.43 70.12 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.249 -1.563 . . . . 0.0 112.191 2.698 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -119.66 147.94 44.92 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.68 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -77.99 13.73 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.592 2.195 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 164.09 128.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.19 159.09 16.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 p -62.8 164.34 8.07 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.241 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 -18.22 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.757 -1.215 . . . . 0.0 109.832 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -51.0 130.76 26.25 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.197 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 7.4 t80 -81.38 126.94 32.22 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.475 1.131 . . . . 0.0 111.446 -177.124 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mmt180 -159.58 75.63 3.1 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.614 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.4 Cg_endo -67.13 144.51 69.5 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.244 2.629 . . . . 0.0 113.288 -176.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.5 mp -129.59 132.68 46.85 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.407 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.644 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.3 t -91.41 161.78 14.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.056 . . . . 0.0 110.319 -178.458 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.45 177.11 18.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.062 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.493 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -70.37 -23.57 62.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.985 . . . . 0.0 108.682 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 41.4 p-10 -77.3 -6.99 55.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.082 179.36 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m120 82.27 28.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.677 -0.639 . . . . 0.0 109.911 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -103.07 136.4 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.515 HG22 ' CB ' ' A' ' 55' ' ' LYS . 23.5 m -88.79 137.91 31.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.713 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.9 m-85 -114.87 136.85 52.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.694 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.08 -48.25 3.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -178.606 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.3 p30 -167.4 -158.8 0.29 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.032 -1.275 . . . . 0.0 110.656 178.942 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.596 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.5 -45.06 73.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 112.574 -176.566 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.522 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 3.6 m -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.491 -1.381 . . . . 0.0 109.704 -178.658 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -53.5 -17.31 1.93 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.0 t80 -83.23 -69.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.586 1.184 . . . . 0.0 110.302 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.68 -46.11 77.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.754 -177.792 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.589 ' OD1' ' CD1' ' A' ' 11' ' ' TYR . 3.0 m-20 -44.96 -29.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.46 -1.4 . . . . 0.0 107.592 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 38' ' ' CYS . . . -71.96 -49.26 38.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.259 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' CYS . 75.4 t -52.49 -62.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.282 0.563 . . . . 0.0 110.198 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 1.5 p -60.75 -23.63 29.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.434 -0.791 . . . . 0.0 111.097 -178.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.9 tt0 -92.03 -11.56 35.6 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.532 -1.355 . . . . 0.0 108.965 179.183 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 44' ' ' SER . 6.1 t -103.79 22.05 15.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.702 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' THR . 7.6 m-80 60.35 43.96 12.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.055 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.26 28.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 45' ' ' ASN . 79.9 p -84.48 -16.18 43.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -1.206 . . . . 0.0 107.89 178.189 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.59 HD22 ' CE1' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -79.51 164.53 23.83 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.576 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.493 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 64.5 p -149.85 130.94 14.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.639 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.3 tp -64.98 146.13 55.42 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.65 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.63 -18.17 11.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.896 -1.127 . . . . 0.0 108.108 179.11 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.644 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 172.75 160.75 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.944 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.01 -166.83 0.17 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.253 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.61 -170.51 2.72 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.65 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER -90.15 158.11 17.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.542 -0.975 . . . . 0.0 108.413 179.99 . . . . . . . . 3 3 . 1 . 038 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.65 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 18.2 m . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.289 179.843 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -77.69 -166.43 0.77 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.786 -179.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 m -156.13 43.45 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -19.15 35.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 110.001 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -114.63 47.37 1.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 108.97 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 58.9 m-85 -142.72 163.95 35.49 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 -178.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -88.75 159.68 40.36 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.743 0.94 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.66 131.95 24.08 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 109.016 179.933 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.08 14.52 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 111.129 -179.699 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.82 142.11 22.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.819 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 17' ' ' THR . 33.0 t -144.78 162.88 35.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 109.565 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 16' ' ' CYS . 32.8 p -60.27 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 108.865 179.238 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pp -134.98 -13.18 2.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.031 -1.043 . . . . 0.0 110.958 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 15.6 pm0 -54.49 132.11 44.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.156 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 t80 -87.6 127.75 35.27 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.551 1.167 . . . . 0.0 111.911 -177.024 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmt85 -161.36 75.49 2.45 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.595 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 20' ' ' TYR . 26.9 Cg_endo -66.21 133.94 34.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.612 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -120.28 124.82 46.54 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.247 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.5 t -79.12 165.89 22.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 108.328 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.512 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -138.7 159.03 25.29 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.398 -1.382 . . . . 0.0 112.497 -176.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' HD13 ' A' ' 48' ' ' LEU . 5.7 t -46.08 -21.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.924 -0.75 . . . . 0.0 110.908 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 29' ' ' LYS . 27.1 p-10 -86.15 26.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 40.0 t-20 47.43 24.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 110.074 179.314 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.0 tttp -110.91 142.61 42.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 15.5 m -92.93 140.03 29.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 108.965 179.533 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 70.3 m-85 -112.91 126.51 55.54 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.513 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.01 -52.66 1.56 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p30 -158.96 -164.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.09 -1.241 . . . . 0.0 110.513 179.549 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.08 -49.65 30.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.598 -0.689 . . . . 0.0 111.999 -177.911 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 10.6 m -61.79 -58.09 9.34 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.57 -1.331 . . . . 0.0 110.43 -178.835 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.8 m-80 -58.68 -13.81 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.98 . . . . 0.0 110.062 -179.503 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 5.8 t80 -83.68 -58.13 2.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.307 1.051 . . . . 0.0 109.992 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 16.7 t -61.13 -29.36 69.73 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.128 -178.476 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.592 ' HA ' HG23 ' A' ' 42' ' ' VAL . 88.0 m-20 -58.71 -29.49 66.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.612 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.81 -30.99 51.51 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.59 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 52.1 t -75.86 -21.3 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.48 0.657 . . . . 0.0 109.435 179.535 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 39' ' ' ASN . 11.6 m -90.25 -22.12 6.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.83 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.709 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -89.81 -30.02 18.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 11.2 p -87.72 17.78 4.5 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.343 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' SER . 9.4 p30 50.63 41.26 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.679 -179.706 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.82 37.75 58.18 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 44' ' ' SER . 7.6 t -111.13 -1.7 16.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.086 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.17 -75.01 0.45 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.303 1.049 . . . . 0.0 109.162 -179.661 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.557 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.8 p 82.44 150.59 0.09 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.383 -177.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 51' ' ' SER . 14.2 tp -63.59 160.65 16.25 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.766 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 5.9 p -115.7 -43.62 3.01 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.1 160.63 1.42 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.264 179.429 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -69.04 172.56 6.54 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.956 179.224 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.48 -167.48 52.04 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -92.85 -172.08 2.91 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.847 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.593 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.4 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.05 124.81 41.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 108.808 179.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.538 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.3 m -135.06 46.91 2.38 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 -179.263 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.24 -0.66 57.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.415 179.6 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -117.88 36.05 4.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 92.8 m-85 -121.5 157.08 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.255 -0.903 . . . . 0.0 108.638 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.15 167.98 78.81 Favored 'Cis proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.022 2.298 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -116.32 142.91 30.13 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.546 -0.721 . . . . 0.0 109.202 -179.656 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -78.72 12.47 2.18 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.424 2.083 . . . . 0.0 110.489 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.87 109.98 0.34 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 92.4 m -95.18 140.56 29.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.785 -179.244 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -52.94 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.662 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.2 pp -128.69 -24.07 3.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.922 -1.111 . . . . 0.0 110.255 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 13.8 pm0 -46.37 134.87 8.64 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.204 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -87.55 126.48 34.95 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.535 1.159 . . . . 0.0 111.387 -177.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mtt-85 -161.57 82.03 1.9 Allowed Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.728 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.4 Cg_endo -65.64 125.6 14.62 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.615 2.21 . . . . 0.0 112.932 -176.489 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -110.12 136.91 48.62 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.924 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.574 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -103.54 122.74 45.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.091 -1.005 . . . . 0.0 111.053 -178.652 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 50' ' ' LEU . . . -62.57 -166.14 0.57 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.178 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -90.17 -25.99 20.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.442 -1.034 . . . . 0.0 108.728 179.31 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -79.29 -2.26 40.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.806 . . . . 0.0 109.086 179.384 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.8 m120 82.99 47.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 0.0 110.356 179.603 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 17.3 ptmt -121.87 116.28 24.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.538 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -75.42 153.06 37.88 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.726 0.774 . . . . 0.0 110.405 -178.564 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 3.6 m-85 -131.45 148.04 52.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.155 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -58.87 -37.59 91.02 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.479 -1.344 . . . . 0.0 111.947 -175.811 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -162.92 -165.78 1.18 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 110.388 -179.704 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.62 -23.63 66.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.6 -0.688 . . . . 0.0 110.536 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.7 t -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.976 -1.078 . . . . 0.0 109.522 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -66.37 -28.22 68.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.572 179.712 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 60.5 t80 -81.76 -45.05 16.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.333 1.063 . . . . 0.0 109.761 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.4 m -65.93 -26.78 67.75 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.758 -178.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.2 m-80 -70.19 -34.68 73.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.146 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.54 -20.33 58.75 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.576 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.462 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 55.0 t -84.67 -34.16 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 110.04 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG13 ' CB ' ' A' ' 11' ' ' TYR . 7.1 p -90.88 -16.29 8.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 0.0 109.996 -179.053 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.4 tm-20 -91.72 -19.8 22.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.991 -1.068 . . . . 0.0 108.422 179.053 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 5.8 p -100.25 23.41 10.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.496 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 66.04 11.72 7.96 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.223 -0.923 . . . . 0.0 109.172 -179.494 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 78.11 19.7 74.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.746 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.9 p -84.55 -12.45 54.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.15 -1.206 . . . . 0.0 108.986 179.549 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 2.1 tp -80.74 136.4 36.15 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.442 -0.786 . . . . 0.0 109.07 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 26' ' ' SER . 5.3 p -135.26 123.5 23.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.069 0.938 . . . . 0.0 110.244 179.385 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.563 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -72.93 153.03 41.15 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.674 0.749 . . . . 0.0 109.398 179.573 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.49 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -105.49 -23.8 12.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.235 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.574 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -165.58 159.36 16.52 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.896 -178.549 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -76.55 176.32 8.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.66 -167.37 54.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 7.4 mtmt -91.49 168.39 11.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.399 -1.059 . . . . 0.0 108.987 179.086 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.563 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.63 -179.45 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.473 ' CG2' ' HB2' ' A' ' 34' ' ' LYS . 6.4 p . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.14 151.62 15.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.548 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 23.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.58 3.66 54.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 110.544 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -131.4 -8.24 3.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.818 -1.177 . . . . 0.0 110.946 -178.977 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.653 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.5 m-85 -81.34 158.28 69.41 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.79 -1.194 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 38.2 Cg_endo -69.99 142.55 71.15 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.762 -1.766 . . . . 0.0 111.534 2.028 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -103.17 142.72 25.14 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.979 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -78.43 14.39 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.781 2.32 . . . . 0.0 111.251 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.94 125.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 179.853 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' THR . 45.3 m -102.91 139.16 38.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.95 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.85 -166.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.541 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -119.24 -28.97 5.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.921 -1.112 . . . . 0.0 109.825 179.969 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.56 119.4 1.64 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.106 -0.996 . . . . 0.0 108.999 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.8 t80 -80.07 124.12 28.45 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.631 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -156.97 82.46 3.21 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.765 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.8 Cg_endo -65.11 120.6 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.425 2.083 . . . . 0.0 111.944 -177.367 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.88 132.24 54.85 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.671 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.716 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 7.3 t -88.85 161.21 16.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.498 -0.751 . . . . 0.0 109.459 -178.965 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.562 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -107.52 172.55 17.75 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.866 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 20.6 t -74.41 -3.36 30.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -1.201 . . . . 0.0 108.84 179.554 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.9 p-10 -98.01 -2.17 40.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.177 179.457 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.5 t30 83.59 43.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 30' ' ' THR . 5.3 tttt -125.43 138.83 54.02 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 179.522 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 55' ' ' LYS . 19.6 m -92.74 152.12 19.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.504 179.804 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -128.57 130.16 46.98 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.706 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.94 -51.29 1.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -177.803 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.5 p30 -160.01 -166.55 1.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.871 -1.37 . . . . 0.0 110.522 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -54.55 -40.32 68.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.657 -0.652 . . . . 0.0 110.907 -178.477 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.5 t -60.48 -69.66 0.21 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.787 -1.195 . . . . 0.0 109.703 -179.324 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.3 m-80 -51.91 -26.09 9.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.447 -0.783 . . . . 0.0 111.272 -179.211 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 14.6 t80 -75.25 -62.02 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.638 -1.289 . . . . 0.0 110.828 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.653 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.4 t -53.32 -49.12 67.71 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.185 -177.413 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -49.16 -31.31 8.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.29 -1.506 . . . . 0.0 108.597 -178.812 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.616 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.64 -36.65 62.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.255 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.463 ' CG2' HD22 ' A' ' 48' ' ' LEU . 41.4 t -67.97 -32.36 55.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.392 0.615 . . . . 0.0 110.253 179.913 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -90.63 -14.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.069 -178.018 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.616 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 9.6 pt-20 -92.54 -29.53 16.14 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.892 -1.13 . . . . 0.0 108.216 178.053 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.0 p -87.68 20.1 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.864 -178.932 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 45.1 m-80 64.23 12.85 7.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 -179.439 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 78.74 19.61 72.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 44' ' ' SER . 20.0 p -91.67 0.41 57.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.927 178.984 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -80.47 -56.19 4.35 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.979 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.597 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 51.0 p 52.37 125.76 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.498 1.142 . . . . 0.0 111.972 179.329 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 6.6 tp -61.97 156.56 20.76 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.123 178.835 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.45 -23.86 8.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.87 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.716 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.4 p80 -179.58 161.82 1.06 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.774 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -78.32 173.33 12.42 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 78.84 -171.57 55.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.46 137.05 32.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.151 -1.205 . . . . 0.0 108.799 178.824 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.574 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.63 -179.772 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.239 0.542 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 042 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.11 137.77 32.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.464 179.924 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 m -135.26 61.91 1.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 109.909 -179.544 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.47 -0.73 57.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.838 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -128.34 39.65 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 042 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.581 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 52.1 m-85 -120.65 161.1 41.45 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 108.842 -179.847 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -75.43 174.56 52.16 Favored 'Cis proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.62 -1.825 . . . . 0.0 111.299 1.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 142.77 32.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.766 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.43 14.48 1.6 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 169.94 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.462 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 50.6 t -105.35 159.59 15.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 109.937 -179.8 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -61.72 -162.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.804 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -118.84 -28.07 5.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.658 -1.276 . . . . 0.0 109.913 179.768 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -42.73 118.4 1.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.793 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.9 t80 -79.23 128.64 33.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.382 1.087 . . . . 0.0 111.041 -177.84 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.31 78.9 2.21 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.217 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.1 Cg_endo -64.71 126.5 16.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.361 2.707 . . . . 0.0 113.366 -177.139 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.4 mp -110.47 127.15 55.01 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.334 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -88.27 119.1 28.36 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.782 -178.627 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.7 -158.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.989 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -91.84 -52.4 4.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.558 -0.966 . . . . 0.0 108.914 179.356 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.618 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -47.52 -24.63 0.89 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.169 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.8 p-10 103.3 33.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.177 0.513 . . . . 0.0 110.216 179.147 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.7 131.39 50.91 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 94.5 m -80.17 142.5 34.66 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 110.314 -179.088 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.5 m-85 -120.34 131.23 54.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.368 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.42 -50.9 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.163 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.2 p30 -167.19 -167.37 0.91 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.008 -1.289 . . . . 0.0 111.136 178.901 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.597 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.56 -42.85 11.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.125 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.1 m -67.74 -66.44 0.56 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.291 -1.506 . . . . 0.0 108.998 -179.262 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.513 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 17.9 m-80 -44.66 -23.17 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.527 -0.733 . . . . 0.0 110.194 -179.918 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 30.9 t80 -84.55 -48.73 9.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.74 1.257 . . . . 0.0 109.763 179.733 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.581 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -62.27 -58.98 5.71 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.072 -178.425 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.01 -31.36 0.17 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.147 -0.971 . . . . 0.0 108.772 -179.351 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -70.8 -50.71 32.74 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.543 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.5 t -51.71 -60.15 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.432 0.634 . . . . 0.0 109.97 179.036 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.538 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -62.6 -21.18 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.411 -0.806 . . . . 0.0 111.665 -178.539 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.2 tt0 -91.98 -11.59 35.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.457 -1.402 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 4.4 t -106.4 20.58 18.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.283 -0.885 . . . . 0.0 109.911 -179.555 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 75.94 1.48 3.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 108.967 -179.148 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 81.48 17.42 71.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' SER . 14.1 t -83.89 -13.05 54.52 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.279 -1.13 . . . . 0.0 108.65 179.053 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.452 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 2.0 tp -81.28 147.12 30.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.394 -0.816 . . . . 0.0 108.958 179.772 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -145.46 158.32 43.86 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.242 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.601 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -104.46 165.64 10.92 Favored 'General case' 0 C--N 1.281 -2.412 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 -178.937 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -106.99 -31.55 8.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.531 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -162.99 160.49 24.72 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.723 0.773 . . . . 0.0 110.068 -178.615 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' CD2' HD22 ' A' ' 23' ' ' LEU . 4.8 m-85 -77.14 -171.64 2.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.699 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.2 -166.57 28.94 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.829 . . . . . . . . 2 2 . 1 . 042 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 167.84 12.28 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.237 . . . . . . . . 3 3 . 1 . 042 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.648 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.7 m . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.723 -179.413 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.26 0.552 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 043 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.415 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 16.4 t0 -67.06 141.02 57.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 22.2 m -146.76 58.82 1.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.106 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.66 0.46 57.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.613 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.64 32.88 5.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.836 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 83.6 m-85 -119.28 158.3 48.95 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.58 169.92 73.22 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.506 -1.872 . . . . 0.0 111.706 1.799 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.578 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -128.05 144.8 52.89 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.959 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.93 14.3 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.652 2.235 . . . . 0.0 111.839 -178.759 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.23 145.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' THR . 54.1 t -122.85 159.99 27.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 109.272 179.449 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.6 p -61.28 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.174 -0.954 . . . . 0.0 108.594 179.24 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.96 -18.47 4.2 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.7 pt-20 -52.14 127.7 22.53 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.756 -1.215 . . . . 0.0 107.746 179.503 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 26.2 t80 -92.91 119.8 32.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 122.422 1.106 . . . . 0.0 110.969 -178.124 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtp-105 -152.17 81.8 5.53 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -65.02 131.31 28.35 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.966 2.444 . . . . 0.0 112.346 -177.448 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.638 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -117.58 121.44 40.95 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.965 179.254 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.608 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 5.1 t -80.49 120.05 23.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 108.593 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.06 -160.66 0.82 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -90.26 -37.88 13.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 108.048 178.328 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -58.55 -17.69 23.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.568 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 96.35 21.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.003 0.43 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -99.33 127.08 45.3 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.005 -1.059 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 m -77.06 140.13 40.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.425 -0.797 . . . . 0.0 109.574 -179.925 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 26.7 m-85 -115.81 129.16 56.33 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.693 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.46 -52.64 0.31 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -178.307 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.3 p30 -164.75 -164.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.806 -1.408 . . . . 0.0 110.992 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.03 -41.55 25.97 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.071 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.527 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 4.3 m -70.17 -64.67 0.85 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.202 -1.561 . . . . 0.0 109.098 -179.318 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.0 m-80 -43.92 -27.28 0.34 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.888 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 39.0 t80 -82.35 -46.87 13.02 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.067 1.413 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -56.9 -37.02 70.83 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.041 -178.349 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.54 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.41 -42.08 99.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.735 -1.228 . . . . 0.0 108.336 179.882 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.677 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -62.27 -25.08 67.64 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.5 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 74.9 t -80.59 -44.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 -179.526 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.522 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -81.27 -7.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.114 -0.992 . . . . 0.0 110.297 -178.791 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.92 -33.95 14.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.965 -1.084 . . . . 0.0 108.447 178.958 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 6.5 p -88.85 24.21 2.12 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.708 -0.62 . . . . 0.0 110.029 -179.528 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 73.4 4.7 4.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.052 -1.03 . . . . 0.0 109.05 -179.488 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 83.51 15.61 70.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.72 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -88.52 -1.8 58.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -1.061 . . . . 0.0 108.866 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 40' ' ' ALA . 1.1 tp -81.19 145.27 31.08 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.283 -0.885 . . . . 0.0 109.124 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 p -137.55 145.92 43.48 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.485 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -94.59 171.05 9.03 Favored 'General case' 0 C--N 1.275 -2.641 0 O-C-N 120.877 -1.139 . . . . 0.0 109.839 -179.412 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.8 -20.23 13.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.778 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.608 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 177.1 154.98 0.26 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.528 -0.733 . . . . 0.0 109.833 -178.884 . . . . . . . . 3 3 . 1 . 043 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CD2' HD22 ' A' ' 23' ' ' LEU . 5.4 m-85 -66.49 -165.78 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.206 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.21 -172.08 1.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.305 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.1 tttt -90.34 159.81 16.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.565 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.292 -1.891 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.605 -179.982 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 044 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -86.61 132.93 33.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.279 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.485 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 10.1 m -133.4 52.33 2.08 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.318 -0.864 . . . . 0.0 109.76 -179.606 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.35 8.02 35.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.774 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -119.64 3.79 11.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 96.2 m-85 -89.78 157.44 46.36 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.166 -0.959 . . . . 0.0 109.001 -179.731 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -74.96 143.01 76.45 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.617 -1.826 . . . . 0.0 111.366 2.495 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttp -84.16 143.93 43.24 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.632 -0.667 . . . . 0.0 109.274 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.73 13.54 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.539 2.159 . . . . 0.0 110.556 179.459 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.01 114.1 0.12 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.4 m -92.57 139.6 30.41 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 110.007 -179.332 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -50.27 178.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.545 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -123.37 -16.11 6.96 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.967 -1.083 . . . . 0.0 110.166 -179.663 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.1 pm0 -55.24 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.359 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.487 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 6.6 t80 -132.93 119.7 20.49 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.737 1.256 . . . . 0.0 110.835 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.9 mtp85 -160.25 74.63 2.92 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.154 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.9 Cg_endo -65.06 134.73 40.83 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.895 2.396 . . . . 0.0 113.4 -176.135 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.565 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.97 143.57 46.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.46 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -94.41 166.74 11.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 -178.861 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -127.44 161.98 21.48 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.501 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -65.69 -28.69 69.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.044 -1.268 . . . . 0.0 108.832 179.996 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -58.34 -15.51 10.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.737 . . . . 0.0 109.304 179.657 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.5 t30 90.28 33.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.04 0.448 . . . . 0.0 110.435 179.396 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -121.28 -176.37 3.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.932 -1.105 . . . . 0.0 109.177 178.683 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 8.9 m -123.17 163.92 19.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.826 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 29.4 m-85 -138.35 141.64 39.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.612 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -61.95 -41.33 99.65 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.312 -176.803 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.0 p-10 -157.8 -164.37 1.52 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.893 -1.357 . . . . 0.0 109.978 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -61.73 -31.71 71.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 110.826 -178.705 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -72.9 -44.17 61.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.665 -1.272 . . . . 0.0 109.632 -179.479 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -63.08 -44.26 96.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.693 179.925 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.4 t80 -65.43 -57.15 9.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.144 0.973 . . . . 0.0 110.963 -179.365 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -53.62 -51.73 62.13 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 -178.282 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.3 m-20 -45.41 -36.4 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.002 -1.061 . . . . 0.0 109.41 -179.758 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.86 -42.03 77.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 108.675 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.421 ' CG2' HD22 ' A' ' 48' ' ' LEU . 86.1 t -60.57 -59.66 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.649 -0.657 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 9.2 p -62.53 -21.51 27.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.226 -0.921 . . . . 0.0 111.013 -178.766 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.2 -15.29 27.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.71 -1.244 . . . . 0.0 108.818 179.065 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' HG21 ' A' ' 47' ' ' THR . 22.7 t -102.43 10.57 38.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.475 -179.935 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 67.21 10.09 7.45 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 109.178 -179.002 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.66 18.55 54.51 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.051 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.522 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 3.9 p -79.56 -15.22 58.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.977 -1.308 . . . . 0.0 107.875 178.076 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.65 160.8 26.2 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.719 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 70.8 p -156.64 124.6 5.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.142 0.972 . . . . 0.0 109.9 178.902 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -62.44 144.12 56.28 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.385 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.429 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.97 -18.29 13.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.857 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 179.72 161.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.629 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -75.89 179.36 5.57 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.217 -0.927 . . . . 0.0 108.93 179.128 . . . . . . . . 1 1 . 1 . 044 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.32 -167.04 54.45 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.534 . . . . . . . . 2 2 . 1 . 044 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.36 144.77 25.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -1.079 . . . . 0.0 109.217 179.573 . . . . . . . . 3 3 . 1 . 044 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.51 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.627 179.953 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -75.21 155.07 37.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.322 179.875 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -151.62 50.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 109.845 -179.867 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' HG3' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -92.11 -13.26 31.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.983 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.412 ' HG3' ' C ' ' A' ' 9' ' ' SER . 1.6 mp0 -134.19 57.33 1.81 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.143 -0.973 . . . . 0.0 110.626 -178.795 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 98.3 m-85 -143.29 149.49 48.41 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 120.86 -1.15 . . . . 0.0 109.326 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -73.97 161.06 95.11 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.438 -1.901 . . . . 0.0 111.654 2.485 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -121.16 139.88 30.18 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.668 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -77.8 13.62 1.65 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.524 2.149 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.23 128.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 179.906 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 51.3 t -114.6 159.7 20.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.407 179.711 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.438 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -61.42 -166.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.512 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -112.61 -17.4 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.866 -1.147 . . . . 0.0 109.643 179.666 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 5.3 pm0 -46.18 137.49 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.132 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.626 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 7.7 t80 -96.55 135.09 38.92 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.487 1.137 . . . . 0.0 111.409 -177.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.1 mtt180 -161.07 73.67 2.64 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.08 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.1 Cg_endo -63.2 119.1 6.04 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.65 2.234 . . . . 0.0 112.689 -176.613 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.51 130.83 54.81 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.059 178.885 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.71 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.21 106.37 11.19 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.761 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.601 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.76 -162.52 0.06 OUTLIER Glycine 0 C--N 1.297 -1.634 0 C-N-CA 118.033 -2.032 . . . . 0.0 108.856 -178.687 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.538 ' OG ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -88.59 -35.79 16.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.31 . . . . 0.0 109.29 -179.939 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p30 -63.21 -12.35 27.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 178.818 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 92.41 16.42 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.323 0.582 . . . . 0.0 109.864 179.697 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -99.33 121.2 40.76 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.341 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.498 HG21 ' N ' ' A' ' 31' ' ' TYR . 97.4 m -59.13 157.62 10.1 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.492 -0.755 . . . . 0.0 109.372 -179.527 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.8 m-85 -128.23 127.87 43.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.142 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.89 -53.0 1.17 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -177.584 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.0 p30 -160.45 -167.62 1.94 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.702 -1.469 . . . . 0.0 110.843 179.053 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 4.8 ptmt -50.53 -40.12 50.8 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.786 -0.571 . . . . 0.0 112.03 -177.116 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.0 m -66.55 -65.45 0.68 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.514 -1.366 . . . . 0.0 109.679 -179.314 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.8 m-80 -47.74 -28.29 2.41 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.437 -0.789 . . . . 0.0 110.366 -179.055 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 14.8 t80 -76.0 -57.6 3.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.616 -1.302 . . . . 0.0 109.797 179.566 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 34.0 t -54.13 -56.76 15.05 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.415 -177.949 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.93 -33.58 0.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.86 -1.15 . . . . 0.0 108.76 -178.693 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -49.11 64.79 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.191 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -56.9 -63.76 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.396 0.617 . . . . 0.0 110.249 179.046 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.486 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 2.1 p -59.47 -22.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.504 -0.748 . . . . 0.0 111.799 -178.197 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.8 -17.74 26.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.348 -1.47 . . . . 0.0 108.451 179.084 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.539 ' O ' ' CG2' ' A' ' 47' ' ' THR . 16.7 p -102.73 29.55 5.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.476 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.46 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.4 p-10 45.1 53.84 7.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 109.103 -179.638 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.452 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 38.33 45.17 1.78 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 44' ' ' SER . 11.1 t -110.48 -8.83 14.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.335 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.628 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.3 tp -81.71 -84.11 0.11 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.837 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.628 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p 79.81 171.62 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.063 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.86 174.42 8.38 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -178.633 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.629 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.58 -35.13 7.54 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.591 . . . . . . . . 3 3 . 1 . 045 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.71 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -165.34 162.15 19.47 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.55 -179.101 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -78.54 177.48 8.53 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 108.975 179.154 . . . . . . . . 1 1 . 1 . 045 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 76.03 -168.16 54.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.949 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.83 141.96 30.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -1.153 . . . . 0.0 109.749 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 046 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.1 104.67 17.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 m -90.87 57.33 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -89.87 -20.35 23.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 108.897 179.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.4 16.7 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.279 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 17.5 m-85 -102.2 168.15 9.39 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.9 Cg_endo -85.03 176.37 30.41 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.465 -1.473 . . . . 0.0 111.238 1.217 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 8.8 mttt -125.64 137.54 30.15 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.881 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -79.81 14.03 1.98 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.575 2.183 . . . . 0.0 110.766 -179.286 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.48 124.0 3.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.624 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -100.72 137.72 38.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.07 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -53.12 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.395 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.5 pp -121.1 -10.23 9.05 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.793 -179.621 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' LEU . 10.5 pm0 -57.3 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 6.9 t80 -136.45 129.2 30.77 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.19 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mtm180 -161.25 79.27 2.19 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.218 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.2 Cg_endo -64.97 116.61 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.233 1.955 . . . . 0.0 112.133 -177.288 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.638 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.81 125.82 52.37 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.432 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 51' ' ' SER . 41.8 t -78.91 165.87 23.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.953 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.69 172.26 20.97 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.18 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -66.04 -35.65 81.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.376 -1.073 . . . . 0.0 109.719 -179.099 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.6 p-10 -62.76 -11.55 18.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.096 -1.002 . . . . 0.0 108.915 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.4 t-20 85.69 30.34 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.457 0.646 . . . . 0.0 109.465 179.831 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 2.8 ttpt -114.71 143.29 45.29 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.087 179.749 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 26.9 m -91.94 155.04 18.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.493 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.569 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 57.3 m-85 -123.56 124.48 42.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.826 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.25 -51.86 0.71 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -154.73 -162.75 1.44 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.926 -1.338 . . . . 0.0 110.499 179.635 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.1 -42.45 93.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.704 . . . . 0.0 111.628 -177.917 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.5 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 42.8 t -55.46 -49.7 71.8 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.247 -1.533 . . . . 0.0 109.275 -179.744 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -61.94 -53.62 53.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.68 -179.122 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 63.1 t80 -53.26 -48.08 68.56 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.402 1.096 . . . . 0.0 110.143 -179.215 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 40.7 m -64.58 -30.58 71.61 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.625 -179.477 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.529 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 10.5 m-80 -70.77 -22.36 62.39 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.98 -1.075 . . . . 0.0 108.528 179.296 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.531 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -82.51 -27.62 31.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 ' CG2' HD22 ' A' ' 48' ' ' LEU . 73.8 t -77.81 -31.95 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.128 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 11' ' ' TYR . 21.5 m -86.42 -28.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.724 -0.61 . . . . 0.0 110.151 -179.431 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.99 -22.36 20.03 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 109.371 -179.586 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 26.2 p -89.88 10.36 24.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.709 -179.465 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 44' ' ' SER . 8.0 t30 74.47 11.24 4.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 108.654 -179.373 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 77.88 14.83 81.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.827 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 t -80.15 -8.4 59.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -1.21 . . . . 0.0 108.857 179.127 . . . . . . . . 1 1 . 1 . 046 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.512 HD22 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.75 163.76 24.22 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.454 -0.779 . . . . 0.0 109.17 179.999 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.493 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 40.0 p -147.71 126.55 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.953 0.882 . . . . 0.0 108.682 177.974 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.4 tp -58.5 125.19 22.32 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.334 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.5 t -83.22 -22.98 32.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.802 -179.753 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . 10.8 p80 154.26 162.42 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.888 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 23' ' ' LEU . 62.0 m-85 -69.71 170.57 10.63 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.791 -1.193 . . . . 0.0 108.821 179.284 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 78.27 -172.46 55.22 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.808 . . . . . . . . 2 2 . 1 . 046 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.78 150.04 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.261 . . . . 0.0 109.313 179.118 . . . . . . . . 3 3 . 1 . 046 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 55' ' ' LYS . 15.3 m . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.578 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 047 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 12.1 t70 -60.86 151.84 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 109.092 179.772 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.6 t -150.58 16.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.481 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.4 t -90.37 10.21 25.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.488 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.481 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.0 mp0 -124.66 -21.18 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 110.442 -179.618 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 91.4 m-85 -79.37 153.52 76.57 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 120.832 -1.167 . . . . 0.0 109.178 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.6 Cg_endo -74.55 144.59 81.44 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.232 -1.987 . . . . 0.0 111.344 1.514 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -105.85 163.24 17.48 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.692 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.28 13.69 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.426 2.084 . . . . 0.0 111.39 -179.75 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 130.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 90.5 m -93.76 152.54 18.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -51.74 -176.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 108.987 179.648 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.2 pt? -122.49 -35.69 3.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.027 -1.046 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.531 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.7 pm0 -53.13 137.98 32.48 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.429 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.1 t80 -86.88 127.61 35.04 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.258 1.028 . . . . 0.0 110.779 -178.462 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.2 mtm180 -160.61 85.31 1.91 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.327 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.8 117.94 4.98 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.755 2.303 . . . . 0.0 112.998 -177.348 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.07 131.04 54.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.89 177.88 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 41.0 t -78.32 162.86 26.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.977 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -144.43 169.1 26.52 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.902 -178.084 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.518 ' N ' HD13 ' A' ' 48' ' ' LEU . 2.3 t -58.55 -19.07 34.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.603 -0.939 . . . . 0.0 110.32 -178.028 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 26.5 p-10 -61.24 -13.24 17.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.102 -0.999 . . . . 0.0 109.416 179.727 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.4 t-20 83.88 14.76 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.681 -0.637 . . . . 0.0 109.697 179.902 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -128.01 -166.36 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 16.3 m -111.81 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.644 -0.66 . . . . 0.0 109.342 -179.898 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.7 m-85 -131.38 121.63 24.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.58 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.2 -52.9 0.28 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.264 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -157.89 -165.02 1.64 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.013 -1.286 . . . . 0.0 110.358 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.66 -42.75 68.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.58 -0.7 . . . . 0.0 110.597 -178.485 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 50.7 t -62.2 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.796 -1.19 . . . . 0.0 109.786 -179.844 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.9 m-80 -52.58 -23.69 6.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 110.211 -179.367 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.1 t80 -75.34 -67.08 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.15 -46.66 75.71 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.796 -177.923 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.2 m-20 -44.09 -30.94 0.82 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.745 -1.222 . . . . 0.0 107.991 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . . . -70.48 -49.5 47.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.537 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.621 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 76.8 t -54.02 -63.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.442 0.639 . . . . 0.0 110.216 178.945 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 11' ' ' TYR . 2.1 p -59.37 -22.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.408 -0.808 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.21 -15.13 27.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.519 -1.363 . . . . 0.0 109.23 179.421 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 5.5 p -100.66 7.58 43.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.885 . . . . 0.0 109.671 -179.685 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.7 t30 75.21 8.66 3.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 -179.579 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 82.26 19.78 63.93 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' SER . 14.5 t -91.7 -0.22 57.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.341 -1.094 . . . . 0.0 108.942 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.621 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.02 -70.32 0.67 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.898 0.856 . . . . 0.0 109.276 -179.494 . . . . . . . . 3 3 . 1 . 047 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.7 p 83.37 154.33 0.1 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.579 -178.756 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.6 tp -72.82 126.01 28.9 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.384 -179.536 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.574 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 8.1 t -79.3 -24.17 43.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 108.874 179.444 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 51' ' ' SER . 17.1 p80 150.67 174.27 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.541 178.378 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 23' ' ' LEU . 61.7 m-85 -82.9 155.86 23.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 110.092 179.741 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 84.1 -174.18 50.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -90.24 146.38 24.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.054 -1.262 . . . . 0.0 109.008 179.249 . . . . . . . . 1 1 . 1 . 047 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.532 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 048 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.64 133.84 39.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.278 -179.989 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB2' HG13 ' A' ' 41' ' ' VAL . 37.3 m -124.42 61.17 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.706 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 1.4 t -90.19 -31.94 16.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.654 179.93 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -81.48 0.94 35.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 109.307 179.792 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.582 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 65.5 m-85 -91.3 165.32 21.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 108.876 -179.839 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.9 Cg_endo -84.58 152.0 59.9 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.162 0.715 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 12.6 mttt -105.5 141.14 22.01 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.638 -0.664 . . . . 0.0 109.677 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.5 14.11 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.464 2.11 . . . . 0.0 110.413 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.68 145.67 14.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.751 . . . . 0.0 109.188 -179.985 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.4 m -123.76 152.71 41.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.955 -179.589 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.458 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.7 -167.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.14 179.695 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -125.08 -18.41 5.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 0.0 110.367 -179.664 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 7.3 pm0 -56.55 -167.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.891 -1.131 . . . . 0.0 108.246 179.591 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -135.73 130.35 34.04 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.401 1.096 . . . . 0.0 111.315 -179.833 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.81 79.0 2.35 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.94 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.1 Cg_endo -64.47 114.85 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.432 2.088 . . . . 0.0 112.675 -176.995 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.57 141.76 45.95 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.736 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 20.6 t -95.49 159.63 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.81 -1.156 . . . . 0.0 109.007 -179.565 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.484 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -129.58 172.08 20.03 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.321 -178.407 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 t -56.26 -38.31 70.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.904 . . . . 0.0 111.458 -177.53 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -52.08 -19.11 1.72 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.69 -1.256 . . . . 0.0 110.038 -179.276 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.2 t30 91.47 27.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.933 -0.48 . . . . 0.0 110.409 179.459 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 178.99 4.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.904 -1.122 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 41.7 m -107.15 162.37 13.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 40' ' ' ALA . 83.8 m-85 -127.74 121.09 29.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.027 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.93 -54.34 0.68 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.968 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.6 p30 -152.36 -167.88 2.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.038 -1.272 . . . . 0.0 109.991 179.114 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.8 -60.71 2.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.348 -178.518 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.483 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 41.9 t -43.45 -62.97 0.92 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.802 -1.186 . . . . 0.0 110.432 -179.425 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -49.65 -34.25 17.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 13.5 t80 -70.5 -60.05 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.31 1.052 . . . . 0.0 110.845 -179.002 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.582 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -53.69 -30.77 45.09 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.711 -0.618 . . . . 0.0 110.18 -179.107 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 1.6 m-80 -64.07 -39.15 93.44 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.106 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 31' ' ' TYR . . . -67.34 -20.21 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.34 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.568 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 41.5 t -84.8 -31.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 11' ' ' TYR . 2.7 m -82.28 -16.01 11.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.626 -0.671 . . . . 0.0 109.619 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.647 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.65 -32.35 15.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.885 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 60.0 p -86.56 10.14 16.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.802 -179.423 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.2 t30 75.05 7.35 4.21 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 108.858 -179.444 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 83.51 13.7 75.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.846 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 44' ' ' SER . 13.9 t -93.44 0.89 56.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 108.995 179.128 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -80.06 -71.57 0.45 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.036 0.922 . . . . 0.0 108.744 179.881 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.4 p 79.62 152.02 0.12 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.384 1.088 . . . . 0.0 109.997 -179.505 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -70.59 152.82 43.51 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.637 -179.734 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 p -99.38 -39.94 8.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.675 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.736 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.85 163.97 2.31 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.23 179.972 . . . . . . . . 3 3 . 1 . 048 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.46 136.68 36.37 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.467 . . . . . . . . 1 1 . 1 . 048 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 110.41 -167.64 12.73 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.798 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 151.72 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -1.216 . . . . 0.0 108.97 179.243 . . . . . . . . 2 2 . 1 . 048 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.511 179.989 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 049 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.65 45.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 16.8 m -102.19 62.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.982 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.35 -4.13 58.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.972 . . . . 0.0 109.943 -179.542 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -117.89 2.45 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.322 179.681 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 35.5 m-85 -85.54 165.38 35.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 109.782 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -88.13 169.42 36.99 Favored 'Cis proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.249 -1.563 . . . . 0.0 110.642 0.837 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HD2' ' CE1' ' A' ' 11' ' ' TYR . 5.2 mtpt -122.55 143.67 40.38 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 108.765 -179.848 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.81 13.88 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.491 2.127 . . . . 0.0 110.582 -179.882 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.7 112.27 1.89 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.636 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.3 m -81.02 143.28 32.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.837 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.3 p -62.73 -163.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.317 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.57 -15.9 8.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.987 -1.071 . . . . 0.0 109.636 179.836 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.5 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -47.92 123.46 6.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.016 -1.052 . . . . 0.0 108.477 179.417 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 27.8 t80 -86.59 110.68 19.99 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.361 1.077 . . . . 0.0 110.376 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 10.4 mtp180 -145.9 86.39 7.21 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.306 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 54' ' ' GLY . 27.8 Cg_endo -67.33 104.19 0.87 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 121.855 1.704 . . . . 0.0 111.596 -177.904 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.82 120.58 40.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.639 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 0.1 OUTLIER -78.82 -179.67 6.7 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.617 -178.867 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.74 165.27 29.63 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.198 -1.477 . . . . 0.0 112.222 -177.216 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -33.04 74.84 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -50.65 -24.93 3.67 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.95 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.61 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 31.1 t-20 96.33 37.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.026 179.57 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -136.88 -169.43 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 179.591 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 31' ' ' TYR . 91.8 m -127.39 158.92 36.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.345 -179.937 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 88.3 m-85 -132.51 105.9 7.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.378 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.78 -55.98 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 O-C-N 122.047 -0.408 . . . . 0.0 112.28 -177.789 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.1 p-10 -140.24 -171.02 3.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.608 -1.525 . . . . 0.0 110.627 -179.541 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.642 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.8 pttt -59.64 -30.77 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.777 -0.577 . . . . 0.0 110.55 -179.036 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.621 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 43.6 t -62.89 -74.12 0.1 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.674 -1.266 . . . . 0.0 108.261 179.194 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.529 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 18.3 m-80 -39.37 -48.67 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 110.557 -179.975 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 74.1 t80 -55.13 -46.37 75.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.665 -1.272 . . . . 0.0 109.265 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.594 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 27.3 m -59.83 -48.32 82.15 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.602 179.957 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.581 ' HA ' HG23 ' A' ' 42' ' ' VAL . 7.2 m120 -45.68 -30.02 1.44 Allowed 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.85 -1.156 . . . . 0.0 109.308 179.35 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -79.08 -40.16 31.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.992 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 58.1 t -69.88 -24.3 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.719 . . . . 0.0 110.146 -179.821 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 39' ' ' ASN . 30.1 m -91.94 -26.97 4.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.534 -179.182 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.504 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -91.29 -15.27 29.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.077 -179.931 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 26.8 t -102.24 19.79 18.02 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.2 m120 65.31 18.58 11.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.454 -0.779 . . . . 0.0 109.044 -179.604 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 71.68 18.37 77.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 45' ' ' ASN . 38.2 p -89.61 -10.02 47.52 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.486 -1.008 . . . . 0.0 108.784 179.401 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.43 148.05 32.08 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.75 . . . . . . . . 3 3 . 1 . 049 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 30.1 p -123.07 139.98 53.5 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.888 0.852 . . . . 0.0 109.721 179.332 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -61.21 130.16 44.85 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.696 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.01 -22.95 44.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.741 -1.224 . . . . 0.0 109.241 -179.913 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' SER . 12.3 p80 154.1 164.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.167 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.77 148.29 40.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.11 -0.993 . . . . 0.0 108.601 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 93.73 -179.31 38.46 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.325 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.97 168.4 17.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.315 . . . . 0.0 109.017 178.821 . . . . . . . . 2 2 . 1 . 049 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 30.7 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.687 -179.464 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.222 0.534 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 050 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -83.9 117.25 23.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.274 179.894 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.19 37.36 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.598 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.28 6.7 41.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.711 -179.859 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 24.1 mp0 -129.01 36.71 4.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 109.775 -179.76 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.608 ' CE2' ' HG3' ' A' ' 13' ' ' LYS . 24.3 m-85 -108.26 164.08 15.54 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 108.541 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.8 Cg_endo -77.7 -177.72 21.93 Favored 'Cis proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.967 -1.68 . . . . 0.0 111.684 2.232 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.608 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mmmt -125.54 148.14 60.56 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.616 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.73 14.01 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 163.62 165.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.688 179.746 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.9 t -140.43 160.0 40.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 179.877 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.48 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.091 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.0 pp -115.02 -24.37 8.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 109.57 179.605 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.9 pt-20 -43.79 116.6 1.0 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.3 t80 -79.26 130.96 35.99 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.496 1.141 . . . . 0.0 111.325 -177.622 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.03 78.35 2.33 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.315 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.53 118.45 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.89 2.394 . . . . 0.0 112.898 -177.097 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -106.67 131.58 53.65 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.779 178.478 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 51' ' ' SER . 40.8 t -79.45 162.54 25.4 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.121 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -141.95 166.49 26.28 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.259 -178.054 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t -55.74 -13.27 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.874 -0.78 . . . . 0.0 110.531 -178.729 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 4.0 p30 -75.01 5.94 4.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.175 . . . . 0.0 109.427 179.236 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 72.1 m-20 63.29 31.32 15.45 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.367 -0.833 . . . . 0.0 109.847 179.763 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -136.39 -168.26 2.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.659 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 18.3 m -119.85 162.45 19.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.571 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 12.8 m-85 -129.97 126.45 37.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.046 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.27 -53.76 0.96 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.527 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.6 p30 -157.54 -164.64 1.6 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.934 -1.333 . . . . 0.0 111.179 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.5 -47.49 63.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.662 -0.649 . . . . 0.0 112.31 -177.304 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.523 ' N ' ' HE3' ' A' ' 34' ' ' LYS . 5.2 m -63.54 -55.08 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.402 -1.436 . . . . 0.0 109.982 -178.62 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.4 m-80 -54.86 -27.87 45.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -0.997 . . . . 0.0 110.027 -179.541 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.0 t80 -74.03 -50.46 19.64 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.997 1.38 . . . . 0.0 109.401 179.639 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 13.5 m -60.56 -26.13 66.69 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.474 -179.257 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 19.7 m-20 -65.26 -34.22 77.85 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.927 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.571 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.61 -39.13 80.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 48' ' ' LEU . 86.5 t -65.11 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.581 -0.699 . . . . 0.0 109.89 -179.727 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.567 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 14.1 p -59.28 -19.75 16.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -0.771 . . . . 0.0 110.7 -179.335 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -90.75 -22.52 21.04 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.6 -1.312 . . . . 0.0 107.909 178.981 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 47' ' ' THR . 0.9 OUTLIER -98.44 29.29 3.69 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.114 179.533 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.516 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 6.0 p-10 44.34 53.82 6.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 39.03 47.1 2.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.31 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 44' ' ' SER . 6.5 t -111.53 -22.97 10.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.453 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.64 150.88 30.84 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.999 . . . . . . . . 3 3 . 1 . 050 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.568 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.2 p -125.02 138.14 54.22 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 109.41 179.621 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.3 tp -54.12 124.49 15.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.574 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 8.4 t -78.0 -22.84 48.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.793 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.58 ' CB ' ' O ' ' A' ' 51' ' ' SER . 12.9 p80 152.65 177.61 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.136 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -87.62 160.95 17.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 109.427 179.653 . . . . . . . . 1 1 . 1 . 050 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.64 -170.43 50.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.385 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 148.33 23.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.06 -1.259 . . . . 0.0 109.159 179.088 . . . . . . . . 2 2 . 1 . 050 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.511 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.546 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.56 60.86 0.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.34 -166.79 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.582 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -95.55 69.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.0 165.38 18.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -97.72 157.35 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.149 -0.97 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -87.93 122.92 32.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.99 19.61 10.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.696 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -19.55 60.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -106.06 42.02 1.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.593 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 42.8 m-85 -137.38 164.37 42.19 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 36.8 Cg_endo -86.89 145.9 31.59 Favored 'Cis proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.08 -1.633 . . . . 0.0 110.646 1.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.6 mttp -98.51 134.57 21.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.98 15.11 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.422 2.082 . . . . 0.0 111.022 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.89 124.47 7.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.387 -0.821 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.5 m -119.38 131.96 55.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 2.6 p -63.79 -169.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 108.61 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -115.35 -13.86 11.66 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.279 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 5.8 pm0 -46.15 127.74 8.89 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -87.33 125.3 34.15 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.68 1.228 . . . . 0.0 112.276 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -162.57 82.26 1.65 Allowed Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.8 Cg_endo -65.92 132.78 31.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.071 2.514 . . . . 0.0 113.67 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.9 mp -118.77 141.1 48.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -99.26 129.84 45.51 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.716 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.551 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -67.17 -167.74 3.27 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.7 t -82.56 -27.81 31.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.096 -1.238 . . . . 0.0 109.101 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.3 p30 -75.09 0.17 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.7 m-20 79.89 37.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 110.187 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' HG3' ' N ' ' A' ' 30' ' ' THR . 3.1 tttm -108.11 144.1 35.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 108.573 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.47 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 32.0 m -90.36 146.26 24.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.738 -1.227 . . . . 0.0 109.514 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.34 -49.27 3.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 7.2 p-10 -163.83 -166.64 1.21 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.274 -1.133 . . . . 0.0 110.217 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.607 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.32 -48.7 73.76 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.435 -0.79 . . . . 0.0 111.213 -177.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.455 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 16.0 t -54.44 -60.97 2.64 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.821 -1.175 . . . . 0.0 111.375 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.427 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 19.5 m-80 -62.43 -26.63 68.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.779 -1.2 . . . . 0.0 110.652 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 7.9 t80 -65.94 -59.84 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.856 -1.153 . . . . 0.0 109.863 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -59.86 -44.07 94.34 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.583 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.527 ' HA ' HG23 ' A' ' 42' ' ' VAL . 3.4 m-80 -43.25 -28.98 0.36 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.666 -1.271 . . . . 0.0 107.882 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.486 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -74.98 -49.78 18.79 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' CYS . 90.1 t -53.65 -56.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.584 0.707 . . . . 0.0 109.43 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.533 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 23.4 m -59.78 -26.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.543 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -88.0 -13.83 40.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.028 -1.045 . . . . 0.0 108.801 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.547 ' O ' ' CG2' ' A' ' 47' ' ' THR . 27.9 p -110.4 29.83 7.34 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.448 -0.782 . . . . 0.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 44.85 55.32 6.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.979 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 36.38 45.54 0.95 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 44' ' ' SER . 12.0 t -110.04 -7.4 14.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.609 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.5 tp -83.0 -71.45 0.5 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.51 0.671 . . . . 0.0 109.313 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.609 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 14.2 p 60.78 138.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.541 0.686 . . . . 0.0 109.37 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.66 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -93.57 165.59 12.66 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.697 0.76 . . . . 0.0 111.135 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.591 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.94 -34.5 6.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 2.6 p80 -156.08 165.21 37.11 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.583 0.706 . . . . 0.0 109.88 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.583 ' CD2' HD22 ' A' ' 23' ' ' LEU . 6.0 m-85 -83.15 -168.9 2.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.692 -0.63 . . . . 0.0 109.641 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 60.07 -166.95 9.81 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.469 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 mtmt -90.41 164.96 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.992 . . . . 0.0 108.657 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.146 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.273 0.559 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.36 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.498 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.15 84.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.428 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 29.1 m -88.55 94.24 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.7 t -177.48 130.33 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.66 154.24 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.86 118.06 23.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.408 -0.807 . . . . 0.0 109.784 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.2 m -97.91 50.45 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.241 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -79.36 -23.79 43.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.858 . . . . 0.0 109.635 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.94 43.18 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.038 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 34.0 m-85 -131.31 165.51 34.75 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.539 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -87.51 169.42 39.49 Favored 'Cis proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.237 -1.568 . . . . 0.0 110.887 -0.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.5 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 2.6 mtpt -125.25 142.99 43.05 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.81 14.86 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.719 2.28 . . . . 0.0 111.308 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 179.57 151.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -126.54 160.31 30.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.448 ' OG1' ' OE1' ' A' ' 19' ' ' GLU . 5.2 p -64.62 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.406 ' N ' ' OG1' ' A' ' 17' ' ' THR . 4.1 pp -132.17 -13.9 3.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.963 -1.086 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 15.2 pm0 -55.42 126.51 25.42 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 120.448 -1.408 . . . . 0.0 108.25 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.595 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 6.0 t80 -81.83 118.98 23.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.555 1.169 . . . . 0.0 110.906 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.9 69.08 10.89 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.5 Cg_endo -65.34 132.4 31.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.227 2.618 . . . . 0.0 113.389 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -125.21 132.99 52.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.198 178.228 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.698 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 32.8 t -78.09 118.67 20.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.52 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -64.01 -163.62 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 C-N-CA 118.648 -1.739 . . . . 0.0 109.481 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 49' ' ' THR . 8.5 t -85.25 -30.03 24.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -1.231 . . . . 0.0 108.766 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -71.07 -4.69 26.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.4 t30 84.83 16.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 110.095 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.63 126.54 44.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 108.375 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.447 HG22 ' HB3' ' A' ' 55' ' ' LYS . 51.8 m -64.71 144.8 56.98 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.047 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 31.7 m-85 -121.74 120.97 36.19 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.96 -50.23 0.21 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.62 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.6 p30 -162.41 -162.87 0.85 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.825 -1.397 . . . . 0.0 109.989 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.22 -47.28 65.76 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.48 -0.763 . . . . 0.0 111.829 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.3 m -62.79 -61.23 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.515 -1.366 . . . . 0.0 110.152 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.8 m-80 -50.04 -22.09 1.48 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.2 t80 -80.93 -52.87 6.97 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.797 1.284 . . . . 0.0 109.486 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.598 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 7.3 m -58.84 -30.15 67.45 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.314 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.614 ' HA ' HG23 ' A' ' 42' ' ' VAL . 4.1 m-80 -61.06 -29.85 69.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.584 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -76.61 -31.29 57.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.501 ' CG2' HD21 ' A' ' 48' ' ' LEU . 53.5 t -77.1 -24.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.5 0.667 . . . . 0.0 110.205 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.614 HG23 ' HA ' ' A' ' 39' ' ' ASN . 4.9 m -90.8 -25.71 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.898 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.51 ' N ' HG21 ' A' ' 42' ' ' VAL . 2.6 tt0 -90.96 -5.43 55.44 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.256 -0.903 . . . . 0.0 108.832 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 22.6 p -111.6 -0.65 16.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.1 t-20 77.43 15.18 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 108.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 81.29 2.51 90.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 t -80.12 0.43 32.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 108.662 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.563 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -82.41 -78.37 0.21 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.563 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.3 p 77.69 172.85 0.2 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.616 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -120.38 170.12 9.66 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.677 -1.264 . . . . 0.0 111.688 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.616 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 1.6 p -92.1 -42.09 10.12 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.476 1.131 . . . . 0.0 108.544 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.698 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -171.99 172.36 4.74 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.174 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -77.21 -174.63 3.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 108.763 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 64.75 -167.27 30.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.98 154.94 19.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.963 . . . . 0.0 109.305 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 55' ' ' LYS . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.5 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.76 63.71 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.376 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.78 165.77 35.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.892 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.546 ' HA ' ' CE1' ' A' ' 53' ' ' PHE . 16.0 m -133.72 70.8 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.212 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 t -174.53 124.2 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.444 HG22 ' CD2' ' A' ' 37' ' ' PHE . 5.4 t -91.05 143.49 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.602 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.63 177.79 6.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -156.2 39.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.211 -0.93 . . . . 0.0 109.715 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 -38.32 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -88.14 -4.76 58.7 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 61.0 m-85 -88.05 161.52 43.51 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.211 -0.931 . . . . 0.0 109.269 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.568 ' HB3' HG22 ' A' ' 42' ' ' VAL . 33.1 Cg_endo -87.27 144.44 27.29 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.424 1.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.473 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -101.07 142.21 24.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.291 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.57 13.63 2.04 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.517 2.144 . . . . 0.0 110.478 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.12 128.25 12.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' THR . 66.7 m -123.12 138.94 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.113 -0.992 . . . . 0.0 109.959 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -52.51 -176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.263 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.9 mt -117.89 -31.45 5.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.739 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.3 pm0 -44.26 135.93 4.24 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.575 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 5.4 t80 -87.27 126.88 35.1 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.789 1.28 . . . . 0.0 111.135 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.3 mtm180 -160.54 71.24 2.89 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.65 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 20.6 Cg_endo -62.97 132.76 38.24 Favored 'Trans proline' 0 C--O 1.196 -1.592 0 C-N-CA 123.844 3.029 . . . . 0.0 114.339 -176.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.658 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 4.3 mp -111.38 161.08 16.45 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.687 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 30.3 t -119.09 137.13 53.78 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.677 -1.89 . . . . 0.0 110.858 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.608 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -96.51 164.37 23.14 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.258 -0.901 . . . . 0.0 111.651 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 23.9 t -67.68 -29.31 68.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.8 p30 -59.51 -14.5 13.1 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.3 t30 88.97 10.15 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.299 0.571 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -99.38 126.52 45.27 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 HG22 ' HA ' ' A' ' 55' ' ' LYS . 20.9 m -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.829 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.73 136.65 36.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -39.52 -42.75 2.0 Favored Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.477 -0.765 . . . . 0.0 111.889 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.648 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 30.0 p30 -172.47 -149.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.684 -1.48 . . . . 0.0 109.813 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.38 -63.0 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.843 -178.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 16.8 t -53.71 -57.07 12.16 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.88 -1.137 . . . . 0.0 109.378 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -52.4 -24.26 7.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 108.842 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.829 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.7 t80 -78.09 -66.5 0.84 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.51 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 43.6 t -50.62 -44.92 57.35 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.587 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.526 ' HA ' HG23 ' A' ' 42' ' ' VAL . 8.1 m-20 -48.77 -35.28 13.95 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.439 ' HB2' ' O ' ' A' ' 37' ' ' PHE . . . -62.07 -45.37 93.84 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.572 ' CG2' HD22 ' A' ' 48' ' ' LEU . 56.6 t -62.73 -59.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.713 0.768 . . . . 0.0 109.662 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' A' ' 12' ' ' PRO . 2.9 m -51.55 -28.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.325 -0.859 . . . . 0.0 110.356 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.402 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -91.64 -20.41 21.66 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.793 -1.192 . . . . 0.0 109.464 -179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 43.8 t -97.11 9.94 40.75 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.642 -0.662 . . . . 0.0 109.906 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.0 m120 62.62 25.61 15.23 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.265 -0.897 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 20.3 73.44 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 44' ' ' SER . 1.5 p -103.72 16.92 25.23 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.602 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -94.4 -48.41 6.15 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.602 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 39.2 p 52.28 125.21 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.347 1.07 . . . . 0.0 111.547 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.516 ' HG ' ' N ' ' A' ' 51' ' ' SER . 7.9 tp -68.66 157.19 36.74 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.516 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.91 -20.21 10.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.687 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 173.68 162.04 0.16 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.546 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 16.8 m-85 -75.17 150.18 38.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.663 0.744 . . . . 0.0 109.131 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.65 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 96.94 -166.74 23.68 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 2.0 mtmt -90.07 158.65 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -1.156 . . . . 0.0 109.104 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 -44.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.01 178.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.724 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.555 HG13 ' CE1' ' A' ' 53' ' ' PHE . 3.7 t -139.94 113.7 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.44 ' HA ' HD21 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.44 150.82 45.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.22 138.24 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.45 160.68 25.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.138 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -134.17 57.75 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.084 -1.01 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.13 -29.64 20.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.69 30.16 2.12 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' HB3' ' HA ' ' A' ' 12' ' ' PRO . 40.5 m-85 -120.84 166.83 14.47 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -89.42 169.13 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.56 -1.433 . . . . 0.0 111.528 0.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -122.08 136.98 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.17 14.76 1.86 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.349 2.033 . . . . 0.0 110.859 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 126.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 109.525 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.0 t -110.37 159.84 17.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 82.5 p -64.7 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.595 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.95 -12.4 9.56 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.808 -1.183 . . . . 0.0 110.088 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.496 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.08 120.45 2.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.104 -0.997 . . . . 0.0 108.729 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.4 t80 -89.77 118.01 29.05 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.657 1.218 . . . . 0.0 110.294 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -151.41 74.54 8.1 Favored Pre-proline 0 C--N 1.287 -2.147 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.5 Cg_endo -63.35 126.13 17.1 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.09 2.526 . . . . 0.0 112.415 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.627 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.09 128.61 55.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.36 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 53.2 t -79.77 161.39 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.5 169.97 21.68 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.136 -1.507 . . . . 0.0 112.078 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.26 -20.8 66.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.016 -0.696 . . . . 0.0 109.969 -178.501 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.3 p30 -65.35 -12.14 49.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 109.153 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.2 t-20 85.29 30.4 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.535 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -132.56 -166.84 1.8 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.97 . . . . 0.0 109.416 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 31' ' ' TYR . 8.2 m -126.2 156.48 40.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.579 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 27.0 m-85 -126.54 126.45 43.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.3 -52.68 0.42 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.8 p30 -162.5 -166.08 1.29 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.802 -1.41 . . . . 0.0 111.152 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.11 -42.08 38.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.799 -0.563 . . . . 0.0 111.958 -177.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.521 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 m -68.72 -54.53 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.623 -1.298 . . . . 0.0 110.165 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.2 m-80 -59.02 -20.38 52.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.051 -1.031 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.626 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 35.6 t80 -80.18 -51.1 9.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.554 1.168 . . . . 0.0 109.285 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.551 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.3 m -60.58 -29.18 69.02 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.593 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.591 ' HA ' HG23 ' A' ' 42' ' ' VAL . 16.4 m-20 -67.1 -31.13 71.4 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.707 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.74 -23.21 49.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.455 ' CG2' HD21 ' A' ' 48' ' ' LEU . 48.6 t -84.16 -25.57 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 39' ' ' ASN . 3.6 m -88.07 -19.3 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.707 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.25 -32.21 15.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.163 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.1 t -84.09 8.88 14.06 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.539 -0.726 . . . . 0.0 109.838 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 69.1 m-20 61.72 27.08 16.56 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.155 -0.965 . . . . 0.0 108.96 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.51 27.3 73.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 26.0 p -105.19 -1.47 25.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.605 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.74 -79.77 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.605 ' CG2' ' O ' ' A' ' 48' ' ' LEU . 7.3 p 95.57 136.52 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.108 0.956 . . . . 0.0 110.185 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.626 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 15.1 tp -67.28 158.64 31.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 4.7 p -109.22 -43.24 4.19 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.695 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 167.01 1.74 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.555 ' CE1' HG13 ' A' ' 4' ' ' VAL . 23.3 m-85 -74.69 171.24 14.27 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.128 -0.983 . . . . 0.0 108.53 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -176.7 46.71 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.34 155.58 18.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.24 . . . . 0.0 109.077 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.454 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.425 HD21 ' N ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.425 ' N ' HD21 ' A' ' 1' ' ' LEU . . . -59.91 -174.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.371 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.47 155.47 44.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 5' ' ' SER . 14.3 m -139.44 75.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.482 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 56.6 p 175.01 149.59 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.246 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.469 HG11 ' SG ' ' A' ' 8' ' ' CYS . 4.1 p -122.06 175.52 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 109.65 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -87.3 134.0 33.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' SG ' HG11 ' A' ' 6' ' ' VAL . 12.8 m -144.7 42.06 1.34 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.221 -0.924 . . . . 0.0 109.869 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.449 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 27.3 t -90.83 -8.82 48.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -0.949 . . . . 0.0 109.685 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.3 mm-40 -97.9 -1.74 42.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.973 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.603 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 41.2 m-85 -82.88 158.16 65.41 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.131 -0.981 . . . . 0.0 109.526 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 37.1 Cg_endo -75.76 165.46 85.54 Favored 'Cis proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.589 1.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.587 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 6.0 mtmt -120.03 143.83 36.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.54 14.57 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.506 2.137 . . . . 0.0 111.1 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.83 128.37 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.355 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -105.51 144.21 32.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.743 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -61.71 -177.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 108.667 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -111.1 -20.77 12.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.052 -1.03 . . . . 0.0 109.738 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.436 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.3 mt-10 -44.89 122.63 3.34 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.121 -0.987 . . . . 0.0 108.751 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.479 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 32.8 t80 -86.93 108.81 18.97 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 122.497 1.141 . . . . 0.0 110.177 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.9 mtm180 -144.26 90.62 6.63 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -67.23 109.21 1.7 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.105 1.87 . . . . 0.0 112.239 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.641 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -105.45 118.49 36.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.538 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -79.33 176.93 9.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 110.542 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -139.91 172.91 23.18 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.425 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.5 t -65.65 -31.27 72.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.746 -0.856 . . . . 0.0 109.678 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.4 p30 -65.77 -8.74 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 83.15 19.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -103.22 154.37 19.4 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.458 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 53.6 m -106.54 143.73 34.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 94.5 m-85 -118.37 116.07 25.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 108.949 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.64 -54.43 0.63 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p-10 -144.11 -170.35 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.656 -1.496 . . . . 0.0 110.706 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.0 -28.22 67.53 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.978 -0.451 . . . . 0.0 111.634 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.5 t -70.98 -51.14 27.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.55 -1.344 . . . . 0.0 109.278 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.539 -0.725 . . . . 0.0 109.914 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.2 t80 -69.12 -53.31 20.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.442 1.115 . . . . 0.0 109.715 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.603 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.6 m -56.28 -47.84 77.81 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.334 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.49 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 6.0 m-20 -48.72 -33.3 9.93 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -72.36 -39.67 67.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.295 -0.878 . . . . 0.0 108.664 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.467 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 77.6 t -60.43 -57.2 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.626 -0.672 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.528 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -64.59 -22.34 31.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.473 -0.767 . . . . 0.0 110.612 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.13 -10.96 36.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.92 -1.113 . . . . 0.0 109.138 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CG2' ' A' ' 47' ' ' THR . 6.2 p -115.05 25.66 10.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 110.438 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' C ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 43.71 53.55 5.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.905 -1.122 . . . . 0.0 109.527 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.09 43.55 8.94 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 44' ' ' SER . 6.1 t -117.12 2.13 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -1.083 . . . . 0.0 108.483 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.655 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -84.61 -50.79 7.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.076 0.941 . . . . 0.0 108.536 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.655 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 62.0 p 57.66 126.34 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.302 1.049 . . . . 0.0 110.32 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.7 tp -61.65 131.15 49.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.44 -23.24 43.28 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 108.656 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.584 ' CD2' ' O ' ' A' ' 51' ' ' SER . 11.0 p80 154.46 163.47 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.15 151.82 44.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.824 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 90.73 -176.4 41.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.581 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.64 169.28 15.5 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.047 -1.266 . . . . 0.0 108.373 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.581 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 30.4 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.33 13.03 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.863 . . . . 0.0 109.353 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.4 -172.0 1.6 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.535 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 4' ' ' VAL . 4.0 p -147.06 66.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.279 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.8 t -165.06 -177.22 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.292 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 79.2 t -120.47 151.65 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.688 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -73.19 147.12 45.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 m -134.49 43.24 2.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -90.21 -11.45 40.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -125.03 49.61 1.85 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 m-85 -135.23 162.61 56.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.313 -0.867 . . . . 0.0 109.076 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.35 157.69 54.38 Favored 'Cis proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.852 -1.728 . . . . 0.0 110.749 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.581 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.39 140.24 25.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 108.688 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.37 14.97 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.679 2.253 . . . . 0.0 111.731 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.83 154.25 0.71 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.155 -0.965 . . . . 0.0 110.056 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 t -148.63 171.05 16.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.57 2.12 8.28 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.751 -1.218 . . . . 0.0 110.289 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.41 127.42 31.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 6.0 t80 -80.04 110.59 15.57 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.553 1.168 . . . . 0.0 111.272 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.22 73.29 37.75 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.462 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.5 Cg_endo -64.29 123.16 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.553 2.169 . . . . 0.0 112.721 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.4 mt -112.74 122.99 49.29 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.577 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -82.92 112.2 19.49 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.126 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.535 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.6 -166.13 0.06 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -78.1 -32.49 50.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -1.16 . . . . 0.0 109.137 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 37.1 p-10 -73.08 0.01 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.825 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 m120 77.27 30.32 0.53 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -98.87 137.5 37.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 m -86.97 122.61 31.06 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 82.0 m-85 -99.17 139.45 34.8 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -54.03 -39.03 62.02 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.111 -1.043 . . . . 0.0 112.021 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.4 p30 -162.58 -157.06 0.43 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.725 -1.456 . . . . 0.0 109.304 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.37 -47.5 85.78 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 111.263 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.516 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 89.3 m -68.07 -43.13 79.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.535 -1.353 . . . . 0.0 109.965 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -59.38 -24.08 63.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.825 -1.172 . . . . 0.0 108.449 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 10.3 t80 -83.15 -63.03 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.05 0.929 . . . . 0.0 111.004 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 t -56.92 -47.0 81.62 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.781 -0.574 . . . . 0.0 110.041 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' HA ' HG23 ' A' ' 42' ' ' VAL . 25.7 m-20 -42.43 -29.45 0.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.17 . . . . 0.0 108.307 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -73.86 -49.8 23.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.532 HG21 ' CD2' ' A' ' 48' ' ' LEU . 92.8 t -53.53 -54.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.573 0.702 . . . . 0.0 109.732 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.536 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 27.6 m -60.17 -30.06 45.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.289 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -85.78 -13.35 48.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 108.729 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.4 p -106.19 -2.75 22.14 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.473 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.565 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.0 OUTLIER 74.66 13.28 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 109.323 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 88.95 7.46 70.58 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.887 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.565 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 70.8 p -82.71 0.19 44.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.637 -1.507 . . . . 0.0 108.609 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.62 ' HG ' ' N ' ' A' ' 49' ' ' THR . 7.5 tp -80.15 -75.48 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.491 0.662 . . . . 0.0 110.117 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.62 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 p 62.56 147.0 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.652 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.06 171.69 7.21 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.858 -177.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.652 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.07 -29.43 8.97 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.57 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -167.92 159.84 11.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.6 -0.688 . . . . 0.0 110.082 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.49 -166.32 0.52 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.2 -167.1 18.25 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.512 ' CD ' ' N ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.34 -179.04 4.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 109.838 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.23 35.52 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.779 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.432 ' O ' ' CG2' ' A' ' 4' ' ' VAL . . . -148.03 115.57 6.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.446 HG12 ' O ' ' A' ' 50' ' ' LEU . 73.0 t -156.77 82.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 t -164.15 106.87 0.92 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 7' ' ' ASP . 9.2 p -104.42 163.81 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.032 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' HG23 ' A' ' 6' ' ' VAL . 25.4 t70 -105.1 108.95 20.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.559 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 17.8 m -128.95 52.86 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 t -90.29 -13.16 35.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -103.54 17.08 24.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 109.31 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.593 ' CE2' ' HB2' ' A' ' 38' ' ' CYS . 73.9 m-85 -96.72 163.68 19.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.8 Cg_endo -83.09 135.63 26.65 Favored 'Cis proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.308 -1.538 . . . . 0.0 111.258 1.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -100.79 138.38 20.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.82 14.04 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.401 2.068 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.21 19.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 94.2 m -103.67 146.46 28.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.261 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.461 HG23 ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -55.73 -166.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.459 -0.775 . . . . 0.0 108.91 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.3 pp -126.55 -37.34 2.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.49 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 5.1 pm0 -50.57 137.57 19.27 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.572 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.5 t80 -79.5 121.37 25.12 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.32 1.057 . . . . 0.0 110.382 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.606 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmm180 -148.61 72.38 10.67 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 28.3 Cg_endo -65.51 114.43 2.89 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.046 1.831 . . . . 0.0 111.743 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -109.42 138.56 45.6 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.675 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -89.15 165.13 14.68 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -127.42 168.55 19.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 35.4 t -66.81 -25.98 66.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -1.047 . . . . 0.0 108.856 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.8 p30 -65.52 -10.88 38.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 t-20 85.38 29.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 110.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.47 ' CG ' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -120.85 -179.37 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.968 -1.082 . . . . 0.0 109.261 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.502 HG23 ' N ' ' A' ' 31' ' ' TYR . 53.1 m -118.95 166.13 13.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.656 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.567 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 72.0 m-85 -138.49 110.9 7.46 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.48 -55.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -177.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.606 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.5 p30 -146.87 -172.54 4.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.771 -1.429 . . . . 0.0 110.787 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -53.26 -36.29 60.95 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.849 -0.532 . . . . 0.0 110.355 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.2 t -62.33 -69.47 0.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.63 -1.294 . . . . 0.0 108.937 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.567 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.6 m-80 -43.22 -38.7 2.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 110.765 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 72.9 t80 -70.59 -40.14 73.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.688 1.233 . . . . 0.0 110.483 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 91.7 m -68.53 -34.94 76.74 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.519 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 9.8 m-80 -69.08 -23.77 64.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.89 -1.131 . . . . 0.0 108.226 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.753 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.64 -24.9 33.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.508 HG21 ' CD2' ' A' ' 48' ' ' LEU . 72.9 t -80.99 -27.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 30.9 m -89.52 -21.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.746 . . . . 0.0 109.127 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.753 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -91.04 -31.15 16.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.545 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 86.4 p -86.93 -0.09 55.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.585 -0.697 . . . . 0.0 109.806 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 77.97 12.74 1.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.247 -0.908 . . . . 0.0 108.813 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 84.1 16.57 66.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.459 HG21 ' HB2' ' A' ' 44' ' ' SER . 7.4 t -98.02 10.1 41.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -1.123 . . . . 0.0 108.95 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.68 -53.3 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.6 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 81.1 p 53.65 124.97 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.644 1.211 . . . . 0.0 111.703 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' HG ' ' N ' ' A' ' 51' ' ' SER . 2.2 tp -71.6 152.75 42.64 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.539 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.74 -25.27 11.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.675 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.2 p80 -173.3 157.92 3.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -79.51 164.31 24.01 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.05 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 92.78 -167.27 29.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.81 129.39 36.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.083 -1.245 . . . . 0.0 109.645 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.508 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.4 ' O ' ' HB1' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.4 ' HB1' ' O ' ' A' ' 1' ' ' LEU . . . 60.19 16.59 6.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.751 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.91 51.4 1.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.071 -1.018 . . . . 0.0 109.591 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.609 ' HB ' ' CE1' ' A' ' 53' ' ' PHE . 16.3 m -97.37 97.44 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.881 . . . . 0.0 109.217 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.3 156.22 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.415 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 7' ' ' ASP . 25.1 t -142.98 151.22 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.423 ' N ' HG11 ' A' ' 6' ' ' VAL . 0.7 OUTLIER -94.35 159.24 15.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.42 36.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 0.0 109.246 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -85.57 -28.65 24.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.788 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.64 46.09 1.03 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.469 -0.769 . . . . 0.0 109.048 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 59.9 m-85 -139.77 161.25 57.4 Favored Pre-proline 0 C--N 1.306 -1.293 0 O-C-N 121.316 -0.865 . . . . 0.0 109.141 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.54 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -83.51 148.95 61.97 Favored 'Cis proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.882 -1.716 . . . . 0.0 110.793 2.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -102.94 137.78 19.37 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.94 14.66 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.658 2.239 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.26 158.04 2.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 30.3 t -146.54 163.04 37.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.694 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -56.91 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.526 HD11 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -122.81 -7.72 8.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.505 -1.372 . . . . 0.0 110.789 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.526 ' N ' HD11 ' A' ' 18' ' ' LEU . 12.1 pm0 -55.93 -173.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.6 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 3.4 t80 -128.93 121.32 27.83 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.622 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.9 mmt180 -151.22 66.17 7.02 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 54' ' ' GLY . 23.4 Cg_endo -63.28 137.17 59.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.494 2.796 . . . . 0.0 112.551 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 2.1 mp -127.49 143.49 51.18 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.202 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.63 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.0 t -101.53 162.3 13.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.236 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.536 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -106.95 178.55 22.17 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.1 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 27.4 t -70.65 -18.79 62.85 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -78.9 -10.98 59.98 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 85.06 33.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.315 0.579 . . . . 0.0 109.662 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -111.94 139.82 47.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.248 -0.908 . . . . 0.0 109.019 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.505 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 18.5 m -90.04 161.97 15.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.147 . . . . 0.0 110.018 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 63.9 m-85 -138.39 137.92 37.74 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.55 -50.23 3.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.622 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -164.37 -166.21 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.152 -1.204 . . . . 0.0 111.123 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.567 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -47.72 -48.48 29.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.717 -0.614 . . . . 0.0 112.374 -177.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.0 m -65.86 -52.64 48.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.473 -1.392 . . . . 0.0 110.457 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.1 m-80 -60.06 -17.45 39.54 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.847 -1.158 . . . . 0.0 109.347 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.615 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 27.6 t80 -82.59 -50.31 8.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.588 1.185 . . . . 0.0 109.762 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.619 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -66.51 -24.02 66.33 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.786 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -64.43 -26.22 68.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.764 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.28 -26.8 26.4 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.558 HG21 ' CD2' ' A' ' 48' ' ' LEU . 93.1 t -80.97 -23.72 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 27.7 m -90.82 -25.65 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.764 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.6 pp20? -90.42 -28.23 18.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.522 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 48.2 t -89.11 3.54 51.48 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.5 t30 77.11 9.77 2.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 108.958 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 82.89 3.21 90.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.5 HG21 ' OG ' ' A' ' 44' ' ' SER . 14.1 t -79.85 2.68 22.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.041 -1.27 . . . . 0.0 108.974 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.6 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.41 -50.02 11.45 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.805 0.812 . . . . 0.0 109.088 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.6 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 25.2 p 54.86 122.13 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.293 1.044 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.615 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.9 tp -60.61 152.99 24.84 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.546 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.15 -20.26 11.01 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.63 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 171.23 158.46 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 5.1 m-85 -71.18 -169.23 0.36 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 109.002 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.11 -168.76 5.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.585 ' N ' ' HD3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.41 146.41 23.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.429 -1.042 . . . . 0.0 109.452 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.599 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.397 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 177.96 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.956 . . . . 0.0 109.68 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.64 106.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.459 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.438 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 74.8 t -90.93 67.73 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.473 ' HA ' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -168.36 175.54 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.88 144.6 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.314 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -67.55 116.75 8.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 m -99.15 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 m -90.48 -8.67 49.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.49 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.437 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 3.9 pm0 -112.97 -7.55 13.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.973 -1.079 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.566 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 97.6 m-85 -88.88 158.9 46.87 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 108.938 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.0 Cg_endo -79.89 134.99 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.841 -1.733 . . . . 0.0 110.631 3.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.63 138.98 19.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.638 -0.664 . . . . 0.0 110.215 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.76 15.05 2.02 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.512 2.141 . . . . 0.0 110.237 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.42 133.42 20.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.806 . . . . 0.0 109.243 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 82.3 m -112.23 150.31 31.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 p -56.75 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 108.942 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -123.6 -28.3 3.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.998 -1.064 . . . . 0.0 109.725 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.463 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 9.5 pm0 -58.57 -166.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.5 t80 -132.83 124.75 28.57 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.258 1.028 . . . . 0.0 110.62 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -154.78 75.83 5.5 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.2 Cg_endo -64.59 123.67 12.08 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.701 2.267 . . . . 0.0 112.557 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.589 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.39 126.78 53.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 49.5 t -79.4 161.78 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.301 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -132.91 166.54 23.6 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.545 -177.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.475 ' N ' HD13 ' A' ' 48' ' ' LEU . 13.2 t -53.15 -48.46 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.945 . . . . 0.0 110.781 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -41.63 -26.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.202 -179.344 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 p-10 97.93 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.273 0.559 . . . . 0.0 109.899 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -125.81 173.64 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 109.583 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -108.9 150.02 28.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 74.0 m-85 -117.36 124.75 49.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.94 -52.32 1.19 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.5 p-10 -158.51 -168.34 2.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.746 -1.444 . . . . 0.0 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.589 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 7.8 pttt -46.86 -49.95 19.37 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.995 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 43.9 t -56.1 -64.88 0.72 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.696 -1.252 . . . . 0.0 110.07 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.4 m-80 -53.64 -18.9 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 6.8 t80 -79.41 -65.06 1.05 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.677 -1.265 . . . . 0.0 110.216 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.566 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.6 t -56.48 -48.71 76.55 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.033 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.0 m-20 -43.91 -28.0 0.41 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.614 -1.304 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB1' ' CE1' ' A' ' 31' ' ' TYR . . . -74.43 -48.03 30.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.591 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 79.7 t -57.08 -54.64 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.646 0.736 . . . . 0.0 109.649 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 20.3 m -58.25 -30.28 39.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.438 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -91.27 -10.59 40.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.154 -0.966 . . . . 0.0 109.36 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 13.7 t -102.96 12.68 35.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 110.398 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.2 m-80 62.44 23.89 14.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.059 -1.026 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 62.88 25.11 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.5 p -95.13 -4.16 46.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.395 -1.062 . . . . 0.0 108.209 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.591 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -88.94 -76.51 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.081 0.943 . . . . 0.0 109.306 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.576 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.7 p 80.94 152.0 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.871 0.843 . . . . 0.0 108.955 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 68.2 tp -68.92 158.21 35.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.478 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p -111.96 -42.38 3.79 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.708 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.01 169.94 1.9 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -82.12 176.37 9.57 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.001 -1.062 . . . . 0.0 108.655 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -168.13 54.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 153.14 20.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 109.145 178.722 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 26.9 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 3' ' ' ALA . . . -112.64 -65.14 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 0.0 109.757 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . -43.4 136.52 3.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 13.1 p -154.16 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.457 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.442 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 28.5 p 178.71 154.87 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 p -115.27 177.51 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 109.282 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 8' ' ' CYS . 61.2 t0 -125.78 130.27 51.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.964 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 15.6 m -129.71 69.51 1.42 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -91.21 -18.79 23.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.65 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.3 mp0 -106.22 27.5 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.134 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.587 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 97.7 m-85 -109.3 158.26 34.98 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.087 -1.008 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 33.5 Cg_endo -80.86 143.97 64.25 Favored 'Cis proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.823 2.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 7.1 mttt -103.5 136.03 19.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.858 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.6 14.71 1.77 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.757 2.305 . . . . 0.0 110.58 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.12 136.84 11.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.6 m -128.55 136.89 51.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 109.841 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.9 p -55.99 -165.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.3 pp -131.87 1.36 3.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.844 -1.16 . . . . 0.0 110.326 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 4.9 mm-40 -57.4 -165.99 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.56 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.1 t80 -139.73 115.08 9.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.448 -1.301 . . . . 0.0 111.38 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.77 74.3 8.64 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 27.9 Cg_endo -65.35 121.9 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.894 -176.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.623 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.34 137.53 50.35 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.67 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER -86.67 167.58 14.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.376 -0.827 . . . . 0.0 109.11 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.38 159.73 23.47 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.497 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -68.62 -19.68 64.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -1.164 . . . . 0.0 108.915 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -66.74 -9.16 33.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.4 t-20 87.48 22.87 0.05 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.85 -0.531 . . . . 0.0 110.669 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.14 177.44 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.82 -1.175 . . . . 0.0 109.627 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.514 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 29.9 m -118.24 166.5 12.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.233 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 73.7 m-85 -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.94 -51.28 7.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.955 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.3 p-10 -149.4 -165.29 2.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.763 -1.433 . . . . 0.0 110.828 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.623 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.22 -24.61 67.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.642 -0.661 . . . . 0.0 111.537 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.6 t -76.27 -39.55 54.05 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.574 -1.328 . . . . 0.0 108.898 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.3 m-80 -72.1 -34.48 68.67 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.506 -0.746 . . . . 0.0 109.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 24' ' ' CYS . 63.2 t80 -75.65 -44.18 43.92 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.393 1.092 . . . . 0.0 109.896 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.587 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 20.9 m -66.51 -38.45 87.25 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.568 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 6.9 m-80 -63.74 -21.37 66.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.57 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -85.15 -27.91 25.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG11 ' HA2' ' A' ' 46' ' ' GLY . 86.4 t -76.45 -26.89 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.553 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 21.0 m -91.07 -26.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.372 0.606 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -90.7 -15.36 30.46 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 20.0 t -101.29 12.6 37.18 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.157 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER 68.64 7.72 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.066 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 87.3 13.16 66.32 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.554 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 3.3 p -79.6 -11.11 59.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.289 . . . . 0.0 108.746 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.5 OUTLIER -78.38 159.34 28.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 48' ' ' LEU . 81.2 p -157.64 126.46 5.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.095 0.95 . . . . 0.0 110.061 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -63.43 145.51 55.47 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.503 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.84 -25.04 11.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.67 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -171.42 160.73 6.14 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -79.35 174.06 11.95 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.197 -0.939 . . . . 0.0 108.768 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.31 -166.64 42.31 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.96 131.06 37.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.047 -1.266 . . . . 0.0 109.048 178.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.579 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.532 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.08 131.14 32.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.57 49.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.462 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.517 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 25.1 m -96.54 87.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 20.9 p 176.11 158.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 t -128.15 153.6 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -64.27 119.07 9.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 108.962 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 6' ' ' VAL . 15.9 m -132.38 40.17 3.32 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.093 -1.004 . . . . 0.0 110.044 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.05 4.95 48.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -126.81 2.72 6.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.069 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 46.1 m-85 -84.71 162.07 51.46 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.13 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -71.68 148.04 89.51 Favored 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.891 2.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -91.5 144.44 29.62 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.92 13.57 1.93 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.53 2.153 . . . . 0.0 110.822 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.35 117.83 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.7 m -102.77 135.14 44.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.469 ' OG1' ' HD3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -55.88 142.92 33.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 19' ' ' GLU . 5.2 mt -75.88 -36.58 59.48 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.97 . . . . 0.0 109.51 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -42.84 122.28 2.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.356 -0.84 . . . . 0.0 108.782 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 21' ' ' ARG . 11.5 t80 -80.82 104.27 11.22 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.672 1.225 . . . . 0.0 110.543 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.61 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 mmt180 -137.55 80.91 31.17 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -66.97 128.83 19.45 Favored 'Trans proline' 0 C--O 1.202 -1.323 0 C-N-CA 123.994 3.129 . . . . 0.0 114.771 -176.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.619 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 2.0 mp -107.83 158.34 17.4 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -116.48 137.3 52.27 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.285 -1.509 . . . . 0.0 110.394 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.577 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -102.07 157.71 18.45 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.221 -0.925 . . . . 0.0 112.969 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.414 ' N ' HD13 ' A' ' 48' ' ' LEU . 41.1 t -55.4 -18.64 7.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.192 -0.593 . . . . 0.0 110.382 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -84.57 20.29 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.998 -1.064 . . . . 0.0 109.398 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 27.4 t30 56.83 15.34 2.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -99.69 127.54 45.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -89.03 126.55 35.47 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.55 -0.719 . . . . 0.0 109.794 -179.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 126.45 43.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -24.8 -42.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -178.73 -154.85 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 109.745 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.578 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.39 -60.13 3.59 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 110.658 -177.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 49.2 t -52.44 -65.75 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.606 -1.309 . . . . 0.0 110.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.501 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 10.2 m-80 -49.28 -21.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.8 t80 -78.8 -71.31 0.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.012 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.601 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -39.72 -40.62 0.96 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.413 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.92 -44.91 94.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.474 -1.391 . . . . 0.0 108.016 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.684 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -54.17 -21.64 9.33 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.49 HG23 ' CD2' ' A' ' 48' ' ' LEU . 56.7 t -85.64 -63.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.55 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 0.7 OUTLIER -59.0 -9.21 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 110.279 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.684 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.02 -32.02 16.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.551 -1.343 . . . . 0.0 107.78 178.302 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -92.22 7.89 40.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 80.93 3.71 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.331 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.94 6.23 79.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -79.79 2.25 23.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -1.188 . . . . 0.0 108.758 179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -89.12 -78.91 0.34 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.364 -0.835 . . . . 0.0 109.339 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.567 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.7 p 83.57 148.13 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.047 0.927 . . . . 0.0 109.276 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 51' ' ' SER . 13.1 tp -67.29 166.47 14.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.584 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -122.6 -44.62 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -160.28 159.37 31.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -77.21 143.43 39.0 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.714 0.768 . . . . 0.0 110.057 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 101.91 -167.42 18.45 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.48 137.63 32.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.438 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.516 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.441 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.34 110.6 14.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.49 96.78 5.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.49 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.77 77.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.902 . . . . 0.0 109.518 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.79 84.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.95 115.7 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.43 104.73 5.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.999 . . . . 0.0 109.601 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.489 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 59.8 m -103.59 52.72 0.77 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -21.53 38.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.0 109.859 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.75 -7.53 59.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.576 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 74.7 m-85 -79.87 163.86 56.01 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.8 Cg_endo -82.38 143.0 51.26 Favored 'Cis proline' 0 C--N 1.306 -1.664 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.088 2.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.2 mttt -97.35 141.11 22.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.033 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.42 15.13 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.755 2.303 . . . . 0.0 110.477 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.27 116.29 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 109.028 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.6 m -82.24 145.59 29.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -52.35 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -114.91 -19.29 11.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.822 -1.174 . . . . 0.0 110.262 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 18' ' ' LEU . 16.5 pm0 -57.9 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.788 -1.195 . . . . 0.0 107.827 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.2 t80 -139.15 126.85 21.95 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.893 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.2 mtm180 -161.52 81.03 1.99 Allowed Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.0 Cg_endo -63.83 107.24 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.192 1.928 . . . . 0.0 111.739 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.602 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -100.6 126.09 47.05 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.198 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.494 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 43.3 t -77.97 168.1 20.43 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -145.46 161.19 28.19 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.102 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -59.45 -35.18 73.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.728 -0.866 . . . . 0.0 109.441 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.635 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -45.18 -27.43 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 109.036 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 101.11 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.063 0.458 . . . . 0.0 109.961 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 175.24 8.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.105 -0.997 . . . . 0.0 109.616 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 HG21 ' N ' ' A' ' 31' ' ' TYR . 38.0 m -106.18 162.08 13.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.7 m-85 -133.26 102.66 5.65 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.188 -0.945 . . . . 0.0 108.618 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.14 -60.29 0.02 OUTLIER Glycine 0 N--CA 1.499 2.856 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.1 p30 -143.42 -170.37 3.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.968 -1.313 . . . . 0.0 110.627 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.19 -48.32 45.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.853 -0.529 . . . . 0.0 110.816 -178.804 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 18.2 t -53.32 -71.59 0.07 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.741 -1.225 . . . . 0.0 109.432 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.2 m-80 -40.28 -39.77 1.01 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.839 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.596 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 35.9 t80 -61.73 -51.51 68.05 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.862 1.315 . . . . 0.0 109.833 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.576 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 90.1 m -57.77 -50.89 71.72 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.575 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -44.37 -29.29 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.833 -1.167 . . . . 0.0 108.66 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.589 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.42 -49.41 49.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.529 ' CG1' ' HA2' ' A' ' 46' ' ' GLY . 38.4 t -57.62 -56.84 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.667 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.52 HG23 ' HA ' ' A' ' 39' ' ' ASN . 13.2 m -58.7 -23.07 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 0.0 110.642 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.1 tt0 -91.43 -17.48 25.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.391 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.507 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 11.9 t -105.69 22.95 14.67 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.342 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' HB2' ' O ' ' A' ' 44' ' ' SER . 21.6 m120 64.74 9.61 5.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 109.524 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 80.92 17.93 71.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.1 p -89.97 -9.43 48.78 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.373 -1.075 . . . . 0.0 108.239 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.561 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -81.47 149.76 28.6 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.561 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 5.1 p -122.41 151.52 41.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.6 tp -65.52 124.28 21.89 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.3 t -78.55 -24.75 45.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.62 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CB ' ' O ' ' A' ' 51' ' ' SER . 15.9 p80 151.02 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.299 0.571 . . . . 0.0 110.056 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 154.91 22.54 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 85.54 178.5 50.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.573 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -79.85 161.37 25.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.892 -1.358 . . . . 0.0 107.947 178.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.488 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 1.6 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.488 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 74.36 142.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.326 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.29 89.12 2.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.892 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.534 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -104.32 80.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 0.0 108.882 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -162.01 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.403 -0.81 . . . . 0.0 109.795 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 6' ' ' VAL . 87.1 t -145.41 47.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.095 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 50.2 t0 63.77 147.42 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.513 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 40.8 t -160.49 20.89 0.15 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.027 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -90.8 -4.01 56.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -108.56 34.82 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.667 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 94.1 m-85 -133.23 159.67 71.7 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.52 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -73.42 159.6 97.14 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.859 -1.725 . . . . 0.0 111.994 2.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttt -117.72 144.78 35.05 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.504 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.26 14.48 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.44 2.093 . . . . 0.0 111.411 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 166.21 134.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.2 t -112.03 157.62 20.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.516 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.486 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 10.6 p -59.3 -162.53 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -120.53 -15.92 8.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.524 -1.36 . . . . 0.0 109.976 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.9 pt-20 -46.62 130.55 11.37 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.1 t80 -89.28 130.02 35.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.391 1.091 . . . . 0.0 111.107 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mtt180 -160.63 74.26 2.79 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.0 Cg_endo -64.59 129.7 24.42 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.145 2.563 . . . . 0.0 112.794 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.646 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.93 135.72 53.94 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.515 -1.274 . . . . 0.0 108.212 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 8.7 t -77.37 133.44 38.72 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -79.94 -162.68 26.03 Favored Glycine 0 C--N 1.292 -1.867 0 C-N-CA 117.67 -2.205 . . . . 0.0 109.218 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.537 ' OG ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -85.85 -33.87 21.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -1.2 . . . . 0.0 108.331 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -57.3 -17.29 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t30 96.31 22.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 120.982 0.42 . . . . 0.0 110.707 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -107.49 -158.5 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 0.0 109.163 178.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.441 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 20.9 m -129.74 158.9 38.12 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.484 -0.76 . . . . 0.0 110.031 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.59 ' CD2' ' HA ' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -132.74 135.02 45.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.95 -50.3 1.5 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -163.73 -157.42 0.4 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.945 -1.327 . . . . 0.0 110.369 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.646 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 112.146 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.644 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -64.9 -57.01 9.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.585 -1.322 . . . . 0.0 110.43 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.06 -32.21 71.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.025 -1.047 . . . . 0.0 110.129 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 7.0 t80 -62.38 -60.06 4.1 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.793 -1.192 . . . . 0.0 109.511 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.8 t -56.79 -49.68 74.61 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.033 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 7.1 m-20 -40.97 -30.82 0.14 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.807 -1.183 . . . . 0.0 108.084 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.38 -49.45 18.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.1 t -60.36 -63.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 7.1 p -55.89 -26.36 20.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 111.785 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.43 -16.17 27.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.08 -1.637 . . . . 0.0 108.737 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 10.7 t -98.85 21.94 10.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 110.097 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' SER . 78.4 m-20 65.22 8.27 4.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.862 . . . . 0.0 109.927 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.12 11.32 85.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.2 p -79.3 -4.24 49.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.025 -1.28 . . . . 0.0 108.194 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.642 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.9 tp -79.94 -86.03 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.642 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p 80.36 168.69 0.16 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -119.82 178.89 4.42 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.639 -1.288 . . . . 0.0 110.565 -178.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.614 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.07 -38.36 3.89 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.3 p80 -163.93 151.67 12.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.752 0.787 . . . . 0.0 110.139 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.586 ' CD2' HD22 ' A' ' 23' ' ' LEU . 15.6 m-85 -62.41 -174.97 0.07 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.69 -0.631 . . . . 0.0 109.413 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 66.15 -169.27 32.15 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 1.2 mtmm -92.51 134.99 34.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.691 -0.888 . . . . 0.0 109.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.539 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.954 -1.091 . . . . 0.0 109.402 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.282 0.563 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.14 -92.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.622 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.43 175.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -142.35 73.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.26 124.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.9 t -98.67 152.72 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.707 -179.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 11.5 p-10 -80.62 -176.37 5.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 7.1 m -157.81 49.77 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.792 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -90.96 -4.27 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.965 . . . . 0.0 110.07 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.436 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 4.6 mp0 -134.11 49.4 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.004 -1.06 . . . . 0.0 110.422 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.617 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 99.1 m-85 -141.66 153.48 65.05 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 120.922 -1.111 . . . . 0.0 109.241 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.28 136.44 44.95 Favored 'Cis proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.396 -1.918 . . . . 0.0 111.439 2.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.481 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.0 tttt -85.4 145.0 41.42 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.662 -0.649 . . . . 0.0 109.62 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.481 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.09 13.73 1.92 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.801 2.334 . . . . 0.0 110.742 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.65 128.07 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.387 -0.821 . . . . 0.0 109.111 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' THR . 71.7 m -91.64 139.08 31.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.85 . . . . 0.0 110.054 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -49.14 174.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.55 -16.83 12.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.96 -1.088 . . . . 0.0 109.928 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -56.53 -168.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.551 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.8 t80 -140.22 123.15 16.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.422 1.106 . . . . 0.0 110.576 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.15 80.92 2.37 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.234 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.554 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -65.59 125.23 14.02 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.694 2.262 . . . . 0.0 112.466 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.38 128.4 55.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.8 t -78.7 135.34 37.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.571 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -82.6 -165.47 36.93 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 118.511 -1.804 . . . . 0.0 108.613 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.485 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 45.8 t -87.45 -29.6 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.664 -1.492 . . . . 0.0 108.728 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -63.06 -14.02 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 109.082 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.1 t-20 96.28 19.26 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 120.929 0.395 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.655 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.97 -165.54 1.25 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.879 -1.138 . . . . 0.0 108.54 178.759 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.508 HG21 ' N ' ' A' ' 31' ' ' TYR . 7.7 m -135.4 157.43 46.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.333 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 70.6 m-85 -129.63 121.69 27.55 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -29.07 -51.94 0.13 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 44.7 p30 -158.28 -162.96 1.2 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.111 -1.229 . . . . 0.0 109.488 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -57.71 -48.12 80.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.43 -0.794 . . . . 0.0 111.051 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.518 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 50.7 t -52.8 -52.71 55.81 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 109.962 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.6 m-80 -63.26 -31.5 72.66 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.488 -0.758 . . . . 0.0 110.942 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.589 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 19.2 t80 -74.02 -61.65 1.78 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.689 -1.257 . . . . 0.0 110.766 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 30.5 t -57.56 -49.4 76.51 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.927 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 38' ' ' CYS . 13.3 m-20 -42.34 -30.89 0.35 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.67 -1.269 . . . . 0.0 108.18 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.6 ' CB ' ' CD2' ' A' ' 48' ' ' LEU . . . -80.12 -43.4 21.76 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.52 ' N ' ' O ' ' A' ' 38' ' ' CYS . 87.5 t -66.78 -65.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.426 -0.796 . . . . 0.0 108.928 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG11 ' N ' ' A' ' 43' ' ' GLU . 9.8 p -50.67 -30.57 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 111.423 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' N ' HG11 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -92.72 -16.96 24.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.056 -1.652 . . . . 0.0 109.137 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.534 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 65.8 p -101.1 19.8 16.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 110.391 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 44' ' ' SER . 1.8 p-10 53.85 29.66 10.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.81 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.21 28.92 73.13 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.258 -0.901 . . . . 0.0 110.861 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 44' ' ' SER . 10.1 t -95.72 -10.62 28.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.6 ' CD2' ' CB ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.55 -53.7 6.33 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER 50.99 172.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.302 0.572 . . . . 0.0 109.586 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.589 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -132.49 163.49 28.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 109.099 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.586 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.49 -30.97 8.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -168.93 163.52 11.52 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.429 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.2 -166.48 0.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 57.67 -173.51 2.56 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.444 ' HB3' HG23 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.13 138.47 31.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.285 -1.126 . . . . 0.0 109.142 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.554 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.29 -77.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . . . -75.86 162.21 28.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.273 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.592 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -117.51 43.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.037 . . . . 0.0 110.395 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER 151.03 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 120.85 0.357 . . . . 0.0 110.235 178.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 5' ' ' SER . 21.3 t -159.32 148.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.077 -1.015 . . . . 0.0 110.423 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.07 122.97 42.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.586 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 12.1 m -125.72 43.04 3.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.003 -1.061 . . . . 0.0 110.652 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 10.47 25.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -131.73 6.1 4.33 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.939 -1.101 . . . . 0.0 110.868 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -84.19 156.97 63.05 Favored Pre-proline 0 C--N 1.307 -1.282 0 O-C-N 120.827 -1.17 . . . . 0.0 109.019 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.516 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.7 144.98 82.5 Favored 'Cis proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.011 2.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.494 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -92.45 147.68 34.88 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.48 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.494 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -77.4 13.6 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 111.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.7 112.45 0.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.024 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 91.8 m -87.86 144.55 26.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.44 ' OG1' ' HG3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -45.37 157.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.83 -33.57 7.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.853 -1.155 . . . . 0.0 110.107 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -62.09 -176.51 0.1 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.579 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -115.83 129.32 56.38 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.411 1.101 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 16.2 mtp-105 -159.86 70.73 3.17 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 54' ' ' GLY . 19.4 Cg_endo -60.27 121.79 10.32 Favored 'Trans proline' 0 C--O 1.192 -1.795 0 C-N-CA 123.295 2.664 . . . . 0.0 112.831 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.648 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 1.7 mp -103.97 158.73 16.22 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.618 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -116.7 132.05 56.79 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 119.795 -1.816 . . . . 0.0 111.949 -178.194 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.598 ' CA ' ' OH ' ' A' ' 31' ' ' TYR . . . -87.46 160.87 32.04 Favored Glycine 0 N--CA 1.503 3.101 0 CA-C-O 121.758 0.643 . . . . 0.0 111.909 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.501 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -64.44 -34.41 78.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -61.49 -11.84 12.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.397 -0.814 . . . . 0.0 109.309 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.3 m-20 88.27 18.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.815 -0.553 . . . . 0.0 110.942 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 1.3 pttm -107.78 122.28 46.44 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.439 HG22 ' HA ' ' A' ' 55' ' ' LYS . 51.1 m -80.7 132.97 35.62 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -178.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 140.98 31.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.306 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.549 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -49.38 -41.51 32.37 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.216 -0.927 . . . . 0.0 112.069 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.9 p30 -164.88 -158.39 0.4 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.448 -1.619 . . . . 0.0 110.363 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' HD3' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -57.75 -45.6 85.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.404 -177.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.519 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 36.4 t -68.43 -57.27 6.11 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.703 -1.248 . . . . 0.0 108.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -49.97 -22.23 1.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.833 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 7.3 t80 -83.04 -63.67 1.32 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.266 1.032 . . . . 0.0 110.918 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 13.5 m -47.87 -51.4 23.17 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.257 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.549 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 9.8 m-20 -48.3 -36.24 13.82 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' A' ' 37' ' ' PHE . . . -60.12 -46.27 90.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.517 ' CG2' HD22 ' A' ' 48' ' ' LEU . 58.0 t -64.93 -65.17 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.56 0.695 . . . . 0.0 110.246 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 11' ' ' TYR . 7.4 p -58.97 -19.58 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.842 . . . . 0.0 112.011 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.549 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -93.42 -16.27 24.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.093 -1.629 . . . . 0.0 109.22 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 4.4 p -98.66 18.39 16.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t30 74.54 4.61 4.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.135 -0.978 . . . . 0.0 108.415 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.81 20.08 69.03 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.0 t -87.53 -1.77 58.16 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -1.03 . . . . 0.0 108.642 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.52 HD22 ' CE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -89.45 161.76 16.1 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 75.8 p -147.9 130.21 15.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.1 tp -68.83 141.16 55.2 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.481 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.04 -17.91 12.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.802 -1.186 . . . . 0.0 108.065 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.618 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 173.88 154.22 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.54 0.686 . . . . 0.0 109.701 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' CZ ' ' HB3' ' A' ' 5' ' ' SER . 4.1 m-85 -70.31 176.77 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.049 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.14 -172.09 44.85 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.68 156.23 17.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -1.211 . . . . 0.0 108.811 178.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.498 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 5.6 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.029 -1.044 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.435 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -97.89 102.76 14.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.487 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 167.13 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.6 t -127.13 91.56 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.39 112.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.497 HG13 ' CE2' ' A' ' 37' ' ' PHE . 2.6 p -110.45 165.04 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.298 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -114.87 132.64 56.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.488 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 79.9 m -130.62 53.58 1.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.3 -16.31 29.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.866 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.51 37.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.159 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.598 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 94.9 m-85 -125.91 161.09 53.37 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.3 Cg_endo -86.29 153.88 50.35 Favored 'Cis proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.281 -1.55 . . . . 0.0 110.999 1.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.545 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.0 140.67 25.85 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.452 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.85 14.4 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.58 2.186 . . . . 0.0 111.141 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 167.95 135.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 108.871 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -133.2 165.44 24.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.933 -1.104 . . . . 0.0 110.737 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -54.99 -165.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 0.0 109.39 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.4 pp -122.86 3.68 9.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.008 -1.057 . . . . 0.0 110.273 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.7 pt-20 -47.63 118.44 2.26 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -79.37 126.91 31.42 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.757 1.265 . . . . 0.0 111.759 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.562 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.2 ptm180 -161.45 75.12 2.45 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.631 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.7 Cg_endo -64.31 118.99 5.91 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.662 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -113.05 128.84 56.61 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.507 179.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.585 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -88.87 112.09 22.84 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.604 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.67 -169.73 0.05 OUTLIER Glycine 0 N--CA 1.484 1.855 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.7 t -75.5 -34.63 60.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -1.173 . . . . 0.0 109.173 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.9 p30 -68.51 -6.64 26.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.882 . . . . 0.0 109.261 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.1 t-20 83.92 30.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.932 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.18 137.77 37.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.222 -0.924 . . . . 0.0 108.536 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 91.1 m -85.12 135.22 34.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.028 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.631 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 6.9 m-85 -113.83 142.68 45.79 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -55.98 -39.13 78.08 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.151 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.562 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 23.1 p-10 -160.05 -164.25 1.26 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.689 -1.477 . . . . 0.0 109.632 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.662 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -29.0 69.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.096 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.598 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 62.5 m -77.18 -57.1 4.03 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.041 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 m120 -48.61 -36.85 16.63 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.782 -1.199 . . . . 0.0 108.528 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.0 t80 -68.38 -56.52 8.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.359 1.076 . . . . 0.0 110.247 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CE2' ' A' ' 11' ' ' TYR . 64.0 m -52.65 -56.6 14.29 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.317 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' HA ' HG23 ' A' ' 42' ' ' VAL . 14.1 m-20 -38.7 -29.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.551 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.31 -51.03 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . 89.8 t -52.24 -53.79 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.646 0.736 . . . . 0.0 109.474 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.531 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 32.8 m -59.96 -34.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -91.83 -2.33 56.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 28.9 t -106.28 -8.26 17.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.8 t-20 80.32 30.41 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.802 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.62 31.93 57.99 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.47 HG21 ' OG ' ' A' ' 44' ' ' SER . 10.5 t -114.13 8.31 16.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.616 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.0 tp -89.76 -71.03 0.63 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.538 0.685 . . . . 0.0 109.292 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.616 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.9 p 60.5 143.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -102.55 171.83 7.21 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.213 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.613 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.23 -30.54 8.31 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.576 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -162.53 158.04 23.01 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.391 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 6.4 m-85 -75.81 -164.45 0.36 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 60.43 -169.49 8.12 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -92.45 168.64 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.494 -1.003 . . . . 0.0 108.773 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.8 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.591 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.01 23.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.61 77.37 5.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.3 m -127.68 80.61 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -143.69 93.7 2.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.4 165.96 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.025 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.0 152.19 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 m -135.01 57.04 1.82 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.273 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -89.1 -15.59 33.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -95.94 4.13 52.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 109.305 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 96.0 m-85 -96.5 159.52 31.66 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.401 -0.812 . . . . 0.0 109.079 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 33.0 Cg_endo -81.68 140.29 45.92 Favored 'Cis proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.531 2.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 10.3 mttt -99.78 139.05 20.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 -179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -80.61 14.2 2.08 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.55 2.167 . . . . 0.0 110.452 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.92 126.25 7.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.421 ' O ' ' O ' ' A' ' 17' ' ' THR . 81.5 m -116.57 139.63 50.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 16' ' ' CYS . 7.1 p -55.4 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 108.729 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -121.84 -25.74 4.96 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.497 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mt-10 -45.37 123.62 4.24 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.537 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.8 t80 -83.97 105.42 14.84 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.694 1.235 . . . . 0.0 110.693 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.668 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.6 mtp180 -136.89 75.33 49.02 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 18.4 Cg_endo -61.15 119.35 6.46 Favored 'Trans proline' 0 C--O 1.193 -1.747 0 C-N-CA 123.523 2.815 . . . . 0.0 114.195 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 2.7 mp -101.77 154.47 18.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.591 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.79 140.35 48.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 119.897 -1.752 . . . . 0.0 109.637 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.624 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.44 161.88 17.96 Favored Glycine 0 N--CA 1.497 2.743 0 CA-C-O 122.4 1.0 . . . . 0.0 113.747 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -37.44 86.15 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.802 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p-10 -58.69 -13.82 6.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.962 . . . . 0.0 109.267 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.8 m-20 91.61 12.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.313 0.578 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 30.5 ttpt -99.28 128.8 45.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 55' ' ' LYS . 96.7 m -88.29 129.54 35.35 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.849 -179.114 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.07 132.02 43.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -45.0 -39.74 6.61 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 121.476 -0.765 . . . . 0.0 112.045 -176.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.668 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -165.57 -157.26 0.31 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.528 -1.572 . . . . 0.0 110.279 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -57.83 -51.2 70.55 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.475 -178.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.3 t -61.3 -60.01 4.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.68 -1.263 . . . . 0.0 109.214 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -48.9 -23.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 108.858 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.1 t80 -80.78 -65.62 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.125 0.964 . . . . 0.0 110.618 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.638 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 12.1 m -50.26 -22.8 1.91 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' O ' HG21 ' A' ' 42' ' ' VAL . 11.1 m-80 -76.83 -40.28 48.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -58.32 -23.38 56.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.595 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 92.4 t -84.04 -53.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -65.71 -12.36 13.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.684 -0.635 . . . . 0.0 109.649 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -93.55 -18.91 21.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 2.5 t -108.41 22.99 15.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.895 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 79.26 -3.82 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 109.057 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.537 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 86.54 11.06 72.26 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.3 t -85.42 -5.94 59.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -1.187 . . . . 0.0 108.838 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.595 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.93 150.91 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.58 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.8 p -123.68 142.99 50.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.11 0.957 . . . . 0.0 109.465 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 3.6 tp -57.73 121.1 9.63 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.0 t -76.76 -24.26 52.94 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.238 -0.913 . . . . 0.0 109.366 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p80 155.72 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.477 0.656 . . . . 0.0 109.362 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 19.3 m-85 -93.83 156.36 16.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.408 -0.808 . . . . 0.0 109.625 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 86.12 -167.94 40.28 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HA ' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.28 -176.56 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -1.071 . . . . 0.0 108.443 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 41.1 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.81 -80.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.38 155.37 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.526 ' CG1' HD22 ' A' ' 50' ' ' LEU . 30.4 t -134.92 113.3 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.28 159.84 13.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.524 ' O ' ' C ' ' A' ' 7' ' ' ASP . 17.9 t -122.87 38.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 110.078 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 6' ' ' VAL . 18.5 t0 21.57 99.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.152 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 7.8 m -121.55 64.62 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.42 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -91.27 -14.71 30.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.391 -0.818 . . . . 0.0 109.33 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.42 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 5.4 mm-40 -105.56 34.93 3.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 110.047 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.628 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 41.7 m-85 -113.73 161.44 27.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.023 -1.048 . . . . 0.0 108.929 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.515 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -73.28 175.99 43.21 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.633 -1.82 . . . . 0.0 111.377 2.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -125.78 144.01 47.0 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.582 -0.698 . . . . 0.0 109.559 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.89 14.22 1.76 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.788 2.326 . . . . 0.0 111.204 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.63 141.13 16.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.583 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -116.01 2.56 13.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.825 -1.172 . . . . 0.0 110.981 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.583 ' OG1' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 67.43 -17.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 178.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 72.21 -9.04 1.06 Allowed 'General case' 0 C--N 1.275 -2.635 0 O-C-N 121.697 -0.627 . . . . 0.0 111.448 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.473 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -59.45 129.07 40.19 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.594 -1.316 . . . . 0.0 107.899 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.3 123.18 33.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.527 1.155 . . . . 0.0 111.701 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.621 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -162.19 81.94 1.76 Allowed Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.545 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -64.83 117.25 4.35 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.615 2.21 . . . . 0.0 113.344 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.12 136.08 47.58 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -98.83 112.39 24.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.878 -1.139 . . . . 0.0 111.672 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.522 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -51.13 176.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.0 t -72.73 -22.66 60.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -1.176 . . . . 0.0 107.829 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.6 p30 -76.42 -5.73 48.6 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.6 m-20 82.04 30.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 110.363 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -102.74 146.44 28.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.522 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 95.8 m -98.3 143.52 28.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 0.0 110.409 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.62 ' CE2' ' CB ' ' A' ' 40' ' ' ALA . 1.9 m-85 -124.81 125.08 43.45 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.59 -46.88 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.363 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.621 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 35.9 p-10 -156.61 -168.17 2.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.445 -1.62 . . . . 0.0 111.492 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.596 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.07 -37.09 71.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.867 -0.521 . . . . 0.0 112.313 -177.608 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.8 p -77.41 -54.39 6.5 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.655 -1.278 . . . . 0.0 108.662 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.551 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 8.9 m-80 -50.36 -26.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.017 -1.052 . . . . 0.0 108.888 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 76.5 t80 -87.02 -35.69 18.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 123.069 1.414 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.2 m -67.34 -29.17 68.65 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.551 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -70.39 -36.09 73.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.733 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.97 -25.35 63.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.526 HG21 ' CD2' ' A' ' 48' ' ' LEU . 54.4 t -77.64 -40.05 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.333 0.587 . . . . 0.0 110.186 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.574 HG13 ' CB ' ' A' ' 11' ' ' TYR . 1.9 p -84.7 -13.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.915 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.733 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -91.73 -33.21 15.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 9.8 t -89.98 20.31 4.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.5 m-80 64.99 10.24 6.1 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.424 -0.797 . . . . 0.0 109.911 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.99 15.69 64.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.7 p -92.26 7.25 43.54 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.018 179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.9 tp -79.5 -66.58 0.85 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.568 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.6 p 50.02 118.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 122.456 1.122 . . . . 0.0 111.904 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -77.89 170.89 15.83 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.72 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.99 -22.85 9.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.55 ' O ' ' CD1' ' A' ' 50' ' ' LEU . 2.2 p80 -164.53 144.53 7.6 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.494 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.11 164.17 13.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 85.81 -170.0 43.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.428 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 8.9 mtmm -90.76 165.67 13.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -1.105 . . . . 0.0 109.395 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 37.3 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.932 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.78 41.77 11.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.25 143.44 45.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.9 m -104.67 82.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 175.55 129.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.238 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG13 ' CD2' ' A' ' 37' ' ' PHE . 7.2 p -88.42 146.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 109.602 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.73 139.91 51.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.153 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 30.6 m -143.29 46.54 1.52 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.735 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.36 -6.38 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.128 -0.982 . . . . 0.0 109.872 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -100.86 13.55 34.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.48 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.607 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 87.5 m-85 -100.4 159.72 28.95 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -76.68 162.94 90.77 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.568 -1.846 . . . . 0.0 111.247 1.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.565 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.58 141.0 26.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.47 13.83 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 109.84 0.49 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -94.28 144.96 25.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.473 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 25.1 p -50.92 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -122.27 -16.81 7.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.058 -1.026 . . . . 0.0 109.904 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' LEU . 13.7 pm0 -55.8 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.59 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.8 t80 -134.74 130.86 36.86 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.25 80.55 2.09 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.8 Cg_endo -63.15 117.76 4.68 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.026 1.817 . . . . 0.0 111.966 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -108.44 132.53 53.69 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.699 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -80.7 120.72 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.584 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.43 -162.98 5.43 Favored Glycine 0 C--N 1.294 -1.757 0 C-N-CA 118.593 -1.765 . . . . 0.0 108.861 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.7 t -85.24 -49.83 7.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.893 -1.357 . . . . 0.0 109.963 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.8 p-10 -57.39 -14.83 5.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.3 t30 98.12 45.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.084 0.468 . . . . 0.0 110.069 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.07 114.17 20.0 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.353 1.073 . . . . 0.0 109.006 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.431 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 20.6 m -60.32 158.23 12.15 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.127 -0.983 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.6 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 1.2 m-85 -129.96 147.53 51.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -53.35 -37.68 55.86 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.555 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.6 p30 -166.59 -163.86 0.61 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.697 -1.472 . . . . 0.0 109.557 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.49 -36.67 78.87 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.665 -178.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' O ' ' C ' ' A' ' 36' ' ' ASN . 11.8 t -70.11 -64.35 0.91 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.497 -1.377 . . . . 0.0 108.391 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.6 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -40.8 -37.55 0.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.9 t80 -72.47 -59.65 2.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.511 1.148 . . . . 0.0 110.349 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.607 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 20.6 m -53.17 -58.54 6.7 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.093 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' CYS . 15.8 m-20 -38.98 -30.43 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.283 -0.886 . . . . 0.0 109.056 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' CB ' HD21 ' A' ' 48' ' ' LEU . . . -74.55 -50.71 17.01 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.39 -59.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.665 -0.647 . . . . 0.0 110.202 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.592 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 11.3 p -61.49 -26.0 38.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.209 -0.932 . . . . 0.0 111.353 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.91 -8.92 44.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.517 -1.364 . . . . 0.0 109.398 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.5 p -109.13 18.19 20.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 110.307 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.4 m-20 63.46 15.26 8.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 0.0 109.717 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 19.73 76.6 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 44' ' ' SER . 24.2 p -88.99 -2.86 58.79 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.307 -1.113 . . . . 0.0 108.061 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.64 ' HG ' ' N ' ' A' ' 49' ' ' THR . 8.3 tp -85.28 -80.31 0.22 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.64 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER 68.41 171.55 0.28 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.11 167.66 14.48 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.376 -0.827 . . . . 0.0 109.697 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.607 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.9 -35.09 7.03 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -162.18 165.24 27.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.611 0.719 . . . . 0.0 109.129 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -80.07 175.25 10.81 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 108.968 179.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.66 -169.25 53.26 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -90.71 129.33 36.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.264 . . . . 0.0 109.787 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.534 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.395 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.521 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -93.45 -120.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.521 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 75.07 179.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.492 HG22 ' CG ' ' A' ' 50' ' ' LEU . 2.4 p -135.77 102.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.6 p -162.38 87.6 0.62 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 110.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.16 146.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.975 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -93.11 147.23 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.808 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.53 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 71.5 m -133.04 30.24 3.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -0.859 . . . . 0.0 109.284 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -75.2 -23.68 57.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.589 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -90.73 19.91 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.61 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 86.8 m-85 -117.58 161.76 32.11 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.0 Cg_endo -82.34 132.96 22.05 Favored 'Cis proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.042 -1.649 . . . . 0.0 110.966 2.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -80.25 143.19 55.9 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.668 -0.645 . . . . 0.0 109.659 -179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.22 14.18 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.564 2.176 . . . . 0.0 110.27 179.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 144.82 2.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.7 m -133.94 144.37 48.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.467 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 80.5 p -56.32 -168.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.0 109.02 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.05 -16.56 6.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 109.74 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -50.69 132.87 26.2 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.589 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 t80 -86.45 125.5 33.75 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 122.824 1.297 . . . . 0.0 111.36 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.2 mtt-85 -160.59 70.64 2.85 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.635 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -62.87 131.07 31.48 Favored 'Trans proline' 0 C--O 1.198 -1.522 0 C-N-CA 124.044 3.163 . . . . 0.0 114.767 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.619 ' C ' ' CE1' ' A' ' 31' ' ' TYR . 3.1 mp -111.22 159.76 17.6 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 176.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.624 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.9 OUTLIER -120.05 141.16 50.0 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.819 -1.801 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.612 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.51 158.95 18.62 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 122.701 1.167 . . . . 0.0 114.473 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -57.73 -17.79 17.36 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.549 -0.825 . . . . 0.0 109.858 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.464 ' OD2' HD11 ' A' ' 48' ' ' LEU . 4.1 p30 -89.62 21.8 3.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 109.007 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.82 16.96 3.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.526 -0.734 . . . . 0.0 109.867 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -99.26 120.54 39.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.242 -0.912 . . . . 0.0 108.592 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.491 ' CG2' ' HD3' ' A' ' 55' ' ' LYS . 42.6 m -84.5 126.49 33.33 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.462 -0.773 . . . . 0.0 109.648 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.82 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.66 136.79 36.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -41.77 -40.51 3.07 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.296 -0.878 . . . . 0.0 111.545 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.657 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.1 p30 -171.02 -153.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.677 -1.484 . . . . 0.0 110.318 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -58.89 -52.31 66.3 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.014 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 7.8 t -64.02 -57.83 8.52 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.737 -1.227 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -49.92 -23.14 1.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.82 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 5.3 t80 -78.25 -67.32 0.75 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.424 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 6.4 m -45.25 -25.73 0.41 Allowed 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.554 ' HA ' HG23 ' A' ' 42' ' ' VAL . 6.7 m-80 -70.06 -46.7 64.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -60.67 -19.97 59.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.579 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 53.1 t -90.91 -29.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.134 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.554 HG23 ' HA ' ' A' ' 39' ' ' ASN . 3.8 m -83.98 -19.37 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.11 -16.78 25.88 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.916 . . . . 0.0 108.703 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 0.4 OUTLIER -100.15 9.29 43.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.64 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.7 t30 76.45 6.29 3.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 79.85 7.73 88.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.466 HG21 ' OG ' ' A' ' 44' ' ' SER . 11.1 t -87.76 9.55 21.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.264 -1.139 . . . . 0.0 108.885 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.648 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -85.66 -77.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.355 -0.841 . . . . 0.0 109.14 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.648 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 4.2 p 92.27 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.084 0.945 . . . . 0.0 110.203 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.601 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 8.5 tp -72.68 157.71 37.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.526 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.08 -18.95 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.655 -1.278 . . . . 0.0 108.385 179.172 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.624 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 174.03 161.17 0.17 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.24 164.78 25.28 Favored 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.635 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.96 -168.5 52.25 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.651 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -91.1 171.72 9.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.651 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 3.0 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.616 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.79 -73.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 45.43 -160.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 5' ' ' SER . 93.2 t -93.7 63.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.271 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 16.4 p 177.68 145.6 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.666 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.4 t -90.67 134.89 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.11 179.737 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.05 112.2 21.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.581 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 38.7 m -108.15 64.53 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -89.49 -23.18 22.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -5.26 59.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 78.0 m-85 -79.83 162.24 63.28 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.181 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.2 Cg_endo -82.08 144.2 57.53 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.201 -1.583 . . . . 0.0 110.933 2.253 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 26.2 mttt -99.46 141.63 23.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 109.934 -179.191 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -80.67 14.26 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.522 2.148 . . . . 0.0 110.27 179.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 119.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.538 -0.726 . . . . 0.0 109.052 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 64.8 m -93.8 148.9 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.472 ' O ' ' O ' ' A' ' 16' ' ' CYS . 66.2 p -56.67 -164.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.3 mt -128.7 -7.58 5.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.94 -1.1 . . . . 0.0 110.654 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.478 ' OE1' ' HG3' ' A' ' 21' ' ' ARG . 1.3 pp20? -65.94 -176.3 0.38 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.55 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 9.4 t80 -122.49 129.43 51.99 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 120.862 -1.149 . . . . 0.0 111.239 -178.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.618 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 17.1 mtm180 -160.31 73.31 2.97 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.9 Cg_endo -64.73 112.85 2.1 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.909 1.739 . . . . 0.0 110.87 -178.274 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.555 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.78 138.61 49.35 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.325 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.664 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 9.2 t -96.24 165.75 12.06 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.912 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.443 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -132.81 176.71 19.35 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.493 -177.484 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.4 t -58.56 -49.24 78.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.667 -0.902 . . . . 0.0 109.049 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.602 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.2 p-10 -47.97 -24.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 108.985 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.3 t-20 91.08 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.22 0.533 . . . . 0.0 109.844 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -127.89 153.5 46.57 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 179.833 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.437 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 36.8 m -92.82 160.98 14.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.605 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 87.5 m-85 -140.11 100.26 3.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 108.679 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -17.43 -61.43 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.113 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.618 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.3 p30 -139.34 -169.82 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.923 -1.339 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 28.5 pttt -53.11 -39.47 63.44 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.821 -0.549 . . . . 0.0 110.533 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -63.03 -66.31 0.56 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.996 -1.065 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.8 m-80 -41.43 -34.74 0.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 109.871 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.605 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 59.0 t80 -71.72 -44.89 63.36 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.914 1.34 . . . . 0.0 109.69 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 71.5 m -61.73 -55.7 27.49 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.534 ' HA ' HG23 ' A' ' 42' ' ' VAL . 4.4 m-80 -44.23 -27.61 0.43 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.757 -1.214 . . . . 0.0 108.667 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.466 ' HB2' HD12 ' A' ' 48' ' ' LEU . . . -72.56 -47.51 47.57 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.631 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 32.8 t -60.19 -56.71 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.823 0.82 . . . . 0.0 109.335 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.534 HG23 ' HA ' ' A' ' 39' ' ' ASN . 15.9 m -56.22 -29.08 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 110.553 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.27 -15.73 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.025 -1.047 . . . . 0.0 108.81 179.536 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 89.5 p -106.33 11.25 31.21 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.414 -0.804 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER 50.65 39.05 20.67 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.69 0.757 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 65.56 32.15 82.39 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.749 178.651 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.521 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 70.1 p -104.93 -6.11 20.43 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.324 -1.104 . . . . 0.0 108.573 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.631 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 -57.11 3.83 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.104 0.954 . . . . 0.0 108.501 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.59 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 32.1 p 63.7 129.47 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.955 -177.373 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -58.21 152.73 16.52 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.1 p -107.38 -42.86 4.7 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.664 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -174.45 160.49 3.19 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.723 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -77.72 139.07 39.36 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.115 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.82 -170.33 16.9 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -89.41 159.17 17.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.884 -1.362 . . . . 0.0 108.007 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.587 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.444 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.07 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 165.29 4.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.405 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.02 110.31 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.629 -179.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.65 -161.62 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.298 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 7' ' ' ASP . 77.0 t -132.18 157.46 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.9 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 6' ' ' VAL . 9.9 t0 -77.94 137.81 38.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 60.1 m -146.6 49.17 1.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.823 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -90.55 -10.83 42.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.971 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.82 21.09 11.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.736 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 90.3 m-85 -106.75 159.69 28.97 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -75.61 175.96 45.71 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.711 -1.787 . . . . 0.0 111.364 2.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 50.5 mttt -135.4 139.07 30.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.82 13.96 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.346 2.031 . . . . 0.0 110.58 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.78 114.72 1.57 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -91.81 150.46 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.55 167.39 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 109.124 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -101.09 -33.79 9.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.026 . . . . 0.0 109.625 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -46.0 125.05 5.94 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.042 -1.036 . . . . 0.0 108.797 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -79.69 116.74 20.05 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.393 1.092 . . . . 0.0 109.915 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.68 76.68 10.68 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -64.01 120.98 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.983 2.455 . . . . 0.0 112.614 -177.53 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.626 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -114.01 127.61 56.02 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.63 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.702 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 37.5 t -79.91 115.97 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -64.75 -170.97 2.5 Favored Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.299 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -80.91 -33.62 34.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.945 -1.327 . . . . 0.0 108.75 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.4 p-10 -60.05 -16.41 31.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 92.9 17.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 109.891 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.54 130.44 45.78 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.169 -0.957 . . . . 0.0 108.725 179.169 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 m -70.88 147.24 49.01 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.57 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 71.7 m-85 -120.69 116.18 24.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -26.85 -47.78 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 -177.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.4 p30 -160.7 -163.47 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.616 -1.52 . . . . 0.0 109.694 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.626 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.31 -41.73 80.45 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.397 -179.069 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 42.4 t -61.59 -66.46 0.53 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.734 -1.229 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 12.8 m-80 -43.71 -34.23 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 0.0 110.708 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 25.9 t80 -72.25 -52.57 15.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.179 . . . . 0.0 109.982 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 32.9 m -53.83 -53.18 56.1 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 4.3 m-20 -41.43 -34.29 0.52 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.154 -0.967 . . . . 0.0 108.864 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' CB ' HD23 ' A' ' 48' ' ' LEU . . . -71.74 -47.24 55.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.468 HG11 ' HA2' ' A' ' 46' ' ' GLY . 97.4 t -58.06 -62.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.433 0.635 . . . . 0.0 110.06 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.593 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 11.8 p -58.96 -22.84 22.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 111.869 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.525 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.07 -16.42 27.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.377 -1.452 . . . . 0.0 108.702 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.539 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 18.9 p -102.63 -2.24 28.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.59 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 78.63 12.83 1.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 109.305 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 88.63 5.86 74.14 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.427 HG21 ' HB2' ' A' ' 44' ' ' SER . 14.3 t -79.61 -4.0 49.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.258 -1.143 . . . . 0.0 108.15 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.633 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.7 tp -80.4 -82.89 0.11 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.633 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 75.27 179.88 0.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.544 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -130.88 -179.79 5.52 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.582 -1.324 . . . . 0.0 110.22 -179.472 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.596 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -111.61 -21.91 11.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.018 -1.051 . . . . 0.0 108.465 -179.82 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.702 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 179.74 155.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.504 -0.748 . . . . 0.0 109.835 -179.211 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -73.65 148.35 42.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.39 -166.97 14.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.74 157.67 16.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -1.103 . . . . 0.0 108.219 178.855 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.09 -1.006 . . . . 0.0 109.627 -179.885 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 24.9 tp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.49 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.429 ' O ' HG11 ' A' ' 4' ' ' VAL . . . -179.43 122.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.099 -1.001 . . . . 0.0 109.556 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.429 HG11 ' O ' ' A' ' 3' ' ' ALA . 3.5 m -142.28 68.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.434 179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.4 t -174.2 119.39 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 109.461 179.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.507 ' CG2' HD23 ' A' ' 23' ' ' LEU . 40.3 t -85.56 151.41 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 0.0 109.647 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -101.26 131.17 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.542 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 29.0 m -122.23 58.69 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 t -82.65 -16.85 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -1.92 40.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.117 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 36.4 m-85 -84.53 165.46 37.85 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.9 Cg_endo -84.5 153.43 62.92 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.338 -1.526 . . . . 0.0 110.913 1.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.9 141.28 22.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.759 . . . . 0.0 109.694 -179.411 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -80.19 13.57 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.561 2.174 . . . . 0.0 110.278 179.433 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.02 112.58 1.0 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.5 m -83.89 143.16 30.06 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.62 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.196 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -125.61 -31.88 2.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.897 -1.127 . . . . 0.0 109.928 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.431 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 2.8 pm0 -49.03 142.08 7.13 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.604 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 7.9 t80 -90.23 126.15 35.73 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 122.731 1.253 . . . . 0.0 111.2 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.655 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.68 71.87 2.83 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.855 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.604 ' HG3' ' CZ ' ' A' ' 20' ' ' TYR . 22.7 Cg_endo -61.16 130.9 34.17 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.531 2.821 . . . . 0.0 113.159 -176.495 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.586 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -115.29 126.44 54.49 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.171 178.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.747 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.4 t -78.07 133.66 37.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -75.72 -157.26 6.62 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 118.534 -1.793 . . . . 0.0 108.784 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -92.99 -66.55 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 110.171 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.629 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -40.16 -40.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.605 -0.684 . . . . 0.0 109.401 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.6 p30 133.38 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 11.3 pttp -108.46 107.27 17.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 109.636 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.481 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 46.6 m -66.37 152.13 45.69 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.531 -0.731 . . . . 0.0 109.101 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.609 ' CD2' ' HA ' ' A' ' 37' ' ' PHE . 1.5 m-85 -129.62 142.74 50.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.676 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.555 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -47.52 -35.06 10.35 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.708 -176.797 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.655 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.1 p30 -173.18 -155.55 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.725 -1.456 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.96 -42.39 97.29 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.436 -0.79 . . . . 0.0 110.786 -178.227 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.8 t -66.55 -57.36 7.45 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.579 -1.326 . . . . 0.0 108.512 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -48.93 -37.0 18.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.82 . . . . 0.0 109.478 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 31.9 t80 -70.22 -51.91 27.23 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.492 1.139 . . . . 0.0 110.247 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.574 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 61.2 m -55.21 -61.03 2.59 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.289 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.545 ' HA ' HG23 ' A' ' 42' ' ' VAL . 3.9 m-20 -37.47 -29.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.302 -0.874 . . . . 0.0 109.657 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -74.33 -52.3 12.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 68.9 t -52.06 -54.72 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.585 0.707 . . . . 0.0 109.738 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 39' ' ' ASN . 6.1 m -61.89 -26.48 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 111.183 -178.898 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 6.9 tt0 -90.63 -6.43 54.6 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.962 -1.087 . . . . 0.0 109.792 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 p -112.57 18.42 18.39 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.118 -0.989 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.562 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.61 -1.58 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 0.0 109.304 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.88 17.24 61.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.562 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 3.1 p -87.0 -10.41 53.21 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.248 . . . . 0.0 108.486 178.435 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -78.26 148.47 33.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.712 0.768 . . . . 0.0 109.467 -179.573 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' SER . 1.3 p -137.77 167.17 22.25 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.147 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.57 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -109.63 170.31 8.15 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.57 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -108.41 -35.77 6.41 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.829 -1.17 . . . . 0.0 107.896 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.747 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -167.86 164.73 14.07 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.568 0.699 . . . . 0.0 109.505 -178.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.65 -167.16 0.33 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.577 -0.702 . . . . 0.0 109.306 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.81 -167.31 4.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.598 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -85.55 165.4 17.11 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.598 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.584 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.77 122.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.448 -179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.405 ' C ' HG21 ' A' ' 4' ' ' VAL . . . -129.7 146.27 51.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 109.521 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.405 HG21 ' C ' ' A' ' 3' ' ' ALA . 3.3 t -139.96 75.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.46 -179.986 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.4 p -165.56 106.64 0.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.43 141.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.674 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.53 131.6 35.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.165 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 54.9 m -139.08 49.61 1.84 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -90.91 -10.18 43.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.689 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.67 23.76 9.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 46.9 m-85 -117.63 158.28 45.69 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.066 -1.021 . . . . 0.0 108.385 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.509 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.24 164.86 84.19 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.003 3.473 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.48 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -119.91 146.85 42.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.478 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.48 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -78.53 13.67 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.5 2.133 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 150.94 1.29 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.9 m -119.83 138.25 53.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.023 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.3 p -54.04 -171.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 108.817 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 ' N ' HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -119.51 -22.87 6.81 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.362 179.577 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.507 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -49.95 118.42 2.88 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.207 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.544 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 12.4 t80 -78.42 126.55 30.93 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.536 1.16 . . . . 0.0 110.501 -178.164 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.554 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.0 ptm180 -160.66 77.91 2.5 Favored Pre-proline 0 C--N 1.293 -1.89 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' HG3' ' CZ ' ' A' ' 20' ' ' TYR . 27.6 Cg_endo -66.11 127.68 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.707 2.271 . . . . 0.0 112.853 -176.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -116.88 135.15 53.95 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.881 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.653 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 19.1 t -92.88 161.48 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.424 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -117.56 168.18 12.9 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.47 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 35.3 t -69.47 -17.97 63.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.64 -0.917 . . . . 0.0 108.636 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 35.7 p30 -73.85 -7.97 54.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.068 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.6 t30 82.33 31.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.756 -0.59 . . . . 0.0 110.044 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -123.94 139.68 53.72 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.143 179.719 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 23.2 m -85.22 159.91 20.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.816 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CE2' ' CB ' ' A' ' 40' ' ' ALA . 48.1 m-85 -130.98 124.85 31.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -38.41 -53.62 2.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.967 -178.129 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.554 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -155.06 -164.45 1.79 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.783 -1.422 . . . . 0.0 110.529 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.15 -25.28 68.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 111.533 -178.253 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -70.78 -53.23 16.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.598 -1.314 . . . . 0.0 109.197 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.13 -37.5 87.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.715 -0.616 . . . . 0.0 110.018 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 58.9 t80 -70.51 -47.61 59.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.942 -1.099 . . . . 0.0 109.791 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 17.3 m -64.02 -29.56 70.7 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 95.1 m-20 -72.64 -39.24 67.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.72 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -72.41 -17.3 61.81 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.565 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 54.2 t -84.54 -50.75 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.001 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 11' ' ' TYR . 6.8 p -68.54 -17.8 22.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.661 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.72 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.08 -31.3 15.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.05 -1.031 . . . . 0.0 108.371 178.548 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 46.5 t -88.15 15.11 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.633 -0.667 . . . . 0.0 110.53 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 64.04 12.79 7.22 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.203 -0.935 . . . . 0.0 109.511 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.465 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 80.04 20.74 66.96 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.405 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.8 p -93.75 3.61 55.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -1.137 . . . . 0.0 108.72 178.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.623 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.56 -52.73 7.63 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.047 0.927 . . . . 0.0 108.745 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.623 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 29.5 p 53.38 119.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.442 1.115 . . . . 0.0 111.323 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 4.2 tp -65.36 152.46 43.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.431 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.471 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -112.52 -16.87 12.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.653 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 175.86 163.52 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.92 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -80.22 177.66 8.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.159 -0.963 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.88 -167.45 54.88 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.432 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.09 173.46 7.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.775 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.496 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.846 -1.159 . . . . 0.0 109.681 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.404 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.252 0.548 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 69.38 120.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.63 -171.35 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 5' ' ' SER . 0.0 OUTLIER -134.13 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.0 109.28 179.834 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.458 ' HA ' HD21 ' A' ' 50' ' ' LEU . 6.5 p 170.31 154.35 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t -99.17 154.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.509 179.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.3 152.51 22.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.804 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -122.98 49.88 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.671 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -90.01 -36.57 14.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.35 43.16 1.07 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.321 -0.862 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 47.2 m-85 -132.38 164.98 39.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.565 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.8 Cg_endo -89.48 173.94 24.77 Favored 'Cis proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.399 -1.5 . . . . 0.0 111.293 0.212 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.4 mtpt -136.53 136.41 21.98 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 109.14 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.95 15.6 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.561 2.174 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.44 14.2 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.49 -0.756 . . . . 0.0 109.064 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.68 160.09 40.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.43 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 1.3 p -60.86 -164.23 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.525 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.594 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.09 -7.67 10.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 110.417 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.512 ' HG3' ' HD3' ' A' ' 21' ' ' ARG . 3.7 pm0 -56.59 119.32 5.91 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -79.6 128.96 34.03 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.505 1.145 . . . . 0.0 111.049 -178.226 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.632 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.56 80.03 2.05 Favored Pre-proline 0 C--N 1.294 -1.809 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.758 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.557 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -65.02 124.87 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.973 2.449 . . . . 0.0 112.975 -176.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.5 mp -112.25 139.93 47.38 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.71 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -102.52 129.32 49.01 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.983 -178.303 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.482 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -70.11 -170.16 8.21 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' THR . 29.5 t -82.03 -22.02 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.938 -1.331 . . . . 0.0 108.416 178.878 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -76.15 -3.42 36.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.836 . . . . 0.0 109.44 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 17.6 t30 80.18 30.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.382 -0.824 . . . . 0.0 110.308 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 10.2 ttmt -105.32 137.1 43.65 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.103 -0.998 . . . . 0.0 108.781 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.9 m -85.66 146.5 26.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 0.0 109.998 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.6 m-85 -125.51 132.23 52.66 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.98 -51.03 0.65 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.619 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.632 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p30 -165.54 -168.32 1.32 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.036 -1.273 . . . . 0.0 111.086 178.916 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.579 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 6.3 ptmt -45.76 -45.98 14.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.88 -0.512 . . . . 0.0 111.868 -177.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.563 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 10.3 m -64.76 -62.73 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.555 -1.341 . . . . 0.0 109.698 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.3 m-80 -50.56 -20.12 1.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 21.3 t80 -82.84 -57.93 3.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.954 -1.091 . . . . 0.0 110.889 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.5 t -58.01 -47.35 83.3 Favored 'General case' 0 C--N 1.286 -2.156 0 O-C-N 121.698 -0.626 . . . . 0.0 110.911 -178.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.537 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -46.29 -28.75 1.39 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.341 -1.475 . . . . 0.0 107.997 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -70.2 -48.31 57.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.478 ' N ' ' O ' ' A' ' 38' ' ' CYS . 87.2 t -55.86 -56.14 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.408 0.623 . . . . 0.0 110.031 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -53.48 -33.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.075 -1.015 . . . . 0.0 111.062 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.531 ' N ' HG21 ' A' ' 42' ' ' VAL . 5.0 tt0 -92.57 -11.27 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.629 -1.295 . . . . 0.0 109.697 -179.526 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 8.5 t -100.65 -5.35 26.76 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.035 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 77.37 27.58 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.0 -179.649 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.407 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 64.79 11.69 50.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 44' ' ' SER . 14.7 t -87.09 -2.44 58.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.293 -1.122 . . . . 0.0 108.666 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.02 -59.87 2.61 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.589 ' O ' ' N ' ' A' ' 26' ' ' SER . 37.6 p 52.58 127.6 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.114 0.959 . . . . 0.0 111.305 178.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -85.94 160.67 19.32 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.563 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.1 -29.13 9.57 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.568 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.8 p80 -160.04 163.1 34.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.89 177.72 8.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 73.63 -167.11 54.52 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.518 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -91.4 164.78 13.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -1.031 . . . . 0.0 109.072 179.041 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.7 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.922 -179.089 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -121.06 -147.31 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.38 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.423 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 69.25 -162.95 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.409 ' O ' HG11 ' A' ' 4' ' ' VAL . 87.4 t -85.27 80.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.65 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.19 122.26 12.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.32 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.1 153.98 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.797 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.83 156.57 39.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.0 109.243 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 19.5 t -160.98 24.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.947 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.18 -4.83 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -112.06 36.95 3.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.906 -1.121 . . . . 0.0 110.217 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 97.0 m-85 -136.51 157.81 74.52 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.994 -1.066 . . . . 0.0 108.817 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.527 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -72.08 145.04 82.12 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.631 -1.821 . . . . 0.0 111.544 3.149 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.485 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -108.1 144.95 30.44 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 -179.768 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.485 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -78.72 14.62 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.781 2.321 . . . . 0.0 110.956 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.03 117.49 2.25 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 109.127 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' THR . 94.3 m -102.21 139.71 37.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.877 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.443 ' HB ' ' CD ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -45.16 142.88 1.81 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.425 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -92.28 -23.08 19.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.947 -1.096 . . . . 0.0 109.851 -179.484 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 14.5 pm0 -57.44 -166.8 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.6 t80 -134.03 116.4 15.46 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.352 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.4 mmt180 -147.92 74.71 11.07 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.475 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.5 Cg_endo -65.91 132.07 29.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.114 2.543 . . . . 0.0 113.144 -176.702 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.639 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -118.78 136.71 53.84 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.583 178.334 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.705 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 51.8 t -79.05 117.98 20.61 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.568 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.28 -165.56 1.32 Allowed Glycine 0 C--N 1.296 -1.663 0 C-N-CA 118.299 -1.905 . . . . 0.0 108.589 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.1 t -85.89 -31.78 22.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.27 . . . . 0.0 109.144 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -69.24 -4.92 19.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 179.57 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.3 t-20 86.11 15.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.742 -0.599 . . . . 0.0 109.881 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -99.56 117.54 34.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.812 179.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.483 HG21 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -54.5 158.05 2.62 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.592 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 4.2 m-85 -129.2 133.13 47.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.338 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.07 -51.51 3.46 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -161.43 -158.5 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.336 -1.096 . . . . 0.0 109.547 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.53 -57.03 10.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.096 -178.099 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.578 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.9 t -42.85 -57.44 2.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.838 -1.164 . . . . 0.0 110.41 -179.264 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.34 -43.22 99.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.277 -0.889 . . . . 0.0 111.129 -178.6 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.671 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.7 t80 -56.07 -60.55 3.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.905 -1.122 . . . . 0.0 110.521 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -55.58 -51.96 65.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.32 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.9 m-20 -41.6 -29.19 0.16 Allowed 'General case' 0 C--N 1.308 -1.196 0 O-C-N 120.567 -1.333 . . . . 0.0 108.773 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.532 ' CB ' ' OH ' ' A' ' 31' ' ' TYR . . . -75.1 -49.34 19.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -58.26 -62.45 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.591 0.71 . . . . 0.0 109.8 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.443 ' HB ' ' SG ' ' A' ' 8' ' ' CYS . 3.3 p -57.47 -26.56 26.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.262 -0.899 . . . . 0.0 111.627 -178.627 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -91.71 -13.44 31.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.283 -1.511 . . . . 0.0 109.059 179.203 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.6 t -104.59 22.85 14.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.509 -0.744 . . . . 0.0 110.082 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.6 p30 65.08 6.25 3.39 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.463 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.15 8.59 87.14 Favored Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.291 -0.881 . . . . 0.0 110.912 178.629 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.6 t -79.45 -4.37 50.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.803 -1.41 . . . . 0.0 108.188 178.672 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.578 ' HG ' ' N ' ' A' ' 49' ' ' THR . 1.7 tp -79.95 -80.29 0.13 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p 70.92 169.07 0.32 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.646 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.14 173.33 7.16 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.425 -0.797 . . . . 0.0 110.486 -178.143 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.648 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.73 -36.38 7.07 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.714 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.705 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -162.54 165.58 25.86 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.456 0.646 . . . . 0.0 109.383 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.52 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 15.7 m-85 -75.61 -164.5 0.35 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.595 -0.691 . . . . 0.0 109.184 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 59.06 -168.99 6.16 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.451 ' HB3' ' CG2' ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.4 143.2 26.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -1.02 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.543 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 32.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.693 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.464 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -153.65 109.09 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 167.35 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' ' CB ' ' A' ' 5' ' ' SER . 14.9 m -135.3 102.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 167.46 140.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.306 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.41 143.16 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.13 143.29 55.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.431 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 7.3 m -139.32 61.37 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -90.83 -1.24 57.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.4 41.59 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.427 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.642 ' CD2' ' HB3' ' A' ' 38' ' ' CYS . 70.8 m-85 -122.83 161.35 44.73 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.247 -0.908 . . . . 0.0 108.934 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.15 -179.77 28.24 Favored 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.698 -1.793 . . . . 0.0 111.41 1.852 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 tttp -123.04 141.34 35.48 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.0 Cg_endo -77.18 13.99 1.43 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.656 2.238 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.448 ' HB1' ' O ' ' A' ' 14' ' ' PRO . . . 170.5 144.37 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 34.6 t -124.08 159.47 29.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.4 p -59.37 -157.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.55 -11.06 8.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.731 -1.231 . . . . 0.0 109.685 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.506 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.3 pt-20 -56.6 124.86 19.75 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.896 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 19.3 t80 -86.04 132.41 34.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.323 1.059 . . . . 0.0 111.537 -177.532 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.73 80.32 2.26 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.769 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.6 Cg_endo -65.42 122.0 9.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.668 2.245 . . . . 0.0 112.415 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.583 HD11 ' CD2' ' A' ' 37' ' ' PHE . 2.0 mt -107.18 128.4 54.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.713 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -79.06 102.28 8.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.384 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.53 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.27 -170.89 0.12 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 118.579 -1.772 . . . . 0.0 109.113 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.9 t -74.32 -45.0 50.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.008 -1.289 . . . . 0.0 109.306 179.409 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -54.99 -16.39 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.817 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER 92.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.375 0.607 . . . . 0.0 109.73 179.754 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -99.41 127.89 45.48 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -69.61 152.79 44.33 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 8.2 m-85 -126.54 125.2 41.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -28.89 -50.5 0.1 Allowed Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -176.851 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -163.04 -159.94 0.58 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.704 -1.468 . . . . 0.0 110.317 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.05 -46.12 79.02 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.307 -0.871 . . . . 0.0 112.213 -177.413 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 5.3 m -66.23 -52.61 46.17 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.477 -1.389 . . . . 0.0 110.17 -178.675 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.0 m-80 -56.42 -23.43 38.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.685 -1.259 . . . . 0.0 110.395 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 16.6 t80 -82.72 -54.59 5.01 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.037 1.399 . . . . 0.0 110.007 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 1.1 m -55.55 -35.99 66.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.324 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 3.5 m-20 -57.48 -36.51 71.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.588 -1.32 . . . . 0.0 108.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.668 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.0 -28.67 66.81 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG21 HD22 ' A' ' 48' ' ' LEU . 79.4 t -72.97 -62.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.512 -0.742 . . . . 0.0 109.119 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.584 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 4.4 p -59.58 -15.15 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 111.299 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.668 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.93 -30.72 15.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.573 -1.329 . . . . 0.0 108.659 179.308 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.1 t -93.22 22.38 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.678 -0.638 . . . . 0.0 110.31 -179.187 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 44' ' ' SER . 17.4 m-80 65.62 8.85 5.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.175 -0.953 . . . . 0.0 109.802 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 84.33 17.82 63.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 p -95.74 5.79 50.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 108.734 179.2 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.579 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.3 tp -79.49 -78.28 0.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.668 0.747 . . . . 0.0 109.394 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.579 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.9 p 68.12 153.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.655 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -110.63 179.64 4.01 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.525 -0.734 . . . . 0.0 111.223 -177.733 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.655 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -109.06 -32.4 7.25 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.783 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.713 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.3 p80 -170.56 159.51 6.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.401 0.619 . . . . 0.0 109.626 -178.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 33.6 m-85 -70.55 -169.17 0.3 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 63.11 -169.29 17.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 138.83 31.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.131 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.523 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.499 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.89 -68.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.09 103.71 15.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.45 92.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -164.94 121.03 1.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.2 t -84.95 151.76 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.273 179.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -59.62 148.1 34.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 108.857 179.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 10.1 t -158.03 24.09 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.944 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.6 0.23 57.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.396 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 11.5 mp0 -122.37 43.18 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.917 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.7 m-85 -139.02 158.77 69.06 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.07 -1.019 . . . . 0.0 108.571 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.507 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.04 159.68 95.04 Favored 'Cis proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.096 3.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 5.0 tttm -110.42 145.9 33.18 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.479 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.3 14.09 1.66 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.536 2.157 . . . . 0.0 110.731 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.69 124.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -79.74 156.08 27.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.745 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -72.66 -172.05 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.633 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -115.27 -20.01 10.53 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.101 -0.999 . . . . 0.0 110.19 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.553 ' N ' HD21 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -57.87 123.17 14.85 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.855 -1.153 . . . . 0.0 108.758 179.324 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.6 t80 -83.96 124.83 31.43 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.248 1.023 . . . . 0.0 109.818 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.581 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.2 mtp180 -161.11 87.33 1.68 Allowed Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -65.46 120.54 7.75 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.147 1.898 . . . . 0.0 112.225 -177.612 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.594 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -112.15 139.83 47.35 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.482 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.573 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.7 OUTLIER -104.24 124.07 48.48 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.964 -178.307 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.501 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -69.34 -171.81 8.22 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 49' ' ' THR . 30.6 t -82.84 -17.69 43.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.696 -1.473 . . . . 0.0 108.045 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -76.68 -8.03 56.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.549 -0.72 . . . . 0.0 109.321 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.6 t30 81.75 36.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.465 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 9.6 tttt -111.99 138.83 48.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.814 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -88.73 145.14 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.917 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.592 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 66.8 m-85 -121.35 124.29 44.2 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.446 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.17 -52.63 0.71 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -177.678 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.581 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.4 p30 -152.63 -163.79 1.8 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.138 -1.213 . . . . 0.0 110.052 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 ptmt -58.27 -68.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 111.297 -178.217 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.576 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.8 p -41.28 -45.43 2.95 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.875 -1.141 . . . . 0.0 110.694 -178.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 12.1 m-80 -63.61 -40.59 97.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.549 -1.345 . . . . 0.0 109.871 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 20.5 t80 -65.35 -60.15 3.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.194 -0.941 . . . . 0.0 110.941 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.662 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -55.05 -41.57 71.6 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.893 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.625 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.4 m-20 -49.42 -37.41 25.45 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.425 -1.422 . . . . 0.0 107.971 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.663 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -72.66 -32.25 65.69 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.491 HG21 ' CD2' ' A' ' 48' ' ' LEU . 88.1 t -70.62 -67.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.296 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.474 HG13 ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -54.05 -17.61 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.705 -0.622 . . . . 0.0 111.551 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.663 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.75 -31.07 15.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.183 -1.573 . . . . 0.0 107.763 178.346 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 10.7 t -88.28 -1.29 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.829 -0.544 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.554 ' OD1' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 84.44 4.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.362 -179.513 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 91.12 8.94 64.18 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.554 ' CG2' ' OD1' ' A' ' 45' ' ' ASN . 18.0 p -85.03 1.1 49.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.915 -1.344 . . . . 0.0 108.868 178.518 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.575 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -78.82 -50.61 10.99 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.923 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 26' ' ' SER . 73.9 p 45.84 121.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.282 1.039 . . . . 0.0 112.574 178.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -82.38 159.4 23.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.513 0.673 . . . . 0.0 109.218 178.901 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.551 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.68 -26.39 10.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.552 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.571 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.8 p80 -164.2 160.21 21.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.573 0.701 . . . . 0.0 109.682 -178.639 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.96 -170.11 1.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.47 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.67 -171.67 20.72 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -90.75 166.58 13.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 108.774 179.3 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.0 m . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.667 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.386 0.613 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.77 -160.16 0.66 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.6 52.38 13.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.54 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 10.6 m -80.89 104.66 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 p -170.12 164.2 9.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.611 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.58 147.61 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.559 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.6 128.37 34.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.998 . . . . 0.0 109.504 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 m -138.0 45.89 2.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 8.43 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.893 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 21.9 mp0 -118.08 3.39 12.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 109.833 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.618 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 32.2 m-85 -85.34 160.4 54.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.202 -0.936 . . . . 0.0 109.421 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -73.91 156.43 99.69 Favored 'Cis proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.775 -1.76 . . . . 0.0 111.939 2.042 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -100.34 142.75 25.21 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.49 14.85 1.71 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.588 2.192 . . . . 0.0 110.757 179.825 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 173.3 133.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 108.994 179.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.7 m -99.44 149.42 23.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 0.0 109.922 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.51 ' HB ' ' HG2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -49.19 -24.28 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.291 1.043 . . . . 0.0 110.037 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 76.22 2.21 3.52 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.239 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.51 ' HG2' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -78.03 -164.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.779 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 5.2 t80 -130.69 126.46 36.58 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.098 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.594 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 45.0 mtm180 -159.88 77.02 2.85 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -64.28 120.3 7.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.44 2.093 . . . . 0.0 112.552 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.38 127.44 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.106 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.681 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.5 t -79.78 126.57 31.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 109.75 -179.37 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.36 169.99 54.96 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 t -64.88 -35.27 80.59 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.133 -1.216 . . . . 0.0 109.916 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -76.53 4.52 9.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.4 t30 80.33 41.41 0.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.0 110.36 179.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.8 109.64 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.39 1.09 . . . . 0.0 109.495 179.38 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -63.72 144.24 57.19 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.006 -1.059 . . . . 0.0 108.221 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.245 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -49.7 -45.42 39.11 Favored Glycine 0 N--CA 1.486 1.977 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.066 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.594 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.2 p-10 -159.04 -164.4 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.011 -1.288 . . . . 0.0 110.329 -179.567 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.2 -26.36 62.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 110.397 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.474 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 29.0 t -69.15 -63.36 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.968 -1.083 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.551 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 37.1 m-80 -59.53 -39.44 83.91 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.439 -0.788 . . . . 0.0 110.201 -179.328 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 61.3 t80 -60.38 -47.21 87.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.621 -1.3 . . . . 0.0 108.752 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.618 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.5 m -64.08 -28.54 69.85 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.356 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.5 m-20 -67.08 -32.6 73.88 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -80.26 -22.86 41.25 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.072 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.442 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 39.9 t -77.67 -33.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.651 -0.656 . . . . 0.0 109.265 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.578 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -90.98 -17.57 7.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.237 -0.914 . . . . 0.0 109.768 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.0 tt0 -91.9 -11.92 34.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.068 -1.02 . . . . 0.0 109.104 179.629 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.1 t -109.49 26.06 11.08 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.249 -0.907 . . . . 0.0 110.223 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 44' ' ' SER . 30.5 m-20 62.14 35.89 15.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.144 -0.972 . . . . 0.0 108.734 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 49.33 25.06 5.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.2 p -88.18 -14.56 38.32 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -1.092 . . . . 0.0 108.688 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.529 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 1.1 tp -80.3 133.24 35.94 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.9 p -135.08 123.5 23.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 108.997 178.666 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.573 ' HA ' ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -64.42 165.29 10.01 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.429 -0.794 . . . . 0.0 109.644 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.567 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.01 -22.77 10.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.718 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.681 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -174.2 152.41 1.83 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.537 -0.727 . . . . 0.0 109.548 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.07 170.77 6.37 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.354 -0.841 . . . . 0.0 108.871 178.868 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.06 -170.82 47.83 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.519 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.39 134.28 35.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.097 -1.237 . . . . 0.0 108.272 178.619 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.575 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.005 -1.06 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.83 -69.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.558 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.94 132.56 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.78 109.49 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.15 -166.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.34 -0.85 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.2 p -125.6 150.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.917 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.53 141.33 29.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 7.1 m -142.87 65.61 1.34 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -90.37 14.94 11.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.068 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 4.9 pm0 -122.17 -10.35 8.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.979 -1.075 . . . . 0.0 109.723 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.621 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 87.6 m-85 -80.37 158.94 71.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.522 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -73.98 178.8 31.85 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.74 -1.775 . . . . 0.0 111.437 3.071 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.19 145.92 57.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.636 -0.665 . . . . 0.0 109.461 -179.001 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -79.27 14.14 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.436 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.47 115.95 0.25 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.1 m -81.09 158.24 25.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 110.174 -179.249 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -50.06 -25.36 3.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.396 1.093 . . . . 0.0 109.778 -179.777 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER 74.57 -12.14 0.95 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.453 179.192 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.423 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -75.33 -167.94 0.72 Allowed 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.466 -1.396 . . . . 0.0 107.855 178.761 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.516 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.1 t80 -123.28 122.19 37.74 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.274 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -155.22 77.36 4.94 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.754 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -65.35 112.42 2.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.164 1.91 . . . . 0.0 112.033 -177.241 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.605 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -108.86 122.02 46.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.758 179.655 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 1.3 m -79.41 103.36 9.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 108.633 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.54 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.21 -174.55 0.08 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -178.18 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.3 t -72.67 -33.4 66.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -1.202 . . . . 0.0 108.876 178.771 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -66.27 -12.34 55.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.42 -0.8 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 88.66 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.803 -0.561 . . . . 0.0 110.161 179.715 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.524 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 ttpt -100.6 143.87 30.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 108.956 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.524 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 33.9 m -87.59 128.59 35.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.018 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 38.2 m-85 -103.8 118.46 36.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.345 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.17 -44.95 0.11 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.972 -0.455 . . . . 0.0 112.476 -176.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.569 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 32.2 p-10 -156.12 -161.8 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.702 -1.47 . . . . 0.0 109.472 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.6 pttt -70.59 -28.38 64.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.398 -0.814 . . . . 0.0 110.377 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 16.8 t -69.52 -59.86 2.7 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.86 -1.15 . . . . 0.0 109.051 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -52.88 -40.9 63.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.621 -0.674 . . . . 0.0 109.811 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 35.7 t80 -64.17 -50.1 69.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.658 1.218 . . . . 0.0 109.225 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -59.37 -26.05 64.76 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.009 -178.937 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -69.13 -35.51 76.47 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.202 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.743 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.15 -23.51 59.27 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.208 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' GLY . 55.1 t -80.36 -35.58 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.651 -0.656 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.513 HG13 ' CB ' ' A' ' 11' ' ' TYR . 5.5 p -88.56 -13.24 9.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.743 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.74 -33.83 14.86 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.005 -1.06 . . . . 0.0 108.148 178.54 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.521 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -85.96 7.44 24.33 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.567 -0.708 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.0 t-20 77.02 6.56 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.117 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 88.84 10.46 66.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.7 t -90.88 7.8 38.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.119 179.421 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.59 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.3 tp -79.42 -73.16 0.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.308 -0.87 . . . . 0.0 109.136 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.59 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.0 p 64.71 142.66 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.803 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.68 172.66 6.68 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 122.125 0.964 . . . . 0.0 111.522 -177.876 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.56 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -97.59 -46.63 5.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.028 0.918 . . . . 0.0 108.591 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.606 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 3.8 p80 -154.82 157.32 37.73 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.646 0.736 . . . . 0.0 110.507 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -77.84 175.49 9.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.53 -171.82 52.89 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.436 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -90.39 158.75 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.293 . . . . 0.0 109.619 179.294 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 57.5 m . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.956 -178.078 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 109.673 . . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 76.54 9.44 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.93 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.632 -179.99 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.53 70.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.27 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.8 113.35 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.541 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.488 HG11 ' N ' ' A' ' 7' ' ' ASP . 90.6 t -85.87 148.06 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.343 179.815 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.488 ' N ' HG11 ' A' ' 6' ' ' VAL . 12.8 t0 -84.26 116.58 23.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.893 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.9 m -119.46 60.1 0.84 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.356 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -90.97 -17.23 26.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.44 31.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.099 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.621 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 90.3 m-85 -117.81 162.2 30.35 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.4 Cg_endo -85.91 163.85 56.08 Favored 'Cis proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.213 -1.578 . . . . 0.0 110.581 1.947 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -122.91 140.61 33.7 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.658 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.66 13.36 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.462 2.108 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.36 116.4 4.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' THR . 76.8 m -92.77 138.18 31.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.839 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.7 p -52.51 -175.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.514 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.1 pt? -114.21 -26.88 7.84 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.041 -1.037 . . . . 0.0 109.636 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.514 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.0 pm0 -48.68 162.97 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.588 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.5 t80 -113.95 131.49 56.29 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.209 1.004 . . . . 0.0 110.935 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.0 mtp180 -161.21 84.84 1.79 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.445 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -67.94 113.27 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.088 1.859 . . . . 0.0 111.586 -177.878 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -107.84 126.53 52.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.513 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' SG ' ' HB3' ' A' ' 51' ' ' SER . 49.0 t -79.29 164.42 24.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.016 . . . . 0.0 108.761 -179.568 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -136.25 168.03 24.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -178.572 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 30.5 t -66.21 -23.27 66.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -1.02 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -61.08 -13.75 19.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 109.121 179.282 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.7 m-20 86.77 22.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.862 -0.524 . . . . 0.0 110.089 179.625 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -126.53 171.88 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.512 179.406 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.468 HG23 ' N ' ' A' ' 31' ' ' TYR . 28.7 m -104.94 163.69 12.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 40' ' ' ALA . 65.1 m-85 -126.12 118.86 26.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.357 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.27 -52.58 0.41 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.655 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.2 p-10 -154.31 -167.96 2.79 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.78 -1.423 . . . . 0.0 109.909 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.563 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.56 -36.1 71.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.621 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 34.7 t -60.9 -61.57 2.49 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 109.72 -179.329 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -56.05 -41.99 75.88 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 74.3 t80 -61.92 -43.85 97.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.768 -1.207 . . . . 0.0 109.607 -179.514 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.621 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 88.4 m -69.49 -24.19 63.74 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.139 -179.697 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 3.6 m120 -74.93 -26.14 59.41 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.178 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.586 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -78.19 -33.53 50.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.439 HG21 ' O ' ' A' ' 37' ' ' PHE . 42.2 t -69.02 -48.45 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.517 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 35.0 m -64.16 -31.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.572 -0.705 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.79 -8.33 43.97 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 109.521 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 46.6 t -111.52 14.03 21.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.104 -0.997 . . . . 0.0 110.958 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.15 48.57 21.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.842 -1.162 . . . . 0.0 109.399 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.52 35.06 5.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.902 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 44' ' ' SER . 30.2 p -110.86 5.5 20.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -1.072 . . . . 0.0 108.391 178.229 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.649 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.7 -51.76 6.99 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.993 0.901 . . . . 0.0 109.143 -179.931 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.649 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 77.5 p 56.24 124.39 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.281 1.038 . . . . 0.0 110.48 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.8 tp -62.05 129.6 41.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.101 179.798 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.564 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 10.9 t -79.47 -21.91 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.865 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.564 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.3 p80 156.23 154.63 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.787 179.416 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -63.48 165.48 7.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.089 . . . . 0.0 108.663 179.398 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.08 -168.76 45.28 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -178.976 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.01 161.68 14.35 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.891 -1.359 . . . . 0.0 108.074 178.052 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.479 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 7.8 m . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.767 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.336 0.589 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.53 106.17 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.35 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.98 146.44 46.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.959 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.446 ' O ' HD23 ' A' ' 50' ' ' LEU . 3.0 m -139.18 86.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t -164.1 166.08 21.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.972 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.18 146.16 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 179.952 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -88.15 145.89 25.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.207 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 35.9 m -134.41 70.69 1.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.275 -0.891 . . . . 0.0 110.009 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -19.46 23.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.867 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 32.77 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.632 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 60.6 m-85 -113.34 164.82 14.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.573 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 32.6 Cg_endo -84.91 152.31 58.0 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.433 -1.486 . . . . 0.0 111.274 2.073 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.5 mtpm? -112.34 138.25 21.83 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.7 Cg_endo -80.39 14.78 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.728 2.285 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.19 160.51 21.36 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.112 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -147.5 159.84 43.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 110.002 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.57 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -117.18 -23.29 7.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.775 -1.203 . . . . 0.0 110.02 179.965 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -45.5 115.94 1.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.519 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.8 t80 -79.19 127.24 31.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.466 1.127 . . . . 0.0 111.354 -177.697 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.628 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 ptm180 -161.65 78.05 2.18 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.15 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.0 Cg_endo -66.16 128.14 18.94 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 123.208 2.605 . . . . 0.0 113.069 -177.135 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.59 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -112.34 130.34 55.99 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.606 178.402 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.1 t -83.56 122.75 28.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.928 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.5 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -68.53 -165.95 3.84 Favored Glycine 0 C--N 1.296 -1.665 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 49' ' ' THR . 7.1 t -89.2 -36.99 15.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.238 . . . . 0.0 107.972 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.624 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.4 p-10 -58.61 -17.37 21.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.532 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 97.17 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.128 0.49 . . . . 0.0 110.01 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.464 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.75 119.85 38.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.217 179.592 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.434 HG22 ' HB3' ' A' ' 55' ' ' LYS . 16.2 m -69.9 152.85 44.03 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.412 -0.805 . . . . 0.0 109.171 -179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 19.4 m-85 -132.7 124.43 28.17 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.793 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.78 -51.96 0.07 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.628 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -163.63 -162.32 0.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -1.232 . . . . 0.0 110.289 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.51 -40.76 60.22 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 112.6 -177.408 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.541 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -69.12 -65.15 0.74 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.209 -1.557 . . . . 0.0 108.911 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.7 m-80 -42.93 -30.5 0.41 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.503 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 27.5 t80 -74.85 -48.25 26.01 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.897 1.332 . . . . 0.0 109.406 179.545 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 87.4 m -55.92 -53.67 53.97 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.735 -178.828 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.546 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -42.23 -26.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.951 -1.093 . . . . 0.0 108.931 -179.475 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.97 -47.75 17.83 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.592 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.51 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 61.6 t -60.5 -28.12 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.715 -0.616 . . . . 0.0 110.422 179.507 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.545 ' CG2' ' HB3' ' A' ' 12' ' ' PRO . 33.2 m -90.93 -26.28 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.88 -1.137 . . . . 0.0 109.897 -179.033 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.3 tt0 -90.47 0.77 57.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.406 -0.808 . . . . 0.0 108.868 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.496 ' O ' ' OG ' ' A' ' 44' ' ' SER . 1.4 t -119.18 22.47 11.82 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.543 ' O ' ' CG2' ' A' ' 47' ' ' THR . 0.8 OUTLIER 64.11 46.47 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.905 1.336 . . . . 0.0 108.082 179.951 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 32.31 37.33 0.04 OUTLIER Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.513 -0.742 . . . . 0.0 111.874 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 45' ' ' ASN . 43.2 p -111.01 0.45 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.265 . . . . 0.0 108.231 177.868 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.493 HD21 ' N ' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.36 152.92 30.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.759 0.79 . . . . 0.0 109.016 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' CB ' ' A' ' 26' ' ' SER . 41.2 p -141.45 149.89 41.56 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.926 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.624 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.22 175.96 6.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.713 -1.242 . . . . 0.0 109.214 -179.544 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.624 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.5 -23.04 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.756 -1.215 . . . . 0.0 108.607 -179.439 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 177.14 155.03 0.27 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 -178.816 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -62.04 -168.0 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.561 -0.712 . . . . 0.0 109.133 178.87 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.6 -167.45 6.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.49 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.434 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.8 175.68 6.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -1.073 . . . . 0.0 108.471 178.571 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.568 -179.807 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.517 ' O ' ' CB ' ' A' ' 3' ' ' ALA . . . -120.75 -5.74 9.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.658 -179.909 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 2' ' ' ALA . . . 76.25 145.24 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 179.926 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.527 HG11 ' CD2' ' A' ' 50' ' ' LEU . 1.6 t -155.16 90.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.181 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.1 p -168.05 85.44 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 110.103 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.43 149.99 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 0.0 108.885 179.461 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.611 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 78.1 m -137.3 47.98 2.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.309 179.81 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.464 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 64.6 p -86.96 -30.21 21.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.464 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 12.0 mm-40 -73.19 -8.92 57.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.597 ' CE2' ' HA ' ' A' ' 35' ' ' CYS . 80.3 m-85 -79.97 161.44 65.87 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.416 -0.802 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.2 Cg_endo -84.51 143.36 40.08 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 123.156 -1.602 . . . . 0.0 110.846 1.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.409 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.0 mtpt -116.09 137.85 23.72 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.484 -0.76 . . . . 0.0 109.369 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -80.49 14.08 2.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.349 2.033 . . . . 0.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.14 126.74 15.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.2 m -112.78 138.75 49.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.78 -179.548 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -56.9 -170.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.734 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.14 -25.48 9.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.099 -1.001 . . . . 0.0 109.603 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.8 mt-10 -41.47 122.51 1.93 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.349 -0.844 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.474 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 15.6 t80 -83.14 107.37 15.66 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.432 1.11 . . . . 0.0 110.357 -179.007 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -141.27 77.7 19.75 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.197 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.542 ' O ' ' O ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -64.25 115.24 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.228 1.952 . . . . 0.0 111.688 -177.933 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.564 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.76 135.7 53.89 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.539 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.69 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 47.4 t -89.99 160.47 16.36 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.536 -179.67 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -133.2 161.21 24.14 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.515 -177.659 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t -45.36 -21.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.817 -0.813 . . . . 0.0 111.177 -178.176 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' CD1' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -86.14 25.23 1.19 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.094 -179.654 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 m120 49.48 20.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.63 141.23 36.79 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.008 -1.058 . . . . 0.0 109.999 -179.84 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.2 m -86.87 157.54 19.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.427 -0.796 . . . . 0.0 108.932 179.53 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.606 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 82.1 m-85 -135.74 99.49 4.2 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.31 -59.28 0.02 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -178.166 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p-10 -137.77 -170.27 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.739 -1.448 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -54.22 -35.37 62.34 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.9 -0.5 . . . . 0.0 110.743 -178.639 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.597 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.7 t -64.57 -67.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.902 -1.124 . . . . 0.0 109.569 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.6 m-80 -44.84 -30.27 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.82 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 24.1 t80 -71.79 -54.31 10.58 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.535 1.16 . . . . 0.0 109.78 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 72.7 m -54.59 -58.9 5.69 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.109 -179.684 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.497 ' HA ' HG23 ' A' ' 42' ' ' VAL . 9.1 m-20 -42.68 -27.78 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.878 -1.139 . . . . 0.0 109.394 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.465 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . . . -73.57 -48.1 35.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.489 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 66.9 t -60.69 -54.11 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.378 0.609 . . . . 0.0 109.57 179.347 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.497 HG23 ' HA ' ' A' ' 39' ' ' ASN . 10.2 m -56.3 -31.31 32.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.237 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -92.2 -12.31 33.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.915 -1.116 . . . . 0.0 109.638 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 17.6 t -98.06 8.19 45.15 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.101 -0.999 . . . . 0.0 110.309 -179.089 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t-20 75.33 12.12 3.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.984 -1.073 . . . . 0.0 108.484 -179.24 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 67.29 8.39 50.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.3 t -86.45 5.51 34.82 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.203 -1.175 . . . . 0.0 108.469 178.615 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.525 ' CD1' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -87.94 -71.81 0.56 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.993 0.901 . . . . 0.0 108.888 -179.666 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.525 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.6 p 81.69 152.11 0.1 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.965 0.888 . . . . 0.0 109.081 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.577 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.5 tp -67.69 156.76 36.17 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.52 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.3 p -106.28 -40.85 5.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.69 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 168.5 1.71 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.132 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -81.61 166.21 20.4 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.262 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 82.84 -175.11 53.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.96 156.49 19.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.949 -1.324 . . . . 0.0 109.132 179.081 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.456 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.332 0.587 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 73.15 117.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -54.5 168.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.294 179.817 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 4' ' ' VAL . 11.6 m -156.14 82.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 178.04 147.84 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.05 155.67 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -92.35 128.87 38.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.136 179.712 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.1 m -123.05 63.56 0.99 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 109.831 -179.674 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.471 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.2 t -90.68 -19.5 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.325 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.9 mm-40 -97.46 26.3 5.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.092 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.577 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 68.9 m-85 -114.71 161.99 26.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.548 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.7 Cg_endo -85.84 156.03 56.88 Favored 'Cis proline' 0 C--N 1.305 -1.752 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.698 1.605 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.552 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 20.3 mtpt -118.31 140.15 27.74 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.869 . . . . 0.0 109.192 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.86 14.33 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.658 2.239 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.99 119.88 5.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.741 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -101.07 139.37 36.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.275 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.61 -172.07 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.422 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.647 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.36 -14.31 11.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.887 -1.133 . . . . 0.0 110.379 -179.461 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.536 ' N ' HD21 ' A' ' 18' ' ' LEU . 3.0 pm0 -49.35 120.96 4.47 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.379 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -79.57 126.62 31.12 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.45 1.119 . . . . 0.0 110.902 -178.273 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.81 80.05 1.99 Allowed Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.408 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.542 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.0 Cg_endo -65.72 119.54 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.286 1.991 . . . . 0.0 112.135 -177.366 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.621 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -110.79 123.13 49.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.151 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.696 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.1 t -79.26 127.65 32.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 0.0 109.101 -179.193 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.462 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -74.3 -173.31 29.28 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.573 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 5.2 t -76.14 -33.47 59.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.695 -1.474 . . . . 0.0 108.902 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.593 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -62.08 -12.18 17.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 109.653 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 59.3 t30 92.23 20.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.956 -0.465 . . . . 0.0 111.041 179.229 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.68 175.03 5.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.799 -1.188 . . . . 0.0 108.017 178.235 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -119.89 148.16 43.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 109.887 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.573 ' CE2' ' HB1' ' A' ' 40' ' ' ALA . 46.2 m-85 -120.67 120.72 36.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.819 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -30.27 -51.24 0.19 Allowed Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -177.768 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.578 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -153.04 -166.4 2.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.738 -1.448 . . . . 0.0 110.252 179.737 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -66.7 -22.54 66.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.569 -0.707 . . . . 0.0 111.323 -178.32 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 49.2 t -74.1 -50.55 19.0 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.612 -1.305 . . . . 0.0 108.859 179.578 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -62.9 -38.47 91.09 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 48.4 t80 -68.87 -47.8 65.02 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.37 1.081 . . . . 0.0 109.635 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.577 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 29.2 m -62.23 -29.34 70.32 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.908 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.529 ' HA ' HG23 ' A' ' 42' ' ' VAL . 19.9 m-20 -71.67 -23.61 61.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.077 -1.015 . . . . 0.0 108.638 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -85.78 -22.82 27.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.472 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.406 HG21 ' CD2' ' A' ' 48' ' ' LEU . 86.7 t -83.2 -26.68 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.272 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 39' ' ' ASN . 33.8 m -86.49 -31.0 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.443 -0.786 . . . . 0.0 109.294 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.92 -15.4 28.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.525 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 27.9 t -96.97 9.63 41.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.957 . . . . 0.0 110.299 -179.385 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.3 m120 62.59 28.31 16.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.155 -0.965 . . . . 0.0 109.355 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.85 63.83 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.3 p -96.28 5.76 50.26 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -1.098 . . . . 0.0 108.584 178.794 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.607 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.82 -63.82 1.28 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.437 -0.789 . . . . 0.0 109.042 -179.712 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.607 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 65.5 p 56.27 124.72 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.96 0.886 . . . . 0.0 110.446 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -85.83 172.08 11.04 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.524 0.678 . . . . 0.0 110.733 -178.709 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.04 -28.72 9.38 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.696 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -174.44 162.7 3.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.766 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 m-85 -71.45 -170.77 0.54 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.51 -174.01 8.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.701 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.421 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -85.6 164.82 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -1.103 . . . . 0.0 108.868 179.396 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 3.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.393 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.1 pp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 179.48 153.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.936 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 173.88 124.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.911 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.469 ' O ' ' CG2' ' A' ' 4' ' ' VAL . 2.5 p -106.71 68.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 t -169.05 106.12 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG11 ' O ' ' A' ' 7' ' ' ASP . 51.8 t -88.82 145.17 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.6 -179.887 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.455 ' O ' HG11 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -76.72 172.89 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.185 179.952 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.4 t -161.15 26.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -90.56 -0.21 57.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.93 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -119.58 38.55 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 110.267 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.3 m-85 -139.83 154.17 70.56 Favored Pre-proline 0 C--N 1.305 -1.334 0 O-C-N 121.057 -1.027 . . . . 0.0 108.369 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -72.13 149.07 92.47 Favored 'Cis proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.597 -1.835 . . . . 0.0 111.622 2.931 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -110.6 148.03 37.65 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.981 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.5 Cg_endo -77.44 13.32 1.63 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.509 2.139 . . . . 0.0 110.968 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 115.26 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.2 m -88.69 149.66 23.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 109.749 -179.612 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -47.92 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.393 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.95 -23.21 9.2 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.869 -1.145 . . . . 0.0 110.228 -179.521 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pm0 -59.18 -168.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.885 -1.134 . . . . 0.0 108.134 179.358 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 20.0 t80 -127.55 129.1 46.75 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.32 81.61 2.0 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.262 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.533 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -66.4 111.33 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.177 1.918 . . . . 0.0 111.27 -178.268 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -105.95 136.78 45.0 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.266 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.678 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 12.1 t -98.22 159.04 15.2 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.251 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -116.53 174.06 15.04 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.441 -177.895 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.1 t -70.33 -13.47 62.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.45 -1.029 . . . . 0.0 108.547 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.7 p-10 -81.92 -8.99 59.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.41 -0.806 . . . . 0.0 109.318 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.6 t-20 82.74 34.78 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.649 -0.657 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 tttp -123.2 147.3 47.02 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.15 -0.969 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.476 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 78.0 m -93.35 162.18 14.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.071 -1.018 . . . . 0.0 109.898 -179.87 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.6 m-85 -138.18 108.22 6.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.69 -57.44 0.12 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -177.252 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.592 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.1 p30 -141.66 -169.88 2.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.817 -1.402 . . . . 0.0 110.535 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.0 ptmt -54.7 -47.06 74.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.794 -0.566 . . . . 0.0 110.708 -178.514 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.7 t -53.79 -52.69 59.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.802 -1.187 . . . . 0.0 109.541 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.1 m-80 -61.64 -29.39 70.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.549 -0.72 . . . . 0.0 110.547 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 11.5 t80 -73.86 -62.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.76 -1.212 . . . . 0.0 110.813 -179.167 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.2 -48.75 73.39 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.81 -0.556 . . . . 0.0 109.523 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.504 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.6 m-80 -41.88 -31.13 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.179 . . . . 0.0 108.321 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.496 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -72.99 -49.08 31.08 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.569 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.551 ' CG2' HD22 ' A' ' 48' ' ' LEU . 71.4 t -55.78 -59.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.401 0.62 . . . . 0.0 110.373 179.207 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 11' ' ' TYR . 2.3 p -60.62 -23.97 30.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.204 -0.935 . . . . 0.0 110.599 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.8 tm-20 -89.35 -15.39 33.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.611 -1.306 . . . . 0.0 107.994 178.276 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -105.6 0.27 26.34 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 44' ' ' SER . 2.4 p30 60.64 22.85 12.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 0.0 109.447 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.45 16.11 57.55 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.666 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.488 ' OG1' ' OG ' ' A' ' 44' ' ' SER . 74.1 p -85.52 -12.04 52.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.26 . . . . 0.0 108.268 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.644 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -78.41 -52.13 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.713 0.768 . . . . 0.0 109.177 -179.967 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.644 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 20.9 p 55.17 123.73 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.312 1.053 . . . . 0.0 109.839 -178.045 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 24.8 tp -56.45 160.22 3.26 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.519 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -115.91 -41.57 3.18 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.54 1.162 . . . . 0.0 107.928 179.545 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.678 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.04 159.64 1.34 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.726 -179.568 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.84 133.8 36.99 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.408 178.792 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 112.91 -172.13 14.33 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.43 134.36 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.042 -1.269 . . . . 0.0 109.295 179.211 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 2' ' ' ALA . 1.9 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 1' ' ' LEU . . . 44.45 78.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 -179.849 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.27 -179.03 3.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.62 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 5' ' ' SER . 5.4 m -131.07 88.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER 164.52 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.53 ' CG2' HD21 ' A' ' 23' ' ' LEU . 99.1 t -106.09 142.61 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.088 -1.007 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' N ' HG11 ' A' ' 6' ' ' VAL . 4.2 t70 -69.42 148.23 49.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.693 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.46 30.38 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -13.85 43.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.651 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.49 -2.19 25.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.629 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 54.5 m-85 -93.56 163.37 24.71 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.1 Cg_endo -83.27 157.7 74.04 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.247 -1.564 . . . . 0.0 110.989 2.114 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.61 142.54 25.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.627 -179.735 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.491 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.7 Cg_endo -79.75 15.27 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.753 2.302 . . . . 0.0 110.861 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 164.35 137.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.478 -0.763 . . . . 0.0 109.025 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 17' ' ' THR . 49.0 t -109.86 157.57 19.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.065 -1.022 . . . . 0.0 110.842 -179.258 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.474 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -64.19 -157.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.058 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -116.69 -8.26 11.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.269 -1.519 . . . . 0.0 110.856 -179.708 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -49.62 136.32 17.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.585 -1.322 . . . . 0.0 107.811 179.276 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.0 t80 -98.29 130.2 44.98 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 122.282 1.039 . . . . 0.0 110.618 -178.602 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.86 77.58 2.46 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.536 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -62.59 121.35 9.27 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.741 2.294 . . . . 0.0 112.55 -177.084 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.574 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -110.03 133.88 52.73 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.563 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.704 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -80.31 111.07 16.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.492 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.59 -169.04 3.28 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.665 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -80.85 -32.38 35.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.839 -1.389 . . . . 0.0 108.812 178.895 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -65.23 -8.15 16.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.836 . . . . 0.0 109.616 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 46.1 t30 86.05 16.37 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.695 -0.628 . . . . 0.0 110.489 179.033 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.1 OUTLIER -109.41 119.98 41.1 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.5 178.856 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.479 ' OG1' ' HA ' ' A' ' 55' ' ' LYS . 27.0 m -58.64 161.93 4.3 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.494 0.664 . . . . 0.0 109.771 -179.354 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -130.54 133.36 46.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.772 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.611 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.3 -50.3 0.25 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -177.313 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.6 p30 -165.31 -164.02 0.72 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.921 -1.34 . . . . 0.0 110.75 178.896 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 pttt -52.82 -40.31 63.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.688 -0.633 . . . . 0.0 111.676 -177.674 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.629 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -72.69 -50.86 22.1 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.628 -1.295 . . . . 0.0 110.173 -178.427 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.1 m-80 -61.65 -18.58 60.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.713 -1.242 . . . . 0.0 108.931 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 9.4 t80 -80.74 -60.85 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.303 1.049 . . . . 0.0 109.636 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 46.8 t -57.78 -49.65 75.89 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.321 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.501 ' HA ' HG23 ' A' ' 42' ' ' VAL . 8.0 m-20 -42.17 -28.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.721 -1.237 . . . . 0.0 108.343 179.357 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -74.32 -49.65 22.05 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.673 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.526 ' N ' ' O ' ' A' ' 38' ' ' CYS . 97.2 t -55.53 -56.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 178.796 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.501 HG23 ' HA ' ' A' ' 39' ' ' ASN . 19.4 m -58.21 -29.67 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -0.974 . . . . 0.0 110.27 -179.544 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.0 tt0 -90.78 -10.46 42.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.01 -1.056 . . . . 0.0 109.426 -179.616 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -105.86 16.14 25.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -179.559 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 10.5 m120 63.16 16.21 9.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.016 -1.053 . . . . 0.0 109.644 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' HG12 ' A' ' 41' ' ' VAL . . . 72.44 21.94 79.19 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -96.2 6.55 48.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 107.99 178.155 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 49' ' ' THR . 5.3 tp -87.78 -76.19 0.39 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.547 0.689 . . . . 0.0 109.841 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.567 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.1 p 66.22 152.86 0.07 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -178.586 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.659 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.87 173.14 6.45 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.635 -0.666 . . . . 0.0 110.198 -178.056 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.659 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.93 -33.53 7.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.659 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.704 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -167.27 163.32 15.32 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.533 0.682 . . . . 0.0 109.667 -178.798 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' CD2' HD22 ' A' ' 23' ' ' LEU . 16.1 m-85 -76.03 -177.72 4.05 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.524 -0.735 . . . . 0.0 109.359 179.15 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.38 -170.48 52.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.11 125.86 36.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -1.082 . . . . 0.0 109.609 179.326 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.53 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.454 179.775 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.92 -70.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.63 141.09 31.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.177 -0.952 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -107.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -162.81 113.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.523 -179.903 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.2 t -80.31 151.27 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.729 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.15 98.28 7.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.957 -179.747 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 34.6 m -93.08 65.55 4.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 108.939 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -88.98 -10.11 48.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.122 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mp0 -116.04 36.98 3.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.594 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 87.1 m-85 -117.87 160.95 36.69 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.644 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 35.4 Cg_endo -83.63 159.66 72.3 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.964 -1.682 . . . . 0.0 110.819 2.364 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLU . 17.0 mtpp -131.35 137.84 31.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.391 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -80.66 14.04 2.13 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.492 2.128 . . . . 0.0 110.687 -179.773 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.1 115.32 10.35 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.72 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.9 m -98.84 139.57 34.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 -179.353 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.509 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 36.0 p -47.13 169.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.16 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.602 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -110.12 -1.79 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.775 -1.203 . . . . 0.0 110.365 -179.869 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' N ' HD21 ' A' ' 18' ' ' LEU . 3.3 pm0 -76.26 -170.83 1.56 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.584 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.8 t80 -133.57 125.5 28.95 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.889 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 53.8 mtt180 -161.16 80.75 2.1 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.241 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.556 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.3 Cg_endo -65.75 122.65 10.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.5 2.134 . . . . 0.0 112.045 -177.188 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.603 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.67 135.58 49.67 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.286 -0.966 . . . . 0.0 108.583 179.17 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.673 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 4.1 t -85.21 162.29 19.24 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 -179.298 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.98 161.49 15.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.479 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -69.23 -19.16 63.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -1.149 . . . . 0.0 109.109 -179.721 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 29.9 p-10 -78.12 -0.16 27.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.073 179.19 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER 79.62 42.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.508 -0.745 . . . . 0.0 109.752 179.857 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -134.18 139.41 45.82 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.944 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 5.5 m -92.23 165.86 12.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.009 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CD2' ' O ' ' A' ' 36' ' ' ASN . 57.9 m-85 -137.83 123.61 19.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.819 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.57 -53.69 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.804 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -157.35 -168.23 2.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.973 -1.31 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.603 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -53.15 -37.9 62.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 111.358 -178.29 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.7 t -63.0 -61.15 2.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.635 -1.29 . . . . 0.0 109.964 -179.581 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.2 m-80 -55.75 -31.29 62.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.456 -0.777 . . . . 0.0 110.837 -179.017 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 69.6 t80 -73.58 -44.23 57.79 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.818 -1.177 . . . . 0.0 109.682 -179.526 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 63.3 m -66.23 -30.1 70.49 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.43 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 11.4 m-20 -68.42 -24.85 64.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.756 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.44 -26.35 32.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.531 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' GLY . 92.1 t -80.08 -26.48 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.534 ' CG2' ' HA ' ' A' ' 39' ' ' ASN . 33.4 m -90.68 -21.02 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.353 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.756 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.54 -31.59 16.66 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.277 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 96.6 p -88.63 23.16 2.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.541 -0.725 . . . . 0.0 109.744 -179.66 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.2 m120 64.97 11.59 7.18 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.377 -0.827 . . . . 0.0 109.319 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 78.1 22.63 67.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.9 p -93.1 -5.34 50.54 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.322 -1.104 . . . . 0.0 109.093 179.418 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.418 ' CD1' ' N ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -78.96 157.57 28.14 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.567 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 70.9 p -149.0 126.22 11.44 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.281 1.039 . . . . 0.0 110.496 179.714 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.2 tp -67.05 150.24 49.49 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.802 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.502 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.15 -22.58 12.32 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.116 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.673 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.4 p80 -175.92 163.29 2.72 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.497 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -78.51 178.58 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 178.921 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 75.73 -172.19 54.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.44 131.42 36.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.081 -1.246 . . . . 0.0 109.429 179.127 . . . . . . . . 3 3 . 1 . 037 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.596 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.562 179.915 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.47 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 166.67 113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.426 ' O ' ' O ' ' A' ' 2' ' ' ALA . . . -49.84 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.612 ' O ' ' CB ' ' A' ' 5' ' ' SER . 53.5 t -101.39 55.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.82 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 4.0 m 100.51 73.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.299 0.571 . . . . 0.0 110.881 179.102 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 5' ' ' SER . 90.0 t -160.59 141.35 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.928 . . . . 0.0 109.193 178.539 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.502 ' N ' HG11 ' A' ' 6' ' ' VAL . 10.6 t0 -99.27 153.68 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 109.199 179.868 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 t -151.87 17.63 0.68 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.08 -1.012 . . . . 0.0 109.945 -179.875 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -90.8 13.02 17.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.149 -0.969 . . . . 0.0 109.748 179.616 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -130.74 -18.39 3.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.008 -1.057 . . . . 0.0 110.972 -179.237 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 96.4 m-85 -79.76 161.59 65.88 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.933 -1.104 . . . . 0.0 109.175 -179.304 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.7 Cg_endo -69.43 167.43 70.12 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.249 -1.563 . . . . 0.0 112.191 2.698 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -119.66 147.94 44.92 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.68 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.502 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -77.99 13.73 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.592 2.195 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.502 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 164.09 128.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.19 159.09 16.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 p -62.8 164.34 8.07 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.241 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 -18.22 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.757 -1.215 . . . . 0.0 109.832 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.52 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -51.0 130.76 26.25 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.197 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.533 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 7.4 t80 -81.38 126.94 32.22 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.475 1.131 . . . . 0.0 111.446 -177.124 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.602 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mmt180 -159.58 75.63 3.1 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.614 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.4 Cg_endo -67.13 144.51 69.5 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.244 2.629 . . . . 0.0 113.288 -176.969 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.596 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.5 mp -129.59 132.68 46.85 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.407 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.644 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.3 t -91.41 161.78 14.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.056 . . . . 0.0 110.319 -178.458 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.45 177.11 18.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.062 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.493 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -70.37 -23.57 62.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.985 . . . . 0.0 108.682 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 41.4 p-10 -77.3 -6.99 55.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.082 179.36 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m120 82.27 28.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.677 -0.639 . . . . 0.0 109.911 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -103.07 136.4 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.515 HG22 ' CB ' ' A' ' 55' ' ' LYS . 23.5 m -88.79 137.91 31.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.713 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.578 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.9 m-85 -114.87 136.85 52.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.694 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.08 -48.25 3.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -178.606 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.602 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.3 p30 -167.4 -158.8 0.29 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.032 -1.275 . . . . 0.0 110.656 178.942 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.596 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.5 -45.06 73.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 112.574 -176.566 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.522 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 3.6 m -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.491 -1.381 . . . . 0.0 109.704 -178.658 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -53.5 -17.31 1.93 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.0 t80 -83.23 -69.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.586 1.184 . . . . 0.0 110.302 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.68 -46.11 77.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.754 -177.792 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.589 ' OD1' ' CD1' ' A' ' 11' ' ' TYR . 3.0 m-20 -44.96 -29.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.46 -1.4 . . . . 0.0 107.592 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.413 ' N ' ' C ' ' A' ' 38' ' ' CYS . . . -71.96 -49.26 38.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.259 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.546 ' N ' ' O ' ' A' ' 38' ' ' CYS . 75.4 t -52.49 -62.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.282 0.563 . . . . 0.0 110.198 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.407 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 1.5 p -60.75 -23.63 29.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.434 -0.791 . . . . 0.0 111.097 -178.456 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.9 tt0 -92.03 -11.56 35.6 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.532 -1.355 . . . . 0.0 108.965 179.183 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 44' ' ' SER . 6.1 t -103.79 22.05 15.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.702 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.483 ' O ' ' N ' ' A' ' 47' ' ' THR . 7.6 m-80 60.35 43.96 12.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.055 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.26 28.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.483 ' N ' ' O ' ' A' ' 45' ' ' ASN . 79.9 p -84.48 -16.18 43.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -1.206 . . . . 0.0 107.89 178.189 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.59 HD22 ' CE1' ' A' ' 37' ' ' PHE . 0.6 OUTLIER -79.51 164.53 23.83 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.576 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.493 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 64.5 p -149.85 130.94 14.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.639 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.3 tp -64.98 146.13 55.42 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.65 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.492 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.63 -18.17 11.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.896 -1.127 . . . . 0.0 108.108 179.11 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.644 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 172.75 160.75 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.944 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 5' ' ' SER . 4.5 m-85 -71.01 -166.83 0.17 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.253 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.61 -170.51 2.72 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.65 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.4 OUTLIER -90.15 158.11 17.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.542 -0.975 . . . . 0.0 108.413 179.99 . . . . . . . . 3 3 . 1 . 038 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.65 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 18.2 m . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.289 179.843 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.63 111.07 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.36 142.96 27.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 4' ' ' VAL . 14.5 p -133.98 69.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 4' ' ' VAL . 40.7 m -171.09 149.7 2.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t -132.22 133.38 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -77.69 -166.43 0.77 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.786 -179.795 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 m -156.13 43.45 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.983 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -19.15 35.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 110.001 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -114.63 47.37 1.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 108.97 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 58.9 m-85 -142.72 163.95 35.49 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 -178.928 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.554 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.2 Cg_endo -88.75 159.68 40.36 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.743 0.94 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.418 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.66 131.95 24.08 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 109.016 179.933 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.08 14.52 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 111.129 -179.699 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.82 142.11 22.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.819 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 17' ' ' THR . 33.0 t -144.78 162.88 35.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 109.565 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 16' ' ' CYS . 32.8 p -60.27 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 108.865 179.238 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pp -134.98 -13.18 2.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.031 -1.043 . . . . 0.0 110.958 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.533 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 15.6 pm0 -54.49 132.11 44.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.156 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.578 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 8.6 t80 -87.6 127.75 35.27 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.551 1.167 . . . . 0.0 111.911 -177.024 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmt85 -161.36 75.49 2.45 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.595 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' HG3' ' CZ ' ' A' ' 20' ' ' TYR . 26.9 Cg_endo -66.21 133.94 34.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.612 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -120.28 124.82 46.54 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.247 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.657 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.5 t -79.12 165.89 22.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 108.328 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.512 ' CA ' HD13 ' A' ' 48' ' ' LEU . . . -138.7 159.03 25.29 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.398 -1.382 . . . . 0.0 112.497 -176.959 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.51 ' N ' HD13 ' A' ' 48' ' ' LEU . 5.7 t -46.08 -21.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.924 -0.75 . . . . 0.0 110.908 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.474 ' OD2' ' HB3' ' A' ' 29' ' ' LYS . 27.1 p-10 -86.15 26.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 40.0 t-20 47.43 24.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 110.074 179.314 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.0 tttp -110.91 142.61 42.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 15.5 m -92.93 140.03 29.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 108.965 179.533 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.6 ' CE1' ' HB1' ' A' ' 40' ' ' ALA . 70.3 m-85 -112.91 126.51 55.54 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.513 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.01 -52.66 1.56 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p30 -158.96 -164.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.09 -1.241 . . . . 0.0 110.513 179.549 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.612 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.08 -49.65 30.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.598 -0.689 . . . . 0.0 111.999 -177.911 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 10.6 m -61.79 -58.09 9.34 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.57 -1.331 . . . . 0.0 110.43 -178.835 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.428 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.8 m-80 -58.68 -13.81 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.98 . . . . 0.0 110.062 -179.503 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.571 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 5.8 t80 -83.68 -58.13 2.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.307 1.051 . . . . 0.0 109.992 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 16.7 t -61.13 -29.36 69.73 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.128 -178.476 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.592 ' HA ' HG23 ' A' ' 42' ' ' VAL . 88.0 m-20 -58.71 -29.49 66.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.612 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.709 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.81 -30.99 51.51 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.59 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 52.1 t -75.86 -21.3 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.48 0.657 . . . . 0.0 109.435 179.535 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 39' ' ' ASN . 11.6 m -90.25 -22.12 6.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.83 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.709 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -89.81 -30.02 18.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.527 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 11.2 p -87.72 17.78 4.5 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.343 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' SER . 9.4 p30 50.63 41.26 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.679 -179.706 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.82 37.75 58.18 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.365 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.507 ' CG2' ' O ' ' A' ' 44' ' ' SER . 7.6 t -111.13 -1.7 16.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.086 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.59 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.17 -75.01 0.45 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.303 1.049 . . . . 0.0 109.162 -179.661 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.557 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.8 p 82.44 150.59 0.09 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.383 -177.892 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 51' ' ' SER . 14.2 tp -63.59 160.65 16.25 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.766 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 5.9 p -115.7 -43.62 3.01 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.657 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.1 160.63 1.42 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.264 179.429 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -69.04 172.56 6.54 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.956 179.224 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.48 -167.48 52.04 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -92.85 -172.08 2.91 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.847 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.593 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.8 tp . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.55 73.13 0.49 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.01 91.63 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.98 75.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -158.17 156.12 30.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 73.4 t -114.52 142.82 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.101 -0.999 . . . . 0.0 109.688 179.93 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.05 124.81 41.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 108.808 179.463 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.3 m -135.06 46.91 2.38 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 -179.263 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.24 -0.66 57.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.415 179.6 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -117.88 36.05 4.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 92.8 m-85 -121.5 157.08 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.255 -0.903 . . . . 0.0 108.638 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.15 167.98 78.81 Favored 'Cis proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.022 2.298 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -116.32 142.91 30.13 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.546 -0.721 . . . . 0.0 109.202 -179.656 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -78.72 12.47 2.18 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.424 2.083 . . . . 0.0 110.489 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.87 109.98 0.34 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.556 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 92.4 m -95.18 140.56 29.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.785 -179.244 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -52.94 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.662 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.2 pp -128.69 -24.07 3.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.922 -1.111 . . . . 0.0 110.255 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 13.8 pm0 -46.37 134.87 8.64 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.204 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -87.55 126.48 34.95 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.535 1.159 . . . . 0.0 111.387 -177.937 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mtt-85 -161.57 82.03 1.9 Allowed Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.728 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.4 Cg_endo -65.64 125.6 14.62 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.615 2.21 . . . . 0.0 112.932 -176.489 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -110.12 136.91 48.62 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.924 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.574 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -103.54 122.74 45.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.091 -1.005 . . . . 0.0 111.053 -178.652 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.495 ' CA ' ' HA ' ' A' ' 50' ' ' LEU . . . -62.57 -166.14 0.57 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.178 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -90.17 -25.99 20.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.442 -1.034 . . . . 0.0 108.728 179.31 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -79.29 -2.26 40.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.806 . . . . 0.0 109.086 179.384 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.8 m120 82.99 47.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 0.0 110.356 179.603 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 17.3 ptmt -121.87 116.28 24.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.538 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.4 m -75.42 153.06 37.88 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.726 0.774 . . . . 0.0 110.405 -178.564 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 3.6 m-85 -131.45 148.04 52.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.155 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -58.87 -37.59 91.02 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.479 -1.344 . . . . 0.0 111.947 -175.811 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -162.92 -165.78 1.18 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 110.388 -179.704 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.531 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.62 -23.63 66.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.6 -0.688 . . . . 0.0 110.536 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.406 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.7 t -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.976 -1.078 . . . . 0.0 109.522 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -66.37 -28.22 68.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.572 179.712 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 60.5 t80 -81.76 -45.05 16.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.333 1.063 . . . . 0.0 109.761 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.4 m -65.93 -26.78 67.75 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.758 -178.953 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.472 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.2 m-80 -70.19 -34.68 73.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.146 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.54 -20.33 58.75 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.576 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.462 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 55.0 t -84.67 -34.16 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 110.04 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG13 ' CB ' ' A' ' 11' ' ' TYR . 7.1 p -90.88 -16.29 8.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 0.0 109.996 -179.053 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.4 tm-20 -91.72 -19.8 22.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.991 -1.068 . . . . 0.0 108.422 179.053 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.468 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 5.8 p -100.25 23.41 10.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.496 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 66.04 11.72 7.96 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.223 -0.923 . . . . 0.0 109.172 -179.494 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.462 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 78.11 19.7 74.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.746 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 21.9 p -84.55 -12.45 54.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.15 -1.206 . . . . 0.0 108.986 179.549 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 2.1 tp -80.74 136.4 36.15 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.442 -0.786 . . . . 0.0 109.07 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 26' ' ' SER . 5.3 p -135.26 123.5 23.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.069 0.938 . . . . 0.0 110.244 179.385 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.563 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -72.93 153.03 41.15 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.674 0.749 . . . . 0.0 109.398 179.573 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.49 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -105.49 -23.8 12.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.235 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.574 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -165.58 159.36 16.52 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.896 -178.549 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -76.55 176.32 8.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.66 -167.37 54.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.526 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 7.4 mtmt -91.49 168.39 11.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.399 -1.059 . . . . 0.0 108.987 179.086 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.563 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.63 -179.45 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 20.2 tp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.315 0.579 . . . . 0.0 109.618 . . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.36 -165.59 1.89 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.96 136.45 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.979 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.423 ' O ' HG23 ' A' ' 4' ' ' VAL . 2.5 p -154.71 76.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.137 -0.977 . . . . 0.0 109.537 -179.816 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.8 t -170.47 141.57 1.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.324 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.473 ' CG2' ' HB2' ' A' ' 34' ' ' LYS . 6.4 p -106.1 159.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.959 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.14 151.62 15.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.548 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 23.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.58 3.66 54.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 110.544 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -131.4 -8.24 3.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.818 -1.177 . . . . 0.0 110.946 -178.977 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.653 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.5 m-85 -81.34 158.28 69.41 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.79 -1.194 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 38.2 Cg_endo -69.99 142.55 71.15 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.762 -1.766 . . . . 0.0 111.534 2.028 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -103.17 142.72 25.14 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.979 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -78.43 14.39 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.781 2.32 . . . . 0.0 111.251 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.94 125.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 179.853 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' THR . 45.3 m -102.91 139.16 38.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.95 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.85 -166.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.541 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.478 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -119.24 -28.97 5.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.921 -1.112 . . . . 0.0 109.825 179.969 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.56 119.4 1.64 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.106 -0.996 . . . . 0.0 108.999 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.8 t80 -80.07 124.12 28.45 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.631 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -156.97 82.46 3.21 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.765 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.531 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.8 Cg_endo -65.11 120.6 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.425 2.083 . . . . 0.0 111.944 -177.367 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.88 132.24 54.85 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.671 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.716 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 7.3 t -88.85 161.21 16.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.498 -0.751 . . . . 0.0 109.459 -178.965 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.562 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -107.52 172.55 17.75 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.866 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.551 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 20.6 t -74.41 -3.36 30.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -1.201 . . . . 0.0 108.84 179.554 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.9 p-10 -98.01 -2.17 40.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.177 179.457 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.5 t30 83.59 43.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' HG3' ' N ' ' A' ' 30' ' ' THR . 5.3 tttt -125.43 138.83 54.02 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 179.522 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.426 HG22 ' HB3' ' A' ' 55' ' ' LYS . 19.6 m -92.74 152.12 19.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.504 179.804 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -128.57 130.16 46.98 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.706 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.94 -51.29 1.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -177.803 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.5 p30 -160.01 -166.55 1.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.871 -1.37 . . . . 0.0 110.522 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -54.55 -40.32 68.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.657 -0.652 . . . . 0.0 110.907 -178.477 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.596 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.5 t -60.48 -69.66 0.21 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.787 -1.195 . . . . 0.0 109.703 -179.324 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.3 m-80 -51.91 -26.09 9.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.447 -0.783 . . . . 0.0 111.272 -179.211 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.617 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 14.6 t80 -75.25 -62.02 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.638 -1.289 . . . . 0.0 110.828 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.653 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.4 t -53.32 -49.12 67.71 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.185 -177.413 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -49.16 -31.31 8.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.29 -1.506 . . . . 0.0 108.597 -178.812 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.616 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.64 -36.65 62.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.255 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.463 ' CG2' HD22 ' A' ' 48' ' ' LEU . 41.4 t -67.97 -32.36 55.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.392 0.615 . . . . 0.0 110.253 179.913 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.484 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -90.63 -14.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.069 -178.018 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.616 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 9.6 pt-20 -92.54 -29.53 16.14 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.892 -1.13 . . . . 0.0 108.216 178.053 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.482 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.0 p -87.68 20.1 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.864 -178.932 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 44' ' ' SER . 45.1 m-80 64.23 12.85 7.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 -179.439 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 78.74 19.61 72.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.258 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.448 HG22 ' O ' ' A' ' 44' ' ' SER . 20.0 p -91.67 0.41 57.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.927 178.984 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -80.47 -56.19 4.35 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.979 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.597 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 51.0 p 52.37 125.76 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.498 1.142 . . . . 0.0 111.972 179.329 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.617 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 6.6 tp -61.97 156.56 20.76 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.123 178.835 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.518 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.45 -23.86 8.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.87 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.716 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.4 p80 -179.58 161.82 1.06 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.774 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -78.32 173.33 12.42 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 78.84 -171.57 55.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.426 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.46 137.05 32.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.151 -1.205 . . . . 0.0 108.799 178.824 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.574 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.63 -179.772 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.37 -18.29 63.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.915 . . . . 0.0 109.582 179.961 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 61.73 -162.5 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.886 179.745 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.503 ' O ' ' CD2' ' A' ' 50' ' ' LEU . 3.3 p -156.58 113.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 179.928 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.421 ' HA ' HD23 ' A' ' 50' ' ' LEU . 4.2 m -145.83 -163.91 1.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.687 -179.951 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.5 t -125.07 157.53 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.732 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -89.11 137.77 32.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.464 179.924 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 m -135.26 61.91 1.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 109.909 -179.544 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.47 -0.73 57.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.838 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -128.34 39.65 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 042 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 52.1 m-85 -120.65 161.1 41.45 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 108.842 -179.847 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -75.43 174.56 52.16 Favored 'Cis proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.62 -1.825 . . . . 0.0 111.299 1.709 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.74 142.77 32.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.766 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.414 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.43 14.48 1.6 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 169.94 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.462 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 50.6 t -105.35 159.59 15.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 109.937 -179.8 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -61.72 -162.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.804 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -118.84 -28.07 5.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.658 -1.276 . . . . 0.0 109.913 179.768 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -42.73 118.4 1.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.793 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.9 t80 -79.23 128.64 33.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.382 1.087 . . . . 0.0 111.041 -177.84 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.31 78.9 2.21 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.217 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.1 Cg_endo -64.71 126.5 16.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.361 2.707 . . . . 0.0 113.366 -177.139 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.597 ' CD1' ' N ' ' A' ' 34' ' ' LYS . 1.4 mp -110.47 127.15 55.01 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.334 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -88.27 119.1 28.36 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.782 -178.627 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.7 -158.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.989 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -91.84 -52.4 4.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.558 -0.966 . . . . 0.0 108.914 179.356 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.618 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -47.52 -24.63 0.89 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.169 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.8 p-10 103.3 33.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.177 0.513 . . . . 0.0 110.216 179.147 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.7 131.39 50.91 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.495 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 94.5 m -80.17 142.5 34.66 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 110.314 -179.088 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.5 m-85 -120.34 131.23 54.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.368 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.42 -50.9 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.163 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.2 p30 -167.19 -167.37 0.91 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.008 -1.289 . . . . 0.0 111.136 178.901 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.597 ' N ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.56 -42.85 11.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.125 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.1 m -67.74 -66.44 0.56 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.291 -1.506 . . . . 0.0 108.998 -179.262 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.513 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 17.9 m-80 -44.66 -23.17 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.527 -0.733 . . . . 0.0 110.194 -179.918 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.517 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 30.9 t80 -84.55 -48.73 9.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.74 1.257 . . . . 0.0 109.763 179.733 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.581 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -62.27 -58.98 5.71 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.072 -178.425 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.01 -31.36 0.17 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.147 -0.971 . . . . 0.0 108.772 -179.351 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB2' ' CD2' ' A' ' 48' ' ' LEU . . . -70.8 -50.71 32.74 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.543 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.5 t -51.71 -60.15 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.432 0.634 . . . . 0.0 109.97 179.036 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.538 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -62.6 -21.18 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.411 -0.806 . . . . 0.0 111.665 -178.539 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.2 tt0 -91.98 -11.59 35.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.457 -1.402 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.516 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 4.4 t -106.4 20.58 18.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.283 -0.885 . . . . 0.0 109.911 -179.555 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 75.94 1.48 3.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 108.967 -179.148 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 81.48 17.42 71.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.848 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' SER . 14.1 t -83.89 -13.05 54.52 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.279 -1.13 . . . . 0.0 108.65 179.053 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.452 ' CD2' ' HB2' ' A' ' 40' ' ' ALA . 2.0 tp -81.28 147.12 30.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.394 -0.816 . . . . 0.0 108.958 179.772 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -145.46 158.32 43.86 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.242 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.601 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -104.46 165.64 10.92 Favored 'General case' 0 C--N 1.281 -2.412 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 -178.937 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.601 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -106.99 -31.55 8.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.531 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -162.99 160.49 24.72 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.723 0.773 . . . . 0.0 110.068 -178.615 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' CD2' HD22 ' A' ' 23' ' ' LEU . 4.8 m-85 -77.14 -171.64 2.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.699 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.2 -166.57 28.94 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.829 . . . . . . . . 2 2 . 1 . 042 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.648 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 167.84 12.28 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.237 . . . . . . . . 3 3 . 1 . 042 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.648 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.7 m . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.723 -179.413 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.84 -151.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.317 -179.819 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 63.71 137.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.463 179.888 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.585 ' CG2' ' CE1' ' A' ' 53' ' ' PHE . 13.6 p -154.65 94.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.959 . . . . 0.0 109.667 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -106.85 -174.72 2.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.196 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.47 136.75 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.0 . . . . 0.0 109.64 -179.945 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.415 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 16.4 t0 -67.06 141.02 57.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 22.2 m -146.76 58.82 1.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.106 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.66 0.46 57.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.613 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.64 32.88 5.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.836 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 83.6 m-85 -119.28 158.3 48.95 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.49 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.58 169.92 73.22 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.506 -1.872 . . . . 0.0 111.706 1.799 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.578 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -128.05 144.8 52.89 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.959 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -77.93 14.3 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.652 2.235 . . . . 0.0 111.839 -178.759 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 177.23 145.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.217 179.77 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' THR . 54.1 t -122.85 159.99 27.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 109.272 179.449 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.6 p -61.28 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.174 -0.954 . . . . 0.0 108.594 179.24 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.96 -18.47 4.2 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.7 pt-20 -52.14 127.7 22.53 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.756 -1.215 . . . . 0.0 107.746 179.503 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 26.2 t80 -92.91 119.8 32.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 122.422 1.106 . . . . 0.0 110.969 -178.124 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtp-105 -152.17 81.8 5.53 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -65.02 131.31 28.35 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.966 2.444 . . . . 0.0 112.346 -177.448 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.638 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -117.58 121.44 40.95 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.965 179.254 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.608 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 5.1 t -80.49 120.05 23.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 108.593 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.06 -160.66 0.82 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -90.26 -37.88 13.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 108.048 178.328 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -58.55 -17.69 23.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.568 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 96.35 21.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.003 0.43 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -99.33 127.08 45.3 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.005 -1.059 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 m -77.06 140.13 40.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.425 -0.797 . . . . 0.0 109.574 -179.925 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 40' ' ' ALA . 26.7 m-85 -115.81 129.16 56.33 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.693 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.46 -52.64 0.31 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -178.307 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.3 p30 -164.75 -164.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.806 -1.408 . . . . 0.0 110.992 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.03 -41.55 25.97 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.071 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.527 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 4.3 m -70.17 -64.67 0.85 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.202 -1.561 . . . . 0.0 109.098 -179.318 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.0 m-80 -43.92 -27.28 0.34 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.888 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 39.0 t80 -82.35 -46.87 13.02 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.067 1.413 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -56.9 -37.02 70.83 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.041 -178.349 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.54 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.41 -42.08 99.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.735 -1.228 . . . . 0.0 108.336 179.882 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.677 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -62.27 -25.08 67.64 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.5 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 74.9 t -80.59 -44.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 -179.526 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.522 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -81.27 -7.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.114 -0.992 . . . . 0.0 110.297 -178.791 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.677 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.92 -33.95 14.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.965 -1.084 . . . . 0.0 108.447 178.958 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 6.5 p -88.85 24.21 2.12 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.708 -0.62 . . . . 0.0 110.029 -179.528 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 73.4 4.7 4.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.052 -1.03 . . . . 0.0 109.05 -179.488 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 83.51 15.61 70.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.72 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 10.0 t -88.52 -1.8 58.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -1.061 . . . . 0.0 108.866 179.15 . . . . . . . . 1 1 . 1 . 043 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 HD23 ' HB2' ' A' ' 40' ' ' ALA . 1.1 tp -81.19 145.27 31.08 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.283 -0.885 . . . . 0.0 109.124 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 p -137.55 145.92 43.48 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.485 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -94.59 171.05 9.03 Favored 'General case' 0 C--N 1.275 -2.641 0 O-C-N 120.877 -1.139 . . . . 0.0 109.839 -179.412 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.534 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.8 -20.23 13.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.778 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.608 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 177.1 154.98 0.26 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.528 -0.733 . . . . 0.0 109.833 -178.884 . . . . . . . . 3 3 . 1 . 043 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.585 ' CE1' ' CG2' ' A' ' 4' ' ' VAL . 5.4 m-85 -66.49 -165.78 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.206 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.21 -172.08 1.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.305 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.565 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.1 tttt -90.34 159.81 16.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.565 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.292 -1.891 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.605 -179.982 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.464 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 1.1 mm? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.464 ' CB ' ' O ' ' A' ' 1' ' ' LEU . . . 72.16 -159.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.89 63.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' CG1' HD22 ' A' ' 50' ' ' LEU . 46.8 t -85.51 96.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 109.468 -179.89 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -159.45 153.98 24.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -126.29 136.67 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.354 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -86.61 132.93 33.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.279 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.485 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 10.1 m -133.4 52.33 2.08 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.318 -0.864 . . . . 0.0 109.76 -179.606 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.35 8.02 35.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.774 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -119.64 3.79 11.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.615 ' CD1' ' HB3' ' A' ' 38' ' ' CYS . 96.2 m-85 -89.78 157.44 46.36 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.166 -0.959 . . . . 0.0 109.001 -179.731 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.496 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -74.96 143.01 76.45 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.617 -1.826 . . . . 0.0 111.366 2.495 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.488 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttp -84.16 143.93 43.24 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.632 -0.667 . . . . 0.0 109.274 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.488 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.73 13.54 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.539 2.159 . . . . 0.0 110.556 179.459 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.01 114.1 0.12 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.4 m -92.57 139.6 30.41 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 110.007 -179.332 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -50.27 178.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.545 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -123.37 -16.11 6.96 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.967 -1.083 . . . . 0.0 110.166 -179.663 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.1 pm0 -55.24 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.359 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.487 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 6.6 t80 -132.93 119.7 20.49 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.737 1.256 . . . . 0.0 110.835 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.58 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.9 mtp85 -160.25 74.63 2.92 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.154 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.9 Cg_endo -65.06 134.73 40.83 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.895 2.396 . . . . 0.0 113.4 -176.135 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.565 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.97 143.57 46.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.46 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.676 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -94.41 166.74 11.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 -178.861 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -127.44 161.98 21.48 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.501 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -65.69 -28.69 69.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.044 -1.268 . . . . 0.0 108.832 179.996 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -58.34 -15.51 10.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.737 . . . . 0.0 109.304 179.657 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.5 t30 90.28 33.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.04 0.448 . . . . 0.0 110.435 179.396 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.452 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -121.28 -176.37 3.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.932 -1.105 . . . . 0.0 109.177 178.683 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.523 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 8.9 m -123.17 163.92 19.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.826 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 29.4 m-85 -138.35 141.64 39.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.612 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -61.95 -41.33 99.65 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.312 -176.803 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.58 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.0 p-10 -157.8 -164.37 1.52 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.893 -1.357 . . . . 0.0 109.978 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.565 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -61.73 -31.71 71.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 110.826 -178.705 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -72.9 -44.17 61.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.665 -1.272 . . . . 0.0 109.632 -179.479 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -63.08 -44.26 96.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.693 179.925 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.4 t80 -65.43 -57.15 9.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.144 0.973 . . . . 0.0 110.963 -179.365 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.615 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -53.62 -51.73 62.13 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 -178.282 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.3 m-20 -45.41 -36.4 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.002 -1.061 . . . . 0.0 109.41 -179.758 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.591 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.86 -42.03 77.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 108.675 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.421 ' CG2' HD22 ' A' ' 48' ' ' LEU . 86.1 t -60.57 -59.66 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.649 -0.657 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.51 ' CG1' ' HB2' ' A' ' 11' ' ' TYR . 9.2 p -62.53 -21.51 27.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.226 -0.921 . . . . 0.0 111.013 -178.766 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.2 -15.29 27.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.71 -1.244 . . . . 0.0 108.818 179.065 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.481 ' O ' HG21 ' A' ' 47' ' ' THR . 22.7 t -102.43 10.57 38.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.475 -179.935 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 67.21 10.09 7.45 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 109.178 -179.002 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.66 18.55 54.51 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.051 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.522 ' CG2' ' ND2' ' A' ' 45' ' ' ASN . 3.9 p -79.56 -15.22 58.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.977 -1.308 . . . . 0.0 107.875 178.076 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 ' O ' ' CG2' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.65 160.8 26.2 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.719 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.501 ' OG1' ' OG ' ' A' ' 26' ' ' SER . 70.8 p -156.64 124.6 5.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.142 0.972 . . . . 0.0 109.9 178.902 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 0.9 OUTLIER -62.44 144.12 56.28 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.385 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.429 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.97 -18.29 13.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.857 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.676 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 179.72 161.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.629 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -75.89 179.36 5.57 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.217 -0.927 . . . . 0.0 108.93 179.128 . . . . . . . . 1 1 . 1 . 044 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.32 -167.04 54.45 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.534 . . . . . . . . 2 2 . 1 . 044 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HB3' HG22 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.36 144.77 25.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -1.079 . . . . 0.0 109.217 179.573 . . . . . . . . 3 3 . 1 . 044 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.51 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.627 179.953 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 045 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.36 -148.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 109.637 179.997 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 109.67 18.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 -179.865 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 m -93.38 82.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.254 179.852 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.2 p -166.68 123.7 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.321 -179.801 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -103.87 169.02 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.818 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -75.21 155.07 37.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.322 179.875 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -151.62 50.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 109.845 -179.867 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.412 ' C ' ' HG3' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -92.11 -13.26 31.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.983 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.412 ' HG3' ' C ' ' A' ' 9' ' ' SER . 1.6 mp0 -134.19 57.33 1.81 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.143 -0.973 . . . . 0.0 110.626 -178.795 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 98.3 m-85 -143.29 149.49 48.41 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 120.86 -1.15 . . . . 0.0 109.326 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.532 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -73.97 161.06 95.11 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.438 -1.901 . . . . 0.0 111.654 2.485 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.432 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -121.16 139.88 30.18 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.668 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.432 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -77.8 13.62 1.65 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.524 2.149 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . 178.23 128.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 179.906 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 51.3 t -114.6 159.7 20.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.407 179.711 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.438 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -61.42 -166.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.512 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -112.61 -17.4 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.866 -1.147 . . . . 0.0 109.643 179.666 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.482 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 5.3 pm0 -46.18 137.49 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.132 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.626 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 7.7 t80 -96.55 135.09 38.92 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.487 1.137 . . . . 0.0 111.409 -177.834 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.1 mtt180 -161.07 73.67 2.64 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.08 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.581 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.1 Cg_endo -63.2 119.1 6.04 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.65 2.234 . . . . 0.0 112.689 -176.613 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.599 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.51 130.83 54.81 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.059 178.885 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.71 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.21 106.37 11.19 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.761 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.601 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.76 -162.52 0.06 OUTLIER Glycine 0 C--N 1.297 -1.634 0 C-N-CA 118.033 -2.032 . . . . 0.0 108.856 -178.687 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.538 ' OG ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -88.59 -35.79 16.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.31 . . . . 0.0 109.29 -179.939 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p30 -63.21 -12.35 27.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 178.818 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 92.41 16.42 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.323 0.582 . . . . 0.0 109.864 179.697 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -99.33 121.2 40.76 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.341 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.498 HG21 ' N ' ' A' ' 31' ' ' TYR . 97.4 m -59.13 157.62 10.1 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.492 -0.755 . . . . 0.0 109.372 -179.527 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.58 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.8 m-85 -128.23 127.87 43.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.142 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.89 -53.0 1.17 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -177.584 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.0 p30 -160.45 -167.62 1.94 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.702 -1.469 . . . . 0.0 110.843 179.053 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 4.8 ptmt -50.53 -40.12 50.8 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.786 -0.571 . . . . 0.0 112.03 -177.116 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.0 m -66.55 -65.45 0.68 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.514 -1.366 . . . . 0.0 109.679 -179.314 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.8 m-80 -47.74 -28.29 2.41 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.437 -0.789 . . . . 0.0 110.366 -179.055 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 14.8 t80 -76.0 -57.6 3.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.616 -1.302 . . . . 0.0 109.797 179.566 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 34.0 t -54.13 -56.76 15.05 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.415 -177.949 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.542 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.93 -33.58 0.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.86 -1.15 . . . . 0.0 108.76 -178.693 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.56 -49.11 64.79 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.191 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -56.9 -63.76 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.396 0.617 . . . . 0.0 110.249 179.046 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.486 ' CG1' ' HA ' ' A' ' 39' ' ' ASN . 2.1 p -59.47 -22.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.504 -0.748 . . . . 0.0 111.799 -178.197 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.8 -17.74 26.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.348 -1.47 . . . . 0.0 108.451 179.084 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.539 ' O ' ' CG2' ' A' ' 47' ' ' THR . 16.7 p -102.73 29.55 5.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.476 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.46 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.4 p-10 45.1 53.84 7.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 109.103 -179.638 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.452 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 38.33 45.17 1.78 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.539 ' CG2' ' O ' ' A' ' 44' ' ' SER . 11.1 t -110.48 -8.83 14.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.335 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.628 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.3 tp -81.71 -84.11 0.11 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.837 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.628 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.2 p 79.81 171.62 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.063 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.634 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.86 174.42 8.38 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -178.633 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.629 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.58 -35.13 7.54 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.591 . . . . . . . . 3 3 . 1 . 045 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.71 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -165.34 162.15 19.47 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.55 -179.101 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -78.54 177.48 8.53 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 108.975 179.154 . . . . . . . . 1 1 . 1 . 045 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 76.03 -168.16 54.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.949 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.83 141.96 30.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -1.153 . . . . 0.0 109.749 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.532 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.306 0.574 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.13 34.71 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.344 -0.847 . . . . 0.0 109.779 179.984 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.63 28.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 179.823 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.6 m -144.34 101.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 179.943 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 115.96 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 -179.903 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.48 130.73 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.242 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.1 104.67 17.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 m -90.87 57.33 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -89.87 -20.35 23.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 108.897 179.762 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.4 16.7 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.279 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.609 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 17.5 m-85 -102.2 168.15 9.39 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 34.9 Cg_endo -85.03 176.37 30.41 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.465 -1.473 . . . . 0.0 111.238 1.217 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 8.8 mttt -125.64 137.54 30.15 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.881 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -79.81 14.03 1.98 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.575 2.183 . . . . 0.0 110.766 -179.286 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.48 124.0 3.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.624 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -100.72 137.72 38.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.07 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -53.12 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.395 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.5 pp -121.1 -10.23 9.05 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.793 -179.621 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' LEU . 10.5 pm0 -57.3 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.788 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 6.9 t80 -136.45 129.2 30.77 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.19 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mtm180 -161.25 79.27 2.19 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.218 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.2 Cg_endo -64.97 116.61 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.233 1.955 . . . . 0.0 112.133 -177.288 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.638 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.81 125.82 52.37 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.432 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 51' ' ' SER . 41.8 t -78.91 165.87 23.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.953 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.69 172.26 20.97 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.18 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -66.04 -35.65 81.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.376 -1.073 . . . . 0.0 109.719 -179.099 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.6 p-10 -62.76 -11.55 18.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.096 -1.002 . . . . 0.0 108.915 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.4 t-20 85.69 30.34 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.457 0.646 . . . . 0.0 109.465 179.831 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 2.8 ttpt -114.71 143.29 45.29 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.087 179.749 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 26.9 m -91.94 155.04 18.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.493 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.569 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 57.3 m-85 -123.56 124.48 42.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.826 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.25 -51.86 0.71 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.669 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.563 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -154.73 -162.75 1.44 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.926 -1.338 . . . . 0.0 110.499 179.635 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.1 -42.45 93.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.704 . . . . 0.0 111.628 -177.917 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.5 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 42.8 t -55.46 -49.7 71.8 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.247 -1.533 . . . . 0.0 109.275 -179.744 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -61.94 -53.62 53.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.68 -179.122 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 63.1 t80 -53.26 -48.08 68.56 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.402 1.096 . . . . 0.0 110.143 -179.215 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.609 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 40.7 m -64.58 -30.58 71.61 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.625 -179.477 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.529 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 10.5 m-80 -70.77 -22.36 62.39 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.98 -1.075 . . . . 0.0 108.528 179.296 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.531 ' HB1' ' CE2' ' A' ' 31' ' ' TYR . . . -82.51 -27.62 31.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 ' CG2' HD22 ' A' ' 48' ' ' LEU . 73.8 t -77.81 -31.95 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.128 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 11' ' ' TYR . 21.5 m -86.42 -28.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.724 -0.61 . . . . 0.0 110.151 -179.431 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.99 -22.36 20.03 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 109.371 -179.586 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 26.2 p -89.88 10.36 24.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.709 -179.465 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 44' ' ' SER . 8.0 t30 74.47 11.24 4.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 108.654 -179.373 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 77.88 14.83 81.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.827 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 9.7 t -80.15 -8.4 59.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -1.21 . . . . 0.0 108.857 179.127 . . . . . . . . 1 1 . 1 . 046 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.512 HD22 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.75 163.76 24.22 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.454 -0.779 . . . . 0.0 109.17 179.999 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.493 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 40.0 p -147.71 126.55 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.953 0.882 . . . . 0.0 108.682 177.974 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.4 tp -58.5 125.19 22.32 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.334 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.5 t -83.22 -22.98 32.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.802 -179.753 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . 10.8 p80 154.26 162.42 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.888 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' HD22 ' A' ' 23' ' ' LEU . 62.0 m-85 -69.71 170.57 10.63 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.791 -1.193 . . . . 0.0 108.821 179.284 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 78.27 -172.46 55.22 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.808 . . . . . . . . 2 2 . 1 . 046 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.78 150.04 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.261 . . . . 0.0 109.313 179.118 . . . . . . . . 3 3 . 1 . 046 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 55' ' ' LYS . 15.3 m . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.578 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.99 -160.84 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.246 -179.839 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.82 130.87 54.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 -180.0 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.8 m -153.1 93.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.398 -0.814 . . . . 0.0 109.285 179.828 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 122.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.369 -179.882 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.65 150.48 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.835 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 12.1 t70 -60.86 151.84 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 109.092 179.772 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.6 t -150.58 16.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.481 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.4 t -90.37 10.21 25.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.488 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.481 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.0 mp0 -124.66 -21.18 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 110.442 -179.618 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.616 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 91.4 m-85 -79.37 153.52 76.57 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 120.832 -1.167 . . . . 0.0 109.178 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.6 Cg_endo -74.55 144.59 81.44 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.232 -1.987 . . . . 0.0 111.344 1.514 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.605 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -105.85 163.24 17.48 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.692 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.28 13.69 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.426 2.084 . . . . 0.0 111.39 -179.75 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 130.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 90.5 m -93.76 152.54 18.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -51.74 -176.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 108.987 179.648 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.531 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.2 pt? -122.49 -35.69 3.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.027 -1.046 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.7 pm0 -53.13 137.98 32.48 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.429 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.495 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.1 t80 -86.88 127.61 35.04 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.258 1.028 . . . . 0.0 110.779 -178.462 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.2 mtm180 -160.61 85.31 1.91 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.327 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.543 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.8 117.94 4.98 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.755 2.303 . . . . 0.0 112.998 -177.348 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.07 131.04 54.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.89 177.88 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 41.0 t -78.32 162.86 26.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.977 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -144.43 169.1 26.52 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.902 -178.084 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.518 ' N ' HD13 ' A' ' 48' ' ' LEU . 2.3 t -58.55 -19.07 34.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.603 -0.939 . . . . 0.0 110.32 -178.028 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 26.5 p-10 -61.24 -13.24 17.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.102 -0.999 . . . . 0.0 109.416 179.727 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.4 t-20 83.88 14.76 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.681 -0.637 . . . . 0.0 109.697 179.902 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -128.01 -166.36 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.548 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 16.3 m -111.81 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.644 -0.66 . . . . 0.0 109.342 -179.898 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 12.7 m-85 -131.38 121.63 24.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.58 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.2 -52.9 0.28 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.264 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.596 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -157.89 -165.02 1.64 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.013 -1.286 . . . . 0.0 110.358 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.66 -42.75 68.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.58 -0.7 . . . . 0.0 110.597 -178.485 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.449 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 50.7 t -62.2 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.796 -1.19 . . . . 0.0 109.786 -179.844 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.9 m-80 -52.58 -23.69 6.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 110.211 -179.367 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.599 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.1 t80 -75.34 -67.08 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.15 -46.66 75.71 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.796 -177.923 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.2 m-20 -44.09 -30.94 0.82 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.745 -1.222 . . . . 0.0 107.991 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' OH ' ' A' ' 31' ' ' TYR . . . -70.48 -49.5 47.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.537 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.621 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 76.8 t -54.02 -63.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.442 0.639 . . . . 0.0 110.216 178.945 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 11' ' ' TYR . 2.1 p -59.37 -22.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.408 -0.808 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.21 -15.13 27.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.519 -1.363 . . . . 0.0 109.23 179.421 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 5.5 p -100.66 7.58 43.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.885 . . . . 0.0 109.671 -179.685 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.7 t30 75.21 8.66 3.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 -179.579 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 82.26 19.78 63.93 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' SER . 14.5 t -91.7 -0.22 57.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.341 -1.094 . . . . 0.0 108.942 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.621 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.02 -70.32 0.67 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.898 0.856 . . . . 0.0 109.276 -179.494 . . . . . . . . 3 3 . 1 . 047 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.526 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.7 p 83.37 154.33 0.1 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.579 -178.756 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.6 tp -72.82 126.01 28.9 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.384 -179.536 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.574 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 8.1 t -79.3 -24.17 43.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 108.874 179.444 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 51' ' ' SER . 17.1 p80 150.67 174.27 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.541 178.378 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 23' ' ' LEU . 61.7 m-85 -82.9 155.86 23.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 110.092 179.741 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 84.1 -174.18 50.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -90.24 146.38 24.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.054 -1.262 . . . . 0.0 109.008 179.249 . . . . . . . . 1 1 . 1 . 047 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.532 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.236 0.541 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.85 -165.19 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.949 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.79 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 179.944 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.459 ' O ' ' HB3' ' A' ' 5' ' ' SER . 2.0 p -105.36 104.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.42 179.933 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 61.1 p 178.37 139.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.485 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 t -80.4 134.0 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.297 179.879 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.64 133.84 39.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.278 -179.989 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.437 ' HB2' HG13 ' A' ' 41' ' ' VAL . 37.3 m -124.42 61.17 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.706 -179.828 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 1.4 t -90.19 -31.94 16.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.654 179.93 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -81.48 0.94 35.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 109.307 179.792 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.582 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 65.5 m-85 -91.3 165.32 21.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 108.876 -179.839 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.563 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 33.9 Cg_endo -84.58 152.0 59.9 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.162 0.715 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 12.6 mttt -105.5 141.14 22.01 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.638 -0.664 . . . . 0.0 109.677 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.5 14.11 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.464 2.11 . . . . 0.0 110.413 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.68 145.67 14.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.751 . . . . 0.0 109.188 -179.985 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.4 m -123.76 152.71 41.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.955 -179.589 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.458 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.7 -167.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.14 179.695 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -125.08 -18.41 5.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 0.0 110.367 -179.664 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 7.3 pm0 -56.55 -167.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.891 -1.131 . . . . 0.0 108.246 179.591 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -135.73 130.35 34.04 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.401 1.096 . . . . 0.0 111.315 -179.833 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.81 79.0 2.35 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.94 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.543 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.1 Cg_endo -64.47 114.85 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.432 2.088 . . . . 0.0 112.675 -176.995 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.57 141.76 45.95 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.736 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 20.6 t -95.49 159.63 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.81 -1.156 . . . . 0.0 109.007 -179.565 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.484 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -129.58 172.08 20.03 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.321 -178.407 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 t -56.26 -38.31 70.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.904 . . . . 0.0 111.458 -177.53 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -52.08 -19.11 1.72 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.69 -1.256 . . . . 0.0 110.038 -179.276 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.2 t30 91.47 27.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.933 -0.48 . . . . 0.0 110.409 179.459 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 178.99 4.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.904 -1.122 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 41.7 m -107.15 162.37 13.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 40' ' ' ALA . 83.8 m-85 -127.74 121.09 29.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.027 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.93 -54.34 0.68 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.968 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.6 p30 -152.36 -167.88 2.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.038 -1.272 . . . . 0.0 109.991 179.114 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.8 -60.71 2.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.348 -178.518 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.483 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 41.9 t -43.45 -62.97 0.92 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.802 -1.186 . . . . 0.0 110.432 -179.425 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -49.65 -34.25 17.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 13.5 t80 -70.5 -60.05 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.31 1.052 . . . . 0.0 110.845 -179.002 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -53.69 -30.77 45.09 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.711 -0.618 . . . . 0.0 110.18 -179.107 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.529 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 1.6 m-80 -64.07 -39.15 93.44 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.106 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 31' ' ' TYR . . . -67.34 -20.21 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.34 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.568 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 41.5 t -84.8 -31.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.526 ' CG1' ' HB3' ' A' ' 11' ' ' TYR . 2.7 m -82.28 -16.01 11.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.626 -0.671 . . . . 0.0 109.619 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.647 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.65 -32.35 15.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.885 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.501 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 60.0 p -86.56 10.14 16.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.802 -179.423 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.2 t30 75.05 7.35 4.21 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 108.858 -179.444 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.479 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 83.51 13.7 75.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.846 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 44' ' ' SER . 13.9 t -93.44 0.89 56.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 108.995 179.128 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' CD2' ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -80.06 -71.57 0.45 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.036 0.922 . . . . 0.0 108.744 179.881 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.534 ' N ' ' CG ' ' A' ' 48' ' ' LEU . 1.4 p 79.62 152.02 0.12 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.384 1.088 . . . . 0.0 109.997 -179.505 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -70.59 152.82 43.51 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.637 -179.734 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.597 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 p -99.38 -39.94 8.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.675 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.736 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.85 163.97 2.31 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.23 179.972 . . . . . . . . 3 3 . 1 . 048 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.46 136.68 36.37 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.467 . . . . . . . . 1 1 . 1 . 048 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 110.41 -167.64 12.73 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.798 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 151.72 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -1.216 . . . . 0.0 108.97 179.243 . . . . . . . . 2 2 . 1 . 048 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.511 179.989 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.408 ' HG ' ' N ' ' A' ' 2' ' ' ALA . 3.0 tp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' N ' ' HG ' ' A' ' 1' ' ' LEU . . . 64.47 -163.01 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.284 -179.93 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.97 176.34 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.845 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' A' ' 5' ' ' SER . 3.6 t -136.1 72.9 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.554 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 165.37 128.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 -179.973 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.89 150.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.233 179.938 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.65 45.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 16.8 m -102.19 62.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.982 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.35 -4.13 58.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.972 . . . . 0.0 109.943 -179.542 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -117.89 2.45 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.322 179.681 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.621 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 35.5 m-85 -85.54 165.38 35.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 109.782 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -88.13 169.42 36.99 Favored 'Cis proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.249 -1.563 . . . . 0.0 110.642 0.837 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.467 ' HD2' ' CE1' ' A' ' 11' ' ' TYR . 5.2 mtpt -122.55 143.67 40.38 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 108.765 -179.848 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.81 13.88 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.491 2.127 . . . . 0.0 110.582 -179.882 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.7 112.27 1.89 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.636 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.3 m -81.02 143.28 32.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.837 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.3 p -62.73 -163.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.317 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.631 ' CD1' ' N ' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.57 -15.9 8.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.987 -1.071 . . . . 0.0 109.636 179.836 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.5 ' N ' ' CD2' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -47.92 123.46 6.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.016 -1.052 . . . . 0.0 108.477 179.417 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.483 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 27.8 t80 -86.59 110.68 19.99 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.361 1.077 . . . . 0.0 110.376 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 10.4 mtp180 -145.9 86.39 7.21 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.306 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 54' ' ' GLY . 27.8 Cg_endo -67.33 104.19 0.87 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 121.855 1.704 . . . . 0.0 111.596 -177.904 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.642 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.82 120.58 40.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.639 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 0.1 OUTLIER -78.82 -179.67 6.7 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.617 -178.867 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.74 165.27 29.63 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.198 -1.477 . . . . 0.0 112.222 -177.216 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -33.04 74.84 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -50.65 -24.93 3.67 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.95 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.61 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 31.1 t-20 96.33 37.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.026 179.57 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -136.88 -169.43 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 179.591 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.516 HG21 ' N ' ' A' ' 31' ' ' TYR . 91.8 m -127.39 158.92 36.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.345 -179.937 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 88.3 m-85 -132.51 105.9 7.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.378 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.78 -55.98 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 O-C-N 122.047 -0.408 . . . . 0.0 112.28 -177.789 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.1 p-10 -140.24 -171.02 3.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.608 -1.525 . . . . 0.0 110.627 -179.541 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.642 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.8 pttt -59.64 -30.77 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.777 -0.577 . . . . 0.0 110.55 -179.036 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.621 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 43.6 t -62.89 -74.12 0.1 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.674 -1.266 . . . . 0.0 108.261 179.194 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.529 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 18.3 m-80 -39.37 -48.67 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 110.557 -179.975 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 74.1 t80 -55.13 -46.37 75.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.665 -1.272 . . . . 0.0 109.265 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 27.3 m -59.83 -48.32 82.15 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.602 179.957 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' HA ' HG23 ' A' ' 42' ' ' VAL . 7.2 m120 -45.68 -30.02 1.44 Allowed 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.85 -1.156 . . . . 0.0 109.308 179.35 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' HB3' ' CE2' ' A' ' 31' ' ' TYR . . . -79.08 -40.16 31.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.992 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 48' ' ' LEU . 58.1 t -69.88 -24.3 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.719 . . . . 0.0 110.146 -179.821 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.581 HG23 ' HA ' ' A' ' 39' ' ' ASN . 30.1 m -91.94 -26.97 4.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.534 -179.182 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.504 ' N ' HG21 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -91.29 -15.27 29.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.077 -179.931 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 26.8 t -102.24 19.79 18.02 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.2 m120 65.31 18.58 11.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.454 -0.779 . . . . 0.0 109.044 -179.604 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 71.68 18.37 77.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.732 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 45' ' ' ASN . 38.2 p -89.61 -10.02 47.52 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.486 -1.008 . . . . 0.0 108.784 179.401 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.43 148.05 32.08 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.75 . . . . . . . . 3 3 . 1 . 049 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 30.1 p -123.07 139.98 53.5 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.888 0.852 . . . . 0.0 109.721 179.332 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -61.21 130.16 44.85 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.696 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.01 -22.95 44.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.741 -1.224 . . . . 0.0 109.241 -179.913 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' SER . 12.3 p80 154.1 164.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.167 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.77 148.29 40.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.11 -0.993 . . . . 0.0 108.601 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 93.73 -179.31 38.46 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.325 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.97 168.4 17.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.315 . . . . 0.0 109.017 178.821 . . . . . . . . 2 2 . 1 . 049 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 30.7 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.687 -179.464 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . 0.418 ' O ' HG12 ' A' ' 4' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.81 24.69 7.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.609 -179.966 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.11 88.21 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 0.0 109.288 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 1' ' ' LEU . 3.8 m -117.7 77.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.412 ' C ' HG21 ' A' ' 6' ' ' VAL . 33.3 m -146.48 163.88 34.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 179.79 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG21 ' C ' ' A' ' 5' ' ' SER . 12.4 t -137.77 149.37 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.56 179.94 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -83.9 117.25 23.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.274 179.894 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.19 37.36 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.598 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.28 6.7 41.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.711 -179.859 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 24.1 mp0 -129.01 36.71 4.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 109.775 -179.76 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.608 ' CE2' ' HG3' ' A' ' 13' ' ' LYS . 24.3 m-85 -108.26 164.08 15.54 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 108.541 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.8 Cg_endo -77.7 -177.72 21.93 Favored 'Cis proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.967 -1.68 . . . . 0.0 111.684 2.232 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.608 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mmmt -125.54 148.14 60.56 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.616 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . 0.507 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.73 14.01 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.507 ' CB ' ' O ' ' A' ' 14' ' ' PRO . . . 163.62 165.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.688 179.746 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.9 t -140.43 160.0 40.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 179.877 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.48 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.091 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.0 pp -115.02 -24.37 8.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 109.57 179.605 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.9 pt-20 -43.79 116.6 1.0 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.3 t80 -79.26 130.96 35.99 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.496 1.141 . . . . 0.0 111.325 -177.622 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.03 78.35 2.33 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.315 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.53 118.45 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.89 2.394 . . . . 0.0 112.898 -177.097 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -106.67 131.58 53.65 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.779 178.478 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.486 ' SG ' ' HB3' ' A' ' 51' ' ' SER . 40.8 t -79.45 162.54 25.4 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.121 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -141.95 166.49 26.28 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.259 -178.054 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t -55.74 -13.27 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.874 -0.78 . . . . 0.0 110.531 -178.729 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 28' ' ' ASN . 4.0 p30 -75.01 5.94 4.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.175 . . . . 0.0 109.427 179.236 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 72.1 m-20 63.29 31.32 15.45 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.367 -0.833 . . . . 0.0 109.847 179.763 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -136.39 -168.26 2.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.659 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.46 ' CG2' ' N ' ' A' ' 31' ' ' TYR . 18.3 m -119.85 162.45 19.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.571 ' CZ ' ' HB1' ' A' ' 40' ' ' ALA . 12.8 m-85 -129.97 126.45 37.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.046 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.27 -53.76 0.96 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.527 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.598 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.6 p30 -157.54 -164.64 1.6 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.934 -1.333 . . . . 0.0 111.179 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.5 -47.49 63.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.662 -0.649 . . . . 0.0 112.31 -177.304 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.523 ' N ' ' HE3' ' A' ' 34' ' ' LYS . 5.2 m -63.54 -55.08 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.402 -1.436 . . . . 0.0 109.982 -178.62 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.4 m-80 -54.86 -27.87 45.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -0.997 . . . . 0.0 110.027 -179.541 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.0 t80 -74.03 -50.46 19.64 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.997 1.38 . . . . 0.0 109.401 179.639 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 13.5 m -60.56 -26.13 66.69 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.474 -179.257 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 19.7 m-20 -65.26 -34.22 77.85 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.927 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.571 ' HB1' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.61 -39.13 80.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.505 HG21 ' CD2' ' A' ' 48' ' ' LEU . 86.5 t -65.11 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.581 -0.699 . . . . 0.0 109.89 -179.727 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.567 ' CG1' ' CB ' ' A' ' 11' ' ' TYR . 14.1 p -59.28 -19.75 16.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -0.771 . . . . 0.0 110.7 -179.335 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -90.75 -22.52 21.04 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.6 -1.312 . . . . 0.0 107.909 178.981 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' ' CG2' ' A' ' 47' ' ' THR . 0.9 OUTLIER -98.44 29.29 3.69 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.114 179.533 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.516 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 6.0 p-10 44.34 53.82 6.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' HA2' HG11 ' A' ' 41' ' ' VAL . . . 39.03 47.1 2.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.31 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 44' ' ' SER . 6.5 t -111.53 -22.97 10.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.453 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.568 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -79.64 150.88 30.84 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.999 . . . . . . . . 3 3 . 1 . 050 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.568 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.2 p -125.02 138.14 54.22 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 109.41 179.621 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.3 tp -54.12 124.49 15.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.574 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 8.4 t -78.0 -22.84 48.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.793 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.58 ' CB ' ' O ' ' A' ' 51' ' ' SER . 12.9 p80 152.65 177.61 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.136 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -87.62 160.95 17.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 109.427 179.653 . . . . . . . . 1 1 . 1 . 050 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.64 -170.43 50.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.385 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 148.33 23.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.06 -1.259 . . . . 0.0 109.159 179.088 . . . . . . . . 2 2 . 1 . 050 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.511 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.546 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.302 0.572 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -87.93 122.92 32.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.99 19.61 10.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.696 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -19.55 60.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -106.06 42.02 1.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.793 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.8 m-85 -137.38 164.37 42.19 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.8 Cg_endo -86.89 145.9 31.59 Favored 'Cis proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.08 -1.633 . . . . 0.0 110.646 1.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.6 mttp -98.51 134.57 21.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.98 15.11 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.422 2.082 . . . . 0.0 111.022 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.89 124.47 7.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.387 -0.821 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.5 m -119.38 131.96 55.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 2.6 p -63.79 -169.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 108.61 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -115.35 -13.86 11.66 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.279 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 5.8 pm0 -46.15 127.74 8.89 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -87.33 125.3 34.15 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.68 1.228 . . . . 0.0 112.276 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -162.57 82.26 1.65 Allowed Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.8 Cg_endo -65.92 132.78 31.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.071 2.514 . . . . 0.0 113.67 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.9 mp -118.77 141.1 48.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -99.26 129.84 45.51 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.716 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.17 -167.74 3.27 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.7 t -82.56 -27.81 31.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.096 -1.238 . . . . 0.0 109.101 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.3 p30 -75.09 0.17 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.7 m-20 79.89 37.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 110.187 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 30' ' ' THR . 3.1 tttm -108.11 144.1 35.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 108.573 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.477 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 32.0 m -90.36 146.26 24.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.738 -1.227 . . . . 0.0 109.514 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.34 -49.27 3.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 7.2 p-10 -163.83 -166.64 1.21 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.274 -1.133 . . . . 0.0 110.217 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.864 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.32 -48.7 73.76 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.435 -0.79 . . . . 0.0 111.213 -177.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 16.0 t -54.44 -60.97 2.64 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.821 -1.175 . . . . 0.0 111.375 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.427 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 19.5 m-80 -62.43 -26.63 68.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.779 -1.2 . . . . 0.0 110.652 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 7.9 t80 -65.94 -59.84 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.856 -1.153 . . . . 0.0 109.863 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -59.86 -44.07 94.34 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.583 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.4 m-80 -43.25 -28.98 0.36 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.666 -1.271 . . . . 0.0 107.882 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.98 -49.78 18.79 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' CYS . 90.1 t -53.65 -56.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.584 0.707 . . . . 0.0 109.43 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 12' ' ' PRO . 23.4 m -59.78 -26.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.543 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -88.0 -13.83 40.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.028 -1.045 . . . . 0.0 108.801 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.905 ' O ' HG22 ' A' ' 47' ' ' THR . 27.9 p -110.4 29.83 7.34 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.448 -0.782 . . . . 0.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 44.85 55.32 6.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.979 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 36.38 45.54 0.95 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -110.04 -7.4 14.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.5 tp -83.0 -71.45 0.5 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.51 0.671 . . . . 0.0 109.313 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.617 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 14.2 p 60.78 138.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.541 0.686 . . . . 0.0 109.37 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -93.57 165.59 12.66 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.697 0.76 . . . . 0.0 111.135 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.94 -34.5 6.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.68 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.6 p80 -156.08 165.21 37.11 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.583 0.706 . . . . 0.0 109.88 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 6.0 m-85 -83.15 -168.9 2.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.692 -0.63 . . . . 0.0 109.641 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 60.07 -166.95 9.81 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 mtmt -90.41 164.96 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.992 . . . . 0.0 108.657 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.146 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.86 118.06 23.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.408 -0.807 . . . . 0.0 109.784 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.2 m -97.91 50.45 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.241 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -79.36 -23.79 43.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.858 . . . . 0.0 109.635 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.94 43.18 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.038 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.891 ' HB3' HG11 ' A' ' 42' ' ' VAL . 34.0 m-85 -131.31 165.51 34.75 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.002 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -87.51 169.42 39.49 Favored 'Cis proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.237 -1.568 . . . . 0.0 110.887 -0.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 2.6 mtpt -125.25 142.99 43.05 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -78.81 14.86 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.719 2.28 . . . . 0.0 111.308 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 179.57 151.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -126.54 160.31 30.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.56 ' HG1' ' CD ' ' A' ' 19' ' ' GLU . 5.2 p -64.62 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.52 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.1 pp -132.17 -13.9 3.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.963 -1.086 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.56 ' CD ' ' HG1' ' A' ' 17' ' ' THR . 15.2 pm0 -55.42 126.51 25.42 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 120.448 -1.408 . . . . 0.0 108.25 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 6.0 t80 -81.83 118.98 23.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.555 1.169 . . . . 0.0 110.906 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.9 69.08 10.89 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.5 Cg_endo -65.34 132.4 31.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.227 2.618 . . . . 0.0 113.389 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -125.21 132.99 52.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.198 178.228 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.783 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 32.8 t -78.09 118.67 20.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -64.01 -163.62 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 C-N-CA 118.648 -1.739 . . . . 0.0 109.481 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 49' ' ' THR . 8.5 t -85.25 -30.03 24.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -1.231 . . . . 0.0 108.766 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -71.07 -4.69 26.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.4 t30 84.83 16.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 110.095 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.63 126.54 44.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 108.375 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.8 m -64.71 144.8 56.98 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.047 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 31.7 m-85 -121.74 120.97 36.19 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.96 -50.23 0.21 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.6 p30 -162.41 -162.87 0.85 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.825 -1.397 . . . . 0.0 109.989 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.22 -47.28 65.76 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.48 -0.763 . . . . 0.0 111.829 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.3 m -62.79 -61.23 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.515 -1.366 . . . . 0.0 110.152 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.8 m-80 -50.04 -22.09 1.48 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.2 t80 -80.93 -52.87 6.97 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.797 1.284 . . . . 0.0 109.486 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.799 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.3 m -58.84 -30.15 67.45 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.314 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.1 m-80 -61.06 -29.85 69.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -76.61 -31.29 57.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 48' ' ' LEU . 53.5 t -77.1 -24.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.5 0.667 . . . . 0.0 110.205 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 12' ' ' PRO . 4.9 m -90.8 -25.71 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.898 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.96 -5.43 55.44 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.256 -0.903 . . . . 0.0 108.832 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 47' ' ' THR . 22.6 p -111.6 -0.65 16.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.1 t-20 77.43 15.18 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 108.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.29 2.51 90.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 44' ' ' SER . 11.4 t -80.12 0.43 32.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 108.662 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.761 ' C ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -82.41 -78.37 0.21 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.761 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 77.69 172.85 0.2 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -120.38 170.12 9.66 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.677 -1.264 . . . . 0.0 111.688 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.641 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 1.6 p -92.1 -42.09 10.12 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.476 1.131 . . . . 0.0 108.544 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.783 ' CE1' ' CB ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -171.99 172.36 4.74 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.174 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -77.21 -174.63 3.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 108.763 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 64.75 -167.27 30.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.98 154.94 19.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.963 . . . . 0.0 109.305 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.643 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.5 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 HD22 ' A' ' 23' ' ' LEU . 5.4 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.367 0.603 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.63 177.79 6.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -156.2 39.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.211 -0.93 . . . . 0.0 109.715 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 -38.32 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -88.14 -4.76 58.7 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 61.0 m-85 -88.05 161.52 43.51 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.211 -0.931 . . . . 0.0 109.269 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.1 Cg_endo -87.27 144.44 27.29 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.424 1.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -101.07 142.21 24.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.291 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.57 13.63 2.04 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.517 2.144 . . . . 0.0 110.478 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.12 128.25 12.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' THR . 66.7 m -123.12 138.94 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.113 -0.992 . . . . 0.0 109.959 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -52.51 -176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.263 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.9 mt -117.89 -31.45 5.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.739 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.3 pm0 -44.26 135.93 4.24 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 5.4 t80 -87.27 126.88 35.1 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.789 1.28 . . . . 0.0 111.135 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.3 mtm180 -160.54 71.24 2.89 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.65 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 20.6 Cg_endo -62.97 132.76 38.24 Favored 'Trans proline' 0 C--O 1.196 -1.592 0 C-N-CA 123.844 3.029 . . . . 0.0 114.339 -176.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 6' ' ' VAL . 4.3 mp -111.38 161.08 16.45 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.861 ' O ' HD12 ' A' ' 50' ' ' LEU . 30.3 t -119.09 137.13 53.78 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.677 -1.89 . . . . 0.0 110.858 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.659 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -96.51 164.37 23.14 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.258 -0.901 . . . . 0.0 111.651 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 23.9 t -67.68 -29.31 68.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.8 p30 -59.51 -14.5 13.1 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.3 t30 88.97 10.15 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.299 0.571 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -99.38 126.52 45.27 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.829 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.73 136.65 36.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -39.52 -42.75 2.0 Favored Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.477 -0.765 . . . . 0.0 111.889 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.669 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 30.0 p30 -172.47 -149.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.684 -1.48 . . . . 0.0 109.813 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -59.38 -63.0 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.843 -178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 16.8 t -53.71 -57.07 12.16 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.88 -1.137 . . . . 0.0 109.378 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -52.4 -24.26 7.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 108.842 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.829 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.7 t80 -78.09 -66.5 0.84 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.51 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 43.6 t -50.62 -44.92 57.35 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.587 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 42' ' ' VAL . 8.1 m-20 -48.77 -35.28 13.95 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -62.07 -45.37 93.84 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.656 HG13 ' HA2' ' A' ' 46' ' ' GLY . 56.6 t -62.73 -59.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.713 0.768 . . . . 0.0 109.662 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.641 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.9 m -51.55 -28.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.325 -0.859 . . . . 0.0 110.356 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.64 -20.41 21.66 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.793 -1.192 . . . . 0.0 109.464 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 47' ' ' THR . 43.8 t -97.11 9.94 40.75 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.642 -0.662 . . . . 0.0 109.906 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.0 m120 62.62 25.61 15.23 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.265 -0.897 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.43 20.3 73.44 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 44' ' ' SER . 1.5 p -103.72 16.92 25.23 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.798 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -94.4 -48.41 6.15 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 39.2 p 52.28 125.21 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.347 1.07 . . . . 0.0 111.547 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 24' ' ' CYS . 7.9 tp -68.66 157.19 36.74 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.91 -20.21 10.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.764 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 173.68 162.04 0.16 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -75.17 150.18 38.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.663 0.744 . . . . 0.0 109.131 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.65 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 96.94 -166.74 23.68 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 2.0 mtmt -90.07 158.65 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -1.156 . . . . 0.0 109.104 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.45 160.68 25.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.138 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -134.17 57.75 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.084 -1.01 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.13 -29.64 20.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.69 30.16 2.12 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 40.5 m-85 -120.84 166.83 14.47 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.731 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -89.42 169.13 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.56 -1.433 . . . . 0.0 111.528 0.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -122.08 136.98 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.17 14.76 1.86 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.349 2.033 . . . . 0.0 110.859 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 126.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 109.525 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.0 t -110.37 159.84 17.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 82.5 p -64.7 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.879 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.95 -12.4 9.56 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.808 -1.183 . . . . 0.0 110.088 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.08 120.45 2.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.104 -0.997 . . . . 0.0 108.729 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.4 t80 -89.77 118.01 29.05 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.657 1.218 . . . . 0.0 110.294 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -151.41 74.54 8.1 Favored Pre-proline 0 C--N 1.287 -2.147 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.5 Cg_endo -63.35 126.13 17.1 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.09 2.526 . . . . 0.0 112.415 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.09 128.61 55.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.36 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.758 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 53.2 t -79.77 161.39 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.5 169.97 21.68 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.136 -1.507 . . . . 0.0 112.078 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.26 -20.8 66.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.016 -0.696 . . . . 0.0 109.969 -178.501 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.3 p30 -65.35 -12.14 49.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 109.153 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.2 t-20 85.29 30.4 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.535 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -132.56 -166.84 1.8 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.97 . . . . 0.0 109.416 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 55' ' ' LYS . 8.2 m -126.2 156.48 40.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.874 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 27.0 m-85 -126.54 126.45 43.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.3 -52.68 0.42 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.8 p30 -162.5 -166.08 1.29 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.802 -1.41 . . . . 0.0 111.152 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.11 -42.08 38.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.799 -0.563 . . . . 0.0 111.958 -177.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 m -68.72 -54.53 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.623 -1.298 . . . . 0.0 110.165 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.2 m-80 -59.02 -20.38 52.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.051 -1.031 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 35.6 t80 -80.18 -51.1 9.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.554 1.168 . . . . 0.0 109.285 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 1.009 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -60.58 -29.18 69.02 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.593 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 42' ' ' VAL . 16.4 m-20 -67.1 -31.13 71.4 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.874 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.74 -23.21 49.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 48' ' ' LEU . 48.6 t -84.16 -25.57 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.6 m -88.07 -19.3 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.703 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.25 -32.21 15.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.163 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 47' ' ' THR . 1.1 t -84.09 8.88 14.06 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.539 -0.726 . . . . 0.0 109.838 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 69.1 m-20 61.72 27.08 16.56 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.155 -0.965 . . . . 0.0 108.96 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.51 27.3 73.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 44' ' ' SER . 26.0 p -105.19 -1.47 25.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.74 -79.77 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 7.3 p 95.57 136.52 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.108 0.956 . . . . 0.0 110.185 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 15.1 tp -67.28 158.64 31.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 4.7 p -109.22 -43.24 4.19 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.758 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -178.71 167.01 1.74 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' HA ' HD23 ' A' ' 23' ' ' LEU . 23.3 m-85 -74.69 171.24 14.27 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.128 -0.983 . . . . 0.0 108.53 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -176.7 46.71 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.34 155.58 18.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.24 . . . . 0.0 109.077 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.454 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.1 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.29 0.567 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.2 t0 -87.3 134.0 33.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 6' ' ' VAL . 12.8 m -144.7 42.06 1.34 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.221 -0.924 . . . . 0.0 109.869 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.438 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 27.3 t -90.83 -8.82 48.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -0.949 . . . . 0.0 109.685 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.3 mm-40 -97.9 -1.74 42.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.973 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.853 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -82.88 158.16 65.41 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.131 -0.981 . . . . 0.0 109.526 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.51 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 37.1 Cg_endo -75.76 165.46 85.54 Favored 'Cis proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.589 1.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.6 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 6.0 mtmt -120.03 143.83 36.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.54 14.57 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.506 2.137 . . . . 0.0 111.1 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.83 128.37 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.355 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -105.51 144.21 32.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.743 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -61.71 -177.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 108.667 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -111.1 -20.77 12.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.052 -1.03 . . . . 0.0 109.738 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.738 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.3 mt-10 -44.89 122.63 3.34 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.121 -0.987 . . . . 0.0 108.751 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.494 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 32.8 t80 -86.93 108.81 18.97 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 122.497 1.141 . . . . 0.0 110.177 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.9 mtm180 -144.26 90.62 6.63 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -67.23 109.21 1.7 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.105 1.87 . . . . 0.0 112.239 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.657 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -105.45 118.49 36.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.572 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -79.33 176.93 9.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 110.542 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -139.91 172.91 23.18 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.425 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.5 t -65.65 -31.27 72.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.746 -0.856 . . . . 0.0 109.678 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.4 p30 -65.77 -8.74 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 83.15 19.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -103.22 154.37 19.4 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 53.6 m -106.54 143.73 34.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.651 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 94.5 m-85 -118.37 116.07 25.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 108.949 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.64 -54.43 0.63 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p-10 -144.11 -170.35 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.656 -1.496 . . . . 0.0 110.706 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.0 -28.22 67.53 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.978 -0.451 . . . . 0.0 111.634 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.5 t -70.98 -51.14 27.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.55 -1.344 . . . . 0.0 109.278 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.539 -0.725 . . . . 0.0 109.914 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE1' HD21 ' A' ' 48' ' ' LEU . 31.2 t80 -69.12 -53.31 20.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.442 1.115 . . . . 0.0 109.715 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.6 m -56.28 -47.84 77.81 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.334 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 6.0 m-20 -48.72 -33.3 9.93 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.36 -39.67 67.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.295 -0.878 . . . . 0.0 108.664 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.764 ' CG2' HD23 ' A' ' 48' ' ' LEU . 77.6 t -60.43 -57.2 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.626 -0.672 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.853 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -64.59 -22.34 31.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.473 -0.767 . . . . 0.0 110.612 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.13 -10.96 36.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.92 -1.113 . . . . 0.0 109.138 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.892 ' O ' HG22 ' A' ' 47' ' ' THR . 6.2 p -115.05 25.66 10.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 110.438 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' C ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 43.71 53.55 5.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.905 -1.122 . . . . 0.0 109.527 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.09 43.55 8.94 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 44' ' ' SER . 6.1 t -117.12 2.13 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -1.083 . . . . 0.0 108.483 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -84.61 -50.79 7.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.076 0.941 . . . . 0.0 108.536 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.675 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 62.0 p 57.66 126.34 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.302 1.049 . . . . 0.0 110.32 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.7 tp -61.65 131.15 49.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.9 t -79.44 -23.24 43.28 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 108.656 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.585 ' O ' HD11 ' A' ' 50' ' ' LEU . 10.1 p-80 154.46 163.47 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.15 151.82 44.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.824 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 90.73 -176.4 41.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.64 169.28 15.5 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.047 -1.266 . . . . 0.0 108.373 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.601 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 30.4 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 23' ' ' LEU . 79.2 t . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.217 0.532 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -73.19 147.12 45.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 m -134.49 43.24 2.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -90.21 -11.45 40.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -125.03 49.61 1.85 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.878 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.9 m-85 -135.23 162.61 56.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.313 -0.867 . . . . 0.0 109.076 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.35 157.69 54.38 Favored 'Cis proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.852 -1.728 . . . . 0.0 110.749 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.39 140.24 25.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 108.688 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.37 14.97 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.679 2.253 . . . . 0.0 111.731 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.83 154.25 0.71 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.155 -0.965 . . . . 0.0 110.056 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 t -148.63 171.05 16.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -124.57 2.12 8.28 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.751 -1.218 . . . . 0.0 110.289 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.41 127.42 31.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.513 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 6.0 t80 -80.04 110.59 15.57 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.553 1.168 . . . . 0.0 111.272 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.22 73.29 37.75 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.462 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.5 Cg_endo -64.29 123.16 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.553 2.169 . . . . 0.0 112.721 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.4 mt -112.74 122.99 49.29 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -82.92 112.2 19.49 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.126 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.6 -166.13 0.06 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -78.1 -32.49 50.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -1.16 . . . . 0.0 109.137 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 37.1 p-10 -73.08 0.01 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.825 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 m120 77.27 30.32 0.53 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -98.87 137.5 37.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 m -86.97 122.61 31.06 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 82.0 m-85 -99.17 139.45 34.8 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -54.03 -39.03 62.02 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.111 -1.043 . . . . 0.0 112.021 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.4 p30 -162.58 -157.06 0.43 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.725 -1.456 . . . . 0.0 109.304 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.37 -47.5 85.78 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 111.263 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.516 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 89.3 m -68.07 -43.13 79.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.535 -1.353 . . . . 0.0 109.965 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -59.38 -24.08 63.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.825 -1.172 . . . . 0.0 108.449 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.915 ' CB ' HD12 ' A' ' 23' ' ' LEU . 10.3 t80 -83.15 -63.03 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.05 0.929 . . . . 0.0 111.004 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 t -56.92 -47.0 81.62 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.781 -0.574 . . . . 0.0 110.041 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 25.7 m-20 -42.43 -29.45 0.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.17 . . . . 0.0 108.307 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -73.86 -49.8 23.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.707 HG13 ' HA2' ' A' ' 46' ' ' GLY . 92.8 t -53.53 -54.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.573 0.702 . . . . 0.0 109.732 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.6 m -60.17 -30.06 45.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.289 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -85.78 -13.35 48.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 108.729 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.4 p -106.19 -2.75 22.14 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.473 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.8 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.0 OUTLIER 74.66 13.28 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 109.323 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.707 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.95 7.46 70.58 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.887 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.8 HG23 ' OD1' ' A' ' 45' ' ' ASN . 70.8 p -82.71 0.19 44.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.637 -1.507 . . . . 0.0 108.609 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 49' ' ' THR . 7.5 tp -80.15 -75.48 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.491 0.662 . . . . 0.0 110.117 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 p 62.56 147.0 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.06 171.69 7.21 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.858 -177.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.677 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.07 -29.43 8.97 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.593 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -167.92 159.84 11.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.6 -0.688 . . . . 0.0 110.082 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.49 -166.32 0.52 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.2 -167.1 18.25 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.34 -179.04 4.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 109.838 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' SG ' ' A' ' 8' ' ' CYS . 9.2 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' N ' HG22 ' A' ' 6' ' ' VAL . 25.4 t70 -105.1 108.95 20.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 17.8 m -128.95 52.86 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 t -90.29 -13.16 35.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -103.54 17.08 24.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 109.31 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 73.9 m-85 -96.72 163.68 19.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.911 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -83.09 135.63 26.65 Favored 'Cis proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.308 -1.538 . . . . 0.0 111.258 1.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -100.79 138.38 20.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.82 14.04 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.401 2.068 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.21 19.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 94.2 m -103.67 146.46 28.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.261 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.459 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -55.73 -166.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.459 -0.775 . . . . 0.0 108.91 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 19' ' ' GLU . 3.3 pp -126.55 -37.34 2.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.49 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.657 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.1 pm0 -50.57 137.57 19.27 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.5 t80 -79.5 121.37 25.12 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.32 1.057 . . . . 0.0 110.382 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmm180 -148.61 72.38 10.67 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -65.51 114.43 2.89 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.046 1.831 . . . . 0.0 111.743 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -109.42 138.56 45.6 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.991 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -89.15 165.13 14.68 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -127.42 168.55 19.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.607 ' H ' HD12 ' A' ' 48' ' ' LEU . 35.4 t -66.81 -25.98 66.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -1.047 . . . . 0.0 108.856 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.8 p30 -65.52 -10.88 38.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 t-20 85.38 29.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 110.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -120.85 -179.37 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.968 -1.082 . . . . 0.0 109.261 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 31' ' ' TYR . 53.1 m -118.95 166.13 13.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.656 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 72.0 m-85 -138.49 110.9 7.46 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.48 -55.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -177.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.5 p30 -146.87 -172.54 4.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.771 -1.429 . . . . 0.0 110.787 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -53.26 -36.29 60.95 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.849 -0.532 . . . . 0.0 110.355 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.2 t -62.33 -69.47 0.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.63 -1.294 . . . . 0.0 108.937 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.567 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.6 m-80 -43.22 -38.7 2.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 110.765 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 48' ' ' LEU . 72.9 t80 -70.59 -40.14 73.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.688 1.233 . . . . 0.0 110.483 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 91.7 m -68.53 -34.94 76.74 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.519 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.649 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.8 m-80 -69.08 -23.77 64.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.89 -1.131 . . . . 0.0 108.226 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.64 -24.9 33.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.561 ' CG2' HD23 ' A' ' 48' ' ' LEU . 72.9 t -80.99 -27.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.9 m -89.52 -21.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.746 . . . . 0.0 109.127 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.74 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -91.04 -31.15 16.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 47' ' ' THR . 86.4 p -86.93 -0.09 55.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.585 -0.697 . . . . 0.0 109.806 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 77.97 12.74 1.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.247 -0.908 . . . . 0.0 108.813 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.1 16.57 66.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 44' ' ' SER . 7.4 t -98.02 10.1 41.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -1.123 . . . . 0.0 108.95 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.68 -53.3 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.615 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 81.1 p 53.65 124.97 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.644 1.211 . . . . 0.0 111.703 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.991 HD12 ' O ' ' A' ' 24' ' ' CYS . 2.2 tp -71.6 152.75 42.64 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.74 -25.27 11.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.977 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.2 p80 -173.3 157.92 3.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -79.51 164.31 24.01 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.05 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 92.78 -167.27 29.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.81 129.39 36.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.083 -1.245 . . . . 0.0 109.645 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.508 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.35 159.24 15.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.42 36.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 0.0 109.246 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -85.57 -28.65 24.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.788 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.64 46.09 1.03 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.469 -0.769 . . . . 0.0 109.048 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 59.9 m-85 -139.77 161.25 57.4 Favored Pre-proline 0 C--N 1.306 -1.293 0 O-C-N 121.316 -0.865 . . . . 0.0 109.141 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.977 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -83.51 148.95 61.97 Favored 'Cis proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.882 -1.716 . . . . 0.0 110.793 2.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -102.94 137.78 19.37 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.94 14.66 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.658 2.239 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.26 158.04 2.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 30.3 t -146.54 163.04 37.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.694 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -56.91 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -122.81 -7.72 8.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.505 -1.372 . . . . 0.0 110.789 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' N ' HD12 ' A' ' 18' ' ' LEU . 12.1 pm0 -55.93 -173.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 3.4 t80 -128.93 121.32 27.83 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.9 mmt180 -151.22 66.17 7.02 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 54' ' ' GLY . 23.4 Cg_endo -63.28 137.17 59.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.494 2.796 . . . . 0.0 112.551 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -127.49 143.49 51.18 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.202 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.654 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.0 t -101.53 162.3 13.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.236 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -106.95 178.55 22.17 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.1 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.649 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 27.4 t -70.65 -18.79 62.85 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -78.9 -10.98 59.98 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 85.06 33.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.315 0.579 . . . . 0.0 109.662 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -111.94 139.82 47.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.248 -0.908 . . . . 0.0 109.019 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.5 m -90.04 161.97 15.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.147 . . . . 0.0 110.018 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 63.9 m-85 -138.39 137.92 37.74 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.55 -50.23 3.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -164.37 -166.21 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.152 -1.204 . . . . 0.0 111.123 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -47.72 -48.48 29.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.717 -0.614 . . . . 0.0 112.374 -177.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 6.0 m -65.86 -52.64 48.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.473 -1.392 . . . . 0.0 110.457 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.1 m-80 -60.06 -17.45 39.54 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.847 -1.158 . . . . 0.0 109.347 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.693 ' CE1' HD21 ' A' ' 48' ' ' LEU . 27.6 t80 -82.59 -50.31 8.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.588 1.185 . . . . 0.0 109.762 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 42' ' ' VAL . 48.7 t -66.51 -24.02 66.33 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.786 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -64.43 -26.22 68.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.771 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.28 -26.8 26.4 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 46' ' ' GLY . 93.1 t -80.97 -23.72 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.7 m -90.82 -25.65 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.771 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.6 pp20? -90.42 -28.23 18.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 47' ' ' THR . 48.2 t -89.11 3.54 51.48 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.5 t30 77.11 9.77 2.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 108.958 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 82.89 3.21 90.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 44' ' ' SER . 14.1 t -79.85 2.68 22.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.041 -1.27 . . . . 0.0 108.974 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.41 -50.02 11.45 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.805 0.812 . . . . 0.0 109.088 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.649 ' HG1' ' HB2' ' A' ' 26' ' ' SER . 25.2 p 54.86 122.13 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.293 1.044 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.634 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.9 tp -60.61 152.99 24.84 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.15 -20.26 11.01 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.654 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 171.23 158.46 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -71.18 -169.23 0.36 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 109.002 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.11 -168.76 5.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -91.41 146.41 23.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.429 -1.042 . . . . 0.0 109.452 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.397 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -67.55 116.75 8.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 m -99.15 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 m -90.48 -8.67 49.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.49 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 3.9 pm0 -112.97 -7.55 13.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.973 -1.079 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.72 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.6 m-85 -88.88 158.9 46.87 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 108.938 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -79.89 134.99 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.841 -1.733 . . . . 0.0 110.631 3.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.63 138.98 19.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.638 -0.664 . . . . 0.0 110.215 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.76 15.05 2.02 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.512 2.141 . . . . 0.0 110.237 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.42 133.42 20.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.806 . . . . 0.0 109.243 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 82.3 m -112.23 150.31 31.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 p -56.75 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 108.942 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -123.6 -28.3 3.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.998 -1.064 . . . . 0.0 109.725 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 9.5 pm0 -58.57 -166.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.5 t80 -132.83 124.75 28.57 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.258 1.028 . . . . 0.0 110.62 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -154.78 75.83 5.5 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.2 Cg_endo -64.59 123.67 12.08 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.701 2.267 . . . . 0.0 112.557 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -117.39 126.78 53.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 49.5 t -79.4 161.78 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.301 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -132.91 166.54 23.6 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.545 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 28' ' ' ASN . 13.2 t -53.15 -48.46 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.945 . . . . 0.0 110.781 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -41.63 -26.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.202 -179.344 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 p-10 97.93 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.273 0.559 . . . . 0.0 109.899 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -125.81 173.64 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 109.583 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -108.9 150.02 28.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 74.0 m-85 -117.36 124.75 49.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.94 -52.32 1.19 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.5 p-10 -158.51 -168.34 2.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.746 -1.444 . . . . 0.0 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 7.8 pttt -46.86 -49.95 19.37 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.995 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 43.9 t -56.1 -64.88 0.72 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.696 -1.252 . . . . 0.0 110.07 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.4 m-80 -53.64 -18.9 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HB2' HD12 ' A' ' 23' ' ' LEU . 6.8 t80 -79.41 -65.06 1.05 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.677 -1.265 . . . . 0.0 110.216 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.566 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.6 t -56.48 -48.71 76.55 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.033 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.0 m-20 -43.91 -28.0 0.41 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.614 -1.304 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -74.43 -48.03 30.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.975 HG22 HD23 ' A' ' 48' ' ' LEU . 79.7 t -57.08 -54.64 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.646 0.736 . . . . 0.0 109.649 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 12' ' ' PRO . 20.3 m -58.25 -30.28 39.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -91.27 -10.59 40.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.154 -0.966 . . . . 0.0 109.36 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 13.7 t -102.96 12.68 35.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 110.398 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.2 m-80 62.44 23.89 14.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.059 -1.026 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.88 25.11 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.5 p -95.13 -4.16 46.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.395 -1.062 . . . . 0.0 108.209 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -88.94 -76.51 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.081 0.943 . . . . 0.0 109.306 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 80.94 152.0 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.871 0.843 . . . . 0.0 108.955 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 68.2 tp -68.92 158.21 35.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p -111.96 -42.38 3.79 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.01 169.94 1.9 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -82.12 176.37 9.57 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.001 -1.062 . . . . 0.0 108.655 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -168.13 54.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 153.14 20.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 109.145 178.722 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 26.9 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.67 ' H ' HG22 ' A' ' 6' ' ' VAL . 61.2 t0 -125.78 130.27 51.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.964 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 15.6 m -129.71 69.51 1.42 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -91.21 -18.79 23.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.65 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.3 mp0 -106.22 27.5 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.134 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.979 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.7 m-85 -109.3 158.26 34.98 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.087 -1.008 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.796 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -80.86 143.97 64.25 Favored 'Cis proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.823 2.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 7.1 mttt -103.5 136.03 19.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.858 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.6 14.71 1.77 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.757 2.305 . . . . 0.0 110.58 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.12 136.84 11.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.6 m -128.55 136.89 51.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 109.841 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.9 p -55.99 -165.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.3 pp -131.87 1.36 3.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.844 -1.16 . . . . 0.0 110.326 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 4.9 mm-40 -57.4 -165.99 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.1 t80 -139.73 115.08 9.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.448 -1.301 . . . . 0.0 111.38 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.77 74.3 8.64 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -65.35 121.9 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.894 -176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.632 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.34 137.53 50.35 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER -86.67 167.58 14.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.376 -0.827 . . . . 0.0 109.11 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.38 159.73 23.47 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -19.68 64.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -1.164 . . . . 0.0 108.915 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -66.74 -9.16 33.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 58.2 t30 87.48 22.87 0.05 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.85 -0.531 . . . . 0.0 110.669 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.14 177.44 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.82 -1.175 . . . . 0.0 109.627 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 31' ' ' TYR . 29.9 m -118.24 166.5 12.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.233 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' N ' HG22 ' A' ' 30' ' ' THR . 73.7 m-85 -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.94 -51.28 7.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.955 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.3 p-10 -149.4 -165.29 2.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.763 -1.433 . . . . 0.0 110.828 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.22 -24.61 67.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.642 -0.661 . . . . 0.0 111.537 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 11.6 t -76.27 -39.55 54.05 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.574 -1.328 . . . . 0.0 108.898 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.3 m-80 -72.1 -34.48 68.67 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.506 -0.746 . . . . 0.0 109.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 24' ' ' CYS . 63.2 t80 -75.65 -44.18 43.92 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.393 1.092 . . . . 0.0 109.896 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 20.9 m -66.51 -38.45 87.25 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.568 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.595 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.9 m-80 -63.74 -21.37 66.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.15 -27.91 25.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.549 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.4 t -76.45 -26.89 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.979 HG11 ' CB ' ' A' ' 11' ' ' TYR . 21.0 m -91.07 -26.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.372 0.606 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -90.7 -15.36 30.46 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 20.0 t -101.29 12.6 37.18 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.157 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.031 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 68.64 7.72 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.066 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 13.16 66.32 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.031 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.3 p -79.6 -11.11 59.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.289 . . . . 0.0 108.746 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -78.38 159.34 28.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.826 ' H ' HD12 ' A' ' 48' ' ' LEU . 81.2 p -157.64 126.46 5.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.095 0.95 . . . . 0.0 110.061 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -63.43 145.51 55.47 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.505 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.84 -25.04 11.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.695 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -171.42 160.73 6.14 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -79.35 174.06 11.95 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.197 -0.939 . . . . 0.0 108.768 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.31 -166.64 42.31 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.586 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.96 131.06 37.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.047 -1.266 . . . . 0.0 109.048 178.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.532 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.251 0.548 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -64.27 119.07 9.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 108.962 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 6' ' ' VAL . 15.9 m -132.38 40.17 3.32 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.093 -1.004 . . . . 0.0 110.044 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.05 4.95 48.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -126.81 2.72 6.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.069 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 46.1 m-85 -84.71 162.07 51.46 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.13 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -71.68 148.04 89.51 Favored 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.891 2.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -91.5 144.44 29.62 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.92 13.57 1.93 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.53 2.153 . . . . 0.0 110.822 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.35 117.83 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.7 m -102.77 135.14 44.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HD3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -55.88 142.92 33.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 18' ' ' LEU . 5.2 mt -75.88 -36.58 59.48 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.97 . . . . 0.0 109.51 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -42.84 122.28 2.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.356 -0.84 . . . . 0.0 108.782 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.5 t80 -80.82 104.27 11.22 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.672 1.225 . . . . 0.0 110.543 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.634 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 mmt180 -137.55 80.91 31.17 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -66.97 128.83 19.45 Favored 'Trans proline' 0 C--O 1.202 -1.323 0 C-N-CA 123.994 3.129 . . . . 0.0 114.771 -176.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mp -107.83 158.34 17.4 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.72 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -116.48 137.3 52.27 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.285 -1.509 . . . . 0.0 110.394 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.841 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -102.07 157.71 18.45 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.221 -0.925 . . . . 0.0 112.969 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -55.4 -18.64 7.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.192 -0.593 . . . . 0.0 110.382 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -84.57 20.29 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.998 -1.064 . . . . 0.0 109.398 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 27.4 t30 56.83 15.34 2.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -99.69 127.54 45.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 55' ' ' LYS . 18.1 m -89.03 126.55 35.47 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.55 -0.719 . . . . 0.0 109.794 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 126.45 43.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -24.8 -42.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.636 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.4 p30 -178.73 -154.85 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 109.745 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.39 -60.13 3.59 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 110.658 -177.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 49.2 t -52.44 -65.75 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.606 -1.309 . . . . 0.0 110.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.536 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 10.2 m-80 -49.28 -21.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE1' HD21 ' A' ' 48' ' ' LEU . 4.8 t80 -78.8 -71.31 0.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.012 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.687 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.1 m -39.72 -40.62 0.96 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.413 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.92 -44.91 94.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.474 -1.391 . . . . 0.0 108.016 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.696 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -54.17 -21.64 9.33 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 48' ' ' LEU . 56.7 t -85.64 -63.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -59.0 -9.21 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 110.279 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.02 -32.02 16.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.551 -1.343 . . . . 0.0 107.78 178.302 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -92.22 7.89 40.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 80.93 3.71 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.331 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 86.94 6.23 79.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -79.79 2.25 23.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -1.188 . . . . 0.0 108.758 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.12 -78.91 0.34 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.364 -0.835 . . . . 0.0 109.339 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.57 148.13 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.047 0.927 . . . . 0.0 109.276 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' A' ' 23' ' ' LEU . 13.1 tp -67.29 166.47 14.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.599 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -122.6 -44.62 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.72 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -160.28 159.37 31.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -77.21 143.43 39.0 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.714 0.768 . . . . 0.0 110.057 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 101.91 -167.42 18.45 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.48 137.63 32.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.438 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.516 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.441 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.43 104.73 5.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.999 . . . . 0.0 109.601 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 59.8 m -103.59 52.72 0.77 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -21.53 38.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.0 109.859 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.75 -7.53 59.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.855 ' HB3' HG11 ' A' ' 42' ' ' VAL . 74.7 m-85 -79.87 163.86 56.01 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.97 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.8 Cg_endo -82.38 143.0 51.26 Favored 'Cis proline' 0 C--N 1.306 -1.664 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.088 2.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.2 mttt -97.35 141.11 22.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.033 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.42 15.13 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.755 2.303 . . . . 0.0 110.477 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.27 116.29 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 109.028 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.6 m -82.24 145.59 29.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -52.35 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -114.91 -19.29 11.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.822 -1.174 . . . . 0.0 110.262 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 18' ' ' LEU . 16.5 pm0 -57.9 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.788 -1.195 . . . . 0.0 107.827 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.2 t80 -139.15 126.85 21.95 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.893 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.2 mtm180 -161.52 81.03 1.99 Allowed Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 21.0 Cg_endo -63.83 107.24 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.192 1.928 . . . . 0.0 111.739 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -100.6 126.09 47.05 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.198 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 43.3 t -77.97 168.1 20.43 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -145.46 161.19 28.19 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.102 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -59.45 -35.18 73.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.728 -0.866 . . . . 0.0 109.441 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.635 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -45.18 -27.43 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 109.036 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.8 t-20 101.11 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.063 0.458 . . . . 0.0 109.961 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 175.24 8.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.105 -0.997 . . . . 0.0 109.616 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 31' ' ' TYR . 38.0 m -106.18 162.08 13.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.883 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.7 m-85 -133.26 102.66 5.65 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.188 -0.945 . . . . 0.0 108.618 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.14 -60.29 0.02 OUTLIER Glycine 0 N--CA 1.499 2.856 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.1 p30 -143.42 -170.37 3.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.968 -1.313 . . . . 0.0 110.627 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.19 -48.32 45.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.853 -0.529 . . . . 0.0 110.816 -178.804 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 18.2 t -53.32 -71.59 0.07 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.741 -1.225 . . . . 0.0 109.432 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.2 m-80 -40.28 -39.77 1.01 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.839 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.608 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 35.9 t80 -61.73 -51.51 68.05 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.862 1.315 . . . . 0.0 109.833 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 90.1 m -57.77 -50.89 71.72 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.575 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -44.37 -29.29 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.833 -1.167 . . . . 0.0 108.66 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.42 -49.41 49.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.814 HG22 ' CD2' ' A' ' 48' ' ' LEU . 38.4 t -57.62 -56.84 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.667 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.97 HG21 ' HB3' ' A' ' 12' ' ' PRO . 13.2 m -58.7 -23.07 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 0.0 110.642 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.1 tt0 -91.43 -17.48 25.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.391 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 11.9 t -105.69 22.95 14.67 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.342 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 21.6 m120 64.74 9.61 5.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 109.524 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 80.92 17.93 71.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.1 p -89.97 -9.43 48.78 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.373 -1.075 . . . . 0.0 108.239 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.814 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.47 149.76 28.6 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 5.1 p -122.41 151.52 41.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.6 tp -65.52 124.28 21.89 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.3 t -78.55 -24.75 45.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.62 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CB ' ' O ' ' A' ' 51' ' ' SER . 15.9 p80 151.02 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.299 0.571 . . . . 0.0 110.056 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 154.91 22.54 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 85.54 178.5 50.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -79.85 161.37 25.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.892 -1.358 . . . . 0.0 107.947 178.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.579 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.766 ' O ' HG12 ' A' ' 6' ' ' VAL . 87.1 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.437 0.637 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 50.2 t0 63.77 147.42 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 40.8 t -160.49 20.89 0.15 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.027 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -90.8 -4.01 56.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -108.56 34.82 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.734 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.1 m-85 -133.23 159.67 71.7 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -73.42 159.6 97.14 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.859 -1.725 . . . . 0.0 111.994 2.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttt -117.72 144.78 35.05 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.26 14.48 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.44 2.093 . . . . 0.0 111.411 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 166.21 134.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.2 t -112.03 157.62 20.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.516 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.486 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 10.6 p -59.3 -162.53 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -120.53 -15.92 8.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.524 -1.36 . . . . 0.0 109.976 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.9 pt-20 -46.62 130.55 11.37 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.1 t80 -89.28 130.02 35.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.391 1.091 . . . . 0.0 111.107 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mtt180 -160.63 74.26 2.79 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.0 Cg_endo -64.59 129.7 24.42 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.145 2.563 . . . . 0.0 112.794 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.654 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.93 135.72 53.94 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.515 -1.274 . . . . 0.0 108.212 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.967 ' O ' HD12 ' A' ' 50' ' ' LEU . 8.7 t -77.37 133.44 38.72 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -79.94 -162.68 26.03 Favored Glycine 0 C--N 1.292 -1.867 0 C-N-CA 117.67 -2.205 . . . . 0.0 109.218 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.544 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -85.85 -33.87 21.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -1.2 . . . . 0.0 108.331 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -57.3 -17.29 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t30 96.31 22.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 120.982 0.42 . . . . 0.0 110.707 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -107.49 -158.5 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 0.0 109.163 178.649 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.9 m -129.74 158.9 38.12 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.484 -0.76 . . . . 0.0 110.031 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -132.74 135.02 45.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.95 -50.3 1.5 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -163.73 -157.42 0.4 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.945 -1.327 . . . . 0.0 110.369 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 112.146 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.652 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -64.9 -57.01 9.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.585 -1.322 . . . . 0.0 110.43 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.06 -32.21 71.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.025 -1.047 . . . . 0.0 110.129 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 7.0 t80 -62.38 -60.06 4.1 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.793 -1.192 . . . . 0.0 109.511 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.8 t -56.79 -49.68 74.61 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.033 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 7.1 m-20 -40.97 -30.82 0.14 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.807 -1.183 . . . . 0.0 108.084 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.38 -49.45 18.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD23 ' A' ' 48' ' ' LEU . 88.1 t -60.36 -63.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.1 p -55.89 -26.36 20.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 111.785 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.43 -16.17 27.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.08 -1.637 . . . . 0.0 108.737 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 10.7 t -98.85 21.94 10.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 110.097 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 78.4 m-20 65.22 8.27 4.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.862 . . . . 0.0 109.927 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.12 11.32 85.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.2 p -79.3 -4.24 49.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.025 -1.28 . . . . 0.0 108.194 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.977 HD23 HG22 ' A' ' 41' ' ' VAL . 1.9 tp -79.94 -86.03 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 80.36 168.69 0.16 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.82 178.89 4.42 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.639 -1.288 . . . . 0.0 110.565 -178.04 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.07 -38.36 3.89 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.74 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.3 p80 -163.93 151.67 12.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.752 0.787 . . . . 0.0 110.139 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.6 m-85 -62.41 -174.97 0.07 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.69 -0.631 . . . . 0.0 109.413 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 66.15 -169.27 32.15 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 1.2 mtmm -92.51 134.99 34.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.691 -0.888 . . . . 0.0 109.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.551 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.954 -1.091 . . . . 0.0 109.402 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 23' ' ' LEU . 63.9 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.195 0.522 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 11.5 p-10 -80.62 -176.37 5.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 7.1 m -157.81 49.77 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.792 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -90.96 -4.27 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.965 . . . . 0.0 110.07 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 4.6 mp0 -134.11 49.4 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.004 -1.06 . . . . 0.0 110.422 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.906 ' HB3' HG11 ' A' ' 42' ' ' VAL . 99.1 m-85 -141.66 153.48 65.05 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 120.922 -1.111 . . . . 0.0 109.241 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.28 136.44 44.95 Favored 'Cis proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.396 -1.918 . . . . 0.0 111.439 2.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.0 tttt -85.4 145.0 41.42 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.662 -0.649 . . . . 0.0 109.62 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.515 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.09 13.73 1.92 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.801 2.334 . . . . 0.0 110.742 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.65 128.07 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.387 -0.821 . . . . 0.0 109.111 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' THR . 71.7 m -91.64 139.08 31.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.85 . . . . 0.0 110.054 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -49.14 174.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.55 -16.83 12.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.96 -1.088 . . . . 0.0 109.928 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -56.53 -168.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.551 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.8 t80 -140.22 123.15 16.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.422 1.106 . . . . 0.0 110.576 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.15 80.92 2.37 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.234 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.59 125.23 14.02 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.694 2.262 . . . . 0.0 112.466 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.38 128.4 55.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.735 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.8 t -78.7 135.34 37.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.58 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -82.6 -165.47 36.93 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 118.511 -1.804 . . . . 0.0 108.613 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 45.8 t -87.45 -29.6 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.664 -1.492 . . . . 0.0 108.728 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -63.06 -14.02 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 109.082 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 53.8 t30 96.28 19.26 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 120.929 0.395 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.655 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.97 -165.54 1.25 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.879 -1.138 . . . . 0.0 108.54 178.759 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.551 HG21 ' HB3' ' A' ' 55' ' ' LYS . 7.7 m -135.4 157.43 46.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.333 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 70.6 m-85 -129.63 121.69 27.55 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -29.07 -51.94 0.13 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 44.7 p30 -158.28 -162.96 1.2 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.111 -1.229 . . . . 0.0 109.488 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -57.71 -48.12 80.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.43 -0.794 . . . . 0.0 111.051 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.7 t -52.8 -52.71 55.81 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 109.962 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.6 m-80 -63.26 -31.5 72.66 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.488 -0.758 . . . . 0.0 110.942 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 19.2 t80 -74.02 -61.65 1.78 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.689 -1.257 . . . . 0.0 110.766 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 30.5 t -57.56 -49.4 76.51 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.927 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.3 m-20 -42.34 -30.89 0.35 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.67 -1.269 . . . . 0.0 108.18 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.839 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -80.12 -43.4 21.76 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.5 t -66.78 -65.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.426 -0.796 . . . . 0.0 108.928 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 11' ' ' TYR . 9.8 p -50.67 -30.57 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 111.423 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.72 -16.96 24.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.056 -1.652 . . . . 0.0 109.137 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.97 ' O ' HG22 ' A' ' 47' ' ' THR . 65.8 p -101.1 19.8 16.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 110.391 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 44' ' ' SER . 1.8 p-10 53.85 29.66 10.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.81 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.21 28.92 73.13 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.258 -0.901 . . . . 0.0 110.861 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' SER . 10.1 t -95.72 -10.62 28.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.839 HD22 ' CB ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.55 -53.7 6.33 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.588 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER 50.99 172.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.302 0.572 . . . . 0.0 109.586 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.49 163.49 28.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 109.099 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.49 -30.97 8.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.735 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -168.93 163.52 11.52 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.429 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.2 -166.48 0.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 57.67 -173.51 2.56 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.13 138.47 31.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.285 -1.126 . . . . 0.0 109.142 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.554 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.07 122.97 42.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 12.1 m -125.72 43.04 3.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.003 -1.061 . . . . 0.0 110.652 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 10.47 25.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -131.73 6.1 4.33 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.939 -1.101 . . . . 0.0 110.868 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -84.19 156.97 63.05 Favored Pre-proline 0 C--N 1.307 -1.282 0 O-C-N 120.827 -1.17 . . . . 0.0 109.019 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.7 144.98 82.5 Favored 'Cis proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.011 2.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -92.45 147.68 34.88 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.48 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -77.4 13.6 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 111.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.7 112.45 0.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.024 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 17' ' ' THR . 91.8 m -87.86 144.55 26.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -45.37 157.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.83 -33.57 7.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.853 -1.155 . . . . 0.0 110.107 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -62.09 -176.51 0.1 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -115.83 129.32 56.38 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.411 1.101 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 16.2 mtp-105 -159.86 70.73 3.17 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 54' ' ' GLY . 19.4 Cg_endo -60.27 121.79 10.32 Favored 'Trans proline' 0 C--O 1.192 -1.795 0 C-N-CA 123.295 2.664 . . . . 0.0 112.831 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 1.7 mp -103.97 158.73 16.22 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.618 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -116.7 132.05 56.79 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 119.795 -1.816 . . . . 0.0 111.949 -178.194 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.638 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -87.46 160.87 32.04 Favored Glycine 0 N--CA 1.503 3.101 0 CA-C-O 121.758 0.643 . . . . 0.0 111.909 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.498 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -64.44 -34.41 78.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -61.49 -11.84 12.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.397 -0.814 . . . . 0.0 109.309 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.3 m-20 88.27 18.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.815 -0.553 . . . . 0.0 110.942 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 1.3 pttm -107.78 122.28 46.44 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.1 m -80.7 132.97 35.62 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 140.98 31.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.306 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -49.38 -41.51 32.37 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.216 -0.927 . . . . 0.0 112.069 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.9 p30 -164.88 -158.39 0.4 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.448 -1.619 . . . . 0.0 110.363 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -57.75 -45.6 85.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.404 -177.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 36.4 t -68.43 -57.27 6.11 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.703 -1.248 . . . . 0.0 108.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -49.97 -22.23 1.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE1' HD21 ' A' ' 48' ' ' LEU . 7.3 t80 -83.04 -63.67 1.32 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.266 1.032 . . . . 0.0 110.918 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 13.5 m -47.87 -51.4 23.17 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.257 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 9.8 m-20 -48.3 -36.24 13.82 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -60.12 -46.27 90.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.0 t -64.93 -65.17 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.56 0.695 . . . . 0.0 110.246 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.4 p -58.97 -19.58 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.842 . . . . 0.0 112.011 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -93.42 -16.27 24.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.093 -1.629 . . . . 0.0 109.22 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.687 ' O ' HG22 ' A' ' 47' ' ' THR . 4.4 p -98.66 18.39 16.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t30 74.54 4.61 4.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.135 -0.978 . . . . 0.0 108.415 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.81 20.08 69.03 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -87.53 -1.77 58.16 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -1.03 . . . . 0.0 108.642 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -89.45 161.76 16.1 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.786 ' H ' HD12 ' A' ' 48' ' ' LEU . 75.8 p -147.9 130.21 15.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.1 tp -68.83 141.16 55.2 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.04 -17.91 12.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.802 -1.186 . . . . 0.0 108.065 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.618 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 173.88 154.22 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.54 0.686 . . . . 0.0 109.701 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -70.31 176.77 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.049 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.14 -172.09 44.85 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CE ' ' OH ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -91.68 156.23 17.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -1.211 . . . . 0.0 108.811 178.569 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.508 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 5.6 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.029 -1.044 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 37' ' ' PHE . 2.6 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -114.87 132.64 56.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 79.9 m -130.62 53.58 1.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.3 -16.31 29.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.866 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.51 37.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.159 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.895 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.9 m-85 -125.91 161.09 53.37 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.873 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.29 153.88 50.35 Favored 'Cis proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.281 -1.55 . . . . 0.0 110.999 1.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.0 140.67 25.85 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.622 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.85 14.4 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.58 2.186 . . . . 0.0 111.141 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 167.95 135.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 108.871 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -133.2 165.44 24.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.933 -1.104 . . . . 0.0 110.737 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -54.99 -165.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 0.0 109.39 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.4 pp -122.86 3.68 9.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.008 -1.057 . . . . 0.0 110.273 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.7 pt-20 -47.63 118.44 2.26 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -79.37 126.91 31.42 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.757 1.265 . . . . 0.0 111.759 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.2 ptm180 -161.45 75.12 2.45 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.7 Cg_endo -64.31 118.99 5.91 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -113.05 128.84 56.61 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.507 179.077 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.599 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -88.87 112.09 22.84 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.604 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.67 -169.73 0.05 OUTLIER Glycine 0 N--CA 1.484 1.855 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.7 t -75.5 -34.63 60.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -1.173 . . . . 0.0 109.173 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.9 p30 -68.51 -6.64 26.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.882 . . . . 0.0 109.261 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.1 t-20 83.92 30.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.932 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.18 137.77 37.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.222 -0.924 . . . . 0.0 108.536 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 91.1 m -85.12 135.22 34.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.028 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.731 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.9 m-85 -113.83 142.68 45.79 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -55.98 -39.13 78.08 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.151 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 23.1 p-10 -160.05 -164.25 1.26 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.689 -1.477 . . . . 0.0 109.632 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -29.0 69.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 62.5 m -77.18 -57.1 4.03 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.041 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 m120 -48.61 -36.85 16.63 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.782 -1.199 . . . . 0.0 108.528 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 23' ' ' LEU . 17.0 t80 -68.38 -56.52 8.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.359 1.076 . . . . 0.0 110.247 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 64.0 m -52.65 -56.6 14.29 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.317 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 14.1 m-20 -38.7 -29.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.31 -51.03 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . 89.8 t -52.24 -53.79 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.646 0.736 . . . . 0.0 109.474 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.895 HG11 ' CB ' ' A' ' 11' ' ' TYR . 32.8 m -59.96 -34.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -91.83 -2.33 56.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.737 ' O ' HG22 ' A' ' 47' ' ' THR . 28.9 t -106.28 -8.26 17.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.8 t-20 80.32 30.41 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.802 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.62 31.93 57.99 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 ' O ' ' A' ' 44' ' ' SER . 10.5 t -114.13 8.31 16.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.0 tp -89.76 -71.03 0.63 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.538 0.685 . . . . 0.0 109.292 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.627 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.9 p 60.5 143.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.646 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -102.55 171.83 7.21 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.213 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.646 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.23 -30.54 8.31 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.599 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -162.53 158.04 23.01 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.391 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 6.4 m-85 -75.81 -164.45 0.36 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 60.43 -169.49 8.12 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -92.45 168.64 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.494 -1.003 . . . . 0.0 108.773 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.8 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.591 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.0 152.19 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 m -135.01 57.04 1.82 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.273 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -89.1 -15.59 33.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.2 mp0 -95.94 4.13 52.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 109.305 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' HB3' HG11 ' A' ' 42' ' ' VAL . 96.0 m-85 -96.5 159.52 31.66 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.401 -0.812 . . . . 0.0 109.079 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.949 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -81.68 140.29 45.92 Favored 'Cis proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.531 2.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 10.3 mttt -99.78 139.05 20.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -80.61 14.2 2.08 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.55 2.167 . . . . 0.0 110.452 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.92 126.25 7.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 81.5 m -116.57 139.63 50.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 16' ' ' CYS . 7.1 p -55.4 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 108.729 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -121.84 -25.74 4.96 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.497 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mt-10 -45.37 123.62 4.24 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.8 t80 -83.97 105.42 14.84 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.694 1.235 . . . . 0.0 110.693 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.6 mtp180 -136.89 75.33 49.02 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 18.4 Cg_endo -61.15 119.35 6.46 Favored 'Trans proline' 0 C--O 1.193 -1.747 0 C-N-CA 123.523 2.815 . . . . 0.0 114.195 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.669 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 2.7 mp -101.77 154.47 18.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -114.79 140.35 48.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 119.897 -1.752 . . . . 0.0 109.637 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.664 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.44 161.88 17.96 Favored Glycine 0 N--CA 1.497 2.743 0 CA-C-O 122.4 1.0 . . . . 0.0 113.747 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -37.44 86.15 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.802 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p-10 -58.69 -13.82 6.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.962 . . . . 0.0 109.267 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.8 m-20 91.61 12.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.313 0.578 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 30.5 ttpt -99.28 128.8 45.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -88.29 129.54 35.35 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.849 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.07 132.02 43.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -45.0 -39.74 6.61 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 121.476 -0.765 . . . . 0.0 112.045 -176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -165.57 -157.26 0.31 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.528 -1.572 . . . . 0.0 110.279 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -57.83 -51.2 70.55 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.475 -178.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.3 t -61.3 -60.01 4.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.68 -1.263 . . . . 0.0 109.214 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -48.9 -23.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 108.858 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.1 t80 -80.78 -65.62 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.125 0.964 . . . . 0.0 110.618 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.85 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.1 m -50.26 -22.8 1.91 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.694 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.1 m-80 -76.83 -40.28 48.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -58.32 -23.38 56.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.0 HG22 HD23 ' A' ' 48' ' ' LEU . 92.4 t -84.04 -53.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.949 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -65.71 -12.36 13.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.684 -0.635 . . . . 0.0 109.649 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -93.55 -18.91 21.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 2.5 t -108.41 22.99 15.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.895 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 79.26 -3.82 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 109.057 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 86.54 11.06 72.26 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.3 t -85.42 -5.94 59.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -1.187 . . . . 0.0 108.838 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.0 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.93 150.91 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.597 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.8 p -123.68 142.99 50.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.11 0.957 . . . . 0.0 109.465 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.6 tp -57.73 121.1 9.63 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.0 t -76.76 -24.26 52.94 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.238 -0.913 . . . . 0.0 109.366 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.57 ' CB ' ' O ' ' A' ' 51' ' ' SER . 16.8 p-80 155.72 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.477 0.656 . . . . 0.0 109.362 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 19.3 m-85 -93.83 156.36 16.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.408 -0.808 . . . . 0.0 109.625 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 86.12 -167.94 40.28 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -176.56 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -1.071 . . . . 0.0 108.443 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 41.1 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 6' ' ' VAL . 17.9 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 6' ' ' VAL . 18.5 t0 21.57 99.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.152 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 7.8 m -121.55 64.62 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.43 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -91.27 -14.71 30.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.391 -0.818 . . . . 0.0 109.33 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 5.4 mm-40 -105.56 34.93 3.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 110.047 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.7 m-85 -113.73 161.44 27.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.023 -1.048 . . . . 0.0 108.929 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -73.28 175.99 43.21 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.633 -1.82 . . . . 0.0 111.377 2.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -125.78 144.01 47.0 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.582 -0.698 . . . . 0.0 109.559 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.89 14.22 1.76 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.788 2.326 . . . . 0.0 111.204 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.63 141.13 16.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.569 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -116.01 2.56 13.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.825 -1.172 . . . . 0.0 110.981 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 67.43 -17.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 178.455 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 72.21 -9.04 1.06 Allowed 'General case' 0 C--N 1.275 -2.635 0 O-C-N 121.697 -0.627 . . . . 0.0 111.448 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -59.45 129.07 40.19 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.594 -1.316 . . . . 0.0 107.899 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.3 123.18 33.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.527 1.155 . . . . 0.0 111.701 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -162.19 81.94 1.76 Allowed Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.545 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -64.83 117.25 4.35 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.615 2.21 . . . . 0.0 113.344 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.12 136.08 47.58 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -98.83 112.39 24.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.878 -1.139 . . . . 0.0 111.672 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.914 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -51.13 176.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.0 t -72.73 -22.66 60.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -1.176 . . . . 0.0 107.829 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.6 p30 -76.42 -5.73 48.6 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.6 m-20 82.04 30.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 110.363 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -102.74 146.44 28.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 95.8 m -98.3 143.52 28.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 0.0 110.409 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.72 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.9 m-85 -124.81 125.08 43.45 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.59 -46.88 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.363 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 35.9 p-10 -156.61 -168.17 2.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.445 -1.62 . . . . 0.0 111.492 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.07 -37.09 71.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.867 -0.521 . . . . 0.0 112.313 -177.608 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.8 p -77.41 -54.39 6.5 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.655 -1.278 . . . . 0.0 108.662 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 2.6 m120 -50.36 -26.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.017 -1.052 . . . . 0.0 108.888 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 76.5 t80 -87.02 -35.69 18.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 123.069 1.414 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.2 m -67.34 -29.17 68.65 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -70.39 -36.09 73.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.97 -25.35 63.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.4 t -77.64 -40.05 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.333 0.587 . . . . 0.0 110.186 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.9 p -84.7 -13.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.915 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.732 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -91.73 -33.21 15.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 47' ' ' THR . 9.8 t -89.98 20.31 4.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.5 m-80 64.99 10.24 6.1 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.424 -0.797 . . . . 0.0 109.911 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.99 15.69 64.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 44' ' ' SER . 7.7 p -92.26 7.25 43.54 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.018 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.914 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.9 tp -79.5 -66.58 0.85 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.6 p 50.02 118.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 122.456 1.122 . . . . 0.0 111.904 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -77.89 170.89 15.83 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.72 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.99 -22.85 9.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.607 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.2 p80 -164.53 144.53 7.6 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.494 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.11 164.17 13.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 85.81 -170.0 43.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 8.9 mtmm -90.76 165.67 13.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -1.105 . . . . 0.0 109.395 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 37.3 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.932 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 37' ' ' PHE . 7.2 p . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.325 0.583 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.73 139.91 51.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.153 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' HG13 ' A' ' 6' ' ' VAL . 30.6 m -143.29 46.54 1.52 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.735 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.36 -6.38 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.128 -0.982 . . . . 0.0 109.872 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -100.86 13.55 34.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.48 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.074 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.5 m-85 -100.4 159.72 28.95 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -76.68 162.94 90.77 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.568 -1.846 . . . . 0.0 111.247 1.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.58 141.0 26.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.47 13.83 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 109.84 0.49 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -94.28 144.96 25.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.473 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 25.1 p -50.92 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -122.27 -16.81 7.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.058 -1.026 . . . . 0.0 109.904 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' LEU . 13.7 pm0 -55.8 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.59 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.8 t80 -134.74 130.86 36.86 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.25 80.55 2.09 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.8 Cg_endo -63.15 117.76 4.68 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.026 1.817 . . . . 0.0 111.966 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -108.44 132.53 53.69 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.699 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.737 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -80.7 120.72 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.602 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.43 -162.98 5.43 Favored Glycine 0 C--N 1.294 -1.757 0 C-N-CA 118.593 -1.765 . . . . 0.0 108.861 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.7 t -85.24 -49.83 7.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.893 -1.357 . . . . 0.0 109.963 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.8 p-10 -57.39 -14.83 5.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.3 t30 98.12 45.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.084 0.468 . . . . 0.0 110.069 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.07 114.17 20.0 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.353 1.073 . . . . 0.0 109.006 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.6 m -60.32 158.23 12.15 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.127 -0.983 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 1.2 m-85 -129.96 147.53 51.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -53.35 -37.68 55.86 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.555 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.651 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.6 p30 -166.59 -163.86 0.61 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.697 -1.472 . . . . 0.0 109.557 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.49 -36.67 78.87 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.665 -178.545 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' O ' ' C ' ' A' ' 36' ' ' ASN . 11.8 t -70.11 -64.35 0.91 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.497 -1.377 . . . . 0.0 108.391 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.6 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -40.8 -37.55 0.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.9 t80 -72.47 -59.65 2.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.511 1.148 . . . . 0.0 110.349 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 20.6 m -53.17 -58.54 6.7 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.093 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 15.8 m-20 -38.98 -30.43 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.283 -0.886 . . . . 0.0 109.056 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -74.55 -50.71 17.01 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.39 -59.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.665 -0.647 . . . . 0.0 110.202 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.074 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.3 p -61.49 -26.0 38.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.209 -0.932 . . . . 0.0 111.353 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.91 -8.92 44.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.517 -1.364 . . . . 0.0 109.398 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.5 p -109.13 18.19 20.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 110.307 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.4 m-20 63.46 15.26 8.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 0.0 109.717 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 19.73 76.6 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 44' ' ' SER . 24.2 p -88.99 -2.86 58.79 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.307 -1.113 . . . . 0.0 108.061 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.73 ' C ' HG23 ' A' ' 49' ' ' THR . 8.3 tp -85.28 -80.31 0.22 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.73 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER 68.41 171.55 0.28 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.63 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.11 167.66 14.48 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.376 -0.827 . . . . 0.0 109.697 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.63 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.9 -35.09 7.03 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.737 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -162.18 165.24 27.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.611 0.719 . . . . 0.0 109.129 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CD2' HD23 ' A' ' 23' ' ' LEU . 58.6 m-85 -80.07 175.25 10.81 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 108.968 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.66 -169.25 53.26 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -90.71 129.33 36.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.264 . . . . 0.0 109.787 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.637 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.395 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -93.11 147.23 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.808 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 71.5 m -133.04 30.24 3.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -0.859 . . . . 0.0 109.284 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -75.2 -23.68 57.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.589 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -90.73 19.91 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.675 ' HB3' HG11 ' A' ' 42' ' ' VAL . 86.8 m-85 -117.58 161.76 32.11 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 1.057 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -82.34 132.96 22.05 Favored 'Cis proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.042 -1.649 . . . . 0.0 110.966 2.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.2 mttt -80.25 143.19 55.9 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.668 -0.645 . . . . 0.0 109.659 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.22 14.18 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.564 2.176 . . . . 0.0 110.27 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 144.82 2.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.7 m -133.94 144.37 48.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 80.5 p -56.32 -168.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.0 109.02 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.05 -16.56 6.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 109.74 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 3.1 pm0 -50.69 132.87 26.2 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 t80 -86.45 125.5 33.75 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 122.824 1.297 . . . . 0.0 111.36 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.2 mtt-85 -160.59 70.64 2.85 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.635 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -62.87 131.07 31.48 Favored 'Trans proline' 0 C--O 1.198 -1.522 0 C-N-CA 124.044 3.163 . . . . 0.0 114.767 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 34' ' ' LYS . 3.1 mp -111.22 159.76 17.6 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 176.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.65 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -120.05 141.16 50.0 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.819 -1.801 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.66 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.51 158.95 18.62 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 122.701 1.167 . . . . 0.0 114.473 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -57.73 -17.79 17.36 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.549 -0.825 . . . . 0.0 109.858 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -89.62 21.8 3.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 109.007 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.82 16.96 3.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.526 -0.734 . . . . 0.0 109.867 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -99.26 120.54 39.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.242 -0.912 . . . . 0.0 108.592 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.869 HG21 ' HD3' ' A' ' 55' ' ' LYS . 42.6 m -84.5 126.49 33.33 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.462 -0.773 . . . . 0.0 109.648 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.82 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.66 136.79 36.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -41.77 -40.51 3.07 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.296 -0.878 . . . . 0.0 111.545 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.1 p30 -171.02 -153.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.677 -1.484 . . . . 0.0 110.318 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.89 -52.31 66.3 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.014 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 7.8 t -64.02 -57.83 8.52 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.737 -1.227 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -49.92 -23.14 1.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.82 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 5.3 t80 -78.25 -67.32 0.75 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.424 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 1.093 ' O ' HG13 ' A' ' 42' ' ' VAL . 6.4 m -45.25 -25.73 0.41 Allowed 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.7 m-80 -70.06 -46.7 64.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -60.67 -19.97 59.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.029 HG22 HD23 ' A' ' 48' ' ' LEU . 53.1 t -90.91 -29.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.134 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.093 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.8 m -83.98 -19.37 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.11 -16.78 25.88 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.916 . . . . 0.0 108.703 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG22 ' A' ' 47' ' ' THR . 0.4 OUTLIER -100.15 9.29 43.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.64 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.7 t30 76.45 6.29 3.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 79.85 7.73 88.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -87.76 9.55 21.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.264 -1.139 . . . . 0.0 108.885 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.029 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -85.66 -77.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.355 -0.841 . . . . 0.0 109.14 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 48' ' ' LEU . 4.2 p 92.27 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.084 0.945 . . . . 0.0 110.203 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 52' ' ' HIS . 8.5 tp -72.68 157.71 37.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.08 -18.95 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.655 -1.278 . . . . 0.0 108.385 179.172 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.717 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 174.03 161.17 0.17 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.24 164.78 25.28 Favored 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.635 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.96 -168.5 52.25 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.869 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -91.1 171.72 9.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 3.0 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.616 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 34' ' ' LYS . 24.4 t . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.05 112.2 21.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 38.7 m -108.15 64.53 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -89.49 -23.18 22.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -5.26 59.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.843 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -79.83 162.24 63.28 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.181 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.917 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.2 Cg_endo -82.08 144.2 57.53 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.201 -1.583 . . . . 0.0 110.933 2.253 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 26.2 mttt -99.46 141.63 23.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 109.934 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.67 14.26 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.522 2.148 . . . . 0.0 110.27 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 119.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.538 -0.726 . . . . 0.0 109.052 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 64.8 m -93.8 148.9 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.644 ' O ' HD23 ' A' ' 18' ' ' LEU . 66.2 p -56.67 -164.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 17' ' ' THR . 7.3 mt -128.7 -7.58 5.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.94 -1.1 . . . . 0.0 110.654 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.488 ' OE1' ' HG3' ' A' ' 21' ' ' ARG . 1.3 pp20? -65.94 -176.3 0.38 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 9.4 t80 -122.49 129.43 51.99 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 120.862 -1.149 . . . . 0.0 111.239 -178.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 17.1 mtm180 -160.31 73.31 2.97 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.9 Cg_endo -64.73 112.85 2.1 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.909 1.739 . . . . 0.0 110.87 -178.274 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.78 138.61 49.35 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.325 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.869 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 9.2 t -96.24 165.75 12.06 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.912 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.435 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -132.81 176.71 19.35 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.493 -177.484 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.4 t -58.56 -49.24 78.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.667 -0.902 . . . . 0.0 109.049 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.602 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.2 p-10 -47.97 -24.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 108.985 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.3 t-20 91.08 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.22 0.533 . . . . 0.0 109.844 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 4.4 ttmt -127.89 153.5 46.57 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 31' ' ' TYR . 36.8 m -92.82 160.98 14.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 87.5 m-85 -140.11 100.26 3.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 108.679 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -17.43 -61.43 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.113 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.3 p30 -139.34 -169.82 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.923 -1.339 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 28.5 pttt -53.11 -39.47 63.44 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.821 -0.549 . . . . 0.0 110.533 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -63.03 -66.31 0.56 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.996 -1.065 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.8 m-80 -41.43 -34.74 0.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 109.871 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 59.0 t80 -71.72 -44.89 63.36 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.914 1.34 . . . . 0.0 109.69 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 71.5 m -61.73 -55.7 27.49 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 42' ' ' VAL . 4.4 m-80 -44.23 -27.61 0.43 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.757 -1.214 . . . . 0.0 108.667 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.56 -47.51 47.57 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 1.008 HG22 ' CD2' ' A' ' 48' ' ' LEU . 32.8 t -60.19 -56.71 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.823 0.82 . . . . 0.0 109.335 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 ' HB3' ' A' ' 12' ' ' PRO . 15.9 m -56.22 -29.08 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 110.553 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.27 -15.73 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.025 -1.047 . . . . 0.0 108.81 179.536 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 89.5 p -106.33 11.25 31.21 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.414 -0.804 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.57 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.9 OUTLIER 50.65 39.05 20.67 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.69 0.757 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 65.56 32.15 82.39 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.749 178.651 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.525 HG23 ' CG ' ' A' ' 45' ' ' ASN . 70.1 p -104.93 -6.11 20.43 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.324 -1.104 . . . . 0.0 108.573 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 1.008 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 -57.11 3.83 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.104 0.954 . . . . 0.0 108.501 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.616 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 32.1 p 63.7 129.47 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.955 -177.373 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -58.21 152.73 16.52 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.1 p -107.38 -42.86 4.7 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.869 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -174.45 160.49 3.19 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.723 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -77.72 139.07 39.36 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.115 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.82 -170.33 16.9 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -89.41 159.17 17.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.884 -1.362 . . . . 0.0 108.007 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.444 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 7' ' ' ASP . 77.0 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.267 0.556 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.9 t0 -77.94 137.81 38.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 60.1 m -146.6 49.17 1.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.823 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -90.55 -10.83 42.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.971 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.82 21.09 11.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.736 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.3 m-85 -106.75 159.69 28.97 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 36.9 Cg_endo -75.61 175.96 45.71 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.711 -1.787 . . . . 0.0 111.364 2.449 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 50.5 mttt -135.4 139.07 30.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.82 13.96 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.346 2.031 . . . . 0.0 110.58 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.78 114.72 1.57 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -91.81 150.46 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.55 167.39 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 109.124 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -101.09 -33.79 9.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.026 . . . . 0.0 109.625 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -46.0 125.05 5.94 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.042 -1.036 . . . . 0.0 108.797 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -79.69 116.74 20.05 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.393 1.092 . . . . 0.0 109.915 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.68 76.68 10.68 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -64.01 120.98 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.983 2.455 . . . . 0.0 112.614 -177.53 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.833 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -114.01 127.61 56.02 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.63 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 37.5 t -79.91 115.97 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -64.75 -170.97 2.5 Favored Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.299 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -80.91 -33.62 34.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.945 -1.327 . . . . 0.0 108.75 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.4 p-10 -60.05 -16.41 31.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 92.9 17.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 109.891 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.54 130.44 45.78 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.169 -0.957 . . . . 0.0 108.725 179.169 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 m -70.88 147.24 49.01 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 71.7 m-85 -120.69 116.18 24.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -26.85 -47.78 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 -177.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.4 p30 -160.7 -163.47 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.616 -1.52 . . . . 0.0 109.694 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.833 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.31 -41.73 80.45 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.397 -179.069 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 42.4 t -61.59 -66.46 0.53 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.734 -1.229 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 12.8 m-80 -43.71 -34.23 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 0.0 110.708 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 25.9 t80 -72.25 -52.57 15.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.179 . . . . 0.0 109.982 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.626 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 32.9 m -53.83 -53.18 56.1 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 4.3 m-20 -41.43 -34.29 0.52 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.154 -0.967 . . . . 0.0 108.864 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.825 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -71.74 -47.24 55.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 46' ' ' GLY . 97.4 t -58.06 -62.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.433 0.635 . . . . 0.0 110.06 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.8 p -58.96 -22.84 22.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 111.869 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.07 -16.42 27.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.377 -1.452 . . . . 0.0 108.702 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' HG22 ' A' ' 47' ' ' THR . 18.9 p -102.63 -2.24 28.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.59 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' SER . 10.5 t30 78.63 12.83 1.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 109.305 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.63 5.86 74.14 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 44' ' ' SER . 14.3 t -79.61 -4.0 49.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.258 -1.143 . . . . 0.0 108.15 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' THR . 4.7 tp -80.4 -82.89 0.11 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 75.27 179.88 0.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.544 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -130.88 -179.79 5.52 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.582 -1.324 . . . . 0.0 110.22 -179.472 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -111.61 -21.91 11.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.018 -1.051 . . . . 0.0 108.465 -179.82 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 179.74 155.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.504 -0.748 . . . . 0.0 109.835 -179.211 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -73.65 148.35 42.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.39 -166.97 14.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.608 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.74 157.67 16.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -1.103 . . . . 0.0 108.219 178.855 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.09 -1.006 . . . . 0.0 109.627 -179.885 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 23' ' ' LEU . 40.3 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.343 0.592 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -101.26 131.17 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.542 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 29.0 m -122.23 58.69 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 t -82.65 -16.85 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -1.92 40.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.117 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.874 ' HB3' HG11 ' A' ' 42' ' ' VAL . 36.4 m-85 -84.53 165.46 37.85 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.985 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.5 153.43 62.92 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.338 -1.526 . . . . 0.0 110.913 1.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -102.9 141.28 22.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.759 . . . . 0.0 109.694 -179.411 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -80.19 13.57 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.561 2.174 . . . . 0.0 110.278 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.02 112.58 1.0 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.5 m -83.89 143.16 30.06 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.62 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.196 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -125.61 -31.88 2.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.897 -1.127 . . . . 0.0 109.928 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 2.8 pm0 -49.03 142.08 7.13 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 7.9 t80 -90.23 126.15 35.73 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 122.731 1.253 . . . . 0.0 111.2 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.68 71.87 2.83 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.855 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -61.16 130.9 34.17 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.531 2.821 . . . . 0.0 113.159 -176.495 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -115.29 126.44 54.49 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.171 178.291 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.779 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.4 t -78.07 133.66 37.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -75.72 -157.26 6.62 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 118.534 -1.793 . . . . 0.0 108.784 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -92.99 -66.55 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 110.171 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.629 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -40.16 -40.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.605 -0.684 . . . . 0.0 109.401 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.6 p30 133.38 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE3' ' CD1' ' A' ' 48' ' ' LEU . 11.3 pttp -108.46 107.27 17.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 109.636 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 46.6 m -66.37 152.13 45.69 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.531 -0.731 . . . . 0.0 109.101 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 m-85 -129.62 142.74 50.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.676 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.555 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -47.52 -35.06 10.35 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.708 -176.797 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 23' ' ' LEU . 43.1 p30 -173.18 -155.55 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.725 -1.456 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.96 -42.39 97.29 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.436 -0.79 . . . . 0.0 110.786 -178.227 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.8 t -66.55 -57.36 7.45 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.579 -1.326 . . . . 0.0 108.512 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -48.93 -37.0 18.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.82 . . . . 0.0 109.478 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 31.9 t80 -70.22 -51.91 27.23 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.492 1.139 . . . . 0.0 110.247 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 61.2 m -55.21 -61.03 2.59 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.289 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' CYS . 3.9 m-20 -37.47 -29.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.302 -0.874 . . . . 0.0 109.657 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -74.33 -52.3 12.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 68.9 t -52.06 -54.72 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.585 0.707 . . . . 0.0 109.738 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.985 HG21 ' HB3' ' A' ' 12' ' ' PRO . 6.1 m -61.89 -26.48 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 111.183 -178.898 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 6.9 tt0 -90.63 -6.43 54.6 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.962 -1.087 . . . . 0.0 109.792 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 p -112.57 18.42 18.39 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.118 -0.989 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.888 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.61 -1.58 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 0.0 109.304 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.88 17.24 61.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.888 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.1 p -87.0 -10.41 53.21 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.248 . . . . 0.0 108.486 178.435 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -78.26 148.47 33.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.712 0.768 . . . . 0.0 109.467 -179.573 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' SER . 1.3 p -137.77 167.17 22.25 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.147 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -109.63 170.31 8.15 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -108.41 -35.77 6.41 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.829 -1.17 . . . . 0.0 107.896 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.779 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -167.86 164.73 14.07 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.568 0.699 . . . . 0.0 109.505 -178.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.65 -167.16 0.33 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.577 -0.702 . . . . 0.0 109.306 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.81 -167.31 4.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -85.55 165.4 17.11 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.614 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.584 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.53 131.6 35.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.165 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 54.9 m -139.08 49.61 1.84 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -90.91 -10.18 43.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.689 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.67 23.76 9.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 42' ' ' VAL . 46.9 m-85 -117.63 158.28 45.69 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.066 -1.021 . . . . 0.0 108.385 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.24 164.86 84.19 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.003 3.473 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -119.91 146.85 42.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.478 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -78.53 13.67 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.5 2.133 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 150.94 1.29 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.9 m -119.83 138.25 53.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.023 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.3 p -54.04 -171.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 108.817 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -119.51 -22.87 6.81 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.362 179.577 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.1 pt-20 -49.95 118.42 2.88 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.207 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.538 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -78.42 126.55 30.93 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.536 1.16 . . . . 0.0 110.501 -178.164 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.0 ptm180 -160.66 77.91 2.5 Favored Pre-proline 0 C--N 1.293 -1.89 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.6 Cg_endo -66.11 127.68 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.707 2.271 . . . . 0.0 112.853 -176.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.749 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -116.88 135.15 53.95 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.881 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.916 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.1 t -92.88 161.48 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.424 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -117.56 168.18 12.9 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.47 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 35.3 t -69.47 -17.97 63.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.64 -0.917 . . . . 0.0 108.636 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 35.7 p30 -73.85 -7.97 54.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.068 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.6 t30 82.33 31.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.756 -0.59 . . . . 0.0 110.044 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -123.94 139.68 53.72 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.143 179.719 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -85.22 159.91 20.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.816 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 48.1 m-85 -130.98 124.85 31.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -38.41 -53.62 2.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.967 -178.129 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -155.06 -164.45 1.79 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.783 -1.422 . . . . 0.0 110.529 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.15 -25.28 68.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 111.533 -178.253 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -70.78 -53.23 16.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.598 -1.314 . . . . 0.0 109.197 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.13 -37.5 87.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.715 -0.616 . . . . 0.0 110.018 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.796 ' CE1' HD21 ' A' ' 48' ' ' LEU . 58.9 t80 -70.51 -47.61 59.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.942 -1.099 . . . . 0.0 109.791 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 17.3 m -64.02 -29.56 70.7 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 95.1 m-20 -72.64 -39.24 67.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.41 -17.3 61.81 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.773 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.2 t -84.54 -50.75 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.001 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 11' ' ' TYR . 6.8 p -68.54 -17.8 22.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.661 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.724 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.08 -31.3 15.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.05 -1.031 . . . . 0.0 108.371 178.548 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' THR . 46.5 t -88.15 15.11 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.633 -0.667 . . . . 0.0 110.53 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.5 m-20 64.04 12.79 7.22 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.203 -0.935 . . . . 0.0 109.511 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 20.74 66.96 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' SER . 10.8 p -93.75 3.61 55.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -1.137 . . . . 0.0 108.72 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.56 -52.73 7.63 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.047 0.927 . . . . 0.0 108.745 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.645 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 29.5 p 53.38 119.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.442 1.115 . . . . 0.0 111.323 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 4.2 tp -65.36 152.46 43.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.431 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -112.52 -16.87 12.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 175.86 163.52 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.92 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -80.22 177.66 8.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.159 -0.963 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.88 -167.45 54.88 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.09 173.46 7.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.775 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.846 -1.159 . . . . 0.0 109.681 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 23' ' ' LEU . 90.7 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' N ' HG12 ' A' ' 6' ' ' VAL . 10.3 t70 -86.3 152.51 22.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -122.98 49.88 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.671 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -90.01 -36.57 14.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.35 43.16 1.07 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.321 -0.862 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 47.2 m-85 -132.38 164.98 39.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -89.48 173.94 24.77 Favored 'Cis proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.399 -1.5 . . . . 0.0 111.293 0.212 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.4 mtpt -136.53 136.41 21.98 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 109.14 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.95 15.6 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.561 2.174 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.44 14.2 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.49 -0.756 . . . . 0.0 109.064 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.68 160.09 40.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 1.3 p -60.86 -164.23 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.525 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.09 -7.67 10.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 110.417 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.775 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.7 pm0 -56.59 119.32 5.91 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -79.6 128.96 34.03 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.505 1.145 . . . . 0.0 111.049 -178.226 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.56 80.03 2.05 Favored Pre-proline 0 C--N 1.294 -1.809 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.758 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.557 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -65.02 124.87 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.973 2.449 . . . . 0.0 112.975 -176.982 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.744 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -112.25 139.93 47.38 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.71 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -102.52 129.32 49.01 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.983 -178.303 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.11 -170.16 8.21 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' THR . 29.5 t -82.03 -22.02 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.938 -1.331 . . . . 0.0 108.416 178.878 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -76.15 -3.42 36.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.836 . . . . 0.0 109.44 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 17.6 t30 80.18 30.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.382 -0.824 . . . . 0.0 110.308 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 10.2 ttmt -105.32 137.1 43.65 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.103 -0.998 . . . . 0.0 108.781 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.9 m -85.66 146.5 26.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 0.0 109.998 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.6 m-85 -125.51 132.23 52.66 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.98 -51.03 0.65 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.619 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p30 -165.54 -168.32 1.32 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.036 -1.273 . . . . 0.0 111.086 178.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HA ' HD13 ' A' ' 23' ' ' LEU . 6.3 ptmt -45.76 -45.98 14.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.88 -0.512 . . . . 0.0 111.868 -177.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 10.3 m -64.76 -62.73 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.555 -1.341 . . . . 0.0 109.698 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.3 m-80 -50.56 -20.12 1.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 21.3 t80 -82.84 -57.93 3.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.954 -1.091 . . . . 0.0 110.889 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.5 t -58.01 -47.35 83.3 Favored 'General case' 0 C--N 1.286 -2.156 0 O-C-N 121.698 -0.626 . . . . 0.0 110.911 -178.203 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.589 ' O ' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.29 -28.75 1.39 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.341 -1.475 . . . . 0.0 107.997 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -70.2 -48.31 57.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.881 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.2 t -55.86 -56.14 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.408 0.623 . . . . 0.0 110.031 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 39' ' ' ASN . 2.8 m -53.48 -33.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.075 -1.015 . . . . 0.0 111.062 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -92.57 -11.27 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.629 -1.295 . . . . 0.0 109.697 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.891 ' O ' HG22 ' A' ' 47' ' ' THR . 8.5 t -100.65 -5.35 26.76 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.035 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 77.37 27.58 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.0 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.881 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 64.79 11.69 50.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 44' ' ' SER . 14.7 t -87.09 -2.44 58.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.293 -1.122 . . . . 0.0 108.666 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.02 -59.87 2.61 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.596 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 37.6 p 52.58 127.6 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.114 0.959 . . . . 0.0 111.305 178.791 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -85.94 160.67 19.32 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.581 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.1 -29.13 9.57 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.575 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.8 p80 -160.04 163.1 34.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.89 177.72 8.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 73.63 -167.11 54.52 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -91.4 164.78 13.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -1.031 . . . . 0.0 109.072 179.041 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.7 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.922 -179.089 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.172 0.51 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.83 156.57 39.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.0 109.243 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 19.5 t -160.98 24.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.947 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.18 -4.83 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -112.06 36.95 3.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.906 -1.121 . . . . 0.0 110.217 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 97.0 m-85 -136.51 157.81 74.52 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.994 -1.066 . . . . 0.0 108.817 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.576 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -72.08 145.04 82.12 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.631 -1.821 . . . . 0.0 111.544 3.149 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -108.1 144.95 30.44 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 -179.768 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -78.72 14.62 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.781 2.321 . . . . 0.0 110.956 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.03 117.49 2.25 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 109.127 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' THR . 94.3 m -102.21 139.71 37.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.877 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CD ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -45.16 142.88 1.81 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.425 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -92.28 -23.08 19.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.947 -1.096 . . . . 0.0 109.851 -179.484 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 14.5 pm0 -57.44 -166.8 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.6 t80 -134.03 116.4 15.46 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.352 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.4 mmt180 -147.92 74.71 11.07 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.475 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.5 Cg_endo -65.91 132.07 29.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.114 2.543 . . . . 0.0 113.144 -176.702 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.705 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -118.78 136.71 53.84 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.583 178.334 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 51.8 t -79.05 117.98 20.61 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.28 -165.56 1.32 Allowed Glycine 0 C--N 1.296 -1.663 0 C-N-CA 118.299 -1.905 . . . . 0.0 108.589 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.1 t -85.89 -31.78 22.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.27 . . . . 0.0 109.144 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -69.24 -4.92 19.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 179.57 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.3 t-20 86.11 15.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.742 -0.599 . . . . 0.0 109.881 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.0 ttpt -99.56 117.54 34.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.812 179.09 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -54.5 158.05 2.62 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 4.2 m-85 -129.2 133.13 47.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.338 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.07 -51.51 3.46 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -161.43 -158.5 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.336 -1.096 . . . . 0.0 109.547 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.53 -57.03 10.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.096 -178.099 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.9 t -42.85 -57.44 2.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.838 -1.164 . . . . 0.0 110.41 -179.264 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.34 -43.22 99.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.277 -0.889 . . . . 0.0 111.129 -178.6 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.7 t80 -56.07 -60.55 3.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.905 -1.122 . . . . 0.0 110.521 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -55.58 -51.96 65.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.32 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.9 m-20 -41.6 -29.19 0.16 Allowed 'General case' 0 C--N 1.308 -1.196 0 O-C-N 120.567 -1.333 . . . . 0.0 108.773 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -75.1 -49.34 19.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.594 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 48' ' ' LEU . 93.0 t -58.26 -62.45 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.591 0.71 . . . . 0.0 109.8 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 38' ' ' CYS . 3.3 p -57.47 -26.56 26.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.262 -0.899 . . . . 0.0 111.627 -178.627 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -91.71 -13.44 31.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.283 -1.511 . . . . 0.0 109.059 179.203 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.6 t -104.59 22.85 14.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.509 -0.744 . . . . 0.0 110.082 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.6 p30 65.08 6.25 3.39 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.463 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.15 8.59 87.14 Favored Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.291 -0.881 . . . . 0.0 110.912 178.629 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.405 ' HB ' ' OD1' ' A' ' 45' ' ' ASN . 9.6 t -79.45 -4.37 50.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.803 -1.41 . . . . 0.0 108.188 178.672 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.698 ' C ' HG23 ' A' ' 49' ' ' THR . 1.7 tp -79.95 -80.29 0.13 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.698 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 70.92 169.07 0.32 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.646 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.14 173.33 7.16 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.425 -0.797 . . . . 0.0 110.486 -178.143 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.667 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.73 -36.38 7.07 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.714 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -162.54 165.58 25.86 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.456 0.646 . . . . 0.0 109.383 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.705 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.7 m-85 -75.61 -164.5 0.35 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.595 -0.691 . . . . 0.0 109.184 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 59.06 -168.99 6.16 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.4 143.2 26.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -1.02 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.557 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 32.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.693 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.18 0.514 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.13 143.29 55.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 7.3 m -139.32 61.37 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -90.83 -1.24 57.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.4 41.59 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.427 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.913 ' CB ' HG11 ' A' ' 42' ' ' VAL . 70.8 m-85 -122.83 161.35 44.73 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.247 -0.908 . . . . 0.0 108.934 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.15 -179.77 28.24 Favored 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.698 -1.793 . . . . 0.0 111.41 1.852 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 tttp -123.04 141.34 35.48 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.0 Cg_endo -77.18 13.99 1.43 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.656 2.238 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 170.5 144.37 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 34.6 t -124.08 159.47 29.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.4 p -59.37 -157.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.55 -11.06 8.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.731 -1.231 . . . . 0.0 109.685 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.3 pt-20 -56.6 124.86 19.75 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.896 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 19.3 t80 -86.04 132.41 34.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.323 1.059 . . . . 0.0 111.537 -177.532 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.73 80.32 2.26 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.769 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.6 Cg_endo -65.42 122.0 9.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.668 2.245 . . . . 0.0 112.415 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mt -107.18 128.4 54.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.748 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -79.06 102.28 8.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.384 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.27 -170.89 0.12 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 118.579 -1.772 . . . . 0.0 109.113 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.9 t -74.32 -45.0 50.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.008 -1.289 . . . . 0.0 109.306 179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -54.99 -16.39 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.817 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER 92.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.375 0.607 . . . . 0.0 109.73 179.754 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -99.41 127.89 45.48 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -69.61 152.79 44.33 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 8.2 m-85 -126.54 125.2 41.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -28.89 -50.5 0.1 Allowed Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -176.851 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -163.04 -159.94 0.58 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.704 -1.468 . . . . 0.0 110.317 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.797 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.05 -46.12 79.02 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.307 -0.871 . . . . 0.0 112.213 -177.413 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 5.3 m -66.23 -52.61 46.17 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.477 -1.389 . . . . 0.0 110.17 -178.675 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.0 m-80 -56.42 -23.43 38.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.685 -1.259 . . . . 0.0 110.395 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CB ' HD12 ' A' ' 23' ' ' LEU . 16.6 t80 -82.72 -54.59 5.01 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.037 1.399 . . . . 0.0 110.007 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.661 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 1.1 m -55.55 -35.99 66.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.324 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 3.5 m-20 -57.48 -36.51 71.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.588 -1.32 . . . . 0.0 108.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.662 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.0 -28.67 66.81 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG13 ' HA2' ' A' ' 46' ' ' GLY . 79.4 t -72.97 -62.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.512 -0.742 . . . . 0.0 109.119 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.913 HG11 ' CB ' ' A' ' 11' ' ' TYR . 4.4 p -59.58 -15.15 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 111.299 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.662 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.93 -30.72 15.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.573 -1.329 . . . . 0.0 108.659 179.308 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.1 t -93.22 22.38 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.678 -0.638 . . . . 0.0 110.31 -179.187 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 17.4 m-80 65.62 8.85 5.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.175 -0.953 . . . . 0.0 109.802 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.33 17.82 63.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.335 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 p -95.74 5.79 50.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 108.734 179.2 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.3 tp -79.49 -78.28 0.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.668 0.747 . . . . 0.0 109.394 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.9 p 68.12 153.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.669 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -110.63 179.64 4.01 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.525 -0.734 . . . . 0.0 111.223 -177.733 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.669 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -109.06 -32.4 7.25 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.783 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.748 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.3 p80 -170.56 159.51 6.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.401 0.619 . . . . 0.0 109.626 -178.985 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 33.6 m-85 -70.55 -169.17 0.3 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 63.11 -169.29 17.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 138.83 31.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.131 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.499 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 HD22 ' A' ' 23' ' ' LEU . 12.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 6' ' ' VAL . 17.9 t70 -59.62 148.1 34.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 108.857 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 10.1 t -158.03 24.09 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.944 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.6 0.23 57.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.396 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 11.5 mp0 -122.37 43.18 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.917 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.7 m-85 -139.02 158.77 69.06 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.07 -1.019 . . . . 0.0 108.571 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.04 159.68 95.04 Favored 'Cis proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.096 3.187 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 5.0 tttm -110.42 145.9 33.18 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.3 14.09 1.66 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.536 2.157 . . . . 0.0 110.731 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.69 124.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 156.08 27.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.745 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -72.66 -172.05 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.894 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -115.27 -20.01 10.53 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.101 -0.999 . . . . 0.0 110.19 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.667 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -57.87 123.17 14.85 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.855 -1.153 . . . . 0.0 108.758 179.324 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.6 t80 -83.96 124.83 31.43 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.248 1.023 . . . . 0.0 109.818 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.2 mtp180 -161.11 87.33 1.68 Allowed Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -65.46 120.54 7.75 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.147 1.898 . . . . 0.0 112.225 -177.612 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -112.15 139.83 47.35 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.482 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.589 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -104.24 124.07 48.48 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.964 -178.307 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -69.34 -171.81 8.22 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 30.6 t -82.84 -17.69 43.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.696 -1.473 . . . . 0.0 108.045 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -76.68 -8.03 56.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.549 -0.72 . . . . 0.0 109.321 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.6 t30 81.75 36.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 9.6 tttt -111.99 138.83 48.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.814 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -88.73 145.14 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.917 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.803 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 66.8 m-85 -121.35 124.29 44.2 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.446 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.17 -52.63 0.71 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -177.678 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.4 p30 -152.63 -163.79 1.8 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.138 -1.213 . . . . 0.0 110.052 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 ptmt -58.27 -68.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 111.297 -178.217 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.8 p -41.28 -45.43 2.95 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.875 -1.141 . . . . 0.0 110.694 -178.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -63.61 -40.59 97.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.549 -1.345 . . . . 0.0 109.871 179.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 20.5 t80 -65.35 -60.15 3.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.194 -0.941 . . . . 0.0 110.941 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.703 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -55.05 -41.57 71.6 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.893 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.625 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.4 m-20 -49.42 -37.41 25.45 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.425 -1.422 . . . . 0.0 107.971 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.66 -32.25 65.69 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.756 HG13 ' HA2' ' A' ' 46' ' ' GLY . 88.1 t -70.62 -67.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.296 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 38' ' ' CYS . 7.3 p -54.05 -17.61 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.705 -0.622 . . . . 0.0 111.551 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.659 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.75 -31.07 15.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.183 -1.573 . . . . 0.0 107.763 178.346 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 10.7 t -88.28 -1.29 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.829 -0.544 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.942 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER 84.44 4.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.362 -179.513 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.756 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 91.12 8.94 64.18 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.942 HG23 ' OD1' ' A' ' 45' ' ' ASN . 18.0 p -85.03 1.1 49.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.915 -1.344 . . . . 0.0 108.868 178.518 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -78.82 -50.61 10.99 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.923 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 73.9 p 45.84 121.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.282 1.039 . . . . 0.0 112.574 178.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -82.38 159.4 23.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.513 0.673 . . . . 0.0 109.218 178.901 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.68 -26.39 10.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.552 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.589 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -164.2 160.21 21.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.573 0.701 . . . . 0.0 109.682 -178.639 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.96 -170.11 1.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.47 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.67 -171.67 20.72 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -90.75 166.58 13.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 108.774 179.3 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.0 m . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.667 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.6 128.37 34.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.998 . . . . 0.0 109.504 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 m -138.0 45.89 2.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 8.43 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.893 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 21.9 mp0 -118.08 3.39 12.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 109.833 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.922 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.2 m-85 -85.34 160.4 54.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.202 -0.936 . . . . 0.0 109.421 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -73.91 156.43 99.69 Favored 'Cis proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.775 -1.76 . . . . 0.0 111.939 2.042 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -100.34 142.75 25.21 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -79.49 14.85 1.71 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.588 2.192 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.3 133.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 108.994 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.7 m -99.44 149.42 23.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 0.0 109.922 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -49.19 -24.28 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.291 1.043 . . . . 0.0 110.037 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 76.22 2.21 3.52 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.239 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.539 ' HG2' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -78.03 -164.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.779 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 5.2 t80 -130.69 126.46 36.58 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.098 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 45.0 mtm180 -159.88 77.02 2.85 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -64.28 120.3 7.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.44 2.093 . . . . 0.0 112.552 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.38 127.44 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.106 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.5 t -79.78 126.57 31.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 109.75 -179.37 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.36 169.99 54.96 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 t -64.88 -35.27 80.59 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.133 -1.216 . . . . 0.0 109.916 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -76.53 4.52 9.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.4 t30 80.33 41.41 0.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.0 110.36 179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.8 109.64 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.39 1.09 . . . . 0.0 109.495 179.38 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -63.72 144.24 57.19 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.006 -1.059 . . . . 0.0 108.221 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.873 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.245 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -49.7 -45.42 39.11 Favored Glycine 0 N--CA 1.486 1.977 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.066 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.2 p-10 -159.04 -164.4 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.011 -1.288 . . . . 0.0 110.329 -179.567 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.2 -26.36 62.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 110.397 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 29.0 t -69.15 -63.36 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.968 -1.083 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 37.1 m-80 -59.53 -39.44 83.91 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.439 -0.788 . . . . 0.0 110.201 -179.328 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 61.3 t80 -60.38 -47.21 87.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.621 -1.3 . . . . 0.0 108.752 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.5 m -64.08 -28.54 69.85 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.356 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.5 m-20 -67.08 -32.6 73.88 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.873 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -80.26 -22.86 41.25 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.072 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 39.9 t -77.67 -33.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.651 -0.656 . . . . 0.0 109.265 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.922 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -90.98 -17.57 7.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.237 -0.914 . . . . 0.0 109.768 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.0 tt0 -91.9 -11.92 34.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.068 -1.02 . . . . 0.0 109.104 179.629 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.1 t -109.49 26.06 11.08 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.249 -0.907 . . . . 0.0 110.223 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 30.5 m-20 62.14 35.89 15.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.144 -0.972 . . . . 0.0 108.734 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 49.33 25.06 5.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.2 p -88.18 -14.56 38.32 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -1.092 . . . . 0.0 108.688 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 49' ' ' THR . 1.1 tp -80.3 133.24 35.94 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.9 p -135.08 123.5 23.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 108.997 178.666 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -64.42 165.29 10.01 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.429 -0.794 . . . . 0.0 109.644 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.01 -22.77 10.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.718 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -174.2 152.41 1.83 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.537 -0.727 . . . . 0.0 109.548 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.07 170.77 6.37 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.354 -0.841 . . . . 0.0 108.871 178.868 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.06 -170.82 47.83 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.39 134.28 35.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.097 -1.237 . . . . 0.0 108.272 178.619 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.005 -1.06 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 37' ' ' PHE . 14.2 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.229 0.537 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.53 141.33 29.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 7.1 m -142.87 65.61 1.34 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -90.37 14.94 11.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.068 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 4.9 pm0 -122.17 -10.35 8.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.979 -1.075 . . . . 0.0 109.723 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 1.055 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.6 m-85 -80.37 158.94 71.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -73.98 178.8 31.85 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.74 -1.775 . . . . 0.0 111.437 3.071 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.19 145.92 57.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.636 -0.665 . . . . 0.0 109.461 -179.001 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.4 Cg_endo -79.27 14.14 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.436 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.47 115.95 0.25 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.1 m -81.09 158.24 25.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 110.174 -179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -50.06 -25.36 3.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.396 1.093 . . . . 0.0 109.778 -179.777 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER 74.57 -12.14 0.95 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.453 179.192 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -75.33 -167.94 0.72 Allowed 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.466 -1.396 . . . . 0.0 107.855 178.761 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.1 t80 -123.28 122.19 37.74 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.274 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -155.22 77.36 4.94 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.754 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -65.35 112.42 2.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.164 1.91 . . . . 0.0 112.033 -177.241 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.891 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -108.86 122.02 46.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.758 179.655 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.813 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 1.3 m -79.41 103.36 9.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 108.633 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.21 -174.55 0.08 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -178.18 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.3 t -72.67 -33.4 66.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -1.202 . . . . 0.0 108.876 178.771 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -66.27 -12.34 55.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.42 -0.8 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 88.66 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.803 -0.561 . . . . 0.0 110.161 179.715 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 ttpt -100.6 143.87 30.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 108.956 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 33.9 m -87.59 128.59 35.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.018 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -103.8 118.46 36.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.345 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.17 -44.95 0.11 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.972 -0.455 . . . . 0.0 112.476 -176.856 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 32.2 p-10 -156.12 -161.8 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.702 -1.47 . . . . 0.0 109.472 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.863 ' HA ' HD11 ' A' ' 23' ' ' LEU . 9.6 pttt -70.59 -28.38 64.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.398 -0.814 . . . . 0.0 110.377 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.515 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 16.8 t -69.52 -59.86 2.7 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.86 -1.15 . . . . 0.0 109.051 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -52.88 -40.9 63.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.621 -0.674 . . . . 0.0 109.811 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CB ' HD12 ' A' ' 23' ' ' LEU . 35.7 t80 -64.17 -50.1 69.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.658 1.218 . . . . 0.0 109.225 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -59.37 -26.05 64.76 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.009 -178.937 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -69.13 -35.51 76.47 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.202 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.15 -23.51 59.27 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.208 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' GLY . 55.1 t -80.36 -35.58 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.651 -0.656 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.055 HG21 ' O ' ' A' ' 11' ' ' TYR . 5.5 p -88.56 -13.24 9.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.74 -33.83 14.86 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.005 -1.06 . . . . 0.0 108.148 178.54 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.96 7.44 24.33 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.567 -0.708 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.0 t-20 77.02 6.56 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.117 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 88.84 10.46 66.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -90.88 7.8 38.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.119 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 ' CE1' ' A' ' 37' ' ' PHE . 3.3 tp -79.42 -73.16 0.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.308 -0.87 . . . . 0.0 109.136 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.0 p 64.71 142.66 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.803 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.68 172.66 6.68 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 122.125 0.964 . . . . 0.0 111.522 -177.876 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.571 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -97.59 -46.63 5.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.028 0.918 . . . . 0.0 108.591 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.813 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 15.8 p-80 -154.82 157.32 37.73 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.646 0.736 . . . . 0.0 110.507 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -77.84 175.49 9.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.53 -171.82 52.89 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -90.39 158.75 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.293 . . . . 0.0 109.619 179.294 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 57.5 m . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.956 -178.078 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.26 116.58 23.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.9 m -119.46 60.1 0.84 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.356 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -90.97 -17.23 26.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.44 31.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.099 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.77 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.3 m-85 -117.81 162.2 30.35 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.4 Cg_endo -85.91 163.85 56.08 Favored 'Cis proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.213 -1.578 . . . . 0.0 110.581 1.947 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -122.91 140.61 33.7 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.658 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.66 13.36 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.462 2.108 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.36 116.4 4.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' THR . 76.8 m -92.77 138.18 31.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.839 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.7 p -52.51 -175.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -114.21 -26.88 7.84 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.041 -1.037 . . . . 0.0 109.636 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.519 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.0 pm0 -48.68 162.97 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.588 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.5 t80 -113.95 131.49 56.29 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.209 1.004 . . . . 0.0 110.935 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.0 mtp180 -161.21 84.84 1.79 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.445 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -67.94 113.27 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.088 1.859 . . . . 0.0 111.586 -177.878 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -107.84 126.53 52.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.513 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 49.0 t -79.29 164.42 24.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.016 . . . . 0.0 108.761 -179.568 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -136.25 168.03 24.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -178.572 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 48' ' ' LEU . 30.5 t -66.21 -23.27 66.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -1.02 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -61.08 -13.75 19.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 109.121 179.282 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.7 m-20 86.77 22.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.862 -0.524 . . . . 0.0 110.089 179.625 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -126.53 171.88 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.512 179.406 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 31' ' ' TYR . 28.7 m -104.94 163.69 12.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.966 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 65.1 m-85 -126.12 118.86 26.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.357 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.27 -52.58 0.41 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.655 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.2 p-10 -154.31 -167.96 2.79 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.78 -1.423 . . . . 0.0 109.909 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.56 -36.1 71.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.621 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.9 -61.57 2.49 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 109.72 -179.329 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -56.05 -41.99 75.88 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 23' ' ' LEU . 74.3 t80 -61.92 -43.85 97.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.768 -1.207 . . . . 0.0 109.607 -179.514 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 88.4 m -69.49 -24.19 63.74 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.139 -179.697 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.519 ' HA ' HG22 ' A' ' 42' ' ' VAL . 32.8 m-20 -74.93 -26.14 59.41 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.178 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.966 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.19 -33.53 50.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.655 ' CG2' HD23 ' A' ' 48' ' ' LEU . 42.2 t -69.02 -48.45 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -64.16 -31.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.572 -0.705 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.79 -8.33 43.97 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 109.521 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 46.6 t -111.52 14.03 21.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.104 -0.997 . . . . 0.0 110.958 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 47' ' ' THR . 6.1 m-20 53.15 48.57 21.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.842 -1.162 . . . . 0.0 109.399 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 45.52 35.06 5.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' ASN . 30.2 p -110.86 5.5 20.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -1.072 . . . . 0.0 108.391 178.229 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.665 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.7 -51.76 6.99 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.993 0.901 . . . . 0.0 109.143 -179.931 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.665 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 77.5 p 56.24 124.39 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.281 1.038 . . . . 0.0 110.48 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 5.8 tp -62.05 129.6 41.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.101 179.798 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 10.9 t -79.47 -21.91 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.865 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 51' ' ' SER . 17.6 p-80 156.23 154.63 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.787 179.416 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -63.48 165.48 7.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.089 . . . . 0.0 108.663 179.398 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.08 -168.76 45.28 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -178.976 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.01 161.68 14.35 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.891 -1.359 . . . . 0.0 108.074 178.052 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 7.8 m . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.767 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -88.15 145.89 25.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.207 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 35.9 m -134.41 70.69 1.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.275 -0.891 . . . . 0.0 110.009 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -19.46 23.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.867 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 32.77 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.854 ' CB ' HG11 ' A' ' 42' ' ' VAL . 60.6 m-85 -113.34 164.82 14.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.856 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.6 Cg_endo -84.91 152.31 58.0 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.433 -1.486 . . . . 0.0 111.274 2.073 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.5 mtpm? -112.34 138.25 21.83 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.7 Cg_endo -80.39 14.78 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.728 2.285 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.19 160.51 21.36 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.112 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -147.5 159.84 43.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 110.002 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.57 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -117.18 -23.29 7.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.775 -1.203 . . . . 0.0 110.02 179.965 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -45.5 115.94 1.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.519 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.8 t80 -79.19 127.24 31.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.466 1.127 . . . . 0.0 111.354 -177.697 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 ptm180 -161.65 78.05 2.18 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.15 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.0 Cg_endo -66.16 128.14 18.94 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 123.208 2.605 . . . . 0.0 113.069 -177.135 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.607 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -112.34 130.34 55.99 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.606 178.402 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.688 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 48.1 t -83.56 122.75 28.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -68.53 -165.95 3.84 Favored Glycine 0 C--N 1.296 -1.665 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 49' ' ' THR . 7.1 t -89.2 -36.99 15.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.238 . . . . 0.0 107.972 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.624 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.4 p-10 -58.61 -17.37 21.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.532 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 97.17 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.128 0.49 . . . . 0.0 110.01 179.486 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.75 119.85 38.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.217 179.592 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.2 m -69.9 152.85 44.03 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.412 -0.805 . . . . 0.0 109.171 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 19.4 m-85 -132.7 124.43 28.17 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.793 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.78 -51.96 0.07 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -163.63 -162.32 0.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -1.232 . . . . 0.0 110.289 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.51 -40.76 60.22 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 112.6 -177.408 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -69.12 -65.15 0.74 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.209 -1.557 . . . . 0.0 108.911 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.7 m-80 -42.93 -30.5 0.41 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 27.5 t80 -74.85 -48.25 26.01 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.897 1.332 . . . . 0.0 109.406 179.545 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 87.4 m -55.92 -53.67 53.97 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.735 -178.828 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -42.23 -26.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.951 -1.093 . . . . 0.0 108.931 -179.475 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.97 -47.75 17.83 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.592 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.683 ' CG2' HD23 ' A' ' 48' ' ' LEU . 61.6 t -60.5 -28.12 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.715 -0.616 . . . . 0.0 110.422 179.507 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.2 m -90.93 -26.28 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.88 -1.137 . . . . 0.0 109.897 -179.033 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.3 tt0 -90.47 0.77 57.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.406 -0.808 . . . . 0.0 108.868 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.496 ' O ' ' OG ' ' A' ' 44' ' ' SER . 1.4 t -119.18 22.47 11.82 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 1.0 ' O ' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 64.11 46.47 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.905 1.336 . . . . 0.0 108.082 179.951 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 32.31 37.33 0.04 OUTLIER Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.513 -0.742 . . . . 0.0 111.874 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' THR . . . . . 1.0 HG23 ' O ' ' A' ' 45' ' ' ASN . 43.2 p -111.01 0.45 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.265 . . . . 0.0 108.231 177.868 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.683 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.36 152.92 30.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.759 0.79 . . . . 0.0 109.016 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' CB ' ' A' ' 26' ' ' SER . 41.2 p -141.45 149.89 41.56 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.926 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.22 175.96 6.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.713 -1.242 . . . . 0.0 109.214 -179.544 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.5 -23.04 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.756 -1.215 . . . . 0.0 108.607 -179.439 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.688 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 2.0 p-80 177.14 155.03 0.27 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -62.04 -168.0 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.561 -0.712 . . . . 0.0 109.133 178.87 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.6 -167.45 6.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.49 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 175.68 6.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -1.073 . . . . 0.0 108.471 178.571 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.568 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.611 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 78.1 m -137.3 47.98 2.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.309 179.81 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.443 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 64.6 p -86.96 -30.21 21.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.443 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 12.0 mm-40 -73.19 -8.92 57.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.744 ' HB3' HG11 ' A' ' 42' ' ' VAL . 80.3 m-85 -79.97 161.44 65.87 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.416 -0.802 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.845 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -84.51 143.36 40.08 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 123.156 -1.602 . . . . 0.0 110.846 1.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.0 mtpt -116.09 137.85 23.72 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.484 -0.76 . . . . 0.0 109.369 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -80.49 14.08 2.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.349 2.033 . . . . 0.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.14 126.74 15.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 60.2 m -112.78 138.75 49.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.78 -179.548 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -56.9 -170.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.734 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.14 -25.48 9.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.099 -1.001 . . . . 0.0 109.603 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.8 mt-10 -41.47 122.51 1.93 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.349 -0.844 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.482 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 15.6 t80 -83.14 107.37 15.66 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.432 1.11 . . . . 0.0 110.357 -179.007 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -141.27 77.7 19.75 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.197 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.7 Cg_endo -64.25 115.24 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.228 1.952 . . . . 0.0 111.688 -177.933 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.76 135.7 53.89 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.539 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.81 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 47.4 t -89.99 160.47 16.36 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.536 -179.67 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -133.2 161.21 24.14 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.515 -177.659 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t -45.36 -21.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.817 -0.813 . . . . 0.0 111.177 -178.176 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' CD1' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -86.14 25.23 1.19 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.094 -179.654 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 m120 49.48 20.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.63 141.23 36.79 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.008 -1.058 . . . . 0.0 109.999 -179.84 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 31' ' ' TYR . 82.2 m -86.87 157.54 19.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.427 -0.796 . . . . 0.0 108.932 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 82.1 m-85 -135.74 99.49 4.2 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.31 -59.28 0.02 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -178.166 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p-10 -137.77 -170.27 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.739 -1.448 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -54.22 -35.37 62.34 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.9 -0.5 . . . . 0.0 110.743 -178.639 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.7 t -64.57 -67.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.902 -1.124 . . . . 0.0 109.569 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.6 m-80 -44.84 -30.27 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.82 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 24.1 t80 -71.79 -54.31 10.58 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.535 1.16 . . . . 0.0 109.78 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 72.7 m -54.59 -58.9 5.69 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.109 -179.684 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.1 m-20 -42.68 -27.78 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.878 -1.139 . . . . 0.0 109.394 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -73.57 -48.1 35.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.862 HG22 ' CD2' ' A' ' 48' ' ' LEU . 66.9 t -60.69 -54.11 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.378 0.609 . . . . 0.0 109.57 179.347 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 12' ' ' PRO . 10.2 m -56.3 -31.31 32.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.237 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -92.2 -12.31 33.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.915 -1.116 . . . . 0.0 109.638 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.598 ' O ' HG22 ' A' ' 47' ' ' THR . 17.6 t -98.06 8.19 45.15 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.101 -0.999 . . . . 0.0 110.309 -179.089 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t-20 75.33 12.12 3.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.984 -1.073 . . . . 0.0 108.484 -179.24 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.619 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 67.29 8.39 50.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 44' ' ' SER . 6.3 t -86.45 5.51 34.82 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.203 -1.175 . . . . 0.0 108.469 178.615 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.862 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.94 -71.81 0.56 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.993 0.901 . . . . 0.0 108.888 -179.666 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.6 p 81.69 152.11 0.1 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.965 0.888 . . . . 0.0 109.081 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 52' ' ' HIS . 11.5 tp -67.69 156.76 36.17 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.3 p -106.28 -40.85 5.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.81 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -178.71 168.5 1.71 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.132 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -81.61 166.21 20.4 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.262 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 82.84 -175.11 53.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.96 156.49 19.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.949 -1.324 . . . . 0.0 109.132 179.081 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 034 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -92.35 128.87 38.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.136 179.712 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.1 m -123.05 63.56 0.99 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 109.831 -179.674 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.2 t -90.68 -19.5 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.325 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.9 mm-40 -97.46 26.3 5.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.092 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.844 ' CB ' HG11 ' A' ' 42' ' ' VAL . 68.9 m-85 -114.71 161.99 26.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.548 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.7 Cg_endo -85.84 156.03 56.88 Favored 'Cis proline' 0 C--N 1.305 -1.752 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.698 1.605 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 20.3 mtpt -118.31 140.15 27.74 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.869 . . . . 0.0 109.192 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.86 14.33 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.658 2.239 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.99 119.88 5.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.741 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -101.07 139.37 36.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.275 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.454 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -63.61 -172.07 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.422 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.926 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.36 -14.31 11.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.887 -1.133 . . . . 0.0 110.379 -179.461 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 3.0 pm0 -49.35 120.96 4.47 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.379 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -79.57 126.62 31.12 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.45 1.119 . . . . 0.0 110.902 -178.273 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.81 80.05 1.99 Allowed Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.408 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.72 119.54 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.286 1.991 . . . . 0.0 112.135 -177.366 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -110.79 123.13 49.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.151 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.1 t -79.26 127.65 32.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 0.0 109.101 -179.193 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -74.3 -173.31 29.28 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 5.2 t -76.14 -33.47 59.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.695 -1.474 . . . . 0.0 108.902 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.593 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -62.08 -12.18 17.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 109.653 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 59.3 t30 92.23 20.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.956 -0.465 . . . . 0.0 111.041 179.229 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.516 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.68 175.03 5.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.799 -1.188 . . . . 0.0 108.017 178.235 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -119.89 148.16 43.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 109.887 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 46.2 m-85 -120.67 120.72 36.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.819 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -30.27 -51.24 0.19 Allowed Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -177.768 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -153.04 -166.4 2.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.738 -1.448 . . . . 0.0 110.252 179.737 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.629 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -66.7 -22.54 66.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.569 -0.707 . . . . 0.0 111.323 -178.32 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 49.2 t -74.1 -50.55 19.0 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.612 -1.305 . . . . 0.0 108.859 179.578 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -62.9 -38.47 91.09 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 48' ' ' LEU . 48.4 t80 -68.87 -47.8 65.02 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.37 1.081 . . . . 0.0 109.635 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 29.2 m -62.23 -29.34 70.32 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.908 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.554 ' HA ' HG22 ' A' ' 42' ' ' VAL . 19.9 m-20 -71.67 -23.61 61.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.077 -1.015 . . . . 0.0 108.638 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.78 -22.82 27.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.472 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.2 -26.68 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.272 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.8 m -86.49 -31.0 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.443 -0.786 . . . . 0.0 109.294 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.92 -15.4 28.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' THR . 27.9 t -96.97 9.63 41.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.957 . . . . 0.0 110.299 -179.385 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.3 m120 62.59 28.31 16.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.155 -0.965 . . . . 0.0 109.355 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.85 63.83 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 44' ' ' SER . 5.3 p -96.28 5.76 50.26 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -1.098 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.743 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -83.82 -63.82 1.28 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.437 -0.789 . . . . 0.0 109.042 -179.712 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 65.5 p 56.27 124.72 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.96 0.886 . . . . 0.0 110.446 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -85.83 172.08 11.04 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.524 0.678 . . . . 0.0 110.733 -178.709 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.647 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.04 -28.72 9.38 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -174.44 162.7 3.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.766 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 m-85 -71.45 -170.77 0.54 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.51 -174.01 8.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.701 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -85.6 164.82 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -1.103 . . . . 0.0 108.868 179.396 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 3.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.393 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 7' ' ' ASP . 51.8 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.218 0.533 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -76.72 172.89 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.185 179.952 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.4 t -161.15 26.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -90.56 -0.21 57.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.93 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -119.58 38.55 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 110.267 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.3 m-85 -139.83 154.17 70.56 Favored Pre-proline 0 C--N 1.305 -1.334 0 O-C-N 121.057 -1.027 . . . . 0.0 108.369 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -72.13 149.07 92.47 Favored 'Cis proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.597 -1.835 . . . . 0.0 111.622 2.931 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -110.6 148.03 37.65 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.981 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.5 Cg_endo -77.44 13.32 1.63 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.509 2.139 . . . . 0.0 110.968 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 115.26 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.2 m -88.69 149.66 23.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 109.749 -179.612 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -47.92 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.393 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.95 -23.21 9.2 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.869 -1.145 . . . . 0.0 110.228 -179.521 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pm0 -59.18 -168.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.885 -1.134 . . . . 0.0 108.134 179.358 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 20.0 t80 -127.55 129.1 46.75 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.32 81.61 2.0 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.262 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -66.4 111.33 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.177 1.918 . . . . 0.0 111.27 -178.268 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -105.95 136.78 45.0 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.266 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.768 ' CB ' ' HE1' ' A' ' 52' ' ' HIS . 12.1 t -98.22 159.04 15.2 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.251 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.564 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -116.53 174.06 15.04 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.441 -177.895 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.525 ' H ' HD12 ' A' ' 48' ' ' LEU . 15.1 t -70.33 -13.47 62.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.45 -1.029 . . . . 0.0 108.547 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.7 p-10 -81.92 -8.99 59.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.41 -0.806 . . . . 0.0 109.318 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.6 t-20 82.74 34.78 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.649 -0.657 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 tttp -123.2 147.3 47.02 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.15 -0.969 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 31' ' ' TYR . 78.0 m -93.35 162.18 14.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.071 -1.018 . . . . 0.0 109.898 -179.87 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.6 m-85 -138.18 108.22 6.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.69 -57.44 0.12 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -177.252 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.1 p30 -141.66 -169.88 2.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.817 -1.402 . . . . 0.0 110.535 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.0 ptmt -54.7 -47.06 74.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.794 -0.566 . . . . 0.0 110.708 -178.514 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.7 t -53.79 -52.69 59.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.802 -1.187 . . . . 0.0 109.541 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.1 m-80 -61.64 -29.39 70.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.549 -0.72 . . . . 0.0 110.547 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.931 ' CE1' HD21 ' A' ' 48' ' ' LEU . 11.5 t80 -73.86 -62.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.76 -1.212 . . . . 0.0 110.813 -179.167 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.2 -48.75 73.39 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.81 -0.556 . . . . 0.0 109.523 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.6 m-80 -41.88 -31.13 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.179 . . . . 0.0 108.321 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -72.99 -49.08 31.08 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.569 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.575 ' N ' HD23 ' A' ' 48' ' ' LEU . 71.4 t -55.78 -59.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.401 0.62 . . . . 0.0 110.373 179.207 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.3 p -60.62 -23.97 30.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.204 -0.935 . . . . 0.0 110.599 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.8 tm-20 -89.35 -15.39 33.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.611 -1.306 . . . . 0.0 107.994 178.276 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -105.6 0.27 26.34 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.666 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 60.64 22.85 12.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 0.0 109.447 -179.136 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.45 16.11 57.55 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.666 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 44' ' ' SER . 74.1 p -85.52 -12.04 52.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.26 . . . . 0.0 108.268 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -78.41 -52.13 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.713 0.768 . . . . 0.0 109.177 -179.967 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.666 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 20.9 p 55.17 123.73 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.312 1.053 . . . . 0.0 109.839 -178.045 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 24' ' ' CYS . 24.8 tp -56.45 160.22 3.26 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.537 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -115.91 -41.57 3.18 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.54 1.162 . . . . 0.0 107.928 179.545 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.768 ' HE1' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.04 159.64 1.34 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.726 -179.568 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.84 133.8 36.99 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.408 178.792 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 112.91 -172.13 14.33 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.43 134.36 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.042 -1.269 . . . . 0.0 109.295 179.211 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.612 HG21 HD22 ' A' ' 23' ' ' LEU . 99.1 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.202 0.525 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.42 148.23 49.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.46 30.38 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -13.85 43.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.651 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.49 -2.19 25.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' HG11 ' A' ' 42' ' ' VAL . 54.5 m-85 -93.56 163.37 24.71 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.925 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.27 157.7 74.04 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.247 -1.564 . . . . 0.0 110.989 2.114 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -107.61 142.54 25.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.627 -179.735 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.7 Cg_endo -79.75 15.27 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.753 2.302 . . . . 0.0 110.861 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.35 137.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.478 -0.763 . . . . 0.0 109.025 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 17' ' ' THR . 49.0 t -109.86 157.57 19.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.065 -1.022 . . . . 0.0 110.842 -179.258 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -64.19 -157.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.058 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -116.69 -8.26 11.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.269 -1.519 . . . . 0.0 110.856 -179.708 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.62 136.32 17.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.585 -1.322 . . . . 0.0 107.811 179.276 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.0 t80 -98.29 130.2 44.98 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 122.282 1.039 . . . . 0.0 110.618 -178.602 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.86 77.58 2.46 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.536 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -62.59 121.35 9.27 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.741 2.294 . . . . 0.0 112.55 -177.084 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD22 HG21 ' A' ' 6' ' ' VAL . 1.2 mp -110.03 133.88 52.73 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.563 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -80.31 111.07 16.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.59 -169.04 3.28 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.665 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -80.85 -32.38 35.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.839 -1.389 . . . . 0.0 108.812 178.895 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -65.23 -8.15 16.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.836 . . . . 0.0 109.616 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 46.1 t30 86.05 16.37 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.695 -0.628 . . . . 0.0 110.489 179.033 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HG2' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -109.41 119.98 41.1 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.5 178.856 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 31' ' ' TYR . 27.0 m -58.64 161.93 4.3 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.494 0.664 . . . . 0.0 109.771 -179.354 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -130.54 133.36 46.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.772 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.611 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.3 -50.3 0.25 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -177.313 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.6 p30 -165.31 -164.02 0.72 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.921 -1.34 . . . . 0.0 110.75 178.896 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 pttt -52.82 -40.31 63.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.688 -0.633 . . . . 0.0 111.676 -177.674 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -72.69 -50.86 22.1 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.628 -1.295 . . . . 0.0 110.173 -178.427 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.1 m-80 -61.65 -18.58 60.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.713 -1.242 . . . . 0.0 108.931 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 9.4 t80 -80.74 -60.85 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.303 1.049 . . . . 0.0 109.636 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 46.8 t -57.78 -49.65 75.89 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.321 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' C ' ' O ' ' A' ' 38' ' ' CYS . 8.0 m-20 -42.17 -28.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.721 -1.237 . . . . 0.0 108.343 179.357 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.32 -49.65 22.05 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.673 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.639 HG22 HD23 ' A' ' 48' ' ' LEU . 97.2 t -55.53 -56.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 178.796 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.925 HG21 ' HB3' ' A' ' 12' ' ' PRO . 19.4 m -58.21 -29.67 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -0.974 . . . . 0.0 110.27 -179.544 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.0 tt0 -90.78 -10.46 42.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.01 -1.056 . . . . 0.0 109.426 -179.616 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -105.86 16.14 25.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -179.559 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 44' ' ' SER . 10.5 m120 63.16 16.21 9.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.016 -1.053 . . . . 0.0 109.644 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.44 21.94 79.19 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -96.2 6.55 48.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 107.99 178.155 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 41' ' ' VAL . 5.3 tp -87.78 -76.19 0.39 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.547 0.689 . . . . 0.0 109.841 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.1 p 66.22 152.86 0.07 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -178.586 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.87 173.14 6.45 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.635 -0.666 . . . . 0.0 110.198 -178.056 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.682 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.93 -33.53 7.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.659 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -167.27 163.32 15.32 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.533 0.682 . . . . 0.0 109.667 -178.798 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -76.03 -177.72 4.05 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.524 -0.735 . . . . 0.0 109.359 179.15 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.38 -170.48 52.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.11 125.86 36.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -1.082 . . . . 0.0 109.609 179.326 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.645 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.454 179.775 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 HD22 ' A' ' 23' ' ' LEU . 17.2 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.15 98.28 7.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.957 -179.747 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 34.6 m -93.08 65.55 4.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 108.939 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -88.98 -10.11 48.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.122 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mp0 -116.04 36.98 3.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' HB3' HG11 ' A' ' 42' ' ' VAL . 87.1 m-85 -117.87 160.95 36.69 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.644 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.965 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -83.63 159.66 72.3 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.964 -1.682 . . . . 0.0 110.819 2.364 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLU . 17.0 mtpp -131.35 137.84 31.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.391 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -80.66 14.04 2.13 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.492 2.128 . . . . 0.0 110.687 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.1 115.32 10.35 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.72 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.9 m -98.84 139.57 34.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 -179.353 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.509 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 36.0 p -47.13 169.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.16 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.862 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -110.12 -1.79 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.775 -1.203 . . . . 0.0 110.365 -179.869 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' OE2' ' CB ' ' A' ' 17' ' ' THR . 3.3 pm0 -76.26 -170.83 1.56 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.584 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.8 t80 -133.57 125.5 28.95 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.889 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 53.8 mtt180 -161.16 80.75 2.1 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.241 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.75 122.65 10.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.5 2.134 . . . . 0.0 112.045 -177.188 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.843 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -108.67 135.58 49.67 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.286 -0.966 . . . . 0.0 108.583 179.17 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.961 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 t -85.21 162.29 19.24 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 -179.298 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.98 161.49 15.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -69.23 -19.16 63.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -1.149 . . . . 0.0 109.109 -179.721 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 29.9 p-10 -78.12 -0.16 27.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.073 179.19 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER 79.62 42.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.508 -0.745 . . . . 0.0 109.752 179.857 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -134.18 139.41 45.82 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.944 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 31' ' ' TYR . 5.5 m -92.23 165.86 12.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.009 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.732 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.9 m-85 -137.83 123.61 19.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.819 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.57 -53.69 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.804 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -157.35 -168.23 2.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.973 -1.31 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -53.15 -37.9 62.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 111.358 -178.29 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 31.7 t -63.0 -61.15 2.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.635 -1.29 . . . . 0.0 109.964 -179.581 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.2 m-80 -55.75 -31.29 62.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.456 -0.777 . . . . 0.0 110.837 -179.017 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 69.6 t80 -73.58 -44.23 57.79 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.818 -1.177 . . . . 0.0 109.682 -179.526 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 63.3 m -66.23 -30.1 70.49 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.43 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.588 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 m-20 -68.42 -24.85 64.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.753 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.44 -26.35 32.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.531 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' GLY . 92.1 t -80.08 -26.48 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.965 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.4 m -90.68 -21.02 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.353 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.753 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.54 -31.59 16.66 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.277 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 96.6 p -88.63 23.16 2.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.541 -0.725 . . . . 0.0 109.744 -179.66 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.2 m120 64.97 11.59 7.18 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.377 -0.827 . . . . 0.0 109.319 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 78.1 22.63 67.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.9 p -93.1 -5.34 50.54 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.322 -1.104 . . . . 0.0 109.093 179.418 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -78.96 157.57 28.14 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.567 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.822 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.9 p -149.0 126.22 11.44 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.281 1.039 . . . . 0.0 110.496 179.714 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 2.2 tp -67.05 150.24 49.49 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.802 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.512 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.15 -22.58 12.32 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.116 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -175.92 163.29 2.72 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.497 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -78.51 178.58 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 178.921 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 75.73 -172.19 54.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.44 131.42 36.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.081 -1.246 . . . . 0.0 109.429 179.127 . . . . . . . . 3 3 . 1 . 037 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.562 179.915 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.582 ' CG2' HD22 ' A' ' 50' ' ' LEU . 90.0 t . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -99.27 153.68 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 109.199 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 t -151.87 17.63 0.68 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.08 -1.012 . . . . 0.0 109.945 -179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -90.8 13.02 17.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.149 -0.969 . . . . 0.0 109.748 179.616 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 1.5 pm0 -130.74 -18.39 3.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.008 -1.057 . . . . 0.0 110.972 -179.237 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 96.4 m-85 -79.76 161.59 65.88 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.933 -1.104 . . . . 0.0 109.175 -179.304 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.7 Cg_endo -69.43 167.43 70.12 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.249 -1.563 . . . . 0.0 112.191 2.698 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -119.66 147.94 44.92 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.68 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -77.99 13.73 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.592 2.195 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.09 128.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.19 159.09 16.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 p -62.8 164.34 8.07 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.241 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 -18.22 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.757 -1.215 . . . . 0.0 109.832 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -51.0 130.76 26.25 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.197 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 7.4 t80 -81.38 126.94 32.22 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.475 1.131 . . . . 0.0 111.446 -177.124 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mmt180 -159.58 75.63 3.1 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.614 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.4 Cg_endo -67.13 144.51 69.5 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.244 2.629 . . . . 0.0 113.288 -176.969 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -129.59 132.68 46.85 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.407 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.672 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.3 t -91.41 161.78 14.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.056 . . . . 0.0 110.319 -178.458 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.45 177.11 18.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.062 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -70.37 -23.57 62.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.985 . . . . 0.0 108.682 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 41.4 p-10 -77.3 -6.99 55.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.082 179.36 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m120 82.27 28.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.677 -0.639 . . . . 0.0 109.911 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -103.07 136.4 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.843 HG21 ' HD3' ' A' ' 55' ' ' LYS . 23.5 m -88.79 137.91 31.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.713 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.9 m-85 -114.87 136.85 52.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.694 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.08 -48.25 3.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -178.606 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.3 p30 -167.4 -158.8 0.29 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.032 -1.275 . . . . 0.0 110.656 178.942 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.5 -45.06 73.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 112.574 -176.566 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 3.6 m -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.491 -1.381 . . . . 0.0 109.704 -178.658 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -53.5 -17.31 1.93 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.682 ' CE1' HD21 ' A' ' 48' ' ' LEU . 4.0 t80 -83.23 -69.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.586 1.184 . . . . 0.0 110.302 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.68 -46.11 77.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.754 -177.792 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.589 ' OD1' ' CD1' ' A' ' 11' ' ' TYR . 3.0 m-20 -44.96 -29.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.46 -1.4 . . . . 0.0 107.592 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.96 -49.26 38.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.259 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.829 ' CG2' HD23 ' A' ' 48' ' ' LEU . 75.4 t -52.49 -62.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.282 0.563 . . . . 0.0 110.198 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.5 p -60.75 -23.63 29.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.434 -0.791 . . . . 0.0 111.097 -178.456 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.9 tt0 -92.03 -11.56 35.6 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.532 -1.355 . . . . 0.0 108.965 179.183 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 44' ' ' SER . 6.1 t -103.79 22.05 15.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.702 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 47' ' ' THR . 7.6 m-80 60.35 43.96 12.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.055 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.26 28.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 45' ' ' ASN . 79.9 p -84.48 -16.18 43.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -1.206 . . . . 0.0 107.89 178.189 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.6 OUTLIER -79.51 164.53 23.83 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.576 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.69 ' H ' HD12 ' A' ' 48' ' ' LEU . 64.5 p -149.85 130.94 14.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.656 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.3 tp -64.98 146.13 55.42 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.65 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.63 -18.17 11.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.896 -1.127 . . . . 0.0 108.108 179.11 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 172.75 160.75 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.944 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.01 -166.83 0.17 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.253 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.61 -170.51 2.72 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.4 OUTLIER -90.15 158.11 17.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.542 -0.975 . . . . 0.0 108.413 179.99 . . . . . . . . 3 3 . 1 . 038 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.66 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 18.2 m . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.289 179.843 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -77.69 -166.43 0.77 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.786 -179.795 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 m -156.13 43.45 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.983 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -19.15 35.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 110.001 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -114.63 47.37 1.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 108.97 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 58.9 m-85 -142.72 163.95 35.49 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 -178.928 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -88.75 159.68 40.36 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.743 0.94 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.66 131.95 24.08 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 109.016 179.933 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.08 14.52 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 111.129 -179.699 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.82 142.11 22.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.819 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 17' ' ' THR . 33.0 t -144.78 162.88 35.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 109.565 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 16' ' ' CYS . 32.8 p -60.27 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 108.865 179.238 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pp -134.98 -13.18 2.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.031 -1.043 . . . . 0.0 110.958 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 15.6 pm0 -54.49 132.11 44.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.156 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.6 t80 -87.6 127.75 35.27 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.551 1.167 . . . . 0.0 111.911 -177.024 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmt85 -161.36 75.49 2.45 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.595 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.9 Cg_endo -66.21 133.94 34.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -120.28 124.82 46.54 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.247 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.85 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 13.5 t -79.12 165.89 22.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 108.328 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -138.7 159.03 25.29 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.398 -1.382 . . . . 0.0 112.497 -176.959 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 5.7 t -46.08 -21.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.924 -0.75 . . . . 0.0 110.908 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 29' ' ' LYS . 27.1 p-10 -86.15 26.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 40.0 t-20 47.43 24.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 110.074 179.314 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.0 tttp -110.91 142.61 42.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 15.5 m -92.93 140.03 29.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 108.965 179.533 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.675 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 70.3 m-85 -112.91 126.51 55.54 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.513 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.01 -52.66 1.56 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p30 -158.96 -164.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.09 -1.241 . . . . 0.0 110.513 179.549 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.08 -49.65 30.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.598 -0.689 . . . . 0.0 111.999 -177.911 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 10.6 m -61.79 -58.09 9.34 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.57 -1.331 . . . . 0.0 110.43 -178.835 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 31' ' ' TYR . 14.8 m-80 -58.68 -13.81 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.98 . . . . 0.0 110.062 -179.503 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 48' ' ' LEU . 5.8 t80 -83.68 -58.13 2.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.307 1.051 . . . . 0.0 109.992 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.679 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.7 t -61.13 -29.36 69.73 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.128 -178.476 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.77 ' O ' HG22 ' A' ' 42' ' ' VAL . 88.0 m-20 -58.71 -29.49 66.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.612 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.713 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.81 -30.99 51.51 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.941 HG22 HD23 ' A' ' 48' ' ' LEU . 52.1 t -75.86 -21.3 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.48 0.657 . . . . 0.0 109.435 179.535 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 39' ' ' ASN . 11.6 m -90.25 -22.12 6.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.83 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -89.81 -30.02 18.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' THR . 11.2 p -87.72 17.78 4.5 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.343 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' SER . 9.4 p30 50.63 41.26 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.679 -179.706 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.82 37.75 58.18 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.365 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 44' ' ' SER . 7.6 t -111.13 -1.7 16.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.086 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.17 -75.01 0.45 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.303 1.049 . . . . 0.0 109.162 -179.661 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.748 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.8 p 82.44 150.59 0.09 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.383 -177.892 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' A' ' 51' ' ' SER . 14.2 tp -63.59 160.65 16.25 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.766 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 5.9 p -115.7 -43.62 3.01 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.85 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -178.1 160.63 1.42 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.264 179.429 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -69.04 172.56 6.54 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.956 179.224 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.48 -167.48 52.04 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.572 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.85 -172.08 2.91 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.847 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.593 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.422 HG12 ' SG ' ' A' ' 8' ' ' CYS . 73.4 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.05 124.81 41.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 108.808 179.463 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.3 m -135.06 46.91 2.38 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 -179.263 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.24 -0.66 57.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.415 179.6 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -117.88 36.05 4.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.943 ' O ' HG21 ' A' ' 42' ' ' VAL . 92.8 m-85 -121.5 157.08 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.255 -0.903 . . . . 0.0 108.638 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.15 167.98 78.81 Favored 'Cis proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.022 2.298 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -116.32 142.91 30.13 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.546 -0.721 . . . . 0.0 109.202 -179.656 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -78.72 12.47 2.18 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.424 2.083 . . . . 0.0 110.489 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.87 109.98 0.34 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.556 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 92.4 m -95.18 140.56 29.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.785 -179.244 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -52.94 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.662 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.2 pp -128.69 -24.07 3.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.922 -1.111 . . . . 0.0 110.255 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.8 pm0 -46.37 134.87 8.64 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.204 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -87.55 126.48 34.95 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.535 1.159 . . . . 0.0 111.387 -177.937 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mtt-85 -161.57 82.03 1.9 Allowed Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.728 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.4 Cg_endo -65.64 125.6 14.62 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.615 2.21 . . . . 0.0 112.932 -176.489 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -110.12 136.91 48.62 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.924 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.574 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -103.54 122.74 45.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.091 -1.005 . . . . 0.0 111.053 -178.652 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.637 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.57 -166.14 0.57 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.178 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -90.17 -25.99 20.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.442 -1.034 . . . . 0.0 108.728 179.31 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -79.29 -2.26 40.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.806 . . . . 0.0 109.086 179.384 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.8 m120 82.99 47.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 0.0 110.356 179.603 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 17.3 ptmt -121.87 116.28 24.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.538 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 31' ' ' TYR . 51.4 m -75.42 153.06 37.88 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.726 0.774 . . . . 0.0 110.405 -178.564 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.6 m-85 -131.45 148.04 52.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.155 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -58.87 -37.59 91.02 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.479 -1.344 . . . . 0.0 111.947 -175.811 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -162.92 -165.78 1.18 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 110.388 -179.704 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.62 -23.63 66.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.6 -0.688 . . . . 0.0 110.536 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.7 t -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.976 -1.078 . . . . 0.0 109.522 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -66.37 -28.22 68.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.572 179.712 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 60.5 t80 -81.76 -45.05 16.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.333 1.063 . . . . 0.0 109.761 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.645 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.4 m -65.93 -26.78 67.75 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.758 -178.953 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.2 m-80 -70.19 -34.68 73.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.146 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.54 -20.33 58.75 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.576 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 55.0 t -84.67 -34.16 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 110.04 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.943 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -90.88 -16.29 8.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 0.0 109.996 -179.053 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.4 tm-20 -91.72 -19.8 22.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.991 -1.068 . . . . 0.0 108.422 179.053 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' THR . 5.8 p -100.25 23.41 10.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.496 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.7 m-20 66.04 11.72 7.96 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.223 -0.923 . . . . 0.0 109.172 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 78.11 19.7 74.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.746 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 44' ' ' SER . 21.9 p -84.55 -12.45 54.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.15 -1.206 . . . . 0.0 108.986 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.637 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.1 tp -80.74 136.4 36.15 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.442 -0.786 . . . . 0.0 109.07 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 26' ' ' SER . 5.3 p -135.26 123.5 23.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.069 0.938 . . . . 0.0 110.244 179.385 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.563 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -72.93 153.03 41.15 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.674 0.749 . . . . 0.0 109.398 179.573 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.506 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -105.49 -23.8 12.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.235 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.574 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -165.58 159.36 16.52 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.896 -178.549 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -76.55 176.32 8.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.66 -167.37 54.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 7.4 mtmt -91.49 168.39 11.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.399 -1.059 . . . . 0.0 108.987 179.086 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.563 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.63 -179.45 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 34' ' ' LYS . 6.4 p . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.14 151.62 15.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.548 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 23.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.58 3.66 54.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 110.544 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -131.4 -8.24 3.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.818 -1.177 . . . . 0.0 110.946 -178.977 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.653 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.5 m-85 -81.34 158.28 69.41 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.79 -1.194 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.596 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 38.2 Cg_endo -69.99 142.55 71.15 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.762 -1.766 . . . . 0.0 111.534 2.028 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -103.17 142.72 25.14 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.979 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -78.43 14.39 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.781 2.32 . . . . 0.0 111.251 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.94 125.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 179.853 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' THR . 45.3 m -102.91 139.16 38.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.95 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.85 -166.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.541 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.484 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -119.24 -28.97 5.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.921 -1.112 . . . . 0.0 109.825 179.969 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.56 119.4 1.64 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.106 -0.996 . . . . 0.0 108.999 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.8 t80 -80.07 124.12 28.45 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.631 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -156.97 82.46 3.21 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.765 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.8 Cg_endo -65.11 120.6 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.425 2.083 . . . . 0.0 111.944 -177.367 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.711 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -111.88 132.24 54.85 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.671 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.009 ' O ' HD12 ' A' ' 50' ' ' LEU . 7.3 t -88.85 161.21 16.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.498 -0.751 . . . . 0.0 109.459 -178.965 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -107.52 172.55 17.75 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.866 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.586 ' H ' HD12 ' A' ' 48' ' ' LEU . 20.6 t -74.41 -3.36 30.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -1.201 . . . . 0.0 108.84 179.554 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.9 p-10 -98.01 -2.17 40.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.177 179.457 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.5 t30 83.59 43.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 30' ' ' THR . 5.3 tttt -125.43 138.83 54.02 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 179.522 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 19.6 m -92.74 152.12 19.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.504 179.804 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -128.57 130.16 46.98 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.706 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.94 -51.29 1.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -177.803 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.5 p30 -160.01 -166.55 1.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.871 -1.37 . . . . 0.0 110.522 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -54.55 -40.32 68.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.657 -0.652 . . . . 0.0 110.907 -178.477 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.5 t -60.48 -69.66 0.21 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.787 -1.195 . . . . 0.0 109.703 -179.324 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.3 m-80 -51.91 -26.09 9.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.447 -0.783 . . . . 0.0 111.272 -179.211 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 48' ' ' LEU . 14.6 t80 -75.25 -62.02 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.638 -1.289 . . . . 0.0 110.828 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.753 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.4 t -53.32 -49.12 67.71 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.185 -177.413 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -49.16 -31.31 8.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.29 -1.506 . . . . 0.0 108.597 -178.812 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.64 -36.65 62.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.255 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' A' ' 48' ' ' LEU . 41.4 t -67.97 -32.36 55.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.392 0.615 . . . . 0.0 110.253 179.913 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -90.63 -14.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.069 -178.018 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 9.6 pt-20 -92.54 -29.53 16.14 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.892 -1.13 . . . . 0.0 108.216 178.053 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.0 p -87.68 20.1 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.864 -178.932 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 45.1 m-80 64.23 12.85 7.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 -179.439 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.74 19.61 72.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.258 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.0 p -91.67 0.41 57.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.927 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -80.47 -56.19 4.35 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.979 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 51.0 p 52.37 125.76 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.498 1.142 . . . . 0.0 111.972 179.329 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.009 HD12 ' O ' ' A' ' 24' ' ' CYS . 6.6 tp -61.97 156.56 20.76 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.123 178.835 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.45 -23.86 8.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.87 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.919 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -179.58 161.82 1.06 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.774 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -78.32 173.33 12.42 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 78.84 -171.57 55.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.46 137.05 32.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.151 -1.205 . . . . 0.0 108.799 178.824 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.63 -179.772 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 7' ' ' ASP . 93.5 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.239 0.542 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 6' ' ' VAL . 16.3 t70 -89.11 137.77 32.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.464 179.924 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 m -135.26 61.91 1.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 109.909 -179.544 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.47 -0.73 57.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.838 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -128.34 39.65 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.908 ' O ' HG21 ' A' ' 42' ' ' VAL . 52.1 m-85 -120.65 161.1 41.45 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 108.842 -179.847 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.2 Cg_endo -75.43 174.56 52.16 Favored 'Cis proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.62 -1.825 . . . . 0.0 111.299 1.709 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -118.74 142.77 32.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.766 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.43 14.48 1.6 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 169.94 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.462 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 50.6 t -105.35 159.59 15.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 109.937 -179.8 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -61.72 -162.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.804 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -118.84 -28.07 5.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.658 -1.276 . . . . 0.0 109.913 179.768 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -42.73 118.4 1.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.793 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.9 t80 -79.23 128.64 33.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.382 1.087 . . . . 0.0 111.041 -177.84 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.31 78.9 2.21 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.217 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.1 Cg_endo -64.71 126.5 16.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.361 2.707 . . . . 0.0 113.366 -177.139 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.4 mp -110.47 127.15 55.01 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.334 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -88.27 119.1 28.36 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.782 -178.627 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.7 -158.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.989 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -91.84 -52.4 4.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.558 -0.966 . . . . 0.0 108.914 179.356 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.618 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -47.52 -24.63 0.89 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.169 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.8 p-10 103.3 33.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.177 0.513 . . . . 0.0 110.216 179.147 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.7 131.39 50.91 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.521 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 94.5 m -80.17 142.5 34.66 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 110.314 -179.088 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.5 m-85 -120.34 131.23 54.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.368 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.42 -50.9 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.163 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.2 p30 -167.19 -167.37 0.91 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.008 -1.289 . . . . 0.0 111.136 178.901 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.766 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.56 -42.85 11.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.125 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.1 m -67.74 -66.44 0.56 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.291 -1.506 . . . . 0.0 108.998 -179.262 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.532 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 17.9 m-80 -44.66 -23.17 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.527 -0.733 . . . . 0.0 110.194 -179.918 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 30.9 t80 -84.55 -48.73 9.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.74 1.257 . . . . 0.0 109.763 179.733 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -62.27 -58.98 5.71 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.072 -178.425 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.01 -31.36 0.17 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.147 -0.971 . . . . 0.0 108.772 -179.351 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -70.8 -50.71 32.74 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.543 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.5 t -51.71 -60.15 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.432 0.634 . . . . 0.0 109.97 179.036 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -62.6 -21.18 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.411 -0.806 . . . . 0.0 111.665 -178.539 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.2 tt0 -91.98 -11.59 35.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.457 -1.402 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.68 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.4 t -106.4 20.58 18.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.283 -0.885 . . . . 0.0 109.911 -179.555 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 75.94 1.48 3.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 108.967 -179.148 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.48 17.42 71.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' OG ' ' A' ' 44' ' ' SER . 14.1 t -83.89 -13.05 54.52 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.279 -1.13 . . . . 0.0 108.65 179.053 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tp -81.28 147.12 30.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.394 -0.816 . . . . 0.0 108.958 179.772 . . . . . . . . 1 1 . 1 . 042 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -145.46 158.32 43.86 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.242 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -104.46 165.64 10.92 Favored 'General case' 0 C--N 1.281 -2.412 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 -178.937 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.622 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -106.99 -31.55 8.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.531 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -162.99 160.49 24.72 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.723 0.773 . . . . 0.0 110.068 -178.615 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 4.8 m-85 -77.14 -171.64 2.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.699 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.2 -166.57 28.94 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.829 . . . . . . . . 2 2 . 1 . 042 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.67 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 167.84 12.28 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.237 . . . . . . . . 3 3 . 1 . 042 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.67 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.7 m . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.723 -179.413 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.26 0.552 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 043 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.415 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 16.4 t0 -67.06 141.02 57.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 22.2 m -146.76 58.82 1.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.106 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.66 0.46 57.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.613 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.64 32.88 5.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.836 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.896 ' CB ' HG11 ' A' ' 42' ' ' VAL . 83.6 m-85 -119.28 158.3 48.95 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.58 169.92 73.22 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.506 -1.872 . . . . 0.0 111.706 1.799 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -128.05 144.8 52.89 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.959 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -77.93 14.3 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.652 2.235 . . . . 0.0 111.839 -178.759 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.23 145.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.217 179.77 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' THR . 54.1 t -122.85 159.99 27.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 109.272 179.449 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.6 p -61.28 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.174 -0.954 . . . . 0.0 108.594 179.24 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.96 -18.47 4.2 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.7 pt-20 -52.14 127.7 22.53 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.756 -1.215 . . . . 0.0 107.746 179.503 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 26.2 t80 -92.91 119.8 32.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 122.422 1.106 . . . . 0.0 110.969 -178.124 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtp-105 -152.17 81.8 5.53 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -65.02 131.31 28.35 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.966 2.444 . . . . 0.0 112.346 -177.448 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -117.58 121.44 40.95 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.965 179.254 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 5.1 t -80.49 120.05 23.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 108.593 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.06 -160.66 0.82 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -90.26 -37.88 13.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 108.048 178.328 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -58.55 -17.69 23.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.568 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 21.7 t30 96.35 21.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.003 0.43 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -99.33 127.08 45.3 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.005 -1.059 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 m -77.06 140.13 40.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.425 -0.797 . . . . 0.0 109.574 -179.925 . . . . . . . . 1 1 . 1 . 043 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 26.7 m-85 -115.81 129.16 56.33 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.693 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.46 -52.64 0.31 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -178.307 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.3 p30 -164.75 -164.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.806 -1.408 . . . . 0.0 110.992 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.03 -41.55 25.97 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.071 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 4.3 m -70.17 -64.67 0.85 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.202 -1.561 . . . . 0.0 109.098 -179.318 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.0 m-80 -43.92 -27.28 0.34 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.888 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 39.0 t80 -82.35 -46.87 13.02 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.067 1.413 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -56.9 -37.02 70.83 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.041 -178.349 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.41 -42.08 99.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.735 -1.228 . . . . 0.0 108.336 179.882 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -62.27 -25.08 67.64 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 74.9 t -80.59 -44.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 -179.526 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.896 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -81.27 -7.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.114 -0.992 . . . . 0.0 110.297 -178.791 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.92 -33.95 14.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.965 -1.084 . . . . 0.0 108.447 178.958 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 47' ' ' THR . 6.5 p -88.85 24.21 2.12 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.708 -0.62 . . . . 0.0 110.029 -179.528 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 73.4 4.7 4.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.052 -1.03 . . . . 0.0 109.05 -179.488 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 83.51 15.61 70.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.72 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 44' ' ' SER . 10.0 t -88.52 -1.8 58.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -1.061 . . . . 0.0 108.866 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.1 tp -81.19 145.27 31.08 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.283 -0.885 . . . . 0.0 109.124 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 p -137.55 145.92 43.48 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.485 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -94.59 171.05 9.03 Favored 'General case' 0 C--N 1.275 -2.641 0 O-C-N 120.877 -1.139 . . . . 0.0 109.839 -179.412 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.8 -20.23 13.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.778 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 177.1 154.98 0.26 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.528 -0.733 . . . . 0.0 109.833 -178.884 . . . . . . . . 3 3 . 1 . 043 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' HA ' HD23 ' A' ' 23' ' ' LEU . 5.4 m-85 -66.49 -165.78 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.206 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.21 -172.08 1.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.305 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.1 tttt -90.34 159.81 16.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.576 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.292 -1.891 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.605 -179.982 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 044 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -86.61 132.93 33.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.279 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 10.1 m -133.4 52.33 2.08 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.318 -0.864 . . . . 0.0 109.76 -179.606 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.35 8.02 35.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.774 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -119.64 3.79 11.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.89 ' O ' HG21 ' A' ' 42' ' ' VAL . 96.2 m-85 -89.78 157.44 46.36 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.166 -0.959 . . . . 0.0 109.001 -179.731 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -74.96 143.01 76.45 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.617 -1.826 . . . . 0.0 111.366 2.495 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttp -84.16 143.93 43.24 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.632 -0.667 . . . . 0.0 109.274 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.73 13.54 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.539 2.159 . . . . 0.0 110.556 179.459 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.01 114.1 0.12 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.4 m -92.57 139.6 30.41 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 110.007 -179.332 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -50.27 178.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.545 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -123.37 -16.11 6.96 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.967 -1.083 . . . . 0.0 110.166 -179.663 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.1 pm0 -55.24 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.359 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.6 t80 -132.93 119.7 20.49 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.737 1.256 . . . . 0.0 110.835 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.9 mtp85 -160.25 74.63 2.92 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.154 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.9 Cg_endo -65.06 134.73 40.83 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.895 2.396 . . . . 0.0 113.4 -176.135 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -117.97 143.57 46.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.46 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -94.41 166.74 11.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 -178.861 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -127.44 161.98 21.48 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -65.69 -28.69 69.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.044 -1.268 . . . . 0.0 108.832 179.996 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -58.34 -15.51 10.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.737 . . . . 0.0 109.304 179.657 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.5 t30 90.28 33.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.04 0.448 . . . . 0.0 110.435 179.396 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -121.28 -176.37 3.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.932 -1.105 . . . . 0.0 109.177 178.683 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 31' ' ' TYR . 8.9 m -123.17 163.92 19.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.826 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 29.4 m-85 -138.35 141.64 39.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.612 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -61.95 -41.33 99.65 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.312 -176.803 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.0 p-10 -157.8 -164.37 1.52 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.893 -1.357 . . . . 0.0 109.978 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -61.73 -31.71 71.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 110.826 -178.705 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -72.9 -44.17 61.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.665 -1.272 . . . . 0.0 109.632 -179.479 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -63.08 -44.26 96.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.693 179.925 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.4 t80 -65.43 -57.15 9.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.144 0.973 . . . . 0.0 110.963 -179.365 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -53.62 -51.73 62.13 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 -178.282 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.3 m-20 -45.41 -36.4 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.002 -1.061 . . . . 0.0 109.41 -179.758 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.86 -42.03 77.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 108.675 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.636 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.1 t -60.57 -59.66 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.649 -0.657 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 11' ' ' TYR . 9.2 p -62.53 -21.51 27.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.226 -0.921 . . . . 0.0 111.013 -178.766 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.2 -15.29 27.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.71 -1.244 . . . . 0.0 108.818 179.065 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 47' ' ' THR . 22.7 t -102.43 10.57 38.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.475 -179.935 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 67.21 10.09 7.45 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 109.178 -179.002 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.66 18.55 54.51 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.051 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 44' ' ' SER . 3.9 p -79.56 -15.22 58.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.977 -1.308 . . . . 0.0 107.875 178.076 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.65 160.8 26.2 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.719 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.862 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.8 p -156.64 124.6 5.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.142 0.972 . . . . 0.0 109.9 178.902 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -62.44 144.12 56.28 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.385 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.97 -18.29 13.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.857 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 179.72 161.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.629 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -75.89 179.36 5.57 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.217 -0.927 . . . . 0.0 108.93 179.128 . . . . . . . . 1 1 . 1 . 044 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.32 -167.04 54.45 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.534 . . . . . . . . 2 2 . 1 . 044 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.36 144.77 25.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -1.079 . . . . 0.0 109.217 179.573 . . . . . . . . 3 3 . 1 . 044 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.627 179.953 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 25.8 t70 -75.21 155.07 37.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.322 179.875 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -151.62 50.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 109.845 -179.867 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.11 -13.26 31.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.983 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.19 57.33 1.81 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.143 -0.973 . . . . 0.0 110.626 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 98.3 m-85 -143.29 149.49 48.41 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 120.86 -1.15 . . . . 0.0 109.326 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -73.97 161.06 95.11 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.438 -1.901 . . . . 0.0 111.654 2.485 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -121.16 139.88 30.18 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.668 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.8 13.62 1.65 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.524 2.149 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 178.23 128.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 179.906 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 51.3 t -114.6 159.7 20.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.407 179.711 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.437 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -61.42 -166.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.512 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -112.61 -17.4 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.866 -1.147 . . . . 0.0 109.643 179.666 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.3 pm0 -46.18 137.49 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.132 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.626 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 7.7 t80 -96.55 135.09 38.92 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.487 1.137 . . . . 0.0 111.409 -177.834 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.1 mtt180 -161.07 73.67 2.64 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.08 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.1 Cg_endo -63.2 119.1 6.04 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.65 2.234 . . . . 0.0 112.689 -176.613 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.51 130.83 54.81 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.059 178.885 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.742 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.21 106.37 11.19 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.761 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.626 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.76 -162.52 0.06 OUTLIER Glycine 0 C--N 1.297 -1.634 0 C-N-CA 118.033 -2.032 . . . . 0.0 108.856 -178.687 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -88.59 -35.79 16.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.31 . . . . 0.0 109.29 -179.939 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p30 -63.21 -12.35 27.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 178.818 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 92.41 16.42 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.323 0.582 . . . . 0.0 109.864 179.697 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -99.33 121.2 40.76 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.341 . . . . . . . . 1 1 . 1 . 045 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 31' ' ' TYR . 97.4 m -59.13 157.62 10.1 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.492 -0.755 . . . . 0.0 109.372 -179.527 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 9.8 m-85 -128.23 127.87 43.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.142 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.89 -53.0 1.17 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -177.584 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.0 p30 -160.45 -167.62 1.94 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.702 -1.469 . . . . 0.0 110.843 179.053 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD11 ' A' ' 23' ' ' LEU . 4.8 ptmt -50.53 -40.12 50.8 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.786 -0.571 . . . . 0.0 112.03 -177.116 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.0 m -66.55 -65.45 0.68 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.514 -1.366 . . . . 0.0 109.679 -179.314 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.8 m-80 -47.74 -28.29 2.41 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.437 -0.789 . . . . 0.0 110.366 -179.055 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CB ' HD13 ' A' ' 23' ' ' LEU . 14.8 t80 -76.0 -57.6 3.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.616 -1.302 . . . . 0.0 109.797 179.566 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 34.0 t -54.13 -56.76 15.05 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.415 -177.949 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.93 -33.58 0.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.86 -1.15 . . . . 0.0 108.76 -178.693 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -67.56 -49.11 64.79 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.191 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -56.9 -63.76 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.396 0.617 . . . . 0.0 110.249 179.046 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -59.47 -22.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.504 -0.748 . . . . 0.0 111.799 -178.197 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.8 -17.74 26.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.348 -1.47 . . . . 0.0 108.451 179.084 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.9 ' O ' HG22 ' A' ' 47' ' ' THR . 16.7 p -102.73 29.55 5.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.476 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.46 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.4 p-10 45.1 53.84 7.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 109.103 -179.638 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.33 45.17 1.78 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -110.48 -8.83 14.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.335 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.799 ' C ' HG23 ' A' ' 49' ' ' THR . 2.3 tp -81.71 -84.11 0.11 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.837 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.799 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 79.81 171.62 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.063 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.86 174.42 8.38 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -178.633 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.652 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.58 -35.13 7.54 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.591 . . . . . . . . 3 3 . 1 . 045 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.742 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -165.34 162.15 19.47 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.55 -179.101 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 23' ' ' LEU . 61.4 m-85 -78.54 177.48 8.53 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 108.975 179.154 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 76.03 -168.16 54.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.949 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.83 141.96 30.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -1.153 . . . . 0.0 109.749 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.606 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 046 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.1 104.67 17.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 m -90.87 57.33 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -89.87 -20.35 23.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 108.897 179.762 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.4 16.7 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.279 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.988 ' HB3' HG11 ' A' ' 42' ' ' VAL . 17.5 m-85 -102.2 168.15 9.39 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.92 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -85.03 176.37 30.41 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.465 -1.473 . . . . 0.0 111.238 1.217 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 8.8 mttt -125.64 137.54 30.15 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.881 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -79.81 14.03 1.98 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.575 2.183 . . . . 0.0 110.766 -179.286 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.48 124.0 3.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.624 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -100.72 137.72 38.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.07 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -53.12 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.395 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.5 pp -121.1 -10.23 9.05 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.793 -179.621 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' LEU . 10.5 pm0 -57.3 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.788 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 6.9 t80 -136.45 129.2 30.77 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.19 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mtm180 -161.25 79.27 2.19 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.218 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.2 Cg_endo -64.97 116.61 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.233 1.955 . . . . 0.0 112.133 -177.288 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.81 125.82 52.37 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.432 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 41.8 t -78.91 165.87 23.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.953 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.69 172.26 20.97 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.18 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -66.04 -35.65 81.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.376 -1.073 . . . . 0.0 109.719 -179.099 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.6 p-10 -62.76 -11.55 18.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.096 -1.002 . . . . 0.0 108.915 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.4 t-20 85.69 30.34 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.457 0.646 . . . . 0.0 109.465 179.831 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 2.8 ttpt -114.71 143.29 45.29 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.087 179.749 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 26.9 m -91.94 155.04 18.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.493 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.849 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.3 m-85 -123.56 124.48 42.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.826 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.25 -51.86 0.71 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.669 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -154.73 -162.75 1.44 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.926 -1.338 . . . . 0.0 110.499 179.635 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.1 -42.45 93.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.704 . . . . 0.0 111.628 -177.917 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 42.8 t -55.46 -49.7 71.8 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.247 -1.533 . . . . 0.0 109.275 -179.744 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -61.94 -53.62 53.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.68 -179.122 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' HD21 ' A' ' 48' ' ' LEU . 63.1 t80 -53.26 -48.08 68.56 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.402 1.096 . . . . 0.0 110.143 -179.215 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.634 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 40.7 m -64.58 -30.58 71.61 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.625 -179.477 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' VAL . 10.5 m-80 -70.77 -22.36 62.39 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.98 -1.075 . . . . 0.0 108.528 179.296 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.849 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.51 -27.62 31.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 48' ' ' LEU . 73.8 t -77.81 -31.95 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.128 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.988 HG11 ' HB3' ' A' ' 11' ' ' TYR . 21.5 m -86.42 -28.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.724 -0.61 . . . . 0.0 110.151 -179.431 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.99 -22.36 20.03 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 109.371 -179.586 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 47' ' ' THR . 26.2 p -89.88 10.36 24.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.709 -179.465 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 44' ' ' SER . 8.0 t30 74.47 11.24 4.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 108.654 -179.373 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.83 81.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.827 . . . . . . . . 1 1 . 1 . 046 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -80.15 -8.4 59.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -1.21 . . . . 0.0 108.857 179.127 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.855 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.75 163.76 24.22 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.454 -0.779 . . . . 0.0 109.17 179.999 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.655 ' H ' HD12 ' A' ' 48' ' ' LEU . 40.0 p -147.71 126.55 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.953 0.882 . . . . 0.0 108.682 177.974 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.4 tp -58.5 125.19 22.32 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.334 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.5 t -83.22 -22.98 32.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.802 -179.753 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . 22.6 p-80 154.26 162.42 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.888 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.432 ' O ' ' HD2' ' A' ' 52' ' ' HIS . 62.0 m-85 -69.71 170.57 10.63 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.791 -1.193 . . . . 0.0 108.821 179.284 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 78.27 -172.46 55.22 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.808 . . . . . . . . 2 2 . 1 . 046 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.78 150.04 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.261 . . . . 0.0 109.313 179.118 . . . . . . . . 3 3 . 1 . 046 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 55' ' ' LYS . 15.3 m . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.578 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 047 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 12.1 t70 -60.86 151.84 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 109.092 179.772 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.6 t -150.58 16.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.4 t -90.37 10.21 25.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.488 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.0 mp0 -124.66 -21.18 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 110.442 -179.618 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 13' ' ' LYS . 91.4 m-85 -79.37 153.52 76.57 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 120.832 -1.167 . . . . 0.0 109.178 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.6 Cg_endo -74.55 144.59 81.44 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.232 -1.987 . . . . 0.0 111.344 1.514 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -105.85 163.24 17.48 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.692 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.28 13.69 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.426 2.084 . . . . 0.0 111.39 -179.75 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 130.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 90.5 m -93.76 152.54 18.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -51.74 -176.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 108.987 179.648 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.2 pt? -122.49 -35.69 3.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.027 -1.046 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.7 pm0 -53.13 137.98 32.48 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.429 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 11.1 t80 -86.88 127.61 35.04 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.258 1.028 . . . . 0.0 110.779 -178.462 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.2 mtm180 -160.61 85.31 1.91 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.327 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.2 Cg_endo -64.8 117.94 4.98 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.755 2.303 . . . . 0.0 112.998 -177.348 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.07 131.04 54.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.89 177.88 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 41.0 t -78.32 162.86 26.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.977 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -144.43 169.1 26.52 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.902 -178.084 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 2.3 t -58.55 -19.07 34.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.603 -0.939 . . . . 0.0 110.32 -178.028 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 26.5 p-10 -61.24 -13.24 17.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.102 -0.999 . . . . 0.0 109.416 179.727 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.4 t-20 83.88 14.76 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.681 -0.637 . . . . 0.0 109.697 179.902 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -128.01 -166.36 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 31' ' ' TYR . 16.3 m -111.81 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.644 -0.66 . . . . 0.0 109.342 -179.898 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.715 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.7 m-85 -131.38 121.63 24.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.58 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.2 -52.9 0.28 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.264 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -157.89 -165.02 1.64 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.013 -1.286 . . . . 0.0 110.358 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.66 -42.75 68.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.58 -0.7 . . . . 0.0 110.597 -178.485 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 50.7 t -62.2 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.796 -1.19 . . . . 0.0 109.786 -179.844 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.9 m-80 -52.58 -23.69 6.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 110.211 -179.367 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.1 t80 -75.34 -67.08 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.15 -46.66 75.71 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.796 -177.923 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.2 m-20 -44.09 -30.94 0.82 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.745 -1.222 . . . . 0.0 107.991 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.48 -49.5 47.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.537 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.878 HG22 HD23 ' A' ' 48' ' ' LEU . 76.8 t -54.02 -63.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.442 0.639 . . . . 0.0 110.216 178.945 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.1 p -59.37 -22.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.408 -0.808 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.21 -15.13 27.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.519 -1.363 . . . . 0.0 109.23 179.421 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.55 ' O ' HG22 ' A' ' 47' ' ' THR . 5.5 p -100.66 7.58 43.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.885 . . . . 0.0 109.671 -179.685 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.7 t30 75.21 8.66 3.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 -179.579 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.26 19.78 63.93 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -91.7 -0.22 57.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.341 -1.094 . . . . 0.0 108.942 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.878 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.02 -70.32 0.67 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.898 0.856 . . . . 0.0 109.276 -179.494 . . . . . . . . 3 3 . 1 . 047 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.37 154.33 0.1 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.579 -178.756 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.6 tp -72.82 126.01 28.9 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.384 -179.536 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.574 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 8.1 t -79.3 -24.17 43.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 108.874 179.444 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 51' ' ' SER . 17.1 p80 150.67 174.27 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.541 178.378 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.9 155.86 23.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 110.092 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 84.1 -174.18 50.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -90.24 146.38 24.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.054 -1.262 . . . . 0.0 109.008 179.249 . . . . . . . . 1 1 . 1 . 047 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 048 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.64 133.84 39.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.278 -179.989 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 m -124.42 61.17 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.706 -179.828 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 1.4 t -90.19 -31.94 16.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.654 179.93 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -81.48 0.94 35.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 109.307 179.792 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.928 ' HB3' HG11 ' A' ' 42' ' ' VAL . 65.5 m-85 -91.3 165.32 21.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 108.876 -179.839 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.58 152.0 59.9 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.162 0.715 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 12.6 mttt -105.5 141.14 22.01 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.638 -0.664 . . . . 0.0 109.677 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.5 14.11 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.464 2.11 . . . . 0.0 110.413 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.68 145.67 14.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.751 . . . . 0.0 109.188 -179.985 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.4 m -123.76 152.71 41.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.955 -179.589 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.7 -167.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.14 179.695 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -125.08 -18.41 5.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 0.0 110.367 -179.664 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 7.3 pm0 -56.55 -167.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.891 -1.131 . . . . 0.0 108.246 179.591 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -135.73 130.35 34.04 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.401 1.096 . . . . 0.0 111.315 -179.833 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.81 79.0 2.35 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.94 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.1 Cg_endo -64.47 114.85 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.432 2.088 . . . . 0.0 112.675 -176.995 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.631 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.57 141.76 45.95 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.73 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 20.6 t -95.49 159.63 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.81 -1.156 . . . . 0.0 109.007 -179.565 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -129.58 172.08 20.03 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.321 -178.407 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 t -56.26 -38.31 70.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.904 . . . . 0.0 111.458 -177.53 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -52.08 -19.11 1.72 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.69 -1.256 . . . . 0.0 110.038 -179.276 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.2 t30 91.47 27.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.933 -0.48 . . . . 0.0 110.409 179.459 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 178.99 4.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.904 -1.122 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 31' ' ' TYR . 41.7 m -107.15 162.37 13.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.862 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.8 m-85 -127.74 121.09 29.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.027 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.93 -54.34 0.68 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.968 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.6 p30 -152.36 -167.88 2.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.038 -1.272 . . . . 0.0 109.991 179.114 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.8 -60.71 2.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.348 -178.518 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 41.9 t -43.45 -62.97 0.92 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.802 -1.186 . . . . 0.0 110.432 -179.425 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -49.65 -34.25 17.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.579 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 13.5 t80 -70.5 -60.05 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.31 1.052 . . . . 0.0 110.845 -179.002 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.87 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.6 m -53.69 -30.77 45.09 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.711 -0.618 . . . . 0.0 110.18 -179.107 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.6 m-80 -64.07 -39.15 93.44 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.106 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -67.34 -20.21 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.34 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HD23 ' A' ' 48' ' ' LEU . 41.5 t -84.8 -31.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.7 m -82.28 -16.01 11.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.626 -0.671 . . . . 0.0 109.619 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.65 -32.35 15.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.885 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.811 ' O ' HG22 ' A' ' 47' ' ' THR . 60.0 p -86.56 10.14 16.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.802 -179.423 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.2 t30 75.05 7.35 4.21 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 108.858 -179.444 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 83.51 13.7 75.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.846 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 44' ' ' SER . 13.9 t -93.44 0.89 56.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 108.995 179.128 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.856 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -80.06 -71.57 0.45 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.036 0.922 . . . . 0.0 108.744 179.881 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.4 p 79.62 152.02 0.12 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.384 1.088 . . . . 0.0 109.997 -179.505 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -70.59 152.82 43.51 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.637 -179.734 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 p -99.38 -39.94 8.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.675 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.73 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.85 163.97 2.31 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.23 179.972 . . . . . . . . 3 3 . 1 . 048 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.46 136.68 36.37 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.467 . . . . . . . . 1 1 . 1 . 048 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 110.41 -167.64 12.73 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.798 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 151.72 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -1.216 . . . . 0.0 108.97 179.243 . . . . . . . . 2 2 . 1 . 048 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.54 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.511 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 049 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.65 45.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 16.8 m -102.19 62.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.982 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.35 -4.13 58.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.972 . . . . 0.0 109.943 -179.542 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -117.89 2.45 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.322 179.681 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.802 ' HB3' HG11 ' A' ' 42' ' ' VAL . 35.5 m-85 -85.54 165.38 35.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 109.782 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -88.13 169.42 36.99 Favored 'Cis proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.249 -1.563 . . . . 0.0 110.642 0.837 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' CE1' ' A' ' 11' ' ' TYR . 5.2 mtpt -122.55 143.67 40.38 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 108.765 -179.848 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.81 13.88 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.491 2.127 . . . . 0.0 110.582 -179.882 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.7 112.27 1.89 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.636 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.3 m -81.02 143.28 32.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.837 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.3 p -62.73 -163.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.317 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.57 -15.9 8.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.987 -1.071 . . . . 0.0 109.636 179.836 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.804 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -47.92 123.46 6.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.016 -1.052 . . . . 0.0 108.477 179.417 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 27.8 t80 -86.59 110.68 19.99 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.361 1.077 . . . . 0.0 110.376 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 10.4 mtp180 -145.9 86.39 7.21 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.306 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -67.33 104.19 0.87 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 121.855 1.704 . . . . 0.0 111.596 -177.904 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.82 120.58 40.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.639 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -78.82 -179.67 6.7 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.617 -178.867 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.74 165.27 29.63 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.198 -1.477 . . . . 0.0 112.222 -177.216 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -33.04 74.84 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -50.65 -24.93 3.67 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.95 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.61 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 31.1 t-20 96.33 37.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.026 179.57 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -136.88 -169.43 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 179.591 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 91.8 m -127.39 158.92 36.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.345 -179.937 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 88.3 m-85 -132.51 105.9 7.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.378 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.78 -55.98 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 O-C-N 122.047 -0.408 . . . . 0.0 112.28 -177.789 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.1 p-10 -140.24 -171.02 3.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.608 -1.525 . . . . 0.0 110.627 -179.541 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.8 pttt -59.64 -30.77 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.777 -0.577 . . . . 0.0 110.55 -179.036 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 43.6 t -62.89 -74.12 0.1 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.674 -1.266 . . . . 0.0 108.261 179.194 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.55 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 18.3 m-80 -39.37 -48.67 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 110.557 -179.975 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.61 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 74.1 t80 -55.13 -46.37 75.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.665 -1.272 . . . . 0.0 109.265 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 27.3 m -59.83 -48.32 82.15 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.602 179.957 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 7.2 m120 -45.68 -30.02 1.44 Allowed 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.85 -1.156 . . . . 0.0 109.308 179.35 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -79.08 -40.16 31.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.992 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.993 HG22 HD23 ' A' ' 48' ' ' LEU . 58.1 t -69.88 -24.3 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.719 . . . . 0.0 110.146 -179.821 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.1 m -91.94 -26.97 4.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.534 -179.182 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -91.29 -15.27 29.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.077 -179.931 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 26.8 t -102.24 19.79 18.02 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.2 m120 65.31 18.58 11.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.454 -0.779 . . . . 0.0 109.044 -179.604 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 18.37 77.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.732 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.2 p -89.61 -10.02 47.52 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.486 -1.008 . . . . 0.0 108.784 179.401 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.993 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.43 148.05 32.08 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.75 . . . . . . . . 3 3 . 1 . 049 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 30.1 p -123.07 139.98 53.5 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.888 0.852 . . . . 0.0 109.721 179.332 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 23' ' ' LEU . 5.1 tp -61.21 130.16 44.85 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.696 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.9 t -79.01 -22.95 44.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.741 -1.224 . . . . 0.0 109.241 -179.913 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' SER . 10.5 p-80 154.1 164.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.167 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.77 148.29 40.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.11 -0.993 . . . . 0.0 108.601 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 93.73 -179.31 38.46 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.325 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.97 168.4 17.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.315 . . . . 0.0 109.017 178.821 . . . . . . . . 2 2 . 1 . 049 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 30.7 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.687 -179.464 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.222 0.534 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 050 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -83.9 117.25 23.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.274 179.894 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.19 37.36 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.598 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.28 6.7 41.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.711 -179.859 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 24.1 mp0 -129.01 36.71 4.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 109.775 -179.76 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.967 ' HB3' HG11 ' A' ' 42' ' ' VAL . 24.3 m-85 -108.26 164.08 15.54 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 108.541 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.8 Cg_endo -77.7 -177.72 21.93 Favored 'Cis proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.967 -1.68 . . . . 0.0 111.684 2.232 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mmmt -125.54 148.14 60.56 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.616 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 14' ' ' PRO . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.73 14.01 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 163.62 165.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.688 179.746 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.9 t -140.43 160.0 40.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 179.877 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.48 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.091 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.0 pp -115.02 -24.37 8.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 109.57 179.605 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.9 pt-20 -43.79 116.6 1.0 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.3 t80 -79.26 130.96 35.99 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.496 1.141 . . . . 0.0 111.325 -177.622 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.03 78.35 2.33 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.315 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.53 118.45 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.89 2.394 . . . . 0.0 112.898 -177.097 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.644 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -106.67 131.58 53.65 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.779 178.478 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 40.8 t -79.45 162.54 25.4 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.121 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -141.95 166.49 26.28 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.259 -178.054 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t -55.74 -13.27 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.874 -0.78 . . . . 0.0 110.531 -178.729 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.0 p30 -75.01 5.94 4.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.175 . . . . 0.0 109.427 179.236 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 72.1 m-20 63.29 31.32 15.45 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.367 -0.833 . . . . 0.0 109.847 179.763 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -136.39 -168.26 2.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.659 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.3 m -119.85 162.45 19.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.8 m-85 -129.97 126.45 37.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.046 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.27 -53.76 0.96 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.527 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.6 p30 -157.54 -164.64 1.6 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.934 -1.333 . . . . 0.0 111.179 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.5 -47.49 63.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.662 -0.649 . . . . 0.0 112.31 -177.304 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HE3' ' A' ' 34' ' ' LYS . 5.2 m -63.54 -55.08 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.402 -1.436 . . . . 0.0 109.982 -178.62 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.4 m-80 -54.86 -27.87 45.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -0.997 . . . . 0.0 110.027 -179.541 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.0 t80 -74.03 -50.46 19.64 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.997 1.38 . . . . 0.0 109.401 179.639 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 13.5 m -60.56 -26.13 66.69 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.474 -179.257 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 19.7 m-20 -65.26 -34.22 77.85 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.927 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.61 -39.13 80.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.627 HG22 HD23 ' A' ' 48' ' ' LEU . 86.5 t -65.11 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.581 -0.699 . . . . 0.0 109.89 -179.727 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.967 HG11 ' HB3' ' A' ' 11' ' ' TYR . 14.1 p -59.28 -19.75 16.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -0.771 . . . . 0.0 110.7 -179.335 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -90.75 -22.52 21.04 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.6 -1.312 . . . . 0.0 107.909 178.981 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.821 ' O ' HG22 ' A' ' 47' ' ' THR . 0.9 OUTLIER -98.44 29.29 3.69 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.114 179.533 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.525 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 6.0 p-10 44.34 53.82 6.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.03 47.1 2.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.31 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -111.53 -22.97 10.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.453 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.627 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.64 150.88 30.84 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.999 . . . . . . . . 3 3 . 1 . 050 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.569 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.2 p -125.02 138.14 54.22 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 109.41 179.621 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.3 tp -54.12 124.49 15.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.574 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 8.4 t -78.0 -22.84 48.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.793 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.58 ' CB ' ' O ' ' A' ' 51' ' ' SER . 12.9 p80 152.65 177.61 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.136 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -87.62 160.95 17.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 109.427 179.653 . . . . . . . . 1 1 . 1 . 050 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.64 -170.43 50.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.385 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 148.33 23.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.06 -1.259 . . . . 0.0 109.159 179.088 . . . . . . . . 2 2 . 1 . 050 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.457 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.546 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.56 60.86 0.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.34 -166.79 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.582 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -95.55 69.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.0 165.38 18.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -97.72 157.35 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.149 -0.97 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -87.93 122.92 32.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.99 19.61 10.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.696 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -19.55 60.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -106.06 42.02 1.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.793 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.8 m-85 -137.38 164.37 42.19 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.8 Cg_endo -86.89 145.9 31.59 Favored 'Cis proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.08 -1.633 . . . . 0.0 110.646 1.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.6 mttp -98.51 134.57 21.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.98 15.11 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.422 2.082 . . . . 0.0 111.022 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.89 124.47 7.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.387 -0.821 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.5 m -119.38 131.96 55.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 2.6 p -63.79 -169.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 108.61 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -115.35 -13.86 11.66 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.279 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 5.8 pm0 -46.15 127.74 8.89 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -87.33 125.3 34.15 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.68 1.228 . . . . 0.0 112.276 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -162.57 82.26 1.65 Allowed Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.8 Cg_endo -65.92 132.78 31.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.071 2.514 . . . . 0.0 113.67 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.9 mp -118.77 141.1 48.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -99.26 129.84 45.51 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.716 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.17 -167.74 3.27 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.7 t -82.56 -27.81 31.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.096 -1.238 . . . . 0.0 109.101 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.3 p30 -75.09 0.17 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.7 m-20 79.89 37.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 110.187 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 30' ' ' THR . 3.1 tttm -108.11 144.1 35.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 108.573 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.477 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 32.0 m -90.36 146.26 24.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.738 -1.227 . . . . 0.0 109.514 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.34 -49.27 3.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 7.2 p-10 -163.83 -166.64 1.21 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.274 -1.133 . . . . 0.0 110.217 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.864 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.32 -48.7 73.76 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.435 -0.79 . . . . 0.0 111.213 -177.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 16.0 t -54.44 -60.97 2.64 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.821 -1.175 . . . . 0.0 111.375 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.427 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 19.5 m-80 -62.43 -26.63 68.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.779 -1.2 . . . . 0.0 110.652 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 7.9 t80 -65.94 -59.84 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.856 -1.153 . . . . 0.0 109.863 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -59.86 -44.07 94.34 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.583 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.4 m-80 -43.25 -28.98 0.36 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.666 -1.271 . . . . 0.0 107.882 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.98 -49.78 18.79 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' CYS . 90.1 t -53.65 -56.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.584 0.707 . . . . 0.0 109.43 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 12' ' ' PRO . 23.4 m -59.78 -26.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.543 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -88.0 -13.83 40.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.028 -1.045 . . . . 0.0 108.801 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.905 ' O ' HG22 ' A' ' 47' ' ' THR . 27.9 p -110.4 29.83 7.34 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.448 -0.782 . . . . 0.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 44.85 55.32 6.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.979 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 36.38 45.54 0.95 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -110.04 -7.4 14.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.5 tp -83.0 -71.45 0.5 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.51 0.671 . . . . 0.0 109.313 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.617 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 14.2 p 60.78 138.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.541 0.686 . . . . 0.0 109.37 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -93.57 165.59 12.66 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.697 0.76 . . . . 0.0 111.135 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.94 -34.5 6.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.68 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.6 p80 -156.08 165.21 37.11 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.583 0.706 . . . . 0.0 109.88 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 6.0 m-85 -83.15 -168.9 2.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.692 -0.63 . . . . 0.0 109.641 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 60.07 -166.95 9.81 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 mtmt -90.41 164.96 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.992 . . . . 0.0 108.657 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.146 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.273 0.559 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.36 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.498 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.15 84.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.661 HG23 ' O ' ' A' ' 4' ' ' VAL . 29.1 m -88.55 94.24 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 50' ' ' LEU . 2.7 t -177.48 130.33 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.66 154.24 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.86 118.06 23.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.408 -0.807 . . . . 0.0 109.784 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.2 m -97.91 50.45 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.241 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -79.36 -23.79 43.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.858 . . . . 0.0 109.635 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.94 43.18 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.038 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.891 ' HB3' HG11 ' A' ' 42' ' ' VAL . 34.0 m-85 -131.31 165.51 34.75 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.002 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -87.51 169.42 39.49 Favored 'Cis proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.237 -1.568 . . . . 0.0 110.887 -0.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 2.6 mtpt -125.25 142.99 43.05 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -78.81 14.86 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.719 2.28 . . . . 0.0 111.308 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 179.57 151.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -126.54 160.31 30.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.56 ' HG1' ' CD ' ' A' ' 19' ' ' GLU . 5.2 p -64.62 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.1 pp -132.17 -13.9 3.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.963 -1.086 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.56 ' CD ' ' HG1' ' A' ' 17' ' ' THR . 15.2 pm0 -55.42 126.51 25.42 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 120.448 -1.408 . . . . 0.0 108.25 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 6.0 t80 -81.83 118.98 23.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.555 1.169 . . . . 0.0 110.906 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.9 69.08 10.89 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.5 Cg_endo -65.34 132.4 31.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.227 2.618 . . . . 0.0 113.389 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -125.21 132.99 52.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.198 178.228 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.783 ' CB ' ' CE1' ' A' ' 52' ' ' HIS . 32.8 t -78.09 118.67 20.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -64.01 -163.62 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 C-N-CA 118.648 -1.739 . . . . 0.0 109.481 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 49' ' ' THR . 8.5 t -85.25 -30.03 24.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -1.231 . . . . 0.0 108.766 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -71.07 -4.69 26.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.4 t30 84.83 16.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 110.095 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.63 126.54 44.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 108.375 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.8 m -64.71 144.8 56.98 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.047 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 31.7 m-85 -121.74 120.97 36.19 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.96 -50.23 0.21 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.6 p30 -162.41 -162.87 0.85 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.825 -1.397 . . . . 0.0 109.989 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.22 -47.28 65.76 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.48 -0.763 . . . . 0.0 111.829 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.3 m -62.79 -61.23 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.515 -1.366 . . . . 0.0 110.152 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.8 m-80 -50.04 -22.09 1.48 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.2 t80 -80.93 -52.87 6.97 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.797 1.284 . . . . 0.0 109.486 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.799 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.3 m -58.84 -30.15 67.45 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.314 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.1 m-80 -61.06 -29.85 69.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -76.61 -31.29 57.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 48' ' ' LEU . 53.5 t -77.1 -24.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.5 0.667 . . . . 0.0 110.205 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 12' ' ' PRO . 4.9 m -90.8 -25.71 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.898 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.96 -5.43 55.44 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.256 -0.903 . . . . 0.0 108.832 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 47' ' ' THR . 22.6 p -111.6 -0.65 16.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.1 t-20 77.43 15.18 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 108.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.29 2.51 90.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 44' ' ' SER . 11.4 t -80.12 0.43 32.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 108.662 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.761 ' C ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -82.41 -78.37 0.21 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.761 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 77.69 172.85 0.2 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -120.38 170.12 9.66 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.677 -1.264 . . . . 0.0 111.688 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.641 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 1.6 p -92.1 -42.09 10.12 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.476 1.131 . . . . 0.0 108.544 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.783 ' CE1' ' CB ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -171.99 172.36 4.74 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.174 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -77.21 -174.63 3.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 108.763 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 64.75 -167.27 30.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.98 154.94 19.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.963 . . . . 0.0 109.305 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.643 ' HA ' ' HE1' ' A' ' 52' ' ' HIS . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.5 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.76 63.71 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.78 165.77 35.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.892 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 4' ' ' VAL . 16.0 m -133.72 70.8 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.212 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 t -174.53 124.2 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 HD22 ' A' ' 23' ' ' LEU . 5.4 t -91.05 143.49 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.602 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.63 177.79 6.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -156.2 39.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.211 -0.93 . . . . 0.0 109.715 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 -38.32 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -88.14 -4.76 58.7 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 61.0 m-85 -88.05 161.52 43.51 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.211 -0.931 . . . . 0.0 109.269 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.1 Cg_endo -87.27 144.44 27.29 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.424 1.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -101.07 142.21 24.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.291 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.57 13.63 2.04 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.517 2.144 . . . . 0.0 110.478 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.12 128.25 12.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' THR . 66.7 m -123.12 138.94 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.113 -0.992 . . . . 0.0 109.959 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -52.51 -176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.263 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.9 mt -117.89 -31.45 5.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.739 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.3 pm0 -44.26 135.93 4.24 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 5.4 t80 -87.27 126.88 35.1 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.789 1.28 . . . . 0.0 111.135 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.3 mtm180 -160.54 71.24 2.89 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.65 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 20.6 Cg_endo -62.97 132.76 38.24 Favored 'Trans proline' 0 C--O 1.196 -1.592 0 C-N-CA 123.844 3.029 . . . . 0.0 114.339 -176.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 6' ' ' VAL . 4.3 mp -111.38 161.08 16.45 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.861 ' O ' HD12 ' A' ' 50' ' ' LEU . 30.3 t -119.09 137.13 53.78 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.677 -1.89 . . . . 0.0 110.858 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.659 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -96.51 164.37 23.14 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.258 -0.901 . . . . 0.0 111.651 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 23.9 t -67.68 -29.31 68.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.8 p30 -59.51 -14.5 13.1 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.3 t30 88.97 10.15 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.299 0.571 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -99.38 126.52 45.27 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.829 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.73 136.65 36.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -39.52 -42.75 2.0 Favored Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.477 -0.765 . . . . 0.0 111.889 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.669 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 30.0 p30 -172.47 -149.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.684 -1.48 . . . . 0.0 109.813 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -59.38 -63.0 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.843 -178.204 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 16.8 t -53.71 -57.07 12.16 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.88 -1.137 . . . . 0.0 109.378 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -52.4 -24.26 7.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 108.842 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.829 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.7 t80 -78.09 -66.5 0.84 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.51 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 43.6 t -50.62 -44.92 57.35 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.587 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 42' ' ' VAL . 8.1 m-20 -48.77 -35.28 13.95 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -62.07 -45.37 93.84 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.656 HG13 ' HA2' ' A' ' 46' ' ' GLY . 56.6 t -62.73 -59.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.713 0.768 . . . . 0.0 109.662 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.641 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.9 m -51.55 -28.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.325 -0.859 . . . . 0.0 110.356 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.64 -20.41 21.66 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.793 -1.192 . . . . 0.0 109.464 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 47' ' ' THR . 43.8 t -97.11 9.94 40.75 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.642 -0.662 . . . . 0.0 109.906 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.0 m120 62.62 25.61 15.23 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.265 -0.897 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.43 20.3 73.44 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 44' ' ' SER . 1.5 p -103.72 16.92 25.23 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.798 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -94.4 -48.41 6.15 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 39.2 p 52.28 125.21 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.347 1.07 . . . . 0.0 111.547 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 24' ' ' CYS . 7.9 tp -68.66 157.19 36.74 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.91 -20.21 10.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.764 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 173.68 162.04 0.16 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.554 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 16.8 m-85 -75.17 150.18 38.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.663 0.744 . . . . 0.0 109.131 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.65 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 96.94 -166.74 23.68 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 2.0 mtmt -90.07 158.65 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -1.156 . . . . 0.0 109.104 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 -44.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.01 178.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.724 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.465 ' O ' HD23 ' A' ' 50' ' ' LEU . 3.7 t -139.94 113.7 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.44 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.44 150.82 45.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.22 138.24 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.45 160.68 25.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.138 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -134.17 57.75 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.084 -1.01 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.13 -29.64 20.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.69 30.16 2.12 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 40.5 m-85 -120.84 166.83 14.47 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.731 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -89.42 169.13 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.56 -1.433 . . . . 0.0 111.528 0.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -122.08 136.98 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.17 14.76 1.86 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.349 2.033 . . . . 0.0 110.859 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 126.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 109.525 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.0 t -110.37 159.84 17.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 82.5 p -64.7 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.879 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.95 -12.4 9.56 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.808 -1.183 . . . . 0.0 110.088 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.08 120.45 2.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.104 -0.997 . . . . 0.0 108.729 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.4 t80 -89.77 118.01 29.05 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.657 1.218 . . . . 0.0 110.294 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -151.41 74.54 8.1 Favored Pre-proline 0 C--N 1.287 -2.147 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.5 Cg_endo -63.35 126.13 17.1 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.09 2.526 . . . . 0.0 112.415 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.09 128.61 55.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.36 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.758 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 53.2 t -79.77 161.39 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.5 169.97 21.68 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.136 -1.507 . . . . 0.0 112.078 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.26 -20.8 66.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.016 -0.696 . . . . 0.0 109.969 -178.501 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.3 p30 -65.35 -12.14 49.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 109.153 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.2 t-20 85.29 30.4 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.535 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -132.56 -166.84 1.8 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.97 . . . . 0.0 109.416 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 55' ' ' LYS . 8.2 m -126.2 156.48 40.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.874 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 27.0 m-85 -126.54 126.45 43.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.3 -52.68 0.42 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.8 p30 -162.5 -166.08 1.29 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.802 -1.41 . . . . 0.0 111.152 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.11 -42.08 38.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.799 -0.563 . . . . 0.0 111.958 -177.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 m -68.72 -54.53 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.623 -1.298 . . . . 0.0 110.165 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.2 m-80 -59.02 -20.38 52.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.051 -1.031 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 35.6 t80 -80.18 -51.1 9.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.554 1.168 . . . . 0.0 109.285 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 1.009 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -60.58 -29.18 69.02 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.593 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 42' ' ' VAL . 16.4 m-20 -67.1 -31.13 71.4 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.874 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.74 -23.21 49.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 48' ' ' LEU . 48.6 t -84.16 -25.57 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.6 m -88.07 -19.3 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.703 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.25 -32.21 15.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.163 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 47' ' ' THR . 1.1 t -84.09 8.88 14.06 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.539 -0.726 . . . . 0.0 109.838 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 69.1 m-20 61.72 27.08 16.56 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.155 -0.965 . . . . 0.0 108.96 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.51 27.3 73.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 44' ' ' SER . 26.0 p -105.19 -1.47 25.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.74 -79.77 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 7.3 p 95.57 136.52 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.108 0.956 . . . . 0.0 110.185 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 15.1 tp -67.28 158.64 31.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 4.7 p -109.22 -43.24 4.19 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.758 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -178.71 167.01 1.74 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' HA ' HD23 ' A' ' 23' ' ' LEU . 23.3 m-85 -74.69 171.24 14.27 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.128 -0.983 . . . . 0.0 108.53 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -176.7 46.71 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.34 155.58 18.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.24 . . . . 0.0 109.077 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.454 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.91 -174.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.371 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.47 155.47 44.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 5' ' ' SER . 14.3 m -139.44 75.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.482 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 56.6 p 175.01 149.59 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.246 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.1 p -122.06 175.52 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 109.65 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.2 t0 -87.3 134.0 33.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 6' ' ' VAL . 12.8 m -144.7 42.06 1.34 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.221 -0.924 . . . . 0.0 109.869 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.438 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 27.3 t -90.83 -8.82 48.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -0.949 . . . . 0.0 109.685 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.3 mm-40 -97.9 -1.74 42.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.973 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.853 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -82.88 158.16 65.41 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.131 -0.981 . . . . 0.0 109.526 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.51 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 37.1 Cg_endo -75.76 165.46 85.54 Favored 'Cis proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.589 1.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.6 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 6.0 mtmt -120.03 143.83 36.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.54 14.57 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.506 2.137 . . . . 0.0 111.1 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.83 128.37 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.355 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -105.51 144.21 32.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.743 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -61.71 -177.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 108.667 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -111.1 -20.77 12.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.052 -1.03 . . . . 0.0 109.738 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.738 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.3 mt-10 -44.89 122.63 3.34 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.121 -0.987 . . . . 0.0 108.751 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.494 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 32.8 t80 -86.93 108.81 18.97 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 122.497 1.141 . . . . 0.0 110.177 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.9 mtm180 -144.26 90.62 6.63 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -67.23 109.21 1.7 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.105 1.87 . . . . 0.0 112.239 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.657 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -105.45 118.49 36.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.572 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -79.33 176.93 9.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 110.542 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -139.91 172.91 23.18 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.425 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.5 t -65.65 -31.27 72.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.746 -0.856 . . . . 0.0 109.678 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.4 p30 -65.77 -8.74 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 83.15 19.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -103.22 154.37 19.4 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 53.6 m -106.54 143.73 34.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.651 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 94.5 m-85 -118.37 116.07 25.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 108.949 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.64 -54.43 0.63 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p-10 -144.11 -170.35 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.656 -1.496 . . . . 0.0 110.706 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.0 -28.22 67.53 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.978 -0.451 . . . . 0.0 111.634 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.5 t -70.98 -51.14 27.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.55 -1.344 . . . . 0.0 109.278 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.539 -0.725 . . . . 0.0 109.914 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE1' HD21 ' A' ' 48' ' ' LEU . 31.2 t80 -69.12 -53.31 20.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.442 1.115 . . . . 0.0 109.715 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.6 m -56.28 -47.84 77.81 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.334 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 6.0 m-20 -48.72 -33.3 9.93 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.36 -39.67 67.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.295 -0.878 . . . . 0.0 108.664 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.764 ' CG2' HD23 ' A' ' 48' ' ' LEU . 77.6 t -60.43 -57.2 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.626 -0.672 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.853 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -64.59 -22.34 31.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.473 -0.767 . . . . 0.0 110.612 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.13 -10.96 36.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.92 -1.113 . . . . 0.0 109.138 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.892 ' O ' HG22 ' A' ' 47' ' ' THR . 6.2 p -115.05 25.66 10.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 110.438 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' C ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 43.71 53.55 5.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.905 -1.122 . . . . 0.0 109.527 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.09 43.55 8.94 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 44' ' ' SER . 6.1 t -117.12 2.13 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -1.083 . . . . 0.0 108.483 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -84.61 -50.79 7.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.076 0.941 . . . . 0.0 108.536 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.675 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 62.0 p 57.66 126.34 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.302 1.049 . . . . 0.0 110.32 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.7 tp -61.65 131.15 49.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.566 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.9 t -79.44 -23.24 43.28 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 108.656 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.585 ' O ' HD11 ' A' ' 50' ' ' LEU . 10.1 p-80 154.46 163.47 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.15 151.82 44.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.824 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 90.73 -176.4 41.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.64 169.28 15.5 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.047 -1.266 . . . . 0.0 108.373 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.601 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 30.4 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.33 13.03 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.863 . . . . 0.0 109.353 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.4 -172.0 1.6 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.535 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.672 ' O ' HG22 ' A' ' 4' ' ' VAL . 4.0 p -147.06 66.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.279 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.8 t -165.06 -177.22 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.292 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 23' ' ' LEU . 79.2 t -120.47 151.65 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.688 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -73.19 147.12 45.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 m -134.49 43.24 2.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -90.21 -11.45 40.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -125.03 49.61 1.85 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.878 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.9 m-85 -135.23 162.61 56.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.313 -0.867 . . . . 0.0 109.076 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.35 157.69 54.38 Favored 'Cis proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.852 -1.728 . . . . 0.0 110.749 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.39 140.24 25.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 108.688 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.37 14.97 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.679 2.253 . . . . 0.0 111.731 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.83 154.25 0.71 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.155 -0.965 . . . . 0.0 110.056 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 t -148.63 171.05 16.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -124.57 2.12 8.28 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.751 -1.218 . . . . 0.0 110.289 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.41 127.42 31.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 6.0 t80 -80.04 110.59 15.57 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.553 1.168 . . . . 0.0 111.272 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.22 73.29 37.75 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.462 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.5 Cg_endo -64.29 123.16 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.553 2.169 . . . . 0.0 112.721 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.4 mt -112.74 122.99 49.29 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -82.92 112.2 19.49 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.126 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.6 -166.13 0.06 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -78.1 -32.49 50.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -1.16 . . . . 0.0 109.137 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 37.1 p-10 -73.08 0.01 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.825 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 m120 77.27 30.32 0.53 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -98.87 137.5 37.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 m -86.97 122.61 31.06 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 82.0 m-85 -99.17 139.45 34.8 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -54.03 -39.03 62.02 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.111 -1.043 . . . . 0.0 112.021 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.4 p30 -162.58 -157.06 0.43 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.725 -1.456 . . . . 0.0 109.304 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.37 -47.5 85.78 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 111.263 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.516 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 89.3 m -68.07 -43.13 79.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.535 -1.353 . . . . 0.0 109.965 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -59.38 -24.08 63.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.825 -1.172 . . . . 0.0 108.449 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.915 ' CB ' HD12 ' A' ' 23' ' ' LEU . 10.3 t80 -83.15 -63.03 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.05 0.929 . . . . 0.0 111.004 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 t -56.92 -47.0 81.62 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.781 -0.574 . . . . 0.0 110.041 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 25.7 m-20 -42.43 -29.45 0.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.17 . . . . 0.0 108.307 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -73.86 -49.8 23.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.707 HG13 ' HA2' ' A' ' 46' ' ' GLY . 92.8 t -53.53 -54.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.573 0.702 . . . . 0.0 109.732 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.6 m -60.17 -30.06 45.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.289 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -85.78 -13.35 48.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 108.729 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.4 p -106.19 -2.75 22.14 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.473 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.8 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.0 OUTLIER 74.66 13.28 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 109.323 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.707 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.95 7.46 70.58 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.887 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.8 HG23 ' OD1' ' A' ' 45' ' ' ASN . 70.8 p -82.71 0.19 44.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.637 -1.507 . . . . 0.0 108.609 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 49' ' ' THR . 7.5 tp -80.15 -75.48 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.491 0.662 . . . . 0.0 110.117 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 p 62.56 147.0 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.06 171.69 7.21 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.858 -177.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.677 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.07 -29.43 8.97 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.593 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -167.92 159.84 11.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.6 -0.688 . . . . 0.0 110.082 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.49 -166.32 0.52 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.2 -167.1 18.25 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.34 -179.04 4.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 109.838 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 1' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.23 35.52 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.779 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 4' ' ' VAL . . . -148.03 115.57 6.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.759 HG13 HD23 ' A' ' 50' ' ' LEU . 73.0 t -156.77 82.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 t -164.15 106.87 0.92 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' SG ' ' A' ' 8' ' ' CYS . 9.2 p -104.42 163.81 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.032 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' N ' HG22 ' A' ' 6' ' ' VAL . 25.4 t70 -105.1 108.95 20.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 17.8 m -128.95 52.86 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 t -90.29 -13.16 35.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -103.54 17.08 24.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 109.31 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 73.9 m-85 -96.72 163.68 19.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.911 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -83.09 135.63 26.65 Favored 'Cis proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.308 -1.538 . . . . 0.0 111.258 1.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -100.79 138.38 20.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.82 14.04 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.401 2.068 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.21 19.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 94.2 m -103.67 146.46 28.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.261 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.459 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -55.73 -166.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.459 -0.775 . . . . 0.0 108.91 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 19' ' ' GLU . 3.3 pp -126.55 -37.34 2.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.49 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.1 pm0 -50.57 137.57 19.27 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.5 t80 -79.5 121.37 25.12 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.32 1.057 . . . . 0.0 110.382 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmm180 -148.61 72.38 10.67 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -65.51 114.43 2.89 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.046 1.831 . . . . 0.0 111.743 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -109.42 138.56 45.6 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.991 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -89.15 165.13 14.68 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -127.42 168.55 19.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.607 ' H ' HD12 ' A' ' 48' ' ' LEU . 35.4 t -66.81 -25.98 66.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -1.047 . . . . 0.0 108.856 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.8 p30 -65.52 -10.88 38.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 t-20 85.38 29.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 110.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -120.85 -179.37 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.968 -1.082 . . . . 0.0 109.261 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 31' ' ' TYR . 53.1 m -118.95 166.13 13.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.656 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 72.0 m-85 -138.49 110.9 7.46 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.48 -55.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -177.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.5 p30 -146.87 -172.54 4.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.771 -1.429 . . . . 0.0 110.787 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -53.26 -36.29 60.95 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.849 -0.532 . . . . 0.0 110.355 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.2 t -62.33 -69.47 0.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.63 -1.294 . . . . 0.0 108.937 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.567 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.6 m-80 -43.22 -38.7 2.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 110.765 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 48' ' ' LEU . 72.9 t80 -70.59 -40.14 73.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.688 1.233 . . . . 0.0 110.483 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 91.7 m -68.53 -34.94 76.74 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.519 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.649 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.8 m-80 -69.08 -23.77 64.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.89 -1.131 . . . . 0.0 108.226 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.64 -24.9 33.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.561 ' CG2' HD23 ' A' ' 48' ' ' LEU . 72.9 t -80.99 -27.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.9 m -89.52 -21.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.746 . . . . 0.0 109.127 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.74 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -91.04 -31.15 16.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 47' ' ' THR . 86.4 p -86.93 -0.09 55.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.585 -0.697 . . . . 0.0 109.806 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 77.97 12.74 1.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.247 -0.908 . . . . 0.0 108.813 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.1 16.57 66.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 44' ' ' SER . 7.4 t -98.02 10.1 41.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -1.123 . . . . 0.0 108.95 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.68 -53.3 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.615 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 81.1 p 53.65 124.97 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.644 1.211 . . . . 0.0 111.703 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.991 HD12 ' O ' ' A' ' 24' ' ' CYS . 2.2 tp -71.6 152.75 42.64 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.74 -25.27 11.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.977 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.2 p80 -173.3 157.92 3.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -79.51 164.31 24.01 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.05 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 92.78 -167.27 29.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.81 129.39 36.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.083 -1.245 . . . . 0.0 109.645 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.508 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 60.19 16.59 6.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.751 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.91 51.4 1.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.071 -1.018 . . . . 0.0 109.591 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 52' ' ' HIS . 16.3 m -97.37 97.44 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.881 . . . . 0.0 109.217 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.3 156.22 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.415 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.98 151.22 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.35 159.24 15.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.42 36.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 0.0 109.246 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -85.57 -28.65 24.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.788 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.64 46.09 1.03 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.469 -0.769 . . . . 0.0 109.048 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 59.9 m-85 -139.77 161.25 57.4 Favored Pre-proline 0 C--N 1.306 -1.293 0 O-C-N 121.316 -0.865 . . . . 0.0 109.141 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.977 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -83.51 148.95 61.97 Favored 'Cis proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.882 -1.716 . . . . 0.0 110.793 2.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -102.94 137.78 19.37 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.94 14.66 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.658 2.239 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.26 158.04 2.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 30.3 t -146.54 163.04 37.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.694 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -56.91 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -122.81 -7.72 8.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.505 -1.372 . . . . 0.0 110.789 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' N ' HD12 ' A' ' 18' ' ' LEU . 12.1 pm0 -55.93 -173.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 3.4 t80 -128.93 121.32 27.83 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.9 mmt180 -151.22 66.17 7.02 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 54' ' ' GLY . 23.4 Cg_endo -63.28 137.17 59.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.494 2.796 . . . . 0.0 112.551 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -127.49 143.49 51.18 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.202 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.654 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.0 t -101.53 162.3 13.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.236 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -106.95 178.55 22.17 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.1 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.649 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 27.4 t -70.65 -18.79 62.85 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -78.9 -10.98 59.98 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 85.06 33.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.315 0.579 . . . . 0.0 109.662 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -111.94 139.82 47.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.248 -0.908 . . . . 0.0 109.019 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.5 m -90.04 161.97 15.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.147 . . . . 0.0 110.018 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 63.9 m-85 -138.39 137.92 37.74 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.55 -50.23 3.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -164.37 -166.21 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.152 -1.204 . . . . 0.0 111.123 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -47.72 -48.48 29.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.717 -0.614 . . . . 0.0 112.374 -177.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 6.0 m -65.86 -52.64 48.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.473 -1.392 . . . . 0.0 110.457 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.1 m-80 -60.06 -17.45 39.54 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.847 -1.158 . . . . 0.0 109.347 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.693 ' CE1' HD21 ' A' ' 48' ' ' LEU . 27.6 t80 -82.59 -50.31 8.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.588 1.185 . . . . 0.0 109.762 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 42' ' ' VAL . 48.7 t -66.51 -24.02 66.33 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.786 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -64.43 -26.22 68.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.771 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.28 -26.8 26.4 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 46' ' ' GLY . 93.1 t -80.97 -23.72 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.7 m -90.82 -25.65 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.771 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.6 pp20? -90.42 -28.23 18.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 47' ' ' THR . 48.2 t -89.11 3.54 51.48 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.5 t30 77.11 9.77 2.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 108.958 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 82.89 3.21 90.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 44' ' ' SER . 14.1 t -79.85 2.68 22.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.041 -1.27 . . . . 0.0 108.974 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.41 -50.02 11.45 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.805 0.812 . . . . 0.0 109.088 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.649 ' HG1' ' HB2' ' A' ' 26' ' ' SER . 25.2 p 54.86 122.13 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.293 1.044 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.634 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.9 tp -60.61 152.99 24.84 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.15 -20.26 11.01 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.713 ' HA ' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER 171.23 158.46 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.624 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 5.1 m-85 -71.18 -169.23 0.36 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 109.002 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.11 -168.76 5.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -91.41 146.41 23.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.429 -1.042 . . . . 0.0 109.452 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.397 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 177.96 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.956 . . . . 0.0 109.68 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.64 106.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.459 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 4' ' ' VAL . 74.8 t -90.93 67.73 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.36 175.54 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.88 144.6 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.314 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -67.55 116.75 8.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 m -99.15 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 m -90.48 -8.67 49.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.49 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 3.9 pm0 -112.97 -7.55 13.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.973 -1.079 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.72 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.6 m-85 -88.88 158.9 46.87 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 108.938 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -79.89 134.99 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.841 -1.733 . . . . 0.0 110.631 3.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.63 138.98 19.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.638 -0.664 . . . . 0.0 110.215 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.76 15.05 2.02 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.512 2.141 . . . . 0.0 110.237 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.42 133.42 20.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.806 . . . . 0.0 109.243 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 82.3 m -112.23 150.31 31.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 p -56.75 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 108.942 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -123.6 -28.3 3.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.998 -1.064 . . . . 0.0 109.725 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 9.5 pm0 -58.57 -166.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.5 t80 -132.83 124.75 28.57 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.258 1.028 . . . . 0.0 110.62 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -154.78 75.83 5.5 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.2 Cg_endo -64.59 123.67 12.08 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.701 2.267 . . . . 0.0 112.557 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -117.39 126.78 53.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 49.5 t -79.4 161.78 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.301 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -132.91 166.54 23.6 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.545 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 28' ' ' ASN . 13.2 t -53.15 -48.46 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.945 . . . . 0.0 110.781 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -41.63 -26.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.202 -179.344 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 p-10 97.93 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.273 0.559 . . . . 0.0 109.899 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -125.81 173.64 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 109.583 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -108.9 150.02 28.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 74.0 m-85 -117.36 124.75 49.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.94 -52.32 1.19 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.5 p-10 -158.51 -168.34 2.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.746 -1.444 . . . . 0.0 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 7.8 pttt -46.86 -49.95 19.37 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.995 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 43.9 t -56.1 -64.88 0.72 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.696 -1.252 . . . . 0.0 110.07 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.4 m-80 -53.64 -18.9 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HB2' HD12 ' A' ' 23' ' ' LEU . 6.8 t80 -79.41 -65.06 1.05 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.677 -1.265 . . . . 0.0 110.216 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.566 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.6 t -56.48 -48.71 76.55 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.033 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.0 m-20 -43.91 -28.0 0.41 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.614 -1.304 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -74.43 -48.03 30.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.975 HG22 HD23 ' A' ' 48' ' ' LEU . 79.7 t -57.08 -54.64 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.646 0.736 . . . . 0.0 109.649 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 12' ' ' PRO . 20.3 m -58.25 -30.28 39.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -91.27 -10.59 40.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.154 -0.966 . . . . 0.0 109.36 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 13.7 t -102.96 12.68 35.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 110.398 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.2 m-80 62.44 23.89 14.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.059 -1.026 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.88 25.11 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.5 p -95.13 -4.16 46.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.395 -1.062 . . . . 0.0 108.209 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -88.94 -76.51 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.081 0.943 . . . . 0.0 109.306 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 80.94 152.0 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.871 0.843 . . . . 0.0 108.955 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 68.2 tp -68.92 158.21 35.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p -111.96 -42.38 3.79 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.01 169.94 1.9 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -82.12 176.37 9.57 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.001 -1.062 . . . . 0.0 108.655 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -168.13 54.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 153.14 20.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 109.145 178.722 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 26.9 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 3' ' ' ALA . . . -112.64 -65.14 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 0.0 109.757 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . -43.4 136.52 3.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.791 ' O ' HG13 ' A' ' 4' ' ' VAL . 13.1 p -154.16 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.457 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 28.5 p 178.71 154.87 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p -115.27 177.51 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 109.282 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.67 ' H ' HG22 ' A' ' 6' ' ' VAL . 61.2 t0 -125.78 130.27 51.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.964 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 15.6 m -129.71 69.51 1.42 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -91.21 -18.79 23.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.65 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.3 mp0 -106.22 27.5 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.134 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.979 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.7 m-85 -109.3 158.26 34.98 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.087 -1.008 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.796 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -80.86 143.97 64.25 Favored 'Cis proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.823 2.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 7.1 mttt -103.5 136.03 19.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.858 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.6 14.71 1.77 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.757 2.305 . . . . 0.0 110.58 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.12 136.84 11.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.6 m -128.55 136.89 51.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 109.841 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.9 p -55.99 -165.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.3 pp -131.87 1.36 3.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.844 -1.16 . . . . 0.0 110.326 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 4.9 mm-40 -57.4 -165.99 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.1 t80 -139.73 115.08 9.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.448 -1.301 . . . . 0.0 111.38 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.77 74.3 8.64 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -65.35 121.9 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.894 -176.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.632 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.34 137.53 50.35 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER -86.67 167.58 14.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.376 -0.827 . . . . 0.0 109.11 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.38 159.73 23.47 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -19.68 64.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -1.164 . . . . 0.0 108.915 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -66.74 -9.16 33.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 58.2 t30 87.48 22.87 0.05 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.85 -0.531 . . . . 0.0 110.669 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.14 177.44 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.82 -1.175 . . . . 0.0 109.627 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 31' ' ' TYR . 29.9 m -118.24 166.5 12.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.233 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' N ' HG22 ' A' ' 30' ' ' THR . 73.7 m-85 -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.94 -51.28 7.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.955 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.3 p-10 -149.4 -165.29 2.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.763 -1.433 . . . . 0.0 110.828 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.22 -24.61 67.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.642 -0.661 . . . . 0.0 111.537 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 11.6 t -76.27 -39.55 54.05 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.574 -1.328 . . . . 0.0 108.898 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.3 m-80 -72.1 -34.48 68.67 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.506 -0.746 . . . . 0.0 109.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 24' ' ' CYS . 63.2 t80 -75.65 -44.18 43.92 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.393 1.092 . . . . 0.0 109.896 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 20.9 m -66.51 -38.45 87.25 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.568 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.595 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.9 m-80 -63.74 -21.37 66.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.15 -27.91 25.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.549 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.4 t -76.45 -26.89 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.979 HG11 ' CB ' ' A' ' 11' ' ' TYR . 21.0 m -91.07 -26.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.372 0.606 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -90.7 -15.36 30.46 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 20.0 t -101.29 12.6 37.18 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.157 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.031 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 68.64 7.72 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.066 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 13.16 66.32 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.031 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.3 p -79.6 -11.11 59.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.289 . . . . 0.0 108.746 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -78.38 159.34 28.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.826 ' H ' HD12 ' A' ' 48' ' ' LEU . 81.2 p -157.64 126.46 5.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.095 0.95 . . . . 0.0 110.061 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -63.43 145.51 55.47 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.505 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.84 -25.04 11.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.695 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -171.42 160.73 6.14 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -79.35 174.06 11.95 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.197 -0.939 . . . . 0.0 108.768 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.31 -166.64 42.31 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.586 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.96 131.06 37.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.047 -1.266 . . . . 0.0 109.048 178.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.532 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 1' ' ' LEU . 5.0 mp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.08 131.14 32.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.57 49.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.462 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 4' ' ' VAL . 25.1 m -96.54 87.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.9 p 176.11 158.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 t -128.15 153.6 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -64.27 119.07 9.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 108.962 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 6' ' ' VAL . 15.9 m -132.38 40.17 3.32 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.093 -1.004 . . . . 0.0 110.044 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.05 4.95 48.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -126.81 2.72 6.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.069 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 46.1 m-85 -84.71 162.07 51.46 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.13 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -71.68 148.04 89.51 Favored 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.891 2.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -91.5 144.44 29.62 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.92 13.57 1.93 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.53 2.153 . . . . 0.0 110.822 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.35 117.83 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.7 m -102.77 135.14 44.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HD3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -55.88 142.92 33.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 18' ' ' LEU . 5.2 mt -75.88 -36.58 59.48 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.97 . . . . 0.0 109.51 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -42.84 122.28 2.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.356 -0.84 . . . . 0.0 108.782 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.5 t80 -80.82 104.27 11.22 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.672 1.225 . . . . 0.0 110.543 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.634 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 mmt180 -137.55 80.91 31.17 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -66.97 128.83 19.45 Favored 'Trans proline' 0 C--O 1.202 -1.323 0 C-N-CA 123.994 3.129 . . . . 0.0 114.771 -176.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mp -107.83 158.34 17.4 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -116.48 137.3 52.27 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.285 -1.509 . . . . 0.0 110.394 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.841 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -102.07 157.71 18.45 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.221 -0.925 . . . . 0.0 112.969 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -55.4 -18.64 7.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.192 -0.593 . . . . 0.0 110.382 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -84.57 20.29 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.998 -1.064 . . . . 0.0 109.398 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 27.4 t30 56.83 15.34 2.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -99.69 127.54 45.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 55' ' ' LYS . 18.1 m -89.03 126.55 35.47 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.55 -0.719 . . . . 0.0 109.794 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 126.45 43.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -24.8 -42.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.636 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.4 p30 -178.73 -154.85 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 109.745 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.39 -60.13 3.59 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 110.658 -177.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 49.2 t -52.44 -65.75 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.606 -1.309 . . . . 0.0 110.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.536 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 10.2 m-80 -49.28 -21.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE1' HD21 ' A' ' 48' ' ' LEU . 4.8 t80 -78.8 -71.31 0.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.012 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.687 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.1 m -39.72 -40.62 0.96 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.413 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.92 -44.91 94.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.474 -1.391 . . . . 0.0 108.016 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.696 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -54.17 -21.64 9.33 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 48' ' ' LEU . 56.7 t -85.64 -63.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -59.0 -9.21 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 110.279 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.02 -32.02 16.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.551 -1.343 . . . . 0.0 107.78 178.302 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -92.22 7.89 40.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 80.93 3.71 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.331 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 86.94 6.23 79.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -79.79 2.25 23.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -1.188 . . . . 0.0 108.758 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.12 -78.91 0.34 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.364 -0.835 . . . . 0.0 109.339 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.57 148.13 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.047 0.927 . . . . 0.0 109.276 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' A' ' 23' ' ' LEU . 13.1 tp -67.29 166.47 14.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.599 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -122.6 -44.62 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.72 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -160.28 159.37 31.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -77.21 143.43 39.0 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.714 0.768 . . . . 0.0 110.057 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 101.91 -167.42 18.45 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.48 137.63 32.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.438 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.516 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.441 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.34 110.6 14.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.49 96.78 5.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.49 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.77 77.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.902 . . . . 0.0 109.518 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.79 84.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.95 115.7 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.43 104.73 5.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.999 . . . . 0.0 109.601 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 59.8 m -103.59 52.72 0.77 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -21.53 38.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.0 109.859 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.75 -7.53 59.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.855 ' HB3' HG11 ' A' ' 42' ' ' VAL . 74.7 m-85 -79.87 163.86 56.01 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.97 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.8 Cg_endo -82.38 143.0 51.26 Favored 'Cis proline' 0 C--N 1.306 -1.664 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.088 2.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.2 mttt -97.35 141.11 22.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.033 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.42 15.13 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.755 2.303 . . . . 0.0 110.477 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.27 116.29 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 109.028 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.6 m -82.24 145.59 29.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -52.35 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -114.91 -19.29 11.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.822 -1.174 . . . . 0.0 110.262 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 18' ' ' LEU . 16.5 pm0 -57.9 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.788 -1.195 . . . . 0.0 107.827 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.2 t80 -139.15 126.85 21.95 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.893 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.2 mtm180 -161.52 81.03 1.99 Allowed Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 21.0 Cg_endo -63.83 107.24 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.192 1.928 . . . . 0.0 111.739 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -100.6 126.09 47.05 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.198 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 43.3 t -77.97 168.1 20.43 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -145.46 161.19 28.19 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.102 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -59.45 -35.18 73.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.728 -0.866 . . . . 0.0 109.441 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.635 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -45.18 -27.43 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 109.036 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.8 t-20 101.11 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.063 0.458 . . . . 0.0 109.961 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 175.24 8.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.105 -0.997 . . . . 0.0 109.616 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 31' ' ' TYR . 38.0 m -106.18 162.08 13.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.883 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.7 m-85 -133.26 102.66 5.65 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.188 -0.945 . . . . 0.0 108.618 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.14 -60.29 0.02 OUTLIER Glycine 0 N--CA 1.499 2.856 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.1 p30 -143.42 -170.37 3.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.968 -1.313 . . . . 0.0 110.627 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.19 -48.32 45.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.853 -0.529 . . . . 0.0 110.816 -178.804 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 18.2 t -53.32 -71.59 0.07 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.741 -1.225 . . . . 0.0 109.432 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.2 m-80 -40.28 -39.77 1.01 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.839 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.608 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 35.9 t80 -61.73 -51.51 68.05 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.862 1.315 . . . . 0.0 109.833 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 90.1 m -57.77 -50.89 71.72 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.575 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -44.37 -29.29 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.833 -1.167 . . . . 0.0 108.66 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.42 -49.41 49.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.814 HG22 ' CD2' ' A' ' 48' ' ' LEU . 38.4 t -57.62 -56.84 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.667 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.97 HG21 ' HB3' ' A' ' 12' ' ' PRO . 13.2 m -58.7 -23.07 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 0.0 110.642 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.1 tt0 -91.43 -17.48 25.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.391 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 11.9 t -105.69 22.95 14.67 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.342 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 21.6 m120 64.74 9.61 5.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 109.524 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 80.92 17.93 71.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.1 p -89.97 -9.43 48.78 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.373 -1.075 . . . . 0.0 108.239 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.814 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.47 149.76 28.6 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 5.1 p -122.41 151.52 41.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.6 tp -65.52 124.28 21.89 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.3 t -78.55 -24.75 45.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.62 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CB ' ' O ' ' A' ' 51' ' ' SER . 15.9 p80 151.02 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.299 0.571 . . . . 0.0 110.056 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 154.91 22.54 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 85.54 178.5 50.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -79.85 161.37 25.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.892 -1.358 . . . . 0.0 107.947 178.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.579 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.687 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.6 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 74.36 142.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.326 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.29 89.12 2.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.892 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.691 ' O ' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -104.32 80.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 0.0 108.882 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -162.01 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.403 -0.81 . . . . 0.0 109.795 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.766 ' O ' HG12 ' A' ' 6' ' ' VAL . 87.1 t -145.41 47.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.095 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 50.2 t0 63.77 147.42 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 40.8 t -160.49 20.89 0.15 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.027 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -90.8 -4.01 56.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -108.56 34.82 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.734 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.1 m-85 -133.23 159.67 71.7 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -73.42 159.6 97.14 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.859 -1.725 . . . . 0.0 111.994 2.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttt -117.72 144.78 35.05 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.26 14.48 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.44 2.093 . . . . 0.0 111.411 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 166.21 134.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.2 t -112.03 157.62 20.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.516 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.486 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 10.6 p -59.3 -162.53 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -120.53 -15.92 8.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.524 -1.36 . . . . 0.0 109.976 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.9 pt-20 -46.62 130.55 11.37 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.1 t80 -89.28 130.02 35.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.391 1.091 . . . . 0.0 111.107 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mtt180 -160.63 74.26 2.79 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.0 Cg_endo -64.59 129.7 24.42 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.145 2.563 . . . . 0.0 112.794 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.654 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.93 135.72 53.94 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.515 -1.274 . . . . 0.0 108.212 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.967 ' O ' HD12 ' A' ' 50' ' ' LEU . 8.7 t -77.37 133.44 38.72 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -79.94 -162.68 26.03 Favored Glycine 0 C--N 1.292 -1.867 0 C-N-CA 117.67 -2.205 . . . . 0.0 109.218 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.544 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -85.85 -33.87 21.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -1.2 . . . . 0.0 108.331 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -57.3 -17.29 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t30 96.31 22.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 120.982 0.42 . . . . 0.0 110.707 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -107.49 -158.5 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 0.0 109.163 178.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.9 m -129.74 158.9 38.12 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.484 -0.76 . . . . 0.0 110.031 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -132.74 135.02 45.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.95 -50.3 1.5 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -163.73 -157.42 0.4 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.945 -1.327 . . . . 0.0 110.369 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 112.146 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.652 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -64.9 -57.01 9.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.585 -1.322 . . . . 0.0 110.43 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.06 -32.21 71.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.025 -1.047 . . . . 0.0 110.129 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 7.0 t80 -62.38 -60.06 4.1 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.793 -1.192 . . . . 0.0 109.511 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.8 t -56.79 -49.68 74.61 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.033 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 7.1 m-20 -40.97 -30.82 0.14 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.807 -1.183 . . . . 0.0 108.084 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.38 -49.45 18.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD23 ' A' ' 48' ' ' LEU . 88.1 t -60.36 -63.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.1 p -55.89 -26.36 20.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 111.785 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.43 -16.17 27.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.08 -1.637 . . . . 0.0 108.737 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 10.7 t -98.85 21.94 10.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 110.097 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 78.4 m-20 65.22 8.27 4.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.862 . . . . 0.0 109.927 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.12 11.32 85.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.2 p -79.3 -4.24 49.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.025 -1.28 . . . . 0.0 108.194 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.977 HD23 HG22 ' A' ' 41' ' ' VAL . 1.9 tp -79.94 -86.03 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 80.36 168.69 0.16 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.82 178.89 4.42 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.639 -1.288 . . . . 0.0 110.565 -178.04 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.07 -38.36 3.89 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.74 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.3 p80 -163.93 151.67 12.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.752 0.787 . . . . 0.0 110.139 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.6 m-85 -62.41 -174.97 0.07 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.69 -0.631 . . . . 0.0 109.413 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 66.15 -169.27 32.15 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 1.2 mtmm -92.51 134.99 34.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.691 -0.888 . . . . 0.0 109.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.551 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.954 -1.091 . . . . 0.0 109.402 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.282 0.563 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.14 -92.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.622 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.43 175.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -142.35 73.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.26 124.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 23' ' ' LEU . 63.9 t -98.67 152.72 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.707 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 11.5 p-10 -80.62 -176.37 5.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 7.1 m -157.81 49.77 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.792 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -90.96 -4.27 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.965 . . . . 0.0 110.07 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 4.6 mp0 -134.11 49.4 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.004 -1.06 . . . . 0.0 110.422 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.906 ' HB3' HG11 ' A' ' 42' ' ' VAL . 99.1 m-85 -141.66 153.48 65.05 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 120.922 -1.111 . . . . 0.0 109.241 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.28 136.44 44.95 Favored 'Cis proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.396 -1.918 . . . . 0.0 111.439 2.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.0 tttt -85.4 145.0 41.42 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.662 -0.649 . . . . 0.0 109.62 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.515 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.09 13.73 1.92 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.801 2.334 . . . . 0.0 110.742 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.65 128.07 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.387 -0.821 . . . . 0.0 109.111 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' THR . 71.7 m -91.64 139.08 31.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.85 . . . . 0.0 110.054 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -49.14 174.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.55 -16.83 12.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.96 -1.088 . . . . 0.0 109.928 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -56.53 -168.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.551 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.8 t80 -140.22 123.15 16.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.422 1.106 . . . . 0.0 110.576 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.15 80.92 2.37 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.234 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.59 125.23 14.02 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.694 2.262 . . . . 0.0 112.466 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.38 128.4 55.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.735 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.8 t -78.7 135.34 37.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.58 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -82.6 -165.47 36.93 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 118.511 -1.804 . . . . 0.0 108.613 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 45.8 t -87.45 -29.6 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.664 -1.492 . . . . 0.0 108.728 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -63.06 -14.02 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 109.082 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 53.8 t30 96.28 19.26 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 120.929 0.395 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.655 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.97 -165.54 1.25 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.879 -1.138 . . . . 0.0 108.54 178.759 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.551 HG21 ' HB3' ' A' ' 55' ' ' LYS . 7.7 m -135.4 157.43 46.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.333 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 70.6 m-85 -129.63 121.69 27.55 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -29.07 -51.94 0.13 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 44.7 p30 -158.28 -162.96 1.2 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.111 -1.229 . . . . 0.0 109.488 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -57.71 -48.12 80.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.43 -0.794 . . . . 0.0 111.051 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.7 t -52.8 -52.71 55.81 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 109.962 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.6 m-80 -63.26 -31.5 72.66 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.488 -0.758 . . . . 0.0 110.942 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 19.2 t80 -74.02 -61.65 1.78 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.689 -1.257 . . . . 0.0 110.766 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 30.5 t -57.56 -49.4 76.51 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.927 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.3 m-20 -42.34 -30.89 0.35 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.67 -1.269 . . . . 0.0 108.18 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.839 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -80.12 -43.4 21.76 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.5 t -66.78 -65.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.426 -0.796 . . . . 0.0 108.928 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 11' ' ' TYR . 9.8 p -50.67 -30.57 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 111.423 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.72 -16.96 24.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.056 -1.652 . . . . 0.0 109.137 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.97 ' O ' HG22 ' A' ' 47' ' ' THR . 65.8 p -101.1 19.8 16.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 110.391 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 44' ' ' SER . 1.8 p-10 53.85 29.66 10.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.81 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.21 28.92 73.13 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.258 -0.901 . . . . 0.0 110.861 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' SER . 10.1 t -95.72 -10.62 28.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.839 HD22 ' CB ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.55 -53.7 6.33 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.588 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER 50.99 172.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.302 0.572 . . . . 0.0 109.586 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.49 163.49 28.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 109.099 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.49 -30.97 8.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.735 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -168.93 163.52 11.52 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.429 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.2 -166.48 0.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 57.67 -173.51 2.56 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.13 138.47 31.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.285 -1.126 . . . . 0.0 109.142 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.554 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.29 -77.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . . . -75.86 162.21 28.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.273 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.692 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -117.51 43.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.037 . . . . 0.0 110.395 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER 151.03 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 120.85 0.357 . . . . 0.0 110.235 178.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 5' ' ' SER . 21.3 t -159.32 148.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.077 -1.015 . . . . 0.0 110.423 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.07 122.97 42.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 12.1 m -125.72 43.04 3.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.003 -1.061 . . . . 0.0 110.652 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 10.47 25.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -131.73 6.1 4.33 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.939 -1.101 . . . . 0.0 110.868 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -84.19 156.97 63.05 Favored Pre-proline 0 C--N 1.307 -1.282 0 O-C-N 120.827 -1.17 . . . . 0.0 109.019 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.7 144.98 82.5 Favored 'Cis proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.011 2.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -92.45 147.68 34.88 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.48 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -77.4 13.6 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 111.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.7 112.45 0.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.024 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 17' ' ' THR . 91.8 m -87.86 144.55 26.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -45.37 157.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.83 -33.57 7.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.853 -1.155 . . . . 0.0 110.107 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -62.09 -176.51 0.1 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -115.83 129.32 56.38 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.411 1.101 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 16.2 mtp-105 -159.86 70.73 3.17 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 54' ' ' GLY . 19.4 Cg_endo -60.27 121.79 10.32 Favored 'Trans proline' 0 C--O 1.192 -1.795 0 C-N-CA 123.295 2.664 . . . . 0.0 112.831 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 1.7 mp -103.97 158.73 16.22 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.618 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -116.7 132.05 56.79 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 119.795 -1.816 . . . . 0.0 111.949 -178.194 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.638 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -87.46 160.87 32.04 Favored Glycine 0 N--CA 1.503 3.101 0 CA-C-O 121.758 0.643 . . . . 0.0 111.909 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.498 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -64.44 -34.41 78.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -61.49 -11.84 12.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.397 -0.814 . . . . 0.0 109.309 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.3 m-20 88.27 18.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.815 -0.553 . . . . 0.0 110.942 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 1.3 pttm -107.78 122.28 46.44 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.1 m -80.7 132.97 35.62 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 140.98 31.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.306 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -49.38 -41.51 32.37 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.216 -0.927 . . . . 0.0 112.069 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.9 p30 -164.88 -158.39 0.4 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.448 -1.619 . . . . 0.0 110.363 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -57.75 -45.6 85.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.404 -177.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 36.4 t -68.43 -57.27 6.11 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.703 -1.248 . . . . 0.0 108.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -49.97 -22.23 1.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE1' HD21 ' A' ' 48' ' ' LEU . 7.3 t80 -83.04 -63.67 1.32 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.266 1.032 . . . . 0.0 110.918 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 13.5 m -47.87 -51.4 23.17 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.257 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 9.8 m-20 -48.3 -36.24 13.82 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -60.12 -46.27 90.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.0 t -64.93 -65.17 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.56 0.695 . . . . 0.0 110.246 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.4 p -58.97 -19.58 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.842 . . . . 0.0 112.011 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -93.42 -16.27 24.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.093 -1.629 . . . . 0.0 109.22 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.687 ' O ' HG22 ' A' ' 47' ' ' THR . 4.4 p -98.66 18.39 16.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t30 74.54 4.61 4.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.135 -0.978 . . . . 0.0 108.415 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.81 20.08 69.03 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -87.53 -1.77 58.16 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -1.03 . . . . 0.0 108.642 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -89.45 161.76 16.1 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.786 ' H ' HD12 ' A' ' 48' ' ' LEU . 75.8 p -147.9 130.21 15.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 4' ' ' VAL . 9.1 tp -68.83 141.16 55.2 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.04 -17.91 12.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.802 -1.186 . . . . 0.0 108.065 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.618 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 173.88 154.22 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.54 0.686 . . . . 0.0 109.701 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 5' ' ' SER . 4.1 m-85 -70.31 176.77 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.049 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.14 -172.09 44.85 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CE ' ' OH ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -91.68 156.23 17.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -1.211 . . . . 0.0 108.811 178.569 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.508 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 5.6 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.029 -1.044 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -97.89 102.76 14.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.487 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 167.13 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.6 t -127.13 91.56 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.39 112.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 37' ' ' PHE . 2.6 p -110.45 165.04 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.298 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -114.87 132.64 56.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 79.9 m -130.62 53.58 1.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.3 -16.31 29.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.866 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.51 37.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.159 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.895 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.9 m-85 -125.91 161.09 53.37 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.873 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.29 153.88 50.35 Favored 'Cis proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.281 -1.55 . . . . 0.0 110.999 1.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.0 140.67 25.85 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.622 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.85 14.4 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.58 2.186 . . . . 0.0 111.141 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 167.95 135.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 108.871 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -133.2 165.44 24.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.933 -1.104 . . . . 0.0 110.737 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -54.99 -165.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 0.0 109.39 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.4 pp -122.86 3.68 9.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.008 -1.057 . . . . 0.0 110.273 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.7 pt-20 -47.63 118.44 2.26 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -79.37 126.91 31.42 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.757 1.265 . . . . 0.0 111.759 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.2 ptm180 -161.45 75.12 2.45 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.7 Cg_endo -64.31 118.99 5.91 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -113.05 128.84 56.61 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.507 179.077 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.599 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -88.87 112.09 22.84 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.604 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.67 -169.73 0.05 OUTLIER Glycine 0 N--CA 1.484 1.855 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.7 t -75.5 -34.63 60.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -1.173 . . . . 0.0 109.173 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.9 p30 -68.51 -6.64 26.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.882 . . . . 0.0 109.261 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.1 t-20 83.92 30.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.932 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.18 137.77 37.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.222 -0.924 . . . . 0.0 108.536 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 91.1 m -85.12 135.22 34.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.028 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.731 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.9 m-85 -113.83 142.68 45.79 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -55.98 -39.13 78.08 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.151 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 23.1 p-10 -160.05 -164.25 1.26 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.689 -1.477 . . . . 0.0 109.632 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -29.0 69.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.096 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 62.5 m -77.18 -57.1 4.03 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.041 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 m120 -48.61 -36.85 16.63 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.782 -1.199 . . . . 0.0 108.528 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 23' ' ' LEU . 17.0 t80 -68.38 -56.52 8.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.359 1.076 . . . . 0.0 110.247 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 64.0 m -52.65 -56.6 14.29 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.317 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 14.1 m-20 -38.7 -29.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.31 -51.03 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . 89.8 t -52.24 -53.79 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.646 0.736 . . . . 0.0 109.474 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.895 HG11 ' CB ' ' A' ' 11' ' ' TYR . 32.8 m -59.96 -34.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -91.83 -2.33 56.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.737 ' O ' HG22 ' A' ' 47' ' ' THR . 28.9 t -106.28 -8.26 17.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.8 t-20 80.32 30.41 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.802 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.62 31.93 57.99 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 ' O ' ' A' ' 44' ' ' SER . 10.5 t -114.13 8.31 16.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.0 tp -89.76 -71.03 0.63 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.538 0.685 . . . . 0.0 109.292 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.627 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.9 p 60.5 143.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.646 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -102.55 171.83 7.21 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.213 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.646 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.23 -30.54 8.31 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.599 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -162.53 158.04 23.01 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.391 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 6.4 m-85 -75.81 -164.45 0.36 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 60.43 -169.49 8.12 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -92.45 168.64 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.494 -1.003 . . . . 0.0 108.773 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.8 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.591 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.01 23.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.61 77.37 5.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.643 HG23 ' O ' ' A' ' 4' ' ' VAL . 27.3 m -127.68 80.61 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -143.69 93.7 2.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.4 165.96 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.025 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.0 152.19 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 m -135.01 57.04 1.82 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.273 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -89.1 -15.59 33.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.2 mp0 -95.94 4.13 52.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 109.305 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' HB3' HG11 ' A' ' 42' ' ' VAL . 96.0 m-85 -96.5 159.52 31.66 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.401 -0.812 . . . . 0.0 109.079 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.949 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -81.68 140.29 45.92 Favored 'Cis proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.531 2.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 10.3 mttt -99.78 139.05 20.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -80.61 14.2 2.08 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.55 2.167 . . . . 0.0 110.452 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.92 126.25 7.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 81.5 m -116.57 139.63 50.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 16' ' ' CYS . 7.1 p -55.4 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 108.729 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -121.84 -25.74 4.96 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.497 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mt-10 -45.37 123.62 4.24 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.8 t80 -83.97 105.42 14.84 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.694 1.235 . . . . 0.0 110.693 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.6 mtp180 -136.89 75.33 49.02 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 18.4 Cg_endo -61.15 119.35 6.46 Favored 'Trans proline' 0 C--O 1.193 -1.747 0 C-N-CA 123.523 2.815 . . . . 0.0 114.195 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.669 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 2.7 mp -101.77 154.47 18.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.524 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -114.79 140.35 48.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 119.897 -1.752 . . . . 0.0 109.637 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.664 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.44 161.88 17.96 Favored Glycine 0 N--CA 1.497 2.743 0 CA-C-O 122.4 1.0 . . . . 0.0 113.747 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -37.44 86.15 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.802 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p-10 -58.69 -13.82 6.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.962 . . . . 0.0 109.267 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.8 m-20 91.61 12.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.313 0.578 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 30.5 ttpt -99.28 128.8 45.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -88.29 129.54 35.35 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.849 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.07 132.02 43.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -45.0 -39.74 6.61 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 121.476 -0.765 . . . . 0.0 112.045 -176.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -165.57 -157.26 0.31 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.528 -1.572 . . . . 0.0 110.279 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -57.83 -51.2 70.55 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.475 -178.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.3 t -61.3 -60.01 4.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.68 -1.263 . . . . 0.0 109.214 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -48.9 -23.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 108.858 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.1 t80 -80.78 -65.62 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.125 0.964 . . . . 0.0 110.618 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.85 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.1 m -50.26 -22.8 1.91 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.694 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.1 m-80 -76.83 -40.28 48.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -58.32 -23.38 56.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.0 HG22 HD23 ' A' ' 48' ' ' LEU . 92.4 t -84.04 -53.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.949 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -65.71 -12.36 13.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.684 -0.635 . . . . 0.0 109.649 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -93.55 -18.91 21.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 2.5 t -108.41 22.99 15.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.895 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 79.26 -3.82 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 109.057 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 86.54 11.06 72.26 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.3 t -85.42 -5.94 59.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -1.187 . . . . 0.0 108.838 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.0 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.93 150.91 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.597 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.8 p -123.68 142.99 50.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.11 0.957 . . . . 0.0 109.465 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.6 tp -57.73 121.1 9.63 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.0 t -76.76 -24.26 52.94 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.238 -0.913 . . . . 0.0 109.366 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.57 ' CB ' ' O ' ' A' ' 51' ' ' SER . 16.8 p-80 155.72 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.477 0.656 . . . . 0.0 109.362 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 19.3 m-85 -93.83 156.36 16.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.408 -0.808 . . . . 0.0 109.625 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 86.12 -167.94 40.28 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -176.56 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -1.071 . . . . 0.0 108.443 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 41.1 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 1' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.81 -80.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.38 155.37 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 50' ' ' LEU . 30.4 t -134.92 113.3 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.28 159.84 13.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.539 ' O ' HG12 ' A' ' 6' ' ' VAL . 17.9 t -122.87 38.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 110.078 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 6' ' ' VAL . 18.5 t0 21.57 99.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.152 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 7.8 m -121.55 64.62 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.43 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -91.27 -14.71 30.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.391 -0.818 . . . . 0.0 109.33 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 5.4 mm-40 -105.56 34.93 3.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 110.047 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.7 m-85 -113.73 161.44 27.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.023 -1.048 . . . . 0.0 108.929 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -73.28 175.99 43.21 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.633 -1.82 . . . . 0.0 111.377 2.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -125.78 144.01 47.0 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.582 -0.698 . . . . 0.0 109.559 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.89 14.22 1.76 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.788 2.326 . . . . 0.0 111.204 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.63 141.13 16.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.569 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -116.01 2.56 13.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.825 -1.172 . . . . 0.0 110.981 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 67.43 -17.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 178.455 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 72.21 -9.04 1.06 Allowed 'General case' 0 C--N 1.275 -2.635 0 O-C-N 121.697 -0.627 . . . . 0.0 111.448 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -59.45 129.07 40.19 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.594 -1.316 . . . . 0.0 107.899 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.3 123.18 33.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.527 1.155 . . . . 0.0 111.701 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -162.19 81.94 1.76 Allowed Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.545 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -64.83 117.25 4.35 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.615 2.21 . . . . 0.0 113.344 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.12 136.08 47.58 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -98.83 112.39 24.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.878 -1.139 . . . . 0.0 111.672 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.914 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -51.13 176.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.0 t -72.73 -22.66 60.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -1.176 . . . . 0.0 107.829 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.6 p30 -76.42 -5.73 48.6 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.6 m-20 82.04 30.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 110.363 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -102.74 146.44 28.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 95.8 m -98.3 143.52 28.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 0.0 110.409 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.72 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.9 m-85 -124.81 125.08 43.45 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.59 -46.88 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.363 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 35.9 p-10 -156.61 -168.17 2.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.445 -1.62 . . . . 0.0 111.492 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.07 -37.09 71.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.867 -0.521 . . . . 0.0 112.313 -177.608 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.8 p -77.41 -54.39 6.5 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.655 -1.278 . . . . 0.0 108.662 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 2.6 m120 -50.36 -26.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.017 -1.052 . . . . 0.0 108.888 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 76.5 t80 -87.02 -35.69 18.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 123.069 1.414 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.2 m -67.34 -29.17 68.65 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -70.39 -36.09 73.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.97 -25.35 63.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.4 t -77.64 -40.05 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.333 0.587 . . . . 0.0 110.186 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.9 p -84.7 -13.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.915 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.732 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -91.73 -33.21 15.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 47' ' ' THR . 9.8 t -89.98 20.31 4.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.5 m-80 64.99 10.24 6.1 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.424 -0.797 . . . . 0.0 109.911 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.99 15.69 64.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 44' ' ' SER . 7.7 p -92.26 7.25 43.54 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.018 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.914 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.9 tp -79.5 -66.58 0.85 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.6 p 50.02 118.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 122.456 1.122 . . . . 0.0 111.904 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -77.89 170.89 15.83 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.72 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.99 -22.85 9.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.607 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.2 p80 -164.53 144.53 7.6 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.494 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.11 164.17 13.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 85.81 -170.0 43.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 8.9 mtmm -90.76 165.67 13.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -1.105 . . . . 0.0 109.395 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 37.3 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.932 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 109.453 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.78 41.77 11.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.25 143.44 45.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 4' ' ' VAL . 7.9 m -104.67 82.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.474 ' HA ' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER 175.55 129.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.238 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 37' ' ' PHE . 7.2 p -88.42 146.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 109.602 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.73 139.91 51.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.153 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' HG13 ' A' ' 6' ' ' VAL . 30.6 m -143.29 46.54 1.52 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.735 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.36 -6.38 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.128 -0.982 . . . . 0.0 109.872 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -100.86 13.55 34.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.48 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.074 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.5 m-85 -100.4 159.72 28.95 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -76.68 162.94 90.77 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.568 -1.846 . . . . 0.0 111.247 1.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.58 141.0 26.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.47 13.83 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 109.84 0.49 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -94.28 144.96 25.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.473 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 25.1 p -50.92 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -122.27 -16.81 7.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.058 -1.026 . . . . 0.0 109.904 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' LEU . 13.7 pm0 -55.8 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.59 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.8 t80 -134.74 130.86 36.86 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.25 80.55 2.09 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.8 Cg_endo -63.15 117.76 4.68 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.026 1.817 . . . . 0.0 111.966 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -108.44 132.53 53.69 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.699 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.737 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -80.7 120.72 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.602 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.43 -162.98 5.43 Favored Glycine 0 C--N 1.294 -1.757 0 C-N-CA 118.593 -1.765 . . . . 0.0 108.861 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.7 t -85.24 -49.83 7.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.893 -1.357 . . . . 0.0 109.963 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.8 p-10 -57.39 -14.83 5.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.3 t30 98.12 45.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.084 0.468 . . . . 0.0 110.069 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.07 114.17 20.0 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.353 1.073 . . . . 0.0 109.006 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.6 m -60.32 158.23 12.15 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.127 -0.983 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 1.2 m-85 -129.96 147.53 51.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -53.35 -37.68 55.86 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.555 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.651 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.6 p30 -166.59 -163.86 0.61 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.697 -1.472 . . . . 0.0 109.557 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.49 -36.67 78.87 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.665 -178.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' O ' ' C ' ' A' ' 36' ' ' ASN . 11.8 t -70.11 -64.35 0.91 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.497 -1.377 . . . . 0.0 108.391 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.6 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -40.8 -37.55 0.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.9 t80 -72.47 -59.65 2.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.511 1.148 . . . . 0.0 110.349 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 20.6 m -53.17 -58.54 6.7 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.093 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 15.8 m-20 -38.98 -30.43 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.283 -0.886 . . . . 0.0 109.056 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -74.55 -50.71 17.01 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.39 -59.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.665 -0.647 . . . . 0.0 110.202 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.074 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.3 p -61.49 -26.0 38.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.209 -0.932 . . . . 0.0 111.353 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.91 -8.92 44.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.517 -1.364 . . . . 0.0 109.398 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.5 p -109.13 18.19 20.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 110.307 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.4 m-20 63.46 15.26 8.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 0.0 109.717 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 19.73 76.6 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 44' ' ' SER . 24.2 p -88.99 -2.86 58.79 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.307 -1.113 . . . . 0.0 108.061 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.73 ' C ' HG23 ' A' ' 49' ' ' THR . 8.3 tp -85.28 -80.31 0.22 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.73 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER 68.41 171.55 0.28 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.63 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.11 167.66 14.48 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.376 -0.827 . . . . 0.0 109.697 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.63 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.9 -35.09 7.03 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.737 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -162.18 165.24 27.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.611 0.719 . . . . 0.0 109.129 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CD2' HD23 ' A' ' 23' ' ' LEU . 58.6 m-85 -80.07 175.25 10.81 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 108.968 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.66 -169.25 53.26 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -90.71 129.33 36.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.264 . . . . 0.0 109.787 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.637 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.395 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.7 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -93.45 -120.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 75.07 179.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 1.034 HG23 HD23 ' A' ' 50' ' ' LEU . 2.4 p -135.77 102.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.6 p -162.38 87.6 0.62 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 110.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.16 146.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.975 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -93.11 147.23 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.808 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 71.5 m -133.04 30.24 3.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -0.859 . . . . 0.0 109.284 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -75.2 -23.68 57.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.589 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -90.73 19.91 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.675 ' HB3' HG11 ' A' ' 42' ' ' VAL . 86.8 m-85 -117.58 161.76 32.11 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 1.057 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -82.34 132.96 22.05 Favored 'Cis proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.042 -1.649 . . . . 0.0 110.966 2.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.2 mttt -80.25 143.19 55.9 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.668 -0.645 . . . . 0.0 109.659 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.22 14.18 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.564 2.176 . . . . 0.0 110.27 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 144.82 2.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.7 m -133.94 144.37 48.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 80.5 p -56.32 -168.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.0 109.02 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.05 -16.56 6.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 109.74 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 3.1 pm0 -50.69 132.87 26.2 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 t80 -86.45 125.5 33.75 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 122.824 1.297 . . . . 0.0 111.36 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.2 mtt-85 -160.59 70.64 2.85 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.635 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -62.87 131.07 31.48 Favored 'Trans proline' 0 C--O 1.198 -1.522 0 C-N-CA 124.044 3.163 . . . . 0.0 114.767 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 34' ' ' LYS . 3.1 mp -111.22 159.76 17.6 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 176.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.65 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -120.05 141.16 50.0 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.819 -1.801 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.66 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.51 158.95 18.62 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 122.701 1.167 . . . . 0.0 114.473 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -57.73 -17.79 17.36 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.549 -0.825 . . . . 0.0 109.858 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -89.62 21.8 3.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 109.007 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.82 16.96 3.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.526 -0.734 . . . . 0.0 109.867 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -99.26 120.54 39.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.242 -0.912 . . . . 0.0 108.592 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.869 HG21 ' HD3' ' A' ' 55' ' ' LYS . 42.6 m -84.5 126.49 33.33 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.462 -0.773 . . . . 0.0 109.648 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.82 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.66 136.79 36.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -41.77 -40.51 3.07 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.296 -0.878 . . . . 0.0 111.545 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.1 p30 -171.02 -153.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.677 -1.484 . . . . 0.0 110.318 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.89 -52.31 66.3 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.014 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 7.8 t -64.02 -57.83 8.52 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.737 -1.227 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -49.92 -23.14 1.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.82 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 5.3 t80 -78.25 -67.32 0.75 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.424 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 1.093 ' O ' HG13 ' A' ' 42' ' ' VAL . 6.4 m -45.25 -25.73 0.41 Allowed 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.7 m-80 -70.06 -46.7 64.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -60.67 -19.97 59.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.029 HG22 HD23 ' A' ' 48' ' ' LEU . 53.1 t -90.91 -29.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.134 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.093 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.8 m -83.98 -19.37 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.11 -16.78 25.88 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.916 . . . . 0.0 108.703 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG22 ' A' ' 47' ' ' THR . 0.4 OUTLIER -100.15 9.29 43.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.64 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.7 t30 76.45 6.29 3.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 79.85 7.73 88.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -87.76 9.55 21.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.264 -1.139 . . . . 0.0 108.885 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.029 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -85.66 -77.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.355 -0.841 . . . . 0.0 109.14 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 48' ' ' LEU . 4.2 p 92.27 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.084 0.945 . . . . 0.0 110.203 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.034 HD23 HG23 ' A' ' 4' ' ' VAL . 8.5 tp -72.68 157.71 37.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.08 -18.95 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.655 -1.278 . . . . 0.0 108.385 179.172 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.717 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 174.03 161.17 0.17 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.24 164.78 25.28 Favored 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.635 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.96 -168.5 52.25 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.869 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -91.1 171.72 9.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 3.0 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.616 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.79 -73.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 45.43 -160.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 4' ' ' VAL . 93.2 t -93.7 63.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.271 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 16.4 p 177.68 145.6 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.666 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 34' ' ' LYS . 24.4 t -90.67 134.89 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.11 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.05 112.2 21.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 38.7 m -108.15 64.53 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -89.49 -23.18 22.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -5.26 59.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.843 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -79.83 162.24 63.28 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.181 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.917 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.2 Cg_endo -82.08 144.2 57.53 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.201 -1.583 . . . . 0.0 110.933 2.253 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 26.2 mttt -99.46 141.63 23.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 109.934 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.67 14.26 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.522 2.148 . . . . 0.0 110.27 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 119.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.538 -0.726 . . . . 0.0 109.052 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 64.8 m -93.8 148.9 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.644 ' O ' HD23 ' A' ' 18' ' ' LEU . 66.2 p -56.67 -164.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 17' ' ' THR . 7.3 mt -128.7 -7.58 5.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.94 -1.1 . . . . 0.0 110.654 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.488 ' OE1' ' HG3' ' A' ' 21' ' ' ARG . 1.3 pp20? -65.94 -176.3 0.38 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 9.4 t80 -122.49 129.43 51.99 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 120.862 -1.149 . . . . 0.0 111.239 -178.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 17.1 mtm180 -160.31 73.31 2.97 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.9 Cg_endo -64.73 112.85 2.1 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.909 1.739 . . . . 0.0 110.87 -178.274 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.78 138.61 49.35 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.325 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.869 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 9.2 t -96.24 165.75 12.06 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.912 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.435 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -132.81 176.71 19.35 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.493 -177.484 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.4 t -58.56 -49.24 78.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.667 -0.902 . . . . 0.0 109.049 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.602 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.2 p-10 -47.97 -24.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 108.985 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.3 t-20 91.08 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.22 0.533 . . . . 0.0 109.844 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 4.4 ttmt -127.89 153.5 46.57 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 31' ' ' TYR . 36.8 m -92.82 160.98 14.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 87.5 m-85 -140.11 100.26 3.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 108.679 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -17.43 -61.43 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.113 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.3 p30 -139.34 -169.82 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.923 -1.339 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 28.5 pttt -53.11 -39.47 63.44 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.821 -0.549 . . . . 0.0 110.533 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -63.03 -66.31 0.56 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.996 -1.065 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.8 m-80 -41.43 -34.74 0.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 109.871 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 59.0 t80 -71.72 -44.89 63.36 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.914 1.34 . . . . 0.0 109.69 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 71.5 m -61.73 -55.7 27.49 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' HG22 ' A' ' 42' ' ' VAL . 4.4 m-80 -44.23 -27.61 0.43 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.757 -1.214 . . . . 0.0 108.667 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.56 -47.51 47.57 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 1.008 HG22 ' CD2' ' A' ' 48' ' ' LEU . 32.8 t -60.19 -56.71 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.823 0.82 . . . . 0.0 109.335 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 ' HB3' ' A' ' 12' ' ' PRO . 15.9 m -56.22 -29.08 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 110.553 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.27 -15.73 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.025 -1.047 . . . . 0.0 108.81 179.536 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 89.5 p -106.33 11.25 31.21 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.414 -0.804 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.57 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.9 OUTLIER 50.65 39.05 20.67 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.69 0.757 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 65.56 32.15 82.39 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.749 178.651 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.525 HG23 ' CG ' ' A' ' 45' ' ' ASN . 70.1 p -104.93 -6.11 20.43 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.324 -1.104 . . . . 0.0 108.573 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 1.008 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 -57.11 3.83 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.104 0.954 . . . . 0.0 108.501 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.616 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 32.1 p 63.7 129.47 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.955 -177.373 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -58.21 152.73 16.52 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.1 p -107.38 -42.86 4.7 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.869 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -174.45 160.49 3.19 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.723 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -77.72 139.07 39.36 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.115 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.82 -170.33 16.9 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -89.41 159.17 17.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.884 -1.362 . . . . 0.0 108.007 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.444 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.07 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 165.29 4.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.405 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG12 ' HE1' ' A' ' 53' ' ' PHE . 21.1 t -112.02 110.31 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.629 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.65 -161.62 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.298 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 7' ' ' ASP . 77.0 t -132.18 157.46 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.9 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.9 t0 -77.94 137.81 38.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 60.1 m -146.6 49.17 1.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.823 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -90.55 -10.83 42.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.971 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.82 21.09 11.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.736 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.3 m-85 -106.75 159.69 28.97 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 36.9 Cg_endo -75.61 175.96 45.71 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.711 -1.787 . . . . 0.0 111.364 2.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 50.5 mttt -135.4 139.07 30.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.82 13.96 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.346 2.031 . . . . 0.0 110.58 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.78 114.72 1.57 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -91.81 150.46 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.55 167.39 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 109.124 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -101.09 -33.79 9.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.026 . . . . 0.0 109.625 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -46.0 125.05 5.94 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.042 -1.036 . . . . 0.0 108.797 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -79.69 116.74 20.05 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.393 1.092 . . . . 0.0 109.915 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.68 76.68 10.68 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -64.01 120.98 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.983 2.455 . . . . 0.0 112.614 -177.53 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -114.01 127.61 56.02 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.63 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 37.5 t -79.91 115.97 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -64.75 -170.97 2.5 Favored Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.299 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -80.91 -33.62 34.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.945 -1.327 . . . . 0.0 108.75 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.4 p-10 -60.05 -16.41 31.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 92.9 17.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 109.891 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.54 130.44 45.78 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.169 -0.957 . . . . 0.0 108.725 179.169 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 m -70.88 147.24 49.01 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 71.7 m-85 -120.69 116.18 24.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -26.85 -47.78 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 -177.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.4 p30 -160.7 -163.47 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.616 -1.52 . . . . 0.0 109.694 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.833 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.31 -41.73 80.45 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.397 -179.069 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 42.4 t -61.59 -66.46 0.53 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.734 -1.229 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 12.8 m-80 -43.71 -34.23 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 0.0 110.708 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 25.9 t80 -72.25 -52.57 15.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.179 . . . . 0.0 109.982 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.626 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 32.9 m -53.83 -53.18 56.1 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 4.3 m-20 -41.43 -34.29 0.52 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.154 -0.967 . . . . 0.0 108.864 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.825 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -71.74 -47.24 55.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 46' ' ' GLY . 97.4 t -58.06 -62.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.433 0.635 . . . . 0.0 110.06 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.8 p -58.96 -22.84 22.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 111.869 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.07 -16.42 27.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.377 -1.452 . . . . 0.0 108.702 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' HG22 ' A' ' 47' ' ' THR . 18.9 p -102.63 -2.24 28.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.59 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' SER . 10.5 t30 78.63 12.83 1.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 109.305 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.63 5.86 74.14 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 44' ' ' SER . 14.3 t -79.61 -4.0 49.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.258 -1.143 . . . . 0.0 108.15 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' THR . 4.7 tp -80.4 -82.89 0.11 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 75.27 179.88 0.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.544 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -130.88 -179.79 5.52 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.582 -1.324 . . . . 0.0 110.22 -179.472 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -111.61 -21.91 11.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.018 -1.051 . . . . 0.0 108.465 -179.82 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 179.74 155.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.504 -0.748 . . . . 0.0 109.835 -179.211 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.612 ' HE1' HG12 ' A' ' 4' ' ' VAL . 30.5 m-85 -73.65 148.35 42.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.39 -166.97 14.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.608 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.74 157.67 16.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -1.103 . . . . 0.0 108.219 178.855 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.09 -1.006 . . . . 0.0 109.627 -179.885 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 1' ' ' LEU . 24.9 tp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.49 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -179.43 122.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.099 -1.001 . . . . 0.0 109.556 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.28 68.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.603 ' HA ' HD22 ' A' ' 50' ' ' LEU . 5.4 t -174.2 119.39 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 23' ' ' LEU . 40.3 t -85.56 151.41 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 0.0 109.647 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -101.26 131.17 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.542 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 29.0 m -122.23 58.69 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 t -82.65 -16.85 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -1.92 40.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.117 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.874 ' HB3' HG11 ' A' ' 42' ' ' VAL . 36.4 m-85 -84.53 165.46 37.85 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.985 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.5 153.43 62.92 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.338 -1.526 . . . . 0.0 110.913 1.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -102.9 141.28 22.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.759 . . . . 0.0 109.694 -179.411 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -80.19 13.57 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.561 2.174 . . . . 0.0 110.278 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.02 112.58 1.0 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.5 m -83.89 143.16 30.06 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.62 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.196 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -125.61 -31.88 2.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.897 -1.127 . . . . 0.0 109.928 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 2.8 pm0 -49.03 142.08 7.13 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 7.9 t80 -90.23 126.15 35.73 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 122.731 1.253 . . . . 0.0 111.2 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.68 71.87 2.83 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.855 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -61.16 130.9 34.17 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.531 2.821 . . . . 0.0 113.159 -176.495 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -115.29 126.44 54.49 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.171 178.291 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.779 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.4 t -78.07 133.66 37.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -75.72 -157.26 6.62 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 118.534 -1.793 . . . . 0.0 108.784 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -92.99 -66.55 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 110.171 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.629 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -40.16 -40.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.605 -0.684 . . . . 0.0 109.401 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.6 p30 133.38 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE3' ' CD1' ' A' ' 48' ' ' LEU . 11.3 pttp -108.46 107.27 17.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 109.636 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 46.6 m -66.37 152.13 45.69 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.531 -0.731 . . . . 0.0 109.101 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 m-85 -129.62 142.74 50.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.676 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.555 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -47.52 -35.06 10.35 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.708 -176.797 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 23' ' ' LEU . 43.1 p30 -173.18 -155.55 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.725 -1.456 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.96 -42.39 97.29 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.436 -0.79 . . . . 0.0 110.786 -178.227 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.8 t -66.55 -57.36 7.45 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.579 -1.326 . . . . 0.0 108.512 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -48.93 -37.0 18.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.82 . . . . 0.0 109.478 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 31.9 t80 -70.22 -51.91 27.23 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.492 1.139 . . . . 0.0 110.247 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 61.2 m -55.21 -61.03 2.59 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.289 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' CYS . 3.9 m-20 -37.47 -29.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.302 -0.874 . . . . 0.0 109.657 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -74.33 -52.3 12.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 68.9 t -52.06 -54.72 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.585 0.707 . . . . 0.0 109.738 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.985 HG21 ' HB3' ' A' ' 12' ' ' PRO . 6.1 m -61.89 -26.48 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 111.183 -178.898 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 6.9 tt0 -90.63 -6.43 54.6 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.962 -1.087 . . . . 0.0 109.792 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 p -112.57 18.42 18.39 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.118 -0.989 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.888 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.61 -1.58 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 0.0 109.304 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.88 17.24 61.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.888 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.1 p -87.0 -10.41 53.21 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.248 . . . . 0.0 108.486 178.435 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -78.26 148.47 33.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.712 0.768 . . . . 0.0 109.467 -179.573 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' SER . 1.3 p -137.77 167.17 22.25 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.147 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -109.63 170.31 8.15 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -108.41 -35.77 6.41 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.829 -1.17 . . . . 0.0 107.896 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.779 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -167.86 164.73 14.07 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.568 0.699 . . . . 0.0 109.505 -178.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.65 -167.16 0.33 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.577 -0.702 . . . . 0.0 109.306 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.81 -167.31 4.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -85.55 165.4 17.11 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.614 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.584 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . -179.77 122.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.448 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.27 51.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.96 75.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.46 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.4 p -165.56 106.64 0.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.43 141.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.674 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.53 131.6 35.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.165 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 54.9 m -139.08 49.61 1.84 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -90.91 -10.18 43.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.689 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.67 23.76 9.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 42' ' ' VAL . 46.9 m-85 -117.63 158.28 45.69 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.066 -1.021 . . . . 0.0 108.385 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.24 164.86 84.19 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.003 3.473 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -119.91 146.85 42.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.478 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -78.53 13.67 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.5 2.133 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 150.94 1.29 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.9 m -119.83 138.25 53.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.023 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.3 p -54.04 -171.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 108.817 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -119.51 -22.87 6.81 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.362 179.577 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 2.1 pt-20 -49.95 118.42 2.88 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.207 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.538 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -78.42 126.55 30.93 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.536 1.16 . . . . 0.0 110.501 -178.164 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.0 ptm180 -160.66 77.91 2.5 Favored Pre-proline 0 C--N 1.293 -1.89 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.6 Cg_endo -66.11 127.68 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.707 2.271 . . . . 0.0 112.853 -176.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.749 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -116.88 135.15 53.95 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.881 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.916 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.1 t -92.88 161.48 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.424 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -117.56 168.18 12.9 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.47 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 35.3 t -69.47 -17.97 63.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.64 -0.917 . . . . 0.0 108.636 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 35.7 p30 -73.85 -7.97 54.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.068 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.6 t30 82.33 31.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.756 -0.59 . . . . 0.0 110.044 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -123.94 139.68 53.72 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.143 179.719 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -85.22 159.91 20.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.816 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 48.1 m-85 -130.98 124.85 31.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -38.41 -53.62 2.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.967 -178.129 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -155.06 -164.45 1.79 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.783 -1.422 . . . . 0.0 110.529 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.15 -25.28 68.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 111.533 -178.253 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -70.78 -53.23 16.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.598 -1.314 . . . . 0.0 109.197 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.13 -37.5 87.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.715 -0.616 . . . . 0.0 110.018 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.796 ' CE1' HD21 ' A' ' 48' ' ' LEU . 58.9 t80 -70.51 -47.61 59.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.942 -1.099 . . . . 0.0 109.791 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 17.3 m -64.02 -29.56 70.7 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 95.1 m-20 -72.64 -39.24 67.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.41 -17.3 61.81 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.773 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.2 t -84.54 -50.75 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.001 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 11' ' ' TYR . 6.8 p -68.54 -17.8 22.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.661 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.724 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.08 -31.3 15.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.05 -1.031 . . . . 0.0 108.371 178.548 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' THR . 46.5 t -88.15 15.11 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.633 -0.667 . . . . 0.0 110.53 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' SER . 5.5 m-20 64.04 12.79 7.22 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.203 -0.935 . . . . 0.0 109.511 179.949 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 20.74 66.96 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' SER . 10.8 p -93.75 3.61 55.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -1.137 . . . . 0.0 108.72 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.56 -52.73 7.63 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.047 0.927 . . . . 0.0 108.745 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.645 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 29.5 p 53.38 119.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.442 1.115 . . . . 0.0 111.323 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 4.2 tp -65.36 152.46 43.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.431 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -112.52 -16.87 12.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 175.86 163.52 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.92 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -80.22 177.66 8.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.159 -0.963 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.88 -167.45 54.88 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.09 173.46 7.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.775 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.846 -1.159 . . . . 0.0 109.681 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.252 0.548 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 69.38 120.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.63 -171.35 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -134.13 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.0 109.28 179.834 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.441 ' HA ' HD22 ' A' ' 50' ' ' LEU . 6.5 p 170.31 154.35 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 23' ' ' LEU . 90.7 t -99.17 154.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.509 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' N ' HG12 ' A' ' 6' ' ' VAL . 10.3 t70 -86.3 152.51 22.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -122.98 49.88 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.671 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -90.01 -36.57 14.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.35 43.16 1.07 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.321 -0.862 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 47.2 m-85 -132.38 164.98 39.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -89.48 173.94 24.77 Favored 'Cis proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.399 -1.5 . . . . 0.0 111.293 0.212 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.4 mtpt -136.53 136.41 21.98 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 109.14 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.95 15.6 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.561 2.174 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.44 14.2 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.49 -0.756 . . . . 0.0 109.064 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.68 160.09 40.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 1.3 p -60.86 -164.23 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.525 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.09 -7.67 10.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 110.417 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.775 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.7 pm0 -56.59 119.32 5.91 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -79.6 128.96 34.03 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.505 1.145 . . . . 0.0 111.049 -178.226 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.56 80.03 2.05 Favored Pre-proline 0 C--N 1.294 -1.809 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.758 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.557 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -65.02 124.87 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.973 2.449 . . . . 0.0 112.975 -176.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.744 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -112.25 139.93 47.38 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.71 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -102.52 129.32 49.01 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.983 -178.303 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.11 -170.16 8.21 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' THR . 29.5 t -82.03 -22.02 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.938 -1.331 . . . . 0.0 108.416 178.878 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -76.15 -3.42 36.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.836 . . . . 0.0 109.44 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 17.6 t30 80.18 30.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.382 -0.824 . . . . 0.0 110.308 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 10.2 ttmt -105.32 137.1 43.65 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.103 -0.998 . . . . 0.0 108.781 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.9 m -85.66 146.5 26.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 0.0 109.998 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.6 m-85 -125.51 132.23 52.66 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.98 -51.03 0.65 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.619 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p30 -165.54 -168.32 1.32 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.036 -1.273 . . . . 0.0 111.086 178.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HA ' HD13 ' A' ' 23' ' ' LEU . 6.3 ptmt -45.76 -45.98 14.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.88 -0.512 . . . . 0.0 111.868 -177.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 10.3 m -64.76 -62.73 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.555 -1.341 . . . . 0.0 109.698 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.3 m-80 -50.56 -20.12 1.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 21.3 t80 -82.84 -57.93 3.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.954 -1.091 . . . . 0.0 110.889 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.5 t -58.01 -47.35 83.3 Favored 'General case' 0 C--N 1.286 -2.156 0 O-C-N 121.698 -0.626 . . . . 0.0 110.911 -178.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.589 ' O ' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.29 -28.75 1.39 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.341 -1.475 . . . . 0.0 107.997 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -70.2 -48.31 57.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.881 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.2 t -55.86 -56.14 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.408 0.623 . . . . 0.0 110.031 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 39' ' ' ASN . 2.8 m -53.48 -33.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.075 -1.015 . . . . 0.0 111.062 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -92.57 -11.27 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.629 -1.295 . . . . 0.0 109.697 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.891 ' O ' HG22 ' A' ' 47' ' ' THR . 8.5 t -100.65 -5.35 26.76 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.035 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 77.37 27.58 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.0 -179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.881 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 64.79 11.69 50.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 44' ' ' SER . 14.7 t -87.09 -2.44 58.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.293 -1.122 . . . . 0.0 108.666 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.02 -59.87 2.61 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.596 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 37.6 p 52.58 127.6 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.114 0.959 . . . . 0.0 111.305 178.791 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -85.94 160.67 19.32 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.581 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.1 -29.13 9.57 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.575 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.8 p80 -160.04 163.1 34.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.89 177.72 8.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 73.63 -167.11 54.52 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -91.4 164.78 13.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -1.031 . . . . 0.0 109.072 179.041 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.7 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.922 -179.089 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -121.06 -147.31 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.38 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 69.25 -162.95 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 4' ' ' VAL . 87.4 t -85.27 80.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.65 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.19 122.26 12.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.32 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.1 153.98 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.797 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.83 156.57 39.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.0 109.243 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 19.5 t -160.98 24.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.947 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.18 -4.83 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -112.06 36.95 3.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.906 -1.121 . . . . 0.0 110.217 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 97.0 m-85 -136.51 157.81 74.52 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.994 -1.066 . . . . 0.0 108.817 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.576 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -72.08 145.04 82.12 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.631 -1.821 . . . . 0.0 111.544 3.149 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -108.1 144.95 30.44 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 -179.768 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -78.72 14.62 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.781 2.321 . . . . 0.0 110.956 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.03 117.49 2.25 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 109.127 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' THR . 94.3 m -102.21 139.71 37.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.877 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CD ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -45.16 142.88 1.81 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.425 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -92.28 -23.08 19.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.947 -1.096 . . . . 0.0 109.851 -179.484 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 14.5 pm0 -57.44 -166.8 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.6 t80 -134.03 116.4 15.46 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.352 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.4 mmt180 -147.92 74.71 11.07 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.475 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.5 Cg_endo -65.91 132.07 29.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.114 2.543 . . . . 0.0 113.144 -176.702 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.705 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -118.78 136.71 53.84 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.583 178.334 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 51.8 t -79.05 117.98 20.61 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.28 -165.56 1.32 Allowed Glycine 0 C--N 1.296 -1.663 0 C-N-CA 118.299 -1.905 . . . . 0.0 108.589 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.1 t -85.89 -31.78 22.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.27 . . . . 0.0 109.144 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -69.24 -4.92 19.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 179.57 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.3 t-20 86.11 15.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.742 -0.599 . . . . 0.0 109.881 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.0 ttpt -99.56 117.54 34.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.812 179.09 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -54.5 158.05 2.62 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 4.2 m-85 -129.2 133.13 47.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.338 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.07 -51.51 3.46 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -161.43 -158.5 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.336 -1.096 . . . . 0.0 109.547 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.53 -57.03 10.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.096 -178.099 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.9 t -42.85 -57.44 2.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.838 -1.164 . . . . 0.0 110.41 -179.264 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.34 -43.22 99.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.277 -0.889 . . . . 0.0 111.129 -178.6 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.7 t80 -56.07 -60.55 3.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.905 -1.122 . . . . 0.0 110.521 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -55.58 -51.96 65.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.32 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.9 m-20 -41.6 -29.19 0.16 Allowed 'General case' 0 C--N 1.308 -1.196 0 O-C-N 120.567 -1.333 . . . . 0.0 108.773 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -75.1 -49.34 19.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 48' ' ' LEU . 93.0 t -58.26 -62.45 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.591 0.71 . . . . 0.0 109.8 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 38' ' ' CYS . 3.3 p -57.47 -26.56 26.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.262 -0.899 . . . . 0.0 111.627 -178.627 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -91.71 -13.44 31.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.283 -1.511 . . . . 0.0 109.059 179.203 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.6 t -104.59 22.85 14.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.509 -0.744 . . . . 0.0 110.082 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.6 p30 65.08 6.25 3.39 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.463 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.15 8.59 87.14 Favored Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.291 -0.881 . . . . 0.0 110.912 178.629 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.405 ' HB ' ' OD1' ' A' ' 45' ' ' ASN . 9.6 t -79.45 -4.37 50.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.803 -1.41 . . . . 0.0 108.188 178.672 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.698 ' C ' HG23 ' A' ' 49' ' ' THR . 1.7 tp -79.95 -80.29 0.13 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.698 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 70.92 169.07 0.32 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.646 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.14 173.33 7.16 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.425 -0.797 . . . . 0.0 110.486 -178.143 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.667 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.73 -36.38 7.07 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.714 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -162.54 165.58 25.86 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.456 0.646 . . . . 0.0 109.383 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.705 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.7 m-85 -75.61 -164.5 0.35 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.595 -0.691 . . . . 0.0 109.184 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 59.06 -168.99 6.16 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.4 143.2 26.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -1.02 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.557 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 32.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.693 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.47 HD23 ' N ' ' A' ' 1' ' ' LEU . 1.3 pt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.649 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -153.65 109.09 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 167.35 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 4' ' ' VAL . 14.9 m -135.3 102.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 167.46 140.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.306 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.41 143.16 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.13 143.29 55.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 7.3 m -139.32 61.37 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -90.83 -1.24 57.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.4 41.59 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.427 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.913 ' CB ' HG11 ' A' ' 42' ' ' VAL . 70.8 m-85 -122.83 161.35 44.73 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.247 -0.908 . . . . 0.0 108.934 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.15 -179.77 28.24 Favored 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.698 -1.793 . . . . 0.0 111.41 1.852 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 tttp -123.04 141.34 35.48 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.0 Cg_endo -77.18 13.99 1.43 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.656 2.238 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 170.5 144.37 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 34.6 t -124.08 159.47 29.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.4 p -59.37 -157.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.55 -11.06 8.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.731 -1.231 . . . . 0.0 109.685 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.3 pt-20 -56.6 124.86 19.75 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.896 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 19.3 t80 -86.04 132.41 34.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.323 1.059 . . . . 0.0 111.537 -177.532 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.73 80.32 2.26 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.769 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.6 Cg_endo -65.42 122.0 9.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.668 2.245 . . . . 0.0 112.415 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mt -107.18 128.4 54.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.748 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -79.06 102.28 8.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.384 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.27 -170.89 0.12 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 118.579 -1.772 . . . . 0.0 109.113 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.9 t -74.32 -45.0 50.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.008 -1.289 . . . . 0.0 109.306 179.409 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -54.99 -16.39 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.817 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER 92.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.375 0.607 . . . . 0.0 109.73 179.754 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -99.41 127.89 45.48 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -69.61 152.79 44.33 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 8.2 m-85 -126.54 125.2 41.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -28.89 -50.5 0.1 Allowed Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -176.851 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -163.04 -159.94 0.58 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.704 -1.468 . . . . 0.0 110.317 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.797 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.05 -46.12 79.02 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.307 -0.871 . . . . 0.0 112.213 -177.413 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 5.3 m -66.23 -52.61 46.17 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.477 -1.389 . . . . 0.0 110.17 -178.675 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.0 m-80 -56.42 -23.43 38.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.685 -1.259 . . . . 0.0 110.395 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CB ' HD12 ' A' ' 23' ' ' LEU . 16.6 t80 -82.72 -54.59 5.01 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.037 1.399 . . . . 0.0 110.007 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.661 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 1.1 m -55.55 -35.99 66.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.324 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 3.5 m-20 -57.48 -36.51 71.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.588 -1.32 . . . . 0.0 108.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.662 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.0 -28.67 66.81 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG13 ' HA2' ' A' ' 46' ' ' GLY . 79.4 t -72.97 -62.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.512 -0.742 . . . . 0.0 109.119 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.913 HG11 ' CB ' ' A' ' 11' ' ' TYR . 4.4 p -59.58 -15.15 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 111.299 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.662 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.93 -30.72 15.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.573 -1.329 . . . . 0.0 108.659 179.308 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.1 t -93.22 22.38 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.678 -0.638 . . . . 0.0 110.31 -179.187 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 17.4 m-80 65.62 8.85 5.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.175 -0.953 . . . . 0.0 109.802 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.33 17.82 63.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.335 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 p -95.74 5.79 50.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 108.734 179.2 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.3 tp -79.49 -78.28 0.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.668 0.747 . . . . 0.0 109.394 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.9 p 68.12 153.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.669 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -110.63 179.64 4.01 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.525 -0.734 . . . . 0.0 111.223 -177.733 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.669 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -109.06 -32.4 7.25 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.783 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.748 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.3 p80 -170.56 159.51 6.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.401 0.619 . . . . 0.0 109.626 -178.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 33.6 m-85 -70.55 -169.17 0.3 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 63.11 -169.29 17.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 138.83 31.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.131 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.499 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.89 -68.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.09 103.71 15.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.45 92.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -164.94 121.03 1.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 HD22 ' A' ' 23' ' ' LEU . 12.2 t -84.95 151.76 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.273 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 6' ' ' VAL . 17.9 t70 -59.62 148.1 34.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 108.857 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 10.1 t -158.03 24.09 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.944 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.6 0.23 57.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.396 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 11.5 mp0 -122.37 43.18 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.917 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.7 m-85 -139.02 158.77 69.06 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.07 -1.019 . . . . 0.0 108.571 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.04 159.68 95.04 Favored 'Cis proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.096 3.187 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 5.0 tttm -110.42 145.9 33.18 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.3 14.09 1.66 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.536 2.157 . . . . 0.0 110.731 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.69 124.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -79.74 156.08 27.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.745 -179.663 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -72.66 -172.05 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.894 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -115.27 -20.01 10.53 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.101 -0.999 . . . . 0.0 110.19 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.667 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -57.87 123.17 14.85 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.855 -1.153 . . . . 0.0 108.758 179.324 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.6 t80 -83.96 124.83 31.43 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.248 1.023 . . . . 0.0 109.818 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.2 mtp180 -161.11 87.33 1.68 Allowed Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -65.46 120.54 7.75 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.147 1.898 . . . . 0.0 112.225 -177.612 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -112.15 139.83 47.35 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.482 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.589 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -104.24 124.07 48.48 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.964 -178.307 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -69.34 -171.81 8.22 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 30.6 t -82.84 -17.69 43.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.696 -1.473 . . . . 0.0 108.045 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -76.68 -8.03 56.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.549 -0.72 . . . . 0.0 109.321 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.6 t30 81.75 36.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 9.6 tttt -111.99 138.83 48.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.814 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -88.73 145.14 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.917 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.803 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 66.8 m-85 -121.35 124.29 44.2 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.446 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.17 -52.63 0.71 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -177.678 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.4 p30 -152.63 -163.79 1.8 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.138 -1.213 . . . . 0.0 110.052 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 ptmt -58.27 -68.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 111.297 -178.217 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.8 p -41.28 -45.43 2.95 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.875 -1.141 . . . . 0.0 110.694 -178.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -63.61 -40.59 97.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.549 -1.345 . . . . 0.0 109.871 179.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 20.5 t80 -65.35 -60.15 3.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.194 -0.941 . . . . 0.0 110.941 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.703 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -55.05 -41.57 71.6 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.893 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.625 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.4 m-20 -49.42 -37.41 25.45 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.425 -1.422 . . . . 0.0 107.971 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.66 -32.25 65.69 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.756 HG13 ' HA2' ' A' ' 46' ' ' GLY . 88.1 t -70.62 -67.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.296 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 38' ' ' CYS . 7.3 p -54.05 -17.61 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.705 -0.622 . . . . 0.0 111.551 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.659 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.75 -31.07 15.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.183 -1.573 . . . . 0.0 107.763 178.346 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 10.7 t -88.28 -1.29 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.829 -0.544 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.942 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER 84.44 4.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.362 -179.513 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.756 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 91.12 8.94 64.18 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.942 HG23 ' OD1' ' A' ' 45' ' ' ASN . 18.0 p -85.03 1.1 49.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.915 -1.344 . . . . 0.0 108.868 178.518 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -78.82 -50.61 10.99 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.923 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 73.9 p 45.84 121.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.282 1.039 . . . . 0.0 112.574 178.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -82.38 159.4 23.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.513 0.673 . . . . 0.0 109.218 178.901 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.68 -26.39 10.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.552 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.589 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -164.2 160.21 21.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.573 0.701 . . . . 0.0 109.682 -178.639 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.96 -170.11 1.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.47 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.67 -171.67 20.72 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -90.75 166.58 13.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 108.774 179.3 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.0 m . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.667 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.386 0.613 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.77 -160.16 0.66 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.6 52.38 13.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.751 HG23 ' O ' ' A' ' 4' ' ' VAL . 10.6 m -80.89 104.66 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 p -170.12 164.2 9.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.611 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.58 147.61 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.559 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.6 128.37 34.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.998 . . . . 0.0 109.504 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 m -138.0 45.89 2.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 8.43 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.893 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 21.9 mp0 -118.08 3.39 12.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 109.833 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.922 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.2 m-85 -85.34 160.4 54.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.202 -0.936 . . . . 0.0 109.421 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -73.91 156.43 99.69 Favored 'Cis proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.775 -1.76 . . . . 0.0 111.939 2.042 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -100.34 142.75 25.21 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -79.49 14.85 1.71 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.588 2.192 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.3 133.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 108.994 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.7 m -99.44 149.42 23.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 0.0 109.922 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -49.19 -24.28 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.291 1.043 . . . . 0.0 110.037 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 76.22 2.21 3.52 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.239 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.539 ' HG2' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -78.03 -164.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.779 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 5.2 t80 -130.69 126.46 36.58 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.098 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 45.0 mtm180 -159.88 77.02 2.85 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -64.28 120.3 7.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.44 2.093 . . . . 0.0 112.552 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.38 127.44 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.106 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.5 t -79.78 126.57 31.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 109.75 -179.37 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.36 169.99 54.96 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 t -64.88 -35.27 80.59 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.133 -1.216 . . . . 0.0 109.916 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -76.53 4.52 9.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.4 t30 80.33 41.41 0.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.0 110.36 179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.8 109.64 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.39 1.09 . . . . 0.0 109.495 179.38 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -63.72 144.24 57.19 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.006 -1.059 . . . . 0.0 108.221 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.873 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.245 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -49.7 -45.42 39.11 Favored Glycine 0 N--CA 1.486 1.977 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.066 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.2 p-10 -159.04 -164.4 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.011 -1.288 . . . . 0.0 110.329 -179.567 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.2 -26.36 62.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 110.397 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 29.0 t -69.15 -63.36 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.968 -1.083 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 37.1 m-80 -59.53 -39.44 83.91 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.439 -0.788 . . . . 0.0 110.201 -179.328 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 61.3 t80 -60.38 -47.21 87.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.621 -1.3 . . . . 0.0 108.752 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.5 m -64.08 -28.54 69.85 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.356 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.5 m-20 -67.08 -32.6 73.88 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.873 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -80.26 -22.86 41.25 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.072 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 39.9 t -77.67 -33.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.651 -0.656 . . . . 0.0 109.265 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.922 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -90.98 -17.57 7.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.237 -0.914 . . . . 0.0 109.768 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.0 tt0 -91.9 -11.92 34.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.068 -1.02 . . . . 0.0 109.104 179.629 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.1 t -109.49 26.06 11.08 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.249 -0.907 . . . . 0.0 110.223 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 30.5 m-20 62.14 35.89 15.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.144 -0.972 . . . . 0.0 108.734 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 49.33 25.06 5.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.2 p -88.18 -14.56 38.32 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -1.092 . . . . 0.0 108.688 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 49' ' ' THR . 1.1 tp -80.3 133.24 35.94 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.9 p -135.08 123.5 23.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 108.997 178.666 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -64.42 165.29 10.01 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.429 -0.794 . . . . 0.0 109.644 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.01 -22.77 10.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.718 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -174.2 152.41 1.83 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.537 -0.727 . . . . 0.0 109.548 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.07 170.77 6.37 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.354 -0.841 . . . . 0.0 108.871 178.868 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.06 -170.82 47.83 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.39 134.28 35.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.097 -1.237 . . . . 0.0 108.272 178.619 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.005 -1.06 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.83 -69.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.558 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.94 132.56 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.78 109.49 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.15 -166.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.34 -0.85 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 37' ' ' PHE . 14.2 p -125.6 150.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.53 141.33 29.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 7.1 m -142.87 65.61 1.34 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -90.37 14.94 11.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.068 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 4.9 pm0 -122.17 -10.35 8.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.979 -1.075 . . . . 0.0 109.723 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 1.055 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.6 m-85 -80.37 158.94 71.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -73.98 178.8 31.85 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.74 -1.775 . . . . 0.0 111.437 3.071 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.19 145.92 57.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.636 -0.665 . . . . 0.0 109.461 -179.001 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.4 Cg_endo -79.27 14.14 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.436 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.47 115.95 0.25 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.1 m -81.09 158.24 25.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 110.174 -179.249 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -50.06 -25.36 3.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.396 1.093 . . . . 0.0 109.778 -179.777 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER 74.57 -12.14 0.95 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.453 179.192 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -75.33 -167.94 0.72 Allowed 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.466 -1.396 . . . . 0.0 107.855 178.761 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.1 t80 -123.28 122.19 37.74 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.274 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -155.22 77.36 4.94 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.754 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -65.35 112.42 2.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.164 1.91 . . . . 0.0 112.033 -177.241 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.891 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -108.86 122.02 46.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.758 179.655 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.813 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 1.3 m -79.41 103.36 9.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 108.633 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.21 -174.55 0.08 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -178.18 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.3 t -72.67 -33.4 66.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -1.202 . . . . 0.0 108.876 178.771 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -66.27 -12.34 55.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.42 -0.8 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 88.66 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.803 -0.561 . . . . 0.0 110.161 179.715 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 ttpt -100.6 143.87 30.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 108.956 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 33.9 m -87.59 128.59 35.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.018 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -103.8 118.46 36.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.345 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.17 -44.95 0.11 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.972 -0.455 . . . . 0.0 112.476 -176.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 32.2 p-10 -156.12 -161.8 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.702 -1.47 . . . . 0.0 109.472 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.863 ' HA ' HD11 ' A' ' 23' ' ' LEU . 9.6 pttt -70.59 -28.38 64.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.398 -0.814 . . . . 0.0 110.377 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.515 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 16.8 t -69.52 -59.86 2.7 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.86 -1.15 . . . . 0.0 109.051 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -52.88 -40.9 63.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.621 -0.674 . . . . 0.0 109.811 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CB ' HD12 ' A' ' 23' ' ' LEU . 35.7 t80 -64.17 -50.1 69.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.658 1.218 . . . . 0.0 109.225 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -59.37 -26.05 64.76 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.009 -178.937 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -69.13 -35.51 76.47 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.202 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.15 -23.51 59.27 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.208 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' GLY . 55.1 t -80.36 -35.58 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.651 -0.656 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.055 HG21 ' O ' ' A' ' 11' ' ' TYR . 5.5 p -88.56 -13.24 9.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.74 -33.83 14.86 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.005 -1.06 . . . . 0.0 108.148 178.54 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.96 7.44 24.33 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.567 -0.708 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.0 t-20 77.02 6.56 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.117 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 88.84 10.46 66.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -90.88 7.8 38.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.119 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 ' CE1' ' A' ' 37' ' ' PHE . 3.3 tp -79.42 -73.16 0.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.308 -0.87 . . . . 0.0 109.136 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.0 p 64.71 142.66 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.803 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.68 172.66 6.68 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 122.125 0.964 . . . . 0.0 111.522 -177.876 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.571 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -97.59 -46.63 5.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.028 0.918 . . . . 0.0 108.591 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.813 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 15.8 p-80 -154.82 157.32 37.73 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.646 0.736 . . . . 0.0 110.507 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -77.84 175.49 9.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.53 -171.82 52.89 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -90.39 158.75 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.293 . . . . 0.0 109.619 179.294 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 57.5 m . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.956 -178.078 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 109.673 . . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 76.54 9.44 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.93 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.632 -179.99 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.53 70.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.27 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.8 113.35 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.541 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.6 t -85.87 148.06 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.343 179.815 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.26 116.58 23.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.9 m -119.46 60.1 0.84 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.356 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -90.97 -17.23 26.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.44 31.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.099 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.77 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.3 m-85 -117.81 162.2 30.35 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.4 Cg_endo -85.91 163.85 56.08 Favored 'Cis proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.213 -1.578 . . . . 0.0 110.581 1.947 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -122.91 140.61 33.7 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.658 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.66 13.36 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.462 2.108 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.36 116.4 4.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' THR . 76.8 m -92.77 138.18 31.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.839 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.7 p -52.51 -175.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.568 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -114.21 -26.88 7.84 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.041 -1.037 . . . . 0.0 109.636 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.519 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.0 pm0 -48.68 162.97 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.588 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.5 t80 -113.95 131.49 56.29 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.209 1.004 . . . . 0.0 110.935 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.0 mtp180 -161.21 84.84 1.79 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.445 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -67.94 113.27 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.088 1.859 . . . . 0.0 111.586 -177.878 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -107.84 126.53 52.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.513 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 49.0 t -79.29 164.42 24.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.016 . . . . 0.0 108.761 -179.568 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -136.25 168.03 24.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -178.572 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 48' ' ' LEU . 30.5 t -66.21 -23.27 66.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -1.02 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -61.08 -13.75 19.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 109.121 179.282 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.7 m-20 86.77 22.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.862 -0.524 . . . . 0.0 110.089 179.625 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -126.53 171.88 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.512 179.406 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 31' ' ' TYR . 28.7 m -104.94 163.69 12.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.966 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 65.1 m-85 -126.12 118.86 26.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.357 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.27 -52.58 0.41 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.655 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.2 p-10 -154.31 -167.96 2.79 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.78 -1.423 . . . . 0.0 109.909 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.56 -36.1 71.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.621 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.7 t -60.9 -61.57 2.49 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 109.72 -179.329 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -56.05 -41.99 75.88 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 23' ' ' LEU . 74.3 t80 -61.92 -43.85 97.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.768 -1.207 . . . . 0.0 109.607 -179.514 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 88.4 m -69.49 -24.19 63.74 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.139 -179.697 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.519 ' HA ' HG22 ' A' ' 42' ' ' VAL . 32.8 m-20 -74.93 -26.14 59.41 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.178 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.966 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.19 -33.53 50.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.655 ' CG2' HD23 ' A' ' 48' ' ' LEU . 42.2 t -69.02 -48.45 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -64.16 -31.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.572 -0.705 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.79 -8.33 43.97 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 109.521 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 46.6 t -111.52 14.03 21.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.104 -0.997 . . . . 0.0 110.958 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 47' ' ' THR . 6.1 m-20 53.15 48.57 21.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.842 -1.162 . . . . 0.0 109.399 179.94 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 45.52 35.06 5.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' ASN . 30.2 p -110.86 5.5 20.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -1.072 . . . . 0.0 108.391 178.229 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.7 -51.76 6.99 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.993 0.901 . . . . 0.0 109.143 -179.931 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.665 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 77.5 p 56.24 124.39 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.281 1.038 . . . . 0.0 110.48 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 5.8 tp -62.05 129.6 41.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.101 179.798 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.55 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 10.9 t -79.47 -21.91 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.865 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.55 ' CB ' ' O ' ' A' ' 51' ' ' SER . 17.6 p-80 156.23 154.63 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.787 179.416 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -63.48 165.48 7.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.089 . . . . 0.0 108.663 179.398 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.08 -168.76 45.28 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -178.976 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.01 161.68 14.35 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.891 -1.359 . . . . 0.0 108.074 178.052 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.442 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 7.8 m . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.767 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.336 0.589 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.53 106.17 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.35 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.98 146.44 46.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.959 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.599 ' O ' HD21 ' A' ' 50' ' ' LEU . 3.0 m -139.18 86.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.443 ' HA ' HD22 ' A' ' 50' ' ' LEU . 1.8 t -164.1 166.08 21.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.18 146.16 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 179.952 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -88.15 145.89 25.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.207 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 35.9 m -134.41 70.69 1.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.275 -0.891 . . . . 0.0 110.009 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -19.46 23.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.867 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 32.77 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.854 ' CB ' HG11 ' A' ' 42' ' ' VAL . 60.6 m-85 -113.34 164.82 14.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.856 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.6 Cg_endo -84.91 152.31 58.0 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.433 -1.486 . . . . 0.0 111.274 2.073 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.5 mtpm? -112.34 138.25 21.83 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.7 Cg_endo -80.39 14.78 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.728 2.285 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.19 160.51 21.36 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.112 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -147.5 159.84 43.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 110.002 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.57 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -117.18 -23.29 7.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.775 -1.203 . . . . 0.0 110.02 179.965 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -45.5 115.94 1.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.519 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.8 t80 -79.19 127.24 31.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.466 1.127 . . . . 0.0 111.354 -177.697 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 ptm180 -161.65 78.05 2.18 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.15 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.0 Cg_endo -66.16 128.14 18.94 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 123.208 2.605 . . . . 0.0 113.069 -177.135 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.607 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -112.34 130.34 55.99 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.606 178.402 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.688 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 48.1 t -83.56 122.75 28.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.928 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -68.53 -165.95 3.84 Favored Glycine 0 C--N 1.296 -1.665 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 49' ' ' THR . 7.1 t -89.2 -36.99 15.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.238 . . . . 0.0 107.972 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.624 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.4 p-10 -58.61 -17.37 21.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.532 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.2 OUTLIER 97.17 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.128 0.49 . . . . 0.0 110.01 179.486 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.75 119.85 38.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.217 179.592 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.2 m -69.9 152.85 44.03 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.412 -0.805 . . . . 0.0 109.171 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 19.4 m-85 -132.7 124.43 28.17 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.793 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.78 -51.96 0.07 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -163.63 -162.32 0.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -1.232 . . . . 0.0 110.289 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.51 -40.76 60.22 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 112.6 -177.408 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -69.12 -65.15 0.74 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.209 -1.557 . . . . 0.0 108.911 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.7 m-80 -42.93 -30.5 0.41 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 27.5 t80 -74.85 -48.25 26.01 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.897 1.332 . . . . 0.0 109.406 179.545 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 87.4 m -55.92 -53.67 53.97 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.735 -178.828 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -42.23 -26.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.951 -1.093 . . . . 0.0 108.931 -179.475 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.97 -47.75 17.83 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.592 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.683 ' CG2' HD23 ' A' ' 48' ' ' LEU . 61.6 t -60.5 -28.12 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.715 -0.616 . . . . 0.0 110.422 179.507 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.2 m -90.93 -26.28 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.88 -1.137 . . . . 0.0 109.897 -179.033 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.3 tt0 -90.47 0.77 57.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.406 -0.808 . . . . 0.0 108.868 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.496 ' O ' ' OG ' ' A' ' 44' ' ' SER . 1.4 t -119.18 22.47 11.82 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 1.0 ' O ' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 64.11 46.47 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.905 1.336 . . . . 0.0 108.082 179.951 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 32.31 37.33 0.04 OUTLIER Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.513 -0.742 . . . . 0.0 111.874 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' THR . . . . . 1.0 HG23 ' O ' ' A' ' 45' ' ' ASN . 43.2 p -111.01 0.45 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.265 . . . . 0.0 108.231 177.868 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.683 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.36 152.92 30.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.759 0.79 . . . . 0.0 109.016 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' CB ' ' A' ' 26' ' ' SER . 41.2 p -141.45 149.89 41.56 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.926 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.22 175.96 6.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.713 -1.242 . . . . 0.0 109.214 -179.544 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.5 -23.04 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.756 -1.215 . . . . 0.0 108.607 -179.439 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.688 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 2.0 p-80 177.14 155.03 0.27 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 -178.816 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -62.04 -168.0 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.561 -0.712 . . . . 0.0 109.133 178.87 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.6 -167.45 6.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.49 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.8 175.68 6.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -1.073 . . . . 0.0 108.471 178.571 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.568 -179.807 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.693 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -120.75 -5.74 9.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.658 -179.909 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.25 145.24 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 179.926 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.669 ' CG1' HD23 ' A' ' 50' ' ' LEU . 1.6 t -155.16 90.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.181 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.1 p -168.05 85.44 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 110.103 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.43 149.99 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 0.0 108.885 179.461 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.611 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 78.1 m -137.3 47.98 2.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.309 179.81 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.443 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 64.6 p -86.96 -30.21 21.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 12.0 mm-40 -73.19 -8.92 57.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.744 ' HB3' HG11 ' A' ' 42' ' ' VAL . 80.3 m-85 -79.97 161.44 65.87 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.416 -0.802 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.845 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -84.51 143.36 40.08 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 123.156 -1.602 . . . . 0.0 110.846 1.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.0 mtpt -116.09 137.85 23.72 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.484 -0.76 . . . . 0.0 109.369 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -80.49 14.08 2.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.349 2.033 . . . . 0.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.14 126.74 15.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 60.2 m -112.78 138.75 49.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.78 -179.548 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -56.9 -170.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.734 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.14 -25.48 9.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.099 -1.001 . . . . 0.0 109.603 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.8 mt-10 -41.47 122.51 1.93 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.349 -0.844 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.482 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 15.6 t80 -83.14 107.37 15.66 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.432 1.11 . . . . 0.0 110.357 -179.007 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -141.27 77.7 19.75 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.197 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.7 Cg_endo -64.25 115.24 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.228 1.952 . . . . 0.0 111.688 -177.933 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.76 135.7 53.89 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.539 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.81 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 47.4 t -89.99 160.47 16.36 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.536 -179.67 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -133.2 161.21 24.14 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.515 -177.659 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t -45.36 -21.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.817 -0.813 . . . . 0.0 111.177 -178.176 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' CD1' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -86.14 25.23 1.19 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.094 -179.654 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 m120 49.48 20.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.63 141.23 36.79 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.008 -1.058 . . . . 0.0 109.999 -179.84 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 31' ' ' TYR . 82.2 m -86.87 157.54 19.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.427 -0.796 . . . . 0.0 108.932 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 82.1 m-85 -135.74 99.49 4.2 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.31 -59.28 0.02 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -178.166 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p-10 -137.77 -170.27 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.739 -1.448 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -54.22 -35.37 62.34 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.9 -0.5 . . . . 0.0 110.743 -178.639 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.7 t -64.57 -67.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.902 -1.124 . . . . 0.0 109.569 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.6 m-80 -44.84 -30.27 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.82 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 24.1 t80 -71.79 -54.31 10.58 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.535 1.16 . . . . 0.0 109.78 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 72.7 m -54.59 -58.9 5.69 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.109 -179.684 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.1 m-20 -42.68 -27.78 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.878 -1.139 . . . . 0.0 109.394 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -73.57 -48.1 35.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.862 HG22 ' CD2' ' A' ' 48' ' ' LEU . 66.9 t -60.69 -54.11 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.378 0.609 . . . . 0.0 109.57 179.347 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 12' ' ' PRO . 10.2 m -56.3 -31.31 32.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.237 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -92.2 -12.31 33.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.915 -1.116 . . . . 0.0 109.638 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.598 ' O ' HG22 ' A' ' 47' ' ' THR . 17.6 t -98.06 8.19 45.15 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.101 -0.999 . . . . 0.0 110.309 -179.089 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t-20 75.33 12.12 3.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.984 -1.073 . . . . 0.0 108.484 -179.24 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.619 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 67.29 8.39 50.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 44' ' ' SER . 6.3 t -86.45 5.51 34.82 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.203 -1.175 . . . . 0.0 108.469 178.615 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.862 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.94 -71.81 0.56 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.993 0.901 . . . . 0.0 108.888 -179.666 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.6 p 81.69 152.11 0.1 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.965 0.888 . . . . 0.0 109.081 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.669 HD23 ' CG1' ' A' ' 4' ' ' VAL . 11.5 tp -67.69 156.76 36.17 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.3 p -106.28 -40.85 5.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.81 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -178.71 168.5 1.71 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.132 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -81.61 166.21 20.4 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.262 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 82.84 -175.11 53.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.96 156.49 19.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.949 -1.324 . . . . 0.0 109.132 179.081 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.332 0.587 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 73.15 117.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -54.5 168.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.294 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 3' ' ' ALA . 11.6 m -156.14 82.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 178.04 147.84 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.05 155.67 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -92.35 128.87 38.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.136 179.712 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.1 m -123.05 63.56 0.99 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 109.831 -179.674 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.2 t -90.68 -19.5 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.325 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.9 mm-40 -97.46 26.3 5.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.092 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.844 ' CB ' HG11 ' A' ' 42' ' ' VAL . 68.9 m-85 -114.71 161.99 26.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.548 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.7 Cg_endo -85.84 156.03 56.88 Favored 'Cis proline' 0 C--N 1.305 -1.752 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.698 1.605 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 20.3 mtpt -118.31 140.15 27.74 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.869 . . . . 0.0 109.192 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.86 14.33 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.658 2.239 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.99 119.88 5.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.741 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -101.07 139.37 36.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.275 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.454 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -63.61 -172.07 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.422 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.926 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.36 -14.31 11.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.887 -1.133 . . . . 0.0 110.379 -179.461 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.526 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 3.0 pm0 -49.35 120.96 4.47 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.379 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -79.57 126.62 31.12 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.45 1.119 . . . . 0.0 110.902 -178.273 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.81 80.05 1.99 Allowed Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.408 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.72 119.54 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.286 1.991 . . . . 0.0 112.135 -177.366 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -110.79 123.13 49.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.151 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.1 t -79.26 127.65 32.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 0.0 109.101 -179.193 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -74.3 -173.31 29.28 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 5.2 t -76.14 -33.47 59.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.695 -1.474 . . . . 0.0 108.902 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.593 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -62.08 -12.18 17.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 109.653 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 59.3 t30 92.23 20.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.956 -0.465 . . . . 0.0 111.041 179.229 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.68 175.03 5.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.799 -1.188 . . . . 0.0 108.017 178.235 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -119.89 148.16 43.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 109.887 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 46.2 m-85 -120.67 120.72 36.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.819 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -30.27 -51.24 0.19 Allowed Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -177.768 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -153.04 -166.4 2.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.738 -1.448 . . . . 0.0 110.252 179.737 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.629 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -66.7 -22.54 66.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.569 -0.707 . . . . 0.0 111.323 -178.32 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 49.2 t -74.1 -50.55 19.0 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.612 -1.305 . . . . 0.0 108.859 179.578 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -62.9 -38.47 91.09 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 48' ' ' LEU . 48.4 t80 -68.87 -47.8 65.02 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.37 1.081 . . . . 0.0 109.635 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 29.2 m -62.23 -29.34 70.32 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.908 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.554 ' HA ' HG22 ' A' ' 42' ' ' VAL . 19.9 m-20 -71.67 -23.61 61.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.077 -1.015 . . . . 0.0 108.638 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.78 -22.82 27.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.472 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.2 -26.68 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.272 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.8 m -86.49 -31.0 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.443 -0.786 . . . . 0.0 109.294 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.92 -15.4 28.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' THR . 27.9 t -96.97 9.63 41.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.957 . . . . 0.0 110.299 -179.385 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.3 m120 62.59 28.31 16.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.155 -0.965 . . . . 0.0 109.355 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.85 63.83 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 44' ' ' SER . 5.3 p -96.28 5.76 50.26 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -1.098 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.743 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -83.82 -63.82 1.28 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.437 -0.789 . . . . 0.0 109.042 -179.712 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 65.5 p 56.27 124.72 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.96 0.886 . . . . 0.0 110.446 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -85.83 172.08 11.04 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.524 0.678 . . . . 0.0 110.733 -178.709 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.647 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.04 -28.72 9.38 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -174.44 162.7 3.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.766 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 m-85 -71.45 -170.77 0.54 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.51 -174.01 8.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.701 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -85.6 164.82 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -1.103 . . . . 0.0 108.868 179.396 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 3.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.393 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 1.1 pp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . 179.48 153.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 173.88 124.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.711 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.5 p -106.71 68.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 t -169.05 106.12 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 7' ' ' ASP . 51.8 t -88.82 145.17 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.6 -179.887 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -76.72 172.89 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.185 179.952 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.4 t -161.15 26.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -90.56 -0.21 57.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.93 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -119.58 38.55 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 110.267 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.3 m-85 -139.83 154.17 70.56 Favored Pre-proline 0 C--N 1.305 -1.334 0 O-C-N 121.057 -1.027 . . . . 0.0 108.369 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -72.13 149.07 92.47 Favored 'Cis proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.597 -1.835 . . . . 0.0 111.622 2.931 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -110.6 148.03 37.65 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.981 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.5 Cg_endo -77.44 13.32 1.63 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.509 2.139 . . . . 0.0 110.968 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 115.26 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.2 m -88.69 149.66 23.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 109.749 -179.612 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -47.92 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.393 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.95 -23.21 9.2 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.869 -1.145 . . . . 0.0 110.228 -179.521 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pm0 -59.18 -168.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.885 -1.134 . . . . 0.0 108.134 179.358 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 20.0 t80 -127.55 129.1 46.75 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.32 81.61 2.0 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.262 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -66.4 111.33 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.177 1.918 . . . . 0.0 111.27 -178.268 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -105.95 136.78 45.0 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.266 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.768 ' CB ' ' HE1' ' A' ' 52' ' ' HIS . 12.1 t -98.22 159.04 15.2 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.251 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.564 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -116.53 174.06 15.04 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.441 -177.895 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.525 ' H ' HD12 ' A' ' 48' ' ' LEU . 15.1 t -70.33 -13.47 62.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.45 -1.029 . . . . 0.0 108.547 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.7 p-10 -81.92 -8.99 59.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.41 -0.806 . . . . 0.0 109.318 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.6 t-20 82.74 34.78 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.649 -0.657 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 tttp -123.2 147.3 47.02 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.15 -0.969 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 31' ' ' TYR . 78.0 m -93.35 162.18 14.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.071 -1.018 . . . . 0.0 109.898 -179.87 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.6 m-85 -138.18 108.22 6.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.69 -57.44 0.12 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -177.252 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.1 p30 -141.66 -169.88 2.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.817 -1.402 . . . . 0.0 110.535 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.0 ptmt -54.7 -47.06 74.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.794 -0.566 . . . . 0.0 110.708 -178.514 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.7 t -53.79 -52.69 59.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.802 -1.187 . . . . 0.0 109.541 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.1 m-80 -61.64 -29.39 70.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.549 -0.72 . . . . 0.0 110.547 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.931 ' CE1' HD21 ' A' ' 48' ' ' LEU . 11.5 t80 -73.86 -62.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.76 -1.212 . . . . 0.0 110.813 -179.167 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.2 -48.75 73.39 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.81 -0.556 . . . . 0.0 109.523 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.6 m-80 -41.88 -31.13 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.179 . . . . 0.0 108.321 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -72.99 -49.08 31.08 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.569 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.575 ' N ' HD23 ' A' ' 48' ' ' LEU . 71.4 t -55.78 -59.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.401 0.62 . . . . 0.0 110.373 179.207 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.3 p -60.62 -23.97 30.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.204 -0.935 . . . . 0.0 110.599 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.8 tm-20 -89.35 -15.39 33.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.611 -1.306 . . . . 0.0 107.994 178.276 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.498 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -105.6 0.27 26.34 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.666 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER 60.64 22.85 12.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 0.0 109.447 -179.136 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.45 16.11 57.55 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.666 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 44' ' ' SER . 74.1 p -85.52 -12.04 52.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.26 . . . . 0.0 108.268 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -78.41 -52.13 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.713 0.768 . . . . 0.0 109.177 -179.967 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.666 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 20.9 p 55.17 123.73 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.312 1.053 . . . . 0.0 109.839 -178.045 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 24' ' ' CYS . 24.8 tp -56.45 160.22 3.26 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.537 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -115.91 -41.57 3.18 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.54 1.162 . . . . 0.0 107.928 179.545 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.768 ' HE1' ' CB ' ' A' ' 24' ' ' CYS . 0.1 OUTLIER -178.04 159.64 1.34 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.726 -179.568 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.84 133.8 36.99 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.408 178.792 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 112.91 -172.13 14.33 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.43 134.36 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.042 -1.269 . . . . 0.0 109.295 179.211 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 2' ' ' ALA . 1.9 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 1' ' ' LEU . . . 44.45 78.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 -179.849 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.27 -179.03 3.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.62 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 5' ' ' SER . 5.4 m -131.07 88.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER 164.52 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.612 HG21 HD22 ' A' ' 23' ' ' LEU . 99.1 t -106.09 142.61 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.088 -1.007 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.42 148.23 49.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.46 30.38 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -13.85 43.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.651 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.49 -2.19 25.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' HG11 ' A' ' 42' ' ' VAL . 54.5 m-85 -93.56 163.37 24.71 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.925 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.27 157.7 74.04 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.247 -1.564 . . . . 0.0 110.989 2.114 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -107.61 142.54 25.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.627 -179.735 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.7 Cg_endo -79.75 15.27 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.753 2.302 . . . . 0.0 110.861 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.35 137.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.478 -0.763 . . . . 0.0 109.025 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 17' ' ' THR . 49.0 t -109.86 157.57 19.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.065 -1.022 . . . . 0.0 110.842 -179.258 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -64.19 -157.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.058 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -116.69 -8.26 11.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.269 -1.519 . . . . 0.0 110.856 -179.708 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.62 136.32 17.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.585 -1.322 . . . . 0.0 107.811 179.276 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.0 t80 -98.29 130.2 44.98 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 122.282 1.039 . . . . 0.0 110.618 -178.602 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.86 77.58 2.46 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.536 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -62.59 121.35 9.27 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.741 2.294 . . . . 0.0 112.55 -177.084 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD22 HG21 ' A' ' 6' ' ' VAL . 1.2 mp -110.03 133.88 52.73 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.563 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -80.31 111.07 16.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.59 -169.04 3.28 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.665 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -80.85 -32.38 35.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.839 -1.389 . . . . 0.0 108.812 178.895 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -65.23 -8.15 16.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.836 . . . . 0.0 109.616 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 46.1 t30 86.05 16.37 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.695 -0.628 . . . . 0.0 110.489 179.033 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HG2' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -109.41 119.98 41.1 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.5 178.856 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 31' ' ' TYR . 27.0 m -58.64 161.93 4.3 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.494 0.664 . . . . 0.0 109.771 -179.354 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -130.54 133.36 46.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.772 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.611 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.3 -50.3 0.25 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -177.313 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.6 p30 -165.31 -164.02 0.72 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.921 -1.34 . . . . 0.0 110.75 178.896 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 pttt -52.82 -40.31 63.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.688 -0.633 . . . . 0.0 111.676 -177.674 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -72.69 -50.86 22.1 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.628 -1.295 . . . . 0.0 110.173 -178.427 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.1 m-80 -61.65 -18.58 60.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.713 -1.242 . . . . 0.0 108.931 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 9.4 t80 -80.74 -60.85 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.303 1.049 . . . . 0.0 109.636 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 46.8 t -57.78 -49.65 75.89 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.321 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' C ' ' O ' ' A' ' 38' ' ' CYS . 8.0 m-20 -42.17 -28.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.721 -1.237 . . . . 0.0 108.343 179.357 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.32 -49.65 22.05 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.673 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.639 HG22 HD23 ' A' ' 48' ' ' LEU . 97.2 t -55.53 -56.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 178.796 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.925 HG21 ' HB3' ' A' ' 12' ' ' PRO . 19.4 m -58.21 -29.67 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -0.974 . . . . 0.0 110.27 -179.544 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.0 tt0 -90.78 -10.46 42.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.01 -1.056 . . . . 0.0 109.426 -179.616 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -105.86 16.14 25.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -179.559 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 44' ' ' SER . 10.5 m120 63.16 16.21 9.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.016 -1.053 . . . . 0.0 109.644 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.44 21.94 79.19 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -96.2 6.55 48.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 107.99 178.155 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 41' ' ' VAL . 5.3 tp -87.78 -76.19 0.39 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.547 0.689 . . . . 0.0 109.841 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.1 p 66.22 152.86 0.07 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -178.586 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.87 173.14 6.45 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.635 -0.666 . . . . 0.0 110.198 -178.056 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.682 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.93 -33.53 7.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.659 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -167.27 163.32 15.32 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.533 0.682 . . . . 0.0 109.667 -178.798 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -76.03 -177.72 4.05 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.524 -0.735 . . . . 0.0 109.359 179.15 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.38 -170.48 52.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.11 125.86 36.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -1.082 . . . . 0.0 109.609 179.326 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.645 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.454 179.775 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.92 -70.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.63 141.09 31.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.177 -0.952 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -107.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -162.81 113.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.523 -179.903 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 HD22 ' A' ' 23' ' ' LEU . 17.2 t -80.31 151.27 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.15 98.28 7.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.957 -179.747 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 34.6 m -93.08 65.55 4.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 108.939 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -88.98 -10.11 48.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.122 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mp0 -116.04 36.98 3.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' HB3' HG11 ' A' ' 42' ' ' VAL . 87.1 m-85 -117.87 160.95 36.69 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.644 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.965 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -83.63 159.66 72.3 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.964 -1.682 . . . . 0.0 110.819 2.364 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLU . 17.0 mtpp -131.35 137.84 31.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.391 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -80.66 14.04 2.13 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.492 2.128 . . . . 0.0 110.687 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.1 115.32 10.35 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.72 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.9 m -98.84 139.57 34.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 -179.353 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.509 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 36.0 p -47.13 169.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.16 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.862 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -110.12 -1.79 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.775 -1.203 . . . . 0.0 110.365 -179.869 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' OE2' ' CB ' ' A' ' 17' ' ' THR . 3.3 pm0 -76.26 -170.83 1.56 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.584 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.8 t80 -133.57 125.5 28.95 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.889 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 53.8 mtt180 -161.16 80.75 2.1 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.241 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.75 122.65 10.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.5 2.134 . . . . 0.0 112.045 -177.188 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.843 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -108.67 135.58 49.67 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.286 -0.966 . . . . 0.0 108.583 179.17 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.961 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 t -85.21 162.29 19.24 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 -179.298 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.98 161.49 15.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -69.23 -19.16 63.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -1.149 . . . . 0.0 109.109 -179.721 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 29.9 p-10 -78.12 -0.16 27.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.073 179.19 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER 79.62 42.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.508 -0.745 . . . . 0.0 109.752 179.857 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -134.18 139.41 45.82 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.944 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 31' ' ' TYR . 5.5 m -92.23 165.86 12.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.009 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.732 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.9 m-85 -137.83 123.61 19.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.819 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.57 -53.69 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.804 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -157.35 -168.23 2.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.973 -1.31 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -53.15 -37.9 62.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 111.358 -178.29 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 31.7 t -63.0 -61.15 2.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.635 -1.29 . . . . 0.0 109.964 -179.581 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.2 m-80 -55.75 -31.29 62.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.456 -0.777 . . . . 0.0 110.837 -179.017 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 69.6 t80 -73.58 -44.23 57.79 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.818 -1.177 . . . . 0.0 109.682 -179.526 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 63.3 m -66.23 -30.1 70.49 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.43 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 m-20 -68.42 -24.85 64.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.753 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.44 -26.35 32.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.531 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' GLY . 92.1 t -80.08 -26.48 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.965 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.4 m -90.68 -21.02 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.353 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.753 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.54 -31.59 16.66 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.277 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 96.6 p -88.63 23.16 2.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.541 -0.725 . . . . 0.0 109.744 -179.66 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.2 m120 64.97 11.59 7.18 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.377 -0.827 . . . . 0.0 109.319 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 78.1 22.63 67.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.9 p -93.1 -5.34 50.54 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.322 -1.104 . . . . 0.0 109.093 179.418 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -78.96 157.57 28.14 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.567 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.822 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.9 p -149.0 126.22 11.44 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.281 1.039 . . . . 0.0 110.496 179.714 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 2.2 tp -67.05 150.24 49.49 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.802 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.512 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.15 -22.58 12.32 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.116 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -175.92 163.29 2.72 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.497 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -78.51 178.58 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 178.921 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 75.73 -172.19 54.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.44 131.42 36.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.081 -1.246 . . . . 0.0 109.429 179.127 . . . . . . . . 3 3 . 1 . 037 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.562 179.915 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.663 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 166.67 113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 50' ' ' LEU . . . -49.84 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.854 ' H ' HD23 ' A' ' 50' ' ' LEU . 53.5 t -101.39 55.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.82 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 4.0 m 100.51 73.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.299 0.571 . . . . 0.0 110.881 179.102 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.582 ' CG2' HD22 ' A' ' 50' ' ' LEU . 90.0 t -160.59 141.35 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.928 . . . . 0.0 109.193 178.539 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -99.27 153.68 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 109.199 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 t -151.87 17.63 0.68 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.08 -1.012 . . . . 0.0 109.945 -179.875 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -90.8 13.02 17.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.149 -0.969 . . . . 0.0 109.748 179.616 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 1.5 pm0 -130.74 -18.39 3.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.008 -1.057 . . . . 0.0 110.972 -179.237 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 96.4 m-85 -79.76 161.59 65.88 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.933 -1.104 . . . . 0.0 109.175 -179.304 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.7 Cg_endo -69.43 167.43 70.12 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.249 -1.563 . . . . 0.0 112.191 2.698 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -119.66 147.94 44.92 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.68 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -77.99 13.73 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.592 2.195 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.09 128.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.19 159.09 16.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 p -62.8 164.34 8.07 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.241 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 -18.22 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.757 -1.215 . . . . 0.0 109.832 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -51.0 130.76 26.25 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.197 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 7.4 t80 -81.38 126.94 32.22 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.475 1.131 . . . . 0.0 111.446 -177.124 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mmt180 -159.58 75.63 3.1 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.614 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.4 Cg_endo -67.13 144.51 69.5 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.244 2.629 . . . . 0.0 113.288 -176.969 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -129.59 132.68 46.85 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.407 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.672 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.3 t -91.41 161.78 14.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.056 . . . . 0.0 110.319 -178.458 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.45 177.11 18.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.062 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -70.37 -23.57 62.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.985 . . . . 0.0 108.682 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 41.4 p-10 -77.3 -6.99 55.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.082 179.36 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m120 82.27 28.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.677 -0.639 . . . . 0.0 109.911 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -103.07 136.4 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.843 HG21 ' HD3' ' A' ' 55' ' ' LYS . 23.5 m -88.79 137.91 31.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.713 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.9 m-85 -114.87 136.85 52.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.694 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.08 -48.25 3.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -178.606 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.3 p30 -167.4 -158.8 0.29 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.032 -1.275 . . . . 0.0 110.656 178.942 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.5 -45.06 73.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 112.574 -176.566 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 3.6 m -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.491 -1.381 . . . . 0.0 109.704 -178.658 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -53.5 -17.31 1.93 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.682 ' CE1' HD21 ' A' ' 48' ' ' LEU . 4.0 t80 -83.23 -69.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.586 1.184 . . . . 0.0 110.302 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.68 -46.11 77.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.754 -177.792 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.589 ' OD1' ' CD1' ' A' ' 11' ' ' TYR . 3.0 m-20 -44.96 -29.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.46 -1.4 . . . . 0.0 107.592 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.96 -49.26 38.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.259 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.829 ' CG2' HD23 ' A' ' 48' ' ' LEU . 75.4 t -52.49 -62.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.282 0.563 . . . . 0.0 110.198 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.5 p -60.75 -23.63 29.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.434 -0.791 . . . . 0.0 111.097 -178.456 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.9 tt0 -92.03 -11.56 35.6 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.532 -1.355 . . . . 0.0 108.965 179.183 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 44' ' ' SER . 6.1 t -103.79 22.05 15.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.702 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 47' ' ' THR . 7.6 m-80 60.35 43.96 12.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.055 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.26 28.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 45' ' ' ASN . 79.9 p -84.48 -16.18 43.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -1.206 . . . . 0.0 107.89 178.189 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.6 OUTLIER -79.51 164.53 23.83 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.576 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.69 ' H ' HD12 ' A' ' 48' ' ' LEU . 64.5 p -149.85 130.94 14.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.854 HD23 ' H ' ' A' ' 4' ' ' VAL . 10.3 tp -64.98 146.13 55.42 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.65 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.63 -18.17 11.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.896 -1.127 . . . . 0.0 108.108 179.11 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 172.75 160.75 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.944 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 5' ' ' SER . 4.5 m-85 -71.01 -166.83 0.17 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.253 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.61 -170.51 2.72 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.4 OUTLIER -90.15 158.11 17.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.542 -0.975 . . . . 0.0 108.413 179.99 . . . . . . . . 3 3 . 1 . 038 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.66 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 18.2 m . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.289 179.843 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.63 111.07 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.36 142.96 27.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.762 ' O ' HG13 ' A' ' 4' ' ' VAL . 14.5 p -133.98 69.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 4' ' ' VAL . 40.7 m -171.09 149.7 2.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t -132.22 133.38 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -77.69 -166.43 0.77 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.786 -179.795 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 m -156.13 43.45 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.983 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -19.15 35.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 110.001 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -114.63 47.37 1.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 108.97 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 58.9 m-85 -142.72 163.95 35.49 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 -178.928 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -88.75 159.68 40.36 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.743 0.94 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.66 131.95 24.08 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 109.016 179.933 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.08 14.52 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 111.129 -179.699 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.82 142.11 22.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.819 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 17' ' ' THR . 33.0 t -144.78 162.88 35.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 109.565 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 16' ' ' CYS . 32.8 p -60.27 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 108.865 179.238 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pp -134.98 -13.18 2.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.031 -1.043 . . . . 0.0 110.958 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 15.6 pm0 -54.49 132.11 44.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.156 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.6 t80 -87.6 127.75 35.27 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.551 1.167 . . . . 0.0 111.911 -177.024 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmt85 -161.36 75.49 2.45 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.595 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.9 Cg_endo -66.21 133.94 34.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -120.28 124.82 46.54 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.247 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.85 ' HB2' ' HE1' ' A' ' 52' ' ' HIS . 13.5 t -79.12 165.89 22.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 108.328 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -138.7 159.03 25.29 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.398 -1.382 . . . . 0.0 112.497 -176.959 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 5.7 t -46.08 -21.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.924 -0.75 . . . . 0.0 110.908 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 29' ' ' LYS . 27.1 p-10 -86.15 26.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 28' ' ' ASN . 40.0 t-20 47.43 24.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 110.074 179.314 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.0 tttp -110.91 142.61 42.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 15.5 m -92.93 140.03 29.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 108.965 179.533 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.675 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 70.3 m-85 -112.91 126.51 55.54 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.513 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.01 -52.66 1.56 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p30 -158.96 -164.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.09 -1.241 . . . . 0.0 110.513 179.549 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.08 -49.65 30.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.598 -0.689 . . . . 0.0 111.999 -177.911 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 10.6 m -61.79 -58.09 9.34 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.57 -1.331 . . . . 0.0 110.43 -178.835 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 31' ' ' TYR . 14.8 m-80 -58.68 -13.81 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.98 . . . . 0.0 110.062 -179.503 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 48' ' ' LEU . 5.8 t80 -83.68 -58.13 2.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.307 1.051 . . . . 0.0 109.992 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.679 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.7 t -61.13 -29.36 69.73 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.128 -178.476 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.77 ' O ' HG22 ' A' ' 42' ' ' VAL . 88.0 m-20 -58.71 -29.49 66.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.612 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.713 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.81 -30.99 51.51 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.941 HG22 HD23 ' A' ' 48' ' ' LEU . 52.1 t -75.86 -21.3 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.48 0.657 . . . . 0.0 109.435 179.535 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 39' ' ' ASN . 11.6 m -90.25 -22.12 6.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.83 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -89.81 -30.02 18.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' THR . 11.2 p -87.72 17.78 4.5 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.343 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' SER . 9.4 p30 50.63 41.26 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.679 -179.706 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.82 37.75 58.18 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.365 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 44' ' ' SER . 7.6 t -111.13 -1.7 16.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.086 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.17 -75.01 0.45 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.303 1.049 . . . . 0.0 109.162 -179.661 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.748 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.8 p 82.44 150.59 0.09 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.383 -177.892 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' A' ' 51' ' ' SER . 14.2 tp -63.59 160.65 16.25 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.766 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 5.9 p -115.7 -43.62 3.01 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.85 ' HE1' ' HB2' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -178.1 160.63 1.42 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.264 179.429 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -69.04 172.56 6.54 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.956 179.224 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.48 -167.48 52.04 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.572 ' CD ' ' H ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.85 -172.08 2.91 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.847 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.593 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.8 tp . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.55 73.13 0.49 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.01 91.63 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.98 75.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -158.17 156.12 30.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.422 HG12 ' SG ' ' A' ' 8' ' ' CYS . 73.4 t -114.52 142.82 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.101 -0.999 . . . . 0.0 109.688 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.05 124.81 41.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 108.808 179.463 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.3 m -135.06 46.91 2.38 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 -179.263 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.24 -0.66 57.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.415 179.6 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -117.88 36.05 4.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.943 ' O ' HG21 ' A' ' 42' ' ' VAL . 92.8 m-85 -121.5 157.08 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.255 -0.903 . . . . 0.0 108.638 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.15 167.98 78.81 Favored 'Cis proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.022 2.298 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -116.32 142.91 30.13 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.546 -0.721 . . . . 0.0 109.202 -179.656 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -78.72 12.47 2.18 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.424 2.083 . . . . 0.0 110.489 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.87 109.98 0.34 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.556 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 92.4 m -95.18 140.56 29.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.785 -179.244 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -52.94 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.662 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.2 pp -128.69 -24.07 3.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.922 -1.111 . . . . 0.0 110.255 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 13.8 pm0 -46.37 134.87 8.64 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.204 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -87.55 126.48 34.95 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.535 1.159 . . . . 0.0 111.387 -177.937 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mtt-85 -161.57 82.03 1.9 Allowed Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.728 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.4 Cg_endo -65.64 125.6 14.62 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.615 2.21 . . . . 0.0 112.932 -176.489 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -110.12 136.91 48.62 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.924 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.574 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -103.54 122.74 45.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.091 -1.005 . . . . 0.0 111.053 -178.652 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.637 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.57 -166.14 0.57 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.178 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -90.17 -25.99 20.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.442 -1.034 . . . . 0.0 108.728 179.31 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -79.29 -2.26 40.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.806 . . . . 0.0 109.086 179.384 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.8 m120 82.99 47.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 0.0 110.356 179.603 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 17.3 ptmt -121.87 116.28 24.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.538 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 31' ' ' TYR . 51.4 m -75.42 153.06 37.88 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.726 0.774 . . . . 0.0 110.405 -178.564 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.6 m-85 -131.45 148.04 52.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.155 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -58.87 -37.59 91.02 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.479 -1.344 . . . . 0.0 111.947 -175.811 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -162.92 -165.78 1.18 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 110.388 -179.704 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.62 -23.63 66.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.6 -0.688 . . . . 0.0 110.536 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.7 t -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.976 -1.078 . . . . 0.0 109.522 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -66.37 -28.22 68.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.572 179.712 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 60.5 t80 -81.76 -45.05 16.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.333 1.063 . . . . 0.0 109.761 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.645 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.4 m -65.93 -26.78 67.75 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.758 -178.953 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.2 m-80 -70.19 -34.68 73.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.146 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.54 -20.33 58.75 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.576 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 55.0 t -84.67 -34.16 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 110.04 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.943 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -90.88 -16.29 8.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 0.0 109.996 -179.053 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.4 tm-20 -91.72 -19.8 22.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.991 -1.068 . . . . 0.0 108.422 179.053 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' THR . 5.8 p -100.25 23.41 10.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.496 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 3.7 m-20 66.04 11.72 7.96 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.223 -0.923 . . . . 0.0 109.172 -179.494 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 78.11 19.7 74.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.746 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 44' ' ' SER . 21.9 p -84.55 -12.45 54.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.15 -1.206 . . . . 0.0 108.986 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.637 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.1 tp -80.74 136.4 36.15 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.442 -0.786 . . . . 0.0 109.07 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 26' ' ' SER . 5.3 p -135.26 123.5 23.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.069 0.938 . . . . 0.0 110.244 179.385 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.563 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -72.93 153.03 41.15 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.674 0.749 . . . . 0.0 109.398 179.573 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.506 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -105.49 -23.8 12.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.235 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.574 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -165.58 159.36 16.52 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.896 -178.549 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -76.55 176.32 8.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.66 -167.37 54.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 7.4 mtmt -91.49 168.39 11.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.399 -1.059 . . . . 0.0 108.987 179.086 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.563 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.63 -179.45 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 1' ' ' LEU . 20.2 tp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.315 0.579 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.36 -165.59 1.89 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.96 136.45 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.979 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 4' ' ' VAL . 2.5 p -154.71 76.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.137 -0.977 . . . . 0.0 109.537 -179.816 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.8 t -170.47 141.57 1.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.324 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 34' ' ' LYS . 6.4 p -106.1 159.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.959 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.14 151.62 15.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.548 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 23.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.58 3.66 54.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 110.544 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -131.4 -8.24 3.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.818 -1.177 . . . . 0.0 110.946 -178.977 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.653 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.5 m-85 -81.34 158.28 69.41 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.79 -1.194 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.596 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 38.2 Cg_endo -69.99 142.55 71.15 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.762 -1.766 . . . . 0.0 111.534 2.028 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -103.17 142.72 25.14 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.979 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -78.43 14.39 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.781 2.32 . . . . 0.0 111.251 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.94 125.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 179.853 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' THR . 45.3 m -102.91 139.16 38.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.95 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.85 -166.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.541 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -119.24 -28.97 5.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.921 -1.112 . . . . 0.0 109.825 179.969 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.56 119.4 1.64 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.106 -0.996 . . . . 0.0 108.999 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.8 t80 -80.07 124.12 28.45 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.631 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -156.97 82.46 3.21 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.765 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.8 Cg_endo -65.11 120.6 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.425 2.083 . . . . 0.0 111.944 -177.367 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.711 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -111.88 132.24 54.85 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.671 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.009 ' O ' HD12 ' A' ' 50' ' ' LEU . 7.3 t -88.85 161.21 16.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.498 -0.751 . . . . 0.0 109.459 -178.965 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -107.52 172.55 17.75 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.866 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.586 ' H ' HD12 ' A' ' 48' ' ' LEU . 20.6 t -74.41 -3.36 30.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -1.201 . . . . 0.0 108.84 179.554 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.9 p-10 -98.01 -2.17 40.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.177 179.457 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.5 t30 83.59 43.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 30' ' ' THR . 5.3 tttt -125.43 138.83 54.02 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 179.522 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 19.6 m -92.74 152.12 19.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.504 179.804 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -128.57 130.16 46.98 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.706 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.94 -51.29 1.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -177.803 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.5 p30 -160.01 -166.55 1.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.871 -1.37 . . . . 0.0 110.522 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -54.55 -40.32 68.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.657 -0.652 . . . . 0.0 110.907 -178.477 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.5 t -60.48 -69.66 0.21 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.787 -1.195 . . . . 0.0 109.703 -179.324 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.3 m-80 -51.91 -26.09 9.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.447 -0.783 . . . . 0.0 111.272 -179.211 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 48' ' ' LEU . 14.6 t80 -75.25 -62.02 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.638 -1.289 . . . . 0.0 110.828 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.753 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.4 t -53.32 -49.12 67.71 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.185 -177.413 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -49.16 -31.31 8.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.29 -1.506 . . . . 0.0 108.597 -178.812 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.64 -36.65 62.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.255 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' A' ' 48' ' ' LEU . 41.4 t -67.97 -32.36 55.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.392 0.615 . . . . 0.0 110.253 179.913 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -90.63 -14.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.069 -178.018 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 9.6 pt-20 -92.54 -29.53 16.14 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.892 -1.13 . . . . 0.0 108.216 178.053 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.0 p -87.68 20.1 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.864 -178.932 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 45.1 m-80 64.23 12.85 7.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 -179.439 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.74 19.61 72.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.258 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.0 p -91.67 0.41 57.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.927 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -80.47 -56.19 4.35 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.979 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 51.0 p 52.37 125.76 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.498 1.142 . . . . 0.0 111.972 179.329 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.009 HD12 ' O ' ' A' ' 24' ' ' CYS . 6.6 tp -61.97 156.56 20.76 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.123 178.835 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.45 -23.86 8.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.87 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.919 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -179.58 161.82 1.06 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.774 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -78.32 173.33 12.42 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 78.84 -171.57 55.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.46 137.05 32.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.151 -1.205 . . . . 0.0 108.799 178.824 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.63 -179.772 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -69.37 -18.29 63.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.915 . . . . 0.0 109.582 179.961 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 61.73 -162.5 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.886 179.745 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.524 ' O ' HG13 ' A' ' 4' ' ' VAL . 3.3 p -156.58 113.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 179.928 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.645 ' HA ' HD22 ' A' ' 50' ' ' LEU . 4.2 m -145.83 -163.91 1.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.687 -179.951 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 7' ' ' ASP . 93.5 t -125.07 157.53 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.732 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 6' ' ' VAL . 16.3 t70 -89.11 137.77 32.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.464 179.924 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 m -135.26 61.91 1.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 109.909 -179.544 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.47 -0.73 57.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.838 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -128.34 39.65 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.908 ' O ' HG21 ' A' ' 42' ' ' VAL . 52.1 m-85 -120.65 161.1 41.45 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 108.842 -179.847 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.2 Cg_endo -75.43 174.56 52.16 Favored 'Cis proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.62 -1.825 . . . . 0.0 111.299 1.709 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -118.74 142.77 32.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.766 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.43 14.48 1.6 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 169.94 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.462 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 50.6 t -105.35 159.59 15.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 109.937 -179.8 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -61.72 -162.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.804 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -118.84 -28.07 5.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.658 -1.276 . . . . 0.0 109.913 179.768 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -42.73 118.4 1.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.793 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.9 t80 -79.23 128.64 33.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.382 1.087 . . . . 0.0 111.041 -177.84 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.31 78.9 2.21 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.217 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.1 Cg_endo -64.71 126.5 16.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.361 2.707 . . . . 0.0 113.366 -177.139 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.4 mp -110.47 127.15 55.01 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.334 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -88.27 119.1 28.36 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.782 -178.627 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.7 -158.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.989 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -91.84 -52.4 4.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.558 -0.966 . . . . 0.0 108.914 179.356 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.618 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -47.52 -24.63 0.89 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.169 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.8 p-10 103.3 33.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.177 0.513 . . . . 0.0 110.216 179.147 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.7 131.39 50.91 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.521 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 94.5 m -80.17 142.5 34.66 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 110.314 -179.088 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.5 m-85 -120.34 131.23 54.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.368 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.42 -50.9 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.163 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.2 p30 -167.19 -167.37 0.91 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.008 -1.289 . . . . 0.0 111.136 178.901 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.766 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.56 -42.85 11.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.125 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.1 m -67.74 -66.44 0.56 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.291 -1.506 . . . . 0.0 108.998 -179.262 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.532 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 17.9 m-80 -44.66 -23.17 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.527 -0.733 . . . . 0.0 110.194 -179.918 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 30.9 t80 -84.55 -48.73 9.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.74 1.257 . . . . 0.0 109.763 179.733 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -62.27 -58.98 5.71 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.072 -178.425 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.01 -31.36 0.17 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.147 -0.971 . . . . 0.0 108.772 -179.351 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -70.8 -50.71 32.74 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.543 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.5 t -51.71 -60.15 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.432 0.634 . . . . 0.0 109.97 179.036 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -62.6 -21.18 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.411 -0.806 . . . . 0.0 111.665 -178.539 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.2 tt0 -91.98 -11.59 35.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.457 -1.402 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.68 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.4 t -106.4 20.58 18.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.283 -0.885 . . . . 0.0 109.911 -179.555 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 75.94 1.48 3.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 108.967 -179.148 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.48 17.42 71.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' OG ' ' A' ' 44' ' ' SER . 14.1 t -83.89 -13.05 54.52 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.279 -1.13 . . . . 0.0 108.65 179.053 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tp -81.28 147.12 30.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.394 -0.816 . . . . 0.0 108.958 179.772 . . . . . . . . 1 1 . 1 . 042 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -145.46 158.32 43.86 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.242 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD22 ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -104.46 165.64 10.92 Favored 'General case' 0 C--N 1.281 -2.412 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 -178.937 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.622 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -106.99 -31.55 8.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.531 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -162.99 160.49 24.72 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.723 0.773 . . . . 0.0 110.068 -178.615 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' HE1' HG22 ' A' ' 4' ' ' VAL . 4.8 m-85 -77.14 -171.64 2.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.699 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.2 -166.57 28.94 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.829 . . . . . . . . 2 2 . 1 . 042 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.67 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 167.84 12.28 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.237 . . . . . . . . 3 3 . 1 . 042 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.67 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.7 m . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.723 -179.413 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 58.84 -151.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.317 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 63.71 137.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 53' ' ' PHE . 13.6 p -154.65 94.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.959 . . . . 0.0 109.667 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -106.85 -174.72 2.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.196 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.47 136.75 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.0 . . . . 0.0 109.64 -179.945 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.415 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 16.4 t0 -67.06 141.02 57.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 22.2 m -146.76 58.82 1.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.106 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.66 0.46 57.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.613 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.64 32.88 5.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.836 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.896 ' CB ' HG11 ' A' ' 42' ' ' VAL . 83.6 m-85 -119.28 158.3 48.95 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.58 169.92 73.22 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.506 -1.872 . . . . 0.0 111.706 1.799 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -128.05 144.8 52.89 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.959 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -77.93 14.3 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.652 2.235 . . . . 0.0 111.839 -178.759 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.23 145.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.217 179.77 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' THR . 54.1 t -122.85 159.99 27.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 109.272 179.449 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.6 p -61.28 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.174 -0.954 . . . . 0.0 108.594 179.24 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.96 -18.47 4.2 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.7 pt-20 -52.14 127.7 22.53 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.756 -1.215 . . . . 0.0 107.746 179.503 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 26.2 t80 -92.91 119.8 32.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 122.422 1.106 . . . . 0.0 110.969 -178.124 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtp-105 -152.17 81.8 5.53 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -65.02 131.31 28.35 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.966 2.444 . . . . 0.0 112.346 -177.448 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -117.58 121.44 40.95 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.965 179.254 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 5.1 t -80.49 120.05 23.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 108.593 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.06 -160.66 0.82 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -90.26 -37.88 13.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 108.048 178.328 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -58.55 -17.69 23.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.568 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 21.7 t30 96.35 21.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.003 0.43 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -99.33 127.08 45.3 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.005 -1.059 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 m -77.06 140.13 40.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.425 -0.797 . . . . 0.0 109.574 -179.925 . . . . . . . . 1 1 . 1 . 043 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 26.7 m-85 -115.81 129.16 56.33 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.693 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.46 -52.64 0.31 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -178.307 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.3 p30 -164.75 -164.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.806 -1.408 . . . . 0.0 110.992 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.03 -41.55 25.97 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.071 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 4.3 m -70.17 -64.67 0.85 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.202 -1.561 . . . . 0.0 109.098 -179.318 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.0 m-80 -43.92 -27.28 0.34 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.888 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 39.0 t80 -82.35 -46.87 13.02 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.067 1.413 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -56.9 -37.02 70.83 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.041 -178.349 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.41 -42.08 99.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.735 -1.228 . . . . 0.0 108.336 179.882 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -62.27 -25.08 67.64 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 74.9 t -80.59 -44.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 -179.526 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.896 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -81.27 -7.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.114 -0.992 . . . . 0.0 110.297 -178.791 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.92 -33.95 14.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.965 -1.084 . . . . 0.0 108.447 178.958 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 47' ' ' THR . 6.5 p -88.85 24.21 2.12 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.708 -0.62 . . . . 0.0 110.029 -179.528 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 73.4 4.7 4.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.052 -1.03 . . . . 0.0 109.05 -179.488 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 83.51 15.61 70.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.72 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 44' ' ' SER . 10.0 t -88.52 -1.8 58.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -1.061 . . . . 0.0 108.866 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.1 tp -81.19 145.27 31.08 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.283 -0.885 . . . . 0.0 109.124 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 p -137.55 145.92 43.48 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.485 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.666 HD21 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -94.59 171.05 9.03 Favored 'General case' 0 C--N 1.275 -2.641 0 O-C-N 120.877 -1.139 . . . . 0.0 109.839 -179.412 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.8 -20.23 13.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.778 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 177.1 154.98 0.26 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.528 -0.733 . . . . 0.0 109.833 -178.884 . . . . . . . . 3 3 . 1 . 043 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.878 ' CE1' HG22 ' A' ' 4' ' ' VAL . 5.4 m-85 -66.49 -165.78 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.206 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.21 -172.08 1.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.305 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.1 tttt -90.34 159.81 16.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.576 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.292 -1.891 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.605 -179.982 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.648 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.1 mm? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 72.16 -159.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.89 63.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 53' ' ' PHE . 46.8 t -85.51 96.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 109.468 -179.89 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -159.45 153.98 24.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -126.29 136.67 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.354 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -86.61 132.93 33.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.279 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 10.1 m -133.4 52.33 2.08 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.318 -0.864 . . . . 0.0 109.76 -179.606 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.35 8.02 35.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.774 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -119.64 3.79 11.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.89 ' O ' HG21 ' A' ' 42' ' ' VAL . 96.2 m-85 -89.78 157.44 46.36 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.166 -0.959 . . . . 0.0 109.001 -179.731 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -74.96 143.01 76.45 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.617 -1.826 . . . . 0.0 111.366 2.495 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttp -84.16 143.93 43.24 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.632 -0.667 . . . . 0.0 109.274 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.73 13.54 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.539 2.159 . . . . 0.0 110.556 179.459 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.01 114.1 0.12 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.4 m -92.57 139.6 30.41 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 110.007 -179.332 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -50.27 178.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.545 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -123.37 -16.11 6.96 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.967 -1.083 . . . . 0.0 110.166 -179.663 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.1 pm0 -55.24 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.359 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.6 t80 -132.93 119.7 20.49 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.737 1.256 . . . . 0.0 110.835 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.9 mtp85 -160.25 74.63 2.92 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.154 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.9 Cg_endo -65.06 134.73 40.83 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.895 2.396 . . . . 0.0 113.4 -176.135 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -117.97 143.57 46.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.46 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -94.41 166.74 11.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 -178.861 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -127.44 161.98 21.48 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -65.69 -28.69 69.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.044 -1.268 . . . . 0.0 108.832 179.996 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -58.34 -15.51 10.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.737 . . . . 0.0 109.304 179.657 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.5 t30 90.28 33.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.04 0.448 . . . . 0.0 110.435 179.396 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -121.28 -176.37 3.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.932 -1.105 . . . . 0.0 109.177 178.683 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 31' ' ' TYR . 8.9 m -123.17 163.92 19.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.826 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 29.4 m-85 -138.35 141.64 39.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.612 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -61.95 -41.33 99.65 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.312 -176.803 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.0 p-10 -157.8 -164.37 1.52 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.893 -1.357 . . . . 0.0 109.978 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -61.73 -31.71 71.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 110.826 -178.705 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -72.9 -44.17 61.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.665 -1.272 . . . . 0.0 109.632 -179.479 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -63.08 -44.26 96.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.693 179.925 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.4 t80 -65.43 -57.15 9.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.144 0.973 . . . . 0.0 110.963 -179.365 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -53.62 -51.73 62.13 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 -178.282 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.3 m-20 -45.41 -36.4 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.002 -1.061 . . . . 0.0 109.41 -179.758 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.86 -42.03 77.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 108.675 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.636 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.1 t -60.57 -59.66 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.649 -0.657 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 11' ' ' TYR . 9.2 p -62.53 -21.51 27.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.226 -0.921 . . . . 0.0 111.013 -178.766 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.2 -15.29 27.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.71 -1.244 . . . . 0.0 108.818 179.065 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 47' ' ' THR . 22.7 t -102.43 10.57 38.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.475 -179.935 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 67.21 10.09 7.45 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 109.178 -179.002 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.66 18.55 54.51 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.051 . . . . . . . . 1 1 . 1 . 044 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 44' ' ' SER . 3.9 p -79.56 -15.22 58.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.977 -1.308 . . . . 0.0 107.875 178.076 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.65 160.8 26.2 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.719 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.862 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.8 p -156.64 124.6 5.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.142 0.972 . . . . 0.0 109.9 178.902 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -62.44 144.12 56.28 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.385 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.97 -18.29 13.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.857 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 179.72 161.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.629 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' CE1' HG13 ' A' ' 4' ' ' VAL . 54.4 m-85 -75.89 179.36 5.57 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.217 -0.927 . . . . 0.0 108.93 179.128 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.32 -167.04 54.45 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.534 . . . . . . . . 2 2 . 1 . 044 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.36 144.77 25.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -1.079 . . . . 0.0 109.217 179.573 . . . . . . . . 3 3 . 1 . 044 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.627 179.953 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 045 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.36 -148.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 109.637 179.997 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 109.67 18.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 -179.865 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HB ' HD23 ' A' ' 50' ' ' LEU . 3.5 m -93.38 82.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.254 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.2 p -166.68 123.7 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.321 -179.801 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -103.87 169.02 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.818 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 25.8 t70 -75.21 155.07 37.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.322 179.875 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -151.62 50.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 109.845 -179.867 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.11 -13.26 31.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.983 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.19 57.33 1.81 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.143 -0.973 . . . . 0.0 110.626 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 98.3 m-85 -143.29 149.49 48.41 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 120.86 -1.15 . . . . 0.0 109.326 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.563 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -73.97 161.06 95.11 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.438 -1.901 . . . . 0.0 111.654 2.485 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -121.16 139.88 30.18 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.668 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.8 13.62 1.65 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.524 2.149 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 178.23 128.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 179.906 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 51.3 t -114.6 159.7 20.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.407 179.711 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.437 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -61.42 -166.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.512 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -112.61 -17.4 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.866 -1.147 . . . . 0.0 109.643 179.666 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 5.3 pm0 -46.18 137.49 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.132 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.626 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 7.7 t80 -96.55 135.09 38.92 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.487 1.137 . . . . 0.0 111.409 -177.834 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.1 mtt180 -161.07 73.67 2.64 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.08 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.1 Cg_endo -63.2 119.1 6.04 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.65 2.234 . . . . 0.0 112.689 -176.613 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.51 130.83 54.81 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.059 178.885 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.742 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.21 106.37 11.19 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.761 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.626 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.76 -162.52 0.06 OUTLIER Glycine 0 C--N 1.297 -1.634 0 C-N-CA 118.033 -2.032 . . . . 0.0 108.856 -178.687 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -88.59 -35.79 16.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.31 . . . . 0.0 109.29 -179.939 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p30 -63.21 -12.35 27.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 178.818 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER 92.41 16.42 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.323 0.582 . . . . 0.0 109.864 179.697 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -99.33 121.2 40.76 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.341 . . . . . . . . 1 1 . 1 . 045 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 31' ' ' TYR . 97.4 m -59.13 157.62 10.1 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.492 -0.755 . . . . 0.0 109.372 -179.527 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 9.8 m-85 -128.23 127.87 43.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.142 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.89 -53.0 1.17 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -177.584 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.0 p30 -160.45 -167.62 1.94 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.702 -1.469 . . . . 0.0 110.843 179.053 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD11 ' A' ' 23' ' ' LEU . 4.8 ptmt -50.53 -40.12 50.8 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.786 -0.571 . . . . 0.0 112.03 -177.116 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.0 m -66.55 -65.45 0.68 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.514 -1.366 . . . . 0.0 109.679 -179.314 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.8 m-80 -47.74 -28.29 2.41 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.437 -0.789 . . . . 0.0 110.366 -179.055 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CB ' HD13 ' A' ' 23' ' ' LEU . 14.8 t80 -76.0 -57.6 3.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.616 -1.302 . . . . 0.0 109.797 179.566 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 34.0 t -54.13 -56.76 15.05 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.415 -177.949 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.93 -33.58 0.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.86 -1.15 . . . . 0.0 108.76 -178.693 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -67.56 -49.11 64.79 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.191 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -56.9 -63.76 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.396 0.617 . . . . 0.0 110.249 179.046 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -59.47 -22.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.504 -0.748 . . . . 0.0 111.799 -178.197 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.8 -17.74 26.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.348 -1.47 . . . . 0.0 108.451 179.084 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.9 ' O ' HG22 ' A' ' 47' ' ' THR . 16.7 p -102.73 29.55 5.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.476 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.46 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.4 p-10 45.1 53.84 7.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 109.103 -179.638 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.33 45.17 1.78 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -110.48 -8.83 14.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.335 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.799 ' C ' HG23 ' A' ' 49' ' ' THR . 2.3 tp -81.71 -84.11 0.11 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.837 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.799 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 79.81 171.62 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.063 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.86 174.42 8.38 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -178.633 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.652 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.58 -35.13 7.54 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.591 . . . . . . . . 3 3 . 1 . 045 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.742 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -165.34 162.15 19.47 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.55 -179.101 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 23' ' ' LEU . 61.4 m-85 -78.54 177.48 8.53 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 108.975 179.154 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 76.03 -168.16 54.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.949 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.83 141.96 30.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -1.153 . . . . 0.0 109.749 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.606 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.306 0.574 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.13 34.71 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.344 -0.847 . . . . 0.0 109.779 179.984 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.63 28.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 179.823 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 4' ' ' VAL . 11.6 m -144.34 101.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 115.96 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 -179.903 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.48 130.73 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.242 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.1 104.67 17.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 m -90.87 57.33 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -89.87 -20.35 23.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 108.897 179.762 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.4 16.7 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.279 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.988 ' HB3' HG11 ' A' ' 42' ' ' VAL . 17.5 m-85 -102.2 168.15 9.39 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.92 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -85.03 176.37 30.41 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.465 -1.473 . . . . 0.0 111.238 1.217 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 8.8 mttt -125.64 137.54 30.15 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.881 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -79.81 14.03 1.98 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.575 2.183 . . . . 0.0 110.766 -179.286 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.48 124.0 3.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.624 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -100.72 137.72 38.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.07 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -53.12 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.395 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.5 pp -121.1 -10.23 9.05 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.793 -179.621 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' LEU . 10.5 pm0 -57.3 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.788 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 6.9 t80 -136.45 129.2 30.77 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.19 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mtm180 -161.25 79.27 2.19 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.218 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.2 Cg_endo -64.97 116.61 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.233 1.955 . . . . 0.0 112.133 -177.288 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.81 125.82 52.37 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.432 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 41.8 t -78.91 165.87 23.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.953 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.69 172.26 20.97 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.18 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -66.04 -35.65 81.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.376 -1.073 . . . . 0.0 109.719 -179.099 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.6 p-10 -62.76 -11.55 18.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.096 -1.002 . . . . 0.0 108.915 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.4 t-20 85.69 30.34 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.457 0.646 . . . . 0.0 109.465 179.831 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 2.8 ttpt -114.71 143.29 45.29 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.087 179.749 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 26.9 m -91.94 155.04 18.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.493 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.849 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.3 m-85 -123.56 124.48 42.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.826 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.25 -51.86 0.71 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.669 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -154.73 -162.75 1.44 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.926 -1.338 . . . . 0.0 110.499 179.635 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.1 -42.45 93.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.704 . . . . 0.0 111.628 -177.917 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 42.8 t -55.46 -49.7 71.8 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.247 -1.533 . . . . 0.0 109.275 -179.744 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -61.94 -53.62 53.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.68 -179.122 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' HD21 ' A' ' 48' ' ' LEU . 63.1 t80 -53.26 -48.08 68.56 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.402 1.096 . . . . 0.0 110.143 -179.215 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.634 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 40.7 m -64.58 -30.58 71.61 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.625 -179.477 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' VAL . 10.5 m-80 -70.77 -22.36 62.39 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.98 -1.075 . . . . 0.0 108.528 179.296 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.849 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.51 -27.62 31.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 48' ' ' LEU . 73.8 t -77.81 -31.95 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.128 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.988 HG11 ' HB3' ' A' ' 11' ' ' TYR . 21.5 m -86.42 -28.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.724 -0.61 . . . . 0.0 110.151 -179.431 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.99 -22.36 20.03 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 109.371 -179.586 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 47' ' ' THR . 26.2 p -89.88 10.36 24.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.709 -179.465 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 44' ' ' SER . 8.0 t30 74.47 11.24 4.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 108.654 -179.373 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.83 81.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.827 . . . . . . . . 1 1 . 1 . 046 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -80.15 -8.4 59.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -1.21 . . . . 0.0 108.857 179.127 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.855 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.75 163.76 24.22 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.454 -0.779 . . . . 0.0 109.17 179.999 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.655 ' H ' HD12 ' A' ' 48' ' ' LEU . 40.0 p -147.71 126.55 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.953 0.882 . . . . 0.0 108.682 177.974 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.4 tp -58.5 125.19 22.32 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.334 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.5 t -83.22 -22.98 32.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.802 -179.753 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . 22.6 p-80 154.26 162.42 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.888 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.432 ' O ' ' HD2' ' A' ' 52' ' ' HIS . 62.0 m-85 -69.71 170.57 10.63 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.791 -1.193 . . . . 0.0 108.821 179.284 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 78.27 -172.46 55.22 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.808 . . . . . . . . 2 2 . 1 . 046 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.78 150.04 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.261 . . . . 0.0 109.313 179.118 . . . . . . . . 3 3 . 1 . 046 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.401 ' O ' ' O ' ' A' ' 55' ' ' LYS . 15.3 m . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.578 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 65.99 -160.84 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.246 -179.839 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -107.82 130.87 54.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 -180.0 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 3' ' ' ALA . 4.8 m -153.1 93.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.398 -0.814 . . . . 0.0 109.285 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 122.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.369 -179.882 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.65 150.48 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.835 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 12.1 t70 -60.86 151.84 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 109.092 179.772 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.6 t -150.58 16.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.4 t -90.37 10.21 25.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.488 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.0 mp0 -124.66 -21.18 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 110.442 -179.618 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 13' ' ' LYS . 91.4 m-85 -79.37 153.52 76.57 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 120.832 -1.167 . . . . 0.0 109.178 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.6 Cg_endo -74.55 144.59 81.44 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.232 -1.987 . . . . 0.0 111.344 1.514 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -105.85 163.24 17.48 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.692 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.28 13.69 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.426 2.084 . . . . 0.0 111.39 -179.75 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 130.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 90.5 m -93.76 152.54 18.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -51.74 -176.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 108.987 179.648 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.708 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.2 pt? -122.49 -35.69 3.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.027 -1.046 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.7 pm0 -53.13 137.98 32.48 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.429 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 11.1 t80 -86.88 127.61 35.04 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.258 1.028 . . . . 0.0 110.779 -178.462 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.2 mtm180 -160.61 85.31 1.91 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.327 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.2 Cg_endo -64.8 117.94 4.98 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.755 2.303 . . . . 0.0 112.998 -177.348 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.07 131.04 54.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.89 177.88 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 41.0 t -78.32 162.86 26.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.977 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -144.43 169.1 26.52 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.902 -178.084 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 2.3 t -58.55 -19.07 34.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.603 -0.939 . . . . 0.0 110.32 -178.028 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 26.5 p-10 -61.24 -13.24 17.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.102 -0.999 . . . . 0.0 109.416 179.727 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.4 t-20 83.88 14.76 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.681 -0.637 . . . . 0.0 109.697 179.902 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -128.01 -166.36 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 31' ' ' TYR . 16.3 m -111.81 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.644 -0.66 . . . . 0.0 109.342 -179.898 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.715 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.7 m-85 -131.38 121.63 24.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.58 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.2 -52.9 0.28 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.264 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -157.89 -165.02 1.64 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.013 -1.286 . . . . 0.0 110.358 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.66 -42.75 68.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.58 -0.7 . . . . 0.0 110.597 -178.485 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 50.7 t -62.2 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.796 -1.19 . . . . 0.0 109.786 -179.844 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.9 m-80 -52.58 -23.69 6.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 110.211 -179.367 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.1 t80 -75.34 -67.08 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.15 -46.66 75.71 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.796 -177.923 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.2 m-20 -44.09 -30.94 0.82 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.745 -1.222 . . . . 0.0 107.991 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.48 -49.5 47.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.537 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.878 HG22 HD23 ' A' ' 48' ' ' LEU . 76.8 t -54.02 -63.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.442 0.639 . . . . 0.0 110.216 178.945 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.1 p -59.37 -22.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.408 -0.808 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.21 -15.13 27.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.519 -1.363 . . . . 0.0 109.23 179.421 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.55 ' O ' HG22 ' A' ' 47' ' ' THR . 5.5 p -100.66 7.58 43.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.885 . . . . 0.0 109.671 -179.685 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.7 t30 75.21 8.66 3.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 -179.579 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.26 19.78 63.93 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -91.7 -0.22 57.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.341 -1.094 . . . . 0.0 108.942 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.878 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.02 -70.32 0.67 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.898 0.856 . . . . 0.0 109.276 -179.494 . . . . . . . . 3 3 . 1 . 047 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.37 154.33 0.1 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.579 -178.756 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.6 tp -72.82 126.01 28.9 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.384 -179.536 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.574 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 8.1 t -79.3 -24.17 43.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 108.874 179.444 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 51' ' ' SER . 17.1 p80 150.67 174.27 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.541 178.378 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.9 155.86 23.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 110.092 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 84.1 -174.18 50.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -90.24 146.38 24.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.054 -1.262 . . . . 0.0 109.008 179.249 . . . . . . . . 1 1 . 1 . 047 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.236 0.541 . . . . 0.0 109.556 . . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.85 -165.19 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.949 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.79 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 179.944 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 5' ' ' SER . 2.0 p -105.36 104.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.42 179.933 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 61.1 p 178.37 139.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.485 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 t -80.4 134.0 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.297 179.879 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.64 133.84 39.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.278 -179.989 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 m -124.42 61.17 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.706 -179.828 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 1.4 t -90.19 -31.94 16.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.654 179.93 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -81.48 0.94 35.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 109.307 179.792 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.928 ' HB3' HG11 ' A' ' 42' ' ' VAL . 65.5 m-85 -91.3 165.32 21.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 108.876 -179.839 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.58 152.0 59.9 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.162 0.715 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 12.6 mttt -105.5 141.14 22.01 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.638 -0.664 . . . . 0.0 109.677 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.5 14.11 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.464 2.11 . . . . 0.0 110.413 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.68 145.67 14.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.751 . . . . 0.0 109.188 -179.985 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.4 m -123.76 152.71 41.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.955 -179.589 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.7 -167.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.14 179.695 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -125.08 -18.41 5.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 0.0 110.367 -179.664 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 7.3 pm0 -56.55 -167.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.891 -1.131 . . . . 0.0 108.246 179.591 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -135.73 130.35 34.04 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.401 1.096 . . . . 0.0 111.315 -179.833 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.81 79.0 2.35 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.94 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.1 Cg_endo -64.47 114.85 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.432 2.088 . . . . 0.0 112.675 -176.995 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.631 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.57 141.76 45.95 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.73 ' HB3' ' CE1' ' A' ' 52' ' ' HIS . 20.6 t -95.49 159.63 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.81 -1.156 . . . . 0.0 109.007 -179.565 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -129.58 172.08 20.03 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.321 -178.407 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 t -56.26 -38.31 70.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.904 . . . . 0.0 111.458 -177.53 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -52.08 -19.11 1.72 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.69 -1.256 . . . . 0.0 110.038 -179.276 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.2 t30 91.47 27.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.933 -0.48 . . . . 0.0 110.409 179.459 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 178.99 4.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.904 -1.122 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 31' ' ' TYR . 41.7 m -107.15 162.37 13.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.862 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.8 m-85 -127.74 121.09 29.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.027 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.93 -54.34 0.68 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.968 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.6 p30 -152.36 -167.88 2.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.038 -1.272 . . . . 0.0 109.991 179.114 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.8 -60.71 2.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.348 -178.518 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 41.9 t -43.45 -62.97 0.92 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.802 -1.186 . . . . 0.0 110.432 -179.425 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -49.65 -34.25 17.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.579 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 13.5 t80 -70.5 -60.05 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.31 1.052 . . . . 0.0 110.845 -179.002 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.87 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.6 m -53.69 -30.77 45.09 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.711 -0.618 . . . . 0.0 110.18 -179.107 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.6 m-80 -64.07 -39.15 93.44 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.106 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -67.34 -20.21 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.34 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HD23 ' A' ' 48' ' ' LEU . 41.5 t -84.8 -31.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.7 m -82.28 -16.01 11.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.626 -0.671 . . . . 0.0 109.619 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.65 -32.35 15.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.885 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.811 ' O ' HG22 ' A' ' 47' ' ' THR . 60.0 p -86.56 10.14 16.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.802 -179.423 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.2 t30 75.05 7.35 4.21 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 108.858 -179.444 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 83.51 13.7 75.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.846 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 44' ' ' SER . 13.9 t -93.44 0.89 56.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 108.995 179.128 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.856 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -80.06 -71.57 0.45 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.036 0.922 . . . . 0.0 108.744 179.881 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.4 p 79.62 152.02 0.12 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.384 1.088 . . . . 0.0 109.997 -179.505 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -70.59 152.82 43.51 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.637 -179.734 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 p -99.38 -39.94 8.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.675 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.73 ' CE1' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.85 163.97 2.31 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.23 179.972 . . . . . . . . 3 3 . 1 . 048 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.46 136.68 36.37 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.467 . . . . . . . . 1 1 . 1 . 048 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 110.41 -167.64 12.73 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.798 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 151.72 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -1.216 . . . . 0.0 108.97 179.243 . . . . . . . . 2 2 . 1 . 048 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.54 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.511 179.989 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 3.0 tp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 64.47 -163.01 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.284 -179.93 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.97 176.34 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.845 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' A' ' 5' ' ' SER . 3.6 t -136.1 72.9 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.554 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 165.37 128.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 -179.973 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.89 150.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.233 179.938 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.65 45.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 16.8 m -102.19 62.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.982 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.35 -4.13 58.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.972 . . . . 0.0 109.943 -179.542 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -117.89 2.45 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.322 179.681 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.802 ' HB3' HG11 ' A' ' 42' ' ' VAL . 35.5 m-85 -85.54 165.38 35.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 109.782 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -88.13 169.42 36.99 Favored 'Cis proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.249 -1.563 . . . . 0.0 110.642 0.837 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' CE1' ' A' ' 11' ' ' TYR . 5.2 mtpt -122.55 143.67 40.38 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 108.765 -179.848 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.81 13.88 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.491 2.127 . . . . 0.0 110.582 -179.882 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.7 112.27 1.89 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.636 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.3 m -81.02 143.28 32.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.837 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.3 p -62.73 -163.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.317 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.57 -15.9 8.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.987 -1.071 . . . . 0.0 109.636 179.836 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.804 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -47.92 123.46 6.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.016 -1.052 . . . . 0.0 108.477 179.417 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 27.8 t80 -86.59 110.68 19.99 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.361 1.077 . . . . 0.0 110.376 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 10.4 mtp180 -145.9 86.39 7.21 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.306 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -67.33 104.19 0.87 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 121.855 1.704 . . . . 0.0 111.596 -177.904 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.82 120.58 40.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.639 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -78.82 -179.67 6.7 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.617 -178.867 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.74 165.27 29.63 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.198 -1.477 . . . . 0.0 112.222 -177.216 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -33.04 74.84 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -50.65 -24.93 3.67 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.95 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.61 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 31.1 t-20 96.33 37.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.026 179.57 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -136.88 -169.43 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 179.591 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 91.8 m -127.39 158.92 36.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.345 -179.937 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 88.3 m-85 -132.51 105.9 7.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.378 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.78 -55.98 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 O-C-N 122.047 -0.408 . . . . 0.0 112.28 -177.789 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.1 p-10 -140.24 -171.02 3.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.608 -1.525 . . . . 0.0 110.627 -179.541 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.8 pttt -59.64 -30.77 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.777 -0.577 . . . . 0.0 110.55 -179.036 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 43.6 t -62.89 -74.12 0.1 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.674 -1.266 . . . . 0.0 108.261 179.194 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.55 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 18.3 m-80 -39.37 -48.67 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 110.557 -179.975 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.61 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 74.1 t80 -55.13 -46.37 75.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.665 -1.272 . . . . 0.0 109.265 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 27.3 m -59.83 -48.32 82.15 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.602 179.957 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 7.2 m120 -45.68 -30.02 1.44 Allowed 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.85 -1.156 . . . . 0.0 109.308 179.35 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -79.08 -40.16 31.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.992 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.993 HG22 HD23 ' A' ' 48' ' ' LEU . 58.1 t -69.88 -24.3 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.719 . . . . 0.0 110.146 -179.821 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.1 m -91.94 -26.97 4.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.534 -179.182 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -91.29 -15.27 29.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.077 -179.931 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 26.8 t -102.24 19.79 18.02 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.2 m120 65.31 18.58 11.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.454 -0.779 . . . . 0.0 109.044 -179.604 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 18.37 77.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.732 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.2 p -89.61 -10.02 47.52 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.486 -1.008 . . . . 0.0 108.784 179.401 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.993 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.43 148.05 32.08 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.75 . . . . . . . . 3 3 . 1 . 049 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 30.1 p -123.07 139.98 53.5 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.888 0.852 . . . . 0.0 109.721 179.332 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 23' ' ' LEU . 5.1 tp -61.21 130.16 44.85 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.696 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.9 t -79.01 -22.95 44.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.741 -1.224 . . . . 0.0 109.241 -179.913 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.559 ' CB ' ' O ' ' A' ' 51' ' ' SER . 10.5 p-80 154.1 164.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.167 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.77 148.29 40.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.11 -0.993 . . . . 0.0 108.601 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 93.73 -179.31 38.46 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.325 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.97 168.4 17.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.315 . . . . 0.0 109.017 178.821 . . . . . . . . 2 2 . 1 . 049 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 30.7 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.687 -179.464 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.81 24.69 7.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.609 -179.966 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.11 88.21 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 0.0 109.288 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 1' ' ' LEU . 3.8 m -117.7 77.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 m -146.48 163.88 34.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 179.79 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 t -137.77 149.37 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -83.9 117.25 23.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.274 179.894 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.19 37.36 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.598 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.28 6.7 41.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.711 -179.859 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 24.1 mp0 -129.01 36.71 4.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 109.775 -179.76 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.967 ' HB3' HG11 ' A' ' 42' ' ' VAL . 24.3 m-85 -108.26 164.08 15.54 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 108.541 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.8 Cg_endo -77.7 -177.72 21.93 Favored 'Cis proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.967 -1.68 . . . . 0.0 111.684 2.232 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mmmt -125.54 148.14 60.56 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.616 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 14' ' ' PRO . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.73 14.01 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 163.62 165.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.688 179.746 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.9 t -140.43 160.0 40.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 179.877 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.48 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.091 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.0 pp -115.02 -24.37 8.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 109.57 179.605 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 19' ' ' GLU . 1.9 pt-20 -43.79 116.6 1.0 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.3 t80 -79.26 130.96 35.99 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.496 1.141 . . . . 0.0 111.325 -177.622 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.03 78.35 2.33 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.315 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.53 118.45 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.89 2.394 . . . . 0.0 112.898 -177.097 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.644 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -106.67 131.58 53.65 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.779 178.478 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 40.8 t -79.45 162.54 25.4 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.121 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -141.95 166.49 26.28 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.259 -178.054 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t -55.74 -13.27 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.874 -0.78 . . . . 0.0 110.531 -178.729 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.0 p30 -75.01 5.94 4.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.175 . . . . 0.0 109.427 179.236 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 72.1 m-20 63.29 31.32 15.45 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.367 -0.833 . . . . 0.0 109.847 179.763 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -136.39 -168.26 2.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.659 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.3 m -119.85 162.45 19.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.8 m-85 -129.97 126.45 37.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.046 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.27 -53.76 0.96 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.527 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.6 p30 -157.54 -164.64 1.6 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.934 -1.333 . . . . 0.0 111.179 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.5 -47.49 63.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.662 -0.649 . . . . 0.0 112.31 -177.304 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HE3' ' A' ' 34' ' ' LYS . 5.2 m -63.54 -55.08 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.402 -1.436 . . . . 0.0 109.982 -178.62 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.4 m-80 -54.86 -27.87 45.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -0.997 . . . . 0.0 110.027 -179.541 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.0 t80 -74.03 -50.46 19.64 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.997 1.38 . . . . 0.0 109.401 179.639 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 13.5 m -60.56 -26.13 66.69 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.474 -179.257 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 19.7 m-20 -65.26 -34.22 77.85 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.927 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.61 -39.13 80.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.627 HG22 HD23 ' A' ' 48' ' ' LEU . 86.5 t -65.11 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.581 -0.699 . . . . 0.0 109.89 -179.727 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.967 HG11 ' HB3' ' A' ' 11' ' ' TYR . 14.1 p -59.28 -19.75 16.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -0.771 . . . . 0.0 110.7 -179.335 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -90.75 -22.52 21.04 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.6 -1.312 . . . . 0.0 107.909 178.981 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.821 ' O ' HG22 ' A' ' 47' ' ' THR . 0.9 OUTLIER -98.44 29.29 3.69 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.114 179.533 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.525 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 6.0 p-10 44.34 53.82 6.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.03 47.1 2.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.31 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -111.53 -22.97 10.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.453 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.627 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.64 150.88 30.84 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.999 . . . . . . . . 3 3 . 1 . 050 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.569 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.2 p -125.02 138.14 54.22 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 109.41 179.621 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.3 tp -54.12 124.49 15.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.574 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 8.4 t -78.0 -22.84 48.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.793 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.58 ' CB ' ' O ' ' A' ' 51' ' ' SER . 12.9 p80 152.65 177.61 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.136 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -87.62 160.95 17.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 109.427 179.653 . . . . . . . . 1 1 . 1 . 050 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.64 -170.43 50.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.385 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 148.33 23.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.06 -1.259 . . . . 0.0 109.159 179.088 . . . . . . . . 2 2 . 1 . 050 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.457 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.546 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.302 0.572 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -87.93 122.92 32.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.99 19.61 10.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.696 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -19.55 60.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -106.06 42.02 1.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.793 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.8 m-85 -137.38 164.37 42.19 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.8 Cg_endo -86.89 145.9 31.59 Favored 'Cis proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.08 -1.633 . . . . 0.0 110.646 1.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.6 mttp -98.51 134.57 21.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.98 15.11 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.422 2.082 . . . . 0.0 111.022 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.89 124.47 7.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.387 -0.821 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.5 m -119.38 131.96 55.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 2.6 p -63.79 -169.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 108.61 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -115.35 -13.86 11.66 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.279 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 5.8 pm0 -46.15 127.74 8.89 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -87.33 125.3 34.15 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.68 1.228 . . . . 0.0 112.276 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -162.57 82.26 1.65 Allowed Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.8 Cg_endo -65.92 132.78 31.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.071 2.514 . . . . 0.0 113.67 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.9 mp -118.77 141.1 48.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -99.26 129.84 45.51 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.716 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.17 -167.74 3.27 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.7 t -82.56 -27.81 31.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.096 -1.238 . . . . 0.0 109.101 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.3 p30 -75.09 0.17 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.7 m-20 79.89 37.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 110.187 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 30' ' ' THR . 3.1 tttm -108.11 144.1 35.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 108.573 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.477 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 32.0 m -90.36 146.26 24.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.738 -1.227 . . . . 0.0 109.514 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.34 -49.27 3.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 7.2 p-10 -163.83 -166.64 1.21 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.274 -1.133 . . . . 0.0 110.217 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.864 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.32 -48.7 73.76 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.435 -0.79 . . . . 0.0 111.213 -177.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 16.0 t -54.44 -60.97 2.64 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.821 -1.175 . . . . 0.0 111.375 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.427 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 19.5 m-80 -62.43 -26.63 68.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.779 -1.2 . . . . 0.0 110.652 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 7.9 t80 -65.94 -59.84 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.856 -1.153 . . . . 0.0 109.863 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -59.86 -44.07 94.34 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.583 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.4 m-80 -43.25 -28.98 0.36 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.666 -1.271 . . . . 0.0 107.882 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.98 -49.78 18.79 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' CYS . 90.1 t -53.65 -56.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.584 0.707 . . . . 0.0 109.43 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 12' ' ' PRO . 23.4 m -59.78 -26.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.543 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -88.0 -13.83 40.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.028 -1.045 . . . . 0.0 108.801 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.905 ' O ' HG22 ' A' ' 47' ' ' THR . 27.9 p -110.4 29.83 7.34 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.448 -0.782 . . . . 0.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 44.85 55.32 6.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.979 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 36.38 45.54 0.95 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -110.04 -7.4 14.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.5 tp -83.0 -71.45 0.5 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.51 0.671 . . . . 0.0 109.313 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.617 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 14.2 p 60.78 138.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.541 0.686 . . . . 0.0 109.37 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -93.57 165.59 12.66 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.697 0.76 . . . . 0.0 111.135 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.94 -34.5 6.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.68 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.6 p80 -156.08 165.21 37.11 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.583 0.706 . . . . 0.0 109.88 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 6.0 m-85 -83.15 -168.9 2.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.692 -0.63 . . . . 0.0 109.641 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 60.07 -166.95 9.81 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 mtmt -90.41 164.96 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.992 . . . . 0.0 108.657 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.146 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.86 118.06 23.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.408 -0.807 . . . . 0.0 109.784 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.2 m -97.91 50.45 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.241 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -79.36 -23.79 43.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.858 . . . . 0.0 109.635 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.94 43.18 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.038 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.891 ' HB3' HG11 ' A' ' 42' ' ' VAL . 34.0 m-85 -131.31 165.51 34.75 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.002 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -87.51 169.42 39.49 Favored 'Cis proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.237 -1.568 . . . . 0.0 110.887 -0.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 2.6 mtpt -125.25 142.99 43.05 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -78.81 14.86 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.719 2.28 . . . . 0.0 111.308 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 179.57 151.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -126.54 160.31 30.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.56 ' HG1' ' CD ' ' A' ' 19' ' ' GLU . 5.2 p -64.62 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.52 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.1 pp -132.17 -13.9 3.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.963 -1.086 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.56 ' CD ' ' HG1' ' A' ' 17' ' ' THR . 15.2 pm0 -55.42 126.51 25.42 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 120.448 -1.408 . . . . 0.0 108.25 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 6.0 t80 -81.83 118.98 23.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.555 1.169 . . . . 0.0 110.906 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.9 69.08 10.89 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.5 Cg_endo -65.34 132.4 31.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.227 2.618 . . . . 0.0 113.389 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -125.21 132.99 52.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.198 178.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 32.8 t -78.09 118.67 20.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -64.01 -163.62 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 C-N-CA 118.648 -1.739 . . . . 0.0 109.481 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 49' ' ' THR . 8.5 t -85.25 -30.03 24.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -1.231 . . . . 0.0 108.766 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -71.07 -4.69 26.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.4 t30 84.83 16.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 110.095 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.63 126.54 44.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 108.375 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.8 m -64.71 144.8 56.98 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.047 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 31.7 m-85 -121.74 120.97 36.19 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.96 -50.23 0.21 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.6 p30 -162.41 -162.87 0.85 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.825 -1.397 . . . . 0.0 109.989 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.22 -47.28 65.76 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.48 -0.763 . . . . 0.0 111.829 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.3 m -62.79 -61.23 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.515 -1.366 . . . . 0.0 110.152 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.8 m-80 -50.04 -22.09 1.48 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.2 t80 -80.93 -52.87 6.97 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.797 1.284 . . . . 0.0 109.486 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.799 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.3 m -58.84 -30.15 67.45 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.314 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.1 m-80 -61.06 -29.85 69.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -76.61 -31.29 57.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 48' ' ' LEU . 53.5 t -77.1 -24.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.5 0.667 . . . . 0.0 110.205 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 12' ' ' PRO . 4.9 m -90.8 -25.71 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.898 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.96 -5.43 55.44 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.256 -0.903 . . . . 0.0 108.832 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 47' ' ' THR . 22.6 p -111.6 -0.65 16.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.1 t-20 77.43 15.18 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 108.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.29 2.51 90.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 44' ' ' SER . 11.4 t -80.12 0.43 32.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 108.662 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.761 ' C ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -82.41 -78.37 0.21 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.761 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 77.69 172.85 0.2 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.641 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -120.38 170.12 9.66 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.677 -1.264 . . . . 0.0 111.688 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.641 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 1.6 p -92.1 -42.09 10.12 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.476 1.131 . . . . 0.0 108.544 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -171.99 172.36 4.74 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.174 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -77.21 -174.63 3.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 108.763 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 64.75 -167.27 30.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.98 154.94 19.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.963 . . . . 0.0 109.305 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 55' ' ' LYS . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.5 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 HD22 ' A' ' 23' ' ' LEU . 5.4 t . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.367 0.603 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.63 177.79 6.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -156.2 39.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.211 -0.93 . . . . 0.0 109.715 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 -38.32 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -88.14 -4.76 58.7 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 61.0 m-85 -88.05 161.52 43.51 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.211 -0.931 . . . . 0.0 109.269 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.641 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.1 Cg_endo -87.27 144.44 27.29 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.424 1.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -101.07 142.21 24.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.291 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.57 13.63 2.04 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.517 2.144 . . . . 0.0 110.478 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.12 128.25 12.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' THR . 66.7 m -123.12 138.94 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.113 -0.992 . . . . 0.0 109.959 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -52.51 -176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.263 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.9 mt -117.89 -31.45 5.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.739 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.3 pm0 -44.26 135.93 4.24 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 5.4 t80 -87.27 126.88 35.1 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.789 1.28 . . . . 0.0 111.135 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.3 mtm180 -160.54 71.24 2.89 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.65 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 20.6 Cg_endo -62.97 132.76 38.24 Favored 'Trans proline' 0 C--O 1.196 -1.592 0 C-N-CA 123.844 3.029 . . . . 0.0 114.339 -176.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 6' ' ' VAL . 4.3 mp -111.38 161.08 16.45 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.861 ' O ' HD12 ' A' ' 50' ' ' LEU . 30.3 t -119.09 137.13 53.78 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.677 -1.89 . . . . 0.0 110.858 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.659 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -96.51 164.37 23.14 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.258 -0.901 . . . . 0.0 111.651 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 23.9 t -67.68 -29.31 68.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.8 p30 -59.51 -14.5 13.1 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.3 t30 88.97 10.15 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.299 0.571 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -99.38 126.52 45.27 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.829 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.73 136.65 36.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -39.52 -42.75 2.0 Favored Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.477 -0.765 . . . . 0.0 111.889 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.669 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 30.0 p30 -172.47 -149.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.684 -1.48 . . . . 0.0 109.813 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -59.38 -63.0 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.843 -178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 16.8 t -53.71 -57.07 12.16 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.88 -1.137 . . . . 0.0 109.378 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -52.4 -24.26 7.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 108.842 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.829 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.7 t80 -78.09 -66.5 0.84 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.51 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 43.6 t -50.62 -44.92 57.35 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.587 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 42' ' ' VAL . 8.1 m-20 -48.77 -35.28 13.95 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -62.07 -45.37 93.84 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.656 HG13 ' HA2' ' A' ' 46' ' ' GLY . 56.6 t -62.73 -59.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.713 0.768 . . . . 0.0 109.662 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.641 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.9 m -51.55 -28.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.325 -0.859 . . . . 0.0 110.356 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.64 -20.41 21.66 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.793 -1.192 . . . . 0.0 109.464 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 47' ' ' THR . 43.8 t -97.11 9.94 40.75 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.642 -0.662 . . . . 0.0 109.906 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.0 m120 62.62 25.61 15.23 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.265 -0.897 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.43 20.3 73.44 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 44' ' ' SER . 1.5 p -103.72 16.92 25.23 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.798 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -94.4 -48.41 6.15 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 39.2 p 52.28 125.21 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.347 1.07 . . . . 0.0 111.547 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 24' ' ' CYS . 7.9 tp -68.66 157.19 36.74 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.91 -20.21 10.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.764 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 173.68 162.04 0.16 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -75.17 150.18 38.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.663 0.744 . . . . 0.0 109.131 178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.65 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 96.94 -166.74 23.68 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 2.0 mtmt -90.07 158.65 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -1.156 . . . . 0.0 109.104 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.307 0.575 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.45 160.68 25.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.138 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -134.17 57.75 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.084 -1.01 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.13 -29.64 20.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.69 30.16 2.12 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 40.5 m-85 -120.84 166.83 14.47 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.731 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -89.42 169.13 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.56 -1.433 . . . . 0.0 111.528 0.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -122.08 136.98 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.17 14.76 1.86 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.349 2.033 . . . . 0.0 110.859 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 126.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 109.525 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.0 t -110.37 159.84 17.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 82.5 p -64.7 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.879 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.95 -12.4 9.56 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.808 -1.183 . . . . 0.0 110.088 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.08 120.45 2.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.104 -0.997 . . . . 0.0 108.729 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.4 t80 -89.77 118.01 29.05 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.657 1.218 . . . . 0.0 110.294 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -151.41 74.54 8.1 Favored Pre-proline 0 C--N 1.287 -2.147 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.5 Cg_endo -63.35 126.13 17.1 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.09 2.526 . . . . 0.0 112.415 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.09 128.61 55.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.36 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.721 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 53.2 t -79.77 161.39 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.5 169.97 21.68 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.136 -1.507 . . . . 0.0 112.078 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.26 -20.8 66.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.016 -0.696 . . . . 0.0 109.969 -178.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.3 p30 -65.35 -12.14 49.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 109.153 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.2 t-20 85.29 30.4 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.535 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -132.56 -166.84 1.8 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.97 . . . . 0.0 109.416 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 55' ' ' LYS . 8.2 m -126.2 156.48 40.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.874 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 27.0 m-85 -126.54 126.45 43.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.3 -52.68 0.42 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.8 p30 -162.5 -166.08 1.29 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.802 -1.41 . . . . 0.0 111.152 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.11 -42.08 38.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.799 -0.563 . . . . 0.0 111.958 -177.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 m -68.72 -54.53 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.623 -1.298 . . . . 0.0 110.165 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.2 m-80 -59.02 -20.38 52.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.051 -1.031 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 35.6 t80 -80.18 -51.1 9.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.554 1.168 . . . . 0.0 109.285 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 1.009 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -60.58 -29.18 69.02 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.593 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 42' ' ' VAL . 16.4 m-20 -67.1 -31.13 71.4 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.874 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.74 -23.21 49.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 48' ' ' LEU . 48.6 t -84.16 -25.57 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.6 m -88.07 -19.3 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.703 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.25 -32.21 15.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 47' ' ' THR . 1.1 t -84.09 8.88 14.06 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.539 -0.726 . . . . 0.0 109.838 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 69.1 m-20 61.72 27.08 16.56 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.155 -0.965 . . . . 0.0 108.96 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.51 27.3 73.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 44' ' ' SER . 26.0 p -105.19 -1.47 25.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.74 -79.77 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 7.3 p 95.57 136.52 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.108 0.956 . . . . 0.0 110.185 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 15.1 tp -67.28 158.64 31.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 4.7 p -109.22 -43.24 4.19 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.721 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 167.01 1.74 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' HA ' HD23 ' A' ' 23' ' ' LEU . 23.3 m-85 -74.69 171.24 14.27 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.128 -0.983 . . . . 0.0 108.53 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -176.7 46.71 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.34 155.58 18.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.24 . . . . 0.0 109.077 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.454 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.1 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.29 0.567 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.2 t0 -87.3 134.0 33.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 6' ' ' VAL . 12.8 m -144.7 42.06 1.34 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.221 -0.924 . . . . 0.0 109.869 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.438 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 27.3 t -90.83 -8.82 48.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -0.949 . . . . 0.0 109.685 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.3 mm-40 -97.9 -1.74 42.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.973 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.853 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -82.88 158.16 65.41 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.131 -0.981 . . . . 0.0 109.526 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.51 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 37.1 Cg_endo -75.76 165.46 85.54 Favored 'Cis proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.589 1.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.6 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 6.0 mtmt -120.03 143.83 36.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.54 14.57 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.506 2.137 . . . . 0.0 111.1 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.83 128.37 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.355 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -105.51 144.21 32.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.743 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -61.71 -177.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 108.667 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -111.1 -20.77 12.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.052 -1.03 . . . . 0.0 109.738 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.738 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.3 mt-10 -44.89 122.63 3.34 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.121 -0.987 . . . . 0.0 108.751 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.494 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 32.8 t80 -86.93 108.81 18.97 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 122.497 1.141 . . . . 0.0 110.177 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.9 mtm180 -144.26 90.62 6.63 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -67.23 109.21 1.7 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.105 1.87 . . . . 0.0 112.239 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.657 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -105.45 118.49 36.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.572 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -79.33 176.93 9.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 110.542 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -139.91 172.91 23.18 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.425 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.5 t -65.65 -31.27 72.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.746 -0.856 . . . . 0.0 109.678 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.4 p30 -65.77 -8.74 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 83.15 19.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -103.22 154.37 19.4 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 53.6 m -106.54 143.73 34.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.651 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 94.5 m-85 -118.37 116.07 25.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 108.949 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.64 -54.43 0.63 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p-10 -144.11 -170.35 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.656 -1.496 . . . . 0.0 110.706 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.0 -28.22 67.53 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.978 -0.451 . . . . 0.0 111.634 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.5 t -70.98 -51.14 27.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.55 -1.344 . . . . 0.0 109.278 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.539 -0.725 . . . . 0.0 109.914 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE1' HD21 ' A' ' 48' ' ' LEU . 31.2 t80 -69.12 -53.31 20.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.442 1.115 . . . . 0.0 109.715 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.6 m -56.28 -47.84 77.81 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.334 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 6.0 m-20 -48.72 -33.3 9.93 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.36 -39.67 67.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.295 -0.878 . . . . 0.0 108.664 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.764 ' CG2' HD23 ' A' ' 48' ' ' LEU . 77.6 t -60.43 -57.2 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.626 -0.672 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.853 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -64.59 -22.34 31.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.473 -0.767 . . . . 0.0 110.612 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.13 -10.96 36.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.92 -1.113 . . . . 0.0 109.138 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.892 ' O ' HG22 ' A' ' 47' ' ' THR . 6.2 p -115.05 25.66 10.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 110.438 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' C ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 43.71 53.55 5.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.905 -1.122 . . . . 0.0 109.527 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.09 43.55 8.94 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 44' ' ' SER . 6.1 t -117.12 2.13 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -1.083 . . . . 0.0 108.483 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -84.61 -50.79 7.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.076 0.941 . . . . 0.0 108.536 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.675 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 62.0 p 57.66 126.34 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.302 1.049 . . . . 0.0 110.32 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.7 tp -61.65 131.15 49.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.44 -23.24 43.28 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 108.656 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.585 ' O ' HD11 ' A' ' 50' ' ' LEU . 11.0 p80 154.46 163.47 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.15 151.82 44.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.824 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 90.73 -176.4 41.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.64 169.28 15.5 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.047 -1.266 . . . . 0.0 108.373 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.601 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 30.4 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 23' ' ' LEU . 79.2 t . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.217 0.532 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -73.19 147.12 45.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 m -134.49 43.24 2.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -90.21 -11.45 40.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -125.03 49.61 1.85 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.878 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.9 m-85 -135.23 162.61 56.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.313 -0.867 . . . . 0.0 109.076 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.35 157.69 54.38 Favored 'Cis proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.852 -1.728 . . . . 0.0 110.749 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.39 140.24 25.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 108.688 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.37 14.97 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.679 2.253 . . . . 0.0 111.731 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.83 154.25 0.71 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.155 -0.965 . . . . 0.0 110.056 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 t -148.63 171.05 16.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -124.57 2.12 8.28 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.751 -1.218 . . . . 0.0 110.289 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.41 127.42 31.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.513 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 6.0 t80 -80.04 110.59 15.57 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.553 1.168 . . . . 0.0 111.272 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.22 73.29 37.75 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.5 Cg_endo -64.29 123.16 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.553 2.169 . . . . 0.0 112.721 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.4 mt -112.74 122.99 49.29 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -82.92 112.2 19.49 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.126 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.6 -166.13 0.06 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -78.1 -32.49 50.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -1.16 . . . . 0.0 109.137 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 37.1 p-10 -73.08 0.01 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.825 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 m120 77.27 30.32 0.53 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -98.87 137.5 37.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 m -86.97 122.61 31.06 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 82.0 m-85 -99.17 139.45 34.8 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -54.03 -39.03 62.02 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.111 -1.043 . . . . 0.0 112.021 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.4 p30 -162.58 -157.06 0.43 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.725 -1.456 . . . . 0.0 109.304 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.37 -47.5 85.78 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 111.263 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.516 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 89.3 m -68.07 -43.13 79.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.535 -1.353 . . . . 0.0 109.965 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -59.38 -24.08 63.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.825 -1.172 . . . . 0.0 108.449 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.915 ' CB ' HD12 ' A' ' 23' ' ' LEU . 10.3 t80 -83.15 -63.03 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.05 0.929 . . . . 0.0 111.004 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 t -56.92 -47.0 81.62 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.781 -0.574 . . . . 0.0 110.041 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 25.7 m-20 -42.43 -29.45 0.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.17 . . . . 0.0 108.307 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -73.86 -49.8 23.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.707 HG13 ' HA2' ' A' ' 46' ' ' GLY . 92.8 t -53.53 -54.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.573 0.702 . . . . 0.0 109.732 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.6 m -60.17 -30.06 45.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.289 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -85.78 -13.35 48.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 108.729 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.4 p -106.19 -2.75 22.14 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.473 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.8 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.0 OUTLIER 74.66 13.28 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 109.323 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.707 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.95 7.46 70.58 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.887 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.8 HG23 ' OD1' ' A' ' 45' ' ' ASN . 70.8 p -82.71 0.19 44.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.637 -1.507 . . . . 0.0 108.609 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 49' ' ' THR . 7.5 tp -80.15 -75.48 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.491 0.662 . . . . 0.0 110.117 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 p 62.56 147.0 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.06 171.69 7.21 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.858 -177.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.677 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.07 -29.43 8.97 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.593 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -167.92 159.84 11.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.6 -0.688 . . . . 0.0 110.082 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.49 -166.32 0.52 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.2 -167.1 18.25 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.589 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.34 -179.04 4.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 109.838 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' SG ' ' A' ' 8' ' ' CYS . 9.2 p . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' N ' HG22 ' A' ' 6' ' ' VAL . 25.4 t70 -105.1 108.95 20.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 17.8 m -128.95 52.86 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 t -90.29 -13.16 35.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -103.54 17.08 24.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 109.31 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 73.9 m-85 -96.72 163.68 19.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.911 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -83.09 135.63 26.65 Favored 'Cis proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.308 -1.538 . . . . 0.0 111.258 1.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -100.79 138.38 20.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.82 14.04 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.401 2.068 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.21 19.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 94.2 m -103.67 146.46 28.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.261 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.459 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -55.73 -166.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.459 -0.775 . . . . 0.0 108.91 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 19' ' ' GLU . 3.3 pp -126.55 -37.34 2.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.49 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.657 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.1 pm0 -50.57 137.57 19.27 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.5 t80 -79.5 121.37 25.12 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.32 1.057 . . . . 0.0 110.382 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmm180 -148.61 72.38 10.67 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -65.51 114.43 2.89 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.046 1.831 . . . . 0.0 111.743 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -109.42 138.56 45.6 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.991 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -89.15 165.13 14.68 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -127.42 168.55 19.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.607 ' H ' HD12 ' A' ' 48' ' ' LEU . 35.4 t -66.81 -25.98 66.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -1.047 . . . . 0.0 108.856 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.8 p30 -65.52 -10.88 38.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 t-20 85.38 29.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 110.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -120.85 -179.37 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.968 -1.082 . . . . 0.0 109.261 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 31' ' ' TYR . 53.1 m -118.95 166.13 13.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.656 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 72.0 m-85 -138.49 110.9 7.46 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.48 -55.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -177.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.5 p30 -146.87 -172.54 4.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.771 -1.429 . . . . 0.0 110.787 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -53.26 -36.29 60.95 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.849 -0.532 . . . . 0.0 110.355 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.2 t -62.33 -69.47 0.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.63 -1.294 . . . . 0.0 108.937 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.567 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.6 m-80 -43.22 -38.7 2.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 110.765 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 48' ' ' LEU . 72.9 t80 -70.59 -40.14 73.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.688 1.233 . . . . 0.0 110.483 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 91.7 m -68.53 -34.94 76.74 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.519 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.649 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.8 m-80 -69.08 -23.77 64.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.89 -1.131 . . . . 0.0 108.226 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.64 -24.9 33.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.561 ' CG2' HD23 ' A' ' 48' ' ' LEU . 72.9 t -80.99 -27.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.9 m -89.52 -21.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.746 . . . . 0.0 109.127 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.74 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -91.04 -31.15 16.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 47' ' ' THR . 86.4 p -86.93 -0.09 55.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.585 -0.697 . . . . 0.0 109.806 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 77.97 12.74 1.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.247 -0.908 . . . . 0.0 108.813 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.1 16.57 66.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 44' ' ' SER . 7.4 t -98.02 10.1 41.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -1.123 . . . . 0.0 108.95 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.68 -53.3 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.615 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 81.1 p 53.65 124.97 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.644 1.211 . . . . 0.0 111.703 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.991 HD12 ' O ' ' A' ' 24' ' ' CYS . 2.2 tp -71.6 152.75 42.64 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.74 -25.27 11.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.977 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.2 p80 -173.3 157.92 3.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -79.51 164.31 24.01 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.05 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 92.78 -167.27 29.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.81 129.39 36.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.083 -1.245 . . . . 0.0 109.645 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.508 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.35 159.24 15.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.42 36.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 0.0 109.246 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -85.57 -28.65 24.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.788 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.64 46.09 1.03 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.469 -0.769 . . . . 0.0 109.048 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 59.9 m-85 -139.77 161.25 57.4 Favored Pre-proline 0 C--N 1.306 -1.293 0 O-C-N 121.316 -0.865 . . . . 0.0 109.141 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.977 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -83.51 148.95 61.97 Favored 'Cis proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.882 -1.716 . . . . 0.0 110.793 2.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -102.94 137.78 19.37 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.94 14.66 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.658 2.239 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.26 158.04 2.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 30.3 t -146.54 163.04 37.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.694 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -56.91 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -122.81 -7.72 8.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.505 -1.372 . . . . 0.0 110.789 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' N ' HD12 ' A' ' 18' ' ' LEU . 12.1 pm0 -55.93 -173.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 3.4 t80 -128.93 121.32 27.83 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.9 mmt180 -151.22 66.17 7.02 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 54' ' ' GLY . 23.4 Cg_endo -63.28 137.17 59.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.494 2.796 . . . . 0.0 112.551 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -127.49 143.49 51.18 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.202 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.654 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.0 t -101.53 162.3 13.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.236 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -106.95 178.55 22.17 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.1 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.649 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 27.4 t -70.65 -18.79 62.85 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -78.9 -10.98 59.98 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 85.06 33.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.315 0.579 . . . . 0.0 109.662 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -111.94 139.82 47.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.248 -0.908 . . . . 0.0 109.019 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.5 m -90.04 161.97 15.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.147 . . . . 0.0 110.018 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 63.9 m-85 -138.39 137.92 37.74 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.55 -50.23 3.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -164.37 -166.21 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.152 -1.204 . . . . 0.0 111.123 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -47.72 -48.48 29.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.717 -0.614 . . . . 0.0 112.374 -177.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.519 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.0 m -65.86 -52.64 48.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.473 -1.392 . . . . 0.0 110.457 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.1 m-80 -60.06 -17.45 39.54 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.847 -1.158 . . . . 0.0 109.347 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.693 ' CE1' HD21 ' A' ' 48' ' ' LEU . 27.6 t80 -82.59 -50.31 8.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.588 1.185 . . . . 0.0 109.762 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 42' ' ' VAL . 48.7 t -66.51 -24.02 66.33 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.786 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -64.43 -26.22 68.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.771 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.28 -26.8 26.4 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 46' ' ' GLY . 93.1 t -80.97 -23.72 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.7 m -90.82 -25.65 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.771 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.6 pp20? -90.42 -28.23 18.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 47' ' ' THR . 48.2 t -89.11 3.54 51.48 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.5 t30 77.11 9.77 2.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 108.958 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 82.89 3.21 90.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 44' ' ' SER . 14.1 t -79.85 2.68 22.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.041 -1.27 . . . . 0.0 108.974 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.41 -50.02 11.45 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.805 0.812 . . . . 0.0 109.088 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.649 ' HG1' ' HB2' ' A' ' 26' ' ' SER . 25.2 p 54.86 122.13 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.293 1.044 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.634 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.9 tp -60.61 152.99 24.84 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.15 -20.26 11.01 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.654 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 171.23 158.46 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -71.18 -169.23 0.36 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 109.002 178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.11 -168.76 5.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -91.41 146.41 23.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.429 -1.042 . . . . 0.0 109.452 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.397 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -67.55 116.75 8.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 m -99.15 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 m -90.48 -8.67 49.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.49 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 3.9 pm0 -112.97 -7.55 13.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.973 -1.079 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.72 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.6 m-85 -88.88 158.9 46.87 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 108.938 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -79.89 134.99 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.841 -1.733 . . . . 0.0 110.631 3.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.63 138.98 19.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.638 -0.664 . . . . 0.0 110.215 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.76 15.05 2.02 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.512 2.141 . . . . 0.0 110.237 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.42 133.42 20.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.806 . . . . 0.0 109.243 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 82.3 m -112.23 150.31 31.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 p -56.75 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 108.942 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -123.6 -28.3 3.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.998 -1.064 . . . . 0.0 109.725 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 9.5 pm0 -58.57 -166.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.5 t80 -132.83 124.75 28.57 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.258 1.028 . . . . 0.0 110.62 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -154.78 75.83 5.5 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.2 Cg_endo -64.59 123.67 12.08 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.701 2.267 . . . . 0.0 112.557 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -117.39 126.78 53.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 49.5 t -79.4 161.78 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.301 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -132.91 166.54 23.6 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.545 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 28' ' ' ASN . 13.2 t -53.15 -48.46 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.945 . . . . 0.0 110.781 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -41.63 -26.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.202 -179.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 p-10 97.93 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.273 0.559 . . . . 0.0 109.899 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -125.81 173.64 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 109.583 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -108.9 150.02 28.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 74.0 m-85 -117.36 124.75 49.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.94 -52.32 1.19 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.5 p-10 -158.51 -168.34 2.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.746 -1.444 . . . . 0.0 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 7.8 pttt -46.86 -49.95 19.37 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.995 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 43.9 t -56.1 -64.88 0.72 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.696 -1.252 . . . . 0.0 110.07 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.4 m-80 -53.64 -18.9 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HB2' HD12 ' A' ' 23' ' ' LEU . 6.8 t80 -79.41 -65.06 1.05 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.677 -1.265 . . . . 0.0 110.216 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.566 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.6 t -56.48 -48.71 76.55 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.033 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.0 m-20 -43.91 -28.0 0.41 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.614 -1.304 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -74.43 -48.03 30.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.975 HG22 HD23 ' A' ' 48' ' ' LEU . 79.7 t -57.08 -54.64 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.646 0.736 . . . . 0.0 109.649 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 12' ' ' PRO . 20.3 m -58.25 -30.28 39.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -91.27 -10.59 40.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.154 -0.966 . . . . 0.0 109.36 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 13.7 t -102.96 12.68 35.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 110.398 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.2 m-80 62.44 23.89 14.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.059 -1.026 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.88 25.11 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.5 p -95.13 -4.16 46.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.395 -1.062 . . . . 0.0 108.209 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -88.94 -76.51 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.081 0.943 . . . . 0.0 109.306 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 80.94 152.0 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.871 0.843 . . . . 0.0 108.955 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 68.2 tp -68.92 158.21 35.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p -111.96 -42.38 3.79 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.01 169.94 1.9 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -82.12 176.37 9.57 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.001 -1.062 . . . . 0.0 108.655 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -168.13 54.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 153.14 20.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 109.145 178.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 26.9 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.67 ' H ' HG22 ' A' ' 6' ' ' VAL . 61.2 t0 -125.78 130.27 51.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.964 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 15.6 m -129.71 69.51 1.42 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -91.21 -18.79 23.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.65 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.3 mp0 -106.22 27.5 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.134 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.979 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.7 m-85 -109.3 158.26 34.98 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.087 -1.008 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.796 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -80.86 143.97 64.25 Favored 'Cis proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.823 2.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 7.1 mttt -103.5 136.03 19.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.858 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.6 14.71 1.77 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.757 2.305 . . . . 0.0 110.58 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.12 136.84 11.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.6 m -128.55 136.89 51.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 109.841 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.9 p -55.99 -165.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.3 pp -131.87 1.36 3.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.844 -1.16 . . . . 0.0 110.326 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 4.9 mm-40 -57.4 -165.99 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.1 t80 -139.73 115.08 9.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.448 -1.301 . . . . 0.0 111.38 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.77 74.3 8.64 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -65.35 121.9 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.894 -176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.632 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.34 137.53 50.35 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER -86.67 167.58 14.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.376 -0.827 . . . . 0.0 109.11 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.38 159.73 23.47 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -19.68 64.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -1.164 . . . . 0.0 108.915 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -66.74 -9.16 33.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.4 t-20 87.48 22.87 0.05 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.85 -0.531 . . . . 0.0 110.669 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.14 177.44 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.82 -1.175 . . . . 0.0 109.627 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 31' ' ' TYR . 29.9 m -118.24 166.5 12.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.233 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' N ' HG22 ' A' ' 30' ' ' THR . 73.7 m-85 -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.94 -51.28 7.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.955 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.3 p-10 -149.4 -165.29 2.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.763 -1.433 . . . . 0.0 110.828 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.22 -24.61 67.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.642 -0.661 . . . . 0.0 111.537 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 11.6 t -76.27 -39.55 54.05 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.574 -1.328 . . . . 0.0 108.898 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.3 m-80 -72.1 -34.48 68.67 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.506 -0.746 . . . . 0.0 109.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 24' ' ' CYS . 63.2 t80 -75.65 -44.18 43.92 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.393 1.092 . . . . 0.0 109.896 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 20.9 m -66.51 -38.45 87.25 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.568 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.595 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.9 m-80 -63.74 -21.37 66.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.15 -27.91 25.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.549 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.4 t -76.45 -26.89 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.979 HG11 ' CB ' ' A' ' 11' ' ' TYR . 21.0 m -91.07 -26.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.372 0.606 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -90.7 -15.36 30.46 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 20.0 t -101.29 12.6 37.18 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.157 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.031 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 68.64 7.72 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.066 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 13.16 66.32 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.031 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.3 p -79.6 -11.11 59.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.289 . . . . 0.0 108.746 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -78.38 159.34 28.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.826 ' H ' HD12 ' A' ' 48' ' ' LEU . 81.2 p -157.64 126.46 5.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.095 0.95 . . . . 0.0 110.061 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -63.43 145.51 55.47 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.505 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.84 -25.04 11.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.695 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -171.42 160.73 6.14 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -79.35 174.06 11.95 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.197 -0.939 . . . . 0.0 108.768 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.31 -166.64 42.31 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.586 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.96 131.06 37.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.047 -1.266 . . . . 0.0 109.048 178.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.532 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 t . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.251 0.548 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -64.27 119.07 9.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 108.962 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 6' ' ' VAL . 15.9 m -132.38 40.17 3.32 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.093 -1.004 . . . . 0.0 110.044 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.05 4.95 48.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -126.81 2.72 6.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.069 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 46.1 m-85 -84.71 162.07 51.46 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.13 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -71.68 148.04 89.51 Favored 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.891 2.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -91.5 144.44 29.62 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.92 13.57 1.93 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.53 2.153 . . . . 0.0 110.822 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.35 117.83 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.7 m -102.77 135.14 44.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HD3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -55.88 142.92 33.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 18' ' ' LEU . 5.2 mt -75.88 -36.58 59.48 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.97 . . . . 0.0 109.51 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -42.84 122.28 2.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.356 -0.84 . . . . 0.0 108.782 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.5 t80 -80.82 104.27 11.22 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.672 1.225 . . . . 0.0 110.543 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.634 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 mmt180 -137.55 80.91 31.17 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.59 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -66.97 128.83 19.45 Favored 'Trans proline' 0 C--O 1.202 -1.323 0 C-N-CA 123.994 3.129 . . . . 0.0 114.771 -176.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mp -107.83 158.34 17.4 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.72 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -116.48 137.3 52.27 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.285 -1.509 . . . . 0.0 110.394 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.841 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -102.07 157.71 18.45 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.221 -0.925 . . . . 0.0 112.969 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -55.4 -18.64 7.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.192 -0.593 . . . . 0.0 110.382 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -84.57 20.29 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.998 -1.064 . . . . 0.0 109.398 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 27.4 t30 56.83 15.34 2.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -99.69 127.54 45.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 55' ' ' LYS . 18.1 m -89.03 126.55 35.47 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.55 -0.719 . . . . 0.0 109.794 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 126.45 43.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -24.8 -42.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.636 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.4 p30 -178.73 -154.85 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 109.745 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.39 -60.13 3.59 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 110.658 -177.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 49.2 t -52.44 -65.75 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.606 -1.309 . . . . 0.0 110.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.536 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 10.2 m-80 -49.28 -21.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE1' HD21 ' A' ' 48' ' ' LEU . 4.8 t80 -78.8 -71.31 0.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.012 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.687 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.1 m -39.72 -40.62 0.96 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.413 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.92 -44.91 94.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.474 -1.391 . . . . 0.0 108.016 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.696 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -54.17 -21.64 9.33 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 48' ' ' LEU . 56.7 t -85.64 -63.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -59.0 -9.21 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 110.279 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.02 -32.02 16.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.551 -1.343 . . . . 0.0 107.78 178.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -92.22 7.89 40.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 80.93 3.71 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.331 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 86.94 6.23 79.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -79.79 2.25 23.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -1.188 . . . . 0.0 108.758 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.12 -78.91 0.34 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.364 -0.835 . . . . 0.0 109.339 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.57 148.13 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.047 0.927 . . . . 0.0 109.276 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' A' ' 23' ' ' LEU . 13.1 tp -67.29 166.47 14.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.599 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -122.6 -44.62 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.72 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -160.28 159.37 31.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -77.21 143.43 39.0 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.714 0.768 . . . . 0.0 110.057 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 101.91 -167.42 18.45 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.48 137.63 32.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.438 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.516 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.441 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.43 104.73 5.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.999 . . . . 0.0 109.601 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 59.8 m -103.59 52.72 0.77 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -21.53 38.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.0 109.859 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.75 -7.53 59.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.855 ' HB3' HG11 ' A' ' 42' ' ' VAL . 74.7 m-85 -79.87 163.86 56.01 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.97 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.8 Cg_endo -82.38 143.0 51.26 Favored 'Cis proline' 0 C--N 1.306 -1.664 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.088 2.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.2 mttt -97.35 141.11 22.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.033 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.42 15.13 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.755 2.303 . . . . 0.0 110.477 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.27 116.29 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 109.028 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.6 m -82.24 145.59 29.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -52.35 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -114.91 -19.29 11.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.822 -1.174 . . . . 0.0 110.262 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 18' ' ' LEU . 16.5 pm0 -57.9 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.788 -1.195 . . . . 0.0 107.827 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.2 t80 -139.15 126.85 21.95 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.893 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.2 mtm180 -161.52 81.03 1.99 Allowed Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 21.0 Cg_endo -63.83 107.24 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.192 1.928 . . . . 0.0 111.739 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -100.6 126.09 47.05 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.198 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 43.3 t -77.97 168.1 20.43 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -145.46 161.19 28.19 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.102 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -59.45 -35.18 73.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.728 -0.866 . . . . 0.0 109.441 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.635 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -45.18 -27.43 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 109.036 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 101.11 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.063 0.458 . . . . 0.0 109.961 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 175.24 8.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.105 -0.997 . . . . 0.0 109.616 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 31' ' ' TYR . 38.0 m -106.18 162.08 13.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.883 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.7 m-85 -133.26 102.66 5.65 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.188 -0.945 . . . . 0.0 108.618 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.14 -60.29 0.02 OUTLIER Glycine 0 N--CA 1.499 2.856 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.1 p30 -143.42 -170.37 3.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.968 -1.313 . . . . 0.0 110.627 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.19 -48.32 45.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.853 -0.529 . . . . 0.0 110.816 -178.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 18.2 t -53.32 -71.59 0.07 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.741 -1.225 . . . . 0.0 109.432 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.2 m-80 -40.28 -39.77 1.01 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.839 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.608 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 35.9 t80 -61.73 -51.51 68.05 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.862 1.315 . . . . 0.0 109.833 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 90.1 m -57.77 -50.89 71.72 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.575 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -44.37 -29.29 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.833 -1.167 . . . . 0.0 108.66 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.42 -49.41 49.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.814 HG22 ' CD2' ' A' ' 48' ' ' LEU . 38.4 t -57.62 -56.84 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.667 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.97 HG21 ' HB3' ' A' ' 12' ' ' PRO . 13.2 m -58.7 -23.07 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 0.0 110.642 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.1 tt0 -91.43 -17.48 25.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.391 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 11.9 t -105.69 22.95 14.67 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.342 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 21.6 m120 64.74 9.61 5.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 109.524 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 80.92 17.93 71.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.1 p -89.97 -9.43 48.78 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.373 -1.075 . . . . 0.0 108.239 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.814 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.47 149.76 28.6 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 5.1 p -122.41 151.52 41.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.6 tp -65.52 124.28 21.89 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.3 t -78.55 -24.75 45.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.62 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CB ' ' O ' ' A' ' 51' ' ' SER . 15.9 p80 151.02 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.299 0.571 . . . . 0.0 110.056 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 154.91 22.54 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 85.54 178.5 50.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -79.85 161.37 25.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.892 -1.358 . . . . 0.0 107.947 178.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.579 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 6' ' ' VAL . 87.1 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.437 0.637 . . . . 0.0 110.095 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 50.2 t0 63.77 147.42 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 40.8 t -160.49 20.89 0.15 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.027 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -90.8 -4.01 56.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -108.56 34.82 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.734 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.1 m-85 -133.23 159.67 71.7 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -73.42 159.6 97.14 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.859 -1.725 . . . . 0.0 111.994 2.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttt -117.72 144.78 35.05 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.26 14.48 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.44 2.093 . . . . 0.0 111.411 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 166.21 134.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.2 t -112.03 157.62 20.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.516 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.486 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 10.6 p -59.3 -162.53 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -120.53 -15.92 8.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.524 -1.36 . . . . 0.0 109.976 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.9 pt-20 -46.62 130.55 11.37 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.1 t80 -89.28 130.02 35.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.391 1.091 . . . . 0.0 111.107 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mtt180 -160.63 74.26 2.79 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.594 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.0 Cg_endo -64.59 129.7 24.42 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.145 2.563 . . . . 0.0 112.794 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.654 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.93 135.72 53.94 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.515 -1.274 . . . . 0.0 108.212 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.967 ' O ' HD12 ' A' ' 50' ' ' LEU . 8.7 t -77.37 133.44 38.72 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -79.94 -162.68 26.03 Favored Glycine 0 C--N 1.292 -1.867 0 C-N-CA 117.67 -2.205 . . . . 0.0 109.218 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.544 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -85.85 -33.87 21.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -1.2 . . . . 0.0 108.331 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -57.3 -17.29 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t30 96.31 22.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 120.982 0.42 . . . . 0.0 110.707 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -107.49 -158.5 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 0.0 109.163 178.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.9 m -129.74 158.9 38.12 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.484 -0.76 . . . . 0.0 110.031 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -132.74 135.02 45.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.95 -50.3 1.5 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -163.73 -157.42 0.4 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.945 -1.327 . . . . 0.0 110.369 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 112.146 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.652 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -64.9 -57.01 9.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.585 -1.322 . . . . 0.0 110.43 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.06 -32.21 71.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.025 -1.047 . . . . 0.0 110.129 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 7.0 t80 -62.38 -60.06 4.1 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.793 -1.192 . . . . 0.0 109.511 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.8 t -56.79 -49.68 74.61 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.033 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 7.1 m-20 -40.97 -30.82 0.14 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.807 -1.183 . . . . 0.0 108.084 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.38 -49.45 18.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD23 ' A' ' 48' ' ' LEU . 88.1 t -60.36 -63.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.1 p -55.89 -26.36 20.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 111.785 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.43 -16.17 27.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.08 -1.637 . . . . 0.0 108.737 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 10.7 t -98.85 21.94 10.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 110.097 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 78.4 m-20 65.22 8.27 4.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.862 . . . . 0.0 109.927 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.12 11.32 85.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.2 p -79.3 -4.24 49.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.025 -1.28 . . . . 0.0 108.194 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.977 HD23 HG22 ' A' ' 41' ' ' VAL . 1.9 tp -79.94 -86.03 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 80.36 168.69 0.16 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.82 178.89 4.42 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.639 -1.288 . . . . 0.0 110.565 -178.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.07 -38.36 3.89 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.74 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.3 p80 -163.93 151.67 12.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.752 0.787 . . . . 0.0 110.139 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.6 m-85 -62.41 -174.97 0.07 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.69 -0.631 . . . . 0.0 109.413 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 66.15 -169.27 32.15 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 1.2 mtmm -92.51 134.99 34.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.691 -0.888 . . . . 0.0 109.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.551 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.954 -1.091 . . . . 0.0 109.402 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 23' ' ' LEU . 63.9 t . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.195 0.522 . . . . 0.0 109.707 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 11.5 p-10 -80.62 -176.37 5.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 7.1 m -157.81 49.77 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.792 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -90.96 -4.27 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.965 . . . . 0.0 110.07 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 4.6 mp0 -134.11 49.4 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.004 -1.06 . . . . 0.0 110.422 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.906 ' HB3' HG11 ' A' ' 42' ' ' VAL . 99.1 m-85 -141.66 153.48 65.05 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 120.922 -1.111 . . . . 0.0 109.241 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.28 136.44 44.95 Favored 'Cis proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.396 -1.918 . . . . 0.0 111.439 2.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.0 tttt -85.4 145.0 41.42 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.662 -0.649 . . . . 0.0 109.62 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.515 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.09 13.73 1.92 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.801 2.334 . . . . 0.0 110.742 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.65 128.07 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.387 -0.821 . . . . 0.0 109.111 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' THR . 71.7 m -91.64 139.08 31.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.85 . . . . 0.0 110.054 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -49.14 174.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.55 -16.83 12.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.96 -1.088 . . . . 0.0 109.928 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -56.53 -168.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.551 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.8 t80 -140.22 123.15 16.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.422 1.106 . . . . 0.0 110.576 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.15 80.92 2.37 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.59 125.23 14.02 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.694 2.262 . . . . 0.0 112.466 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.38 128.4 55.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.735 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.8 t -78.7 135.34 37.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.58 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -82.6 -165.47 36.93 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 118.511 -1.804 . . . . 0.0 108.613 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 45.8 t -87.45 -29.6 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.664 -1.492 . . . . 0.0 108.728 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -63.06 -14.02 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 109.082 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.1 t-20 96.28 19.26 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 120.929 0.395 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.655 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.97 -165.54 1.25 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.879 -1.138 . . . . 0.0 108.54 178.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.551 HG21 ' HB3' ' A' ' 55' ' ' LYS . 7.7 m -135.4 157.43 46.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.333 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 70.6 m-85 -129.63 121.69 27.55 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -29.07 -51.94 0.13 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 44.7 p30 -158.28 -162.96 1.2 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.111 -1.229 . . . . 0.0 109.488 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -57.71 -48.12 80.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.43 -0.794 . . . . 0.0 111.051 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.7 t -52.8 -52.71 55.81 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 109.962 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.591 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.6 m-80 -63.26 -31.5 72.66 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.488 -0.758 . . . . 0.0 110.942 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 19.2 t80 -74.02 -61.65 1.78 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.689 -1.257 . . . . 0.0 110.766 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 30.5 t -57.56 -49.4 76.51 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.927 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.3 m-20 -42.34 -30.89 0.35 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.67 -1.269 . . . . 0.0 108.18 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.839 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -80.12 -43.4 21.76 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.5 t -66.78 -65.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.426 -0.796 . . . . 0.0 108.928 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 11' ' ' TYR . 9.8 p -50.67 -30.57 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 111.423 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.72 -16.96 24.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.056 -1.652 . . . . 0.0 109.137 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.97 ' O ' HG22 ' A' ' 47' ' ' THR . 65.8 p -101.1 19.8 16.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 110.391 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 44' ' ' SER . 1.8 p-10 53.85 29.66 10.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.81 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.21 28.92 73.13 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.258 -0.901 . . . . 0.0 110.861 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' SER . 10.1 t -95.72 -10.62 28.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.839 HD22 ' CB ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.55 -53.7 6.33 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.588 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER 50.99 172.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.302 0.572 . . . . 0.0 109.586 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.49 163.49 28.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 109.099 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.49 -30.97 8.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.735 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -168.93 163.52 11.52 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.429 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.2 -166.48 0.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 57.67 -173.51 2.56 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.13 138.47 31.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.285 -1.126 . . . . 0.0 109.142 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.554 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.633 0.73 . . . . 0.0 110.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.07 122.97 42.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 12.1 m -125.72 43.04 3.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.003 -1.061 . . . . 0.0 110.652 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 10.47 25.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -131.73 6.1 4.33 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.939 -1.101 . . . . 0.0 110.868 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -84.19 156.97 63.05 Favored Pre-proline 0 C--N 1.307 -1.282 0 O-C-N 120.827 -1.17 . . . . 0.0 109.019 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.7 144.98 82.5 Favored 'Cis proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.011 2.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -92.45 147.68 34.88 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -77.4 13.6 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 111.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.7 112.45 0.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.024 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 17' ' ' THR . 91.8 m -87.86 144.55 26.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -45.37 157.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.83 -33.57 7.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.853 -1.155 . . . . 0.0 110.107 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -62.09 -176.51 0.1 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -115.83 129.32 56.38 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.411 1.101 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 16.2 mtp-105 -159.86 70.73 3.17 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 54' ' ' GLY . 19.4 Cg_endo -60.27 121.79 10.32 Favored 'Trans proline' 0 C--O 1.192 -1.795 0 C-N-CA 123.295 2.664 . . . . 0.0 112.831 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 1.7 mp -103.97 158.73 16.22 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.618 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -116.7 132.05 56.79 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 119.795 -1.816 . . . . 0.0 111.949 -178.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.638 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -87.46 160.87 32.04 Favored Glycine 0 N--CA 1.503 3.101 0 CA-C-O 121.758 0.643 . . . . 0.0 111.909 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.498 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -64.44 -34.41 78.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -61.49 -11.84 12.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.397 -0.814 . . . . 0.0 109.309 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.3 m-20 88.27 18.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.815 -0.553 . . . . 0.0 110.942 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 1.3 pttm -107.78 122.28 46.44 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.1 m -80.7 132.97 35.62 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 140.98 31.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.306 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.553 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -49.38 -41.51 32.37 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.216 -0.927 . . . . 0.0 112.069 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.9 p30 -164.88 -158.39 0.4 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.448 -1.619 . . . . 0.0 110.363 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -57.75 -45.6 85.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.404 -177.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 36.4 t -68.43 -57.27 6.11 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.703 -1.248 . . . . 0.0 108.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -49.97 -22.23 1.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE1' HD21 ' A' ' 48' ' ' LEU . 7.3 t80 -83.04 -63.67 1.32 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.266 1.032 . . . . 0.0 110.918 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 13.5 m -47.87 -51.4 23.17 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.257 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 9.8 m-20 -48.3 -36.24 13.82 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -60.12 -46.27 90.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.444 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.0 t -64.93 -65.17 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.56 0.695 . . . . 0.0 110.246 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.4 p -58.97 -19.58 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.842 . . . . 0.0 112.011 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -93.42 -16.27 24.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.093 -1.629 . . . . 0.0 109.22 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.687 ' O ' HG22 ' A' ' 47' ' ' THR . 4.4 p -98.66 18.39 16.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t30 74.54 4.61 4.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.135 -0.978 . . . . 0.0 108.415 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.81 20.08 69.03 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -87.53 -1.77 58.16 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -1.03 . . . . 0.0 108.642 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -89.45 161.76 16.1 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.786 ' H ' HD12 ' A' ' 48' ' ' LEU . 75.8 p -147.9 130.21 15.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.635 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.1 tp -68.83 141.16 55.2 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.04 -17.91 12.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.802 -1.186 . . . . 0.0 108.065 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.618 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 173.88 154.22 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.54 0.686 . . . . 0.0 109.701 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -70.31 176.77 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.049 178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.14 -172.09 44.85 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CE ' ' OH ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -91.68 156.23 17.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -1.211 . . . . 0.0 108.811 178.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.508 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 5.6 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.029 -1.044 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 37' ' ' PHE . 2.6 p . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -114.87 132.64 56.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 79.9 m -130.62 53.58 1.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.3 -16.31 29.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.866 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.51 37.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.159 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.895 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.9 m-85 -125.91 161.09 53.37 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.873 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.29 153.88 50.35 Favored 'Cis proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.281 -1.55 . . . . 0.0 110.999 1.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.0 140.67 25.85 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.622 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.85 14.4 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.58 2.186 . . . . 0.0 111.141 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 167.95 135.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 108.871 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -133.2 165.44 24.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.933 -1.104 . . . . 0.0 110.737 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -54.99 -165.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 0.0 109.39 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.4 pp -122.86 3.68 9.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.008 -1.057 . . . . 0.0 110.273 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.7 pt-20 -47.63 118.44 2.26 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -79.37 126.91 31.42 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.757 1.265 . . . . 0.0 111.759 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.2 ptm180 -161.45 75.12 2.45 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.7 Cg_endo -64.31 118.99 5.91 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -113.05 128.84 56.61 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.507 179.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.599 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -88.87 112.09 22.84 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.604 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.67 -169.73 0.05 OUTLIER Glycine 0 N--CA 1.484 1.855 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.7 t -75.5 -34.63 60.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -1.173 . . . . 0.0 109.173 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.9 p30 -68.51 -6.64 26.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.882 . . . . 0.0 109.261 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.1 t-20 83.92 30.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.932 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.18 137.77 37.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.222 -0.924 . . . . 0.0 108.536 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 91.1 m -85.12 135.22 34.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.028 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.731 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.9 m-85 -113.83 142.68 45.79 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -55.98 -39.13 78.08 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.151 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 23.1 p-10 -160.05 -164.25 1.26 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.689 -1.477 . . . . 0.0 109.632 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -29.0 69.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 62.5 m -77.18 -57.1 4.03 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.041 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 m120 -48.61 -36.85 16.63 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.782 -1.199 . . . . 0.0 108.528 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 23' ' ' LEU . 17.0 t80 -68.38 -56.52 8.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.359 1.076 . . . . 0.0 110.247 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.596 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 64.0 m -52.65 -56.6 14.29 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.317 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 14.1 m-20 -38.7 -29.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.31 -51.03 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . 89.8 t -52.24 -53.79 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.646 0.736 . . . . 0.0 109.474 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.895 HG11 ' CB ' ' A' ' 11' ' ' TYR . 32.8 m -59.96 -34.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -91.83 -2.33 56.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.737 ' O ' HG22 ' A' ' 47' ' ' THR . 28.9 t -106.28 -8.26 17.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.8 t-20 80.32 30.41 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.802 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.62 31.93 57.99 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 ' O ' ' A' ' 44' ' ' SER . 10.5 t -114.13 8.31 16.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.0 tp -89.76 -71.03 0.63 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.538 0.685 . . . . 0.0 109.292 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.627 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.9 p 60.5 143.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.646 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -102.55 171.83 7.21 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.213 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.646 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.23 -30.54 8.31 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.599 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -162.53 158.04 23.01 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.391 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 6.4 m-85 -75.81 -164.45 0.36 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 60.43 -169.49 8.12 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -92.45 168.64 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.494 -1.003 . . . . 0.0 108.773 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.8 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.591 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.0 152.19 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 m -135.01 57.04 1.82 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.273 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -89.1 -15.59 33.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.2 mp0 -95.94 4.13 52.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 109.305 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.73 ' HB3' HG11 ' A' ' 42' ' ' VAL . 96.0 m-85 -96.5 159.52 31.66 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.401 -0.812 . . . . 0.0 109.079 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.949 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -81.68 140.29 45.92 Favored 'Cis proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.531 2.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 10.3 mttt -99.78 139.05 20.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -80.61 14.2 2.08 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.55 2.167 . . . . 0.0 110.452 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.92 126.25 7.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 81.5 m -116.57 139.63 50.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 16' ' ' CYS . 7.1 p -55.4 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 108.729 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -121.84 -25.74 4.96 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.497 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mt-10 -45.37 123.62 4.24 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.8 t80 -83.97 105.42 14.84 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.694 1.235 . . . . 0.0 110.693 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.6 mtp180 -136.89 75.33 49.02 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.6 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 18.4 Cg_endo -61.15 119.35 6.46 Favored 'Trans proline' 0 C--O 1.193 -1.747 0 C-N-CA 123.523 2.815 . . . . 0.0 114.195 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.669 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 2.7 mp -101.77 154.47 18.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.614 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.79 140.35 48.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 119.897 -1.752 . . . . 0.0 109.637 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.664 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.44 161.88 17.96 Favored Glycine 0 N--CA 1.497 2.743 0 CA-C-O 122.4 1.0 . . . . 0.0 113.747 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -37.44 86.15 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.802 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p-10 -58.69 -13.82 6.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.962 . . . . 0.0 109.267 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.8 m-20 91.61 12.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.313 0.578 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 30.5 ttpt -99.28 128.8 45.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -88.29 129.54 35.35 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.849 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.07 132.02 43.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -45.0 -39.74 6.61 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 121.476 -0.765 . . . . 0.0 112.045 -176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -165.57 -157.26 0.31 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.528 -1.572 . . . . 0.0 110.279 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -57.83 -51.2 70.55 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.475 -178.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.3 t -61.3 -60.01 4.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.68 -1.263 . . . . 0.0 109.214 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -48.9 -23.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 108.858 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.1 t80 -80.78 -65.62 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.125 0.964 . . . . 0.0 110.618 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.85 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.1 m -50.26 -22.8 1.91 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.694 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.1 m-80 -76.83 -40.28 48.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -58.32 -23.38 56.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.0 HG22 HD23 ' A' ' 48' ' ' LEU . 92.4 t -84.04 -53.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.949 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -65.71 -12.36 13.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.684 -0.635 . . . . 0.0 109.649 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -93.55 -18.91 21.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 2.5 t -108.41 22.99 15.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.895 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 79.26 -3.82 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 109.057 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 86.54 11.06 72.26 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.3 t -85.42 -5.94 59.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -1.187 . . . . 0.0 108.838 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.0 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.93 150.91 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.597 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.8 p -123.68 142.99 50.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.11 0.957 . . . . 0.0 109.465 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.6 tp -57.73 121.1 9.63 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.0 t -76.76 -24.26 52.94 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.238 -0.913 . . . . 0.0 109.366 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p80 155.72 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.477 0.656 . . . . 0.0 109.362 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 19.3 m-85 -93.83 156.36 16.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.408 -0.808 . . . . 0.0 109.625 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 86.12 -167.94 40.28 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -176.56 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -1.071 . . . . 0.0 108.443 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 41.1 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 6' ' ' VAL . 17.9 t . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 6' ' ' VAL . 18.5 t0 21.57 99.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.152 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 7.8 m -121.55 64.62 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.43 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -91.27 -14.71 30.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.391 -0.818 . . . . 0.0 109.33 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 5.4 mm-40 -105.56 34.93 3.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 110.047 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.7 m-85 -113.73 161.44 27.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.023 -1.048 . . . . 0.0 108.929 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -73.28 175.99 43.21 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.633 -1.82 . . . . 0.0 111.377 2.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -125.78 144.01 47.0 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.582 -0.698 . . . . 0.0 109.559 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.89 14.22 1.76 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.788 2.326 . . . . 0.0 111.204 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.63 141.13 16.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.569 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -116.01 2.56 13.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.825 -1.172 . . . . 0.0 110.981 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 67.43 -17.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 178.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 72.21 -9.04 1.06 Allowed 'General case' 0 C--N 1.275 -2.635 0 O-C-N 121.697 -0.627 . . . . 0.0 111.448 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -59.45 129.07 40.19 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.594 -1.316 . . . . 0.0 107.899 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.3 123.18 33.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.527 1.155 . . . . 0.0 111.701 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -162.19 81.94 1.76 Allowed Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -64.83 117.25 4.35 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.615 2.21 . . . . 0.0 113.344 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.12 136.08 47.58 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -98.83 112.39 24.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.878 -1.139 . . . . 0.0 111.672 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.914 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -51.13 176.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.0 t -72.73 -22.66 60.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -1.176 . . . . 0.0 107.829 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.6 p30 -76.42 -5.73 48.6 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.6 m-20 82.04 30.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 110.363 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -102.74 146.44 28.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 95.8 m -98.3 143.52 28.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 0.0 110.409 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.72 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.9 m-85 -124.81 125.08 43.45 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.59 -46.88 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.363 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 35.9 p-10 -156.61 -168.17 2.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.445 -1.62 . . . . 0.0 111.492 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.07 -37.09 71.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.867 -0.521 . . . . 0.0 112.313 -177.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.8 p -77.41 -54.39 6.5 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.655 -1.278 . . . . 0.0 108.662 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 8.9 m-80 -50.36 -26.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.017 -1.052 . . . . 0.0 108.888 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 76.5 t80 -87.02 -35.69 18.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 123.069 1.414 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.2 m -67.34 -29.17 68.65 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -70.39 -36.09 73.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.97 -25.35 63.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.4 t -77.64 -40.05 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.333 0.587 . . . . 0.0 110.186 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.9 p -84.7 -13.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.915 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.732 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -91.73 -33.21 15.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 47' ' ' THR . 9.8 t -89.98 20.31 4.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.5 m-80 64.99 10.24 6.1 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.424 -0.797 . . . . 0.0 109.911 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.99 15.69 64.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 44' ' ' SER . 7.7 p -92.26 7.25 43.54 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.018 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.914 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.9 tp -79.5 -66.58 0.85 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.6 p 50.02 118.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 122.456 1.122 . . . . 0.0 111.904 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -77.89 170.89 15.83 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.72 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.99 -22.85 9.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.607 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.2 p80 -164.53 144.53 7.6 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.494 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.11 164.17 13.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 85.81 -170.0 43.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 8.9 mtmm -90.76 165.67 13.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -1.105 . . . . 0.0 109.395 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 37.3 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.932 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 37' ' ' PHE . 7.2 p . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.325 0.583 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.73 139.91 51.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.153 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' HG13 ' A' ' 6' ' ' VAL . 30.6 m -143.29 46.54 1.52 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.735 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.36 -6.38 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.128 -0.982 . . . . 0.0 109.872 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -100.86 13.55 34.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.48 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.074 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.5 m-85 -100.4 159.72 28.95 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -76.68 162.94 90.77 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.568 -1.846 . . . . 0.0 111.247 1.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.58 141.0 26.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.47 13.83 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 109.84 0.49 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -94.28 144.96 25.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.473 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 25.1 p -50.92 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -122.27 -16.81 7.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.058 -1.026 . . . . 0.0 109.904 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' LEU . 13.7 pm0 -55.8 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.59 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.8 t80 -134.74 130.86 36.86 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.25 80.55 2.09 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.8 Cg_endo -63.15 117.76 4.68 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.026 1.817 . . . . 0.0 111.966 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -108.44 132.53 53.69 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.699 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.737 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -80.7 120.72 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.602 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.43 -162.98 5.43 Favored Glycine 0 C--N 1.294 -1.757 0 C-N-CA 118.593 -1.765 . . . . 0.0 108.861 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.7 t -85.24 -49.83 7.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.893 -1.357 . . . . 0.0 109.963 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.8 p-10 -57.39 -14.83 5.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.3 t30 98.12 45.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.084 0.468 . . . . 0.0 110.069 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.07 114.17 20.0 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.353 1.073 . . . . 0.0 109.006 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.6 m -60.32 158.23 12.15 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.127 -0.983 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 1.2 m-85 -129.96 147.53 51.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -53.35 -37.68 55.86 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.555 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.651 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.6 p30 -166.59 -163.86 0.61 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.697 -1.472 . . . . 0.0 109.557 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.49 -36.67 78.87 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.665 -178.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.467 ' O ' ' C ' ' A' ' 36' ' ' ASN . 11.8 t -70.11 -64.35 0.91 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.497 -1.377 . . . . 0.0 108.391 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.6 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -40.8 -37.55 0.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.9 t80 -72.47 -59.65 2.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.511 1.148 . . . . 0.0 110.349 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 20.6 m -53.17 -58.54 6.7 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.093 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 15.8 m-20 -38.98 -30.43 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.283 -0.886 . . . . 0.0 109.056 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -74.55 -50.71 17.01 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.39 -59.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.665 -0.647 . . . . 0.0 110.202 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.074 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.3 p -61.49 -26.0 38.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.209 -0.932 . . . . 0.0 111.353 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.91 -8.92 44.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.517 -1.364 . . . . 0.0 109.398 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.5 p -109.13 18.19 20.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 110.307 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.4 m-20 63.46 15.26 8.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 0.0 109.717 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 19.73 76.6 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 44' ' ' SER . 24.2 p -88.99 -2.86 58.79 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.307 -1.113 . . . . 0.0 108.061 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.73 ' C ' HG23 ' A' ' 49' ' ' THR . 8.3 tp -85.28 -80.31 0.22 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.73 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER 68.41 171.55 0.28 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.63 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.11 167.66 14.48 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.376 -0.827 . . . . 0.0 109.697 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.63 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.9 -35.09 7.03 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.737 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -162.18 165.24 27.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.611 0.719 . . . . 0.0 109.129 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CD2' HD23 ' A' ' 23' ' ' LEU . 58.6 m-85 -80.07 175.25 10.81 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 108.968 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.66 -169.25 53.26 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -90.71 129.33 36.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.264 . . . . 0.0 109.787 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.637 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.395 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -93.11 147.23 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.808 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 71.5 m -133.04 30.24 3.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -0.859 . . . . 0.0 109.284 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -75.2 -23.68 57.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.589 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -90.73 19.91 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.675 ' HB3' HG11 ' A' ' 42' ' ' VAL . 86.8 m-85 -117.58 161.76 32.11 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 1.057 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -82.34 132.96 22.05 Favored 'Cis proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.042 -1.649 . . . . 0.0 110.966 2.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.2 mttt -80.25 143.19 55.9 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.668 -0.645 . . . . 0.0 109.659 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.22 14.18 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.564 2.176 . . . . 0.0 110.27 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 144.82 2.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.7 m -133.94 144.37 48.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 80.5 p -56.32 -168.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.0 109.02 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.05 -16.56 6.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 109.74 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -50.69 132.87 26.2 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 t80 -86.45 125.5 33.75 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 122.824 1.297 . . . . 0.0 111.36 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.2 mtt-85 -160.59 70.64 2.85 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.635 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -62.87 131.07 31.48 Favored 'Trans proline' 0 C--O 1.198 -1.522 0 C-N-CA 124.044 3.163 . . . . 0.0 114.767 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 34' ' ' LYS . 3.1 mp -111.22 159.76 17.6 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 176.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.65 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -120.05 141.16 50.0 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.819 -1.801 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.66 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.51 158.95 18.62 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 122.701 1.167 . . . . 0.0 114.473 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -57.73 -17.79 17.36 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.549 -0.825 . . . . 0.0 109.858 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -89.62 21.8 3.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 109.007 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.82 16.96 3.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.526 -0.734 . . . . 0.0 109.867 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -99.26 120.54 39.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.242 -0.912 . . . . 0.0 108.592 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.869 HG21 ' HD3' ' A' ' 55' ' ' LYS . 42.6 m -84.5 126.49 33.33 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.462 -0.773 . . . . 0.0 109.648 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.82 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.66 136.79 36.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -41.77 -40.51 3.07 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.296 -0.878 . . . . 0.0 111.545 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.1 p30 -171.02 -153.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.677 -1.484 . . . . 0.0 110.318 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.89 -52.31 66.3 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.014 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 7.8 t -64.02 -57.83 8.52 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.737 -1.227 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -49.92 -23.14 1.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.82 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 5.3 t80 -78.25 -67.32 0.75 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.424 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 1.093 ' O ' HG13 ' A' ' 42' ' ' VAL . 6.4 m -45.25 -25.73 0.41 Allowed 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.7 m-80 -70.06 -46.7 64.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -60.67 -19.97 59.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.029 HG22 HD23 ' A' ' 48' ' ' LEU . 53.1 t -90.91 -29.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.134 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.093 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.8 m -83.98 -19.37 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.11 -16.78 25.88 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.916 . . . . 0.0 108.703 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG22 ' A' ' 47' ' ' THR . 0.4 OUTLIER -100.15 9.29 43.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.64 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.7 t30 76.45 6.29 3.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 79.85 7.73 88.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -87.76 9.55 21.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.264 -1.139 . . . . 0.0 108.885 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.029 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -85.66 -77.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.355 -0.841 . . . . 0.0 109.14 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 48' ' ' LEU . 4.2 p 92.27 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.084 0.945 . . . . 0.0 110.203 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 52' ' ' HIS . 8.5 tp -72.68 157.71 37.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.08 -18.95 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.655 -1.278 . . . . 0.0 108.385 179.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.717 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 174.03 161.17 0.17 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.24 164.78 25.28 Favored 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.635 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.96 -168.5 52.25 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.869 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -91.1 171.72 9.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 3.0 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.616 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 34' ' ' LYS . 24.4 t . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.05 112.2 21.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 38.7 m -108.15 64.53 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -89.49 -23.18 22.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -5.26 59.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.843 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -79.83 162.24 63.28 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.181 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.917 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.2 Cg_endo -82.08 144.2 57.53 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.201 -1.583 . . . . 0.0 110.933 2.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 26.2 mttt -99.46 141.63 23.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 109.934 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.67 14.26 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.522 2.148 . . . . 0.0 110.27 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 119.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.538 -0.726 . . . . 0.0 109.052 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 64.8 m -93.8 148.9 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.644 ' O ' HD23 ' A' ' 18' ' ' LEU . 66.2 p -56.67 -164.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 17' ' ' THR . 7.3 mt -128.7 -7.58 5.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.94 -1.1 . . . . 0.0 110.654 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.488 ' OE1' ' HG3' ' A' ' 21' ' ' ARG . 1.3 pp20? -65.94 -176.3 0.38 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 9.4 t80 -122.49 129.43 51.99 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 120.862 -1.149 . . . . 0.0 111.239 -178.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 17.1 mtm180 -160.31 73.31 2.97 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.9 Cg_endo -64.73 112.85 2.1 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.909 1.739 . . . . 0.0 110.87 -178.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.78 138.61 49.35 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.325 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.689 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 9.2 t -96.24 165.75 12.06 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.912 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.435 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -132.81 176.71 19.35 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.493 -177.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.4 t -58.56 -49.24 78.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.667 -0.902 . . . . 0.0 109.049 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.602 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.2 p-10 -47.97 -24.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 108.985 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.3 t-20 91.08 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.22 0.533 . . . . 0.0 109.844 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 4.4 ttmt -127.89 153.5 46.57 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 31' ' ' TYR . 36.8 m -92.82 160.98 14.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 87.5 m-85 -140.11 100.26 3.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 108.679 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -17.43 -61.43 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.113 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.3 p30 -139.34 -169.82 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.923 -1.339 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 28.5 pttt -53.11 -39.47 63.44 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.821 -0.549 . . . . 0.0 110.533 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -63.03 -66.31 0.56 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.996 -1.065 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.8 m-80 -41.43 -34.74 0.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 109.871 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 59.0 t80 -71.72 -44.89 63.36 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.914 1.34 . . . . 0.0 109.69 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 71.5 m -61.73 -55.7 27.49 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 4.4 m-80 -44.23 -27.61 0.43 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.757 -1.214 . . . . 0.0 108.667 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.56 -47.51 47.57 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 1.008 HG22 ' CD2' ' A' ' 48' ' ' LEU . 32.8 t -60.19 -56.71 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.823 0.82 . . . . 0.0 109.335 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 ' HB3' ' A' ' 12' ' ' PRO . 15.9 m -56.22 -29.08 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 110.553 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.27 -15.73 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.025 -1.047 . . . . 0.0 108.81 179.536 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 89.5 p -106.33 11.25 31.21 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.414 -0.804 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER 50.65 39.05 20.67 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.69 0.757 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.573 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 65.56 32.15 82.39 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.749 178.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.525 HG23 ' CG ' ' A' ' 45' ' ' ASN . 70.1 p -104.93 -6.11 20.43 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.324 -1.104 . . . . 0.0 108.573 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 1.008 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 -57.11 3.83 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.104 0.954 . . . . 0.0 108.501 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.616 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 32.1 p 63.7 129.47 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.955 -177.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -58.21 152.73 16.52 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.1 p -107.38 -42.86 4.7 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.689 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -174.45 160.49 3.19 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.723 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -77.72 139.07 39.36 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.115 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.82 -170.33 16.9 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -89.41 159.17 17.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.884 -1.362 . . . . 0.0 108.007 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.444 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 7' ' ' ASP . 77.0 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.267 0.556 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.9 t0 -77.94 137.81 38.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 60.1 m -146.6 49.17 1.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.823 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -90.55 -10.83 42.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.971 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.82 21.09 11.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.736 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.3 m-85 -106.75 159.69 28.97 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 36.9 Cg_endo -75.61 175.96 45.71 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.711 -1.787 . . . . 0.0 111.364 2.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 50.5 mttt -135.4 139.07 30.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.82 13.96 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.346 2.031 . . . . 0.0 110.58 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.78 114.72 1.57 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -91.81 150.46 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.55 167.39 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 109.124 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -101.09 -33.79 9.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.026 . . . . 0.0 109.625 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -46.0 125.05 5.94 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.042 -1.036 . . . . 0.0 108.797 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -79.69 116.74 20.05 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.393 1.092 . . . . 0.0 109.915 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.68 76.68 10.68 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -64.01 120.98 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.983 2.455 . . . . 0.0 112.614 -177.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.833 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -114.01 127.61 56.02 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.63 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 37.5 t -79.91 115.97 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -64.75 -170.97 2.5 Favored Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.299 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -80.91 -33.62 34.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.945 -1.327 . . . . 0.0 108.75 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.4 p-10 -60.05 -16.41 31.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 92.9 17.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 109.891 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.54 130.44 45.78 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.169 -0.957 . . . . 0.0 108.725 179.169 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 m -70.88 147.24 49.01 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 71.7 m-85 -120.69 116.18 24.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -26.85 -47.78 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 -177.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.4 p30 -160.7 -163.47 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.616 -1.52 . . . . 0.0 109.694 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.833 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.31 -41.73 80.45 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.397 -179.069 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 42.4 t -61.59 -66.46 0.53 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.734 -1.229 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 12.8 m-80 -43.71 -34.23 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 0.0 110.708 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 25.9 t80 -72.25 -52.57 15.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.179 . . . . 0.0 109.982 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.626 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 32.9 m -53.83 -53.18 56.1 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 4.3 m-20 -41.43 -34.29 0.52 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.154 -0.967 . . . . 0.0 108.864 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.825 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -71.74 -47.24 55.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 46' ' ' GLY . 97.4 t -58.06 -62.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.433 0.635 . . . . 0.0 110.06 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.8 p -58.96 -22.84 22.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 111.869 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.07 -16.42 27.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.377 -1.452 . . . . 0.0 108.702 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' HG22 ' A' ' 47' ' ' THR . 18.9 p -102.63 -2.24 28.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.59 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 78.63 12.83 1.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 109.305 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.63 5.86 74.14 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 44' ' ' SER . 14.3 t -79.61 -4.0 49.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.258 -1.143 . . . . 0.0 108.15 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' THR . 4.7 tp -80.4 -82.89 0.11 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 75.27 179.88 0.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.544 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -130.88 -179.79 5.52 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.582 -1.324 . . . . 0.0 110.22 -179.472 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -111.61 -21.91 11.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.018 -1.051 . . . . 0.0 108.465 -179.82 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 179.74 155.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.504 -0.748 . . . . 0.0 109.835 -179.211 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -73.65 148.35 42.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.749 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.566 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.39 -166.97 14.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.608 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.74 157.67 16.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -1.103 . . . . 0.0 108.219 178.855 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.09 -1.006 . . . . 0.0 109.627 -179.885 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 23' ' ' LEU . 40.3 t . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.343 0.592 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -101.26 131.17 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.542 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 29.0 m -122.23 58.69 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 t -82.65 -16.85 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -1.92 40.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.117 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.874 ' HB3' HG11 ' A' ' 42' ' ' VAL . 36.4 m-85 -84.53 165.46 37.85 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.985 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.5 153.43 62.92 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.338 -1.526 . . . . 0.0 110.913 1.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -102.9 141.28 22.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.759 . . . . 0.0 109.694 -179.411 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -80.19 13.57 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.561 2.174 . . . . 0.0 110.278 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.02 112.58 1.0 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.5 m -83.89 143.16 30.06 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.62 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.196 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -125.61 -31.88 2.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.897 -1.127 . . . . 0.0 109.928 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 2.8 pm0 -49.03 142.08 7.13 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 7.9 t80 -90.23 126.15 35.73 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 122.731 1.253 . . . . 0.0 111.2 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.68 71.87 2.83 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -61.16 130.9 34.17 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.531 2.821 . . . . 0.0 113.159 -176.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -115.29 126.44 54.49 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.171 178.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.779 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.4 t -78.07 133.66 37.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -75.72 -157.26 6.62 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 118.534 -1.793 . . . . 0.0 108.784 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -92.99 -66.55 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 110.171 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.629 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -40.16 -40.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.605 -0.684 . . . . 0.0 109.401 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.6 p30 133.38 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE3' ' CD1' ' A' ' 48' ' ' LEU . 11.3 pttp -108.46 107.27 17.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 109.636 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 46.6 m -66.37 152.13 45.69 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.531 -0.731 . . . . 0.0 109.101 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 m-85 -129.62 142.74 50.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.555 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -47.52 -35.06 10.35 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.708 -176.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 23' ' ' LEU . 43.1 p30 -173.18 -155.55 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.725 -1.456 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.96 -42.39 97.29 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.436 -0.79 . . . . 0.0 110.786 -178.227 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.8 t -66.55 -57.36 7.45 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.579 -1.326 . . . . 0.0 108.512 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -48.93 -37.0 18.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.82 . . . . 0.0 109.478 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 31.9 t80 -70.22 -51.91 27.23 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.492 1.139 . . . . 0.0 110.247 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 61.2 m -55.21 -61.03 2.59 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.289 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' CYS . 3.9 m-20 -37.47 -29.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.302 -0.874 . . . . 0.0 109.657 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -74.33 -52.3 12.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 68.9 t -52.06 -54.72 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.585 0.707 . . . . 0.0 109.738 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.985 HG21 ' HB3' ' A' ' 12' ' ' PRO . 6.1 m -61.89 -26.48 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 111.183 -178.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 6.9 tt0 -90.63 -6.43 54.6 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.962 -1.087 . . . . 0.0 109.792 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 p -112.57 18.42 18.39 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.118 -0.989 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.888 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.61 -1.58 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 0.0 109.304 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.88 17.24 61.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.888 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.1 p -87.0 -10.41 53.21 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.248 . . . . 0.0 108.486 178.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.537 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -78.26 148.47 33.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.712 0.768 . . . . 0.0 109.467 -179.573 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' SER . 1.3 p -137.77 167.17 22.25 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -109.63 170.31 8.15 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -108.41 -35.77 6.41 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.829 -1.17 . . . . 0.0 107.896 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.779 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -167.86 164.73 14.07 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.568 0.699 . . . . 0.0 109.505 -178.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.65 -167.16 0.33 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.577 -0.702 . . . . 0.0 109.306 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.81 -167.31 4.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -85.55 165.4 17.11 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.614 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.584 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.255 0.55 . . . . 0.0 109.674 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.53 131.6 35.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.165 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 54.9 m -139.08 49.61 1.84 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -90.91 -10.18 43.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.689 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.67 23.76 9.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 42' ' ' VAL . 46.9 m-85 -117.63 158.28 45.69 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.066 -1.021 . . . . 0.0 108.385 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.566 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.24 164.86 84.19 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.003 3.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -119.91 146.85 42.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.478 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -78.53 13.67 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.5 2.133 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 150.94 1.29 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.9 m -119.83 138.25 53.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.023 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.3 p -54.04 -171.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 108.817 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -119.51 -22.87 6.81 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.362 179.577 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -49.95 118.42 2.88 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.538 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -78.42 126.55 30.93 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.536 1.16 . . . . 0.0 110.501 -178.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.0 ptm180 -160.66 77.91 2.5 Favored Pre-proline 0 C--N 1.293 -1.89 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.6 Cg_endo -66.11 127.68 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.707 2.271 . . . . 0.0 112.853 -176.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.749 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -116.88 135.15 53.95 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.881 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.916 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.1 t -92.88 161.48 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.424 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.566 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -117.56 168.18 12.9 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 35.3 t -69.47 -17.97 63.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.64 -0.917 . . . . 0.0 108.636 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 35.7 p30 -73.85 -7.97 54.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.068 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.6 t30 82.33 31.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.756 -0.59 . . . . 0.0 110.044 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -123.94 139.68 53.72 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.143 179.719 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -85.22 159.91 20.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.816 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 48.1 m-85 -130.98 124.85 31.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -38.41 -53.62 2.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.967 -178.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -155.06 -164.45 1.79 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.783 -1.422 . . . . 0.0 110.529 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.15 -25.28 68.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 111.533 -178.253 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -70.78 -53.23 16.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.598 -1.314 . . . . 0.0 109.197 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.13 -37.5 87.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.715 -0.616 . . . . 0.0 110.018 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.796 ' CE1' HD21 ' A' ' 48' ' ' LEU . 58.9 t80 -70.51 -47.61 59.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.942 -1.099 . . . . 0.0 109.791 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 17.3 m -64.02 -29.56 70.7 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 95.1 m-20 -72.64 -39.24 67.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.41 -17.3 61.81 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.773 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.2 t -84.54 -50.75 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.001 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 11' ' ' TYR . 6.8 p -68.54 -17.8 22.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.661 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.724 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.08 -31.3 15.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.05 -1.031 . . . . 0.0 108.371 178.548 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' THR . 46.5 t -88.15 15.11 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.633 -0.667 . . . . 0.0 110.53 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 64.04 12.79 7.22 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.203 -0.935 . . . . 0.0 109.511 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 20.74 66.96 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' SER . 10.8 p -93.75 3.61 55.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -1.137 . . . . 0.0 108.72 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.796 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.56 -52.73 7.63 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.047 0.927 . . . . 0.0 108.745 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.645 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 29.5 p 53.38 119.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.442 1.115 . . . . 0.0 111.323 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 4.2 tp -65.36 152.46 43.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -112.52 -16.87 12.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 175.86 163.52 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.92 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -80.22 177.66 8.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.159 -0.963 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.88 -167.45 54.88 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.529 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.09 173.46 7.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.846 -1.159 . . . . 0.0 109.681 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 23' ' ' LEU . 90.7 t . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' N ' HG12 ' A' ' 6' ' ' VAL . 10.3 t70 -86.3 152.51 22.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -122.98 49.88 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.671 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -90.01 -36.57 14.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.35 43.16 1.07 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.321 -0.862 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 47.2 m-85 -132.38 164.98 39.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -89.48 173.94 24.77 Favored 'Cis proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.399 -1.5 . . . . 0.0 111.293 0.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.4 mtpt -136.53 136.41 21.98 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 109.14 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.95 15.6 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.561 2.174 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.44 14.2 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.49 -0.756 . . . . 0.0 109.064 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.68 160.09 40.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 1.3 p -60.86 -164.23 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.09 -7.67 10.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 110.417 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.775 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.7 pm0 -56.59 119.32 5.91 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.484 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -79.6 128.96 34.03 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.505 1.145 . . . . 0.0 111.049 -178.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.56 80.03 2.05 Favored Pre-proline 0 C--N 1.294 -1.809 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.758 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.557 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -65.02 124.87 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.973 2.449 . . . . 0.0 112.975 -176.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.744 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -112.25 139.93 47.38 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -102.52 129.32 49.01 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.983 -178.303 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.11 -170.16 8.21 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' THR . 29.5 t -82.03 -22.02 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.938 -1.331 . . . . 0.0 108.416 178.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -76.15 -3.42 36.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.836 . . . . 0.0 109.44 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 17.6 t30 80.18 30.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.382 -0.824 . . . . 0.0 110.308 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 10.2 ttmt -105.32 137.1 43.65 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.103 -0.998 . . . . 0.0 108.781 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.9 m -85.66 146.5 26.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 0.0 109.998 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.6 m-85 -125.51 132.23 52.66 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.98 -51.03 0.65 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p30 -165.54 -168.32 1.32 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.036 -1.273 . . . . 0.0 111.086 178.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HA ' HD13 ' A' ' 23' ' ' LEU . 6.3 ptmt -45.76 -45.98 14.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.88 -0.512 . . . . 0.0 111.868 -177.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 10.3 m -64.76 -62.73 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.555 -1.341 . . . . 0.0 109.698 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.3 m-80 -50.56 -20.12 1.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 21.3 t80 -82.84 -57.93 3.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.954 -1.091 . . . . 0.0 110.889 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.5 t -58.01 -47.35 83.3 Favored 'General case' 0 C--N 1.286 -2.156 0 O-C-N 121.698 -0.626 . . . . 0.0 110.911 -178.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.589 ' O ' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.29 -28.75 1.39 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.341 -1.475 . . . . 0.0 107.997 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -70.2 -48.31 57.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.881 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.2 t -55.86 -56.14 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.408 0.623 . . . . 0.0 110.031 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 39' ' ' ASN . 2.8 m -53.48 -33.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.075 -1.015 . . . . 0.0 111.062 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -92.57 -11.27 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.629 -1.295 . . . . 0.0 109.697 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.891 ' O ' HG22 ' A' ' 47' ' ' THR . 8.5 t -100.65 -5.35 26.76 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.035 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 77.37 27.58 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.0 -179.649 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.881 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 64.79 11.69 50.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 44' ' ' SER . 14.7 t -87.09 -2.44 58.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.293 -1.122 . . . . 0.0 108.666 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.02 -59.87 2.61 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.596 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 37.6 p 52.58 127.6 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.114 0.959 . . . . 0.0 111.305 178.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -85.94 160.67 19.32 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.581 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.1 -29.13 9.57 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.575 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.8 p80 -160.04 163.1 34.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.89 177.72 8.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.557 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 73.63 -167.11 54.52 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -91.4 164.78 13.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -1.031 . . . . 0.0 109.072 179.041 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.7 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.922 -179.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 121.172 0.51 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.83 156.57 39.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.0 109.243 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 19.5 t -160.98 24.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.947 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.18 -4.83 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -112.06 36.95 3.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.906 -1.121 . . . . 0.0 110.217 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 97.0 m-85 -136.51 157.81 74.52 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.994 -1.066 . . . . 0.0 108.817 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.576 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -72.08 145.04 82.12 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.631 -1.821 . . . . 0.0 111.544 3.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -108.1 144.95 30.44 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 -179.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -78.72 14.62 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.781 2.321 . . . . 0.0 110.956 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.03 117.49 2.25 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 109.127 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' THR . 94.3 m -102.21 139.71 37.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.877 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CD ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -45.16 142.88 1.81 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.425 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -92.28 -23.08 19.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.947 -1.096 . . . . 0.0 109.851 -179.484 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 14.5 pm0 -57.44 -166.8 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.6 t80 -134.03 116.4 15.46 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.352 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.4 mmt180 -147.92 74.71 11.07 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.582 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.5 Cg_endo -65.91 132.07 29.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.114 2.543 . . . . 0.0 113.144 -176.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.705 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -118.78 136.71 53.84 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.583 178.334 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 51.8 t -79.05 117.98 20.61 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.28 -165.56 1.32 Allowed Glycine 0 C--N 1.296 -1.663 0 C-N-CA 118.299 -1.905 . . . . 0.0 108.589 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.1 t -85.89 -31.78 22.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.27 . . . . 0.0 109.144 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -69.24 -4.92 19.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 179.57 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.3 t-20 86.11 15.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.742 -0.599 . . . . 0.0 109.881 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.0 ttpt -99.56 117.54 34.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.812 179.09 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -54.5 158.05 2.62 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 4.2 m-85 -129.2 133.13 47.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.07 -51.51 3.46 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -161.43 -158.5 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.336 -1.096 . . . . 0.0 109.547 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.53 -57.03 10.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.096 -178.099 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.9 t -42.85 -57.44 2.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.838 -1.164 . . . . 0.0 110.41 -179.264 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.34 -43.22 99.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.277 -0.889 . . . . 0.0 111.129 -178.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.7 t80 -56.07 -60.55 3.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.905 -1.122 . . . . 0.0 110.521 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -55.58 -51.96 65.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.32 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.9 m-20 -41.6 -29.19 0.16 Allowed 'General case' 0 C--N 1.308 -1.196 0 O-C-N 120.567 -1.333 . . . . 0.0 108.773 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -75.1 -49.34 19.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 48' ' ' LEU . 93.0 t -58.26 -62.45 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.591 0.71 . . . . 0.0 109.8 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 38' ' ' CYS . 3.3 p -57.47 -26.56 26.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.262 -0.899 . . . . 0.0 111.627 -178.627 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -91.71 -13.44 31.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.283 -1.511 . . . . 0.0 109.059 179.203 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.6 t -104.59 22.85 14.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.509 -0.744 . . . . 0.0 110.082 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.6 p30 65.08 6.25 3.39 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.463 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.15 8.59 87.14 Favored Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.291 -0.881 . . . . 0.0 110.912 178.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.405 ' HB ' ' OD1' ' A' ' 45' ' ' ASN . 9.6 t -79.45 -4.37 50.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.803 -1.41 . . . . 0.0 108.188 178.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.698 ' C ' HG23 ' A' ' 49' ' ' THR . 1.7 tp -79.95 -80.29 0.13 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.698 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 70.92 169.07 0.32 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.14 173.33 7.16 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.425 -0.797 . . . . 0.0 110.486 -178.143 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.667 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.73 -36.38 7.07 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.714 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -162.54 165.58 25.86 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.456 0.646 . . . . 0.0 109.383 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.705 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.7 m-85 -75.61 -164.5 0.35 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.595 -0.691 . . . . 0.0 109.184 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 59.06 -168.99 6.16 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.4 143.2 26.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -1.02 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.557 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 32.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.693 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.18 0.514 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.13 143.29 55.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 7.3 m -139.32 61.37 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -90.83 -1.24 57.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.4 41.59 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.427 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.913 ' CB ' HG11 ' A' ' 42' ' ' VAL . 70.8 m-85 -122.83 161.35 44.73 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.247 -0.908 . . . . 0.0 108.934 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.15 -179.77 28.24 Favored 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.698 -1.793 . . . . 0.0 111.41 1.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 tttp -123.04 141.34 35.48 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.0 Cg_endo -77.18 13.99 1.43 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.656 2.238 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 170.5 144.37 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 34.6 t -124.08 159.47 29.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.4 p -59.37 -157.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.55 -11.06 8.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.731 -1.231 . . . . 0.0 109.685 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.3 pt-20 -56.6 124.86 19.75 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 19.3 t80 -86.04 132.41 34.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.323 1.059 . . . . 0.0 111.537 -177.532 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.73 80.32 2.26 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.769 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.6 Cg_endo -65.42 122.0 9.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.668 2.245 . . . . 0.0 112.415 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mt -107.18 128.4 54.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.748 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -79.06 102.28 8.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.384 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.538 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.27 -170.89 0.12 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 118.579 -1.772 . . . . 0.0 109.113 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.9 t -74.32 -45.0 50.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.008 -1.289 . . . . 0.0 109.306 179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -54.99 -16.39 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.817 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER 92.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.375 0.607 . . . . 0.0 109.73 179.754 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -99.41 127.89 45.48 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -69.61 152.79 44.33 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 8.2 m-85 -126.54 125.2 41.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -28.89 -50.5 0.1 Allowed Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -176.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -163.04 -159.94 0.58 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.704 -1.468 . . . . 0.0 110.317 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.797 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.05 -46.12 79.02 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.307 -0.871 . . . . 0.0 112.213 -177.413 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 5.3 m -66.23 -52.61 46.17 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.477 -1.389 . . . . 0.0 110.17 -178.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.0 m-80 -56.42 -23.43 38.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.685 -1.259 . . . . 0.0 110.395 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CB ' HD12 ' A' ' 23' ' ' LEU . 16.6 t80 -82.72 -54.59 5.01 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.037 1.399 . . . . 0.0 110.007 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.661 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 1.1 m -55.55 -35.99 66.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.324 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 3.5 m-20 -57.48 -36.51 71.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.588 -1.32 . . . . 0.0 108.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.662 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.0 -28.67 66.81 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.417 HG13 ' HA2' ' A' ' 46' ' ' GLY . 79.4 t -72.97 -62.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.512 -0.742 . . . . 0.0 109.119 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.913 HG11 ' CB ' ' A' ' 11' ' ' TYR . 4.4 p -59.58 -15.15 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 111.299 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.662 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.93 -30.72 15.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.573 -1.329 . . . . 0.0 108.659 179.308 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.1 t -93.22 22.38 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.678 -0.638 . . . . 0.0 110.31 -179.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 17.4 m-80 65.62 8.85 5.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.175 -0.953 . . . . 0.0 109.802 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.33 17.82 63.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 p -95.74 5.79 50.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 108.734 179.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.3 tp -79.49 -78.28 0.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.668 0.747 . . . . 0.0 109.394 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.9 p 68.12 153.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.669 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -110.63 179.64 4.01 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.525 -0.734 . . . . 0.0 111.223 -177.733 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.669 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -109.06 -32.4 7.25 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.783 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.748 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.3 p80 -170.56 159.51 6.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.401 0.619 . . . . 0.0 109.626 -178.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 33.6 m-85 -70.55 -169.17 0.3 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 63.11 -169.29 17.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 138.83 31.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.131 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.499 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 HD22 ' A' ' 23' ' ' LEU . 12.2 t . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 6' ' ' VAL . 17.9 t70 -59.62 148.1 34.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 108.857 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 10.1 t -158.03 24.09 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.944 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.6 0.23 57.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.396 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 11.5 mp0 -122.37 43.18 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.917 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.7 m-85 -139.02 158.77 69.06 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.07 -1.019 . . . . 0.0 108.571 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.04 159.68 95.04 Favored 'Cis proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.096 3.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 5.0 tttm -110.42 145.9 33.18 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.3 14.09 1.66 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.536 2.157 . . . . 0.0 110.731 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.69 124.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -79.74 156.08 27.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.745 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -72.66 -172.05 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.894 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -115.27 -20.01 10.53 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.101 -0.999 . . . . 0.0 110.19 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.667 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -57.87 123.17 14.85 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.855 -1.153 . . . . 0.0 108.758 179.324 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.6 t80 -83.96 124.83 31.43 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.248 1.023 . . . . 0.0 109.818 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.2 mtp180 -161.11 87.33 1.68 Allowed Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -65.46 120.54 7.75 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.147 1.898 . . . . 0.0 112.225 -177.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -112.15 139.83 47.35 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.482 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.589 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -104.24 124.07 48.48 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.964 -178.307 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -69.34 -171.81 8.22 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 30.6 t -82.84 -17.69 43.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.696 -1.473 . . . . 0.0 108.045 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -76.68 -8.03 56.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.549 -0.72 . . . . 0.0 109.321 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.6 t30 81.75 36.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 9.6 tttt -111.99 138.83 48.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.814 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -88.73 145.14 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.917 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.803 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 66.8 m-85 -121.35 124.29 44.2 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.17 -52.63 0.71 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -177.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.4 p30 -152.63 -163.79 1.8 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.138 -1.213 . . . . 0.0 110.052 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 ptmt -58.27 -68.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 111.297 -178.217 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.8 p -41.28 -45.43 2.95 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.875 -1.141 . . . . 0.0 110.694 -178.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.457 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 12.1 m-80 -63.61 -40.59 97.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.549 -1.345 . . . . 0.0 109.871 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 20.5 t80 -65.35 -60.15 3.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.194 -0.941 . . . . 0.0 110.941 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.703 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -55.05 -41.57 71.6 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.893 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.625 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.4 m-20 -49.42 -37.41 25.45 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.425 -1.422 . . . . 0.0 107.971 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.66 -32.25 65.69 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.756 HG13 ' HA2' ' A' ' 46' ' ' GLY . 88.1 t -70.62 -67.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.296 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 38' ' ' CYS . 7.3 p -54.05 -17.61 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.705 -0.622 . . . . 0.0 111.551 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.659 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.75 -31.07 15.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.183 -1.573 . . . . 0.0 107.763 178.346 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 10.7 t -88.28 -1.29 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.829 -0.544 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.942 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER 84.44 4.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.362 -179.513 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.756 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 91.12 8.94 64.18 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.942 HG23 ' OD1' ' A' ' 45' ' ' ASN . 18.0 p -85.03 1.1 49.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.915 -1.344 . . . . 0.0 108.868 178.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -78.82 -50.61 10.99 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.923 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 73.9 p 45.84 121.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.282 1.039 . . . . 0.0 112.574 178.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -82.38 159.4 23.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.513 0.673 . . . . 0.0 109.218 178.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.68 -26.39 10.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.552 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.589 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -164.2 160.21 21.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.573 0.701 . . . . 0.0 109.682 -178.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.96 -170.11 1.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.67 -171.67 20.72 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -90.75 166.58 13.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 108.774 179.3 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.0 m . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.667 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.6 128.37 34.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.998 . . . . 0.0 109.504 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 m -138.0 45.89 2.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 8.43 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.893 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 21.9 mp0 -118.08 3.39 12.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 109.833 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.922 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.2 m-85 -85.34 160.4 54.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.202 -0.936 . . . . 0.0 109.421 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -73.91 156.43 99.69 Favored 'Cis proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.775 -1.76 . . . . 0.0 111.939 2.042 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -100.34 142.75 25.21 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -79.49 14.85 1.71 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.588 2.192 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.3 133.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 108.994 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.7 m -99.44 149.42 23.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 0.0 109.922 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -49.19 -24.28 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.291 1.043 . . . . 0.0 110.037 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 76.22 2.21 3.52 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.239 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.539 ' HG2' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -78.03 -164.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.779 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 5.2 t80 -130.69 126.46 36.58 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.098 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 45.0 mtm180 -159.88 77.02 2.85 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -64.28 120.3 7.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.44 2.093 . . . . 0.0 112.552 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.38 127.44 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.106 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.5 t -79.78 126.57 31.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 109.75 -179.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.36 169.99 54.96 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 t -64.88 -35.27 80.59 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.133 -1.216 . . . . 0.0 109.916 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -76.53 4.52 9.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.4 t30 80.33 41.41 0.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.0 110.36 179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.8 109.64 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.39 1.09 . . . . 0.0 109.495 179.38 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -63.72 144.24 57.19 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.006 -1.059 . . . . 0.0 108.221 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.873 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.245 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -49.7 -45.42 39.11 Favored Glycine 0 N--CA 1.486 1.977 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.066 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.2 p-10 -159.04 -164.4 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.011 -1.288 . . . . 0.0 110.329 -179.567 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.2 -26.36 62.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 110.397 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 29.0 t -69.15 -63.36 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.968 -1.083 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.561 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 37.1 m-80 -59.53 -39.44 83.91 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.439 -0.788 . . . . 0.0 110.201 -179.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 61.3 t80 -60.38 -47.21 87.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.621 -1.3 . . . . 0.0 108.752 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.5 m -64.08 -28.54 69.85 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.356 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.5 m-20 -67.08 -32.6 73.88 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.873 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -80.26 -22.86 41.25 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 39.9 t -77.67 -33.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.651 -0.656 . . . . 0.0 109.265 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.922 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -90.98 -17.57 7.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.237 -0.914 . . . . 0.0 109.768 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.0 tt0 -91.9 -11.92 34.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.068 -1.02 . . . . 0.0 109.104 179.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.1 t -109.49 26.06 11.08 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.249 -0.907 . . . . 0.0 110.223 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 30.5 m-20 62.14 35.89 15.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.144 -0.972 . . . . 0.0 108.734 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 49.33 25.06 5.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.2 p -88.18 -14.56 38.32 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -1.092 . . . . 0.0 108.688 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 49' ' ' THR . 1.1 tp -80.3 133.24 35.94 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.9 p -135.08 123.5 23.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 108.997 178.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -64.42 165.29 10.01 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.429 -0.794 . . . . 0.0 109.644 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.01 -22.77 10.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.718 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -174.2 152.41 1.83 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.537 -0.727 . . . . 0.0 109.548 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.07 170.77 6.37 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.354 -0.841 . . . . 0.0 108.871 178.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.06 -170.82 47.83 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.607 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.39 134.28 35.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.097 -1.237 . . . . 0.0 108.272 178.619 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.005 -1.06 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 37' ' ' PHE . 14.2 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.229 0.537 . . . . 0.0 109.614 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.53 141.33 29.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.578 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 7.1 m -142.87 65.61 1.34 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -90.37 14.94 11.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.068 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 4.9 pm0 -122.17 -10.35 8.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.979 -1.075 . . . . 0.0 109.723 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 1.055 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.6 m-85 -80.37 158.94 71.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -73.98 178.8 31.85 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.74 -1.775 . . . . 0.0 111.437 3.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.19 145.92 57.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.636 -0.665 . . . . 0.0 109.461 -179.001 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.4 Cg_endo -79.27 14.14 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.436 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.47 115.95 0.25 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.1 m -81.09 158.24 25.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 110.174 -179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -50.06 -25.36 3.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.396 1.093 . . . . 0.0 109.778 -179.777 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER 74.57 -12.14 0.95 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.453 179.192 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -75.33 -167.94 0.72 Allowed 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.466 -1.396 . . . . 0.0 107.855 178.761 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.1 t80 -123.28 122.19 37.74 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.274 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -155.22 77.36 4.94 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.754 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -65.35 112.42 2.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.164 1.91 . . . . 0.0 112.033 -177.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.891 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -108.86 122.02 46.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.758 179.655 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 1.3 m -79.41 103.36 9.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 108.633 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.21 -174.55 0.08 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -178.18 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.3 t -72.67 -33.4 66.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -1.202 . . . . 0.0 108.876 178.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -66.27 -12.34 55.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.42 -0.8 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 88.66 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.803 -0.561 . . . . 0.0 110.161 179.715 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 ttpt -100.6 143.87 30.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 108.956 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 33.9 m -87.59 128.59 35.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.018 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -103.8 118.46 36.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.17 -44.95 0.11 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.972 -0.455 . . . . 0.0 112.476 -176.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 32.2 p-10 -156.12 -161.8 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.702 -1.47 . . . . 0.0 109.472 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.863 ' HA ' HD11 ' A' ' 23' ' ' LEU . 9.6 pttt -70.59 -28.38 64.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.398 -0.814 . . . . 0.0 110.377 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.515 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 16.8 t -69.52 -59.86 2.7 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.86 -1.15 . . . . 0.0 109.051 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -52.88 -40.9 63.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.621 -0.674 . . . . 0.0 109.811 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CB ' HD12 ' A' ' 23' ' ' LEU . 35.7 t80 -64.17 -50.1 69.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.658 1.218 . . . . 0.0 109.225 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -59.37 -26.05 64.76 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.009 -178.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -69.13 -35.51 76.47 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.202 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.15 -23.51 59.27 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.208 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' GLY . 55.1 t -80.36 -35.58 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.651 -0.656 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.055 HG21 ' O ' ' A' ' 11' ' ' TYR . 5.5 p -88.56 -13.24 9.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.74 -33.83 14.86 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.005 -1.06 . . . . 0.0 108.148 178.54 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.96 7.44 24.33 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.567 -0.708 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.0 t-20 77.02 6.56 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.117 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 88.84 10.46 66.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -90.88 7.8 38.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.119 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 ' CE1' ' A' ' 37' ' ' PHE . 3.3 tp -79.42 -73.16 0.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.308 -0.87 . . . . 0.0 109.136 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.0 p 64.71 142.66 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.68 172.66 6.68 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 122.125 0.964 . . . . 0.0 111.522 -177.876 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.571 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -97.59 -46.63 5.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.028 0.918 . . . . 0.0 108.591 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.613 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 3.8 p80 -154.82 157.32 37.73 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.646 0.736 . . . . 0.0 110.507 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -77.84 175.49 9.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.53 -171.82 52.89 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -90.39 158.75 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.293 . . . . 0.0 109.619 179.294 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 57.5 m . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.956 -178.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.6 t . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.26 116.58 23.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.9 m -119.46 60.1 0.84 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.356 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -90.97 -17.23 26.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.44 31.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.099 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.77 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.3 m-85 -117.81 162.2 30.35 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.4 Cg_endo -85.91 163.85 56.08 Favored 'Cis proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.213 -1.578 . . . . 0.0 110.581 1.947 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -122.91 140.61 33.7 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.658 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.66 13.36 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.462 2.108 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.36 116.4 4.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' THR . 76.8 m -92.77 138.18 31.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.839 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.7 p -52.51 -175.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 18' ' ' LEU . 1.1 pt? -114.21 -26.88 7.84 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.041 -1.037 . . . . 0.0 109.636 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.519 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.0 pm0 -48.68 162.97 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.588 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.5 t80 -113.95 131.49 56.29 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.209 1.004 . . . . 0.0 110.935 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.0 mtp180 -161.21 84.84 1.79 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.445 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -67.94 113.27 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.088 1.859 . . . . 0.0 111.586 -177.878 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -107.84 126.53 52.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.513 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 49.0 t -79.29 164.42 24.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.016 . . . . 0.0 108.761 -179.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.544 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -136.25 168.03 24.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -178.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 48' ' ' LEU . 30.5 t -66.21 -23.27 66.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -1.02 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -61.08 -13.75 19.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 109.121 179.282 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.7 m-20 86.77 22.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.862 -0.524 . . . . 0.0 110.089 179.625 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -126.53 171.88 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.512 179.406 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 31' ' ' TYR . 28.7 m -104.94 163.69 12.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.966 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 65.1 m-85 -126.12 118.86 26.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.357 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.27 -52.58 0.41 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.655 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.2 p-10 -154.31 -167.96 2.79 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.78 -1.423 . . . . 0.0 109.909 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.56 -36.1 71.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.621 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 34.7 t -60.9 -61.57 2.49 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 109.72 -179.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -56.05 -41.99 75.88 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 23' ' ' LEU . 74.3 t80 -61.92 -43.85 97.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.768 -1.207 . . . . 0.0 109.607 -179.514 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 88.4 m -69.49 -24.19 63.74 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.139 -179.697 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 3.6 m120 -74.93 -26.14 59.41 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.178 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.966 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.19 -33.53 50.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.655 ' CG2' HD23 ' A' ' 48' ' ' LEU . 42.2 t -69.02 -48.45 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -64.16 -31.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.572 -0.705 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.79 -8.33 43.97 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 109.521 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 46.6 t -111.52 14.03 21.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.104 -0.997 . . . . 0.0 110.958 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER 53.15 48.57 21.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.842 -1.162 . . . . 0.0 109.399 179.94 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 45.52 35.06 5.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' ASN . 30.2 p -110.86 5.5 20.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -1.072 . . . . 0.0 108.391 178.229 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.665 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.7 -51.76 6.99 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.993 0.901 . . . . 0.0 109.143 -179.931 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.665 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 77.5 p 56.24 124.39 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.281 1.038 . . . . 0.0 110.48 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 5.8 tp -62.05 129.6 41.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.101 179.798 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.564 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 10.9 t -79.47 -21.91 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.865 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.564 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.3 p80 156.23 154.63 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.787 179.416 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -63.48 165.48 7.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.089 . . . . 0.0 108.663 179.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.08 -168.76 45.28 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -178.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.01 161.68 14.35 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.891 -1.359 . . . . 0.0 108.074 178.052 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 7.8 m . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.767 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.1 t . . . . . 0 N--CA 1.489 1.51 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -88.15 145.89 25.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.207 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 35.9 m -134.41 70.69 1.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.275 -0.891 . . . . 0.0 110.009 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -19.46 23.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.867 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 32.77 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.854 ' CB ' HG11 ' A' ' 42' ' ' VAL . 60.6 m-85 -113.34 164.82 14.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.856 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.6 Cg_endo -84.91 152.31 58.0 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.433 -1.486 . . . . 0.0 111.274 2.073 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.5 mtpm? -112.34 138.25 21.83 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.7 Cg_endo -80.39 14.78 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.728 2.285 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.19 160.51 21.36 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.112 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -147.5 159.84 43.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 110.002 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.57 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -117.18 -23.29 7.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.775 -1.203 . . . . 0.0 110.02 179.965 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -45.5 115.94 1.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.519 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.8 t80 -79.19 127.24 31.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.466 1.127 . . . . 0.0 111.354 -177.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 ptm180 -161.65 78.05 2.18 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.15 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.0 Cg_endo -66.16 128.14 18.94 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 123.208 2.605 . . . . 0.0 113.069 -177.135 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.607 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -112.34 130.34 55.99 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.606 178.402 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.73 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.1 t -83.56 122.75 28.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -68.53 -165.95 3.84 Favored Glycine 0 C--N 1.296 -1.665 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 49' ' ' THR . 7.1 t -89.2 -36.99 15.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.238 . . . . 0.0 107.972 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.624 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.4 p-10 -58.61 -17.37 21.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.532 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 97.17 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.128 0.49 . . . . 0.0 110.01 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.75 119.85 38.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.217 179.592 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.2 m -69.9 152.85 44.03 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.412 -0.805 . . . . 0.0 109.171 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 19.4 m-85 -132.7 124.43 28.17 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.793 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.78 -51.96 0.07 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -163.63 -162.32 0.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -1.232 . . . . 0.0 110.289 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.51 -40.76 60.22 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 112.6 -177.408 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -69.12 -65.15 0.74 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.209 -1.557 . . . . 0.0 108.911 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.7 m-80 -42.93 -30.5 0.41 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 27.5 t80 -74.85 -48.25 26.01 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.897 1.332 . . . . 0.0 109.406 179.545 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 87.4 m -55.92 -53.67 53.97 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.735 -178.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -42.23 -26.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.951 -1.093 . . . . 0.0 108.931 -179.475 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.97 -47.75 17.83 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.683 ' CG2' HD23 ' A' ' 48' ' ' LEU . 61.6 t -60.5 -28.12 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.715 -0.616 . . . . 0.0 110.422 179.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.2 m -90.93 -26.28 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.88 -1.137 . . . . 0.0 109.897 -179.033 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.3 tt0 -90.47 0.77 57.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.406 -0.808 . . . . 0.0 108.868 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.496 ' O ' ' OG ' ' A' ' 44' ' ' SER . 1.4 t -119.18 22.47 11.82 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 1.0 ' O ' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 64.11 46.47 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.905 1.336 . . . . 0.0 108.082 179.951 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 32.31 37.33 0.04 OUTLIER Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.513 -0.742 . . . . 0.0 111.874 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 1.0 HG23 ' O ' ' A' ' 45' ' ' ASN . 43.2 p -111.01 0.45 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.265 . . . . 0.0 108.231 177.868 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.683 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.36 152.92 30.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.759 0.79 . . . . 0.0 109.016 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' CB ' ' A' ' 26' ' ' SER . 41.2 p -141.45 149.89 41.56 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.22 175.96 6.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.713 -1.242 . . . . 0.0 109.214 -179.544 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.5 -23.04 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.756 -1.215 . . . . 0.0 108.607 -179.439 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.73 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 177.14 155.03 0.27 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 -178.816 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -62.04 -168.0 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.561 -0.712 . . . . 0.0 109.133 178.87 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.6 -167.45 6.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.49 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -90.8 175.68 6.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -1.073 . . . . 0.0 108.471 178.571 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.568 -179.807 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.611 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 78.1 m -137.3 47.98 2.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.309 179.81 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.443 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 64.6 p -86.96 -30.21 21.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.443 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 12.0 mm-40 -73.19 -8.92 57.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.744 ' HB3' HG11 ' A' ' 42' ' ' VAL . 80.3 m-85 -79.97 161.44 65.87 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.416 -0.802 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.845 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -84.51 143.36 40.08 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 123.156 -1.602 . . . . 0.0 110.846 1.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.0 mtpt -116.09 137.85 23.72 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.484 -0.76 . . . . 0.0 109.369 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -80.49 14.08 2.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.349 2.033 . . . . 0.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.14 126.74 15.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 60.2 m -112.78 138.75 49.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.78 -179.548 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -56.9 -170.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.734 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.14 -25.48 9.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.099 -1.001 . . . . 0.0 109.603 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.8 mt-10 -41.47 122.51 1.93 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.349 -0.844 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.482 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 15.6 t80 -83.14 107.37 15.66 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.432 1.11 . . . . 0.0 110.357 -179.007 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -141.27 77.7 19.75 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.197 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.7 Cg_endo -64.25 115.24 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.228 1.952 . . . . 0.0 111.688 -177.933 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.76 135.7 53.89 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.539 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.716 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 47.4 t -89.99 160.47 16.36 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.536 -179.67 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -133.2 161.21 24.14 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.515 -177.659 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t -45.36 -21.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.817 -0.813 . . . . 0.0 111.177 -178.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' CD1' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -86.14 25.23 1.19 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.094 -179.654 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 m120 49.48 20.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.433 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.63 141.23 36.79 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.008 -1.058 . . . . 0.0 109.999 -179.84 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 31' ' ' TYR . 82.2 m -86.87 157.54 19.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.427 -0.796 . . . . 0.0 108.932 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.621 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 82.1 m-85 -135.74 99.49 4.2 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.31 -59.28 0.02 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -178.166 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p-10 -137.77 -170.27 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.739 -1.448 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -54.22 -35.37 62.34 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.9 -0.5 . . . . 0.0 110.743 -178.639 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.7 t -64.57 -67.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.902 -1.124 . . . . 0.0 109.569 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.6 m-80 -44.84 -30.27 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.82 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 24.1 t80 -71.79 -54.31 10.58 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.535 1.16 . . . . 0.0 109.78 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 72.7 m -54.59 -58.9 5.69 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.109 -179.684 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.1 m-20 -42.68 -27.78 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.878 -1.139 . . . . 0.0 109.394 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -73.57 -48.1 35.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.862 HG22 ' CD2' ' A' ' 48' ' ' LEU . 66.9 t -60.69 -54.11 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.378 0.609 . . . . 0.0 109.57 179.347 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 12' ' ' PRO . 10.2 m -56.3 -31.31 32.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.237 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -92.2 -12.31 33.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.915 -1.116 . . . . 0.0 109.638 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.598 ' O ' HG22 ' A' ' 47' ' ' THR . 17.6 t -98.06 8.19 45.15 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.101 -0.999 . . . . 0.0 110.309 -179.089 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t-20 75.33 12.12 3.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.984 -1.073 . . . . 0.0 108.484 -179.24 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.619 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 67.29 8.39 50.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 44' ' ' SER . 6.3 t -86.45 5.51 34.82 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.203 -1.175 . . . . 0.0 108.469 178.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.862 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.94 -71.81 0.56 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.993 0.901 . . . . 0.0 108.888 -179.666 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.6 p 81.69 152.11 0.1 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.965 0.888 . . . . 0.0 109.081 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.606 HD11 ' O ' ' A' ' 52' ' ' HIS . 11.5 tp -67.69 156.76 36.17 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.3 p -106.28 -40.85 5.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.716 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 168.5 1.71 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.132 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -81.61 166.21 20.4 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.262 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 82.84 -175.11 53.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.96 156.49 19.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.949 -1.324 . . . . 0.0 109.132 179.081 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -92.35 128.87 38.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.136 179.712 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.1 m -123.05 63.56 0.99 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 109.831 -179.674 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.2 t -90.68 -19.5 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.325 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.9 mm-40 -97.46 26.3 5.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.092 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.844 ' CB ' HG11 ' A' ' 42' ' ' VAL . 68.9 m-85 -114.71 161.99 26.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.548 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.7 Cg_endo -85.84 156.03 56.88 Favored 'Cis proline' 0 C--N 1.305 -1.752 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.698 1.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 20.3 mtpt -118.31 140.15 27.74 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.869 . . . . 0.0 109.192 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.86 14.33 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.658 2.239 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.99 119.88 5.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.741 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -101.07 139.37 36.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.275 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.454 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -63.61 -172.07 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.422 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.926 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.36 -14.31 11.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.887 -1.133 . . . . 0.0 110.379 -179.461 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.0 pm0 -49.35 120.96 4.47 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.379 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -79.57 126.62 31.12 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.45 1.119 . . . . 0.0 110.902 -178.273 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.81 80.05 1.99 Allowed Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.408 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.72 119.54 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.286 1.991 . . . . 0.0 112.135 -177.366 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -110.79 123.13 49.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.151 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.1 t -79.26 127.65 32.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 0.0 109.101 -179.193 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -74.3 -173.31 29.28 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 5.2 t -76.14 -33.47 59.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.695 -1.474 . . . . 0.0 108.902 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.593 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -62.08 -12.18 17.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 109.653 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 59.3 t30 92.23 20.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.956 -0.465 . . . . 0.0 111.041 179.229 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.516 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.68 175.03 5.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.799 -1.188 . . . . 0.0 108.017 178.235 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -119.89 148.16 43.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 109.887 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 46.2 m-85 -120.67 120.72 36.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -30.27 -51.24 0.19 Allowed Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -177.768 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -153.04 -166.4 2.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.738 -1.448 . . . . 0.0 110.252 179.737 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.629 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -66.7 -22.54 66.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.569 -0.707 . . . . 0.0 111.323 -178.32 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 49.2 t -74.1 -50.55 19.0 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.612 -1.305 . . . . 0.0 108.859 179.578 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -62.9 -38.47 91.09 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 48' ' ' LEU . 48.4 t80 -68.87 -47.8 65.02 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.37 1.081 . . . . 0.0 109.635 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 29.2 m -62.23 -29.34 70.32 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.908 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.554 ' HA ' HG22 ' A' ' 42' ' ' VAL . 19.9 m-20 -71.67 -23.61 61.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.077 -1.015 . . . . 0.0 108.638 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.78 -22.82 27.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.472 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.2 -26.68 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.272 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.8 m -86.49 -31.0 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.443 -0.786 . . . . 0.0 109.294 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.92 -15.4 28.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' THR . 27.9 t -96.97 9.63 41.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.957 . . . . 0.0 110.299 -179.385 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.3 m120 62.59 28.31 16.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.155 -0.965 . . . . 0.0 109.355 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.85 63.83 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 44' ' ' SER . 5.3 p -96.28 5.76 50.26 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -1.098 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.743 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -83.82 -63.82 1.28 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.437 -0.789 . . . . 0.0 109.042 -179.712 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 65.5 p 56.27 124.72 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.96 0.886 . . . . 0.0 110.446 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -85.83 172.08 11.04 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.524 0.678 . . . . 0.0 110.733 -178.709 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.647 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.04 -28.72 9.38 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -174.44 162.7 3.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.766 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 m-85 -71.45 -170.77 0.54 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.51 -174.01 8.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.701 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -85.6 164.82 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -1.103 . . . . 0.0 108.868 179.396 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 3.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.393 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 7' ' ' ASP . 51.8 t . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.218 0.533 . . . . 0.0 109.6 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -76.72 172.89 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.185 179.952 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.4 t -161.15 26.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -90.56 -0.21 57.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.93 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -119.58 38.55 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 110.267 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.3 m-85 -139.83 154.17 70.56 Favored Pre-proline 0 C--N 1.305 -1.334 0 O-C-N 121.057 -1.027 . . . . 0.0 108.369 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -72.13 149.07 92.47 Favored 'Cis proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.597 -1.835 . . . . 0.0 111.622 2.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -110.6 148.03 37.65 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.981 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.5 Cg_endo -77.44 13.32 1.63 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.509 2.139 . . . . 0.0 110.968 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 115.26 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.2 m -88.69 149.66 23.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 109.749 -179.612 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -47.92 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.393 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.95 -23.21 9.2 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.869 -1.145 . . . . 0.0 110.228 -179.521 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pm0 -59.18 -168.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.885 -1.134 . . . . 0.0 108.134 179.358 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 20.0 t80 -127.55 129.1 46.75 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.32 81.61 2.0 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.262 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -66.4 111.33 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.177 1.918 . . . . 0.0 111.27 -178.268 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -105.95 136.78 45.0 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.266 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.711 ' O ' HD12 ' A' ' 50' ' ' LEU . 12.1 t -98.22 159.04 15.2 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.251 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.564 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -116.53 174.06 15.04 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.441 -177.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.525 ' H ' HD12 ' A' ' 48' ' ' LEU . 15.1 t -70.33 -13.47 62.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.45 -1.029 . . . . 0.0 108.547 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.7 p-10 -81.92 -8.99 59.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.41 -0.806 . . . . 0.0 109.318 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.6 t-20 82.74 34.78 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.649 -0.657 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 tttp -123.2 147.3 47.02 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.15 -0.969 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 31' ' ' TYR . 78.0 m -93.35 162.18 14.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.071 -1.018 . . . . 0.0 109.898 -179.87 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.6 m-85 -138.18 108.22 6.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.69 -57.44 0.12 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -177.252 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.1 p30 -141.66 -169.88 2.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.817 -1.402 . . . . 0.0 110.535 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.0 ptmt -54.7 -47.06 74.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.794 -0.566 . . . . 0.0 110.708 -178.514 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.7 t -53.79 -52.69 59.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.802 -1.187 . . . . 0.0 109.541 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.1 m-80 -61.64 -29.39 70.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.549 -0.72 . . . . 0.0 110.547 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.931 ' CE1' HD21 ' A' ' 48' ' ' LEU . 11.5 t80 -73.86 -62.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.76 -1.212 . . . . 0.0 110.813 -179.167 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.2 -48.75 73.39 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.81 -0.556 . . . . 0.0 109.523 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.6 m-80 -41.88 -31.13 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.179 . . . . 0.0 108.321 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -72.99 -49.08 31.08 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.569 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.575 ' N ' HD23 ' A' ' 48' ' ' LEU . 71.4 t -55.78 -59.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.401 0.62 . . . . 0.0 110.373 179.207 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.3 p -60.62 -23.97 30.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.204 -0.935 . . . . 0.0 110.599 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.8 tm-20 -89.35 -15.39 33.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.611 -1.306 . . . . 0.0 107.994 178.276 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -105.6 0.27 26.34 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 44' ' ' SER . 2.4 p30 60.64 22.85 12.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 0.0 109.447 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.45 16.11 57.55 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 44' ' ' SER . 74.1 p -85.52 -12.04 52.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.26 . . . . 0.0 108.268 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -78.41 -52.13 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.713 0.768 . . . . 0.0 109.177 -179.967 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.666 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 20.9 p 55.17 123.73 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.312 1.053 . . . . 0.0 109.839 -178.045 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 24' ' ' CYS . 24.8 tp -56.45 160.22 3.26 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.537 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -115.91 -41.57 3.18 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.54 1.162 . . . . 0.0 107.928 179.545 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.703 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.04 159.64 1.34 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.726 -179.568 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.84 133.8 36.99 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.408 178.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 112.91 -172.13 14.33 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.43 134.36 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.042 -1.269 . . . . 0.0 109.295 179.211 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.582 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.612 HG21 HD22 ' A' ' 23' ' ' LEU . 99.1 t . . . . . 0 N--CA 1.488 1.443 0 CA-C-O 121.202 0.525 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.42 148.23 49.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.46 30.38 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -13.85 43.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.651 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.49 -2.19 25.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' HG11 ' A' ' 42' ' ' VAL . 54.5 m-85 -93.56 163.37 24.71 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.925 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.27 157.7 74.04 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.247 -1.564 . . . . 0.0 110.989 2.114 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -107.61 142.54 25.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.627 -179.735 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.7 Cg_endo -79.75 15.27 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.753 2.302 . . . . 0.0 110.861 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.35 137.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.478 -0.763 . . . . 0.0 109.025 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 17' ' ' THR . 49.0 t -109.86 157.57 19.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.065 -1.022 . . . . 0.0 110.842 -179.258 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -64.19 -157.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.058 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -116.69 -8.26 11.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.269 -1.519 . . . . 0.0 110.856 -179.708 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.62 136.32 17.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.585 -1.322 . . . . 0.0 107.811 179.276 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.0 t80 -98.29 130.2 44.98 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 122.282 1.039 . . . . 0.0 110.618 -178.602 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.86 77.58 2.46 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.536 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -62.59 121.35 9.27 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.741 2.294 . . . . 0.0 112.55 -177.084 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD22 HG21 ' A' ' 6' ' ' VAL . 1.2 mp -110.03 133.88 52.73 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.563 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -80.31 111.07 16.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.59 -169.04 3.28 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.665 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -80.85 -32.38 35.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.839 -1.389 . . . . 0.0 108.812 178.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -65.23 -8.15 16.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.836 . . . . 0.0 109.616 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 46.1 t30 86.05 16.37 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.695 -0.628 . . . . 0.0 110.489 179.033 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HG2' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -109.41 119.98 41.1 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.5 178.856 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 31' ' ' TYR . 27.0 m -58.64 161.93 4.3 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.494 0.664 . . . . 0.0 109.771 -179.354 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -130.54 133.36 46.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.772 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.611 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.3 -50.3 0.25 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -177.313 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.6 p30 -165.31 -164.02 0.72 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.921 -1.34 . . . . 0.0 110.75 178.896 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 pttt -52.82 -40.31 63.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.688 -0.633 . . . . 0.0 111.676 -177.674 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -72.69 -50.86 22.1 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.628 -1.295 . . . . 0.0 110.173 -178.427 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.1 m-80 -61.65 -18.58 60.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.713 -1.242 . . . . 0.0 108.931 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 9.4 t80 -80.74 -60.85 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.303 1.049 . . . . 0.0 109.636 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 46.8 t -57.78 -49.65 75.89 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.321 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' C ' ' O ' ' A' ' 38' ' ' CYS . 8.0 m-20 -42.17 -28.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.721 -1.237 . . . . 0.0 108.343 179.357 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.32 -49.65 22.05 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.639 HG22 HD23 ' A' ' 48' ' ' LEU . 97.2 t -55.53 -56.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 178.796 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.925 HG21 ' HB3' ' A' ' 12' ' ' PRO . 19.4 m -58.21 -29.67 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -0.974 . . . . 0.0 110.27 -179.544 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.0 tt0 -90.78 -10.46 42.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.01 -1.056 . . . . 0.0 109.426 -179.616 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -105.86 16.14 25.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -179.559 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 44' ' ' SER . 10.5 m120 63.16 16.21 9.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.016 -1.053 . . . . 0.0 109.644 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.44 21.94 79.19 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -96.2 6.55 48.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 107.99 178.155 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 41' ' ' VAL . 5.3 tp -87.78 -76.19 0.39 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.547 0.689 . . . . 0.0 109.841 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.1 p 66.22 152.86 0.07 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -178.586 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.87 173.14 6.45 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.635 -0.666 . . . . 0.0 110.198 -178.056 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.682 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.93 -33.53 7.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.659 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -167.27 163.32 15.32 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.533 0.682 . . . . 0.0 109.667 -178.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -76.03 -177.72 4.05 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.524 -0.735 . . . . 0.0 109.359 179.15 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.38 -170.48 52.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.11 125.86 36.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -1.082 . . . . 0.0 109.609 179.326 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.645 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.454 179.775 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 HD22 ' A' ' 23' ' ' LEU . 17.2 t . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.15 98.28 7.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.957 -179.747 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 34.6 m -93.08 65.55 4.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 108.939 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -88.98 -10.11 48.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.122 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mp0 -116.04 36.98 3.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.688 ' HB3' HG11 ' A' ' 42' ' ' VAL . 87.1 m-85 -117.87 160.95 36.69 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.644 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.965 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -83.63 159.66 72.3 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.964 -1.682 . . . . 0.0 110.819 2.364 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLU . 17.0 mtpp -131.35 137.84 31.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.391 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -80.66 14.04 2.13 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.492 2.128 . . . . 0.0 110.687 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.1 115.32 10.35 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.72 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.9 m -98.84 139.57 34.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 -179.353 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.509 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 36.0 p -47.13 169.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.16 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.862 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -110.12 -1.79 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.775 -1.203 . . . . 0.0 110.365 -179.869 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' OE2' ' CB ' ' A' ' 17' ' ' THR . 3.3 pm0 -76.26 -170.83 1.56 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.584 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.8 t80 -133.57 125.5 28.95 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.889 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 53.8 mtt180 -161.16 80.75 2.1 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.241 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.75 122.65 10.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.5 2.134 . . . . 0.0 112.045 -177.188 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.843 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -108.67 135.58 49.67 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.286 -0.966 . . . . 0.0 108.583 179.17 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.961 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 t -85.21 162.29 19.24 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 -179.298 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.98 161.49 15.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -69.23 -19.16 63.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -1.149 . . . . 0.0 109.109 -179.721 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 29.9 p-10 -78.12 -0.16 27.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.073 179.19 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER 79.62 42.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.508 -0.745 . . . . 0.0 109.752 179.857 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -134.18 139.41 45.82 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.944 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 31' ' ' TYR . 5.5 m -92.23 165.86 12.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.009 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.732 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.9 m-85 -137.83 123.61 19.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.57 -53.69 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.804 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -157.35 -168.23 2.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.973 -1.31 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -53.15 -37.9 62.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 111.358 -178.29 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 31.7 t -63.0 -61.15 2.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.635 -1.29 . . . . 0.0 109.964 -179.581 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.2 m-80 -55.75 -31.29 62.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.456 -0.777 . . . . 0.0 110.837 -179.017 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 69.6 t80 -73.58 -44.23 57.79 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.818 -1.177 . . . . 0.0 109.682 -179.526 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 63.3 m -66.23 -30.1 70.49 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.43 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.588 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 m-20 -68.42 -24.85 64.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.753 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.44 -26.35 32.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.531 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' GLY . 92.1 t -80.08 -26.48 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.965 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.4 m -90.68 -21.02 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.353 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.753 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.54 -31.59 16.66 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.277 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 96.6 p -88.63 23.16 2.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.541 -0.725 . . . . 0.0 109.744 -179.66 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.2 m120 64.97 11.59 7.18 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.377 -0.827 . . . . 0.0 109.319 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 78.1 22.63 67.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.9 p -93.1 -5.34 50.54 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.322 -1.104 . . . . 0.0 109.093 179.418 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -78.96 157.57 28.14 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.567 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.822 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.9 p -149.0 126.22 11.44 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.281 1.039 . . . . 0.0 110.496 179.714 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 2.2 tp -67.05 150.24 49.49 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.802 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.512 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.15 -22.58 12.32 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.116 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -175.92 163.29 2.72 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.497 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -78.51 178.58 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 178.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 75.73 -172.19 54.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.41 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.44 131.42 36.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.081 -1.246 . . . . 0.0 109.429 179.127 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.562 179.915 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.582 ' CG2' HD22 ' A' ' 50' ' ' LEU . 90.0 t . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -99.27 153.68 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 109.199 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 t -151.87 17.63 0.68 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.08 -1.012 . . . . 0.0 109.945 -179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -90.8 13.02 17.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.149 -0.969 . . . . 0.0 109.748 179.616 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 1.5 pm0 -130.74 -18.39 3.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.008 -1.057 . . . . 0.0 110.972 -179.237 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 96.4 m-85 -79.76 161.59 65.88 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.933 -1.104 . . . . 0.0 109.175 -179.304 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.574 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.7 Cg_endo -69.43 167.43 70.12 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.249 -1.563 . . . . 0.0 112.191 2.698 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -119.66 147.94 44.92 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.68 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.692 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -77.99 13.73 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.592 2.195 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.09 128.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.19 159.09 16.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 p -62.8 164.34 8.07 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.241 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 -18.22 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.757 -1.215 . . . . 0.0 109.832 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -51.0 130.76 26.25 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.197 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 7.4 t80 -81.38 126.94 32.22 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.475 1.131 . . . . 0.0 111.446 -177.124 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mmt180 -159.58 75.63 3.1 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.614 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.4 Cg_endo -67.13 144.51 69.5 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.244 2.629 . . . . 0.0 113.288 -176.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -129.59 132.68 46.85 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.407 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.672 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.3 t -91.41 161.78 14.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.056 . . . . 0.0 110.319 -178.458 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.45 177.11 18.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.062 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -70.37 -23.57 62.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.985 . . . . 0.0 108.682 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 41.4 p-10 -77.3 -6.99 55.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.082 179.36 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m120 82.27 28.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.677 -0.639 . . . . 0.0 109.911 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -103.07 136.4 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.843 HG21 ' HD3' ' A' ' 55' ' ' LYS . 23.5 m -88.79 137.91 31.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.713 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.9 m-85 -114.87 136.85 52.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.694 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.08 -48.25 3.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -178.606 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.3 p30 -167.4 -158.8 0.29 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.032 -1.275 . . . . 0.0 110.656 178.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.5 -45.06 73.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 112.574 -176.566 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 3.6 m -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.491 -1.381 . . . . 0.0 109.704 -178.658 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -53.5 -17.31 1.93 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.682 ' CE1' HD21 ' A' ' 48' ' ' LEU . 4.0 t80 -83.23 -69.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.586 1.184 . . . . 0.0 110.302 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.68 -46.11 77.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.754 -177.792 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.589 ' OD1' ' CD1' ' A' ' 11' ' ' TYR . 3.0 m-20 -44.96 -29.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.46 -1.4 . . . . 0.0 107.592 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.96 -49.26 38.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.259 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.829 ' CG2' HD23 ' A' ' 48' ' ' LEU . 75.4 t -52.49 -62.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.282 0.563 . . . . 0.0 110.198 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.5 p -60.75 -23.63 29.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.434 -0.791 . . . . 0.0 111.097 -178.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.9 tt0 -92.03 -11.56 35.6 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.532 -1.355 . . . . 0.0 108.965 179.183 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 44' ' ' SER . 6.1 t -103.79 22.05 15.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.702 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 47' ' ' THR . 7.6 m-80 60.35 43.96 12.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.055 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.26 28.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 45' ' ' ASN . 79.9 p -84.48 -16.18 43.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -1.206 . . . . 0.0 107.89 178.189 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.6 OUTLIER -79.51 164.53 23.83 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.576 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.69 ' H ' HD12 ' A' ' 48' ' ' LEU . 64.5 p -149.85 130.94 14.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.656 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 10.3 tp -64.98 146.13 55.42 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.65 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.63 -18.17 11.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.896 -1.127 . . . . 0.0 108.108 179.11 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 172.75 160.75 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -71.01 -166.83 0.17 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.253 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.61 -170.51 2.72 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.4 OUTLIER -90.15 158.11 17.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.542 -0.975 . . . . 0.0 108.413 179.99 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.66 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 18.2 m . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.289 179.843 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 . . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -77.69 -166.43 0.77 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.786 -179.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 m -156.13 43.45 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.983 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -19.15 35.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 110.001 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -114.63 47.37 1.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 108.97 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 58.9 m-85 -142.72 163.95 35.49 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 -178.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -88.75 159.68 40.36 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.743 0.94 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.66 131.95 24.08 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 109.016 179.933 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.08 14.52 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 111.129 -179.699 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.82 142.11 22.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.819 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 17' ' ' THR . 33.0 t -144.78 162.88 35.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 109.565 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 16' ' ' CYS . 32.8 p -60.27 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 108.865 179.238 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pp -134.98 -13.18 2.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.031 -1.043 . . . . 0.0 110.958 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 15.6 pm0 -54.49 132.11 44.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.156 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.6 t80 -87.6 127.75 35.27 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.551 1.167 . . . . 0.0 111.911 -177.024 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmt85 -161.36 75.49 2.45 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.595 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.9 Cg_endo -66.21 133.94 34.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -120.28 124.82 46.54 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.247 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.679 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.5 t -79.12 165.89 22.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 108.328 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -138.7 159.03 25.29 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.398 -1.382 . . . . 0.0 112.497 -176.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 5.7 t -46.08 -21.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.924 -0.75 . . . . 0.0 110.908 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 29' ' ' LYS . 27.1 p-10 -86.15 26.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 40.0 t-20 47.43 24.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 110.074 179.314 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.0 tttp -110.91 142.61 42.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 15.5 m -92.93 140.03 29.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 108.965 179.533 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.675 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 70.3 m-85 -112.91 126.51 55.54 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.513 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.01 -52.66 1.56 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p30 -158.96 -164.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.09 -1.241 . . . . 0.0 110.513 179.549 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.08 -49.65 30.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.598 -0.689 . . . . 0.0 111.999 -177.911 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 10.6 m -61.79 -58.09 9.34 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.57 -1.331 . . . . 0.0 110.43 -178.835 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 31' ' ' TYR . 14.8 m-80 -58.68 -13.81 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.98 . . . . 0.0 110.062 -179.503 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 48' ' ' LEU . 5.8 t80 -83.68 -58.13 2.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.307 1.051 . . . . 0.0 109.992 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.679 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.7 t -61.13 -29.36 69.73 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.128 -178.476 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.77 ' O ' HG22 ' A' ' 42' ' ' VAL . 88.0 m-20 -58.71 -29.49 66.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.612 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.713 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.81 -30.99 51.51 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.941 HG22 HD23 ' A' ' 48' ' ' LEU . 52.1 t -75.86 -21.3 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.48 0.657 . . . . 0.0 109.435 179.535 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 39' ' ' ASN . 11.6 m -90.25 -22.12 6.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.83 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -89.81 -30.02 18.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' THR . 11.2 p -87.72 17.78 4.5 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.343 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' SER . 9.4 p30 50.63 41.26 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.679 -179.706 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.82 37.75 58.18 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 44' ' ' SER . 7.6 t -111.13 -1.7 16.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.086 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.17 -75.01 0.45 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.303 1.049 . . . . 0.0 109.162 -179.661 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.748 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.8 p 82.44 150.59 0.09 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.383 -177.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' A' ' 51' ' ' SER . 14.2 tp -63.59 160.65 16.25 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.766 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 5.9 p -115.7 -43.62 3.01 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.679 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.1 160.63 1.42 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.264 179.429 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -69.04 172.56 6.54 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.956 179.224 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.48 -167.48 52.04 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.593 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -92.85 -172.08 2.91 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.847 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.593 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.422 HG12 ' SG ' ' A' ' 8' ' ' CYS . 73.4 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.209 0.528 . . . . 0.0 109.688 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.05 124.81 41.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 108.808 179.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.3 m -135.06 46.91 2.38 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 -179.263 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.24 -0.66 57.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.415 179.6 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -117.88 36.05 4.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.943 ' O ' HG21 ' A' ' 42' ' ' VAL . 92.8 m-85 -121.5 157.08 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.255 -0.903 . . . . 0.0 108.638 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.15 167.98 78.81 Favored 'Cis proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.022 2.298 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -116.32 142.91 30.13 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.546 -0.721 . . . . 0.0 109.202 -179.656 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -78.72 12.47 2.18 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.424 2.083 . . . . 0.0 110.489 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.87 109.98 0.34 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 92.4 m -95.18 140.56 29.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.785 -179.244 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -52.94 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.662 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.2 pp -128.69 -24.07 3.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.922 -1.111 . . . . 0.0 110.255 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 13.8 pm0 -46.37 134.87 8.64 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.204 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -87.55 126.48 34.95 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.535 1.159 . . . . 0.0 111.387 -177.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mtt-85 -161.57 82.03 1.9 Allowed Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.728 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.4 Cg_endo -65.64 125.6 14.62 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.615 2.21 . . . . 0.0 112.932 -176.489 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -110.12 136.91 48.62 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.924 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.574 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -103.54 122.74 45.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.091 -1.005 . . . . 0.0 111.053 -178.652 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.637 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.57 -166.14 0.57 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.178 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -90.17 -25.99 20.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.442 -1.034 . . . . 0.0 108.728 179.31 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -79.29 -2.26 40.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.806 . . . . 0.0 109.086 179.384 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.8 m120 82.99 47.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 0.0 110.356 179.603 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 17.3 ptmt -121.87 116.28 24.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 31' ' ' TYR . 51.4 m -75.42 153.06 37.88 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.726 0.774 . . . . 0.0 110.405 -178.564 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.6 m-85 -131.45 148.04 52.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.155 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -58.87 -37.59 91.02 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.479 -1.344 . . . . 0.0 111.947 -175.811 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -162.92 -165.78 1.18 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 110.388 -179.704 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.62 -23.63 66.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.6 -0.688 . . . . 0.0 110.536 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.7 t -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.976 -1.078 . . . . 0.0 109.522 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -66.37 -28.22 68.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.572 179.712 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 60.5 t80 -81.76 -45.05 16.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.333 1.063 . . . . 0.0 109.761 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.645 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.4 m -65.93 -26.78 67.75 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.758 -178.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.2 m-80 -70.19 -34.68 73.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.146 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.54 -20.33 58.75 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.576 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 55.0 t -84.67 -34.16 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 110.04 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.943 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -90.88 -16.29 8.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 0.0 109.996 -179.053 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.4 tm-20 -91.72 -19.8 22.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.991 -1.068 . . . . 0.0 108.422 179.053 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' THR . 5.8 p -100.25 23.41 10.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.496 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 66.04 11.72 7.96 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.223 -0.923 . . . . 0.0 109.172 -179.494 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 78.11 19.7 74.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.746 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 44' ' ' SER . 21.9 p -84.55 -12.45 54.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.15 -1.206 . . . . 0.0 108.986 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.637 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.1 tp -80.74 136.4 36.15 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.442 -0.786 . . . . 0.0 109.07 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 26' ' ' SER . 5.3 p -135.26 123.5 23.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.069 0.938 . . . . 0.0 110.244 179.385 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.563 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -72.93 153.03 41.15 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.674 0.749 . . . . 0.0 109.398 179.573 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.506 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -105.49 -23.8 12.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.235 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.574 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -165.58 159.36 16.52 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.896 -178.549 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -76.55 176.32 8.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.66 -167.37 54.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 7.4 mtmt -91.49 168.39 11.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.399 -1.059 . . . . 0.0 108.987 179.086 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.563 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.63 -179.45 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 34' ' ' LYS . 6.4 p . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.14 151.62 15.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.548 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 23.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.58 3.66 54.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 110.544 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -131.4 -8.24 3.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.818 -1.177 . . . . 0.0 110.946 -178.977 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.653 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.5 m-85 -81.34 158.28 69.41 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.79 -1.194 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.596 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 38.2 Cg_endo -69.99 142.55 71.15 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.762 -1.766 . . . . 0.0 111.534 2.028 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -103.17 142.72 25.14 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.979 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -78.43 14.39 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.781 2.32 . . . . 0.0 111.251 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.94 125.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 179.853 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' THR . 45.3 m -102.91 139.16 38.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.95 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.85 -166.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.541 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.484 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -119.24 -28.97 5.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.921 -1.112 . . . . 0.0 109.825 179.969 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.56 119.4 1.64 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.106 -0.996 . . . . 0.0 108.999 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.8 t80 -80.07 124.12 28.45 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.631 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -156.97 82.46 3.21 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.765 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.8 Cg_endo -65.11 120.6 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.425 2.083 . . . . 0.0 111.944 -177.367 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.711 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -111.88 132.24 54.85 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.671 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.009 ' O ' HD12 ' A' ' 50' ' ' LEU . 7.3 t -88.85 161.21 16.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.498 -0.751 . . . . 0.0 109.459 -178.965 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -107.52 172.55 17.75 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.866 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.586 ' H ' HD12 ' A' ' 48' ' ' LEU . 20.6 t -74.41 -3.36 30.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -1.201 . . . . 0.0 108.84 179.554 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.9 p-10 -98.01 -2.17 40.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.177 179.457 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.5 t30 83.59 43.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 30' ' ' THR . 5.3 tttt -125.43 138.83 54.02 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 179.522 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 19.6 m -92.74 152.12 19.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.504 179.804 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -128.57 130.16 46.98 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.706 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.94 -51.29 1.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -177.803 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.5 p30 -160.01 -166.55 1.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.871 -1.37 . . . . 0.0 110.522 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -54.55 -40.32 68.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.657 -0.652 . . . . 0.0 110.907 -178.477 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.5 t -60.48 -69.66 0.21 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.787 -1.195 . . . . 0.0 109.703 -179.324 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.3 m-80 -51.91 -26.09 9.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.447 -0.783 . . . . 0.0 111.272 -179.211 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 48' ' ' LEU . 14.6 t80 -75.25 -62.02 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.638 -1.289 . . . . 0.0 110.828 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.753 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.4 t -53.32 -49.12 67.71 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.185 -177.413 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -49.16 -31.31 8.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.29 -1.506 . . . . 0.0 108.597 -178.812 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.64 -36.65 62.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.255 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' A' ' 48' ' ' LEU . 41.4 t -67.97 -32.36 55.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.392 0.615 . . . . 0.0 110.253 179.913 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -90.63 -14.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.069 -178.018 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 9.6 pt-20 -92.54 -29.53 16.14 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.892 -1.13 . . . . 0.0 108.216 178.053 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.0 p -87.68 20.1 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.864 -178.932 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 45.1 m-80 64.23 12.85 7.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 -179.439 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.74 19.61 72.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.258 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.0 p -91.67 0.41 57.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.927 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -80.47 -56.19 4.35 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.979 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 51.0 p 52.37 125.76 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.498 1.142 . . . . 0.0 111.972 179.329 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.009 HD12 ' O ' ' A' ' 24' ' ' CYS . 6.6 tp -61.97 156.56 20.76 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.123 178.835 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.45 -23.86 8.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.87 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.919 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -179.58 161.82 1.06 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.774 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -78.32 173.33 12.42 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 78.84 -171.57 55.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.46 137.05 32.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.151 -1.205 . . . . 0.0 108.799 178.824 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.63 -179.772 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 7' ' ' ASP . 93.5 t . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.239 0.542 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 6' ' ' VAL . 16.3 t70 -89.11 137.77 32.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.464 179.924 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 m -135.26 61.91 1.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 109.909 -179.544 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.47 -0.73 57.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.838 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -128.34 39.65 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.908 ' O ' HG21 ' A' ' 42' ' ' VAL . 52.1 m-85 -120.65 161.1 41.45 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 108.842 -179.847 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.2 Cg_endo -75.43 174.56 52.16 Favored 'Cis proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.62 -1.825 . . . . 0.0 111.299 1.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -118.74 142.77 32.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.766 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.43 14.48 1.6 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 169.94 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.462 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 50.6 t -105.35 159.59 15.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 109.937 -179.8 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -61.72 -162.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.804 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -118.84 -28.07 5.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.658 -1.276 . . . . 0.0 109.913 179.768 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -42.73 118.4 1.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.793 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.9 t80 -79.23 128.64 33.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.382 1.087 . . . . 0.0 111.041 -177.84 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.31 78.9 2.21 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.217 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.1 Cg_endo -64.71 126.5 16.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.361 2.707 . . . . 0.0 113.366 -177.139 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.4 mp -110.47 127.15 55.01 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.334 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.586 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -88.27 119.1 28.36 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.782 -178.627 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.7 -158.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.989 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -91.84 -52.4 4.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.558 -0.966 . . . . 0.0 108.914 179.356 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.618 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -47.52 -24.63 0.89 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.169 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.8 p-10 103.3 33.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.177 0.513 . . . . 0.0 110.216 179.147 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.7 131.39 50.91 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.521 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 94.5 m -80.17 142.5 34.66 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 110.314 -179.088 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.5 m-85 -120.34 131.23 54.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.368 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.513 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.42 -50.9 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.163 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.2 p30 -167.19 -167.37 0.91 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.008 -1.289 . . . . 0.0 111.136 178.901 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.766 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.56 -42.85 11.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.125 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.1 m -67.74 -66.44 0.56 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.291 -1.506 . . . . 0.0 108.998 -179.262 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.532 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 17.9 m-80 -44.66 -23.17 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.527 -0.733 . . . . 0.0 110.194 -179.918 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 30.9 t80 -84.55 -48.73 9.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.74 1.257 . . . . 0.0 109.763 179.733 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -62.27 -58.98 5.71 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.072 -178.425 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.01 -31.36 0.17 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.147 -0.971 . . . . 0.0 108.772 -179.351 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -70.8 -50.71 32.74 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.543 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.5 t -51.71 -60.15 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.432 0.634 . . . . 0.0 109.97 179.036 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -62.6 -21.18 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.411 -0.806 . . . . 0.0 111.665 -178.539 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.2 tt0 -91.98 -11.59 35.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.457 -1.402 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.68 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.4 t -106.4 20.58 18.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.283 -0.885 . . . . 0.0 109.911 -179.555 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 75.94 1.48 3.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 108.967 -179.148 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.48 17.42 71.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' OG ' ' A' ' 44' ' ' SER . 14.1 t -83.89 -13.05 54.52 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.279 -1.13 . . . . 0.0 108.65 179.053 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tp -81.28 147.12 30.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.394 -0.816 . . . . 0.0 108.958 179.772 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -145.46 158.32 43.86 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.242 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -104.46 165.64 10.92 Favored 'General case' 0 C--N 1.281 -2.412 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 -178.937 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.622 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -106.99 -31.55 8.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.531 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -162.99 160.49 24.72 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.723 0.773 . . . . 0.0 110.068 -178.615 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 4.8 m-85 -77.14 -171.64 2.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.699 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.2 -166.57 28.94 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.829 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.67 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 167.84 12.28 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.237 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.67 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.7 m . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.723 -179.413 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.26 0.552 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 043 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.415 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 16.4 t0 -67.06 141.02 57.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 22.2 m -146.76 58.82 1.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.106 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.66 0.46 57.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.613 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.64 32.88 5.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.836 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.896 ' CB ' HG11 ' A' ' 42' ' ' VAL . 83.6 m-85 -119.28 158.3 48.95 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.58 169.92 73.22 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.506 -1.872 . . . . 0.0 111.706 1.799 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -128.05 144.8 52.89 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.959 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -77.93 14.3 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.652 2.235 . . . . 0.0 111.839 -178.759 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.23 145.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.217 179.77 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' THR . 54.1 t -122.85 159.99 27.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 109.272 179.449 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.6 p -61.28 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.174 -0.954 . . . . 0.0 108.594 179.24 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.96 -18.47 4.2 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.7 pt-20 -52.14 127.7 22.53 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.756 -1.215 . . . . 0.0 107.746 179.503 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 26.2 t80 -92.91 119.8 32.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 122.422 1.106 . . . . 0.0 110.969 -178.124 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtp-105 -152.17 81.8 5.53 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -65.02 131.31 28.35 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.966 2.444 . . . . 0.0 112.346 -177.448 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.66 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -117.58 121.44 40.95 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.965 179.254 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 5.1 t -80.49 120.05 23.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 108.593 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.06 -160.66 0.82 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -90.26 -37.88 13.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 108.048 178.328 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -58.55 -17.69 23.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.568 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 96.35 21.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.003 0.43 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -99.33 127.08 45.3 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.005 -1.059 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 m -77.06 140.13 40.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.425 -0.797 . . . . 0.0 109.574 -179.925 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 26.7 m-85 -115.81 129.16 56.33 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.693 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.46 -52.64 0.31 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -178.307 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.3 p30 -164.75 -164.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.806 -1.408 . . . . 0.0 110.992 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.03 -41.55 25.97 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.071 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 4.3 m -70.17 -64.67 0.85 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.202 -1.561 . . . . 0.0 109.098 -179.318 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.0 m-80 -43.92 -27.28 0.34 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.888 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 39.0 t80 -82.35 -46.87 13.02 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.067 1.413 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -56.9 -37.02 70.83 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.041 -178.349 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.41 -42.08 99.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.735 -1.228 . . . . 0.0 108.336 179.882 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -62.27 -25.08 67.64 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 74.9 t -80.59 -44.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 -179.526 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.896 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -81.27 -7.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.114 -0.992 . . . . 0.0 110.297 -178.791 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.92 -33.95 14.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.965 -1.084 . . . . 0.0 108.447 178.958 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 47' ' ' THR . 6.5 p -88.85 24.21 2.12 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.708 -0.62 . . . . 0.0 110.029 -179.528 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 73.4 4.7 4.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.052 -1.03 . . . . 0.0 109.05 -179.488 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 83.51 15.61 70.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.72 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 44' ' ' SER . 10.0 t -88.52 -1.8 58.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -1.061 . . . . 0.0 108.866 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.1 tp -81.19 145.27 31.08 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.283 -0.885 . . . . 0.0 109.124 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 p -137.55 145.92 43.48 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.485 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -94.59 171.05 9.03 Favored 'General case' 0 C--N 1.275 -2.641 0 O-C-N 120.877 -1.139 . . . . 0.0 109.839 -179.412 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.8 -20.23 13.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.778 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 177.1 154.98 0.26 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.528 -0.733 . . . . 0.0 109.833 -178.884 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' HA ' HD23 ' A' ' 23' ' ' LEU . 5.4 m-85 -66.49 -165.78 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.206 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.21 -172.08 1.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.305 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.1 tttt -90.34 159.81 16.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.576 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.292 -1.891 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.605 -179.982 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t . . . . . 0 N--CA 1.492 1.646 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 044 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -86.61 132.93 33.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.279 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 10.1 m -133.4 52.33 2.08 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.318 -0.864 . . . . 0.0 109.76 -179.606 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.35 8.02 35.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.774 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -119.64 3.79 11.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.89 ' O ' HG21 ' A' ' 42' ' ' VAL . 96.2 m-85 -89.78 157.44 46.36 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.166 -0.959 . . . . 0.0 109.001 -179.731 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -74.96 143.01 76.45 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.617 -1.826 . . . . 0.0 111.366 2.495 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttp -84.16 143.93 43.24 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.632 -0.667 . . . . 0.0 109.274 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.73 13.54 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.539 2.159 . . . . 0.0 110.556 179.459 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.01 114.1 0.12 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.4 m -92.57 139.6 30.41 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 110.007 -179.332 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -50.27 178.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.545 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -123.37 -16.11 6.96 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.967 -1.083 . . . . 0.0 110.166 -179.663 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.1 pm0 -55.24 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.359 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.6 t80 -132.93 119.7 20.49 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.737 1.256 . . . . 0.0 110.835 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.9 mtp85 -160.25 74.63 2.92 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.154 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.9 Cg_endo -65.06 134.73 40.83 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.895 2.396 . . . . 0.0 113.4 -176.135 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -117.97 143.57 46.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.46 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -94.41 166.74 11.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 -178.861 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -127.44 161.98 21.48 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -65.69 -28.69 69.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.044 -1.268 . . . . 0.0 108.832 179.996 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -58.34 -15.51 10.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.737 . . . . 0.0 109.304 179.657 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.5 t30 90.28 33.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.04 0.448 . . . . 0.0 110.435 179.396 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -121.28 -176.37 3.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.932 -1.105 . . . . 0.0 109.177 178.683 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 31' ' ' TYR . 8.9 m -123.17 163.92 19.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.826 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 29.4 m-85 -138.35 141.64 39.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.612 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -61.95 -41.33 99.65 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.312 -176.803 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.0 p-10 -157.8 -164.37 1.52 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.893 -1.357 . . . . 0.0 109.978 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -61.73 -31.71 71.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 110.826 -178.705 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -72.9 -44.17 61.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.665 -1.272 . . . . 0.0 109.632 -179.479 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -63.08 -44.26 96.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.693 179.925 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.4 t80 -65.43 -57.15 9.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.144 0.973 . . . . 0.0 110.963 -179.365 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -53.62 -51.73 62.13 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 -178.282 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.3 m-20 -45.41 -36.4 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.002 -1.061 . . . . 0.0 109.41 -179.758 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.86 -42.03 77.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 108.675 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.636 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.1 t -60.57 -59.66 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.649 -0.657 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 11' ' ' TYR . 9.2 p -62.53 -21.51 27.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.226 -0.921 . . . . 0.0 111.013 -178.766 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.2 -15.29 27.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.71 -1.244 . . . . 0.0 108.818 179.065 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 47' ' ' THR . 22.7 t -102.43 10.57 38.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.475 -179.935 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 67.21 10.09 7.45 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 109.178 -179.002 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.66 18.55 54.51 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.051 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 44' ' ' SER . 3.9 p -79.56 -15.22 58.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.977 -1.308 . . . . 0.0 107.875 178.076 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.65 160.8 26.2 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.719 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.862 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.8 p -156.64 124.6 5.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.142 0.972 . . . . 0.0 109.9 178.902 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -62.44 144.12 56.28 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.385 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.97 -18.29 13.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.857 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 179.72 161.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.629 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 54.4 m-85 -75.89 179.36 5.57 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.217 -0.927 . . . . 0.0 108.93 179.128 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.32 -167.04 54.45 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.534 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.36 144.77 25.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -1.079 . . . . 0.0 109.217 179.573 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.522 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.627 179.953 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 25.8 t70 -75.21 155.07 37.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.322 179.875 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -151.62 50.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 109.845 -179.867 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.11 -13.26 31.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.983 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.19 57.33 1.81 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.143 -0.973 . . . . 0.0 110.626 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 98.3 m-85 -143.29 149.49 48.41 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 120.86 -1.15 . . . . 0.0 109.326 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.563 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -73.97 161.06 95.11 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.438 -1.901 . . . . 0.0 111.654 2.485 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -121.16 139.88 30.18 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.668 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.8 13.62 1.65 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.524 2.149 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 178.23 128.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 179.906 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 51.3 t -114.6 159.7 20.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.407 179.711 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.437 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -61.42 -166.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.512 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -112.61 -17.4 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.866 -1.147 . . . . 0.0 109.643 179.666 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 5.3 pm0 -46.18 137.49 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.132 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.626 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 7.7 t80 -96.55 135.09 38.92 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.487 1.137 . . . . 0.0 111.409 -177.834 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.1 mtt180 -161.07 73.67 2.64 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.08 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.1 Cg_endo -63.2 119.1 6.04 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.65 2.234 . . . . 0.0 112.689 -176.613 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.51 130.83 54.81 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.059 178.885 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.742 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.21 106.37 11.19 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.761 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.626 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.76 -162.52 0.06 OUTLIER Glycine 0 C--N 1.297 -1.634 0 C-N-CA 118.033 -2.032 . . . . 0.0 108.856 -178.687 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -88.59 -35.79 16.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.31 . . . . 0.0 109.29 -179.939 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p30 -63.21 -12.35 27.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 178.818 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 92.41 16.42 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.323 0.582 . . . . 0.0 109.864 179.697 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -99.33 121.2 40.76 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.341 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 31' ' ' TYR . 97.4 m -59.13 157.62 10.1 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.492 -0.755 . . . . 0.0 109.372 -179.527 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 9.8 m-85 -128.23 127.87 43.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.142 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.89 -53.0 1.17 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -177.584 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.0 p30 -160.45 -167.62 1.94 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.702 -1.469 . . . . 0.0 110.843 179.053 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD11 ' A' ' 23' ' ' LEU . 4.8 ptmt -50.53 -40.12 50.8 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.786 -0.571 . . . . 0.0 112.03 -177.116 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.0 m -66.55 -65.45 0.68 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.514 -1.366 . . . . 0.0 109.679 -179.314 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.8 m-80 -47.74 -28.29 2.41 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.437 -0.789 . . . . 0.0 110.366 -179.055 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CB ' HD13 ' A' ' 23' ' ' LEU . 14.8 t80 -76.0 -57.6 3.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.616 -1.302 . . . . 0.0 109.797 179.566 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 34.0 t -54.13 -56.76 15.05 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.415 -177.949 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.93 -33.58 0.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.86 -1.15 . . . . 0.0 108.76 -178.693 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -67.56 -49.11 64.79 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.191 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -56.9 -63.76 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.396 0.617 . . . . 0.0 110.249 179.046 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -59.47 -22.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.504 -0.748 . . . . 0.0 111.799 -178.197 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.8 -17.74 26.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.348 -1.47 . . . . 0.0 108.451 179.084 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.9 ' O ' HG22 ' A' ' 47' ' ' THR . 16.7 p -102.73 29.55 5.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.476 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.46 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.4 p-10 45.1 53.84 7.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 109.103 -179.638 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.33 45.17 1.78 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -110.48 -8.83 14.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.335 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.799 ' C ' HG23 ' A' ' 49' ' ' THR . 2.3 tp -81.71 -84.11 0.11 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.837 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.799 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 79.81 171.62 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.063 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.86 174.42 8.38 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -178.633 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.652 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.58 -35.13 7.54 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.591 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.742 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -165.34 162.15 19.47 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.55 -179.101 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 23' ' ' LEU . 61.4 m-85 -78.54 177.48 8.53 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 108.975 179.154 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 76.03 -168.16 54.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.949 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.83 141.96 30.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -1.153 . . . . 0.0 109.749 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.606 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 . . . . . . . . . 0 0 . 1 . 046 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.1 104.67 17.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 m -90.87 57.33 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -89.87 -20.35 23.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 108.897 179.762 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.4 16.7 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.279 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.988 ' HB3' HG11 ' A' ' 42' ' ' VAL . 17.5 m-85 -102.2 168.15 9.39 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.92 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -85.03 176.37 30.41 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.465 -1.473 . . . . 0.0 111.238 1.217 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 8.8 mttt -125.64 137.54 30.15 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.881 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -79.81 14.03 1.98 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.575 2.183 . . . . 0.0 110.766 -179.286 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.48 124.0 3.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.624 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -100.72 137.72 38.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.07 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -53.12 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.395 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.5 pp -121.1 -10.23 9.05 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.793 -179.621 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' LEU . 10.5 pm0 -57.3 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 6.9 t80 -136.45 129.2 30.77 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.19 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mtm180 -161.25 79.27 2.19 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.218 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.2 Cg_endo -64.97 116.61 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.233 1.955 . . . . 0.0 112.133 -177.288 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.81 125.82 52.37 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.432 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 41.8 t -78.91 165.87 23.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.953 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.69 172.26 20.97 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.18 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -66.04 -35.65 81.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.376 -1.073 . . . . 0.0 109.719 -179.099 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.6 p-10 -62.76 -11.55 18.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.096 -1.002 . . . . 0.0 108.915 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.4 t-20 85.69 30.34 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.457 0.646 . . . . 0.0 109.465 179.831 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 2.8 ttpt -114.71 143.29 45.29 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.087 179.749 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 26.9 m -91.94 155.04 18.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.493 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.849 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.3 m-85 -123.56 124.48 42.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.826 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.25 -51.86 0.71 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -154.73 -162.75 1.44 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.926 -1.338 . . . . 0.0 110.499 179.635 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.1 -42.45 93.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.704 . . . . 0.0 111.628 -177.917 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 42.8 t -55.46 -49.7 71.8 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.247 -1.533 . . . . 0.0 109.275 -179.744 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -61.94 -53.62 53.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.68 -179.122 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' HD21 ' A' ' 48' ' ' LEU . 63.1 t80 -53.26 -48.08 68.56 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.402 1.096 . . . . 0.0 110.143 -179.215 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.634 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 40.7 m -64.58 -30.58 71.61 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.625 -179.477 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' VAL . 10.5 m-80 -70.77 -22.36 62.39 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.98 -1.075 . . . . 0.0 108.528 179.296 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.849 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.51 -27.62 31.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 48' ' ' LEU . 73.8 t -77.81 -31.95 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.128 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.988 HG11 ' HB3' ' A' ' 11' ' ' TYR . 21.5 m -86.42 -28.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.724 -0.61 . . . . 0.0 110.151 -179.431 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.99 -22.36 20.03 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 109.371 -179.586 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 47' ' ' THR . 26.2 p -89.88 10.36 24.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.709 -179.465 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 44' ' ' SER . 8.0 t30 74.47 11.24 4.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 108.654 -179.373 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.83 81.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.827 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -80.15 -8.4 59.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -1.21 . . . . 0.0 108.857 179.127 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.855 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.75 163.76 24.22 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.454 -0.779 . . . . 0.0 109.17 179.999 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.655 ' H ' HD12 ' A' ' 48' ' ' LEU . 40.0 p -147.71 126.55 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.953 0.882 . . . . 0.0 108.682 177.974 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.4 tp -58.5 125.19 22.32 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.334 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.5 t -83.22 -22.98 32.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.802 -179.753 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . 10.8 p80 154.26 162.42 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.888 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -69.71 170.57 10.63 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.791 -1.193 . . . . 0.0 108.821 179.284 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 78.27 -172.46 55.22 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.808 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.78 150.04 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.261 . . . . 0.0 109.313 179.118 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 15.3 m . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.578 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 047 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 12.1 t70 -60.86 151.84 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 109.092 179.772 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.6 t -150.58 16.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.4 t -90.37 10.21 25.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.488 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.0 mp0 -124.66 -21.18 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 110.442 -179.618 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 13' ' ' LYS . 91.4 m-85 -79.37 153.52 76.57 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 120.832 -1.167 . . . . 0.0 109.178 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.6 Cg_endo -74.55 144.59 81.44 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.232 -1.987 . . . . 0.0 111.344 1.514 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -105.85 163.24 17.48 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.692 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.28 13.69 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.426 2.084 . . . . 0.0 111.39 -179.75 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 130.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 90.5 m -93.76 152.54 18.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -51.74 -176.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 108.987 179.648 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.708 ' H ' HD23 ' A' ' 18' ' ' LEU . 1.2 pt? -122.49 -35.69 3.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.027 -1.046 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.7 pm0 -53.13 137.98 32.48 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.429 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 11.1 t80 -86.88 127.61 35.04 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.258 1.028 . . . . 0.0 110.779 -178.462 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.2 mtm180 -160.61 85.31 1.91 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.327 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.2 Cg_endo -64.8 117.94 4.98 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.755 2.303 . . . . 0.0 112.998 -177.348 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.07 131.04 54.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.89 177.88 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 41.0 t -78.32 162.86 26.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.977 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -144.43 169.1 26.52 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.902 -178.084 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 2.3 t -58.55 -19.07 34.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.603 -0.939 . . . . 0.0 110.32 -178.028 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 26.5 p-10 -61.24 -13.24 17.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.102 -0.999 . . . . 0.0 109.416 179.727 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.4 t-20 83.88 14.76 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.681 -0.637 . . . . 0.0 109.697 179.902 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -128.01 -166.36 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 31' ' ' TYR . 16.3 m -111.81 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.644 -0.66 . . . . 0.0 109.342 -179.898 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.715 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.7 m-85 -131.38 121.63 24.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.58 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.2 -52.9 0.28 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.264 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -157.89 -165.02 1.64 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.013 -1.286 . . . . 0.0 110.358 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.66 -42.75 68.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.58 -0.7 . . . . 0.0 110.597 -178.485 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 50.7 t -62.2 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.796 -1.19 . . . . 0.0 109.786 -179.844 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.9 m-80 -52.58 -23.69 6.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 110.211 -179.367 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.1 t80 -75.34 -67.08 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.15 -46.66 75.71 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.796 -177.923 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.2 m-20 -44.09 -30.94 0.82 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.745 -1.222 . . . . 0.0 107.991 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.48 -49.5 47.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.537 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.878 HG22 HD23 ' A' ' 48' ' ' LEU . 76.8 t -54.02 -63.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.442 0.639 . . . . 0.0 110.216 178.945 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.1 p -59.37 -22.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.408 -0.808 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.21 -15.13 27.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.519 -1.363 . . . . 0.0 109.23 179.421 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.55 ' O ' HG22 ' A' ' 47' ' ' THR . 5.5 p -100.66 7.58 43.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.885 . . . . 0.0 109.671 -179.685 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.7 t30 75.21 8.66 3.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 -179.579 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.26 19.78 63.93 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -91.7 -0.22 57.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.341 -1.094 . . . . 0.0 108.942 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.878 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.02 -70.32 0.67 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.898 0.856 . . . . 0.0 109.276 -179.494 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.37 154.33 0.1 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.579 -178.756 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.6 tp -72.82 126.01 28.9 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.384 -179.536 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.574 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 8.1 t -79.3 -24.17 43.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 108.874 179.444 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 51' ' ' SER . 17.1 p80 150.67 174.27 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.541 178.378 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.9 155.86 23.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 110.092 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 84.1 -174.18 50.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -90.24 146.38 24.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.054 -1.262 . . . . 0.0 109.008 179.249 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 t . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 0 0 . 1 . 048 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.64 133.84 39.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.278 -179.989 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 m -124.42 61.17 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.706 -179.828 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 1.4 t -90.19 -31.94 16.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.654 179.93 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -81.48 0.94 35.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 109.307 179.792 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.928 ' HB3' HG11 ' A' ' 42' ' ' VAL . 65.5 m-85 -91.3 165.32 21.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 108.876 -179.839 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.58 152.0 59.9 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.162 0.715 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 12.6 mttt -105.5 141.14 22.01 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.638 -0.664 . . . . 0.0 109.677 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.5 14.11 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.464 2.11 . . . . 0.0 110.413 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.68 145.67 14.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.751 . . . . 0.0 109.188 -179.985 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.4 m -123.76 152.71 41.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.955 -179.589 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.7 -167.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.14 179.695 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -125.08 -18.41 5.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 0.0 110.367 -179.664 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 7.3 pm0 -56.55 -167.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.891 -1.131 . . . . 0.0 108.246 179.591 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -135.73 130.35 34.04 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.401 1.096 . . . . 0.0 111.315 -179.833 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.81 79.0 2.35 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.94 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.1 Cg_endo -64.47 114.85 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.432 2.088 . . . . 0.0 112.675 -176.995 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.631 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.57 141.76 45.95 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.765 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 20.6 t -95.49 159.63 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.81 -1.156 . . . . 0.0 109.007 -179.565 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -129.58 172.08 20.03 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.321 -178.407 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 t -56.26 -38.31 70.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.904 . . . . 0.0 111.458 -177.53 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -52.08 -19.11 1.72 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.69 -1.256 . . . . 0.0 110.038 -179.276 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.2 t30 91.47 27.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.933 -0.48 . . . . 0.0 110.409 179.459 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 178.99 4.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.904 -1.122 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 31' ' ' TYR . 41.7 m -107.15 162.37 13.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.862 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.8 m-85 -127.74 121.09 29.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.027 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.93 -54.34 0.68 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.968 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.6 p30 -152.36 -167.88 2.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.038 -1.272 . . . . 0.0 109.991 179.114 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.8 -60.71 2.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.348 -178.518 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 41.9 t -43.45 -62.97 0.92 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.802 -1.186 . . . . 0.0 110.432 -179.425 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -49.65 -34.25 17.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.579 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 13.5 t80 -70.5 -60.05 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.31 1.052 . . . . 0.0 110.845 -179.002 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.87 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.6 m -53.69 -30.77 45.09 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.711 -0.618 . . . . 0.0 110.18 -179.107 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.6 m-80 -64.07 -39.15 93.44 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.106 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -67.34 -20.21 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.34 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HD23 ' A' ' 48' ' ' LEU . 41.5 t -84.8 -31.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.7 m -82.28 -16.01 11.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.626 -0.671 . . . . 0.0 109.619 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.65 -32.35 15.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.885 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.811 ' O ' HG22 ' A' ' 47' ' ' THR . 60.0 p -86.56 10.14 16.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.802 -179.423 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.2 t30 75.05 7.35 4.21 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 108.858 -179.444 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 83.51 13.7 75.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.846 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 44' ' ' SER . 13.9 t -93.44 0.89 56.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 108.995 179.128 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.856 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -80.06 -71.57 0.45 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.036 0.922 . . . . 0.0 108.744 179.881 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.4 p 79.62 152.02 0.12 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.384 1.088 . . . . 0.0 109.997 -179.505 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -70.59 152.82 43.51 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.637 -179.734 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 p -99.38 -39.94 8.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.675 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.765 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.85 163.97 2.31 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.23 179.972 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.46 136.68 36.37 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.467 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 110.41 -167.64 12.73 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.798 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 151.72 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -1.216 . . . . 0.0 108.97 179.243 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.511 179.989 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 t . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 . . . . . . . . . 0 0 . 1 . 049 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.65 45.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 16.8 m -102.19 62.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.982 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.35 -4.13 58.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.972 . . . . 0.0 109.943 -179.542 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -117.89 2.45 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.322 179.681 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.802 ' HB3' HG11 ' A' ' 42' ' ' VAL . 35.5 m-85 -85.54 165.38 35.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 109.782 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -88.13 169.42 36.99 Favored 'Cis proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.249 -1.563 . . . . 0.0 110.642 0.837 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' CE1' ' A' ' 11' ' ' TYR . 5.2 mtpt -122.55 143.67 40.38 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 108.765 -179.848 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.81 13.88 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.491 2.127 . . . . 0.0 110.582 -179.882 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.7 112.27 1.89 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.636 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.3 m -81.02 143.28 32.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.837 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.3 p -62.73 -163.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.317 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.57 -15.9 8.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.987 -1.071 . . . . 0.0 109.636 179.836 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.804 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -47.92 123.46 6.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.016 -1.052 . . . . 0.0 108.477 179.417 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 27.8 t80 -86.59 110.68 19.99 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.361 1.077 . . . . 0.0 110.376 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 10.4 mtp180 -145.9 86.39 7.21 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.306 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -67.33 104.19 0.87 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 121.855 1.704 . . . . 0.0 111.596 -177.904 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.82 120.58 40.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.639 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -78.82 -179.67 6.7 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.617 -178.867 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.74 165.27 29.63 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.198 -1.477 . . . . 0.0 112.222 -177.216 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -33.04 74.84 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -50.65 -24.93 3.67 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.95 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.61 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 31.1 t-20 96.33 37.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.026 179.57 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -136.88 -169.43 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 179.591 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 91.8 m -127.39 158.92 36.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.345 -179.937 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 88.3 m-85 -132.51 105.9 7.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.378 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.78 -55.98 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 O-C-N 122.047 -0.408 . . . . 0.0 112.28 -177.789 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.1 p-10 -140.24 -171.02 3.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.608 -1.525 . . . . 0.0 110.627 -179.541 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.8 pttt -59.64 -30.77 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.777 -0.577 . . . . 0.0 110.55 -179.036 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 43.6 t -62.89 -74.12 0.1 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.674 -1.266 . . . . 0.0 108.261 179.194 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.55 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 18.3 m-80 -39.37 -48.67 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 110.557 -179.975 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.61 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 74.1 t80 -55.13 -46.37 75.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.665 -1.272 . . . . 0.0 109.265 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 27.3 m -59.83 -48.32 82.15 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.602 179.957 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 7.2 m120 -45.68 -30.02 1.44 Allowed 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.85 -1.156 . . . . 0.0 109.308 179.35 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -79.08 -40.16 31.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.992 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.993 HG22 HD23 ' A' ' 48' ' ' LEU . 58.1 t -69.88 -24.3 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.719 . . . . 0.0 110.146 -179.821 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.1 m -91.94 -26.97 4.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.534 -179.182 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -91.29 -15.27 29.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.077 -179.931 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 26.8 t -102.24 19.79 18.02 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.2 m120 65.31 18.58 11.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.454 -0.779 . . . . 0.0 109.044 -179.604 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 18.37 77.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.732 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.2 p -89.61 -10.02 47.52 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.486 -1.008 . . . . 0.0 108.784 179.401 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.993 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.43 148.05 32.08 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.75 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 30.1 p -123.07 139.98 53.5 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.888 0.852 . . . . 0.0 109.721 179.332 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 23' ' ' LEU . 5.1 tp -61.21 130.16 44.85 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.696 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.01 -22.95 44.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.741 -1.224 . . . . 0.0 109.241 -179.913 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' SER . 12.3 p80 154.1 164.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.167 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.77 148.29 40.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.11 -0.993 . . . . 0.0 108.601 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 93.73 -179.31 38.46 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.325 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.97 168.4 17.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.315 . . . . 0.0 109.017 178.821 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 30.7 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.687 -179.464 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.222 0.534 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 050 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -83.9 117.25 23.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.274 179.894 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.19 37.36 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.598 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.28 6.7 41.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.711 -179.859 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 24.1 mp0 -129.01 36.71 4.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 109.775 -179.76 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.967 ' HB3' HG11 ' A' ' 42' ' ' VAL . 24.3 m-85 -108.26 164.08 15.54 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 108.541 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.8 Cg_endo -77.7 -177.72 21.93 Favored 'Cis proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.967 -1.68 . . . . 0.0 111.684 2.232 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mmmt -125.54 148.14 60.56 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.616 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.73 14.01 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 163.62 165.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.688 179.746 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.9 t -140.43 160.0 40.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 179.877 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.48 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.091 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.0 pp -115.02 -24.37 8.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 109.57 179.605 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.9 pt-20 -43.79 116.6 1.0 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.3 t80 -79.26 130.96 35.99 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.496 1.141 . . . . 0.0 111.325 -177.622 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.03 78.35 2.33 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.315 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.53 118.45 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.89 2.394 . . . . 0.0 112.898 -177.097 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.644 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -106.67 131.58 53.65 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.779 178.478 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 40.8 t -79.45 162.54 25.4 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.121 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -141.95 166.49 26.28 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.259 -178.054 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t -55.74 -13.27 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.874 -0.78 . . . . 0.0 110.531 -178.729 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.0 p30 -75.01 5.94 4.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.175 . . . . 0.0 109.427 179.236 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 72.1 m-20 63.29 31.32 15.45 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.367 -0.833 . . . . 0.0 109.847 179.763 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -136.39 -168.26 2.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.659 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.3 m -119.85 162.45 19.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.8 m-85 -129.97 126.45 37.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.046 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.27 -53.76 0.96 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.527 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.6 p30 -157.54 -164.64 1.6 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.934 -1.333 . . . . 0.0 111.179 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.5 -47.49 63.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.662 -0.649 . . . . 0.0 112.31 -177.304 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HE3' ' A' ' 34' ' ' LYS . 5.2 m -63.54 -55.08 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.402 -1.436 . . . . 0.0 109.982 -178.62 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.4 m-80 -54.86 -27.87 45.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -0.997 . . . . 0.0 110.027 -179.541 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.0 t80 -74.03 -50.46 19.64 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.997 1.38 . . . . 0.0 109.401 179.639 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 13.5 m -60.56 -26.13 66.69 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.474 -179.257 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 19.7 m-20 -65.26 -34.22 77.85 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.927 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.61 -39.13 80.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.627 HG22 HD23 ' A' ' 48' ' ' LEU . 86.5 t -65.11 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.581 -0.699 . . . . 0.0 109.89 -179.727 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.967 HG11 ' HB3' ' A' ' 11' ' ' TYR . 14.1 p -59.28 -19.75 16.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -0.771 . . . . 0.0 110.7 -179.335 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -90.75 -22.52 21.04 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.6 -1.312 . . . . 0.0 107.909 178.981 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.821 ' O ' HG22 ' A' ' 47' ' ' THR . 0.9 OUTLIER -98.44 29.29 3.69 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.114 179.533 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.525 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 6.0 p-10 44.34 53.82 6.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.03 47.1 2.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.31 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -111.53 -22.97 10.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.453 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.627 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.64 150.88 30.84 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.999 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.569 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.2 p -125.02 138.14 54.22 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 109.41 179.621 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.3 tp -54.12 124.49 15.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.574 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 8.4 t -78.0 -22.84 48.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.793 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.58 ' CB ' ' O ' ' A' ' 51' ' ' SER . 12.9 p80 152.65 177.61 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.136 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -87.62 160.95 17.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 109.427 179.653 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.64 -170.43 50.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.385 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 148.33 23.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.06 -1.259 . . . . 0.0 109.159 179.088 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.457 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.546 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.277 0.56 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.56 60.86 0.9 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 109.508 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -117.34 -166.79 1.22 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.202 -0.936 . . . . 0.0 109.582 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 39.1 t -95.55 69.34 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.284 -0.885 . . . . 0.0 109.523 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -166.0 165.38 18.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.381 -0.824 . . . . 0.0 109.108 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -97.72 157.35 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.149 -0.97 . . . . 0.0 109.622 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -87.93 122.92 32.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.358 -0.839 . . . . 0.0 109.496 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 m -94.99 19.61 10.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 109.696 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.56 -19.55 60.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.676 -179.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -106.06 42.02 1.32 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.388 -0.82 . . . . 0.0 109.192 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.793 ' HB3' HG11 ' A' ' 42' ' ' VAL . 42.8 m-85 -137.38 164.37 42.19 Favored Pre-proline 0 C--N 1.305 -1.354 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.8 Cg_endo -86.89 145.9 31.59 Favored 'Cis proline' 0 C--N 1.306 -1.704 0 C-N-CA 123.08 -1.633 . . . . 0.0 110.646 1.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.6 mttp -98.51 134.57 21.67 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.347 -0.846 . . . . 0.0 109.137 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.98 15.11 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.293 0 C-N-CA 122.422 2.082 . . . . 0.0 111.022 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.89 124.47 7.74 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.387 -0.821 . . . . 0.0 109.471 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 19.5 m -119.38 131.96 55.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.244 -0.91 . . . . 0.0 109.611 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.45 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 2.6 p -63.79 -169.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.233 -0.917 . . . . 0.0 108.61 179.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -115.35 -13.86 11.66 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.279 -179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' HG3' ' NH1' ' A' ' 21' ' ' ARG . 5.8 pm0 -46.15 127.74 8.89 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -87.33 125.3 34.15 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-O 122.68 1.228 . . . . 0.0 112.276 -177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -162.57 82.26 1.65 Allowed Pre-proline 0 C--N 1.294 -1.813 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 178.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 26.8 Cg_endo -65.92 132.78 31.35 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 123.071 2.514 . . . . 0.0 113.67 -176.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.864 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.9 mp -118.77 141.1 48.93 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.606 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -99.26 129.84 45.51 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.951 -1.1 . . . . 0.0 110.716 -178.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -67.17 -167.74 3.27 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.055 -1.618 . . . . 0.0 109.055 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.545 ' N ' ' O ' ' A' ' 49' ' ' THR . 6.7 t -82.56 -27.81 31.37 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.096 -1.238 . . . . 0.0 109.101 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.541 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.3 p30 -75.09 0.17 17.03 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.201 -0.937 . . . . 0.0 109.63 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.7 m-20 79.89 37.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 110.187 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' N ' ' A' ' 30' ' ' THR . 3.1 tttm -108.11 144.1 35.95 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.197 -0.939 . . . . 0.0 108.573 179.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.477 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 32.0 m -90.36 146.26 24.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.738 -1.227 . . . . 0.0 109.514 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -125.45 137.73 53.99 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 178.294 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -40.34 -49.27 3.75 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -177.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.649 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 7.2 p-10 -163.83 -166.64 1.21 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.274 -1.133 . . . . 0.0 110.217 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.864 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -55.32 -48.7 73.76 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.435 -0.79 . . . . 0.0 111.213 -177.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 16.0 t -54.44 -60.97 2.64 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.821 -1.175 . . . . 0.0 111.375 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.427 ' O ' ' CE1' ' A' ' 31' ' ' TYR . 19.5 m-80 -62.43 -26.63 68.6 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.779 -1.2 . . . . 0.0 110.652 -178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 7.9 t80 -65.94 -59.84 3.44 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.856 -1.153 . . . . 0.0 109.863 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 48.7 t -59.86 -44.07 94.34 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.583 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.53 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 3.4 m-80 -43.25 -28.98 0.36 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.666 -1.271 . . . . 0.0 107.882 178.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -74.98 -49.78 18.79 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 177.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.516 ' N ' ' O ' ' A' ' 38' ' ' CYS . 90.1 t -53.65 -56.99 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 121.584 0.707 . . . . 0.0 109.43 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.037 HG21 ' HB3' ' A' ' 12' ' ' PRO . 23.4 m -59.78 -26.67 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.532 -0.73 . . . . 0.0 110.543 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -88.0 -13.83 40.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.028 -1.045 . . . . 0.0 108.801 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.905 ' O ' HG22 ' A' ' 47' ' ' THR . 27.9 p -110.4 29.83 7.34 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.448 -0.782 . . . . 0.0 109.844 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.453 ' CG ' ' O ' ' A' ' 44' ' ' SER . 0.5 OUTLIER 44.85 55.32 6.12 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.154 -0.966 . . . . 0.0 108.979 -179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 36.38 45.54 0.95 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.719 -0.952 . . . . 0.0 110.719 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.905 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -110.04 -7.4 14.94 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 178.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.617 ' HG ' ' N ' ' A' ' 49' ' ' THR . 3.5 tp -83.0 -71.45 0.5 Allowed 'General case' 0 C--N 1.307 -1.242 0 CA-C-O 121.51 0.671 . . . . 0.0 109.313 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.617 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 14.2 p 60.78 138.35 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.541 0.686 . . . . 0.0 109.37 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.68 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -93.57 165.59 12.66 Favored 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.697 0.76 . . . . 0.0 111.135 -177.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.94 -34.5 6.61 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.68 ' O ' HD11 ' A' ' 50' ' ' LEU . 2.6 p80 -156.08 165.21 37.11 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.583 0.706 . . . . 0.0 109.88 -178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.434 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 6.0 m-85 -83.15 -168.9 2.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.692 -0.63 . . . . 0.0 109.641 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.555 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 60.07 -166.95 9.81 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 3.7 mtmt -90.41 164.96 14.1 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.513 -0.992 . . . . 0.0 108.657 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.606 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.9 m . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.028 -0.987 . . . . 0.0 110.146 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.273 0.559 . . . . 0.0 109.506 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 48.36 -170.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.498 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 49.15 84.89 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.661 ' O ' HG23 ' A' ' 4' ' ' VAL . 29.1 m -88.55 94.24 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.306 -0.872 . . . . 0.0 109.355 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.649 ' HA ' HD22 ' A' ' 50' ' ' LEU . 2.7 t -177.48 130.33 0.16 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.21 -0.931 . . . . 0.0 109.336 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.66 154.24 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.296 -0.877 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.86 118.06 23.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.408 -0.807 . . . . 0.0 109.784 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 77.2 m -97.91 50.45 1.03 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 0.0 109.241 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.2 m -79.36 -23.79 43.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.328 -0.858 . . . . 0.0 109.635 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -101.94 43.18 1.08 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.038 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.891 ' HB3' HG11 ' A' ' 42' ' ' VAL . 34.0 m-85 -131.31 165.51 34.75 Favored Pre-proline 0 C--N 1.304 -1.375 0 O-C-N 121.403 -0.811 . . . . 0.0 108.944 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.002 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.7 Cg_endo -87.51 169.42 39.49 Favored 'Cis proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.237 -1.568 . . . . 0.0 110.887 -0.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.52 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 2.6 mtpt -125.25 142.99 43.05 Favored Pre-proline 0 N--CA 1.491 1.6 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.8 Cg_endo -78.81 14.86 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.719 2.28 . . . . 0.0 111.308 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 179.57 151.12 0.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.897 . . . . 0.0 109.683 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 38.4 t -126.54 160.31 30.97 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.145 -0.972 . . . . 0.0 110.129 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.56 ' HG1' ' CD ' ' A' ' 19' ' ' GLU . 5.2 p -64.62 -144.88 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.52 ' C ' HD12 ' A' ' 18' ' ' LEU . 4.1 pp -132.17 -13.9 3.07 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.963 -1.086 . . . . 0.0 110.905 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.56 ' CD ' ' HG1' ' A' ' 17' ' ' THR . 15.2 pm0 -55.42 126.51 25.42 Favored 'General case' 0 C--N 1.309 -1.188 0 O-C-N 120.448 -1.408 . . . . 0.0 108.25 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 6.0 t80 -81.83 118.98 23.33 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.555 1.169 . . . . 0.0 110.906 -177.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.641 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.9 69.08 10.89 Favored Pre-proline 0 C--N 1.292 -1.914 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HG3' ' CE2' ' A' ' 20' ' ' TYR . 25.5 Cg_endo -65.34 132.4 31.31 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 123.227 2.618 . . . . 0.0 113.389 -176.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.733 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER -125.21 132.99 52.9 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.198 178.228 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 32.8 t -78.09 118.67 20.58 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 105.725 -1.954 . . . . 0.0 105.725 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -64.01 -163.62 0.63 Allowed Glycine 0 C--N 1.293 -1.846 0 C-N-CA 118.648 -1.739 . . . . 0.0 109.481 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.549 ' CB ' ' O ' ' A' ' 49' ' ' THR . 8.5 t -85.25 -30.03 24.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.107 -1.231 . . . . 0.0 108.766 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -71.07 -4.69 26.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.451 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 30.4 t30 84.83 16.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.653 -0.654 . . . . 0.0 110.095 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.63 126.54 44.25 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.071 -1.018 . . . . 0.0 108.375 179.13 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.8 m -64.71 144.8 56.98 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 119.638 -0.825 . . . . 0.0 109.047 -179.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 31.7 m-85 -121.74 120.97 36.19 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.96 -50.23 0.21 Allowed Glycine 0 N--CA 1.497 2.713 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.6 p30 -162.41 -162.87 0.85 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 120.825 -1.397 . . . . 0.0 109.989 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.733 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -52.22 -47.28 65.76 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.48 -0.763 . . . . 0.0 111.829 -177.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.3 m -62.79 -61.23 2.55 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 120.515 -1.366 . . . . 0.0 110.152 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.572 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.8 m-80 -50.04 -22.09 1.48 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.021 -1.049 . . . . 0.0 110.29 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.2 t80 -80.93 -52.87 6.97 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.797 1.284 . . . . 0.0 109.486 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.799 ' O ' HG13 ' A' ' 42' ' ' VAL . 7.3 m -58.84 -30.15 67.45 Favored 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.705 -1.134 . . . . 0.0 110.314 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.516 ' O ' HG22 ' A' ' 42' ' ' VAL . 4.1 m-80 -61.06 -29.85 69.98 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.548 -1.278 . . . . 0.0 107.548 179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.615 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -76.61 -31.29 57.35 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.679 HG22 HD23 ' A' ' 48' ' ' LEU . 53.5 t -77.1 -24.13 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-O 121.5 0.667 . . . . 0.0 110.205 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.002 HG21 ' HB3' ' A' ' 12' ' ' PRO . 4.9 m -90.8 -25.71 5.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.898 -178.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -90.96 -5.43 55.44 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.256 -0.903 . . . . 0.0 108.832 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.714 ' O ' HG22 ' A' ' 47' ' ' THR . 22.6 p -111.6 -0.65 16.04 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.244 -0.91 . . . . 0.0 109.631 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.1 t-20 77.43 15.18 1.73 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 108.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.29 2.51 90.52 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 44' ' ' SER . 11.4 t -80.12 0.43 32.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 108.662 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.761 ' C ' HG23 ' A' ' 49' ' ' THR . 0.2 OUTLIER -82.41 -78.37 0.21 Allowed 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.519 -0.738 . . . . 0.0 109.438 -179.556 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.761 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.3 p 77.69 172.85 0.2 Allowed 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.649 HD22 ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -120.38 170.12 9.66 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.677 -1.264 . . . . 0.0 111.688 -177.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.641 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 1.6 p -92.1 -42.09 10.12 Favored 'General case' 0 N--CA 1.486 1.336 0 CA-C-O 122.476 1.131 . . . . 0.0 108.544 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -171.99 172.36 4.74 Favored 'General case' 0 C--N 1.292 -1.892 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.174 -178.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -77.21 -174.63 3.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.336 -0.852 . . . . 0.0 108.763 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 64.75 -167.27 30.03 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.01 -1.236 . . . . 0.0 110.01 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.98 154.94 19.08 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.563 -0.963 . . . . 0.0 109.305 179.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.463 ' O ' ' O ' ' A' ' 55' ' ' LYS . 24.9 m . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.909 -1.043 . . . . 0.0 109.5 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.441 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.76 63.71 1.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.945 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.78 165.77 35.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.274 -0.892 . . . . 0.0 109.39 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 4' ' ' VAL . 16.0 m -133.72 70.8 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.241 -0.912 . . . . 0.0 109.212 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 t -174.53 124.2 0.29 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 0.0 109.366 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.699 HG21 HD22 ' A' ' 23' ' ' LEU . 5.4 t -91.05 143.49 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.152 -0.967 . . . . 0.0 109.602 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -87.63 177.79 6.95 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.282 -0.886 . . . . 0.0 109.631 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 10.2 m -156.2 39.7 0.36 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.211 -0.93 . . . . 0.0 109.715 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.19 -38.32 13.55 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.174 -0.954 . . . . 0.0 109.707 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -88.14 -4.76 58.7 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.571 -0.706 . . . . 0.0 109.575 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 61.0 m-85 -88.05 161.52 43.51 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 121.211 -0.931 . . . . 0.0 109.269 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.641 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.1 Cg_endo -87.27 144.44 27.29 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 123.014 -1.661 . . . . 0.0 110.424 1.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.483 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -101.07 142.21 24.16 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.482 -0.761 . . . . 0.0 109.291 -179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.57 13.63 2.04 Favored 'Trans proline' 0 C--N 1.314 -1.281 0 C-N-CA 122.517 2.144 . . . . 0.0 110.478 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -149.12 128.25 12.79 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.437 ' O ' ' O ' ' A' ' 17' ' ' THR . 66.7 m -123.12 138.94 54.53 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.113 -0.992 . . . . 0.0 109.959 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.437 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -52.51 -176.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.263 179.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 19' ' ' GLU . 1.9 mt -117.89 -31.45 5.1 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.157 -0.965 . . . . 0.0 109.739 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.501 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.3 pm0 -44.26 135.93 4.24 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.566 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 5.4 t80 -87.27 126.88 35.1 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.789 1.28 . . . . 0.0 111.135 -178.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.669 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 15.3 mtm180 -160.54 71.24 2.89 Favored Pre-proline 0 C--N 1.291 -1.969 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.65 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 20.6 Cg_endo -62.97 132.76 38.24 Favored 'Trans proline' 0 C--O 1.196 -1.592 0 C-N-CA 123.844 3.029 . . . . 0.0 114.339 -176.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.699 HD22 HG21 ' A' ' 6' ' ' VAL . 4.3 mp -111.38 161.08 16.45 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 106.074 -1.824 . . . . 0.0 106.074 176.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.861 ' O ' HD12 ' A' ' 50' ' ' LEU . 30.3 t -119.09 137.13 53.78 Favored 'General case' 0 N--CA 1.509 2.522 0 O-C-N 119.677 -1.89 . . . . 0.0 110.858 -179.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.659 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -96.51 164.37 23.14 Favored Glycine 0 N--CA 1.501 2.98 0 O-C-N 121.258 -0.901 . . . . 0.0 111.651 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.535 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 23.9 t -67.68 -29.31 68.55 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.587 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 10.8 p30 -59.51 -14.5 13.1 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.587 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 13.3 t30 88.97 10.15 0.09 Allowed 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 121.299 0.571 . . . . 0.0 109.811 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -99.38 126.52 45.27 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 20.9 m -81.29 130.03 34.86 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.339 -0.851 . . . . 0.0 108.919 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.829 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.73 136.65 36.97 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 178.631 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.546 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -39.52 -42.75 2.0 Favored Glycine 0 N--CA 1.493 2.456 0 O-C-N 121.477 -0.765 . . . . 0.0 111.889 -177.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.669 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 30.0 p30 -172.47 -149.73 0.05 Allowed 'General case' 0 C--N 1.297 -1.714 0 O-C-N 120.684 -1.48 . . . . 0.0 109.813 -178.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 0.5 OUTLIER -59.38 -63.0 1.46 Allowed 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.843 -178.204 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 16.8 t -53.71 -57.07 12.16 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.88 -1.137 . . . . 0.0 109.378 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.598 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -52.4 -24.26 7.47 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.001 -1.062 . . . . 0.0 108.842 179.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.829 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 4.7 t80 -78.09 -66.5 0.84 Allowed 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.394 -0.922 . . . . 0.0 111.51 -178.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 43.6 t -50.62 -44.92 57.35 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.587 -177.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.607 ' O ' HG22 ' A' ' 42' ' ' VAL . 8.1 m-20 -48.77 -35.28 13.95 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -62.07 -45.37 93.84 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.656 HG13 ' HA2' ' A' ' 46' ' ' GLY . 56.6 t -62.73 -59.94 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 CA-C-O 121.713 0.768 . . . . 0.0 109.662 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.641 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.9 m -51.55 -28.41 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.325 -0.859 . . . . 0.0 110.356 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.64 -20.41 21.66 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.793 -1.192 . . . . 0.0 109.464 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.577 ' O ' HG23 ' A' ' 47' ' ' THR . 43.8 t -97.11 9.94 40.75 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.642 -0.662 . . . . 0.0 109.906 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.0 m120 62.62 25.61 15.23 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.265 -0.897 . . . . 0.0 109.59 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.656 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.43 20.3 73.44 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.26 -1.136 . . . . 0.0 110.26 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 44' ' ' SER . 1.5 p -103.72 16.92 25.23 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.798 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -94.4 -48.41 6.15 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.524 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 39.2 p 52.28 125.21 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.915 0 CA-C-O 122.347 1.07 . . . . 0.0 111.547 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.861 HD12 ' O ' ' A' ' 24' ' ' CYS . 7.9 tp -68.66 157.19 36.74 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.528 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.91 -20.21 10.65 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.764 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 173.68 162.04 0.16 Allowed 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.554 ' CE1' ' HA ' ' A' ' 4' ' ' VAL . 16.8 m-85 -75.17 150.18 38.79 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.663 0.744 . . . . 0.0 109.131 178.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.65 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 96.94 -166.74 23.68 Favored Glycine 0 N--CA 1.496 2.673 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 2.0 mtmt -90.07 158.65 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -1.156 . . . . 0.0 109.104 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.07 -44.93 0.12 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.928 . . . . 0.0 109.594 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -59.01 178.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.93 . . . . 0.0 109.724 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.465 ' O ' HD23 ' A' ' 50' ' ' LEU . 3.7 t -139.94 113.7 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.43 -0.793 . . . . 0.0 109.334 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.44 ' HA ' HD23 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -124.44 150.82 45.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.262 -0.899 . . . . 0.0 109.567 -179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.22 138.24 28.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.246 -0.909 . . . . 0.0 109.555 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -80.45 160.68 25.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.138 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.4 m -134.17 57.75 1.79 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.084 -1.01 . . . . 0.0 109.351 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.13 -29.64 20.43 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.231 -0.918 . . . . 0.0 109.558 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -94.69 30.16 2.12 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 40.5 m-85 -120.84 166.83 14.47 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.731 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -89.42 169.13 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.726 0 C-N-CA 123.56 -1.433 . . . . 0.0 111.528 0.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 12.1 mttt -122.08 136.98 26.81 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -80.17 14.76 1.86 Allowed 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.349 2.033 . . . . 0.0 110.859 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 126.18 0.28 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.383 -0.823 . . . . 0.0 109.525 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.401 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.0 t -110.37 159.84 17.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.248 -0.907 . . . . 0.0 109.911 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 82.5 p -64.7 -150.26 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.879 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.95 -12.4 9.56 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.808 -1.183 . . . . 0.0 110.088 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -45.08 120.45 2.4 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.104 -0.997 . . . . 0.0 108.729 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.577 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.4 t80 -89.77 118.01 29.05 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 122.657 1.218 . . . . 0.0 110.294 -179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.63 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -151.41 74.54 8.1 Favored Pre-proline 0 C--N 1.287 -2.147 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.5 Cg_endo -63.35 126.13 17.1 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 123.09 2.526 . . . . 0.0 112.415 -176.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.647 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -117.09 128.61 55.31 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 118.941 -1.104 . . . . 0.0 108.36 178.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.721 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 53.2 t -79.77 161.39 25.75 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.5 169.97 21.68 Favored Glycine 0 N--CA 1.483 1.814 0 C-N-CA 119.136 -1.507 . . . . 0.0 112.078 -177.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER -64.26 -20.8 66.3 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 122.016 -0.696 . . . . 0.0 109.969 -178.501 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.565 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.3 p30 -65.35 -12.14 49.03 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.183 -0.948 . . . . 0.0 109.153 179.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.565 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.2 t-20 85.29 30.4 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.845 -0.535 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -132.56 -166.84 1.8 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.147 -0.97 . . . . 0.0 109.416 179.464 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 55' ' ' LYS . 8.2 m -126.2 156.48 40.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.392 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.874 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 27.0 m-85 -126.54 126.45 43.7 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.577 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.3 -52.68 0.42 Allowed Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -177.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.63 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.8 p30 -162.5 -166.08 1.29 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 120.802 -1.41 . . . . 0.0 111.152 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.647 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.11 -42.08 38.03 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.799 -0.563 . . . . 0.0 111.958 -177.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.535 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 5.9 m -68.72 -54.53 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.623 -1.298 . . . . 0.0 110.165 -178.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.2 m-80 -59.02 -20.38 52.55 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.051 -1.031 . . . . 0.0 109.774 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 35.6 t80 -80.18 -51.1 9.38 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.554 1.168 . . . . 0.0 109.285 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 1.009 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.3 m -60.58 -29.18 69.02 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.593 -179.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 42' ' ' VAL . 16.4 m-20 -67.1 -31.13 71.4 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.874 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -77.74 -23.21 49.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.75 HG22 HD23 ' A' ' 48' ' ' LEU . 48.6 t -84.16 -25.57 7.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.6 m -88.07 -19.3 7.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.703 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.25 -32.21 15.84 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.163 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 47' ' ' THR . 1.1 t -84.09 8.88 14.06 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.539 -0.726 . . . . 0.0 109.838 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 69.1 m-20 61.72 27.08 16.56 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.155 -0.965 . . . . 0.0 108.96 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.51 27.3 73.88 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 44' ' ' SER . 26.0 p -105.19 -1.47 25.38 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.815 ' O ' HG23 ' A' ' 49' ' ' THR . 0.0 OUTLIER -79.74 -79.77 0.14 Allowed 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.815 HG23 ' O ' ' A' ' 48' ' ' LEU . 7.3 p 95.57 136.52 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 122.108 0.956 . . . . 0.0 110.185 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.632 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 15.1 tp -67.28 158.64 31.0 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 4.7 p -109.22 -43.24 4.19 Favored 'General case' 0 C--N 1.294 -1.815 0 N-CA-C 106.605 -1.628 . . . . 0.0 106.605 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.721 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 167.01 1.74 Allowed 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' HA ' HD23 ' A' ' 23' ' ' LEU . 23.3 m-85 -74.69 171.24 14.27 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.128 -0.983 . . . . 0.0 108.53 178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.592 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -176.7 46.71 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.536 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.34 155.58 18.4 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.092 -1.24 . . . . 0.0 109.077 178.945 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.454 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.91 -174.62 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.23 -0.919 . . . . 0.0 109.371 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -128.47 155.47 44.77 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 5' ' ' SER . 14.3 m -139.44 75.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.323 -0.86 . . . . 0.0 109.482 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 56.6 p 175.01 149.59 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.356 -0.84 . . . . 0.0 109.246 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.632 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.1 p -122.06 175.52 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.125 -0.984 . . . . 0.0 109.65 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 6' ' ' VAL . 24.2 t0 -87.3 134.0 33.62 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 0.0 109.312 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 6' ' ' VAL . 12.8 m -144.7 42.06 1.34 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.221 -0.924 . . . . 0.0 109.869 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.438 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 27.3 t -90.83 -8.82 48.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.182 -0.949 . . . . 0.0 109.685 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.438 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 3.3 mm-40 -97.9 -1.74 42.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.973 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.853 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.2 m-85 -82.88 158.16 65.41 Favored Pre-proline 0 C--N 1.304 -1.387 0 O-C-N 121.131 -0.981 . . . . 0.0 109.526 -179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.51 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 37.1 Cg_endo -75.76 165.46 85.54 Favored 'Cis proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.558 -1.851 . . . . 0.0 111.589 1.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.6 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 6.0 mtmt -120.03 143.83 36.27 Favored Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.54 14.57 1.6 Allowed 'Trans proline' 0 C--N 1.312 -1.349 0 C-N-CA 122.506 2.137 . . . . 0.0 111.1 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.83 128.37 0.76 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.374 -0.829 . . . . 0.0 109.355 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -105.51 144.21 32.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.166 -0.959 . . . . 0.0 109.743 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.3 p -61.71 -177.62 0.12 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 108.667 179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -111.1 -20.77 12.26 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.052 -1.03 . . . . 0.0 109.738 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.738 ' N ' HD12 ' A' ' 18' ' ' LEU . 1.3 mt-10 -44.89 122.63 3.34 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 121.121 -0.987 . . . . 0.0 108.751 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.494 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 32.8 t80 -86.93 108.81 18.97 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 122.497 1.141 . . . . 0.0 110.177 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.9 mtm180 -144.26 90.62 6.63 Favored Pre-proline 0 C--N 1.289 -2.035 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.57 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -67.23 109.21 1.7 Allowed 'Trans proline' 0 C--N 1.302 -1.9 0 C-N-CA 122.105 1.87 . . . . 0.0 112.239 -177.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.657 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 1.1 mt -105.45 118.49 36.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 178.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.572 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -79.33 176.93 9.23 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.052 -1.03 . . . . 0.0 110.542 -177.625 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.588 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -139.91 172.91 23.18 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 120.334 -0.936 . . . . 0.0 111.425 -177.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.5 t -65.65 -31.27 72.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.746 -0.856 . . . . 0.0 109.678 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.4 p30 -65.77 -8.74 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.541 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.549 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER 83.15 19.6 0.22 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.634 -0.666 . . . . 0.0 109.474 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -103.22 154.37 19.4 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 121.386 -0.821 . . . . 0.0 109.16 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 53.6 m -106.54 143.73 34.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.386 -0.821 . . . . 0.0 109.087 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.651 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 94.5 m-85 -118.37 116.07 25.97 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.275 -0.891 . . . . 0.0 108.949 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.452 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -33.64 -54.43 0.63 Allowed Glycine 0 N--CA 1.495 2.57 0 N-CA-C 111.853 -0.499 . . . . 0.0 111.853 -178.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.604 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.7 p-10 -144.11 -170.35 3.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.656 -1.496 . . . . 0.0 110.706 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.657 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.0 -28.22 67.53 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.978 -0.451 . . . . 0.0 111.634 -178.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.5 t -70.98 -51.14 27.37 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 120.55 -1.344 . . . . 0.0 109.278 -179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 21.3 m-80 -63.77 -33.92 76.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.539 -0.725 . . . . 0.0 109.914 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.685 ' CE1' HD21 ' A' ' 48' ' ' LEU . 31.2 t80 -69.12 -53.31 20.87 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 122.442 1.115 . . . . 0.0 109.715 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.628 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 5.6 m -56.28 -47.84 77.81 Favored 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.334 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.51 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 6.0 m-20 -48.72 -33.3 9.93 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.651 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.36 -39.67 67.9 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.295 -0.878 . . . . 0.0 108.664 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.764 ' CG2' HD23 ' A' ' 48' ' ' LEU . 77.6 t -60.43 -57.2 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.626 -0.672 . . . . 0.0 109.9 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.853 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.2 p -64.59 -22.34 31.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.473 -0.767 . . . . 0.0 110.612 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.13 -10.96 36.98 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.92 -1.113 . . . . 0.0 109.138 179.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.892 ' O ' HG22 ' A' ' 47' ' ' THR . 6.2 p -115.05 25.66 10.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.319 -0.863 . . . . 0.0 110.438 -179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.433 ' CG ' ' C ' ' A' ' 44' ' ' SER . 0.8 OUTLIER 43.71 53.55 5.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.905 -1.122 . . . . 0.0 109.527 -179.833 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 45.09 43.55 8.94 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.336 -1.106 . . . . 0.0 110.336 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.892 HG22 ' O ' ' A' ' 44' ' ' SER . 6.1 t -117.12 2.13 12.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.359 -1.083 . . . . 0.0 108.483 178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.764 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.0 OUTLIER -84.61 -50.79 7.37 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-O 122.076 0.941 . . . . 0.0 108.536 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.675 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 62.0 p 57.66 126.34 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.302 1.049 . . . . 0.0 110.32 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.644 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 9.7 tp -61.65 131.15 49.05 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.584 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.44 -23.24 43.28 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.071 -1.018 . . . . 0.0 108.656 179.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.585 ' O ' HD11 ' A' ' 50' ' ' LEU . 11.0 p80 154.46 163.47 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -70.15 151.82 44.99 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.9 -1.125 . . . . 0.0 108.824 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.515 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 90.73 -176.4 41.16 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -83.64 169.28 15.5 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.047 -1.266 . . . . 0.0 108.373 179.067 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.601 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 30.4 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-O 118.079 -0.962 . . . . 0.0 109.65 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.33 13.03 6.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.863 . . . . 0.0 109.353 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -168.4 -172.0 1.6 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.535 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.672 HG22 ' O ' ' A' ' 4' ' ' VAL . 4.0 p -147.06 66.87 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.279 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.8 t -165.06 -177.22 4.51 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.402 -0.811 . . . . 0.0 109.292 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.414 HG21 HD13 ' A' ' 23' ' ' LEU . 79.2 t -120.47 151.65 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.688 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -73.19 147.12 45.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.918 . . . . 0.0 109.316 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 9.4 m -134.49 43.24 2.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.11 -0.994 . . . . 0.0 109.695 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 5.1 t -90.21 -11.45 40.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -125.03 49.61 1.85 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.337 -0.852 . . . . 0.0 109.522 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.878 ' CB ' HG11 ' A' ' 42' ' ' VAL . 38.9 m-85 -135.23 162.61 56.46 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.313 -0.867 . . . . 0.0 109.076 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.892 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.35 157.69 54.38 Favored 'Cis proline' 0 C--N 1.305 -1.719 0 C-N-CA 122.852 -1.728 . . . . 0.0 110.749 0.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.39 140.24 25.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.27 -0.894 . . . . 0.0 108.688 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -78.37 14.97 1.47 Allowed 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.679 2.253 . . . . 0.0 111.731 -179.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -178.83 154.25 0.71 Allowed 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.155 -0.965 . . . . 0.0 110.056 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.6 t -148.63 171.05 16.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.246 -0.909 . . . . 0.0 110.122 179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.78 -164.74 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -124.57 2.12 8.28 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.751 -1.218 . . . . 0.0 110.289 -179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -60.41 127.42 31.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 6.0 t80 -80.04 110.59 15.57 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.553 1.168 . . . . 0.0 111.272 -177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -139.22 73.29 37.75 Favored Pre-proline 0 C--N 1.29 -2.013 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 178.462 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.5 Cg_endo -64.29 123.16 11.39 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.553 2.169 . . . . 0.0 112.721 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.915 HD12 ' CB ' ' A' ' 37' ' ' PHE . 1.4 mt -112.74 122.99 49.29 Favored 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.593 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -82.92 112.2 19.49 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 118.8 -1.16 . . . . 0.0 109.126 -179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.55 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.6 -166.13 0.06 OUTLIER Glycine 0 N--CA 1.482 1.765 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 49' ' ' THR . 4.6 t -78.1 -32.49 50.59 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.229 -1.16 . . . . 0.0 109.137 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 37.1 p-10 -73.08 0.01 12.73 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.351 -0.843 . . . . 0.0 109.825 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 9.4 m120 77.27 30.32 0.53 Allowed 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.255 -0.903 . . . . 0.0 109.517 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -98.87 137.5 37.35 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 43.4 m -86.97 122.61 31.06 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.08 -1.012 . . . . 0.0 110.844 -178.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.589 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 82.0 m-85 -99.17 139.45 34.8 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 178.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -54.03 -39.03 62.02 Favored Glycine 0 N--CA 1.493 2.457 0 C-N-CA 120.111 -1.043 . . . . 0.0 112.021 -175.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.607 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.4 p30 -162.58 -157.06 0.43 Allowed 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.725 -1.456 . . . . 0.0 109.304 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.835 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.37 -47.5 85.78 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.397 -0.814 . . . . 0.0 111.263 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.516 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 89.3 m -68.07 -43.13 79.29 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.535 -1.353 . . . . 0.0 109.965 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -59.38 -24.08 63.13 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 120.825 -1.172 . . . . 0.0 108.449 179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.915 ' CB ' HD12 ' A' ' 23' ' ' LEU . 10.3 t80 -83.15 -63.03 1.44 Allowed 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 122.05 0.929 . . . . 0.0 111.004 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 49.9 t -56.92 -47.0 81.62 Favored 'General case' 0 C--N 1.287 -2.119 0 O-C-N 121.781 -0.574 . . . . 0.0 110.041 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 25.7 m-20 -42.43 -29.45 0.27 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.829 -1.17 . . . . 0.0 108.307 179.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -73.86 -49.8 23.32 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.707 HG13 ' HA2' ' A' ' 46' ' ' GLY . 92.8 t -53.53 -54.43 18.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.573 0.702 . . . . 0.0 109.732 178.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.892 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.6 m -60.17 -30.06 45.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 110.289 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -85.78 -13.35 48.49 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.218 -0.926 . . . . 0.0 108.729 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.472 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 1.4 p -106.19 -2.75 22.14 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.473 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.8 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.0 OUTLIER 74.66 13.28 3.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.34 -0.85 . . . . 0.0 109.323 -179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.707 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.95 7.46 70.58 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.887 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.8 HG23 ' OD1' ' A' ' 45' ' ' ASN . 70.8 p -82.71 0.19 44.56 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.637 -1.507 . . . . 0.0 108.609 178.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.626 ' HG ' ' N ' ' A' ' 49' ' ' THR . 7.5 tp -80.15 -75.48 0.26 Allowed 'General case' 0 C--N 1.302 -1.48 0 CA-C-O 121.491 0.662 . . . . 0.0 110.117 -179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 8.1 p 62.56 147.0 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -106.06 171.69 7.21 Favored 'General case' 0 C--N 1.289 -2.028 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.858 -177.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.677 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.07 -29.43 8.97 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.593 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 0.8 OUTLIER -167.92 159.84 11.76 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.6 -0.688 . . . . 0.0 110.082 -178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.6 m-85 -75.49 -166.32 0.52 Allowed 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.2 -167.1 18.25 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 109.714 -1.354 . . . . 0.0 109.714 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.589 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.34 -179.04 4.93 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 177.681 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.577 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.6 m . . . . . 0 N--CA 1.49 1.555 0 O-C-N 120.959 -1.088 . . . . 0.0 109.838 -179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.449 ' HA ' HD22 ' A' ' 1' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.23 35.52 0.73 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.147 -0.971 . . . . 0.0 109.779 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.463 ' O ' HG23 ' A' ' 4' ' ' VAL . . . -148.03 115.57 6.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.275 -0.891 . . . . 0.0 109.337 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.759 HG13 HD23 ' A' ' 50' ' ' LEU . 73.0 t -156.77 82.77 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.475 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.1 t -164.15 106.87 0.92 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.157 -0.964 . . . . 0.0 109.921 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG13 ' SG ' ' A' ' 8' ' ' CYS . 9.2 p -104.42 163.81 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.265 -0.897 . . . . 0.0 109.032 179.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' N ' HG22 ' A' ' 6' ' ' VAL . 25.4 t70 -105.1 108.95 20.74 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 110.069 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.566 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 17.8 m -128.95 52.86 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.245 -0.909 . . . . 0.0 109.348 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.0 t -90.29 -13.16 35.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.13 -0.981 . . . . 0.0 110.05 -179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.3 mp0 -103.54 17.08 24.88 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.118 -0.989 . . . . 0.0 109.31 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.764 ' HB3' HG11 ' A' ' 42' ' ' VAL . 73.9 m-85 -96.72 163.68 19.76 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.911 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -83.09 135.63 26.65 Favored 'Cis proline' 0 C--N 1.305 -1.756 0 C-N-CA 123.308 -1.538 . . . . 0.0 111.258 1.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -100.79 138.38 20.05 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 109.198 -0.668 . . . . 0.0 109.198 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -79.82 14.04 1.98 Allowed 'Trans proline' 0 C--N 1.314 -1.237 0 C-N-CA 122.401 2.068 . . . . 0.0 110.747 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.98 133.21 19.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 17' ' ' THR . 94.2 m -103.67 146.46 28.55 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.039 -1.038 . . . . 0.0 110.261 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.459 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -55.73 -166.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.459 -0.775 . . . . 0.0 108.91 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.657 HD12 ' N ' ' A' ' 19' ' ' GLU . 3.3 pp -126.55 -37.34 2.18 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.49 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.657 ' N ' HD12 ' A' ' 18' ' ' LEU . 5.1 pm0 -50.57 137.57 19.27 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.5 t80 -79.5 121.37 25.12 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 122.32 1.057 . . . . 0.0 110.382 -178.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmm180 -148.61 72.38 10.67 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 28.3 Cg_endo -65.51 114.43 2.89 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 C-N-CA 122.046 1.831 . . . . 0.0 111.743 -177.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.609 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -109.42 138.56 45.6 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.991 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -89.15 165.13 14.68 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.497 -0.752 . . . . 0.0 109.205 -179.073 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.593 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -127.42 168.55 19.46 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 -179.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.607 ' H ' HD12 ' A' ' 48' ' ' LEU . 35.4 t -66.81 -25.98 66.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.42 -1.047 . . . . 0.0 108.856 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.568 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.8 p30 -65.52 -10.88 38.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.568 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 t-20 85.38 29.48 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.732 -0.605 . . . . 0.0 110.766 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -120.85 -179.37 3.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.968 -1.082 . . . . 0.0 109.261 179.26 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 31' ' ' TYR . 53.1 m -118.95 166.13 13.23 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 0.0 109.656 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 72.0 m-85 -138.49 110.9 7.46 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.48 -55.98 0.08 OUTLIER Glycine 0 N--CA 1.496 2.676 0 N-CA-C 111.7 -0.56 . . . . 0.0 111.7 -177.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 46.5 p30 -146.87 -172.54 4.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.771 -1.429 . . . . 0.0 110.787 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.609 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.9 ptmt -53.26 -36.29 60.95 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.849 -0.532 . . . . 0.0 110.355 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.491 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 17.2 t -62.33 -69.47 0.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 120.63 -1.294 . . . . 0.0 108.937 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.567 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 18.6 m-80 -43.22 -38.7 2.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.349 -0.844 . . . . 0.0 110.765 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.556 ' CE1' HD21 ' A' ' 48' ' ' LEU . 72.9 t80 -70.59 -40.14 73.43 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 122.688 1.233 . . . . 0.0 110.483 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 91.7 m -68.53 -34.94 76.74 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 114.649 -1.16 . . . . 0.0 110.519 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.649 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.8 m-80 -69.08 -23.77 64.06 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.89 -1.131 . . . . 0.0 108.226 179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.64 -24.9 33.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.561 ' CG2' HD23 ' A' ' 48' ' ' LEU . 72.9 t -80.99 -27.33 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.911 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.9 m -89.52 -21.29 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.507 -0.746 . . . . 0.0 109.127 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.74 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -91.04 -31.15 16.4 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.644 -0.873 . . . . 0.0 108.644 179.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.597 ' O ' HG22 ' A' ' 47' ' ' THR . 86.4 p -86.93 -0.09 55.95 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.585 -0.697 . . . . 0.0 109.806 -179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 77.97 12.74 1.77 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.247 -0.908 . . . . 0.0 108.813 -179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.1 16.57 66.94 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.736 -1.346 . . . . 0.0 109.736 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.597 HG22 ' O ' ' A' ' 44' ' ' SER . 7.4 t -98.02 10.1 41.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.291 -1.123 . . . . 0.0 108.95 179.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.692 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.68 -53.3 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.733 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.615 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 81.1 p 53.65 124.97 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.043 0 CA-C-O 122.644 1.211 . . . . 0.0 111.703 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.991 HD12 ' O ' ' A' ' 24' ' ' CYS . 2.2 tp -71.6 152.75 42.64 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 178.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.549 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.74 -25.27 11.35 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.11 -1.441 . . . . 0.0 107.11 178.452 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.977 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.2 p80 -173.3 157.92 3.46 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -79.51 164.31 24.01 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.05 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 92.78 -167.27 29.47 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -89.81 129.39 36.2 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.083 -1.245 . . . . 0.0 109.645 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.549 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.95 -1.024 . . . . 0.0 109.508 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 60.19 16.59 6.18 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.751 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -140.91 51.4 1.62 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.071 -1.018 . . . . 0.0 109.591 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.713 HG21 ' HA ' ' A' ' 52' ' ' HIS . 16.3 m -97.37 97.44 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.291 -0.881 . . . . 0.0 109.217 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.3 156.22 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.415 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 25.1 t -142.98 151.22 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -94.35 159.24 15.2 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.2 m -140.42 36.64 1.86 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.494 -0.754 . . . . 0.0 109.246 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.6 t -85.57 -28.65 24.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 0.0 109.788 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -97.64 46.09 1.03 Allowed 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.469 -0.769 . . . . 0.0 109.048 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 59.9 m-85 -139.77 161.25 57.4 Favored Pre-proline 0 C--N 1.306 -1.293 0 O-C-N 121.316 -0.865 . . . . 0.0 109.141 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.977 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -83.51 148.95 61.97 Favored 'Cis proline' 0 C--N 1.306 -1.701 0 C-N-CA 122.882 -1.716 . . . . 0.0 110.793 2.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.3 mtpt -102.94 137.78 19.37 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.419 -0.801 . . . . 0.0 109.507 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.94 14.66 1.84 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.658 2.239 . . . . 0.0 111.044 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.26 158.04 2.31 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.271 -0.893 . . . . 0.0 109.576 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 30.3 t -146.54 163.04 37.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.694 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -56.91 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.631 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.481 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -122.81 -7.72 8.45 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.505 -1.372 . . . . 0.0 110.789 -179.54 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' N ' HD12 ' A' ' 18' ' ' LEU . 12.1 pm0 -55.93 -173.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 3.4 t80 -128.93 121.32 27.83 Favored 'General case' 0 C--N 1.285 -2.205 0 C-N-CA 118.607 -1.237 . . . . 0.0 110.653 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.639 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.9 mmt180 -151.22 66.17 7.02 Favored Pre-proline 0 C--N 1.288 -2.077 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.647 ' O ' ' N ' ' A' ' 54' ' ' GLY . 23.4 Cg_endo -63.28 137.17 59.42 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.494 2.796 . . . . 0.0 112.551 -177.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.76 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.1 mp -127.49 143.49 51.18 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 119.405 -0.918 . . . . 0.0 109.202 179.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.654 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 21.0 t -101.53 162.3 13.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.299 -0.875 . . . . 0.0 109.236 -179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.574 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -106.95 178.55 22.17 Favored Glycine 0 N--CA 1.486 1.971 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.1 -178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.649 ' HB2' ' HG1' ' A' ' 49' ' ' THR . 27.4 t -70.65 -18.79 62.85 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -78.9 -10.98 59.98 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 85.06 33.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.315 0.579 . . . . 0.0 109.662 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -111.94 139.82 47.12 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.248 -0.908 . . . . 0.0 109.019 179.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.5 m -90.04 161.97 15.58 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.865 -1.147 . . . . 0.0 110.018 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.597 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 63.9 m-85 -138.39 137.92 37.74 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 178.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.55 -50.23 3.9 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -177.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.7 p30 -164.37 -166.21 1.08 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.152 -1.204 . . . . 0.0 111.123 178.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.76 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -47.72 -48.48 29.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.717 -0.614 . . . . 0.0 112.374 -177.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.519 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 6.0 m -65.86 -52.64 48.57 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 120.473 -1.392 . . . . 0.0 110.457 -178.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 14.1 m-80 -60.06 -17.45 39.54 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 120.847 -1.158 . . . . 0.0 109.347 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.693 ' CE1' HD21 ' A' ' 48' ' ' LEU . 27.6 t80 -82.59 -50.31 8.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 122.588 1.185 . . . . 0.0 109.762 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 42' ' ' VAL . 48.7 t -66.51 -24.02 66.33 Favored 'General case' 0 C--N 1.279 -2.488 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.786 -178.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.535 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.8 OUTLIER -64.43 -26.22 68.35 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.771 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -85.28 -26.8 26.4 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.685 HG13 ' HA2' ' A' ' 46' ' ' GLY . 93.1 t -80.97 -23.72 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.977 HG21 ' HB3' ' A' ' 12' ' ' PRO . 27.7 m -90.82 -25.65 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.771 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.6 pp20? -90.42 -28.23 18.77 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.655 ' O ' HG22 ' A' ' 47' ' ' THR . 48.2 t -89.11 3.54 51.48 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.828 -0.545 . . . . 0.0 109.988 -178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.5 t30 77.11 9.77 2.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.246 -0.909 . . . . 0.0 108.958 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.685 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 82.89 3.21 90.59 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 44' ' ' SER . 14.1 t -79.85 2.68 22.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.041 -1.27 . . . . 0.0 108.974 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.729 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -79.41 -50.02 11.45 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 121.805 0.812 . . . . 0.0 109.088 179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.649 ' HG1' ' HB2' ' A' ' 26' ' ' SER . 25.2 p 54.86 122.13 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.293 1.044 . . . . 0.0 111.335 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.634 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 1.9 tp -60.61 152.99 24.84 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.23 179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.564 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -114.15 -20.26 11.01 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 177.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.713 ' HA ' HG21 ' A' ' 4' ' ' VAL . 0.3 OUTLIER 171.23 158.46 0.08 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.624 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 5.1 m-85 -71.18 -169.23 0.36 Allowed 'General case' 0 C--N 1.295 -1.804 0 O-C-N 121.211 -0.931 . . . . 0.0 109.002 178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.11 -168.76 5.12 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HD3' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -91.41 146.41 23.83 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.429 -1.042 . . . . 0.0 109.452 178.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.608 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.08 -0.962 . . . . 0.0 109.397 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 177.96 80.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.171 -0.956 . . . . 0.0 109.68 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -175.64 106.25 0.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.198 -0.939 . . . . 0.0 109.459 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.682 HG12 ' O ' ' A' ' 4' ' ' VAL . 74.8 t -90.93 67.73 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.338 -0.851 . . . . 0.0 109.679 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.36 175.54 6.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.501 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 27.6 t -113.88 144.6 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.225 -0.922 . . . . 0.0 109.314 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -67.55 116.75 8.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.365 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.4 m -99.15 43.5 1.06 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.164 -0.96 . . . . 0.0 109.522 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.9 m -90.48 -8.67 49.83 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.137 -0.977 . . . . 0.0 110.49 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 3.9 pm0 -112.97 -7.55 13.71 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.973 -1.079 . . . . 0.0 109.812 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.72 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.6 m-85 -88.88 158.9 46.87 Favored Pre-proline 0 C--N 1.303 -1.45 0 O-C-N 121.265 -0.897 . . . . 0.0 108.938 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.742 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -79.89 134.99 32.56 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.841 -1.733 . . . . 0.0 110.631 3.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.63 138.98 19.69 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.638 -0.664 . . . . 0.0 110.215 -178.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -81.76 15.05 2.02 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.512 2.141 . . . . 0.0 110.237 179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -146.42 133.42 20.28 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.411 -0.806 . . . . 0.0 109.243 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 82.3 m -112.23 150.31 31.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.813 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.47 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 1.5 p -56.75 -170.42 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.349 -0.844 . . . . 0.0 108.942 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.415 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -123.6 -28.3 3.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.998 -1.064 . . . . 0.0 109.725 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.47 ' OE2' ' HB ' ' A' ' 17' ' ' THR . 9.5 pm0 -58.57 -166.71 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.594 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.5 t80 -132.83 124.75 28.57 Favored 'General case' 0 C--N 1.289 -2.034 0 CA-C-O 122.258 1.028 . . . . 0.0 110.62 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -154.78 75.83 5.5 Favored Pre-proline 0 C--N 1.293 -1.869 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 179.328 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.2 Cg_endo -64.59 123.67 12.08 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.701 2.267 . . . . 0.0 112.557 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.616 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -117.39 126.78 53.24 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.144 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 49.5 t -79.4 161.78 25.94 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.06 -1.056 . . . . 0.0 108.301 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -132.91 166.54 23.6 Favored Glycine 0 N--CA 1.486 2.005 0 C-N-CA 120.134 -1.031 . . . . 0.0 111.545 -177.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.452 ' O ' ' N ' ' A' ' 28' ' ' ASN . 13.2 t -53.15 -48.46 67.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.593 -0.945 . . . . 0.0 110.781 -178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.597 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -41.63 -26.82 0.08 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.983 -1.073 . . . . 0.0 110.202 -179.344 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.597 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.5 p-10 97.93 31.58 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.273 0.559 . . . . 0.0 109.899 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' O ' ' SG ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -125.81 173.64 8.92 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.1 -1.0 . . . . 0.0 109.583 179.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.3 m -108.9 150.02 28.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.6 -0.687 . . . . 0.0 109.242 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.615 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 74.0 m-85 -117.36 124.75 49.67 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.594 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.94 -52.32 1.19 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 -178.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 17.5 p-10 -158.51 -168.34 2.41 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 120.746 -1.444 . . . . 0.0 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.594 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 7.8 pttt -46.86 -49.95 19.37 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.521 -0.737 . . . . 0.0 110.995 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.539 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 43.9 t -56.1 -64.88 0.72 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.696 -1.252 . . . . 0.0 110.07 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 13.4 m-80 -53.64 -18.9 3.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 110.531 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HB2' HD12 ' A' ' 23' ' ' LEU . 6.8 t80 -79.41 -65.06 1.05 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.677 -1.265 . . . . 0.0 110.216 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.566 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 51.6 t -56.48 -48.71 76.55 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.033 -178.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 7.0 m-20 -43.91 -28.0 0.41 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.614 -1.304 . . . . 0.0 108.514 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.579 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -74.43 -48.03 30.03 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.975 HG22 HD23 ' A' ' 48' ' ' LEU . 79.7 t -57.08 -54.64 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 121.646 0.736 . . . . 0.0 109.649 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.742 HG21 ' HB3' ' A' ' 12' ' ' PRO . 20.3 m -58.25 -30.28 39.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.36 0 O-C-N 121.447 -0.783 . . . . 0.0 109.883 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 4.8 tt0 -91.27 -10.59 40.9 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.154 -0.966 . . . . 0.0 109.36 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 13.7 t -102.96 12.68 35.77 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 110.398 -179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.486 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.2 m-80 62.44 23.89 14.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.059 -1.026 . . . . 0.0 109.496 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 62.88 25.11 67.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 43.5 p -95.13 -4.16 46.65 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.395 -1.062 . . . . 0.0 108.209 178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.975 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -88.94 -76.51 0.4 Allowed 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 122.081 0.943 . . . . 0.0 109.306 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.752 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 80.94 152.0 0.11 Allowed 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 121.871 0.843 . . . . 0.0 108.955 -178.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 68.2 tp -68.92 158.21 35.07 Favored 'General case' 0 C--N 1.292 -1.92 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.469 ' OG ' ' HB3' ' A' ' 24' ' ' CYS . 4.1 p -111.96 -42.38 3.79 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.01 169.94 1.9 Allowed 'General case' 0 C--N 1.292 -1.919 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -82.12 176.37 9.57 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.001 -1.062 . . . . 0.0 108.655 178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.16 -168.13 54.4 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.405 ' O ' ' C ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 153.14 20.58 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.293 . . . . 0.0 109.145 178.722 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 26.9 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.483 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 89.1 mt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.414 ' O ' ' C ' ' A' ' 3' ' ' ALA . . . -112.64 -65.14 1.21 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 0.0 109.757 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 2' ' ' ALA . . . -43.4 136.52 3.11 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.791 HG13 ' O ' ' A' ' 4' ' ' VAL . 13.1 p -154.16 85.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.296 -0.877 . . . . 0.0 109.457 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 28.5 p 178.71 154.87 0.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.416 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.67 HG22 ' H ' ' A' ' 7' ' ' ASP . 4.0 p -115.27 177.51 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.96 . . . . 0.0 109.282 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.67 ' H ' HG22 ' A' ' 6' ' ' VAL . 61.2 t0 -125.78 130.27 51.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.157 -0.964 . . . . 0.0 109.637 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 15.6 m -129.71 69.51 1.42 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.202 -0.936 . . . . 0.0 109.414 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.4 p -91.21 -18.79 23.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.18 -0.95 . . . . 0.0 110.65 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.3 mp0 -106.22 27.5 8.6 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.129 -0.982 . . . . 0.0 110.134 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.979 ' CB ' HG11 ' A' ' 42' ' ' VAL . 97.7 m-85 -109.3 158.26 34.98 Favored Pre-proline 0 C--N 1.302 -1.461 0 O-C-N 121.087 -1.008 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.796 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.5 Cg_endo -80.86 143.97 64.25 Favored 'Cis proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.823 2.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' O ' ' A' ' 10' ' ' GLU . 7.1 mttt -103.5 136.03 19.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.465 -0.772 . . . . 0.0 109.858 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -79.6 14.71 1.77 Allowed 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.757 2.305 . . . . 0.0 110.58 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.12 136.84 11.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.44 -0.788 . . . . 0.0 108.921 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 17' ' ' THR . 60.6 m -128.55 136.89 51.37 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.176 -0.953 . . . . 0.0 109.841 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.464 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.9 p -55.99 -165.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.3 pp -131.87 1.36 3.96 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.844 -1.16 . . . . 0.0 110.326 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 4.9 mm-40 -57.4 -165.99 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.552 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.1 t80 -139.73 115.08 9.85 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 118.448 -1.301 . . . . 0.0 111.38 179.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -150.77 74.3 8.64 Favored Pre-proline 0 C--N 1.289 -2.049 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 178.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.9 Cg_endo -65.35 121.9 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.774 2.316 . . . . 0.0 112.894 -176.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.632 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.34 137.53 50.35 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.695 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER -86.67 167.58 14.37 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.376 -0.827 . . . . 0.0 109.11 -179.198 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.542 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -132.38 159.73 23.47 Favored Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.082 -1.207 . . . . 0.0 110.082 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -19.68 64.45 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.222 -1.164 . . . . 0.0 108.915 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.2 p30 -66.74 -9.16 33.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.269 -0.895 . . . . 0.0 109.129 179.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.4 t-20 87.48 22.87 0.05 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.85 -0.531 . . . . 0.0 110.669 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.482 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -122.14 177.44 5.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.82 -1.175 . . . . 0.0 109.627 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.621 HG22 ' N ' ' A' ' 31' ' ' TYR . 29.9 m -118.24 166.5 12.53 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.638 -0.664 . . . . 0.0 109.233 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' N ' HG22 ' A' ' 30' ' ' THR . 73.7 m-85 -137.44 128.5 27.58 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -43.94 -51.28 7.2 Favored Glycine 0 N--CA 1.488 2.103 0 C-N-CA 119.964 -1.113 . . . . 0.0 110.955 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.3 p-10 -149.4 -165.29 2.24 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.763 -1.433 . . . . 0.0 110.828 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.632 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.22 -24.61 67.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.642 -0.661 . . . . 0.0 111.537 -178.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 11.6 t -76.27 -39.55 54.05 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.574 -1.328 . . . . 0.0 108.898 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 5.3 m-80 -72.1 -34.48 68.67 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.506 -0.746 . . . . 0.0 109.403 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.44 ' CE1' ' O ' ' A' ' 24' ' ' CYS . 63.2 t80 -75.65 -44.18 43.92 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.393 1.092 . . . . 0.0 109.896 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.61 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 20.9 m -66.51 -38.45 87.25 Favored 'General case' 0 C--N 1.28 -2.414 0 CA-C-N 115.256 -0.884 . . . . 0.0 109.568 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.595 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.9 m-80 -63.74 -21.37 66.37 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.15 -27.91 25.87 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.549 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.4 t -76.45 -26.89 17.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.979 HG11 ' CB ' ' A' ' 11' ' ' TYR . 21.0 m -91.07 -26.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 CA-C-O 121.372 0.606 . . . . 0.0 109.542 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -90.7 -15.36 30.46 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.479 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 20.0 t -101.29 12.6 37.18 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.746 -0.782 . . . . 0.0 109.157 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.031 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 68.64 7.72 6.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.066 -179.561 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.3 13.16 66.32 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.031 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.3 p -79.6 -11.11 59.89 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.008 -1.289 . . . . 0.0 108.746 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.826 HD12 ' H ' ' A' ' 49' ' ' THR . 0.5 OUTLIER -78.38 159.34 28.39 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.826 ' H ' HD12 ' A' ' 48' ' ' LEU . 81.2 p -157.64 126.46 5.71 Favored 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.095 0.95 . . . . 0.0 110.061 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.546 ' CD1' ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -63.43 145.51 55.47 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.505 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.84 -25.04 11.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.695 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -171.42 160.73 6.14 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -79.35 174.06 11.95 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.197 -0.939 . . . . 0.0 108.768 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.481 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.31 -166.64 42.31 Favored Glycine 0 N--CA 1.487 2.044 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.586 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.96 131.06 37.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.047 -1.266 . . . . 0.0 109.048 178.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.532 179.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 1' ' ' LEU . 5.0 mp . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -137.08 131.14 32.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.294 -0.879 . . . . 0.0 109.496 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -150.57 49.67 0.88 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.462 -179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.762 ' O ' HG23 ' A' ' 4' ' ' VAL . 25.1 m -96.54 87.4 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.266 -0.896 . . . . 0.0 109.475 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 20.9 p 176.11 158.66 0.27 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.416 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 t -128.15 153.6 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.377 -0.827 . . . . 0.0 109.805 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.3 t0 -64.27 119.07 9.59 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.264 -0.897 . . . . 0.0 108.962 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 6' ' ' VAL . 15.9 m -132.38 40.17 3.32 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.093 -1.004 . . . . 0.0 110.044 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.05 4.95 48.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.27 -0.894 . . . . 0.0 109.665 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 23.9 mp0 -126.81 2.72 6.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.069 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.629 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 46.1 m-85 -84.71 162.07 51.46 Favored Pre-proline 0 C--N 1.304 -1.397 0 O-C-N 121.063 -1.023 . . . . 0.0 109.13 -179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.2 Cg_endo -71.68 148.04 89.51 Favored 'Cis proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.836 -1.735 . . . . 0.0 111.891 2.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.482 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -91.5 144.44 29.62 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -179.8 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.92 13.57 1.93 Allowed 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.53 2.153 . . . . 0.0 110.822 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -163.35 117.83 1.63 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 109.492 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 62.7 m -102.77 135.14 44.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 109.45 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.461 ' OG1' ' HD3' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -55.88 142.92 33.5 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD23 ' N ' ' A' ' 18' ' ' LEU . 5.2 mt -75.88 -36.58 59.48 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.147 -0.97 . . . . 0.0 109.51 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 18' ' ' LEU . 0.9 OUTLIER -42.84 122.28 2.33 Favored 'General case' 0 N--CA 1.484 1.231 0 O-C-N 121.356 -0.84 . . . . 0.0 108.782 179.542 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.454 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.5 t80 -80.82 104.27 11.22 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 122.672 1.225 . . . . 0.0 110.543 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.634 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 4.0 mmt180 -137.55 80.91 31.17 Favored Pre-proline 0 C--N 1.286 -2.159 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.59 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 23.9 Cg_endo -66.97 128.83 19.45 Favored 'Trans proline' 0 C--O 1.202 -1.323 0 C-N-CA 123.994 3.129 . . . . 0.0 114.771 -176.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD13 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mp -107.83 158.34 17.4 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -116.48 137.3 52.27 Favored 'General case' 0 N--CA 1.508 2.453 0 O-C-N 120.285 -1.509 . . . . 0.0 110.394 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.841 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -102.07 157.71 18.45 Favored Glycine 0 N--CA 1.5 2.923 0 O-C-N 121.221 -0.925 . . . . 0.0 112.969 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 41.1 t -55.4 -18.64 7.19 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.192 -0.593 . . . . 0.0 110.382 -178.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.9 p30 -84.57 20.29 1.76 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.998 -1.064 . . . . 0.0 109.398 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.432 ' O ' ' CG ' ' A' ' 28' ' ' ASN . 27.4 t30 56.83 15.34 2.2 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.288 -0.883 . . . . 0.0 109.863 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -99.69 127.54 45.81 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.48 HG21 ' HB3' ' A' ' 55' ' ' LYS . 18.1 m -89.03 126.55 35.47 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.55 -0.719 . . . . 0.0 109.794 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 126.45 43.37 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.489 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -24.8 -42.86 0.01 OUTLIER Glycine 0 N--CA 1.5 2.928 0 N-CA-C 111.962 -0.455 . . . . 0.0 111.962 -178.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.636 ' C ' HD12 ' A' ' 23' ' ' LEU . 47.4 p30 -178.73 -154.85 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 120.86 -1.376 . . . . 0.0 109.745 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.1 OUTLIER -52.39 -60.13 3.59 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.082 -1.011 . . . . 0.0 110.658 -177.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 49.2 t -52.44 -65.75 0.5 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.606 -1.309 . . . . 0.0 110.091 -179.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.536 ' HB2' ' H ' ' A' ' 33' ' ' ASN . 10.2 m-80 -49.28 -21.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.106 -0.996 . . . . 0.0 109.272 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.841 ' HE1' HD21 ' A' ' 48' ' ' LEU . 4.8 t80 -78.8 -71.31 0.44 Allowed 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 118.918 -1.113 . . . . 0.0 111.012 -178.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.687 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.1 m -39.72 -40.62 0.96 Allowed 'General case' 0 C--N 1.282 -2.36 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.413 -178.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.585 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.92 -44.91 94.81 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.474 -1.391 . . . . 0.0 108.016 179.634 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.696 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -54.17 -21.64 9.33 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.877 HG22 HD23 ' A' ' 48' ' ' LEU . 56.7 t -85.64 -63.47 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.799 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.687 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.7 OUTLIER -59.0 -9.21 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.413 -0.804 . . . . 0.0 110.279 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.696 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.02 -32.02 16.08 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.551 -1.343 . . . . 0.0 107.78 178.302 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.551 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -92.22 7.89 40.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.769 -0.582 . . . . 0.0 109.568 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.551 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.0 OUTLIER 80.93 3.71 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.456 -0.778 . . . . 0.0 109.331 -179.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 86.94 6.23 79.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 44' ' ' SER . 13.7 t -79.79 2.25 23.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.18 -1.188 . . . . 0.0 108.758 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.877 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.12 -78.91 0.34 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.364 -0.835 . . . . 0.0 109.339 -179.616 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.78 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.57 148.13 0.08 Allowed 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.047 0.927 . . . . 0.0 109.276 -178.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.644 HD13 ' HB3' ' A' ' 23' ' ' LEU . 13.1 tp -67.29 166.47 14.24 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.599 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.1 OUTLIER -122.6 -44.62 2.22 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.72 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER -160.28 159.37 31.28 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -77.21 143.43 39.0 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.714 0.768 . . . . 0.0 110.057 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.59 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 101.91 -167.42 18.45 Favored Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.528 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -90.48 137.63 32.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.438 179.558 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.516 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.441 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.34 110.6 14.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.251 -0.905 . . . . 0.0 109.433 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.49 96.78 5.68 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.49 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 47.3 t -93.77 77.39 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.902 . . . . 0.0 109.518 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 171.79 84.68 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.57 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.95 115.7 29.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 0.0 109.131 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -74.43 104.73 5.27 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.102 -0.999 . . . . 0.0 109.601 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 59.8 m -103.59 52.72 0.77 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.237 -0.914 . . . . 0.0 109.434 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.69 -21.53 38.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.176 -0.952 . . . . 0.0 109.859 -179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -84.75 -7.53 59.17 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -0.918 . . . . 0.0 109.25 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.855 ' HB3' HG11 ' A' ' 42' ' ' VAL . 74.7 m-85 -79.87 163.86 56.01 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.97 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.8 Cg_endo -82.38 143.0 51.26 Favored 'Cis proline' 0 C--N 1.306 -1.664 0 C-N-CA 123.304 -1.54 . . . . 0.0 111.088 2.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.2 mttt -97.35 141.11 22.53 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.633 -0.667 . . . . 0.0 110.033 -179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.42 15.13 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.755 2.303 . . . . 0.0 110.477 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.27 116.29 1.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.522 -0.736 . . . . 0.0 109.028 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 98.6 m -82.24 145.59 29.95 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.341 -0.849 . . . . 0.0 109.892 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.8 OUTLIER -52.35 -175.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -114.91 -19.29 11.03 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.822 -1.174 . . . . 0.0 110.262 -179.707 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 18' ' ' LEU . 16.5 pm0 -57.9 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.258 0 O-C-N 120.788 -1.195 . . . . 0.0 107.827 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.439 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.2 t80 -139.15 126.85 21.95 Favored 'General case' 0 C--N 1.291 -1.972 0 C-N-CA 119.043 -1.063 . . . . 0.0 110.893 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.2 mtm180 -161.52 81.03 1.99 Allowed Pre-proline 0 C--N 1.294 -1.827 0 N-CA-C 107.481 -1.304 . . . . 0.0 107.481 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 21.0 Cg_endo -63.83 107.24 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.192 1.928 . . . . 0.0 111.739 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.615 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -100.6 126.09 47.05 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.198 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.509 ' HB3' ' NE2' ' A' ' 52' ' ' HIS . 43.3 t -77.97 168.1 20.43 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -145.46 161.19 28.19 Favored Glycine 0 N--CA 1.486 1.98 0 C-N-CA 119.279 -1.439 . . . . 0.0 111.102 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -59.45 -35.18 73.56 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.728 -0.866 . . . . 0.0 109.441 -179.005 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.635 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.3 OUTLIER -45.18 -27.43 0.61 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.081 -1.012 . . . . 0.0 109.036 179.836 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.635 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 101.11 19.53 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.063 0.458 . . . . 0.0 109.961 179.72 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.99 175.24 8.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.105 -0.997 . . . . 0.0 109.616 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.506 HG22 ' N ' ' A' ' 31' ' ' TYR . 38.0 m -106.18 162.08 13.95 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.883 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 86.7 m-85 -133.26 102.66 5.65 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.188 -0.945 . . . . 0.0 108.618 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.527 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.14 -60.29 0.02 OUTLIER Glycine 0 N--CA 1.499 2.856 0 N-CA-C 111.953 -0.459 . . . . 0.0 111.953 -178.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.1 p30 -143.42 -170.37 3.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.968 -1.313 . . . . 0.0 110.627 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.615 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -49.19 -48.32 45.3 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.853 -0.529 . . . . 0.0 110.816 -178.804 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 18.2 t -53.32 -71.59 0.07 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.741 -1.225 . . . . 0.0 109.432 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.563 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.2 m-80 -40.28 -39.77 1.01 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.279 -0.888 . . . . 0.0 110.839 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.608 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 35.9 t80 -61.73 -51.51 68.05 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-O 122.862 1.315 . . . . 0.0 109.833 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.599 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 90.1 m -57.77 -50.89 71.72 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 114.804 -1.089 . . . . 0.0 109.575 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -44.37 -29.29 0.66 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.833 -1.167 . . . . 0.0 108.66 179.506 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.883 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.42 -49.41 49.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.814 HG22 ' CD2' ' A' ' 48' ' ' LEU . 38.4 t -57.62 -56.84 13.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.453 0.644 . . . . 0.0 109.667 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.97 HG21 ' HB3' ' A' ' 12' ' ' PRO . 13.2 m -58.7 -23.07 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.059 -1.026 . . . . 0.0 110.642 -179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.547 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 2.1 tt0 -91.43 -17.48 25.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.048 -1.033 . . . . 0.0 109.391 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 11.9 t -105.69 22.95 14.67 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.444 -0.902 . . . . 0.0 110.342 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 21.6 m120 64.74 9.61 5.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.267 -0.895 . . . . 0.0 109.524 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.561 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 80.92 17.93 71.22 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 53.1 p -89.97 -9.43 48.78 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.373 -1.075 . . . . 0.0 108.239 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.814 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -81.47 149.76 28.6 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.564 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 5.1 p -122.41 151.52 41.16 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.25 -0.906 . . . . 0.0 109.608 179.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 11.6 tp -65.52 124.28 21.89 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 7.3 t -78.55 -24.75 45.45 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.62 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CB ' ' O ' ' A' ' 51' ' ' SER . 15.9 p80 151.02 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-O 121.299 0.571 . . . . 0.0 110.056 178.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -84.4 154.91 22.54 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 85.54 178.5 50.46 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.579 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -79.85 161.37 25.66 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.892 -1.358 . . . . 0.0 107.947 178.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.579 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.742 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.673 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.687 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.6 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.687 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 74.36 142.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.176 -0.953 . . . . 0.0 109.326 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -133.29 89.12 2.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.18 -0.95 . . . . 0.0 109.892 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.691 ' O ' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -104.32 80.39 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.832 . . . . 0.0 108.882 179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.21 -162.01 0.9 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.403 -0.81 . . . . 0.0 109.795 -179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 6' ' ' VAL . 87.1 t -145.41 47.44 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.095 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.456 ' HB3' ' O ' ' A' ' 6' ' ' VAL . 50.2 t0 63.77 147.42 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.886 0 O-C-N 121.465 -0.772 . . . . 0.0 109.238 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 40.8 t -160.49 20.89 0.15 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.058 -1.027 . . . . 0.0 110.261 -179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.8 t -90.8 -4.01 56.96 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.097 -1.002 . . . . 0.0 110.04 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 51.1 mp0 -108.56 34.82 3.45 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.042 -1.036 . . . . 0.0 109.975 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.734 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.1 m-85 -133.23 159.67 71.7 Favored Pre-proline 0 C--N 1.306 -1.317 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -73.42 159.6 97.14 Favored 'Cis proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.859 -1.725 . . . . 0.0 111.994 2.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.493 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttt -117.72 144.78 35.05 Favored Pre-proline 0 N--CA 1.487 1.424 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.686 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.26 14.48 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.44 2.093 . . . . 0.0 111.411 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.686 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 166.21 134.34 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 0.0 110.129 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.486 ' SG ' ' N ' ' A' ' 17' ' ' THR . 42.2 t -112.03 157.62 20.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.123 -0.986 . . . . 0.0 109.516 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.486 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 10.6 p -59.3 -162.53 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -120.53 -15.92 8.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.524 -1.36 . . . . 0.0 109.976 179.534 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.546 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.9 pt-20 -46.62 130.55 11.37 Favored 'General case' 0 C--N 1.306 -1.326 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.585 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.1 t80 -89.28 130.02 35.74 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 122.391 1.091 . . . . 0.0 111.107 -177.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mtt180 -160.63 74.26 2.79 Favored Pre-proline 0 C--N 1.293 -1.882 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 179.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 22.0 Cg_endo -64.59 129.7 24.42 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 123.145 2.563 . . . . 0.0 112.794 -177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.654 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -117.93 135.72 53.94 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 118.515 -1.274 . . . . 0.0 108.212 178.002 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.967 ' O ' HD12 ' A' ' 50' ' ' LEU . 8.7 t -77.37 133.44 38.72 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -79.94 -162.68 26.03 Favored Glycine 0 C--N 1.292 -1.867 0 C-N-CA 117.67 -2.205 . . . . 0.0 109.218 -179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.544 ' HG ' ' HG ' ' A' ' 48' ' ' LEU . 0.3 OUTLIER -85.85 -33.87 21.19 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -1.2 . . . . 0.0 108.331 179.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -57.3 -17.29 11.44 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 62.0 t30 96.31 22.12 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 CA-C-O 120.982 0.42 . . . . 0.0 110.707 179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -107.49 -158.5 0.65 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.953 -1.092 . . . . 0.0 109.163 178.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.489 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.9 m -129.74 158.9 38.12 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.484 -0.76 . . . . 0.0 110.031 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.641 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -132.74 135.02 45.49 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 178.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.585 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.95 -50.3 1.5 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 54.5 p30 -163.73 -157.42 0.4 Allowed 'General case' 0 C--N 1.297 -1.707 0 O-C-N 120.945 -1.327 . . . . 0.0 110.369 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.654 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -64.07 -39.94 95.16 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 112.146 -177.059 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.652 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.0 m -64.9 -57.01 9.94 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.585 -1.322 . . . . 0.0 110.43 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -61.06 -32.21 71.85 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.025 -1.047 . . . . 0.0 110.129 -179.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.652 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 7.0 t80 -62.38 -60.06 4.1 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.793 -1.192 . . . . 0.0 109.511 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.667 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.8 t -56.79 -49.68 74.61 Favored 'General case' 0 C--N 1.286 -2.157 0 CA-C-N 115.002 -0.999 . . . . 0.0 110.033 -178.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.57 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 7.1 m-20 -40.97 -30.82 0.14 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.807 -1.183 . . . . 0.0 108.084 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.641 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.38 -49.45 18.96 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.977 HG22 HD23 ' A' ' 48' ' ' LEU . 88.1 t -60.36 -63.68 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 CA-C-O 121.457 0.646 . . . . 0.0 109.825 178.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.734 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.1 p -55.89 -26.36 20.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.141 -0.974 . . . . 0.0 111.785 -178.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.57 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.43 -16.17 27.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.08 -1.637 . . . . 0.0 108.737 178.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.51 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 10.7 t -98.85 21.94 10.83 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.393 -0.817 . . . . 0.0 110.097 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 44' ' ' SER . 78.4 m-20 65.22 8.27 4.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.32 -0.862 . . . . 0.0 109.927 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.49 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 78.12 11.32 85.48 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 110.613 -0.995 . . . . 0.0 110.613 179.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 37.2 p -79.3 -4.24 49.87 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.025 -1.28 . . . . 0.0 108.194 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.977 HD23 HG22 ' A' ' 41' ' ' VAL . 1.9 tp -79.94 -86.03 0.08 Allowed 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 80.36 168.69 0.16 Allowed 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 -178.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.967 HD12 ' O ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -119.82 178.89 4.42 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.639 -1.288 . . . . 0.0 110.565 -178.04 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.621 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.07 -38.36 3.89 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.724 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.74 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 2.3 p80 -163.93 151.67 12.61 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.752 0.787 . . . . 0.0 110.139 -179.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.523 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.6 m-85 -62.41 -174.97 0.07 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.69 -0.631 . . . . 0.0 109.413 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.594 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 66.15 -169.27 32.15 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.261 -1.135 . . . . 0.0 110.261 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 1.2 mtmm -92.51 134.99 34.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.691 -0.888 . . . . 0.0 109.274 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.551 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 120.954 -1.091 . . . . 0.0 109.402 179.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.282 0.563 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -162.14 -92.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.0 109.622 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.43 175.87 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.9 m -142.35 73.07 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.358 -0.839 . . . . 0.0 109.374 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.26 124.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 109.267 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG21 HD13 ' A' ' 23' ' ' LEU . 63.9 t -98.67 152.72 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.401 -0.812 . . . . 0.0 109.707 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' O ' ' SG ' ' A' ' 8' ' ' CYS . 11.5 p-10 -80.62 -176.37 5.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.265 -0.897 . . . . 0.0 109.598 -179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.401 ' SG ' ' O ' ' A' ' 7' ' ' ASP . 7.1 m -157.81 49.77 0.42 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.792 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -90.96 -4.27 56.61 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.965 . . . . 0.0 110.07 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.485 ' HB3' ' HE3' ' A' ' 13' ' ' LYS . 4.6 mp0 -134.11 49.4 2.26 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.004 -1.06 . . . . 0.0 110.422 -179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.906 ' HB3' HG11 ' A' ' 42' ' ' VAL . 99.1 m-85 -141.66 153.48 65.05 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 120.922 -1.111 . . . . 0.0 109.241 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -74.28 136.44 44.95 Favored 'Cis proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.396 -1.918 . . . . 0.0 111.439 2.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.515 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 6.0 tttt -85.4 145.0 41.42 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.662 -0.649 . . . . 0.0 109.62 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.515 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.7 Cg_endo -79.09 13.73 1.92 Allowed 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.801 2.334 . . . . 0.0 110.742 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.65 128.07 0.32 Allowed 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.387 -0.821 . . . . 0.0 109.111 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.451 ' O ' ' O ' ' A' ' 17' ' ' THR . 71.7 m -91.64 139.08 31.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.339 -0.85 . . . . 0.0 110.054 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.451 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.3 OUTLIER -49.14 174.88 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.272 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.458 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.55 -16.83 12.77 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.96 -1.088 . . . . 0.0 109.928 -179.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -56.53 -168.58 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 178.864 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.551 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.8 t80 -140.22 123.15 16.55 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-O 122.422 1.106 . . . . 0.0 110.576 179.073 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.556 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.15 80.92 2.37 Favored Pre-proline 0 C--N 1.292 -1.924 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.234 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.59 125.23 14.02 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.694 2.262 . . . . 0.0 112.466 -177.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -111.38 128.4 55.96 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.215 -1.031 . . . . 0.0 108.215 179.05 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.735 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 1.8 t -78.7 135.34 37.14 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.58 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -82.6 -165.47 36.93 Favored Glycine 0 N--CA 1.481 1.65 0 C-N-CA 118.511 -1.804 . . . . 0.0 108.613 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.498 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 45.8 t -87.45 -29.6 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.664 -1.492 . . . . 0.0 108.728 179.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.612 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -63.06 -14.02 43.02 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.526 -0.734 . . . . 0.0 109.082 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.612 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.1 t-20 96.28 19.26 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.102 0 CA-C-O 120.929 0.395 . . . . 0.0 110.474 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.655 ' N ' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -98.97 -165.54 1.25 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.879 -1.138 . . . . 0.0 108.54 178.759 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.551 HG21 ' HB3' ' A' ' 55' ' ' LYS . 7.7 m -135.4 157.43 46.91 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.356 -0.84 . . . . 0.0 109.333 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.591 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 70.6 m-85 -129.63 121.69 27.55 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.551 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -29.07 -51.94 0.13 Allowed Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.556 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 44.7 p30 -158.28 -162.96 1.2 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.111 -1.229 . . . . 0.0 109.488 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -57.71 -48.12 80.47 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.43 -0.794 . . . . 0.0 111.051 -178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 50.7 t -52.8 -52.71 55.81 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.625 -1.297 . . . . 0.0 109.962 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.591 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.6 m-80 -63.26 -31.5 72.66 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 121.488 -0.758 . . . . 0.0 110.942 -178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.611 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 19.2 t80 -74.02 -61.65 1.78 Allowed 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.689 -1.257 . . . . 0.0 110.766 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.617 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 30.5 t -57.56 -49.4 76.51 Favored 'General case' 0 C--N 1.287 -2.146 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.927 -178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.3 m-20 -42.34 -30.89 0.35 Allowed 'General case' 0 C--N 1.305 -1.327 0 O-C-N 120.67 -1.269 . . . . 0.0 108.18 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.839 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -80.12 -43.4 21.76 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.733 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.5 t -66.78 -65.92 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.426 -0.796 . . . . 0.0 108.928 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.906 HG11 ' HB3' ' A' ' 11' ' ' TYR . 9.8 p -50.67 -30.57 8.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.033 -1.042 . . . . 0.0 111.423 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.527 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -92.72 -16.96 24.83 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.056 -1.652 . . . . 0.0 109.137 178.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.97 ' O ' HG22 ' A' ' 47' ' ' THR . 65.8 p -101.1 19.8 16.81 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.486 -0.759 . . . . 0.0 110.391 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' OD1' ' O ' ' A' ' 44' ' ' SER . 1.8 p-10 53.85 29.66 10.16 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.37 -0.831 . . . . 0.0 110.81 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.733 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 68.21 28.92 73.13 Favored Glycine 0 N--CA 1.491 2.364 0 O-C-N 121.258 -0.901 . . . . 0.0 110.861 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.97 HG22 ' O ' ' A' ' 44' ' ' SER . 10.1 t -95.72 -10.62 28.76 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.839 HD22 ' CB ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -80.55 -53.7 6.33 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.266 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.588 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 0.8 OUTLIER 50.99 172.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 121.302 0.572 . . . . 0.0 109.586 179.797 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.612 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -132.49 163.49 28.68 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.179 -0.951 . . . . 0.0 109.099 -179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.612 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.49 -30.97 8.75 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.735 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -168.93 163.52 11.52 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 120.115 -0.634 . . . . 0.0 109.429 -178.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -70.2 -166.48 0.13 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 57.67 -173.51 2.56 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.551 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.13 138.47 31.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.285 -1.126 . . . . 0.0 109.142 179.074 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.599 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.554 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -74.29 -77.82 0.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 50' ' ' LEU . . . -75.86 162.21 28.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.273 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.692 ' H ' HD23 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -117.51 43.55 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.037 . . . . 0.0 110.395 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER 151.03 39.01 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 CA-C-O 120.85 0.357 . . . . 0.0 110.235 178.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 5' ' ' SER . 21.3 t -159.32 148.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.077 -1.015 . . . . 0.0 110.423 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.07 122.97 42.25 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.593 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 12.1 m -125.72 43.04 3.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.003 -1.061 . . . . 0.0 110.652 -178.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.78 10.47 25.93 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.113 -0.992 . . . . 0.0 109.616 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.5 mp0 -131.73 6.1 4.33 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 120.939 -1.101 . . . . 0.0 110.868 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.624 ' CG ' ' HB3' ' A' ' 38' ' ' CYS . 62.1 m-85 -84.19 156.97 63.05 Favored Pre-proline 0 C--N 1.307 -1.282 0 O-C-N 120.827 -1.17 . . . . 0.0 109.019 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.547 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.7 144.98 82.5 Favored 'Cis proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.747 -1.772 . . . . 0.0 112.011 2.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.514 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -92.45 147.68 34.88 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.48 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.514 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.4 Cg_endo -77.4 13.6 1.56 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 111.275 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.7 112.45 0.57 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.335 -0.853 . . . . 0.0 109.024 179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' O ' ' C ' ' A' ' 17' ' ' THR . 91.8 m -87.86 144.55 26.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.53 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.453 ' OG1' ' HG3' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -45.37 157.16 0.09 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.83 -33.57 7.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.853 -1.155 . . . . 0.0 110.107 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.8 pm0 -62.09 -176.51 0.1 Allowed 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.565 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 9.7 t80 -115.83 129.32 56.38 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 122.411 1.101 . . . . 0.0 110.202 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 16.2 mtp-105 -159.86 70.73 3.17 Favored Pre-proline 0 C--N 1.291 -1.945 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.634 ' O ' ' N ' ' A' ' 54' ' ' GLY . 19.4 Cg_endo -60.27 121.79 10.32 Favored 'Trans proline' 0 C--O 1.192 -1.795 0 C-N-CA 123.295 2.664 . . . . 0.0 112.831 -176.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 1.7 mp -103.97 158.73 16.22 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.618 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -116.7 132.05 56.79 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 119.795 -1.816 . . . . 0.0 111.949 -178.194 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.638 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -87.46 160.87 32.04 Favored Glycine 0 N--CA 1.503 3.101 0 CA-C-O 121.758 0.643 . . . . 0.0 111.909 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.498 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -64.44 -34.41 78.12 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -61.49 -11.84 12.46 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.397 -0.814 . . . . 0.0 109.309 179.422 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.3 m-20 88.27 18.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.815 -0.553 . . . . 0.0 110.942 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 1.3 pttm -107.78 122.28 46.44 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 51.1 m -80.7 132.97 35.62 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-O 121.729 0.776 . . . . 0.0 110.774 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.833 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.95 140.98 31.49 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.306 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.553 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -49.38 -41.51 32.37 Favored Glycine 0 N--CA 1.495 2.621 0 O-C-N 121.216 -0.927 . . . . 0.0 112.069 -176.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.692 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.9 p30 -164.88 -158.39 0.4 Allowed 'General case' 0 C--N 1.297 -1.69 0 O-C-N 120.448 -1.619 . . . . 0.0 110.363 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -57.75 -45.6 85.66 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.404 -177.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 36.4 t -68.43 -57.27 6.11 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.703 -1.248 . . . . 0.0 108.906 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -49.97 -22.23 1.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.862 ' CE1' HD21 ' A' ' 48' ' ' LEU . 7.3 t80 -83.04 -63.67 1.32 Allowed 'General case' 0 N--CA 1.483 1.21 0 CA-C-O 122.266 1.032 . . . . 0.0 110.918 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 13.5 m -47.87 -51.4 23.17 Favored 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.257 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 9.8 m-20 -48.3 -36.24 13.82 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.734 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -60.12 -46.27 90.18 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 178.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.444 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.0 t -64.93 -65.17 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.56 0.695 . . . . 0.0 110.246 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.588 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.4 p -58.97 -19.58 15.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.352 -0.842 . . . . 0.0 112.011 -178.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.574 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -93.42 -16.27 24.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.093 -1.629 . . . . 0.0 109.22 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.687 ' O ' HG22 ' A' ' 47' ' ' THR . 4.4 p -98.66 18.39 16.94 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.441 -0.787 . . . . 0.0 109.807 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t30 74.54 4.61 4.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.135 -0.978 . . . . 0.0 108.415 -178.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.81 20.08 69.03 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.687 HG22 ' O ' ' A' ' 44' ' ' SER . 12.0 t -87.53 -1.77 58.16 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.449 -1.03 . . . . 0.0 108.642 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -89.45 161.76 16.1 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.786 ' H ' HD12 ' A' ' 48' ' ' LEU . 75.8 p -147.9 130.21 15.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.234 -0.916 . . . . 0.0 109.807 178.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 4' ' ' VAL . 9.1 tp -68.83 141.16 55.2 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.04 -17.91 12.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.802 -1.186 . . . . 0.0 108.065 179.418 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.618 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 173.88 154.22 0.11 Allowed 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.54 0.686 . . . . 0.0 109.701 -179.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.48 ' CZ ' ' HB3' ' A' ' 5' ' ' SER . 4.1 m-85 -70.31 176.77 3.71 Favored 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.049 178.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.14 -172.09 44.85 Favored Glycine 0 N--CA 1.496 2.7 0 N-CA-C 110.124 -1.19 . . . . 0.0 110.124 -179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.402 ' CE ' ' OH ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -91.68 156.23 17.74 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.142 -1.211 . . . . 0.0 108.811 178.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.508 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 5.6 m . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.029 -1.044 . . . . 0.0 109.556 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -97.89 102.76 14.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.487 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.656 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 167.13 97.74 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.515 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.6 t -127.13 91.56 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.281 -0.887 . . . . 0.0 109.432 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -174.39 112.52 0.16 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.252 -0.905 . . . . 0.0 109.642 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.502 HG11 ' CE2' ' A' ' 37' ' ' PHE . 2.6 p -110.45 165.04 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.235 -0.916 . . . . 0.0 109.298 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -114.87 132.64 56.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.172 -0.955 . . . . 0.0 109.605 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.491 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 79.9 m -130.62 53.58 1.95 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.28 -0.888 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.3 -16.31 29.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.219 -0.926 . . . . 0.0 109.866 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.51 37.42 1.91 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 109.159 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.895 ' CB ' HG11 ' A' ' 42' ' ' VAL . 94.9 m-85 -125.91 161.09 53.37 Favored Pre-proline 0 C--N 1.304 -1.396 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.873 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.3 Cg_endo -86.29 153.88 50.35 Favored 'Cis proline' 0 C--N 1.305 -1.76 0 C-N-CA 123.281 -1.55 . . . . 0.0 110.999 1.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.0 140.67 25.85 Favored Pre-proline 0 N--CA 1.491 1.584 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.622 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.85 14.4 1.7 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.58 2.186 . . . . 0.0 111.141 -179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.622 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 167.95 135.04 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.348 -0.845 . . . . 0.0 108.871 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 13' ' ' LYS . 0.1 OUTLIER -133.2 165.44 24.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.933 -1.104 . . . . 0.0 110.737 -179.658 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.463 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.1 OUTLIER -54.99 -165.22 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.58 -0.7 . . . . 0.0 109.39 -179.664 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.596 ' C ' HD12 ' A' ' 18' ' ' LEU . 3.4 pp -122.86 3.68 9.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.008 -1.057 . . . . 0.0 110.273 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.7 pt-20 -47.63 118.44 2.26 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -79.37 126.91 31.42 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 122.757 1.265 . . . . 0.0 111.759 -177.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 3.2 ptm180 -161.45 75.12 2.45 Favored Pre-proline 0 C--N 1.291 -1.937 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.65 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.7 Cg_endo -64.31 118.99 5.91 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.458 2.105 . . . . 0.0 113.035 -176.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.795 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -113.05 128.84 56.61 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 119.29 -0.964 . . . . 0.0 108.507 179.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.599 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -88.87 112.09 22.84 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.604 -179.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.67 -169.73 0.05 OUTLIER Glycine 0 N--CA 1.484 1.855 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.7 t -75.5 -34.63 60.85 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.205 -1.173 . . . . 0.0 109.173 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.562 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.9 p30 -68.51 -6.64 26.32 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.29 -0.882 . . . . 0.0 109.261 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.562 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.1 t-20 83.92 30.39 0.07 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.587 -0.696 . . . . 0.0 109.932 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 0.0 OUTLIER -99.18 137.77 37.22 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.222 -0.924 . . . . 0.0 108.536 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.411 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 91.1 m -85.12 135.22 34.07 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.056 -1.028 . . . . 0.0 109.865 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.731 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 6.9 m-85 -113.83 142.68 45.79 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.584 -1.636 . . . . 0.0 106.584 178.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -55.98 -39.13 78.08 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.831 -1.176 . . . . 0.0 112.151 -175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 23.1 p-10 -160.05 -164.25 1.26 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 120.689 -1.477 . . . . 0.0 109.632 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.795 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -61.84 -29.0 69.88 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.096 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.625 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 62.5 m -77.18 -57.1 4.03 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.938 -1.101 . . . . 0.0 109.041 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 1.2 m120 -48.61 -36.85 16.63 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.782 -1.199 . . . . 0.0 108.528 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.688 ' HB2' HD12 ' A' ' 23' ' ' LEU . 17.0 t80 -68.38 -56.52 8.21 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.359 1.076 . . . . 0.0 110.247 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.596 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 64.0 m -52.65 -56.6 14.29 Favored 'General case' 0 C--N 1.281 -2.38 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.317 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 14.1 m-20 -38.7 -29.43 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.056 -1.028 . . . . 0.0 109.463 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.731 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.31 -51.03 14.18 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.503 ' N ' ' O ' ' A' ' 38' ' ' CYS . 89.8 t -52.24 -53.79 17.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 CA-C-O 121.646 0.736 . . . . 0.0 109.474 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.895 HG11 ' CB ' ' A' ' 11' ' ' TYR . 32.8 m -59.96 -34.01 54.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -91.83 -2.33 56.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.128 -0.983 . . . . 0.0 109.629 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.737 ' O ' HG22 ' A' ' 47' ' ' THR . 28.9 t -106.28 -8.26 17.37 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.277 -0.889 . . . . 0.0 109.97 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.537 ' CB ' ' O ' ' A' ' 44' ' ' SER . 2.8 t-20 80.32 30.41 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.416 -0.802 . . . . 0.0 109.102 -179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 55.62 31.93 57.99 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.737 HG22 ' O ' ' A' ' 44' ' ' SER . 10.5 t -114.13 8.31 16.91 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.834 -1.172 . . . . 0.0 107.834 178.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.627 ' HG ' ' N ' ' A' ' 49' ' ' THR . 2.0 tp -89.76 -71.03 0.63 Allowed 'General case' 0 C--N 1.311 -1.098 0 CA-C-O 121.538 0.685 . . . . 0.0 109.292 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.627 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.9 p 60.5 143.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.646 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -102.55 171.83 7.21 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.213 -178.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.646 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.23 -30.54 8.31 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.747 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.599 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -162.53 158.04 23.01 Favored 'General case' 0 C--N 1.303 -1.447 0 C-N-CA 119.623 -0.831 . . . . 0.0 110.391 -178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 6.4 m-85 -75.81 -164.45 0.36 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 178.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 60.43 -169.49 8.12 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -92.45 168.64 11.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.494 -1.003 . . . . 0.0 108.773 178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 33.8 m . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.935 -1.031 . . . . 0.0 109.591 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.73 136.01 23.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -0.916 . . . . 0.0 109.508 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.61 77.37 5.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.643 ' O ' HG23 ' A' ' 4' ' ' VAL . 27.3 m -127.68 80.61 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.408 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 m -143.69 93.7 2.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.187 -0.945 . . . . 0.0 109.688 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 p -88.4 165.96 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.201 -0.937 . . . . 0.0 109.025 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -111.0 152.19 27.11 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.038 -1.039 . . . . 0.0 110.057 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.6 m -135.01 57.04 1.82 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.303 -0.873 . . . . 0.0 109.273 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.7 t -89.1 -15.59 33.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.731 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 13' ' ' LYS . 1.2 mp0 -95.94 4.13 52.98 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.88 . . . . 0.0 109.305 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.73 ' HB3' HG11 ' A' ' 42' ' ' VAL . 96.0 m-85 -96.5 159.52 31.66 Favored Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.401 -0.812 . . . . 0.0 109.079 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.949 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -81.68 140.29 45.92 Favored 'Cis proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.808 -1.747 . . . . 0.0 110.531 2.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 10.3 mttt -99.78 139.05 20.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.52 -0.738 . . . . 0.0 109.744 -179.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.1 Cg_endo -80.61 14.2 2.08 Favored 'Trans proline' 0 C--N 1.314 -1.284 0 C-N-CA 122.55 2.167 . . . . 0.0 110.452 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.92 126.25 7.98 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 81.5 m -116.57 139.63 50.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.651 -179.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.421 ' O ' ' O ' ' A' ' 16' ' ' CYS . 7.1 p -55.4 -169.96 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.247 -0.908 . . . . 0.0 108.729 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.4 OUTLIER -121.84 -25.74 4.96 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.142 -0.973 . . . . 0.0 109.497 179.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.6 mt-10 -45.37 123.62 4.24 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 179.273 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.517 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 13.8 t80 -83.97 105.42 14.84 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 122.694 1.235 . . . . 0.0 110.693 -178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.685 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 8.6 mtp180 -136.89 75.33 49.02 Favored Pre-proline 0 C--N 1.285 -2.198 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.6 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 18.4 Cg_endo -61.15 119.35 6.46 Favored 'Trans proline' 0 C--O 1.193 -1.747 0 C-N-CA 123.523 2.815 . . . . 0.0 114.195 -176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.669 ' HB2' ' CD2' ' A' ' 31' ' ' TYR . 2.7 mp -101.77 154.47 18.88 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.614 ' HB2' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -114.79 140.35 48.98 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 119.897 -1.752 . . . . 0.0 109.637 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.664 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.44 161.88 17.96 Favored Glycine 0 N--CA 1.497 2.743 0 CA-C-O 122.4 1.0 . . . . 0.0 113.747 -178.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.55 -37.44 86.15 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 115.109 -0.546 . . . . 0.0 109.802 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.57 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p-10 -58.69 -13.82 6.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.962 . . . . 0.0 109.267 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.57 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 19.8 m-20 91.61 12.2 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 121.313 0.578 . . . . 0.0 109.576 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 30.5 ttpt -99.28 128.8 45.45 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 178.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 96.7 m -88.29 129.54 35.35 Favored 'General case' 0 C--N 1.294 -1.846 0 C-N-CA 119.646 -0.821 . . . . 0.0 109.849 -179.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.795 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -97.07 132.02 43.28 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 107.405 -1.331 . . . . 0.0 107.405 178.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' HA3' ' OD1' ' A' ' 36' ' ' ASN . . . -45.0 -39.74 6.61 Favored Glycine 0 N--CA 1.494 2.511 0 O-C-N 121.476 -0.765 . . . . 0.0 112.045 -176.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.685 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -165.57 -157.26 0.31 Allowed 'General case' 0 C--N 1.298 -1.673 0 O-C-N 120.528 -1.572 . . . . 0.0 110.279 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 0.1 OUTLIER -57.83 -51.2 70.55 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 119.373 -0.931 . . . . 0.0 109.475 -178.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.566 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 17.3 t -61.3 -60.01 4.4 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.68 -1.263 . . . . 0.0 109.214 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.549 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -48.9 -23.81 1.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.148 -0.97 . . . . 0.0 108.858 179.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.795 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 9.1 t80 -80.78 -65.62 0.99 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 122.125 0.964 . . . . 0.0 110.618 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.85 ' O ' HG13 ' A' ' 42' ' ' VAL . 12.1 m -50.26 -22.8 1.91 Allowed 'General case' 0 C--N 1.282 -2.346 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.694 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.1 m-80 -76.83 -40.28 48.41 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -58.32 -23.38 56.41 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.0 HG22 HD23 ' A' ' 48' ' ' LEU . 92.4 t -84.04 -53.14 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.82 -0.808 . . . . 0.0 108.82 179.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.949 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.8 m -65.71 -12.36 13.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 121.684 -0.635 . . . . 0.0 109.649 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -93.55 -18.91 21.71 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.198 -0.939 . . . . 0.0 109.441 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.541 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 2.5 t -108.41 22.99 15.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.312 -0.867 . . . . 0.0 109.895 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.1 OUTLIER 79.26 -3.82 2.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.221 -0.925 . . . . 0.0 109.057 -179.256 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.566 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 86.54 11.06 72.26 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 110.212 -1.155 . . . . 0.0 110.212 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.3 t -85.42 -5.94 59.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -1.187 . . . . 0.0 108.838 179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.0 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.93 150.91 30.37 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.382 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.597 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 2.8 p -123.68 142.99 50.54 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.11 0.957 . . . . 0.0 109.465 179.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.604 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 3.6 tp -57.73 121.1 9.63 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.0 t -76.76 -24.26 52.94 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.238 -0.913 . . . . 0.0 109.366 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 24' ' ' CYS . 10.6 p80 155.72 -175.14 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.059 0 CA-C-O 121.477 0.656 . . . . 0.0 109.362 179.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 53' ' ' PHE . 19.3 m-85 -93.83 156.36 16.69 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.408 -0.808 . . . . 0.0 109.625 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.6 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 86.12 -167.94 40.28 Favored Glycine 0 N--CA 1.496 2.657 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.28 -176.56 4.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.38 -1.071 . . . . 0.0 108.443 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.524 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 41.1 m . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.157 -0.964 . . . . 0.0 109.615 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 1' ' ' LEU . 3.7 mm? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.81 -80.34 0.25 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.216 -0.927 . . . . 0.0 109.656 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -172.38 155.37 3.48 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.163 -0.961 . . . . 0.0 109.583 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 50' ' ' LEU . 30.4 t -134.92 113.3 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -167.28 159.84 13.03 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 -179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 6' ' ' VAL . 17.9 t -122.87 38.62 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.212 -0.93 . . . . 0.0 110.078 -179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.524 ' C ' ' O ' ' A' ' 6' ' ' VAL . 18.5 t0 21.57 99.4 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.154 0.502 . . . . 0.0 111.152 179.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 7.8 m -121.55 64.62 0.89 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.904 . . . . 0.0 109.793 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.43 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 0.4 OUTLIER -91.27 -14.71 30.37 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.391 -0.818 . . . . 0.0 109.33 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.43 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 5.4 mm-40 -105.56 34.93 3.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.427 -0.796 . . . . 0.0 110.047 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.787 ' CB ' HG11 ' A' ' 42' ' ' VAL . 41.7 m-85 -113.73 161.44 27.61 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.023 -1.048 . . . . 0.0 108.929 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -73.28 175.99 43.21 Favored 'Cis proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.633 -1.82 . . . . 0.0 111.377 2.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.9 mttt -125.78 144.01 47.0 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.582 -0.698 . . . . 0.0 109.559 -179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.89 14.22 1.76 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.788 2.326 . . . . 0.0 111.204 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -156.63 141.13 16.76 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.569 ' O ' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -116.01 2.56 13.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.825 -1.172 . . . . 0.0 110.981 -179.542 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.569 ' OG1' ' O ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER 67.43 -17.39 0.15 Allowed 'General case' 0 N--CA 1.503 2.222 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 178.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.497 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 72.21 -9.04 1.06 Allowed 'General case' 0 C--N 1.275 -2.635 0 O-C-N 121.697 -0.627 . . . . 0.0 111.448 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.511 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.0 OUTLIER -59.45 129.07 40.19 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 120.594 -1.316 . . . . 0.0 107.899 179.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.3 123.18 33.26 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-O 122.527 1.155 . . . . 0.0 111.701 -178.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.64 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.7 OUTLIER -162.19 81.94 1.76 Allowed Pre-proline 0 C--N 1.295 -1.764 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.545 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -64.83 117.25 4.35 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.615 2.21 . . . . 0.0 113.344 -176.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.616 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.12 136.08 47.58 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 178.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.5 OUTLIER -98.83 112.39 24.49 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.878 -1.139 . . . . 0.0 111.672 -178.02 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.914 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -51.13 176.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 178.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 49' ' ' THR . 9.0 t -72.73 -22.66 60.84 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.2 -1.176 . . . . 0.0 107.829 178.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.6 p30 -76.42 -5.73 48.6 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.6 m-20 82.04 30.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.626 -0.671 . . . . 0.0 110.363 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -102.74 146.44 28.23 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.531 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 95.8 m -98.3 143.52 28.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.681 -1.262 . . . . 0.0 110.409 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.72 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.9 m-85 -124.81 125.08 43.45 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.59 -46.88 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.363 -176.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.64 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 35.9 p-10 -156.61 -168.17 2.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.445 -1.62 . . . . 0.0 111.492 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.616 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.07 -37.09 71.36 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.867 -0.521 . . . . 0.0 112.313 -177.608 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.608 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 1.8 p -77.41 -54.39 6.5 Favored 'General case' 0 C--N 1.298 -1.674 0 O-C-N 120.655 -1.278 . . . . 0.0 108.662 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.554 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 8.9 m-80 -50.36 -26.61 5.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.017 -1.052 . . . . 0.0 108.888 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 76.5 t80 -87.02 -35.69 18.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 123.069 1.414 . . . . 0.0 109.589 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.784 ' O ' HG12 ' A' ' 42' ' ' VAL . 2.2 m -67.34 -29.17 68.65 Favored 'General case' 0 C--N 1.272 -2.791 0 CA-C-N 114.032 -1.44 . . . . 0.0 110.874 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.554 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -70.39 -36.09 73.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 179.467 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.732 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.97 -25.35 63.58 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.533 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.4 t -77.64 -40.05 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 CA-C-O 121.333 0.587 . . . . 0.0 110.186 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.787 HG11 ' CB ' ' A' ' 11' ' ' TYR . 1.9 p -84.7 -13.04 11.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.915 -178.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.732 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -91.73 -33.21 15.11 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.772 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.517 ' O ' HG23 ' A' ' 47' ' ' THR . 9.8 t -89.98 20.31 4.32 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.586 -0.696 . . . . 0.0 109.896 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.514 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.5 m-80 64.99 10.24 6.1 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.424 -0.797 . . . . 0.0 109.911 -180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 85.99 15.69 64.59 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.075 -1.21 . . . . 0.0 110.075 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 44' ' ' SER . 7.7 p -92.26 7.25 43.54 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.322 -1.105 . . . . 0.0 109.018 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.914 HD11 ' HA3' ' A' ' 25' ' ' GLY . 1.9 tp -79.5 -66.58 0.85 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.577 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.6 p 50.02 118.73 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.879 0 CA-C-O 122.456 1.122 . . . . 0.0 111.904 179.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -77.89 170.89 15.83 Favored 'General case' 0 C--N 1.28 -2.456 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.72 179.348 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.548 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -114.99 -22.85 9.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.607 ' C ' HD11 ' A' ' 50' ' ' LEU . 2.2 p80 -164.53 144.53 7.6 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.494 -178.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -65.11 164.17 13.54 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 85.81 -170.0 43.29 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.112 -1.195 . . . . 0.0 110.112 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.445 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 8.9 mtmm -90.76 165.67 13.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.321 -1.105 . . . . 0.0 109.395 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 37.3 m . . . . . 0 N--CA 1.488 1.472 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.932 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.434 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.348 0.594 . . . . 0.0 109.453 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.434 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.78 41.77 11.39 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.93 . . . . 0.0 109.406 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -116.25 143.44 45.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.239 -0.913 . . . . 0.0 109.412 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 4' ' ' VAL . 7.9 m -104.67 82.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.181 -0.949 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.474 ' HA ' HD22 ' A' ' 50' ' ' LEU . 0.4 OUTLIER 175.55 129.92 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.238 179.918 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.486 HG12 ' CE2' ' A' ' 37' ' ' PHE . 7.2 p -88.42 146.43 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.228 -0.92 . . . . 0.0 109.602 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -70.73 139.91 51.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 0.0 109.153 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.444 ' SG ' HG13 ' A' ' 6' ' ' VAL . 30.6 m -143.29 46.54 1.52 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.284 -0.885 . . . . 0.0 109.735 -179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.36 -6.38 55.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.128 -0.982 . . . . 0.0 109.872 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.6 mp0 -100.86 13.55 34.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.103 -0.998 . . . . 0.0 109.48 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.074 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.5 m-85 -100.4 159.72 28.95 Favored Pre-proline 0 C--N 1.303 -1.413 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.526 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -76.68 162.94 90.77 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.568 -1.846 . . . . 0.0 111.247 1.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.589 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.58 141.0 26.69 Favored Pre-proline 0 N--CA 1.489 1.507 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.47 13.83 1.97 Allowed 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.43 2.087 . . . . 0.0 110.333 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -168.94 109.84 0.49 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -94.28 144.96 25.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.38 -0.825 . . . . 0.0 109.473 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 ' O ' ' O ' ' A' ' 16' ' ' CYS . 25.1 p -50.92 -179.07 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.239 -0.913 . . . . 0.0 108.917 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.468 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -122.27 -16.81 7.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.058 -1.026 . . . . 0.0 109.904 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.468 ' O ' ' O ' ' A' ' 18' ' ' LEU . 13.7 pm0 -55.8 -167.55 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.59 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.8 t80 -134.74 130.86 36.86 Favored 'General case' 0 C--N 1.289 -2.034 0 C-N-CA 118.809 -1.156 . . . . 0.0 111.128 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.651 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.25 80.55 2.09 Favored Pre-proline 0 C--N 1.297 -1.677 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.612 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.8 Cg_endo -63.15 117.76 4.68 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 122.026 1.817 . . . . 0.0 111.966 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.572 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -108.44 132.53 53.69 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 118.876 -1.129 . . . . 0.0 109.699 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.737 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -80.7 120.72 24.96 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.602 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -71.43 -162.98 5.43 Favored Glycine 0 C--N 1.294 -1.757 0 C-N-CA 118.593 -1.765 . . . . 0.0 108.861 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 29.7 t -85.24 -49.83 7.87 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.893 -1.357 . . . . 0.0 109.963 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 8.8 p-10 -57.39 -14.83 5.22 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 10.3 t30 98.12 45.44 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.084 0.468 . . . . 0.0 110.069 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.587 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -123.07 114.17 20.0 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 122.353 1.073 . . . . 0.0 109.006 178.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 31' ' ' TYR . 20.6 m -60.32 158.23 12.15 Favored 'General case' 0 C--N 1.289 -2.039 0 O-C-N 121.127 -0.983 . . . . 0.0 109.326 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.612 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 1.2 m-85 -129.96 147.53 51.73 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 177.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.59 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -53.35 -37.68 55.86 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.511 -1.328 . . . . 0.0 111.555 -176.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.651 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.6 p30 -166.59 -163.86 0.61 Allowed 'General case' 0 C--N 1.296 -1.746 0 O-C-N 120.697 -1.472 . . . . 0.0 109.557 -179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.572 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -60.49 -36.67 78.87 Favored 'General case' 0 C--N 1.296 -1.729 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.665 -178.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.467 ' O ' ' C ' ' A' ' 36' ' ' ASN . 11.8 t -70.11 -64.35 0.91 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.497 -1.377 . . . . 0.0 108.391 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.6 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -40.8 -37.55 0.79 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.433 179.435 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.627 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 17.9 t80 -72.47 -59.65 2.62 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 122.511 1.148 . . . . 0.0 110.349 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.627 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 20.6 m -53.17 -58.54 6.7 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.093 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 15.8 m-20 -38.98 -30.43 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.283 -0.886 . . . . 0.0 109.056 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.592 ' HB1' HD22 ' A' ' 48' ' ' LEU . . . -74.55 -50.71 17.01 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 178.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.489 ' N ' ' O ' ' A' ' 38' ' ' CYS . 88.5 t -53.39 -59.21 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.665 -0.647 . . . . 0.0 110.202 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.074 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.3 p -61.49 -26.0 38.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 O-C-N 121.209 -0.932 . . . . 0.0 111.353 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.91 -8.92 44.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.517 -1.364 . . . . 0.0 109.398 179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 2.5 p -109.13 18.19 20.83 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.246 -0.909 . . . . 0.0 110.307 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.4 m-20 63.46 15.26 8.64 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 0.0 109.717 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.16 19.73 76.6 Favored Glycine 0 N--CA 1.494 2.538 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 179.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 44' ' ' SER . 24.2 p -88.99 -2.86 58.79 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.307 -1.113 . . . . 0.0 108.061 178.123 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.73 ' C ' HG23 ' A' ' 49' ' ' THR . 8.3 tp -85.28 -80.31 0.22 Allowed 'General case' 0 C--N 1.308 -1.197 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.73 HG23 ' C ' ' A' ' 48' ' ' LEU . 0.7 OUTLIER 68.41 171.55 0.28 Allowed 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.324 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.63 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -125.11 167.66 14.48 Favored 'General case' 0 C--N 1.29 -1.988 0 O-C-N 121.376 -0.827 . . . . 0.0 109.697 -179.001 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.63 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.9 -35.09 7.03 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -179.735 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.737 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -162.18 165.24 27.19 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.611 0.719 . . . . 0.0 109.129 -179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.4 ' CD2' HD23 ' A' ' 23' ' ' LEU . 58.6 m-85 -80.07 175.25 10.81 Favored 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.313 -0.867 . . . . 0.0 108.968 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.66 -169.25 53.26 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -90.71 129.33 36.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.052 -1.264 . . . . 0.0 109.787 179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.637 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 118.06 -0.971 . . . . 0.0 109.395 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 12.6 mt . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.7 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -93.45 -120.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.344 -0.847 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.7 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 75.07 179.78 0.19 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.732 -1.23 . . . . 0.0 109.456 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 1.034 HG23 HD23 ' A' ' 50' ' ' LEU . 2.4 p -135.77 102.59 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.348 -0.845 . . . . 0.0 109.342 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.6 p -162.38 87.6 0.62 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.968 . . . . 0.0 110.097 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.1 t -119.16 146.37 23.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.975 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -93.11 147.23 23.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.093 -1.004 . . . . 0.0 109.808 -179.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 11' ' ' TYR . 71.5 m -133.04 30.24 3.99 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.325 -0.859 . . . . 0.0 109.284 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 t -75.2 -23.68 57.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 109.589 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mp0 -90.73 19.91 5.1 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.675 ' HB3' HG11 ' A' ' 42' ' ' VAL . 86.8 m-85 -117.58 161.76 32.11 Favored Pre-proline 0 C--N 1.303 -1.42 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 1.057 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.0 Cg_endo -82.34 132.96 22.05 Favored 'Cis proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.042 -1.649 . . . . 0.0 110.966 2.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 13.2 mttt -80.25 143.19 55.9 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.668 -0.645 . . . . 0.0 109.659 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.22 14.18 2.02 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.564 2.176 . . . . 0.0 110.27 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -171.25 144.82 2.09 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 76.7 m -133.94 144.37 48.77 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.058 -1.026 . . . . 0.0 109.889 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 80.5 p -56.32 -168.79 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.0 109.02 179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.0 pp -125.05 -16.56 6.02 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.166 -0.959 . . . . 0.0 109.74 179.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.1 pm0 -50.69 132.87 26.2 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.573 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 5.7 t80 -86.45 125.5 33.75 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-O 122.824 1.297 . . . . 0.0 111.36 -177.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.673 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.2 mtt-85 -160.59 70.64 2.85 Favored Pre-proline 0 C--N 1.29 -1.984 0 N-CA-C 105.292 -2.114 . . . . 0.0 105.292 178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.635 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -62.87 131.07 31.48 Favored 'Trans proline' 0 C--O 1.198 -1.522 0 C-N-CA 124.044 3.163 . . . . 0.0 114.767 -175.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 34' ' ' LYS . 3.1 mp -111.22 159.76 17.6 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 105.93 -1.878 . . . . 0.0 105.93 176.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.65 ' O ' HD12 ' A' ' 50' ' ' LEU . 0.9 OUTLIER -120.05 141.16 50.0 Favored 'General case' 0 N--CA 1.503 2.201 0 O-C-N 119.819 -1.801 . . . . 0.0 110.091 -179.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.66 ' HA2' ' OH ' ' A' ' 31' ' ' TYR . . . -101.51 158.95 18.62 Favored Glycine 0 N--CA 1.495 2.595 0 CA-C-O 122.701 1.167 . . . . 0.0 114.473 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.512 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.5 OUTLIER -57.73 -17.79 17.36 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.549 -0.825 . . . . 0.0 109.858 -179.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -89.62 21.8 3.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.138 -0.976 . . . . 0.0 109.007 179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 57.82 16.96 3.89 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.526 -0.734 . . . . 0.0 109.867 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 18.3 ttmt -99.26 120.54 39.72 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.242 -0.912 . . . . 0.0 108.592 179.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.869 HG21 ' HD3' ' A' ' 55' ' ' LYS . 42.6 m -84.5 126.49 33.33 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.462 -0.773 . . . . 0.0 109.648 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.82 ' CZ ' ' CD1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -96.66 136.79 36.69 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.519 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -41.77 -40.51 3.07 Favored Glycine 0 N--CA 1.49 2.277 0 O-C-N 121.296 -0.878 . . . . 0.0 111.545 -177.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.673 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 34.1 p30 -171.02 -153.79 0.09 Allowed 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.677 -1.484 . . . . 0.0 110.318 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.656 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -58.89 -52.31 66.3 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.743 -0.783 . . . . 0.0 110.014 -178.255 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.572 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 7.8 t -64.02 -57.83 8.52 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.737 -1.227 . . . . 0.0 109.143 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' OD1' ' N ' ' A' ' 33' ' ' ASN . 0.8 OUTLIER -49.92 -23.14 1.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.108 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.82 ' CD1' ' CZ ' ' A' ' 31' ' ' TYR . 5.3 t80 -78.25 -67.32 0.75 Allowed 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.424 -179.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 1.093 ' O ' HG13 ' A' ' 42' ' ' VAL . 6.4 m -45.25 -25.73 0.41 Allowed 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' VAL . 6.7 m-80 -70.06 -46.7 64.4 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 178.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 37' ' ' PHE . . . -60.67 -19.97 59.75 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 178.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.029 HG22 HD23 ' A' ' 48' ' ' LEU . 53.1 t -90.91 -29.91 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.134 -179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.093 HG13 ' O ' ' A' ' 38' ' ' CYS . 3.8 m -83.98 -19.37 9.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.326 -0.859 . . . . 0.0 109.329 -179.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.11 -16.78 25.88 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.235 -0.916 . . . . 0.0 108.703 179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.644 ' O ' HG22 ' A' ' 47' ' ' THR . 0.4 OUTLIER -100.15 9.29 43.03 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.64 -179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.7 t30 76.45 6.29 3.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.257 -0.902 . . . . 0.0 108.947 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 79.85 7.73 88.27 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.644 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -87.76 9.55 21.3 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.264 -1.139 . . . . 0.0 108.885 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.029 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -85.66 -77.74 0.29 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.355 -0.841 . . . . 0.0 109.14 -179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.827 HG23 ' O ' ' A' ' 48' ' ' LEU . 4.2 p 92.27 139.03 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 CA-C-O 122.084 0.945 . . . . 0.0 110.203 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.034 HD23 HG23 ' A' ' 4' ' ' VAL . 8.5 tp -72.68 157.71 37.01 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.54 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -118.08 -18.95 9.27 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 120.655 -1.278 . . . . 0.0 108.385 179.172 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.717 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 174.03 161.17 0.17 Allowed 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -77.24 164.78 25.28 Favored 'General case' 0 C--N 1.292 -1.891 0 O-C-N 121.436 -0.79 . . . . 0.0 109.228 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.635 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 79.96 -168.5 52.25 Favored Glycine 0 N--CA 1.496 2.678 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.869 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -91.1 171.72 9.06 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 178.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 3.0 m . . . . . 0 C--N 1.295 -1.796 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.616 179.659 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.79 -73.86 0.25 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 0.0 109.398 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 45.43 -160.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.263 -0.898 . . . . 0.0 109.423 179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 4' ' ' VAL . 93.2 t -93.7 63.06 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.253 -0.904 . . . . 0.0 109.271 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 16.4 p 177.68 145.6 0.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.462 -0.774 . . . . 0.0 109.666 179.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.412 HG11 ' HB2' ' A' ' 34' ' ' LYS . 24.4 t -90.67 134.89 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.891 . . . . 0.0 109.11 179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -86.05 112.2 21.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.768 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 38.7 m -108.15 64.53 0.62 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.428 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.8 t -89.49 -23.18 22.14 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.238 -0.914 . . . . 0.0 109.588 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.6 -5.26 59.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.843 ' HB3' HG11 ' A' ' 42' ' ' VAL . 78.0 m-85 -79.83 162.24 63.28 Favored Pre-proline 0 C--N 1.304 -1.4 0 O-C-N 121.368 -0.833 . . . . 0.0 109.181 -179.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.917 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.2 Cg_endo -82.08 144.2 57.53 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 123.201 -1.583 . . . . 0.0 110.933 2.253 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 26.2 mttt -99.46 141.63 23.17 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.652 -0.655 . . . . 0.0 109.934 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.3 Cg_endo -80.67 14.26 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.522 2.148 . . . . 0.0 110.27 179.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 119.95 0.92 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.538 -0.726 . . . . 0.0 109.052 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.472 ' O ' ' O ' ' A' ' 17' ' ' THR . 64.8 m -93.8 148.9 21.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.12 -0.987 . . . . 0.0 109.88 -179.625 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.644 ' O ' HD23 ' A' ' 18' ' ' LEU . 66.2 p -56.67 -164.86 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.644 HD23 ' O ' ' A' ' 17' ' ' THR . 7.3 mt -128.7 -7.58 5.08 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.94 -1.1 . . . . 0.0 110.654 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.488 ' OE1' ' HG3' ' A' ' 21' ' ' ARG . 1.3 pp20? -65.94 -176.3 0.38 Allowed 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 179.507 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 9.4 t80 -122.49 129.43 51.99 Favored 'General case' 0 C--N 1.289 -2.061 0 O-C-N 120.862 -1.149 . . . . 0.0 111.239 -178.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 17.1 mtm180 -160.31 73.31 2.97 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.9 Cg_endo -64.73 112.85 2.1 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 C-N-CA 121.909 1.739 . . . . 0.0 110.87 -178.274 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.568 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.78 138.61 49.35 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.197 -1.001 . . . . 0.0 108.325 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.689 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 9.2 t -96.24 165.75 12.06 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.138 -1.025 . . . . 0.0 108.912 -179.546 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.435 ' HA3' HD12 ' A' ' 48' ' ' LEU . . . -132.81 176.71 19.35 Favored Glycine 0 N--CA 1.491 2.314 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.493 -177.484 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 48' ' ' LEU . 15.4 t -58.56 -49.24 78.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.667 -0.902 . . . . 0.0 109.049 179.88 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.602 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.2 p-10 -47.97 -24.73 1.13 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.401 -0.812 . . . . 0.0 108.985 179.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.602 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 8.3 t-20 91.08 44.68 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 121.22 0.533 . . . . 0.0 109.844 179.791 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 4.4 ttmt -127.89 153.5 46.57 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.259 -0.901 . . . . 0.0 109.511 179.833 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.526 HG22 ' N ' ' A' ' 31' ' ' TYR . 36.8 m -92.82 160.98 14.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.383 -0.823 . . . . 0.0 109.166 179.54 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.618 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 87.5 m-85 -140.11 100.26 3.87 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.304 -0.872 . . . . 0.0 108.679 179.662 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -17.43 -61.43 0.01 OUTLIER Glycine 0 N--CA 1.499 2.866 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.113 -178.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 49.3 p30 -139.34 -169.82 2.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.923 -1.339 . . . . 0.0 110.526 179.921 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 28.5 pttt -53.11 -39.47 63.44 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.821 -0.549 . . . . 0.0 110.533 -178.627 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 52.9 t -63.03 -66.31 0.56 Allowed 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.996 -1.065 . . . . 0.0 109.028 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 21.8 m-80 -41.43 -34.74 0.58 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.456 -0.777 . . . . 0.0 109.871 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.618 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 59.0 t80 -71.72 -44.89 63.36 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 122.914 1.34 . . . . 0.0 109.69 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.664 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 71.5 m -61.73 -55.7 27.49 Favored 'General case' 0 C--N 1.269 -2.911 0 CA-C-N 114.284 -1.325 . . . . 0.0 110.29 -179.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.514 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 4.4 m-80 -44.23 -27.61 0.43 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.757 -1.214 . . . . 0.0 108.667 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -72.56 -47.51 47.57 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 1.008 HG22 ' CD2' ' A' ' 48' ' ' LEU . 32.8 t -60.19 -56.71 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 121.823 0.82 . . . . 0.0 109.335 179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.917 HG21 ' HB3' ' A' ' 12' ' ' PRO . 15.9 m -56.22 -29.08 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.357 -0.84 . . . . 0.0 110.553 -178.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.5 OUTLIER -91.27 -15.73 28.71 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.025 -1.047 . . . . 0.0 108.81 179.536 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.498 ' O ' ' OD1' ' A' ' 45' ' ' ASN . 89.5 p -106.33 11.25 31.21 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.414 -0.804 . . . . 0.0 109.542 179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.57 ' ND2' ' O ' ' A' ' 45' ' ' ASN . 0.9 OUTLIER 50.65 39.05 20.67 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-O 121.69 0.757 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 65.56 32.15 82.39 Favored Glycine 0 N--CA 1.494 2.531 0 O-C-N 121.137 -0.977 . . . . 0.0 110.749 178.651 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.525 HG23 ' CG ' ' A' ' 45' ' ' ASN . 70.1 p -104.93 -6.11 20.43 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.324 -1.104 . . . . 0.0 108.573 178.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 1.008 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.72 -57.11 3.83 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 122.104 0.954 . . . . 0.0 108.501 179.718 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.616 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 32.1 p 63.7 129.47 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 115.066 -0.97 . . . . 0.0 108.955 -177.373 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.576 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 5.1 tp -58.21 152.73 16.52 Favored 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 -179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.1 p -107.38 -42.86 4.7 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.689 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -174.45 160.49 3.19 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 114.803 -1.089 . . . . 0.0 108.723 -179.649 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -77.72 139.07 39.36 Favored 'General case' 0 C--N 1.295 -1.774 0 C-N-CA 119.72 -0.792 . . . . 0.0 109.115 178.876 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.82 -170.33 16.9 Favored Glycine 0 N--CA 1.495 2.62 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -89.41 159.17 17.44 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 120.884 -1.362 . . . . 0.0 108.007 179.294 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.604 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.293 -1.851 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.444 179.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -52.07 102.3 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.401 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -173.17 165.29 4.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.219 -0.926 . . . . 0.0 109.405 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.612 HG12 ' HE1' ' A' ' 53' ' ' PHE . 21.1 t -112.02 110.31 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.629 -179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -132.65 -161.62 1.15 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.273 -0.892 . . . . 0.0 109.298 179.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 7' ' ' ASP . 77.0 t -132.18 157.46 43.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.9 -179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.45 ' N ' HG12 ' A' ' 6' ' ' VAL . 9.9 t0 -77.94 137.81 38.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.221 -0.924 . . . . 0.0 109.297 179.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.483 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 60.1 m -146.6 49.17 1.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.195 -0.941 . . . . 0.0 109.823 -179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.5 m -90.55 -10.83 42.03 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.971 -179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -98.82 21.09 11.97 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 109.736 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.044 ' O ' HG21 ' A' ' 42' ' ' VAL . 90.3 m-85 -106.75 159.69 28.97 Favored Pre-proline 0 C--N 1.306 -1.323 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HB3' ' OD1' ' A' ' 39' ' ' ASN . 36.9 Cg_endo -75.61 175.96 45.71 Favored 'Cis proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.711 -1.787 . . . . 0.0 111.364 2.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 50.5 mttt -135.4 139.07 30.31 Favored Pre-proline 0 N--CA 1.489 1.488 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 -179.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -79.82 13.96 2.0 Allowed 'Trans proline' 0 C--N 1.313 -1.29 0 C-N-CA 122.346 2.031 . . . . 0.0 110.58 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.78 114.72 1.57 Allowed 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.521 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 95.6 m -91.81 150.46 21.07 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.238 -0.914 . . . . 0.0 109.884 -179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -59.55 167.39 2.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.371 -0.831 . . . . 0.0 109.124 179.61 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.6 OUTLIER -101.09 -33.79 9.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.059 -1.026 . . . . 0.0 109.625 179.951 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.417 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.4 mt-10 -46.0 125.05 5.94 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.042 -1.036 . . . . 0.0 108.797 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.593 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -79.69 116.74 20.05 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-O 122.393 1.092 . . . . 0.0 109.915 -179.432 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -147.68 76.68 10.68 Favored Pre-proline 0 C--N 1.289 -2.029 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.383 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.566 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 21.2 Cg_endo -64.01 120.98 8.51 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.983 2.455 . . . . 0.0 112.614 -177.53 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.833 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -114.01 127.61 56.02 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.63 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 37.5 t -79.91 115.97 19.79 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -64.75 -170.97 2.5 Favored Glycine 0 C--N 1.293 -1.807 0 C-N-CA 118.885 -1.626 . . . . 0.0 109.299 -179.603 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.565 ' OG ' ' O ' ' A' ' 48' ' ' LEU . 0.9 OUTLIER -80.91 -33.62 34.02 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.945 -1.327 . . . . 0.0 108.75 178.93 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.573 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 25.4 p-10 -60.05 -16.41 31.09 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.573 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 92.9 17.43 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 121.203 0.525 . . . . 0.0 109.891 179.546 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.432 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.54 130.44 45.78 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.169 -0.957 . . . . 0.0 108.725 179.169 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 78.7 m -70.88 147.24 49.01 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.313 -0.867 . . . . 0.0 109.507 -179.561 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 71.7 m-85 -120.69 116.18 24.79 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.593 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -26.85 -47.78 0.04 OUTLIER Glycine 0 N--CA 1.497 2.747 0 N-CA-C 111.927 -0.469 . . . . 0.0 111.927 -177.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.4 p30 -160.7 -163.47 1.07 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 120.616 -1.52 . . . . 0.0 109.694 179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.833 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.31 -41.73 80.45 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.397 -179.069 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.435 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 42.4 t -61.59 -66.46 0.53 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 120.734 -1.229 . . . . 0.0 109.601 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.517 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 12.8 m-80 -43.71 -34.23 1.46 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.186 -0.947 . . . . 0.0 110.708 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.633 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 25.9 t80 -72.25 -52.57 15.76 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 120.814 -1.179 . . . . 0.0 109.982 -179.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.626 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 32.9 m -53.83 -53.18 56.1 Favored 'General case' 0 C--N 1.281 -2.387 0 CA-C-N 115.056 -0.975 . . . . 0.0 110.24 -179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 4.3 m-20 -41.43 -34.29 0.52 Allowed 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.154 -0.967 . . . . 0.0 108.864 179.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.825 ' CB ' HD22 ' A' ' 48' ' ' LEU . . . -71.74 -47.24 55.09 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 178.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG13 ' HA2' ' A' ' 46' ' ' GLY . 97.4 t -58.06 -62.99 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 CA-C-O 121.433 0.635 . . . . 0.0 110.06 179.557 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.044 HG21 ' O ' ' A' ' 11' ' ' TYR . 11.8 p -58.96 -22.84 22.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 111.869 -178.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.551 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -91.07 -16.42 27.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.377 -1.452 . . . . 0.0 108.702 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' HG22 ' A' ' 47' ' ' THR . 18.9 p -102.63 -2.24 28.7 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.601 -0.687 . . . . 0.0 109.59 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.539 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 78.63 12.83 1.45 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.244 -0.91 . . . . 0.0 109.305 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 88.63 5.86 74.14 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.565 HG22 ' O ' ' A' ' 44' ' ' SER . 14.3 t -79.61 -4.0 49.59 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.258 -1.143 . . . . 0.0 108.15 178.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.855 ' O ' HG23 ' A' ' 49' ' ' THR . 4.7 tp -80.4 -82.89 0.11 Allowed 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 -179.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER 75.27 179.88 0.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -178.544 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -130.88 -179.79 5.52 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 120.582 -1.324 . . . . 0.0 110.22 -179.472 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -111.61 -21.91 11.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.018 -1.051 . . . . 0.0 108.465 -179.82 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 179.74 155.56 0.57 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.504 -0.748 . . . . 0.0 109.835 -179.211 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.612 ' HE1' HG12 ' A' ' 4' ' ' VAL . 30.5 m-85 -73.65 148.35 42.88 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.566 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 105.39 -166.97 14.55 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.608 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -91.74 157.67 16.79 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.326 -1.103 . . . . 0.0 108.219 178.855 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.09 -1.006 . . . . 0.0 109.627 -179.885 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 1' ' ' LEU . 24.9 tp . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -179.49 51.58 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.479 -179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -179.43 122.39 0.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.099 -1.001 . . . . 0.0 109.556 179.956 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 m -142.28 68.35 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.603 ' HA ' HD22 ' A' ' 50' ' ' LEU . 5.4 t -174.2 119.39 0.25 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.413 -0.804 . . . . 0.0 109.461 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.653 HG21 HD22 ' A' ' 23' ' ' LEU . 40.3 t -85.56 151.41 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 0.0 109.647 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -101.26 131.17 47.4 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.334 -0.853 . . . . 0.0 109.542 -179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 29.0 m -122.23 58.69 1.03 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.2 t -82.65 -16.85 46.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.264 -0.898 . . . . 0.0 109.437 179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.35 -1.92 40.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.456 -0.777 . . . . 0.0 109.117 179.472 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.874 ' HB3' HG11 ' A' ' 42' ' ' VAL . 36.4 m-85 -84.53 165.46 37.85 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.407 -0.808 . . . . 0.0 109.12 -179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.985 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.5 153.43 62.92 Favored 'Cis proline' 0 C--N 1.307 -1.624 0 C-N-CA 123.338 -1.526 . . . . 0.0 110.913 1.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -102.9 141.28 22.16 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.485 -0.759 . . . . 0.0 109.694 -179.411 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.0 Cg_endo -80.19 13.57 2.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 122.561 2.174 . . . . 0.0 110.278 179.433 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -165.02 112.58 1.0 Allowed 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.851 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 85.5 m -83.89 143.16 30.06 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.368 -0.833 . . . . 0.0 109.996 -179.422 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.5 OUTLIER -54.62 -171.32 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.196 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.438 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -125.61 -31.88 2.93 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.897 -1.127 . . . . 0.0 109.928 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 2.8 pm0 -49.03 142.08 7.13 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 178.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.58 ' CZ ' ' HG3' ' A' ' 22' ' ' PRO . 7.9 t80 -90.23 126.15 35.73 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-O 122.731 1.253 . . . . 0.0 111.2 -178.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -160.68 71.87 2.83 Favored Pre-proline 0 C--N 1.291 -1.955 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 178.855 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.597 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -61.16 130.9 34.17 Favored 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 123.531 2.821 . . . . 0.0 113.159 -176.495 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.774 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.2 mp -115.29 126.44 54.49 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.044 -1.062 . . . . 0.0 108.171 178.291 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.779 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.4 t -78.07 133.66 37.87 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -179.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.573 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -75.72 -157.26 6.62 Favored Glycine 0 C--N 1.295 -1.722 0 C-N-CA 118.534 -1.793 . . . . 0.0 108.784 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.538 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -92.99 -66.55 0.92 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 110.171 -179.93 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.629 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.0 p-10 -40.16 -40.02 1.02 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.605 -0.684 . . . . 0.0 109.401 -179.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.629 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 50.6 p30 133.38 34.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.609 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' HE3' ' CD1' ' A' ' 48' ' ' LEU . 11.3 pttp -108.46 107.27 17.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.924 -1.11 . . . . 0.0 109.636 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.488 ' OG1' ' HD2' ' A' ' 55' ' ' LYS . 46.6 m -66.37 152.13 45.69 Favored 'General case' 0 C--N 1.287 -2.149 0 O-C-N 121.531 -0.731 . . . . 0.0 109.101 179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.75 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 1.5 m-85 -129.62 142.74 50.68 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.676 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.555 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -47.52 -35.06 10.35 Favored Glycine 0 N--CA 1.487 2.034 0 C-N-CA 119.44 -1.362 . . . . 0.0 110.708 -176.797 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.754 ' C ' HD12 ' A' ' 23' ' ' LEU . 43.1 p30 -173.18 -155.55 0.08 Allowed 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.725 -1.456 . . . . 0.0 110.47 -179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.774 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.96 -42.39 97.29 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.436 -0.79 . . . . 0.0 110.786 -178.227 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.613 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.8 t -66.55 -57.36 7.45 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.579 -1.326 . . . . 0.0 108.512 179.509 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.606 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -48.93 -37.0 18.63 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.387 -0.82 . . . . 0.0 109.478 179.75 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 31' ' ' TYR . 31.9 t80 -70.22 -51.91 27.23 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 122.492 1.139 . . . . 0.0 110.247 -179.578 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 61.2 m -55.21 -61.03 2.59 Favored 'General case' 0 C--N 1.28 -2.418 0 CA-C-N 115.199 -0.909 . . . . 0.0 110.289 -179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' C ' ' O ' ' A' ' 38' ' ' CYS . 3.9 m-20 -37.47 -29.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.302 -0.874 . . . . 0.0 109.657 -179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.75 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -74.33 -52.3 12.64 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 68.9 t -52.06 -54.72 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-O 121.585 0.707 . . . . 0.0 109.738 178.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.985 HG21 ' HB3' ' A' ' 12' ' ' PRO . 6.1 m -61.89 -26.48 40.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.429 -0.794 . . . . 0.0 111.183 -178.898 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 6.9 tt0 -90.63 -6.43 54.6 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.962 -1.087 . . . . 0.0 109.792 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 1.4 p -112.57 18.42 18.39 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.118 -0.989 . . . . 0.0 109.538 -179.838 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.888 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.2 OUTLIER 76.61 -1.58 2.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.428 -0.795 . . . . 0.0 109.304 -179.342 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' A' ' 41' ' ' VAL . . . 85.88 17.24 61.85 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 179.084 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.888 HG23 ' OD1' ' A' ' 45' ' ' ASN . 3.1 p -87.0 -10.41 53.21 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.078 -1.248 . . . . 0.0 108.486 178.435 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.537 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -78.26 148.47 33.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.712 0.768 . . . . 0.0 109.467 -179.573 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.538 ' O ' ' N ' ' A' ' 26' ' ' SER . 1.3 p -137.77 167.17 22.25 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.147 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.605 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -109.63 170.31 8.15 Favored 'General case' 0 C--N 1.287 -2.136 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 -179.838 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.605 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -108.41 -35.77 6.41 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 120.829 -1.17 . . . . 0.0 107.896 -179.65 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.779 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 -167.86 164.73 14.07 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-O 121.568 0.699 . . . . 0.0 109.505 -178.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -72.65 -167.16 0.33 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.577 -0.702 . . . . 0.0 109.306 179.065 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.81 -167.31 4.31 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.614 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.9 OUTLIER -85.55 165.4 17.11 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 179.151 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.614 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-O 117.986 -1.006 . . . . 0.0 109.584 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . -179.77 122.4 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.24 -0.913 . . . . 0.0 109.448 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -129.7 146.27 51.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.177 -0.952 . . . . 0.0 109.521 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.3 t -139.96 75.06 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -0.965 . . . . 0.0 109.46 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.4 p -165.56 106.64 0.75 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -90.43 141.61 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.247 -0.908 . . . . 0.0 109.674 -179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -80.53 131.6 35.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.224 -0.922 . . . . 0.0 109.165 179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.588 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 54.9 m -139.08 49.61 1.84 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.208 -0.933 . . . . 0.0 109.905 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.5 t -90.91 -10.18 43.48 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.132 -0.98 . . . . 0.0 109.689 179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -99.67 23.76 9.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.341 -0.849 . . . . 0.0 109.933 -179.537 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 42' ' ' VAL . 46.9 m-85 -117.63 158.28 45.69 Favored Pre-proline 0 C--N 1.304 -1.408 0 O-C-N 121.066 -1.021 . . . . 0.0 108.385 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.566 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.5 Cg_endo -72.24 164.86 84.19 Favored 'Cis proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.74 -1.775 . . . . 0.0 112.003 3.473 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.504 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.9 OUTLIER -119.91 146.85 42.93 Favored Pre-proline 0 N--CA 1.49 1.535 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -179.478 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.504 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -78.53 13.67 1.81 Allowed 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.5 2.133 . . . . 0.0 110.909 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -174.93 150.94 1.29 Allowed 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.9 m -119.83 138.25 53.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.023 -179.817 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.456 ' O ' ' O ' ' A' ' 16' ' ' CYS . 23.3 p -54.04 -171.99 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 108.817 179.453 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.672 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -119.51 -22.87 6.81 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.362 179.577 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 2.1 pt-20 -49.95 118.42 2.88 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.207 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.538 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.4 t80 -78.42 126.55 30.93 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-O 122.536 1.16 . . . . 0.0 110.501 -178.164 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.568 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 6.0 ptm180 -160.66 77.91 2.5 Favored Pre-proline 0 C--N 1.293 -1.89 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.555 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.6 Cg_endo -66.11 127.68 18.07 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.707 2.271 . . . . 0.0 112.853 -176.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.749 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -116.88 135.15 53.95 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 178.881 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.916 ' O ' HD12 ' A' ' 50' ' ' LEU . 19.1 t -92.88 161.48 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 118.984 -1.086 . . . . 0.0 109.424 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.566 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -117.56 168.18 12.9 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 111.037 -0.825 . . . . 0.0 111.037 -178.47 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 35.3 t -69.47 -17.97 63.67 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.64 -0.917 . . . . 0.0 108.636 179.525 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.553 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 35.7 p30 -73.85 -7.97 54.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.403 -0.811 . . . . 0.0 109.068 179.212 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.553 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 32.6 t30 82.33 31.05 0.1 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.756 -0.59 . . . . 0.0 110.044 179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.2 OUTLIER -123.94 139.68 53.72 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.26 -0.9 . . . . 0.0 109.143 179.719 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -85.22 159.91 20.0 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.273 -0.892 . . . . 0.0 109.816 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.766 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 48.1 m-85 -130.98 124.85 31.87 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 178.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.538 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -38.41 -53.62 2.24 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 120.456 -0.878 . . . . 0.0 110.967 -178.129 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -155.06 -164.45 1.79 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.783 -1.422 . . . . 0.0 110.529 -179.76 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.586 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -63.15 -25.28 68.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.452 -0.78 . . . . 0.0 111.533 -178.253 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -70.78 -53.23 16.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.598 -1.314 . . . . 0.0 109.197 -179.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -64.13 -37.5 87.68 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.715 -0.616 . . . . 0.0 110.018 -179.57 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.796 ' CE1' HD21 ' A' ' 48' ' ' LEU . 58.9 t80 -70.51 -47.61 59.61 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.942 -1.099 . . . . 0.0 109.791 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.648 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 17.3 m -64.02 -29.56 70.7 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.793 -178.836 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.545 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 95.1 m-20 -72.64 -39.24 67.33 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.766 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.41 -17.3 61.81 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.773 ' CG2' HD23 ' A' ' 48' ' ' LEU . 54.2 t -84.54 -50.75 14.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.479 -0.763 . . . . 0.0 109.001 179.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 11' ' ' TYR . 6.8 p -68.54 -17.8 22.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.133 -0.979 . . . . 0.0 109.661 -179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.724 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -92.08 -31.3 15.6 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.05 -1.031 . . . . 0.0 108.371 178.548 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' THR . 46.5 t -88.15 15.11 7.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.633 -0.667 . . . . 0.0 110.53 -178.827 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.9 OUTLIER 64.04 12.79 7.22 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.203 -0.935 . . . . 0.0 109.511 179.949 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.04 20.74 66.96 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 110.183 -1.167 . . . . 0.0 110.183 179.405 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 44' ' ' SER . 10.8 p -93.75 3.61 55.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.268 -1.137 . . . . 0.0 108.72 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.796 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -79.56 -52.73 7.63 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.047 0.927 . . . . 0.0 108.745 179.922 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.645 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 29.5 p 53.38 119.41 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 122.442 1.115 . . . . 0.0 111.323 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 4.2 tp -65.36 152.46 43.78 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.431 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -112.52 -16.87 12.78 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.89 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER 175.86 163.52 0.34 Allowed 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.92 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -80.22 177.66 8.8 Favored 'General case' 0 C--N 1.293 -1.859 0 O-C-N 121.159 -0.963 . . . . 0.0 108.838 179.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.88 -167.45 54.88 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.032 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.529 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.2 OUTLIER -92.09 173.46 7.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 177.775 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.504 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.538 0 O-C-N 120.846 -1.159 . . . . 0.0 109.681 -179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.252 0.548 . . . . 0.0 109.56 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 69.38 120.7 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.268 -0.895 . . . . 0.0 109.308 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.63 -171.35 0.1 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.303 -0.873 . . . . 0.0 109.315 -179.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.418 ' O ' ' CB ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -134.13 78.07 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.173 -0.955 . . . . 0.0 109.28 179.834 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.441 ' HA ' HD22 ' A' ' 50' ' ' LEU . 6.5 p 170.31 154.35 0.05 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.294 -0.879 . . . . 0.0 109.391 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG21 HD22 ' A' ' 23' ' ' LEU . 90.7 t -99.17 154.55 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.119 -0.988 . . . . 0.0 109.509 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' N ' HG12 ' A' ' 6' ' ' VAL . 10.3 t70 -86.3 152.51 22.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.279 179.804 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 3.6 m -122.98 49.88 1.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.108 -0.995 . . . . 0.0 109.671 -179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.0 m -90.01 -36.57 14.87 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.122 -0.987 . . . . 0.0 110.005 -179.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -99.35 43.16 1.07 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.321 -0.862 . . . . 0.0 109.428 179.992 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.586 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 47.2 m-85 -132.38 164.98 39.6 Favored Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.584 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.8 Cg_endo -89.48 173.94 24.77 Favored 'Cis proline' 0 C--N 1.304 -1.787 0 C-N-CA 123.399 -1.5 . . . . 0.0 111.293 0.212 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 6.4 mtpt -136.53 136.41 21.98 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.447 -0.783 . . . . 0.0 109.14 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.95 15.6 1.81 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.561 2.174 . . . . 0.0 110.811 -179.564 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -162.99 151.44 14.2 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.49 -0.756 . . . . 0.0 109.064 179.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 42.4 t -140.68 160.09 40.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 110.185 -179.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.436 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 1.3 p -60.86 -164.23 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 178.525 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.87 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -118.09 -7.67 10.79 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.625 -1.297 . . . . 0.0 110.417 -179.866 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.775 ' N ' HD22 ' A' ' 18' ' ' LEU . 3.7 pm0 -56.59 119.32 5.91 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.583 -1.266 . . . . 0.0 107.583 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.484 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -79.6 128.96 34.03 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-O 122.505 1.145 . . . . 0.0 111.049 -178.226 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.647 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.56 80.03 2.05 Favored Pre-proline 0 C--N 1.294 -1.809 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 179.758 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.557 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.7 Cg_endo -65.02 124.87 13.68 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.973 2.449 . . . . 0.0 112.975 -176.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.744 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -112.25 139.93 47.38 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.71 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.589 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -102.52 129.32 49.01 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.983 -178.303 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.623 ' CA ' HD11 ' A' ' 48' ' ' LEU . . . -70.11 -170.16 8.21 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 179.673 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 49' ' ' THR . 29.5 t -82.03 -22.02 36.66 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.938 -1.331 . . . . 0.0 108.416 178.878 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.52 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.9 p30 -76.15 -3.42 36.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.363 -0.836 . . . . 0.0 109.44 179.549 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 17.6 t30 80.18 30.56 0.23 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.382 -0.824 . . . . 0.0 110.308 179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 10.2 ttmt -105.32 137.1 43.65 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.103 -0.998 . . . . 0.0 108.781 179.329 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.9 m -85.66 146.5 26.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.137 -0.977 . . . . 0.0 109.998 -179.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 9.6 m-85 -125.51 132.23 52.66 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 178.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.98 -51.03 0.65 Allowed Glycine 0 N--CA 1.493 2.491 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.619 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.647 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.7 p30 -165.54 -168.32 1.32 Allowed 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.036 -1.273 . . . . 0.0 111.086 178.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.744 ' HA ' HD13 ' A' ' 23' ' ' LEU . 6.3 ptmt -45.76 -45.98 14.89 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.88 -0.512 . . . . 0.0 111.868 -177.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.584 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 10.3 m -64.76 -62.73 1.39 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.555 -1.341 . . . . 0.0 109.698 -178.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.3 m-80 -50.56 -20.12 1.09 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.294 -0.879 . . . . 0.0 109.9 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.609 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 21.3 t80 -82.84 -57.93 3.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.954 -1.091 . . . . 0.0 110.889 -179.466 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 39.5 t -58.01 -47.35 83.3 Favored 'General case' 0 C--N 1.286 -2.156 0 O-C-N 121.698 -0.626 . . . . 0.0 110.911 -178.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.589 ' O ' HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -46.29 -28.75 1.39 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.341 -1.475 . . . . 0.0 107.997 -179.827 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -70.2 -48.31 57.71 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 177.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.881 HG13 ' HA2' ' A' ' 46' ' ' GLY . 87.2 t -55.86 -56.14 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 CA-C-O 121.408 0.623 . . . . 0.0 110.031 178.929 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 39' ' ' ASN . 2.8 m -53.48 -33.34 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.075 -1.015 . . . . 0.0 111.062 -178.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -92.57 -11.27 34.81 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.629 -1.295 . . . . 0.0 109.697 -179.526 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.891 ' O ' HG22 ' A' ' 47' ' ' THR . 8.5 t -100.65 -5.35 26.76 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 110.035 -179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.51 ' CB ' ' O ' ' A' ' 44' ' ' SER . 0.2 OUTLIER 77.37 27.58 0.64 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.273 -0.892 . . . . 0.0 109.0 -179.649 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.881 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 64.79 11.69 50.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 -179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.891 HG22 ' O ' ' A' ' 44' ' ' SER . 14.7 t -87.09 -2.44 58.63 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.293 -1.122 . . . . 0.0 108.666 178.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.75 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -79.02 -59.87 2.61 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.596 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 37.6 p 52.58 127.6 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 122.114 0.959 . . . . 0.0 111.305 178.791 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.609 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -85.94 160.67 19.32 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.581 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.1 -29.13 9.57 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -179.374 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.575 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.8 p80 -160.04 163.1 34.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.672 0.749 . . . . 0.0 109.939 -178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -81.89 177.72 8.71 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.557 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 73.63 -167.11 54.52 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.4 OUTLIER -91.4 164.78 13.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -1.031 . . . . 0.0 109.072 179.041 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.589 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 38.7 m . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.922 -179.089 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 1' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.602 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -121.06 -147.31 0.39 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.38 -179.972 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.602 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 69.25 -162.95 0.18 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 109.618 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 4' ' ' VAL . 87.4 t -85.27 80.64 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.65 -179.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -143.19 122.26 12.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.32 179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -92.1 153.98 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.176 -0.952 . . . . 0.0 109.797 -179.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -70.83 156.57 39.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.0 109.243 179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 19.5 t -160.98 24.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.104 -0.997 . . . . 0.0 109.947 -179.492 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.18 -4.83 55.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 110.247 -179.748 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -112.06 36.95 3.13 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.906 -1.121 . . . . 0.0 110.217 -179.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 97.0 m-85 -136.51 157.81 74.52 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.994 -1.066 . . . . 0.0 108.817 -179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.576 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -72.08 145.04 82.12 Favored 'Cis proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.631 -1.821 . . . . 0.0 111.544 3.149 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.495 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -108.1 144.95 30.44 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.585 -0.697 . . . . 0.0 109.214 -179.768 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.495 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 36.6 Cg_endo -78.72 14.62 1.62 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.781 2.321 . . . . 0.0 110.956 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.03 117.49 2.25 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.374 -0.829 . . . . 0.0 109.127 179.737 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.427 ' O ' ' C ' ' A' ' 17' ' ' THR . 94.3 m -102.21 139.71 37.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.226 -0.921 . . . . 0.0 109.877 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.452 ' HB ' ' CD ' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -45.16 142.88 1.81 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.425 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -92.28 -23.08 19.41 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 120.947 -1.096 . . . . 0.0 109.851 -179.484 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 14.5 pm0 -57.44 -166.8 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 179.114 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.587 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.6 t80 -134.03 116.4 15.46 Favored 'General case' 0 C--N 1.285 -2.197 0 C-N-CA 118.538 -1.265 . . . . 0.0 111.352 -179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.4 mmt180 -147.92 74.71 11.07 Favored Pre-proline 0 C--N 1.29 -1.987 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 178.475 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' O ' ' CA ' ' A' ' 54' ' ' GLY . 24.5 Cg_endo -65.91 132.07 29.2 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 123.114 2.543 . . . . 0.0 113.144 -176.702 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.705 HD23 ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -118.78 136.71 53.84 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.583 178.334 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.746 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 51.8 t -79.05 117.98 20.61 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.655 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.579 ' HA2' ' CE1' ' A' ' 37' ' ' PHE . . . -65.28 -165.56 1.32 Allowed Glycine 0 C--N 1.296 -1.663 0 C-N-CA 118.299 -1.905 . . . . 0.0 108.589 -179.77 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.562 ' N ' ' O ' ' A' ' 49' ' ' THR . 8.1 t -85.89 -31.78 22.02 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.041 -1.27 . . . . 0.0 109.144 179.215 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.558 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -69.24 -4.92 19.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.245 -0.91 . . . . 0.0 109.265 179.57 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.558 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.3 t-20 86.11 15.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.742 -0.599 . . . . 0.0 109.881 179.559 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.412 ' HB3' ' OD1' ' A' ' 27' ' ' ASP . 2.0 ttpt -99.56 117.54 34.16 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.191 -0.943 . . . . 0.0 108.812 179.09 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.472 HG22 ' N ' ' A' ' 31' ' ' TYR . 23.2 m -54.5 158.05 2.62 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.527 -0.733 . . . . 0.0 109.571 -179.601 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 4.2 m-85 -129.2 133.13 47.42 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.338 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.587 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.07 -51.51 3.46 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.4 p30 -161.43 -158.5 0.57 Allowed 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.336 -1.096 . . . . 0.0 109.547 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.65 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -64.53 -57.03 10.3 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 121.277 -0.89 . . . . 0.0 111.096 -178.099 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.58 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 41.9 t -42.85 -57.44 2.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.838 -1.164 . . . . 0.0 110.41 -179.264 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 35.5 m-80 -61.34 -43.22 99.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.277 -0.889 . . . . 0.0 111.129 -178.6 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 12.7 t80 -56.07 -60.55 3.33 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 120.905 -1.122 . . . . 0.0 110.521 -178.98 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 1.3 t -55.58 -51.96 65.36 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.32 -178.275 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.563 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.9 m-20 -41.6 -29.19 0.16 Allowed 'General case' 0 C--N 1.308 -1.196 0 O-C-N 120.567 -1.333 . . . . 0.0 108.773 -179.439 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.621 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -75.1 -49.34 19.96 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 177.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.682 HG22 HD23 ' A' ' 48' ' ' LEU . 93.0 t -58.26 -62.45 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 CA-C-O 121.591 0.71 . . . . 0.0 109.8 179.146 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.626 HG12 ' O ' ' A' ' 38' ' ' CYS . 3.3 p -57.47 -26.56 26.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.262 -0.899 . . . . 0.0 111.627 -178.627 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.9 OUTLIER -91.71 -13.44 31.68 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.283 -1.511 . . . . 0.0 109.059 179.203 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' ' CG ' ' A' ' 45' ' ' ASN . 2.6 t -104.59 22.85 14.28 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.509 -0.744 . . . . 0.0 110.082 -179.512 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.523 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.6 p30 65.08 6.25 3.39 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.562 -0.711 . . . . 0.0 110.463 -179.742 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.594 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 81.15 8.59 87.14 Favored Glycine 0 N--CA 1.491 2.317 0 O-C-N 121.291 -0.881 . . . . 0.0 110.912 178.629 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.405 ' HB ' ' OD1' ' A' ' 45' ' ' ASN . 9.6 t -79.45 -4.37 50.86 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.803 -1.41 . . . . 0.0 108.188 178.672 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.698 ' C ' HG23 ' A' ' 49' ' ' THR . 1.7 tp -79.95 -80.29 0.13 Allowed 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.71 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.698 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 70.92 169.07 0.32 Allowed 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -178.646 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -120.14 173.33 7.16 Favored 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.425 -0.797 . . . . 0.0 110.486 -178.143 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.667 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.73 -36.38 7.07 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 179.714 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.746 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -162.54 165.58 25.86 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-O 121.456 0.646 . . . . 0.0 109.383 -178.827 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.705 ' CD2' HD23 ' A' ' 23' ' ' LEU . 15.7 m-85 -75.61 -164.5 0.35 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.595 -0.691 . . . . 0.0 109.184 179.224 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.582 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 59.06 -168.99 6.16 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 -179.168 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.454 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.1 OUTLIER -92.4 143.2 26.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.465 -1.02 . . . . 0.0 108.946 178.722 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.557 ' HA ' ' NE2' ' A' ' 52' ' ' HIS . 32.5 m . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.693 179.67 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.47 ' N ' HD23 ' A' ' 1' ' ' LEU . 1.3 pt? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.649 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . -153.65 109.09 3.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.607 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.649 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 167.35 -176.85 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.511 179.838 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 4' ' ' VAL . 14.9 m -135.3 102.23 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.207 -0.933 . . . . 0.0 109.569 -179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.452 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 167.46 140.75 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.255 -0.903 . . . . 0.0 109.306 -179.987 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.7 t -112.41 143.16 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.17 -0.956 . . . . 0.0 109.694 -179.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -68.13 143.29 55.48 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.327 -0.858 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' HA ' ' CD2' ' A' ' 11' ' ' TYR . 7.3 m -139.32 61.37 1.56 Allowed 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.134 -0.979 . . . . 0.0 110.068 -179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 t -90.83 -1.24 57.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.166 -0.959 . . . . 0.0 109.552 179.655 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -127.4 41.59 3.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.427 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.913 ' CB ' HG11 ' A' ' 42' ' ' VAL . 70.8 m-85 -122.83 161.35 44.73 Favored Pre-proline 0 C--N 1.306 -1.299 0 O-C-N 121.247 -0.908 . . . . 0.0 108.934 -179.442 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 36.7 Cg_endo -76.15 -179.77 28.24 Favored 'Cis proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.698 -1.793 . . . . 0.0 111.41 1.852 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.511 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 4.7 tttp -123.04 141.34 35.48 Favored Pre-proline 0 N--CA 1.488 1.439 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.617 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.6 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.0 Cg_endo -77.18 13.99 1.43 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.656 2.238 . . . . 0.0 111.305 -179.253 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.6 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 170.5 144.37 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.46 ' O ' ' O ' ' A' ' 17' ' ' THR . 34.6 t -124.08 159.47 29.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.187 -0.946 . . . . 0.0 109.837 -179.978 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.46 ' O ' ' O ' ' A' ' 16' ' ' CYS . 49.4 p -59.37 -157.83 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 178.787 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.55 -11.06 8.32 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.731 -1.231 . . . . 0.0 109.685 179.39 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG3' ' HD2' ' A' ' 21' ' ' ARG . 1.3 pt-20 -56.6 124.86 19.75 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 178.896 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 19.3 t80 -86.04 132.41 34.06 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-O 122.323 1.059 . . . . 0.0 111.537 -177.532 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.613 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.73 80.32 2.26 Favored Pre-proline 0 C--N 1.297 -1.674 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.769 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.6 Cg_endo -65.42 122.0 9.57 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.668 2.245 . . . . 0.0 112.415 -177.268 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.797 HD11 ' HA ' ' A' ' 34' ' ' LYS . 2.0 mt -107.18 128.4 54.37 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.306 -0.958 . . . . 0.0 108.974 179.236 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.748 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER -79.06 102.28 8.31 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.384 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.538 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -56.27 -170.89 0.12 Allowed Glycine 0 N--CA 1.48 1.601 0 C-N-CA 118.579 -1.772 . . . . 0.0 109.113 -179.29 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.546 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.9 t -74.32 -45.0 50.15 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.008 -1.289 . . . . 0.0 109.306 179.409 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -54.99 -16.39 2.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.23 -0.919 . . . . 0.0 109.402 179.817 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.8 OUTLIER 92.96 18.3 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.375 0.607 . . . . 0.0 109.73 179.754 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -99.41 127.89 45.48 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.1 m -69.61 152.79 44.33 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.442 -0.786 . . . . 0.0 109.892 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 8.2 m-85 -126.54 125.2 41.63 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.435 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.598 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -28.89 -50.5 0.1 Allowed Glycine 0 N--CA 1.498 2.826 0 N-CA-C 111.511 -0.636 . . . . 0.0 111.511 -176.851 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -163.04 -159.94 0.58 Allowed 'General case' 0 C--N 1.299 -1.603 0 O-C-N 120.704 -1.468 . . . . 0.0 110.317 179.299 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.797 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -56.05 -46.12 79.02 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.307 -0.871 . . . . 0.0 112.213 -177.413 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 5.3 m -66.23 -52.61 46.17 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 120.477 -1.389 . . . . 0.0 110.17 -178.675 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.534 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.0 m-80 -56.42 -23.43 38.39 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.685 -1.259 . . . . 0.0 110.395 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.728 ' CB ' HD12 ' A' ' 23' ' ' LEU . 16.6 t80 -82.72 -54.59 5.01 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-O 123.037 1.399 . . . . 0.0 110.007 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.661 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 1.1 m -55.55 -35.99 66.32 Favored 'General case' 0 C--N 1.279 -2.46 0 CA-C-N 114.601 -1.181 . . . . 0.0 110.324 -178.559 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 3.5 m-20 -57.48 -36.51 71.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.588 -1.32 . . . . 0.0 108.088 179.538 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.662 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -69.0 -28.67 66.81 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.14 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.417 HG13 ' HA2' ' A' ' 46' ' ' GLY . 79.4 t -72.97 -62.68 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 O-C-N 121.512 -0.742 . . . . 0.0 109.119 178.816 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.913 HG11 ' CB ' ' A' ' 11' ' ' TYR . 4.4 p -59.58 -15.15 7.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.484 -0.76 . . . . 0.0 111.299 -179.292 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.662 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -91.93 -30.72 15.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.573 -1.329 . . . . 0.0 108.659 179.308 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.1 t -93.22 22.38 5.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.678 -0.638 . . . . 0.0 110.31 -179.187 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 44' ' ' SER . 17.4 m-80 65.62 8.85 5.44 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.175 -0.953 . . . . 0.0 109.802 -179.717 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 84.33 17.82 63.75 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.163 -1.175 . . . . 0.0 110.163 179.335 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 p -95.74 5.79 50.52 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.311 -1.111 . . . . 0.0 108.734 179.2 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.584 ' HG ' ' N ' ' A' ' 49' ' ' THR . 4.3 tp -79.49 -78.28 0.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.668 0.747 . . . . 0.0 109.394 -179.687 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 1.9 p 68.12 153.7 0.1 Allowed 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -178.313 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.669 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -110.63 179.64 4.01 Favored 'General case' 0 C--N 1.287 -2.12 0 O-C-N 121.525 -0.734 . . . . 0.0 111.223 -177.733 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.669 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -109.06 -32.4 7.25 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 179.783 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.748 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.3 p80 -170.56 159.51 6.81 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.401 0.619 . . . . 0.0 109.626 -178.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.537 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 33.6 m-85 -70.55 -169.17 0.3 Allowed 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.486 -0.759 . . . . 0.0 109.109 178.933 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 63.11 -169.29 17.82 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.669 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.66 138.83 31.27 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.131 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.626 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.499 179.868 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.89 -68.18 0.06 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -97.09 103.71 15.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.499 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 25.5 t -105.45 92.71 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.2 p -164.94 121.03 1.43 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.436 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.585 HG21 HD22 ' A' ' 23' ' ' LEU . 12.2 t -84.95 151.76 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 0.0 109.273 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 6' ' ' VAL . 17.9 t70 -59.62 148.1 34.89 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.176 -0.952 . . . . 0.0 108.857 179.441 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.46 ' SG ' ' HB ' ' A' ' 42' ' ' VAL . 10.1 t -158.03 24.09 0.26 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.039 -1.038 . . . . 0.0 109.944 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.6 0.23 57.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.396 179.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.427 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 11.5 mp0 -122.37 43.18 2.96 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.93 . . . . 0.0 109.917 -179.682 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.662 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 78.7 m-85 -139.02 158.77 69.06 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.07 -1.019 . . . . 0.0 108.571 179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.556 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.3 Cg_endo -72.04 159.68 95.04 Favored 'Cis proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.727 -1.78 . . . . 0.0 112.096 3.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.512 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 5.0 tttm -110.42 145.9 33.18 Favored Pre-proline 0 N--CA 1.489 1.508 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 -179.945 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.512 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.6 Cg_endo -78.3 14.09 1.66 Allowed 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.536 2.157 . . . . 0.0 110.731 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -175.69 124.12 0.21 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.861 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' SG ' ' ND2' ' A' ' 36' ' ' ASN . 0.1 OUTLIER -79.74 156.08 27.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.124 -0.985 . . . . 0.0 109.745 -179.663 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.1 p -72.66 -172.05 0.92 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.397 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.894 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -115.27 -20.01 10.53 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.101 -0.999 . . . . 0.0 110.19 -179.751 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.667 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -57.87 123.17 14.85 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 120.855 -1.153 . . . . 0.0 108.758 179.324 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.557 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 11.6 t80 -83.96 124.83 31.43 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 122.248 1.023 . . . . 0.0 109.818 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.2 mtp180 -161.11 87.33 1.68 Allowed Pre-proline 0 C--N 1.29 -1.994 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.3 Cg_endo -65.46 120.54 7.75 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.147 1.898 . . . . 0.0 112.225 -177.612 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.61 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -112.15 139.83 47.35 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.482 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.589 ' HB2' ' NE2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -104.24 124.07 48.48 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 119.283 -0.967 . . . . 0.0 110.964 -178.307 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.563 ' HA3' ' CD1' ' A' ' 48' ' ' LEU . . . -69.34 -171.81 8.22 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 108.934 -1.666 . . . . 0.0 108.934 179.474 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.582 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 30.6 t -82.84 -17.69 43.07 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.696 -1.473 . . . . 0.0 108.045 178.295 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -76.68 -8.03 56.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.549 -0.72 . . . . 0.0 109.321 179.468 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 15.6 t30 81.75 36.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.65 -0.656 . . . . 0.0 109.85 -179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 9.6 tttt -111.99 138.83 48.08 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.315 -0.866 . . . . 0.0 108.814 179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 86.7 m -88.73 145.14 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.917 -179.521 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.803 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 66.8 m-85 -121.35 124.29 44.2 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.446 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.557 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.17 -52.63 0.71 Allowed Glycine 0 N--CA 1.495 2.588 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -177.678 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.4 p30 -152.63 -163.79 1.8 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.138 -1.213 . . . . 0.0 110.052 179.791 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.61 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 1.2 ptmt -58.27 -68.14 0.28 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 0.0 111.297 -178.217 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.579 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 25.8 p -41.28 -45.43 2.95 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.875 -1.141 . . . . 0.0 110.694 -178.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.457 ' ND2' ' SG ' ' A' ' 16' ' ' CYS . 12.1 m-80 -63.61 -40.59 97.3 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.549 -1.345 . . . . 0.0 109.871 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.661 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 20.5 t80 -65.35 -60.15 3.28 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.194 -0.941 . . . . 0.0 110.941 -179.074 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.703 ' O ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -55.05 -41.57 71.6 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 -178.893 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.625 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 5.4 m-20 -49.42 -37.41 25.45 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.425 -1.422 . . . . 0.0 107.971 -179.671 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.803 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -72.66 -32.25 65.69 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.756 HG13 ' HA2' ' A' ' 46' ' ' GLY . 88.1 t -70.62 -67.84 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.296 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.703 HG12 ' O ' ' A' ' 38' ' ' CYS . 7.3 p -54.05 -17.61 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 O-C-N 121.705 -0.622 . . . . 0.0 111.551 -179.692 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.659 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.75 -31.07 15.92 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.183 -1.573 . . . . 0.0 107.763 178.346 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 45' ' ' ASN . 10.7 t -88.28 -1.29 57.94 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.829 -0.544 . . . . 0.0 109.641 -179.819 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.942 ' OD1' HG23 ' A' ' 47' ' ' THR . 0.4 OUTLIER 84.44 4.23 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.503 -0.748 . . . . 0.0 109.362 -179.513 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.756 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 91.12 8.94 64.18 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 178.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.942 HG23 ' OD1' ' A' ' 45' ' ' ASN . 18.0 p -85.03 1.1 49.14 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.915 -1.344 . . . . 0.0 108.868 178.518 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.725 ' C ' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -78.82 -50.61 10.99 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 -179.923 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 73.9 p 45.84 121.06 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 122.282 1.039 . . . . 0.0 112.574 178.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.661 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -82.38 159.4 23.03 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.513 0.673 . . . . 0.0 109.218 178.901 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.68 -26.39 10.86 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.552 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.589 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 1.8 p80 -164.2 160.21 21.01 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.573 0.701 . . . . 0.0 109.682 -178.639 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -77.96 -170.11 1.8 Allowed 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 178.47 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.67 -171.67 20.72 Favored Glycine 0 N--CA 1.488 2.1 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.889 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.475 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.7 OUTLIER -90.75 166.58 13.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.199 -1.177 . . . . 0.0 108.774 179.3 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.573 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.0 m . . . . . 0 C--N 1.301 -1.513 0 CA-C-O 118.001 -0.999 . . . . 0.0 109.667 -178.938 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.386 0.613 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.77 -160.16 0.66 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 179.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 53.6 52.38 13.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.92 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.751 ' O ' HG23 ' A' ' 4' ' ' VAL . 10.6 m -80.89 104.66 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 109.295 179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 p -170.12 164.2 9.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.081 -1.012 . . . . 0.0 109.611 -179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.58 147.61 17.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.559 179.903 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -86.6 128.37 34.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.102 -0.998 . . . . 0.0 109.504 179.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 6.9 m -138.0 45.89 2.1 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.207 -0.933 . . . . 0.0 109.647 -179.513 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.46 8.43 33.85 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.173 -0.954 . . . . 0.0 109.893 -179.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.406 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 21.9 mp0 -118.08 3.39 12.08 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.188 -0.945 . . . . 0.0 109.833 -179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.922 ' CB ' HG11 ' A' ' 42' ' ' VAL . 32.2 m-85 -85.34 160.4 54.31 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.202 -0.936 . . . . 0.0 109.421 -179.603 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.514 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.9 Cg_endo -73.91 156.43 99.69 Favored 'Cis proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.775 -1.76 . . . . 0.0 111.939 2.042 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 5.5 mttt -100.34 142.75 25.21 Favored Pre-proline 0 N--CA 1.489 1.525 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -179.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.517 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -79.49 14.85 1.71 Allowed 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.588 2.192 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 173.3 133.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.4 -0.812 . . . . 0.0 108.994 179.999 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 59.7 m -99.44 149.42 23.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.007 . . . . 0.0 109.922 -179.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.539 ' HB ' ' HG2' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -49.19 -24.28 1.66 Allowed 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 122.291 1.043 . . . . 0.0 110.037 -179.707 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.2 OUTLIER 76.22 2.21 3.52 Favored 'General case' 0 C--N 1.28 -2.43 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.239 179.164 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.539 ' HG2' ' HB ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -78.03 -164.92 0.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 177.779 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.531 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 5.2 t80 -130.69 126.46 36.58 Favored 'General case' 0 C--N 1.29 -2.007 0 C-N-CA 118.546 -1.262 . . . . 0.0 111.098 179.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 45.0 mtm180 -159.88 77.02 2.85 Favored Pre-proline 0 C--N 1.294 -1.829 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 179.241 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.629 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.5 Cg_endo -64.28 120.3 7.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.44 2.093 . . . . 0.0 112.552 -176.418 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -114.38 127.44 55.85 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.106 179.861 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.706 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 2.5 t -79.78 126.57 31.13 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.409 -0.807 . . . . 0.0 109.75 -179.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -77.36 169.99 54.96 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 178.923 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.563 ' HB2' ' O ' ' A' ' 49' ' ' THR . 2.0 t -64.88 -35.27 80.59 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.133 -1.216 . . . . 0.0 109.916 179.672 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 2.9 p30 -76.53 4.52 9.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.244 -0.91 . . . . 0.0 110.017 -179.372 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 44.4 t30 80.33 41.41 0.06 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.403 -0.811 . . . . 0.0 110.36 179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.6 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -116.8 109.64 17.37 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.39 1.09 . . . . 0.0 109.495 179.38 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.5 m -63.72 144.24 57.19 Favored 'General case' 0 C--N 1.286 -2.159 0 O-C-N 121.006 -1.059 . . . . 0.0 108.221 179.431 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.873 ' OH ' ' HB2' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -119.96 139.98 51.62 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 179.245 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.531 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -49.7 -45.42 39.11 Favored Glycine 0 N--CA 1.486 1.977 0 C-N-CA 119.765 -1.207 . . . . 0.0 111.066 -177.075 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.2 p-10 -159.04 -164.4 1.4 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.011 -1.288 . . . . 0.0 110.329 -179.567 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.627 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -71.2 -26.36 62.91 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 110.397 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.489 ' HA ' ' OH ' ' A' ' 11' ' ' TYR . 29.0 t -69.15 -63.36 1.08 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.968 -1.083 . . . . 0.0 109.065 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.561 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 37.1 m-80 -59.53 -39.44 83.91 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.439 -0.788 . . . . 0.0 110.201 -179.328 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 61.3 t80 -60.38 -47.21 87.05 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.621 -1.3 . . . . 0.0 108.752 179.335 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.642 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 3.5 m -64.08 -28.54 69.85 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.356 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 13.5 m-20 -67.08 -32.6 73.88 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 179.196 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.873 ' HB2' ' OH ' ' A' ' 31' ' ' TYR . . . -80.26 -22.86 41.25 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.437 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 39.9 t -77.67 -33.41 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.651 -0.656 . . . . 0.0 109.265 179.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.922 HG11 ' CB ' ' A' ' 11' ' ' TYR . 7.3 p -90.98 -17.57 7.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.237 -0.914 . . . . 0.0 109.768 -179.531 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.0 tt0 -91.9 -11.92 34.96 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.068 -1.02 . . . . 0.0 109.104 179.629 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 29.1 t -109.49 26.06 11.08 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.249 -0.907 . . . . 0.0 110.223 -179.406 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 44' ' ' SER . 30.5 m-20 62.14 35.89 15.42 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.144 -0.972 . . . . 0.0 108.734 -179.706 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 49.33 25.06 5.65 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.623 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.2 p -88.18 -14.56 38.32 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.343 -1.092 . . . . 0.0 108.688 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 49' ' ' THR . 1.1 tp -80.3 133.24 35.94 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 26' ' ' SER . 5.9 p -135.08 123.5 23.3 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.225 -0.922 . . . . 0.0 108.997 178.666 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.706 HD11 ' O ' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -64.42 165.29 10.01 Favored 'General case' 0 C--N 1.285 -2.234 0 O-C-N 121.429 -0.794 . . . . 0.0 109.644 -179.253 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.58 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.01 -22.77 10.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -179.718 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.706 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.8 p80 -174.2 152.41 1.83 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.537 -0.727 . . . . 0.0 109.548 -179.155 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -67.07 170.77 6.37 Favored 'General case' 0 C--N 1.294 -1.826 0 O-C-N 121.354 -0.841 . . . . 0.0 108.871 178.868 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.496 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.06 -170.82 47.83 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.852 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.607 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -92.39 134.28 35.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.097 -1.237 . . . . 0.0 108.272 178.619 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.585 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 O-C-N 121.005 -1.06 . . . . 0.0 109.408 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -174.83 -69.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.187 -0.946 . . . . 0.0 109.558 -179.902 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.94 132.56 34.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 t -124.78 109.49 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.313 -0.867 . . . . 0.0 109.467 -179.954 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -171.15 -166.01 0.44 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.34 -0.85 . . . . 0.0 109.44 179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.403 HG12 ' HE2' ' A' ' 37' ' ' PHE . 14.2 p -125.6 150.27 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -85.53 141.33 29.96 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.187 -0.946 . . . . 0.0 109.23 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.578 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 7.1 m -142.87 65.61 1.34 Allowed 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.271 -0.893 . . . . 0.0 109.58 -179.431 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.5 t -90.37 14.94 11.55 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.191 -0.943 . . . . 0.0 110.068 -179.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.476 ' HG2' ' CD1' ' A' ' 11' ' ' TYR . 4.9 pm0 -122.17 -10.35 8.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.979 -1.075 . . . . 0.0 109.723 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 1.055 ' O ' HG21 ' A' ' 42' ' ' VAL . 87.6 m-85 -80.37 158.94 71.02 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.284 -0.885 . . . . 0.0 109.242 -179.578 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.1 Cg_endo -73.98 178.8 31.85 Favored 'Cis proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.74 -1.775 . . . . 0.0 111.437 3.071 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -134.19 145.92 57.53 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.636 -0.665 . . . . 0.0 109.461 -179.001 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.4 Cg_endo -79.27 14.14 1.85 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.502 2.135 . . . . 0.0 110.436 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -173.47 115.95 0.25 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.833 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.1 m -81.09 158.24 25.1 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.095 -1.003 . . . . 0.0 110.174 -179.249 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.502 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -50.06 -25.36 3.36 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.396 1.093 . . . . 0.0 109.778 -179.777 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 17' ' ' THR . 0.4 OUTLIER 74.57 -12.14 0.95 Allowed 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.453 179.192 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' CD ' ' HB ' ' A' ' 17' ' ' THR . 0.1 OUTLIER -75.33 -167.94 0.72 Allowed 'General case' 0 N--CA 1.484 1.253 0 O-C-N 120.466 -1.396 . . . . 0.0 107.855 178.761 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.521 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.1 t80 -123.28 122.19 37.74 Favored 'General case' 0 C--N 1.291 -1.949 0 C-N-CA 118.632 -1.227 . . . . 0.0 111.274 179.976 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.582 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.9 OUTLIER -155.22 77.36 4.94 Favored Pre-proline 0 C--N 1.294 -1.818 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.754 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.607 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.7 Cg_endo -65.35 112.42 2.11 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 C-N-CA 122.164 1.91 . . . . 0.0 112.033 -177.241 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.891 HD12 ' CB ' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -108.86 122.02 46.31 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.566 -0.854 . . . . 0.0 108.758 179.655 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.675 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 1.3 m -79.41 103.36 9.28 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.156 -0.965 . . . . 0.0 108.633 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -54.21 -174.55 0.08 OUTLIER Glycine 0 N--CA 1.485 1.933 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 -178.18 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.572 ' CB ' ' O ' ' A' ' 49' ' ' THR . 3.3 t -72.67 -33.4 66.51 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.157 -1.202 . . . . 0.0 108.876 178.771 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.0 p30 -66.27 -12.34 55.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.42 -0.8 . . . . 0.0 109.309 179.776 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.564 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.6 OUTLIER 88.66 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.803 -0.561 . . . . 0.0 110.161 179.715 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 ttpt -100.6 143.87 30.25 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 108.956 179.68 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.533 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 33.9 m -87.59 128.59 35.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.022 -1.049 . . . . 0.0 110.018 -179.67 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.652 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 38.2 m-85 -103.8 118.46 36.76 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 178.345 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.468 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -31.17 -44.95 0.11 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 121.972 -0.455 . . . . 0.0 112.476 -176.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.582 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 32.2 p-10 -156.12 -161.8 1.19 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.702 -1.47 . . . . 0.0 109.472 -179.495 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.863 ' HA ' HD11 ' A' ' 23' ' ' LEU . 9.6 pttt -70.59 -28.38 64.82 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.398 -0.814 . . . . 0.0 110.377 -179.331 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.515 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 16.8 t -69.52 -59.86 2.7 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.86 -1.15 . . . . 0.0 109.051 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -52.88 -40.9 63.84 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.621 -0.674 . . . . 0.0 109.811 -179.893 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.891 ' CB ' HD12 ' A' ' 23' ' ' LEU . 35.7 t80 -64.17 -50.1 69.46 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-O 122.658 1.218 . . . . 0.0 109.225 179.604 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.641 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.0 m -59.37 -26.05 64.76 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.009 -178.937 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.543 ' O ' ' CG ' ' A' ' 43' ' ' GLU . 0.9 OUTLIER -69.13 -35.51 76.47 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 179.202 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.752 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.15 -23.51 59.27 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.208 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.403 ' O ' ' N ' ' A' ' 46' ' ' GLY . 55.1 t -80.36 -35.58 15.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.651 -0.656 . . . . 0.0 109.73 -179.751 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.055 HG21 ' O ' ' A' ' 11' ' ' TYR . 5.5 p -88.56 -13.24 9.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.258 -0.901 . . . . 0.0 109.798 -179.286 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.752 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -91.74 -33.83 14.86 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.005 -1.06 . . . . 0.0 108.148 178.54 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.523 ' O ' HG22 ' A' ' 47' ' ' THR . 1.0 OUTLIER -85.96 7.44 24.33 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.567 -0.708 . . . . 0.0 109.485 -179.982 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 44' ' ' SER . 6.0 t-20 77.02 6.56 3.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -0.91 . . . . 0.0 109.117 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 88.84 10.46 66.89 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.523 HG22 ' O ' ' A' ' 44' ' ' SER . 6.7 t -90.88 7.8 38.19 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.15 -1.206 . . . . 0.0 109.119 179.421 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.613 HD21 ' CE1' ' A' ' 37' ' ' PHE . 3.3 tp -79.42 -73.16 0.36 Allowed 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.308 -0.87 . . . . 0.0 109.136 -179.809 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.593 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.0 p 64.71 142.66 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.803 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.628 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -103.68 172.66 6.68 Favored 'General case' 0 C--N 1.283 -2.314 0 CA-C-O 122.125 0.964 . . . . 0.0 111.522 -177.876 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.571 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.0 p -97.59 -46.63 5.95 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 122.028 0.918 . . . . 0.0 108.591 179.913 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.613 ' NE2' ' HB2' ' A' ' 24' ' ' CYS . 3.8 p80 -154.82 157.32 37.73 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 121.646 0.736 . . . . 0.0 110.507 -178.671 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -77.84 175.49 9.95 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.664 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.53 -171.82 52.89 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.166 -1.573 . . . . 0.0 109.166 -179.455 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.453 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.9 OUTLIER -90.39 158.75 16.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.002 -1.293 . . . . 0.0 109.619 179.294 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.675 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 57.5 m . . . . . 0 C--N 1.3 -1.578 0 CA-C-O 117.993 -1.003 . . . . 0.0 109.956 -178.078 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.688 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.305 0.574 . . . . 0.0 109.673 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 76.54 9.44 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.277 -0.889 . . . . 0.0 109.482 179.999 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.93 56.98 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 0.0 109.632 -179.99 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.53 70.63 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.27 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.8 113.35 1.26 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.541 -179.838 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 90.6 t -85.87 148.06 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.238 -0.914 . . . . 0.0 109.343 179.815 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t0 -84.26 116.58 23.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.234 -0.916 . . . . 0.0 109.554 -179.893 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 58.9 m -119.46 60.1 0.84 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 0.0 109.356 179.687 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.0 t -90.97 -17.23 26.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 0.0 109.34 179.519 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.44 31.53 1.97 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.364 -0.835 . . . . 0.0 109.099 179.943 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.77 ' CB ' HG11 ' A' ' 42' ' ' VAL . 90.3 m-85 -117.81 162.2 30.35 Favored Pre-proline 0 C--N 1.305 -1.363 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.753 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.4 Cg_endo -85.91 163.85 56.08 Favored 'Cis proline' 0 C--N 1.305 -1.753 0 C-N-CA 123.213 -1.578 . . . . 0.0 110.581 1.947 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -122.91 140.61 33.7 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.518 -0.739 . . . . 0.0 109.658 -179.118 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -79.66 13.36 2.12 Favored 'Trans proline' 0 C--N 1.314 -1.259 0 C-N-CA 122.462 2.108 . . . . 0.0 110.788 -179.911 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -152.36 116.4 4.9 Favored 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.496 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 17' ' ' THR . 76.8 m -92.77 138.18 31.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.839 -179.614 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.462 ' O ' ' O ' ' A' ' 16' ' ' CYS . 2.7 p -52.51 -175.95 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 179.556 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.568 ' H ' HD23 ' A' ' 18' ' ' LEU . 1.1 pt? -114.21 -26.88 7.84 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.041 -1.037 . . . . 0.0 109.636 179.773 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.519 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.0 pm0 -48.68 162.97 0.09 Allowed 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 179.201 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.588 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.5 t80 -113.95 131.49 56.29 Favored 'General case' 0 C--N 1.287 -2.13 0 CA-C-O 122.209 1.004 . . . . 0.0 110.935 -179.223 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 18.0 mtp180 -161.21 84.84 1.79 Allowed Pre-proline 0 C--N 1.295 -1.768 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.445 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.576 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 29.4 Cg_endo -67.94 113.27 2.96 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.088 1.859 . . . . 0.0 111.586 -177.878 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.751 HD12 ' HB2' ' A' ' 37' ' ' PHE . 0.8 OUTLIER -107.84 126.53 52.77 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.513 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.663 ' O ' HD12 ' A' ' 50' ' ' LEU . 49.0 t -79.29 164.42 24.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.016 . . . . 0.0 108.761 -179.568 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.544 ' CA ' ' CD1' ' A' ' 48' ' ' LEU . . . -136.25 168.03 24.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -178.572 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.633 ' H ' HD12 ' A' ' 48' ' ' LEU . 30.5 t -66.21 -23.27 66.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.465 -1.02 . . . . 0.0 109.089 -179.64 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.578 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 1.0 OUTLIER -61.08 -13.75 19.19 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.331 -0.855 . . . . 0.0 109.121 179.282 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.578 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.7 m-20 86.77 22.62 0.06 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.862 -0.524 . . . . 0.0 110.089 179.625 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.483 ' HG3' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -126.53 171.88 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.092 -1.005 . . . . 0.0 109.512 179.406 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.547 HG22 ' N ' ' A' ' 31' ' ' TYR . 28.7 m -104.94 163.69 12.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.966 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 65.1 m-85 -126.12 118.86 26.14 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.357 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -32.27 -52.58 0.41 Allowed Glycine 0 N--CA 1.493 2.485 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 -177.655 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.555 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 42.2 p-10 -154.31 -167.96 2.79 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.78 -1.423 . . . . 0.0 109.909 179.92 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.663 ' HA ' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -57.56 -36.1 71.22 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.707 -0.621 . . . . 0.0 111.24 -178.744 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.532 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 34.7 t -60.9 -61.57 2.49 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 120.585 -1.322 . . . . 0.0 109.72 -179.329 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 -56.05 -41.99 75.88 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.522 -0.736 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.751 ' HB2' HD12 ' A' ' 23' ' ' LEU . 74.3 t80 -61.92 -43.85 97.98 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.768 -1.207 . . . . 0.0 109.607 -179.514 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.655 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 88.4 m -69.49 -24.19 63.74 Favored 'General case' 0 C--N 1.276 -2.61 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.139 -179.697 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 35' ' ' CYS . 3.6 m120 -74.93 -26.14 59.41 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.178 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.966 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -78.19 -33.53 50.05 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.152 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.655 ' CG2' HD23 ' A' ' 48' ' ' LEU . 42.2 t -69.02 -48.45 69.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 178.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG11 ' CB ' ' A' ' 11' ' ' TYR . 35.0 m -64.16 -31.88 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.572 -0.705 . . . . 0.0 109.519 -179.897 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.79 -8.33 43.97 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.328 -0.858 . . . . 0.0 109.521 179.882 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 40' ' ' ALA . 46.6 t -111.52 14.03 21.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.104 -0.997 . . . . 0.0 110.958 -178.776 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.709 ' O ' HG23 ' A' ' 47' ' ' THR . 0.9 OUTLIER 53.15 48.57 21.91 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 120.842 -1.162 . . . . 0.0 109.399 179.94 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.435 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 45.52 35.06 5.29 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 179.902 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.709 HG23 ' O ' ' A' ' 45' ' ' ASN . 30.2 p -110.86 5.5 20.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -1.072 . . . . 0.0 108.391 178.229 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' HG ' ' N ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -83.7 -51.76 6.99 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.993 0.901 . . . . 0.0 109.143 -179.931 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.665 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 77.5 p 56.24 124.39 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.019 0 CA-C-O 122.281 1.038 . . . . 0.0 110.48 -178.653 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' CYS . 5.8 tp -62.05 129.6 41.6 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.101 179.798 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.564 ' C ' ' CD2' ' A' ' 52' ' ' HIS . 10.9 t -79.47 -21.91 44.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.054 -1.029 . . . . 0.0 108.865 179.189 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.564 ' CD2' ' C ' ' A' ' 51' ' ' SER . 9.3 p80 156.23 154.63 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.215 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.787 179.416 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -63.48 165.48 7.83 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.958 -1.089 . . . . 0.0 108.663 179.398 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.516 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 84.08 -168.76 45.28 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.776 -1.73 . . . . 0.0 108.776 -178.976 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' H ' ' CD ' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -93.01 161.68 14.35 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.891 -1.359 . . . . 0.0 108.074 178.052 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 7.8 m . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.974 -1.013 . . . . 0.0 109.767 179.982 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 121.336 0.589 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.53 106.17 18.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.35 179.934 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.98 146.44 46.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 -179.959 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.599 ' O ' HD21 ' A' ' 50' ' ' LEU . 3.0 m -139.18 86.71 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 179.924 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.443 ' HA ' HD22 ' A' ' 50' ' ' LEU . 1.8 t -164.1 166.08 21.65 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.353 -0.842 . . . . 0.0 109.321 179.972 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 54.1 t -118.18 146.16 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.197 -0.939 . . . . 0.0 109.518 179.952 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -88.15 145.89 25.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.404 -0.81 . . . . 0.0 109.207 179.957 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 35.9 m -134.41 70.69 1.45 Allowed 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.275 -0.891 . . . . 0.0 110.009 -179.341 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.46 -19.46 23.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.183 -0.948 . . . . 0.0 109.867 -179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -104.85 32.77 3.95 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 109.321 -179.992 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.854 ' CB ' HG11 ' A' ' 42' ' ' VAL . 60.6 m-85 -113.34 164.82 14.7 Favored Pre-proline 0 C--N 1.301 -1.511 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.387 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.856 ' HB3' HG21 ' A' ' 42' ' ' VAL . 32.6 Cg_endo -84.91 152.31 58.0 Favored 'Cis proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.433 -1.486 . . . . 0.0 111.274 2.073 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 3.5 mtpm? -112.34 138.25 21.83 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.537 -0.727 . . . . 0.0 109.465 -179.743 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.7 Cg_endo -80.39 14.78 1.89 Allowed 'Trans proline' 0 C--N 1.313 -1.325 0 C-N-CA 122.728 2.285 . . . . 0.0 110.77 -179.956 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -164.19 160.51 21.36 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.358 -0.839 . . . . 0.0 109.112 179.837 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 45.2 t -147.5 159.84 43.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.888 . . . . 0.0 110.002 -179.775 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.44 -164.11 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 178.57 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -117.18 -23.29 7.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.775 -1.203 . . . . 0.0 110.02 179.965 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -45.5 115.94 1.05 Allowed 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.519 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.49 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 9.8 t80 -79.19 127.24 31.79 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-O 122.466 1.127 . . . . 0.0 111.354 -177.697 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.653 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.6 ptm180 -161.65 78.05 2.18 Favored Pre-proline 0 C--N 1.295 -1.762 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.15 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.609 ' O ' ' N ' ' A' ' 54' ' ' GLY . 24.0 Cg_endo -66.16 128.14 18.94 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 123.208 2.605 . . . . 0.0 113.069 -177.135 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.607 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.8 OUTLIER -112.34 130.34 55.99 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.606 178.402 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.73 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 48.1 t -83.56 122.75 28.99 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 179.928 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.521 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -68.53 -165.95 3.84 Favored Glycine 0 C--N 1.296 -1.665 0 N-CA-C 108.856 -1.698 . . . . 0.0 108.856 179.918 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.595 ' CB ' ' O ' ' A' ' 49' ' ' THR . 7.1 t -89.2 -36.99 15.34 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.096 -1.238 . . . . 0.0 107.972 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.624 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 4.4 p-10 -58.61 -17.37 21.51 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 178.532 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.624 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 97.17 20.08 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.128 0.49 . . . . 0.0 110.01 179.486 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.485 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.75 119.85 38.8 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.073 -1.017 . . . . 0.0 109.217 179.592 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.2 m -69.9 152.85 44.03 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.412 -0.805 . . . . 0.0 109.171 -179.953 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.602 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 19.4 m-85 -132.7 124.43 28.17 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.793 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.53 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -26.78 -51.96 0.07 OUTLIER Glycine 0 N--CA 1.499 2.852 0 N-CA-C 110.649 -0.981 . . . . 0.0 110.649 -177.686 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.653 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.3 p30 -163.63 -162.32 0.71 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.106 -1.232 . . . . 0.0 110.289 178.908 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.607 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.51 -40.76 60.22 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.404 -0.81 . . . . 0.0 112.6 -177.408 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.556 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -69.12 -65.15 0.74 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 120.209 -1.557 . . . . 0.0 108.911 -179.621 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.7 m-80 -42.93 -30.5 0.41 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.44 -0.787 . . . . 0.0 109.57 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.513 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 27.5 t80 -74.85 -48.25 26.01 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.897 1.332 . . . . 0.0 109.406 179.545 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.665 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 87.4 m -55.92 -53.67 53.97 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.735 -178.828 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.559 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 0.0 OUTLIER -42.23 -26.68 0.11 Allowed 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.951 -1.093 . . . . 0.0 108.931 -179.475 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -77.97 -47.75 17.83 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.592 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.683 ' CG2' HD23 ' A' ' 48' ' ' LEU . 61.6 t -60.5 -28.12 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.715 -0.616 . . . . 0.0 110.422 179.507 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.856 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.2 m -90.93 -26.28 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.88 -1.137 . . . . 0.0 109.897 -179.033 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.3 tt0 -90.47 0.77 57.18 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.406 -0.808 . . . . 0.0 108.868 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.496 ' O ' ' OG ' ' A' ' 44' ' ' SER . 1.4 t -119.18 22.47 11.82 Favored 'General case' 0 N--CA 1.484 1.272 0 O-C-N 121.221 -0.925 . . . . 0.0 109.854 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 1.0 ' O ' HG23 ' A' ' 47' ' ' THR . 0.8 OUTLIER 64.11 46.47 3.67 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 122.905 1.336 . . . . 0.0 108.082 179.951 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 32.31 37.33 0.04 OUTLIER Glycine 0 N--CA 1.496 2.648 0 O-C-N 121.513 -0.742 . . . . 0.0 111.874 -179.984 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 1.0 HG23 ' O ' ' A' ' 45' ' ' ASN . 43.2 p -111.01 0.45 16.98 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.049 -1.265 . . . . 0.0 108.231 177.868 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.683 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.36 152.92 30.15 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.759 0.79 . . . . 0.0 109.016 179.957 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.595 ' O ' ' CB ' ' A' ' 26' ' ' SER . 41.2 p -141.45 149.89 41.56 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.65 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -97.22 175.96 6.09 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.713 -1.242 . . . . 0.0 109.214 -179.544 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.65 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -112.5 -23.04 10.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.756 -1.215 . . . . 0.0 108.607 -179.439 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.73 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.5 OUTLIER 177.14 155.03 0.27 Allowed 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.595 -0.691 . . . . 0.0 109.321 -178.816 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -62.04 -168.0 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.926 0 O-C-N 121.561 -0.712 . . . . 0.0 109.133 178.87 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.609 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 58.6 -167.45 6.55 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 -179.49 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.416 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER -90.8 175.68 6.91 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.377 -1.073 . . . . 0.0 108.471 178.571 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 117.904 -1.046 . . . . 0.0 109.568 -179.807 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.3 pp . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.693 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -120.75 -5.74 9.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.23 -0.919 . . . . 0.0 109.658 -179.909 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.693 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 76.25 145.24 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.237 -0.914 . . . . 0.0 109.541 179.926 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.669 ' CG1' HD23 ' A' ' 50' ' ' LEU . 1.6 t -155.16 90.48 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.325 -0.86 . . . . 0.0 109.181 179.917 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 54.1 p -168.05 85.44 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.053 -1.03 . . . . 0.0 110.103 -179.676 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 22.2 t -97.43 149.99 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.264 -0.898 . . . . 0.0 108.885 179.461 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.9 t0 -95.38 130.18 42.26 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.123 -0.986 . . . . 0.0 109.669 -179.611 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 38' ' ' CYS . 78.1 m -137.3 47.98 2.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.869 . . . . 0.0 109.309 179.81 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.443 ' OG ' ' OE2' ' A' ' 10' ' ' GLU . 64.6 p -86.96 -30.21 21.47 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' OE2' ' OG ' ' A' ' 9' ' ' SER . 12.0 mm-40 -73.19 -8.92 57.91 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.358 -0.839 . . . . 0.0 109.157 179.704 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.744 ' HB3' HG11 ' A' ' 42' ' ' VAL . 80.3 m-85 -79.97 161.44 65.87 Favored Pre-proline 0 C--N 1.303 -1.455 0 O-C-N 121.416 -0.802 . . . . 0.0 109.461 -179.71 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.845 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.2 Cg_endo -84.51 143.36 40.08 Favored 'Cis proline' 0 C--N 1.306 -1.688 0 C-N-CA 123.156 -1.602 . . . . 0.0 110.846 1.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 2.0 mtpt -116.09 137.85 23.72 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.484 -0.76 . . . . 0.0 109.369 -179.541 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 35.5 Cg_endo -80.49 14.08 2.09 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.349 2.033 . . . . 0.0 110.542 179.91 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -145.14 126.74 15.13 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.602 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 35' ' ' CYS . 60.2 m -112.78 138.75 49.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.243 -0.911 . . . . 0.0 109.78 -179.548 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.4 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.2 p -56.9 -170.18 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.201 -0.937 . . . . 0.0 108.734 179.528 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -112.14 -25.48 9.3 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.099 -1.001 . . . . 0.0 109.603 179.894 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.452 ' C ' ' O ' ' A' ' 18' ' ' LEU . 1.8 mt-10 -41.47 122.51 1.93 Allowed 'General case' 0 N--CA 1.484 1.262 0 O-C-N 121.349 -0.844 . . . . 0.0 109.142 179.76 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.482 ' C ' ' HG2' ' A' ' 21' ' ' ARG . 15.6 t80 -83.14 107.37 15.66 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 122.432 1.11 . . . . 0.0 110.357 -179.007 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -141.27 77.7 19.75 Favored Pre-proline 0 C--N 1.289 -2.064 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.197 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.56 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.7 Cg_endo -64.25 115.24 3.04 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 C-N-CA 122.228 1.952 . . . . 0.0 111.688 -177.933 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.573 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -114.76 135.7 53.89 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.539 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.716 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 47.4 t -89.99 160.47 16.36 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.976 -1.09 . . . . 0.0 108.536 -179.67 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.572 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -133.2 161.21 24.14 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.515 -177.659 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t -45.36 -21.67 0.1 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.817 -0.813 . . . . 0.0 111.177 -178.176 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.525 ' OD2' ' CD1' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -86.14 25.23 1.19 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.772 -1.205 . . . . 0.0 110.094 -179.654 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.2 m120 49.48 20.09 0.44 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 110.204 179.656 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.433 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -104.63 141.23 36.79 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.008 -1.058 . . . . 0.0 109.999 -179.84 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 31' ' ' TYR . 82.2 m -86.87 157.54 19.52 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.427 -0.796 . . . . 0.0 108.932 179.53 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.621 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 82.1 m-85 -135.74 99.49 4.2 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.78 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -21.31 -59.28 0.02 OUTLIER Glycine 0 N--CA 1.498 2.821 0 N-CA-C 111.909 -0.476 . . . . 0.0 111.909 -178.166 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.626 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p-10 -137.77 -170.27 2.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.739 -1.448 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.573 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -54.22 -35.37 62.34 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.9 -0.5 . . . . 0.0 110.743 -178.639 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.616 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 40.7 t -64.57 -67.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 120.902 -1.124 . . . . 0.0 109.569 -179.623 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.565 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.6 m-80 -44.84 -30.27 0.95 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.389 -0.819 . . . . 0.0 109.82 -179.803 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 24.1 t80 -71.79 -54.31 10.58 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 122.535 1.16 . . . . 0.0 109.78 -179.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.602 ' HB2' ' CE2' ' A' ' 11' ' ' TYR . 72.7 m -54.59 -58.9 5.69 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.109 -179.684 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.458 ' HA ' HG22 ' A' ' 42' ' ' VAL . 9.1 m-20 -42.68 -27.78 0.19 Allowed 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.878 -1.139 . . . . 0.0 109.394 -179.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.577 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -73.57 -48.1 35.51 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 178.833 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.862 HG22 ' CD2' ' A' ' 48' ' ' LEU . 66.9 t -60.69 -54.11 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 CA-C-O 121.378 0.609 . . . . 0.0 109.57 179.347 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.845 HG21 ' HB3' ' A' ' 12' ' ' PRO . 10.2 m -56.3 -31.31 32.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.156 -0.965 . . . . 0.0 110.237 -179.506 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -92.2 -12.31 33.09 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 120.915 -1.116 . . . . 0.0 109.638 -179.915 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.598 ' O ' HG22 ' A' ' 47' ' ' THR . 17.6 t -98.06 8.19 45.15 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.101 -0.999 . . . . 0.0 110.309 -179.089 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.517 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.8 t-20 75.33 12.12 3.31 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.984 -1.073 . . . . 0.0 108.484 -179.24 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.619 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 67.29 8.39 50.34 Favored Glycine 0 N--CA 1.486 2.022 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 -179.589 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.598 HG22 ' O ' ' A' ' 44' ' ' SER . 6.3 t -86.45 5.51 34.82 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.203 -1.175 . . . . 0.0 108.469 178.615 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.862 ' CD2' HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -87.94 -71.81 0.56 Allowed 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 121.993 0.901 . . . . 0.0 108.888 -179.666 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.6 p 81.69 152.11 0.1 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 121.965 0.888 . . . . 0.0 109.081 -178.867 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.669 HD23 ' CG1' ' A' ' 4' ' ' VAL . 11.5 tp -67.69 156.76 36.17 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.682 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.535 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.3 p -106.28 -40.85 5.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.936 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.716 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.71 168.5 1.71 Allowed 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 114.421 -1.263 . . . . 0.0 108.132 179.949 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -81.61 166.21 20.4 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 178.262 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 82.84 -175.11 53.16 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 -179.652 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.96 156.49 19.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.949 -1.324 . . . . 0.0 109.132 179.081 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.466 -179.968 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.635 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.332 0.587 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 73.15 117.42 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.448 179.923 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -54.5 168.96 0.22 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.294 179.817 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.501 HG13 ' O ' ' A' ' 3' ' ' ALA . 11.6 m -156.14 82.94 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.29 -0.881 . . . . 0.0 109.417 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 178.04 147.84 0.16 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -0.878 . . . . 0.0 109.628 -179.885 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.2 t -99.05 155.67 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.256 -0.903 . . . . 0.0 109.234 179.895 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.6 t0 -92.35 128.87 38.36 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.136 179.712 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 21.1 m -123.05 63.56 0.99 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.098 -1.001 . . . . 0.0 109.831 -179.674 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.2 t -90.68 -19.5 23.53 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.128 -0.982 . . . . 0.0 109.325 179.769 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.9 mm-40 -97.46 26.3 5.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.318 -0.864 . . . . 0.0 109.092 179.864 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.844 ' CB ' HG11 ' A' ' 42' ' ' VAL . 68.9 m-85 -114.71 161.99 26.03 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.548 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.895 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.7 Cg_endo -85.84 156.03 56.88 Favored 'Cis proline' 0 C--N 1.305 -1.752 0 C-N-CA 123.084 -1.632 . . . . 0.0 110.698 1.605 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 20.3 mtpt -118.31 140.15 27.74 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.309 -0.869 . . . . 0.0 109.192 -179.938 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -79.86 14.33 1.91 Allowed 'Trans proline' 0 C--N 1.313 -1.299 0 C-N-CA 122.658 2.239 . . . . 0.0 110.75 -179.663 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.99 119.88 5.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 179.741 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 98.6 m -101.07 139.37 36.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.132 -0.98 . . . . 0.0 110.275 -179.226 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.454 ' C ' HD13 ' A' ' 18' ' ' LEU . 0.7 OUTLIER -63.61 -172.07 0.05 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.422 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.926 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -116.36 -14.31 11.01 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.887 -1.133 . . . . 0.0 110.379 -179.461 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 3.0 pm0 -49.35 120.96 4.47 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.379 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -79.57 126.62 31.12 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-O 122.45 1.119 . . . . 0.0 110.902 -178.273 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.81 80.05 1.99 Allowed Pre-proline 0 C--N 1.292 -1.916 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 179.408 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.575 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.0 Cg_endo -65.72 119.54 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.286 1.991 . . . . 0.0 112.135 -177.366 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.629 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -110.79 123.13 49.48 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.151 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.1 t -79.26 127.65 32.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 0.0 109.101 -179.193 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -74.3 -173.31 29.28 Favored Glycine 0 N--CA 1.484 1.9 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.759 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.594 ' HB3' ' O ' ' A' ' 48' ' ' LEU . 5.2 t -76.14 -33.47 59.41 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.695 -1.474 . . . . 0.0 108.902 179.073 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.593 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -62.08 -12.18 17.84 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.414 -0.804 . . . . 0.0 109.653 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 59.3 t30 92.23 20.6 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.956 -0.465 . . . . 0.0 111.041 179.229 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.516 ' CG ' ' OD1' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -99.68 175.03 5.95 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.799 -1.188 . . . . 0.0 108.017 178.235 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.7 m -119.89 148.16 43.83 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.27 -0.894 . . . . 0.0 109.887 -179.73 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.576 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 46.2 m-85 -120.67 120.72 36.53 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.819 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -30.27 -51.24 0.19 Allowed Glycine 0 N--CA 1.496 2.666 0 N-CA-C 111.513 -0.635 . . . . 0.0 111.513 -177.768 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.4 p-10 -153.04 -166.4 2.44 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.738 -1.448 . . . . 0.0 110.252 179.737 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.629 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -66.7 -22.54 66.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.569 -0.707 . . . . 0.0 111.323 -178.32 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.581 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 49.2 t -74.1 -50.55 19.0 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.612 -1.305 . . . . 0.0 108.859 179.578 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -62.9 -38.47 91.09 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 120.019 -0.672 . . . . 0.0 109.523 179.982 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.743 ' CE1' HD21 ' A' ' 48' ' ' LEU . 48.4 t80 -68.87 -47.8 65.02 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 122.37 1.081 . . . . 0.0 109.635 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 29.2 m -62.23 -29.34 70.32 Favored 'General case' 0 C--N 1.281 -2.397 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.908 -179.409 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.554 ' HA ' HG22 ' A' ' 42' ' ' VAL . 19.9 m-20 -71.67 -23.61 61.7 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.077 -1.015 . . . . 0.0 108.638 179.636 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -85.78 -22.82 27.5 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.472 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 86.7 t -83.2 -26.68 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.272 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.895 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.8 m -86.49 -31.0 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.443 -0.786 . . . . 0.0 109.294 -179.901 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -91.92 -15.4 28.11 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.23 179.682 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.569 ' O ' HG23 ' A' ' 47' ' ' THR . 27.9 t -96.97 9.63 41.45 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.17 -0.957 . . . . 0.0 110.299 -179.385 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 44' ' ' SER . 7.3 m120 62.59 28.31 16.6 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.155 -0.965 . . . . 0.0 109.355 -179.871 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 63.4 20.85 63.83 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 110.193 -1.163 . . . . 0.0 110.193 179.697 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 44' ' ' SER . 5.3 p -96.28 5.76 50.26 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.333 -1.098 . . . . 0.0 108.584 178.794 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.743 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -83.82 -63.82 1.28 Allowed 'General case' 0 C--N 1.308 -1.199 0 O-C-N 121.437 -0.789 . . . . 0.0 109.042 -179.712 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.626 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 65.5 p 56.27 124.72 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.96 0.886 . . . . 0.0 110.446 179.899 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -85.83 172.08 11.04 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 121.524 0.678 . . . . 0.0 110.733 -178.709 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.647 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.04 -28.72 9.38 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 179.992 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.6 OUTLIER -174.44 162.7 3.55 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.766 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.43 ' CD2' ' CD2' ' A' ' 23' ' ' LEU . 34.0 m-85 -71.45 -170.77 0.54 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.276 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 62.51 -174.01 8.39 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.37 -1.092 . . . . 0.0 110.37 179.701 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.439 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -85.6 164.82 17.51 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.325 -1.103 . . . . 0.0 108.868 179.396 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 29' ' ' LYS . 3.0 m . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.393 -179.928 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 1.1 pp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 3' ' ' ALA . . . 179.48 153.39 0.45 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.225 -0.922 . . . . 0.0 109.558 -179.936 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 2' ' ' ALA . . . 173.88 124.18 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.305 -0.872 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.711 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.5 p -106.71 68.32 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.1 t -169.05 106.12 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.958 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.462 HG12 ' O ' ' A' ' 7' ' ' ASP . 51.8 t -88.82 145.17 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.248 -0.907 . . . . 0.0 109.6 -179.887 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' O ' HG12 ' A' ' 6' ' ' VAL . 0.2 OUTLIER -76.72 172.89 12.33 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.193 -0.942 . . . . 0.0 109.185 179.952 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 8.4 t -161.15 26.51 0.14 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.004 -1.06 . . . . 0.0 109.809 -179.786 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 t -90.56 -0.21 57.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.93 -179.801 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -119.58 38.55 3.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.138 -0.976 . . . . 0.0 110.267 -179.59 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.682 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 96.3 m-85 -139.83 154.17 70.56 Favored Pre-proline 0 C--N 1.305 -1.334 0 O-C-N 121.057 -1.027 . . . . 0.0 108.369 179.59 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.577 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.5 Cg_endo -72.13 149.07 92.47 Favored 'Cis proline' 0 C--N 1.305 -1.721 0 C-N-CA 122.597 -1.835 . . . . 0.0 111.622 2.931 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.499 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.8 OUTLIER -110.6 148.03 37.65 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -179.981 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.499 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 34.5 Cg_endo -77.44 13.32 1.63 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.509 2.139 . . . . 0.0 110.968 -179.903 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -167.41 115.26 0.78 Allowed 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.518 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 17' ' ' THR . 86.2 m -88.69 149.66 23.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.264 -0.897 . . . . 0.0 109.749 -179.612 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.455 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -47.92 172.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 179.393 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -114.95 -23.21 9.2 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.869 -1.145 . . . . 0.0 110.228 -179.521 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.9 pm0 -59.18 -168.9 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 120.885 -1.134 . . . . 0.0 108.134 179.358 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.471 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 20.0 t80 -127.55 129.1 46.75 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 119.13 -1.028 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.601 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.32 81.61 2.0 Allowed Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.262 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.7 Cg_endo -66.4 111.33 2.04 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.177 1.918 . . . . 0.0 111.27 -178.268 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.608 HD13 ' CB ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -105.95 136.78 45.0 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.266 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.711 ' O ' HD12 ' A' ' 50' ' ' LEU . 12.1 t -98.22 159.04 15.2 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.073 -1.051 . . . . 0.0 109.251 -179.461 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.564 ' HA3' HD13 ' A' ' 48' ' ' LEU . . . -116.53 174.06 15.04 Favored Glycine 0 N--CA 1.491 2.321 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.441 -177.895 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.525 ' H ' HD12 ' A' ' 48' ' ' LEU . 15.1 t -70.33 -13.47 62.17 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.45 -1.029 . . . . 0.0 108.547 178.984 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 5.7 p-10 -81.92 -8.99 59.72 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.41 -0.806 . . . . 0.0 109.318 179.637 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.563 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 5.6 t-20 82.74 34.78 0.06 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.649 -0.657 . . . . 0.0 109.909 179.808 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.49 ' HG3' ' N ' ' A' ' 30' ' ' THR . 2.1 tttp -123.2 147.3 47.02 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.15 -0.969 . . . . 0.0 109.23 179.819 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.521 HG22 ' N ' ' A' ' 31' ' ' TYR . 78.0 m -93.35 162.18 14.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.071 -1.018 . . . . 0.0 109.898 -179.87 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.611 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 83.6 m-85 -138.18 108.22 6.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 178.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.69 -57.44 0.12 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 111.721 -0.552 . . . . 0.0 111.721 -177.252 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.601 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 48.1 p30 -141.66 -169.88 2.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.817 -1.402 . . . . 0.0 110.535 179.835 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.583 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.0 ptmt -54.7 -47.06 74.16 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.794 -0.566 . . . . 0.0 110.708 -178.514 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.529 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.7 t -53.79 -52.69 59.48 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.802 -1.187 . . . . 0.0 109.541 -179.817 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.579 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 22.1 m-80 -61.64 -29.39 70.03 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.549 -0.72 . . . . 0.0 110.547 -179.093 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.931 ' CE1' HD21 ' A' ' 48' ' ' LEU . 11.5 t80 -73.86 -62.73 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.76 -1.212 . . . . 0.0 110.813 -179.167 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.682 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.2 -48.75 73.39 Favored 'General case' 0 C--N 1.288 -2.08 0 O-C-N 121.81 -0.556 . . . . 0.0 109.523 -178.782 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.521 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.6 m-80 -41.88 -31.13 0.3 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.179 . . . . 0.0 108.321 -179.604 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -72.99 -49.08 31.08 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 177.569 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.575 ' N ' HD23 ' A' ' 48' ' ' LEU . 71.4 t -55.78 -59.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 CA-C-O 121.401 0.62 . . . . 0.0 110.373 179.207 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 38' ' ' CYS . 2.3 p -60.62 -23.97 30.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.204 -0.935 . . . . 0.0 110.599 -178.458 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.511 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.8 tm-20 -89.35 -15.39 33.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.611 -1.306 . . . . 0.0 107.994 178.276 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.518 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.1 OUTLIER -105.6 0.27 26.34 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.699 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 44' ' ' SER . 2.4 p30 60.64 22.85 12.67 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.452 -0.78 . . . . 0.0 109.447 -179.136 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.45 16.11 57.55 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 178.666 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 44' ' ' SER . 74.1 p -85.52 -12.04 52.7 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.059 -1.26 . . . . 0.0 108.268 178.147 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.931 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -78.41 -52.13 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.713 0.768 . . . . 0.0 109.177 -179.967 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.666 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 20.9 p 55.17 123.73 0.0 OUTLIER 'General case' 0 C--N 1.292 -1.895 0 CA-C-O 122.312 1.053 . . . . 0.0 109.839 -178.045 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.711 HD12 ' O ' ' A' ' 24' ' ' CYS . 24.8 tp -56.45 160.22 3.26 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.919 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.537 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 3.5 p -115.91 -41.57 3.18 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 122.54 1.162 . . . . 0.0 107.928 179.545 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.703 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.04 159.64 1.34 Allowed 'General case' 0 C--N 1.292 -1.918 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.726 -179.568 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -78.84 133.8 36.99 Favored 'General case' 0 C--N 1.295 -1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 109.408 178.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.514 ' C ' ' O ' ' A' ' 22' ' ' PRO . . . 112.91 -172.13 14.33 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 -179.886 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.43 134.36 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.042 -1.269 . . . . 0.0 109.295 179.211 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.582 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.413 ' O ' ' C ' ' A' ' 2' ' ' ALA . 1.9 mm? . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 1' ' ' LEU . . . 44.45 78.05 0.06 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.302 -0.874 . . . . 0.0 109.317 -179.849 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.27 -179.03 3.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.269 -0.894 . . . . 0.0 109.62 -179.87 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.493 ' O ' ' CB ' ' A' ' 5' ' ' SER . 5.4 m -131.07 88.89 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.313 -0.867 . . . . 0.0 109.427 179.98 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.4 OUTLIER 164.52 153.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.35 -0.844 . . . . 0.0 109.149 -179.856 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.612 HG21 HD22 ' A' ' 23' ' ' LEU . 99.1 t -106.09 142.61 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.088 -1.007 . . . . 0.0 109.626 -179.915 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -69.42 148.23 49.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.246 -0.909 . . . . 0.0 109.108 179.693 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.7 m -131.46 30.38 4.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.0 109.933 -179.788 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.11 -13.85 43.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.097 -1.002 . . . . 0.0 109.651 -179.819 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.49 -2.19 25.61 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.0 109.554 179.87 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.733 ' HB3' HG11 ' A' ' 42' ' ' VAL . 54.5 m-85 -93.56 163.37 24.71 Favored Pre-proline 0 C--N 1.303 -1.42 0 O-C-N 121.34 -0.85 . . . . 0.0 109.362 -179.421 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.925 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.1 Cg_endo -83.27 157.7 74.04 Favored 'Cis proline' 0 C--N 1.307 -1.645 0 C-N-CA 123.247 -1.564 . . . . 0.0 110.989 2.114 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -107.61 142.54 25.4 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.459 -0.776 . . . . 0.0 109.627 -179.735 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.682 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.7 Cg_endo -79.75 15.27 1.67 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.753 2.302 . . . . 0.0 110.861 179.876 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.682 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.35 137.51 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.478 -0.763 . . . . 0.0 109.025 -179.933 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' A' ' 17' ' ' THR . 49.0 t -109.86 157.57 19.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.065 -1.022 . . . . 0.0 110.842 -179.258 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.472 ' OG1' ' OE2' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -64.19 -157.92 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 178.058 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.601 HD12 ' N ' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -116.69 -8.26 11.45 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.269 -1.519 . . . . 0.0 110.856 -179.708 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 18' ' ' LEU . 0.4 OUTLIER -49.62 136.32 17.25 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 120.585 -1.322 . . . . 0.0 107.811 179.276 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.611 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.0 t80 -98.29 130.2 44.98 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-O 122.282 1.039 . . . . 0.0 110.618 -178.602 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.86 77.58 2.46 Favored Pre-proline 0 C--N 1.294 -1.814 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 179.536 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.7 Cg_endo -62.59 121.35 9.27 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.741 2.294 . . . . 0.0 112.55 -177.084 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD22 HG21 ' A' ' 6' ' ' VAL . 1.2 mp -110.03 133.88 52.73 Favored 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.563 179.466 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.739 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.8 OUTLIER -80.31 111.07 16.35 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 179.822 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.504 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.59 -169.04 3.28 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 108.22 -1.952 . . . . 0.0 108.22 179.665 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.556 ' N ' ' O ' ' A' ' 49' ' ' THR . 5.5 t -80.85 -32.38 35.05 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.839 -1.389 . . . . 0.0 108.812 178.895 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.56 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER -65.23 -8.15 16.23 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.363 -0.836 . . . . 0.0 109.616 179.963 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 46.1 t30 86.05 16.37 0.12 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.695 -0.628 . . . . 0.0 110.489 179.033 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.491 ' HG2' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -109.41 119.98 41.1 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.007 -1.058 . . . . 0.0 108.5 178.856 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.558 HG22 ' N ' ' A' ' 31' ' ' TYR . 27.0 m -58.64 161.93 4.3 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-O 121.494 0.664 . . . . 0.0 109.771 -179.354 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 0.8 OUTLIER -130.54 133.36 46.16 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 177.772 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.611 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.3 -50.3 0.25 Allowed Glycine 0 N--CA 1.498 2.806 0 N-CA-C 110.263 -1.135 . . . . 0.0 110.263 -177.313 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.664 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 55.6 p30 -165.31 -164.02 0.72 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 120.921 -1.34 . . . . 0.0 110.75 178.896 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 12.9 pttt -52.82 -40.31 63.19 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.688 -0.633 . . . . 0.0 111.676 -177.674 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 3.8 m -72.69 -50.86 22.1 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 120.628 -1.295 . . . . 0.0 110.173 -178.427 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.585 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 16.1 m-80 -61.65 -18.58 60.09 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.713 -1.242 . . . . 0.0 108.931 179.78 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.632 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 9.4 t80 -80.74 -60.85 2.15 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-O 122.303 1.049 . . . . 0.0 109.636 179.432 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.577 ' SG ' ' CG ' ' A' ' 11' ' ' TYR . 46.8 t -57.78 -49.65 75.89 Favored 'General case' 0 C--N 1.29 -1.998 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.321 -178.646 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' C ' ' O ' ' A' ' 38' ' ' CYS . 8.0 m-20 -42.17 -28.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.721 -1.237 . . . . 0.0 108.343 179.357 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -74.32 -49.65 22.05 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 177.673 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.639 HG22 HD23 ' A' ' 48' ' ' LEU . 97.2 t -55.53 -56.01 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-O 121.423 0.63 . . . . 0.0 109.747 178.796 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.925 HG21 ' HB3' ' A' ' 12' ' ' PRO . 19.4 m -58.21 -29.67 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -0.974 . . . . 0.0 110.27 -179.544 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 7.0 tt0 -90.78 -10.46 42.79 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.01 -1.056 . . . . 0.0 109.426 -179.616 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 1.0 OUTLIER -105.86 16.14 25.62 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -179.559 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 44' ' ' SER . 10.5 m120 63.16 16.21 9.18 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.016 -1.053 . . . . 0.0 109.644 -179.917 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 72.44 21.94 79.19 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.528 -1.029 . . . . 0.0 110.528 179.454 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.4 p -96.2 6.55 48.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.244 -1.15 . . . . 0.0 107.99 178.155 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.639 HD23 HG22 ' A' ' 41' ' ' VAL . 5.3 tp -87.78 -76.19 0.39 Allowed 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.547 0.689 . . . . 0.0 109.841 -179.249 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 6.1 p 66.22 152.86 0.07 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 -178.586 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.682 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.0 OUTLIER -108.87 173.14 6.45 Favored 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.635 -0.666 . . . . 0.0 110.198 -178.056 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.682 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -106.93 -33.53 7.49 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.659 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.9 p80 -167.27 163.32 15.32 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.533 0.682 . . . . 0.0 109.667 -178.798 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -76.03 -177.72 4.05 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.524 -0.735 . . . . 0.0 109.359 179.15 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.38 -170.48 52.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.97 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.476 ' HA ' ' OG1' ' A' ' 30' ' ' THR . 0.0 OUTLIER -91.11 125.86 36.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.36 -1.082 . . . . 0.0 109.609 179.326 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.645 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.454 179.775 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -96.92 -70.12 0.73 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.224 -0.923 . . . . 0.0 109.422 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -142.63 141.09 31.85 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.177 -0.952 . . . . 0.0 109.352 179.842 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 t -107.41 79.51 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.0 109.334 179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.1 p -162.81 113.95 1.5 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.523 -179.903 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.476 HG21 HD22 ' A' ' 23' ' ' LEU . 17.2 t -80.31 151.27 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.086 179.729 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -108.15 98.28 7.85 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.957 -179.747 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.579 ' HB3' ' CD2' ' A' ' 11' ' ' TYR . 34.6 m -93.08 65.55 4.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.292 -0.88 . . . . 0.0 108.939 179.499 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.7 m -88.98 -10.11 48.91 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.228 -0.92 . . . . 0.0 110.122 -179.341 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.536 ' O ' ' CG ' ' A' ' 13' ' ' LYS . 3.7 mp0 -116.04 36.98 3.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 109.398 179.997 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.688 ' HB3' HG11 ' A' ' 42' ' ' VAL . 87.1 m-85 -117.87 160.95 36.69 Favored Pre-proline 0 C--N 1.304 -1.395 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 -179.644 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.965 ' HB3' HG21 ' A' ' 42' ' ' VAL . 35.4 Cg_endo -83.63 159.66 72.3 Favored 'Cis proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.964 -1.682 . . . . 0.0 110.819 2.364 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.536 ' CG ' ' O ' ' A' ' 10' ' ' GLU . 17.0 mtpp -131.35 137.84 31.45 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.382 -0.824 . . . . 0.0 109.391 -179.614 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.2 Cg_endo -80.66 14.04 2.13 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.492 2.128 . . . . 0.0 110.687 -179.773 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.1 115.32 10.35 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.72 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.452 ' O ' ' O ' ' A' ' 17' ' ' THR . 79.9 m -98.84 139.57 34.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.302 -0.874 . . . . 0.0 109.99 -179.353 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.509 ' CB ' ' OE2' ' A' ' 19' ' ' GLU . 36.0 p -47.13 169.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.16 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.862 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -110.12 -1.79 17.28 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.775 -1.203 . . . . 0.0 110.365 -179.869 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' OE2' ' CB ' ' A' ' 17' ' ' THR . 3.3 pm0 -76.26 -170.83 1.56 Allowed 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 178.584 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.52 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 10.8 t80 -133.57 125.5 28.95 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.469 -1.292 . . . . 0.0 110.889 179.517 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 53.8 mtt180 -161.16 80.75 2.1 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 179.241 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.3 Cg_endo -65.75 122.65 10.32 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.5 2.134 . . . . 0.0 112.045 -177.188 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.843 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.4 OUTLIER -108.67 135.58 49.67 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.286 -0.966 . . . . 0.0 108.583 179.17 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.961 ' O ' HD12 ' A' ' 50' ' ' LEU . 4.1 t -85.21 162.29 19.24 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.553 -0.717 . . . . 0.0 109.071 -179.298 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -120.98 161.49 15.0 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.631 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.0 OUTLIER -69.23 -19.16 63.95 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.246 -1.149 . . . . 0.0 109.109 -179.721 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.531 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 29.9 p-10 -78.12 -0.16 27.12 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.073 179.19 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER 79.62 42.52 0.07 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.508 -0.745 . . . . 0.0 109.752 179.857 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.481 ' HG3' ' N ' ' A' ' 30' ' ' THR . 0.0 OUTLIER -134.18 139.41 45.82 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.258 -0.901 . . . . 0.0 109.412 -179.944 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.579 HG22 ' N ' ' A' ' 31' ' ' TYR . 5.5 m -92.23 165.86 12.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.009 179.637 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.732 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.9 m-85 -137.83 123.61 19.95 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 178.819 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.52 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -30.57 -53.69 0.24 Allowed Glycine 0 N--CA 1.494 2.56 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 -177.804 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.574 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 38.5 p-10 -157.35 -168.23 2.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.973 -1.31 . . . . 0.0 110.49 179.534 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.613 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 9.9 ptmt -53.15 -37.9 62.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.584 -0.698 . . . . 0.0 111.358 -178.29 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 16' ' ' CYS . 31.7 t -63.0 -61.15 2.59 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 120.635 -1.29 . . . . 0.0 109.964 -179.581 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.578 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 15.2 m-80 -55.75 -31.29 62.42 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.456 -0.777 . . . . 0.0 110.837 -179.017 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 69.6 t80 -73.58 -44.23 57.79 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.818 -1.177 . . . . 0.0 109.682 -179.526 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 63.3 m -66.23 -30.1 70.49 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.43 -179.744 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' HA ' HG22 ' A' ' 42' ' ' VAL . 11.4 m-20 -68.42 -24.85 64.79 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.326 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.753 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -82.44 -26.35 32.78 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.531 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 46' ' ' GLY . 92.1 t -80.08 -26.48 11.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.296 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.965 HG21 ' HB3' ' A' ' 12' ' ' PRO . 33.4 m -90.68 -21.02 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.59 -0.694 . . . . 0.0 109.353 -179.983 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.753 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -90.54 -31.59 16.66 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.277 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 96.6 p -88.63 23.16 2.35 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.541 -0.725 . . . . 0.0 109.744 -179.66 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 44' ' ' SER . 9.2 m120 64.97 11.59 7.18 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.377 -0.827 . . . . 0.0 109.319 -179.799 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 41' ' ' VAL . . . 78.1 22.63 67.98 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.585 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.9 p -93.1 -5.34 50.54 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.322 -1.104 . . . . 0.0 109.093 179.418 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.822 HD12 ' H ' ' A' ' 49' ' ' THR . 0.7 OUTLIER -78.96 157.57 28.14 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.567 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.822 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.9 p -149.0 126.22 11.44 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 122.281 1.039 . . . . 0.0 110.496 179.714 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.993 HD11 ' O ' ' A' ' 52' ' ' HIS . 2.2 tp -67.05 150.24 49.49 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.802 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.512 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.15 -22.58 12.32 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.116 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.993 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -175.92 163.29 2.72 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -179.497 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -78.51 178.58 7.65 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.074 -1.016 . . . . 0.0 109.05 178.921 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 75.73 -172.19 54.07 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.638 -1.385 . . . . 0.0 109.638 -179.346 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.41 ' O ' ' OXT' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.44 131.42 36.21 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.081 -1.246 . . . . 0.0 109.429 179.127 . . . . . . . . 3 3 . 1 . 037 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.609 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.562 179.915 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.663 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.663 ' HB2' ' O ' ' A' ' 1' ' ' LEU . . . 166.67 113.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.278 -0.889 . . . . 0.0 109.434 179.967 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.623 ' HB1' ' HB3' ' A' ' 50' ' ' LEU . . . -49.84 176.66 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.217 -0.927 . . . . 0.0 109.308 179.894 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.854 ' H ' HD23 ' A' ' 50' ' ' LEU . 53.5 t -101.39 55.2 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.188 -0.945 . . . . 0.0 109.677 179.82 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 4.0 m 100.51 73.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.107 0 CA-C-O 121.299 0.571 . . . . 0.0 110.881 179.102 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.582 ' CG2' HD22 ' A' ' 50' ' ' LEU . 90.0 t -160.59 141.35 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.216 -0.928 . . . . 0.0 109.193 178.539 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -99.27 153.68 18.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -0.977 . . . . 0.0 109.199 179.868 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.3 t -151.87 17.63 0.68 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.08 -1.012 . . . . 0.0 109.945 -179.875 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.2 t -90.8 13.02 17.46 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.149 -0.969 . . . . 0.0 109.748 179.616 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.401 ' HG2' ' CD2' ' A' ' 11' ' ' TYR . 1.5 pm0 -130.74 -18.39 3.09 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.008 -1.057 . . . . 0.0 110.972 -179.237 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.592 ' CD2' ' SG ' ' A' ' 38' ' ' CYS . 96.4 m-85 -79.76 161.59 65.88 Favored Pre-proline 0 C--N 1.305 -1.363 0 O-C-N 120.933 -1.104 . . . . 0.0 109.175 -179.304 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.574 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.7 Cg_endo -69.43 167.43 70.12 Favored 'Cis proline' 0 C--N 1.311 -1.409 0 C-N-CA 123.249 -1.563 . . . . 0.0 112.191 2.698 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -119.66 147.94 44.92 Favored Pre-proline 0 N--CA 1.489 1.506 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -179.68 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.692 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -77.99 13.73 1.67 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.592 2.195 . . . . 0.0 111.062 -179.741 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.692 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 164.09 128.91 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.278 -0.889 . . . . 0.0 109.478 179.689 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 48.6 t -105.19 159.09 16.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.265 -0.897 . . . . 0.0 109.84 179.963 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.3 p -62.8 164.34 8.07 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 178.241 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.64 -18.22 19.03 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.757 -1.215 . . . . 0.0 109.832 -179.758 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.538 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -51.0 130.76 26.25 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.197 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.525 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 7.4 t80 -81.38 126.94 32.22 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-O 122.475 1.131 . . . . 0.0 111.446 -177.124 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.8 mmt180 -159.58 75.63 3.1 Favored Pre-proline 0 C--N 1.294 -1.822 0 N-CA-C 106.443 -1.688 . . . . 0.0 106.443 178.984 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.614 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.4 Cg_endo -67.13 144.51 69.5 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.244 2.629 . . . . 0.0 113.288 -176.969 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.89 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.5 mp -129.59 132.68 46.85 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.407 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.672 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 34.3 t -91.41 161.78 14.85 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.011 -1.056 . . . . 0.0 110.319 -178.458 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.45 177.11 18.83 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 -179.062 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.504 ' CB ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -70.37 -23.57 62.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.525 -0.985 . . . . 0.0 108.682 179.474 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 41.4 p-10 -77.3 -6.99 55.23 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.383 -0.823 . . . . 0.0 109.082 179.36 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.557 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.5 m120 82.27 28.2 0.14 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.677 -0.639 . . . . 0.0 109.911 179.651 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 ttmm -103.07 136.4 42.95 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.722 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.843 HG21 ' HD3' ' A' ' 55' ' ' LYS . 23.5 m -88.79 137.91 31.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.11 -0.994 . . . . 0.0 109.713 179.913 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 86.9 m-85 -114.87 136.85 52.65 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.694 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.516 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -40.08 -48.25 3.48 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -178.606 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.625 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.3 p30 -167.4 -158.8 0.29 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.032 -1.275 . . . . 0.0 110.656 178.942 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.89 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.4 OUTLIER -54.5 -45.06 73.21 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.796 . . . . 0.0 112.574 -176.566 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' N ' ' HG3' ' A' ' 34' ' ' LYS . 3.6 m -67.71 -60.61 2.4 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.491 -1.381 . . . . 0.0 109.704 -178.658 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -53.5 -17.31 1.93 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.004 -1.06 . . . . 0.0 109.544 179.921 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.682 ' CE1' HD21 ' A' ' 48' ' ' LEU . 4.0 t80 -83.23 -69.32 0.64 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 122.586 1.184 . . . . 0.0 110.302 -179.927 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.592 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.68 -46.11 77.65 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.754 -177.792 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.589 ' OD1' ' CD1' ' A' ' 11' ' ' TYR . 3.0 m-20 -44.96 -29.62 0.86 Allowed 'General case' 0 N--CA 1.486 1.331 0 O-C-N 120.46 -1.4 . . . . 0.0 107.592 -179.918 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -71.96 -49.26 38.83 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.259 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.829 ' CG2' HD23 ' A' ' 48' ' ' LEU . 75.4 t -52.49 -62.05 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 CA-C-O 121.282 0.563 . . . . 0.0 110.198 178.603 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 38' ' ' CYS . 1.5 p -60.75 -23.63 29.69 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 O-C-N 121.434 -0.791 . . . . 0.0 111.097 -178.456 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.9 tt0 -92.03 -11.56 35.6 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 120.532 -1.355 . . . . 0.0 108.965 179.183 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 44' ' ' SER . 6.1 t -103.79 22.05 15.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.46 -0.775 . . . . 0.0 109.851 -179.702 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.507 ' O ' HG23 ' A' ' 47' ' ' THR . 7.6 m-80 60.35 43.96 12.86 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -179.055 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.26 28.32 0.05 OUTLIER Glycine 0 N--CA 1.488 2.118 0 N-CA-C 110.585 -1.006 . . . . 0.0 110.585 -179.034 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.507 HG23 ' O ' ' A' ' 45' ' ' ASN . 79.9 p -84.48 -16.18 43.41 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.15 -1.206 . . . . 0.0 107.89 178.189 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.829 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.6 OUTLIER -79.51 164.53 23.83 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.576 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.69 ' H ' HD12 ' A' ' 48' ' ' LEU . 64.5 p -149.85 130.94 14.42 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.105 -0.997 . . . . 0.0 110.41 179.231 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.854 HD23 ' H ' ' A' ' 4' ' ' VAL . 10.3 tp -64.98 146.13 55.42 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 178.65 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -113.63 -18.17 11.97 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 120.896 -1.127 . . . . 0.0 108.108 179.11 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.672 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER 172.75 160.75 0.12 Allowed 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.944 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 5' ' ' SER . 4.5 m-85 -71.01 -166.83 0.17 Allowed 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.253 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.614 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.61 -170.51 2.72 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.843 ' HD3' HG21 ' A' ' 30' ' ' THR . 0.4 OUTLIER -90.15 158.11 17.42 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.542 -0.975 . . . . 0.0 108.413 179.99 . . . . . . . . 3 3 . 1 . 038 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.66 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 18.2 m . . . . . 0 C--N 1.292 -1.908 0 CA-C-O 117.967 -1.015 . . . . 0.0 109.289 179.843 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.63 111.07 0.55 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.917 . . . . 0.0 109.47 179.975 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -87.36 142.96 27.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.0 109.521 179.984 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 4' ' ' VAL . 14.5 p -133.98 69.74 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.228 -0.92 . . . . 0.0 109.413 179.947 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.441 ' OG ' ' O ' ' A' ' 4' ' ' VAL . 40.7 m -171.09 149.7 2.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.291 -0.881 . . . . 0.0 109.675 179.968 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.6 t -132.22 133.38 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -0.861 . . . . 0.0 109.284 179.757 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.9 p-10 -77.69 -166.43 0.77 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.786 -179.795 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.8 m -156.13 43.45 0.41 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.254 -179.983 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.96 -19.15 35.1 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.185 -0.947 . . . . 0.0 110.001 -179.464 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -114.63 47.37 1.25 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.307 -0.871 . . . . 0.0 108.97 179.801 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.596 ' CG ' ' SG ' ' A' ' 38' ' ' CYS . 58.9 m-85 -142.72 163.95 35.49 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.407 -0.808 . . . . 0.0 109.496 -178.928 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.737 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.2 Cg_endo -88.75 159.68 40.36 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 123.13 -1.612 . . . . 0.0 110.743 0.94 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HG3' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -127.66 131.95 24.08 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.318 -0.864 . . . . 0.0 109.016 179.933 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.08 14.52 1.72 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.54 2.16 . . . . 0.0 111.129 -179.699 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -151.82 142.11 22.41 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.197 -0.939 . . . . 0.0 109.819 -179.861 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.477 ' O ' ' O ' ' A' ' 17' ' ' THR . 33.0 t -144.78 162.88 35.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.426 -0.796 . . . . 0.0 109.565 179.925 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.477 ' O ' ' O ' ' A' ' 16' ' ' CYS . 32.8 p -60.27 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.249 -0.907 . . . . 0.0 108.865 179.238 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.5 pp -134.98 -13.18 2.16 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.031 -1.043 . . . . 0.0 110.958 179.733 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 15.6 pm0 -54.49 132.11 44.02 Favored 'General case' 0 C--N 1.31 -1.115 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 179.156 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE2' ' HG3' ' A' ' 22' ' ' PRO . 8.6 t80 -87.6 127.75 35.27 Favored 'General case' 0 C--N 1.292 -1.928 0 CA-C-O 122.551 1.167 . . . . 0.0 111.911 -177.024 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mmt85 -161.36 75.49 2.45 Favored Pre-proline 0 C--N 1.295 -1.765 0 N-CA-C 106.616 -1.624 . . . . 0.0 106.616 178.595 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 54' ' ' GLY . 26.9 Cg_endo -66.21 133.94 34.72 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 123.189 2.593 . . . . 0.0 113.217 -176.885 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.625 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.7 OUTLIER -120.28 124.82 46.54 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.247 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.679 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 13.5 t -79.12 165.89 22.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.911 -1.118 . . . . 0.0 108.328 -179.426 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.714 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -138.7 159.03 25.29 Favored Glycine 0 N--CA 1.49 2.258 0 C-N-CA 119.398 -1.382 . . . . 0.0 112.497 -176.959 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.491 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 5.7 t -46.08 -21.59 0.16 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.924 -0.75 . . . . 0.0 110.908 -178.723 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.503 ' OD2' ' HB3' ' A' ' 29' ' ' LYS . 27.1 p-10 -86.15 26.65 1.0 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.791 -1.193 . . . . 0.0 110.276 -179.524 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 28' ' ' ASN . 40.0 t-20 47.43 24.77 0.51 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.17 -0.956 . . . . 0.0 110.074 179.314 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' HB3' ' OD2' ' A' ' 27' ' ' ASP . 7.0 tttp -110.91 142.61 42.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.033 -1.042 . . . . 0.0 109.264 179.847 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.421 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 15.5 m -92.93 140.03 29.91 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 108.965 179.533 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.675 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 70.3 m-85 -112.91 126.51 55.54 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.513 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -37.01 -52.66 1.56 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -178.137 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.612 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 45.0 p30 -158.96 -164.39 1.41 Allowed 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.09 -1.241 . . . . 0.0 110.513 179.549 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.625 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.08 -49.65 30.93 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.598 -0.689 . . . . 0.0 111.999 -177.911 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.524 ' N ' ' CG ' ' A' ' 34' ' ' LYS . 10.6 m -61.79 -58.09 9.34 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.57 -1.331 . . . . 0.0 110.43 -178.835 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' C ' ' HB3' ' A' ' 31' ' ' TYR . 14.8 m-80 -58.68 -13.81 6.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.133 -0.98 . . . . 0.0 110.062 -179.503 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.614 ' CE1' HD21 ' A' ' 48' ' ' LEU . 5.8 t80 -83.68 -58.13 2.93 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-O 122.307 1.051 . . . . 0.0 109.992 -179.698 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.679 ' O ' HG13 ' A' ' 42' ' ' VAL . 16.7 t -61.13 -29.36 69.73 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.128 -178.476 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.77 ' O ' HG22 ' A' ' 42' ' ' VAL . 88.0 m-20 -58.71 -29.49 66.71 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.612 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.713 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -77.81 -30.99 51.51 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 178.441 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.941 HG22 HD23 ' A' ' 48' ' ' LEU . 52.1 t -75.86 -21.3 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 121.48 0.657 . . . . 0.0 109.435 179.535 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.77 HG22 ' O ' ' A' ' 39' ' ' ASN . 11.6 m -90.25 -22.12 6.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -179.83 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.713 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 1.4 pp20? -89.81 -30.02 18.24 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -179.937 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.888 ' O ' HG22 ' A' ' 47' ' ' THR . 11.2 p -87.72 17.78 4.5 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.976 -0.69 . . . . 0.0 110.343 -179.335 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 44' ' ' SER . 9.4 p30 50.63 41.26 25.56 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.269 -0.895 . . . . 0.0 109.679 -179.706 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 53.82 37.75 58.18 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.365 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.888 HG22 ' O ' ' A' ' 44' ' ' SER . 7.6 t -111.13 -1.7 16.1 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.086 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.941 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -89.17 -75.01 0.45 Allowed 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 122.303 1.049 . . . . 0.0 109.162 -179.661 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.748 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.8 p 82.44 150.59 0.09 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.383 -177.892 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' HG ' ' N ' ' A' ' 51' ' ' SER . 14.2 tp -63.59 160.65 16.25 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.766 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.583 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 5.9 p -115.7 -43.62 3.01 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.953 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.679 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -178.1 160.63 1.42 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.264 179.429 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -69.04 172.56 6.54 Favored 'General case' 0 C--N 1.291 -1.957 0 C-N-CA 119.518 -0.873 . . . . 0.0 108.956 179.224 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 71.48 -167.48 52.04 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 -179.162 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.593 ' O ' ' CE1' ' A' ' 52' ' ' HIS . 0.2 OUTLIER -92.85 -172.08 2.91 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.354 -1.35 . . . . 0.0 107.354 177.847 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.023 -1.048 . . . . 0.0 109.593 179.583 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.8 tp . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.55 73.13 0.49 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.01 91.63 4.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.935 . . . . 0.0 109.44 -179.93 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.3 t -132.98 75.95 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.271 -0.893 . . . . 0.0 109.385 -179.979 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 t -158.17 156.12 30.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.273 -0.892 . . . . 0.0 109.404 -179.968 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.422 HG12 ' SG ' ' A' ' 8' ' ' CYS . 73.4 t -114.52 142.82 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.101 -0.999 . . . . 0.0 109.688 179.93 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -97.05 124.81 41.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 108.808 179.463 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.548 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.3 m -135.06 46.91 2.38 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.009 -1.057 . . . . 0.0 109.998 -179.263 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.24 -0.66 57.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.415 179.6 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -117.88 36.05 4.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -0.942 . . . . 0.0 109.52 -179.867 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.943 ' O ' HG21 ' A' ' 42' ' ' VAL . 92.8 m-85 -121.5 157.08 57.39 Favored Pre-proline 0 C--N 1.306 -1.283 0 O-C-N 121.255 -0.903 . . . . 0.0 108.638 179.924 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.517 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 36.8 Cg_endo -75.15 167.98 78.81 Favored 'Cis proline' 0 C--N 1.305 -1.728 0 C-N-CA 122.437 -1.901 . . . . 0.0 111.022 2.298 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 2.8 mttm -116.32 142.91 30.13 Favored Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 121.546 -0.721 . . . . 0.0 109.202 -179.656 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -78.72 12.47 2.18 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.424 2.083 . . . . 0.0 110.489 179.873 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -170.87 109.98 0.34 Allowed 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.556 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.476 ' O ' ' O ' ' A' ' 17' ' ' THR . 92.4 m -95.18 140.56 29.92 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.265 -0.897 . . . . 0.0 109.785 -179.244 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.6 OUTLIER -52.94 -172.06 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.662 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.447 ' O ' ' C ' ' A' ' 19' ' ' GLU . 2.2 pp -128.69 -24.07 3.05 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.922 -1.111 . . . . 0.0 110.255 179.624 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.536 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 13.8 pm0 -46.37 134.87 8.64 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.204 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -87.55 126.48 34.95 Favored 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.535 1.159 . . . . 0.0 111.387 -177.937 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.7 mtt-85 -161.57 82.03 1.9 Allowed Pre-proline 0 C--N 1.294 -1.824 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.728 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.572 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.4 Cg_endo -65.64 125.6 14.62 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.615 2.21 . . . . 0.0 112.932 -176.489 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -110.12 136.91 48.62 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 178.924 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.574 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -103.54 122.74 45.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.091 -1.005 . . . . 0.0 111.053 -178.652 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.637 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -62.57 -166.14 0.57 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.178 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.1 OUTLIER -90.17 -25.99 20.37 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.442 -1.034 . . . . 0.0 108.728 179.31 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.555 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.7 p-10 -79.29 -2.26 40.49 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.806 . . . . 0.0 109.086 179.384 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.555 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 6.8 m120 82.99 47.07 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.72 -0.613 . . . . 0.0 110.356 179.603 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.541 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 17.3 ptmt -121.87 116.28 24.12 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.538 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 31' ' ' TYR . 51.4 m -75.42 153.06 37.88 Favored 'General case' 0 C--N 1.288 -2.096 0 CA-C-O 121.726 0.774 . . . . 0.0 110.405 -178.564 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.679 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 3.6 m-85 -131.45 148.04 52.61 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.155 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -58.87 -37.59 91.02 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.479 -1.344 . . . . 0.0 111.947 -175.811 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 37.0 p-10 -162.92 -165.78 1.18 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.735 -1.45 . . . . 0.0 110.388 -179.704 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.537 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -61.62 -23.63 66.16 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.6 -0.688 . . . . 0.0 110.536 -178.654 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.421 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 6.7 t -81.81 -45.66 15.26 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 120.976 -1.078 . . . . 0.0 109.522 -179.781 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.602 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -66.37 -28.22 68.48 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.246 -0.982 . . . . 0.0 108.572 179.712 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.563 ' CZ ' ' CB ' ' A' ' 50' ' ' LEU . 60.5 t80 -81.76 -45.05 16.17 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.333 1.063 . . . . 0.0 109.761 179.758 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.645 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 4.4 m -65.93 -26.78 67.75 Favored 'General case' 0 C--N 1.283 -2.288 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.758 -178.953 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.5 ' OD1' ' HB3' ' A' ' 12' ' ' PRO . 1.2 m-80 -70.19 -34.68 73.25 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.146 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.679 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -75.54 -20.33 58.75 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.576 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.461 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 55.0 t -84.67 -34.16 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.598 -0.689 . . . . 0.0 110.04 -179.794 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.943 HG21 ' O ' ' A' ' 11' ' ' TYR . 7.1 p -90.88 -16.29 8.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.108 -0.995 . . . . 0.0 109.996 -179.053 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 1.4 tm-20 -91.72 -19.8 22.24 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 120.991 -1.068 . . . . 0.0 108.422 179.053 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.578 ' O ' HG23 ' A' ' 47' ' ' THR . 5.8 p -100.25 23.41 10.11 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.608 -0.683 . . . . 0.0 109.496 -179.954 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 44' ' ' SER . 0.6 OUTLIER 66.04 11.72 7.96 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.223 -0.923 . . . . 0.0 109.172 -179.494 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 78.11 19.7 74.27 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.746 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.578 HG23 ' O ' ' A' ' 44' ' ' SER . 21.9 p -84.55 -12.45 54.12 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.15 -1.206 . . . . 0.0 108.986 179.549 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.637 HD11 ' HA3' ' A' ' 25' ' ' GLY . 2.1 tp -80.74 136.4 36.15 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.442 -0.786 . . . . 0.0 109.07 179.902 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.584 ' O ' ' N ' ' A' ' 26' ' ' SER . 5.3 p -135.26 123.5 23.07 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-O 122.069 0.938 . . . . 0.0 110.244 179.385 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.563 ' CB ' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -72.93 153.03 41.15 Favored 'General case' 0 C--N 1.276 -2.613 0 CA-C-O 121.674 0.749 . . . . 0.0 109.398 179.573 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.506 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -105.49 -23.8 12.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -179.235 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.574 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -165.58 159.36 16.52 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.796 -0.762 . . . . 0.0 109.896 -178.549 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -76.55 176.32 8.43 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.531 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 74.66 -167.37 54.81 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 -179.935 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.543 ' HG2' ' CG ' ' A' ' 22' ' ' PRO . 7.4 mtmt -91.49 168.39 11.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.399 -1.059 . . . . 0.0 108.987 179.086 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.563 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 35.3 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.901 -1.047 . . . . 0.0 109.63 -179.45 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 1' ' ' LEU . 20.2 tp . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.315 0.579 . . . . 0.0 109.618 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.36 -165.59 1.89 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.252 -0.905 . . . . 0.0 109.304 179.875 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -159.96 136.45 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.427 179.979 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 4' ' ' VAL . 2.5 p -154.71 76.65 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.137 -0.977 . . . . 0.0 109.537 -179.816 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.8 t -170.47 141.57 1.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.284 -0.885 . . . . 0.0 109.324 179.902 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.784 HG21 ' HB2' ' A' ' 34' ' ' LYS . 6.4 p -106.1 159.23 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.129 -0.982 . . . . 0.0 109.476 -179.959 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -57.14 151.62 15.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 109.548 179.918 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.51 23.02 0.15 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.186 -0.946 . . . . 0.0 109.601 -179.887 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.58 3.66 54.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 110.544 -179.592 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.1 pm0 -131.4 -8.24 3.73 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.818 -1.177 . . . . 0.0 110.946 -178.977 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.653 ' CD1' ' SG ' ' A' ' 38' ' ' CYS . 90.5 m-85 -81.34 158.28 69.41 Favored Pre-proline 0 C--N 1.306 -1.295 0 O-C-N 120.79 -1.194 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.596 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 38.2 Cg_endo -69.99 142.55 71.15 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.762 -1.766 . . . . 0.0 111.534 2.028 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -103.17 142.72 25.14 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.979 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.4 Cg_endo -78.43 14.39 1.62 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.781 2.32 . . . . 0.0 111.251 -179.605 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -166.94 125.42 1.36 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.366 -0.834 . . . . 0.0 109.09 179.853 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 17' ' ' THR . 45.3 m -102.91 139.16 38.84 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.179 -0.95 . . . . 0.0 109.781 -179.682 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.466 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -55.85 -166.11 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 179.541 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.484 ' HG ' ' N ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -119.24 -28.97 5.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 120.921 -1.112 . . . . 0.0 109.825 179.969 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HB2' ' NH1' ' A' ' 21' ' ' ARG . 0.8 OUTLIER -43.56 119.4 1.64 Allowed 'General case' 0 C--N 1.308 -1.204 0 O-C-N 121.106 -0.996 . . . . 0.0 108.999 179.577 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.8 t80 -80.07 124.12 28.45 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.631 -179.676 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -156.97 82.46 3.21 Favored Pre-proline 0 C--N 1.288 -2.106 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 179.765 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.564 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.8 Cg_endo -65.11 120.6 7.86 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.425 2.083 . . . . 0.0 111.944 -177.367 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.711 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -111.88 132.24 54.85 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 179.671 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.009 ' O ' HD12 ' A' ' 50' ' ' LEU . 7.3 t -88.85 161.21 16.83 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.498 -0.751 . . . . 0.0 109.459 -178.965 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.586 ' HA2' HD11 ' A' ' 48' ' ' LEU . . . -107.52 172.55 17.75 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.866 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.586 ' H ' HD12 ' A' ' 48' ' ' LEU . 20.6 t -74.41 -3.36 30.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.158 -1.201 . . . . 0.0 108.84 179.554 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.544 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.9 p-10 -98.01 -2.17 40.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.407 -0.808 . . . . 0.0 109.177 179.457 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.544 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 51.5 t30 83.59 43.2 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.663 -0.648 . . . . 0.0 110.07 179.73 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.426 ' HG3' ' N ' ' A' ' 30' ' ' THR . 5.3 tttt -125.43 138.83 54.02 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.224 -0.922 . . . . 0.0 109.337 179.522 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.426 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 19.6 m -92.74 152.12 19.67 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.504 179.804 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' CD1' ' O ' ' A' ' 36' ' ' ASN . 26.0 m-85 -128.57 130.16 46.98 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.706 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.554 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -36.94 -51.29 1.53 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 -177.803 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 41.5 p30 -160.01 -166.55 1.74 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.871 -1.37 . . . . 0.0 110.522 179.928 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.784 ' HB2' HG21 ' A' ' 6' ' ' VAL . 0.1 OUTLIER -54.55 -40.32 68.59 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.657 -0.652 . . . . 0.0 110.907 -178.477 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.61 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 43.5 t -60.48 -69.66 0.21 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 120.787 -1.195 . . . . 0.0 109.703 -179.324 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 18.3 m-80 -51.91 -26.09 9.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.447 -0.783 . . . . 0.0 111.272 -179.211 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.708 ' CE1' HD21 ' A' ' 48' ' ' LEU . 14.6 t80 -75.25 -62.02 1.7 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 120.638 -1.289 . . . . 0.0 110.828 -179.078 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.753 ' O ' HG12 ' A' ' 42' ' ' VAL . 1.4 t -53.32 -49.12 67.71 Favored 'General case' 0 C--N 1.285 -2.224 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.185 -177.413 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.574 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -49.16 -31.31 8.08 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.29 -1.506 . . . . 0.0 108.597 -178.812 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.617 ' HA ' ' CG ' ' A' ' 43' ' ' GLU . . . -74.64 -36.65 62.89 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.255 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.401 HG22 ' HG ' ' A' ' 48' ' ' LEU . 41.4 t -67.97 -32.36 55.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-O 121.392 0.615 . . . . 0.0 110.253 179.913 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.753 HG12 ' O ' ' A' ' 38' ' ' CYS . 0.5 OUTLIER -90.63 -14.08 8.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 O-C-N 121.284 -0.885 . . . . 0.0 110.069 -178.018 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.617 ' CG ' ' HA ' ' A' ' 40' ' ' ALA . 9.6 pt-20 -92.54 -29.53 16.14 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 120.892 -1.13 . . . . 0.0 108.216 178.053 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 12.0 p -87.68 20.1 3.14 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.864 -178.932 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' A' ' 44' ' ' SER . 45.1 m-80 64.23 12.85 7.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.249 -0.907 . . . . 0.0 109.293 -179.439 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 78.74 19.61 72.88 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 179.258 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.0 p -91.67 0.41 57.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.214 -1.168 . . . . 0.0 108.927 178.984 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD21 ' CE1' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -80.47 -56.19 4.35 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.979 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.619 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 51.0 p 52.37 125.76 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 122.498 1.142 . . . . 0.0 111.972 179.329 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.009 HD12 ' O ' ' A' ' 24' ' ' CYS . 6.6 tp -61.97 156.56 20.76 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.615 -0.721 . . . . 0.0 109.123 178.835 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.532 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -115.45 -23.86 8.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.87 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.919 ' O ' HD11 ' A' ' 50' ' ' LEU . 1.4 p80 -179.58 161.82 1.06 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.774 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -78.32 173.33 12.42 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.282 -0.886 . . . . 0.0 109.167 179.46 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.508 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 78.84 -171.57 55.13 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 -179.666 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.46 137.05 32.66 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.151 -1.205 . . . . 0.0 108.799 178.824 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.021 . . . . 0.0 109.63 -179.772 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.472 ' HA ' HD22 ' A' ' 1' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . -69.37 -18.29 63.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.235 -0.915 . . . . 0.0 109.582 179.961 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 61.73 -162.5 0.28 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.886 179.745 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 4' ' ' VAL . 3.3 p -156.58 113.35 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.35 -0.844 . . . . 0.0 109.375 179.928 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.645 ' HA ' HD22 ' A' ' 50' ' ' LEU . 4.2 m -145.83 -163.91 1.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.214 -0.929 . . . . 0.0 109.687 -179.951 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.453 HG12 ' N ' ' A' ' 7' ' ' ASP . 93.5 t -125.07 157.53 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.659 -179.732 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.453 ' N ' HG12 ' A' ' 6' ' ' VAL . 16.3 t70 -89.11 137.77 32.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.464 179.924 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 m -135.26 61.91 1.65 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.253 -0.904 . . . . 0.0 109.909 -179.544 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -90.47 -0.73 57.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.189 -0.944 . . . . 0.0 109.838 -179.898 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -128.34 39.65 3.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 0.0 109.732 -179.922 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.908 ' O ' HG21 ' A' ' 42' ' ' VAL . 52.1 m-85 -120.65 161.1 41.45 Favored Pre-proline 0 C--N 1.304 -1.377 0 O-C-N 121.217 -0.927 . . . . 0.0 108.842 -179.847 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 39' ' ' ASN . 37.2 Cg_endo -75.43 174.56 52.16 Favored 'Cis proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.62 -1.825 . . . . 0.0 111.299 1.709 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.404 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.0 OUTLIER -118.74 142.77 32.3 Favored Pre-proline 0 N--CA 1.489 1.483 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.766 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.43 14.48 1.6 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.574 2.183 . . . . 0.0 111.254 -179.43 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 169.94 128.19 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.333 -0.854 . . . . 0.0 109.462 179.801 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 50.6 t -105.35 159.59 15.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 109.937 -179.8 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.423 ' N ' ' SG ' ' A' ' 16' ' ' CYS . 0.2 OUTLIER -61.72 -162.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 178.804 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.457 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -118.84 -28.07 5.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.658 -1.276 . . . . 0.0 109.913 179.768 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -42.73 118.4 1.23 Allowed 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.793 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.513 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 14.9 t80 -79.23 128.64 33.56 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.382 1.087 . . . . 0.0 111.041 -177.84 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.645 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.31 78.9 2.21 Favored Pre-proline 0 C--N 1.294 -1.826 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 179.217 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' O ' ' N ' ' A' ' 54' ' ' GLY . 21.1 Cg_endo -64.71 126.5 16.84 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 123.361 2.707 . . . . 0.0 113.366 -177.139 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.766 HD13 ' HA ' ' A' ' 34' ' ' LYS . 1.4 mp -110.47 127.15 55.01 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.334 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.586 ' CB ' ' NE2' ' A' ' 52' ' ' HIS . 0.5 OUTLIER -88.27 119.1 28.36 Favored 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.782 -178.627 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -60.7 -158.57 0.06 OUTLIER Glycine 0 N--CA 1.481 1.645 0 N-CA-C 110.338 -1.105 . . . . 0.0 110.338 -178.989 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.524 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -91.84 -52.4 4.75 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.558 -0.966 . . . . 0.0 108.914 179.356 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.618 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.8 p30 -47.52 -24.63 0.89 Allowed 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.169 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.618 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 2.8 p-10 103.3 33.36 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 121.177 0.513 . . . . 0.0 110.216 179.147 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.7 131.39 50.91 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 178.838 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.521 ' OG1' ' HD3' ' A' ' 55' ' ' LYS . 94.5 m -80.17 142.5 34.66 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 121.245 -0.909 . . . . 0.0 110.314 -179.088 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' O ' ' C ' ' A' ' 32' ' ' GLY . 73.5 m-85 -120.34 131.23 54.77 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.368 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.513 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -34.42 -50.9 0.72 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 -178.163 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.2 p30 -167.19 -167.37 0.91 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.008 -1.289 . . . . 0.0 111.136 178.901 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.766 ' HA ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -45.56 -42.85 11.49 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -177.125 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.59 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 4.1 m -67.74 -66.44 0.56 Allowed 'General case' 0 C--N 1.296 -1.759 0 O-C-N 120.291 -1.506 . . . . 0.0 108.998 -179.262 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.532 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 17.9 m-80 -44.66 -23.17 0.11 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.527 -0.733 . . . . 0.0 110.194 -179.918 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.534 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 30.9 t80 -84.55 -48.73 9.26 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 122.74 1.257 . . . . 0.0 109.763 179.733 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.604 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 1.6 m -62.27 -58.98 5.71 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 114.639 -1.164 . . . . 0.0 111.072 -178.425 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.01 -31.36 0.17 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.147 -0.971 . . . . 0.0 108.772 -179.351 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.426 ' N ' ' O ' ' A' ' 38' ' ' CYS . . . -70.8 -50.71 32.74 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 178.543 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.476 ' N ' ' O ' ' A' ' 38' ' ' CYS . 78.5 t -51.71 -60.15 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 CA-C-O 121.432 0.634 . . . . 0.0 109.97 179.036 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.908 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.5 p -62.6 -21.18 26.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.411 -0.806 . . . . 0.0 111.665 -178.539 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 3.2 tt0 -91.98 -11.59 35.67 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.457 -1.402 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.68 ' OG ' HG22 ' A' ' 47' ' ' THR . 4.4 t -106.4 20.58 18.76 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.283 -0.885 . . . . 0.0 109.911 -179.555 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.516 ' CB ' ' O ' ' A' ' 44' ' ' SER . 4.5 t-20 75.94 1.48 3.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.14 -0.975 . . . . 0.0 108.967 -179.148 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.48 17.42 71.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -179.848 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.68 HG22 ' OG ' ' A' ' 44' ' ' SER . 14.1 t -83.89 -13.05 54.52 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.279 -1.13 . . . . 0.0 108.65 179.053 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tp -81.28 147.12 30.07 Favored 'General case' 0 C--N 1.306 -1.308 0 O-C-N 121.394 -0.816 . . . . 0.0 108.958 179.772 . . . . . . . . 1 1 . 1 . 042 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.524 ' O ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -145.46 158.32 43.86 Favored 'General case' 0 C--N 1.295 -1.797 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.242 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.645 HD22 ' HA ' ' A' ' 5' ' ' SER . 0.0 OUTLIER -104.46 165.64 10.92 Favored 'General case' 0 C--N 1.281 -2.412 0 O-C-N 121.379 -0.826 . . . . 0.0 109.925 -178.937 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.622 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -106.99 -31.55 8.26 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.531 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' NE2' ' CB ' ' A' ' 24' ' ' CYS . 1.3 p80 -162.99 160.49 24.72 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.723 0.773 . . . . 0.0 110.068 -178.615 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.494 ' HE1' HG22 ' A' ' 4' ' ' VAL . 4.8 m-85 -77.14 -171.64 2.1 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.699 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 64.2 -166.57 28.94 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 179.829 . . . . . . . . 2 2 . 1 . 042 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.67 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.51 167.84 12.28 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 179.237 . . . . . . . . 3 3 . 1 . 042 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.67 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 31.7 m . . . . . 0 C--N 1.29 -1.987 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.723 -179.413 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.488 ' O ' ' HB3' ' A' ' 3' ' ' ALA . . . 58.84 -151.38 0.42 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.317 -179.819 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 2' ' ' ALA . . . 63.71 137.05 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 53' ' ' PHE . 13.6 p -154.65 94.16 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.165 -0.959 . . . . 0.0 109.667 179.914 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.0 p -106.85 -174.72 2.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.277 -0.889 . . . . 0.0 109.196 179.911 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.8 t -131.47 136.75 56.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.101 -1.0 . . . . 0.0 109.64 -179.945 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.415 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 16.4 t0 -67.06 141.02 57.65 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.218 -0.926 . . . . 0.0 109.386 179.894 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.415 ' SG ' ' C ' ' A' ' 7' ' ' ASP . 22.2 m -146.76 58.82 1.19 Allowed 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.126 -0.984 . . . . 0.0 110.098 -179.106 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.66 0.46 57.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 179.613 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -118.64 32.88 5.9 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 0.0 109.836 -179.604 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.896 ' CB ' HG11 ' A' ' 42' ' ' VAL . 83.6 m-85 -119.28 158.3 48.95 Favored Pre-proline 0 C--N 1.305 -1.366 0 O-C-N 121.224 -0.923 . . . . 0.0 108.973 -179.839 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.485 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -75.58 169.92 73.22 Favored 'Cis proline' 0 C--N 1.305 -1.717 0 C-N-CA 122.506 -1.872 . . . . 0.0 111.706 1.799 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.601 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -128.05 144.8 52.89 Favored Pre-proline 0 N--CA 1.493 1.694 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.959 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.5 Cg_endo -77.93 14.3 1.53 Allowed 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.652 2.235 . . . . 0.0 111.839 -178.759 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 177.23 145.67 0.1 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.08 -1.012 . . . . 0.0 110.217 179.77 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 17' ' ' THR . 54.1 t -122.85 159.99 27.0 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.408 -0.807 . . . . 0.0 109.272 179.449 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' O ' ' A' ' 16' ' ' CYS . 30.6 p -61.28 -149.98 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.174 -0.954 . . . . 0.0 108.594 179.24 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.96 -18.47 4.2 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.157 -0.964 . . . . 0.0 110.123 179.707 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.541 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.7 pt-20 -52.14 127.7 22.53 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.756 -1.215 . . . . 0.0 107.746 179.503 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.582 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 26.2 t80 -92.91 119.8 32.58 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-O 122.422 1.106 . . . . 0.0 110.969 -178.124 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.597 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 5.6 mtp-105 -152.17 81.8 5.53 Favored Pre-proline 0 C--N 1.293 -1.87 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 178.954 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.626 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.8 Cg_endo -65.02 131.31 28.35 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.966 2.444 . . . . 0.0 112.346 -177.448 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.66 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.9 OUTLIER -117.58 121.44 40.95 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.136 -1.026 . . . . 0.0 108.965 179.254 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.635 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 5.1 t -80.49 120.05 23.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.146 -0.971 . . . . 0.0 108.593 179.975 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.509 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -66.06 -160.66 0.82 Allowed Glycine 0 N--CA 1.483 1.825 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 -179.551 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.569 ' CB ' ' O ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -90.26 -37.88 13.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 108.048 178.328 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.631 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.4 OUTLIER -58.55 -17.69 23.57 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.568 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.631 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.1 t-20 96.35 21.23 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.003 0.43 . . . . 0.0 110.409 179.277 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 ttmt -99.33 127.08 45.3 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.005 -1.059 . . . . 0.0 109.499 179.485 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 m -77.06 140.13 40.22 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.425 -0.797 . . . . 0.0 109.574 -179.925 . . . . . . . . 1 1 . 1 . 043 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 26.7 m-85 -115.81 129.16 56.33 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.693 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.582 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.46 -52.64 0.31 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.491 -1.043 . . . . 0.0 110.491 -178.307 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 50.3 p30 -164.75 -164.9 0.85 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.806 -1.408 . . . . 0.0 110.992 179.077 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.66 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -48.03 -41.55 25.97 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -177.071 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.544 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 4.3 m -70.17 -64.67 0.85 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.202 -1.561 . . . . 0.0 109.098 -179.318 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 17.0 m-80 -43.92 -27.28 0.34 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.38 -0.825 . . . . 0.0 110.178 -179.888 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 39.0 t80 -82.35 -46.87 13.02 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-O 123.067 1.413 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.643 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 1.8 m -56.9 -37.02 70.83 Favored 'General case' 0 C--N 1.278 -2.515 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.041 -178.349 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HG2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -62.41 -42.08 99.17 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.735 -1.228 . . . . 0.0 108.336 179.882 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.711 ' HA ' ' HG2' ' A' ' 43' ' ' GLU . . . -62.27 -25.08 67.64 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.16 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 46' ' ' GLY . 74.9 t -80.59 -44.9 21.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.65 -0.656 . . . . 0.0 110.35 -179.526 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.896 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.5 p -81.27 -7.26 10.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 O-C-N 121.114 -0.992 . . . . 0.0 110.297 -178.791 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.711 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.92 -33.95 14.68 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.965 -1.084 . . . . 0.0 108.447 178.958 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 47' ' ' THR . 6.5 p -88.85 24.21 2.12 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.708 -0.62 . . . . 0.0 110.029 -179.528 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.471 ' CB ' ' O ' ' A' ' 44' ' ' SER . 1.4 t-20 73.4 4.7 4.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.052 -1.03 . . . . 0.0 109.05 -179.488 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 41' ' ' VAL . . . 83.51 15.61 70.72 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -179.72 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 44' ' ' SER . 10.0 t -88.52 -1.8 58.25 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.396 -1.061 . . . . 0.0 108.866 179.15 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD23 ' CG2' ' A' ' 41' ' ' VAL . 1.1 tp -81.19 145.27 31.08 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.283 -0.885 . . . . 0.0 109.124 -179.951 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.569 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 p -137.55 145.92 43.48 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.485 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.666 HD21 ' O ' ' A' ' 4' ' ' VAL . 0.0 OUTLIER -94.59 171.05 9.03 Favored 'General case' 0 C--N 1.275 -2.641 0 O-C-N 120.877 -1.139 . . . . 0.0 109.839 -179.412 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.541 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -107.8 -20.23 13.27 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -179.778 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.635 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.4 OUTLIER 177.1 154.98 0.26 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.528 -0.733 . . . . 0.0 109.833 -178.884 . . . . . . . . 3 3 . 1 . 043 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.878 ' CE1' HG22 ' A' ' 4' ' ' VAL . 5.4 m-85 -66.49 -165.78 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.206 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 56.21 -172.08 1.93 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.278 -1.129 . . . . 0.0 110.278 -179.305 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 56' ' ' CYS . 2.1 tttt -90.34 159.81 16.44 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 179.455 . . . . . . . . 2 2 . 1 . 043 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.576 ' N ' ' HG3' ' A' ' 55' ' ' LYS . 0.8 OUTLIER . . . . . 0 C--N 1.292 -1.891 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.605 -179.982 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.648 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.1 mm? . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.648 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 72.16 -159.66 0.11 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 109.526 179.91 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.89 63.55 1.06 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.991 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.561 HG13 ' CE1' ' A' ' 53' ' ' PHE . 46.8 t -85.51 96.31 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.339 -0.851 . . . . 0.0 109.468 -179.89 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.9 p -159.45 153.98 24.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.963 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 37.0 t -126.29 136.67 60.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.243 -0.911 . . . . 0.0 109.354 179.894 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -86.61 132.93 33.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.921 . . . . 0.0 109.279 -179.972 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.495 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 10.1 m -133.4 52.33 2.08 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.318 -0.864 . . . . 0.0 109.76 -179.606 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -90.35 8.02 35.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 0.0 109.774 179.998 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -119.64 3.79 11.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.1 -1.0 . . . . 0.0 109.661 -179.962 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.89 ' O ' HG21 ' A' ' 42' ' ' VAL . 96.2 m-85 -89.78 157.44 46.36 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.166 -0.959 . . . . 0.0 109.001 -179.731 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.524 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.1 Cg_endo -74.96 143.01 76.45 Favored 'Cis proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.617 -1.826 . . . . 0.0 111.366 2.495 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.51 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 1.4 tttp -84.16 143.93 43.24 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.632 -0.667 . . . . 0.0 109.274 -179.931 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.51 ' HD2' ' HG2' ' A' ' 13' ' ' LYS . 35.8 Cg_endo -78.73 13.54 1.89 Allowed 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.539 2.159 . . . . 0.0 110.556 179.459 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -176.01 114.1 0.12 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.779 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 72.4 m -92.57 139.6 30.41 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 110.007 -179.332 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -50.27 178.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.545 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 19' ' ' GLU . 0.1 OUTLIER -123.37 -16.11 6.96 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.967 -1.083 . . . . 0.0 110.166 -179.663 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.455 ' O ' ' O ' ' A' ' 18' ' ' LEU . 9.1 pm0 -55.24 -169.6 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.359 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.501 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 6.6 t80 -132.93 119.7 20.49 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.737 1.256 . . . . 0.0 110.835 179.417 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.595 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 14.9 mtp85 -160.25 74.63 2.92 Favored Pre-proline 0 C--N 1.288 -2.105 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 179.154 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.561 ' O ' ' N ' ' A' ' 54' ' ' GLY . 25.9 Cg_endo -65.06 134.73 40.83 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.895 2.396 . . . . 0.0 113.4 -176.135 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -117.97 143.57 46.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 178.46 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.701 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -94.41 166.74 11.92 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.248 -178.861 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -127.44 161.98 21.48 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.281 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HG ' ' HG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -65.69 -28.69 69.25 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.044 -1.268 . . . . 0.0 108.832 179.996 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.605 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.7 OUTLIER -58.34 -15.51 10.76 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.521 -0.737 . . . . 0.0 109.304 179.657 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.605 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 14.5 t30 90.28 33.35 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.04 0.448 . . . . 0.0 110.435 179.396 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.479 ' HG3' ' CG ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -121.28 -176.37 3.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.932 -1.105 . . . . 0.0 109.177 178.683 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.546 HG22 ' N ' ' A' ' 31' ' ' TYR . 8.9 m -123.17 163.92 19.68 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.826 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 29.4 m-85 -138.35 141.64 39.69 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 178.612 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.521 ' CA ' ' OD1' ' A' ' 36' ' ' ASN . . . -61.95 -41.33 99.65 Favored Glycine 0 N--CA 1.488 2.11 0 C-N-CA 119.613 -1.28 . . . . 0.0 111.312 -176.803 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.595 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 40.0 p-10 -157.8 -164.37 1.52 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.893 -1.357 . . . . 0.0 109.978 -179.85 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.8 OUTLIER -61.73 -31.71 71.9 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.424 -0.798 . . . . 0.0 110.826 -178.705 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -72.9 -44.17 61.59 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.665 -1.272 . . . . 0.0 109.632 -179.479 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.589 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -63.08 -44.26 96.24 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.222 -0.991 . . . . 0.0 108.693 179.925 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.592 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 31.4 t80 -65.43 -57.15 9.02 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-O 122.144 0.973 . . . . 0.0 110.963 -179.365 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.636 ' HB3' ' CD1' ' A' ' 11' ' ' TYR . 2.1 m -53.62 -51.73 62.13 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.28 -178.282 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.503 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 8.3 m-20 -45.41 -36.4 4.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.002 -1.061 . . . . 0.0 109.41 -179.758 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.599 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.86 -42.03 77.6 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.076 -1.015 . . . . 0.0 108.675 179.266 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.636 ' CG2' HD23 ' A' ' 48' ' ' LEU . 86.1 t -60.57 -59.66 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.649 -0.657 . . . . 0.0 110.072 179.811 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.89 HG21 ' O ' ' A' ' 11' ' ' TYR . 9.2 p -62.53 -21.51 27.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.226 -0.921 . . . . 0.0 111.013 -178.766 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -92.2 -15.29 27.76 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.71 -1.244 . . . . 0.0 108.818 179.065 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.886 ' O ' HG23 ' A' ' 47' ' ' THR . 22.7 t -102.43 10.57 38.9 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.418 -0.801 . . . . 0.0 109.475 -179.935 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.522 ' ND2' ' CG2' ' A' ' 47' ' ' THR . 0.4 OUTLIER 67.21 10.09 7.45 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.314 -0.866 . . . . 0.0 109.178 -179.002 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.66 18.55 54.51 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.946 -0.862 . . . . 0.0 110.946 178.051 . . . . . . . . 1 1 . 1 . 044 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.886 HG23 ' O ' ' A' ' 44' ' ' SER . 3.9 p -79.56 -15.22 58.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.977 -1.308 . . . . 0.0 107.875 178.076 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.862 HD12 ' H ' ' A' ' 49' ' ' THR . 0.2 OUTLIER -79.65 160.8 26.2 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.719 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.862 ' H ' HD12 ' A' ' 48' ' ' LEU . 70.8 p -156.64 124.6 5.57 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 122.142 0.972 . . . . 0.0 109.9 178.902 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.695 HD13 ' HB3' ' A' ' 23' ' ' LEU . 0.9 OUTLIER -62.44 144.12 56.28 Favored 'General case' 0 C--N 1.286 -2.182 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.385 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.439 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.3 OUTLIER -108.97 -18.29 13.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.857 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.701 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.1 p80 179.72 161.78 0.9 Allowed 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -179.629 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.561 ' CE1' HG13 ' A' ' 4' ' ' VAL . 54.4 m-85 -75.89 179.36 5.57 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.217 -0.927 . . . . 0.0 108.93 179.128 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.561 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 73.32 -167.04 54.45 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.534 . . . . . . . . 2 2 . 1 . 044 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.46 ' HB3' HG21 ' A' ' 30' ' ' THR . 0.0 OUTLIER -90.36 144.77 25.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.365 -1.079 . . . . 0.0 109.217 179.573 . . . . . . . . 3 3 . 1 . 044 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.522 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.042 -0.98 . . . . 0.0 109.627 179.953 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 2.0 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 0 0 . 1 . 045 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.36 -148.9 0.26 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.965 . . . . 0.0 109.637 179.997 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.75 109.67 18.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.247 -0.908 . . . . 0.0 109.433 -179.865 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.553 ' HB ' HD23 ' A' ' 50' ' ' LEU . 3.5 m -93.38 82.16 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.912 . . . . 0.0 109.254 179.852 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.2 p -166.68 123.7 1.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.321 -179.801 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -103.87 169.02 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.234 -0.916 . . . . 0.0 109.463 -179.818 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.455 ' O ' HG13 ' A' ' 6' ' ' VAL . 25.8 t70 -75.21 155.07 37.23 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.322 179.875 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.0 m -151.62 50.68 0.81 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.19 -0.944 . . . . 0.0 109.845 -179.867 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -92.11 -13.26 31.05 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.171 -0.956 . . . . 0.0 109.858 -179.983 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -134.19 57.33 1.81 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.143 -0.973 . . . . 0.0 110.626 -178.795 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.619 ' CE1' ' HA ' ' A' ' 35' ' ' CYS . 98.3 m-85 -143.29 149.49 48.41 Favored Pre-proline 0 C--N 1.305 -1.339 0 O-C-N 120.86 -1.15 . . . . 0.0 109.326 179.563 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.563 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 37.4 Cg_endo -73.97 161.06 95.11 Favored 'Cis proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.438 -1.901 . . . . 0.0 111.654 2.485 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.444 ' HG2' ' HD2' ' A' ' 14' ' ' PRO . 0.1 OUTLIER -121.16 139.88 30.18 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.668 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.8 13.62 1.65 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.524 2.149 . . . . 0.0 111.029 179.831 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 178.23 128.14 0.06 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -0.885 . . . . 0.0 109.789 179.906 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.423 ' SG ' ' N ' ' A' ' 17' ' ' THR . 51.3 t -114.6 159.7 20.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 0.0 109.407 179.711 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.437 ' HB ' ' OE1' ' A' ' 19' ' ' GLU . 0.2 OUTLIER -61.42 -166.6 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.512 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' O ' ' C ' ' A' ' 19' ' ' GLU . 0.7 OUTLIER -112.61 -17.4 12.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.866 -1.147 . . . . 0.0 109.643 179.666 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 5.3 pm0 -46.18 137.49 6.07 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.132 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.626 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 7.7 t80 -96.55 135.09 38.92 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.487 1.137 . . . . 0.0 111.409 -177.834 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.635 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 1.1 mtt180 -161.07 73.67 2.64 Favored Pre-proline 0 C--N 1.296 -1.718 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 179.08 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.584 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 25.1 Cg_endo -63.2 119.1 6.04 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.65 2.234 . . . . 0.0 112.689 -176.613 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.721 HD11 ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.51 130.83 54.81 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.059 178.885 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.742 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 0.7 OUTLIER -79.21 106.37 11.19 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.34 -1.726 . . . . 0.0 106.34 178.761 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.626 ' C ' ' HA ' ' A' ' 50' ' ' LEU . . . -58.76 -162.52 0.06 OUTLIER Glycine 0 C--N 1.297 -1.634 0 C-N-CA 118.033 -2.032 . . . . 0.0 108.856 -178.687 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 49' ' ' THR . 0.3 OUTLIER -88.59 -35.79 16.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.974 -1.31 . . . . 0.0 109.29 -179.939 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.55 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 7.6 p30 -63.21 -12.35 27.77 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.149 -0.969 . . . . 0.0 108.899 178.818 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.55 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER 92.41 16.42 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.323 0.582 . . . . 0.0 109.864 179.697 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 38.9 tttm -99.33 121.2 40.76 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.341 . . . . . . . . 1 1 . 1 . 045 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.469 HG22 ' N ' ' A' ' 31' ' ' TYR . 97.4 m -59.13 157.62 10.1 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.492 -0.755 . . . . 0.0 109.372 -179.527 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.584 ' O ' ' HA ' ' A' ' 22' ' ' PRO . 9.8 m-85 -128.23 127.87 43.65 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 178.142 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.626 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.89 -53.0 1.17 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 110.096 -1.202 . . . . 0.0 110.096 -177.584 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.635 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.0 p30 -160.45 -167.62 1.94 Allowed 'General case' 0 C--N 1.297 -1.694 0 O-C-N 120.702 -1.469 . . . . 0.0 110.843 179.053 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.721 ' HA ' HD11 ' A' ' 23' ' ' LEU . 4.8 ptmt -50.53 -40.12 50.8 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.786 -0.571 . . . . 0.0 112.03 -177.116 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 17.0 m -66.55 -65.45 0.68 Allowed 'General case' 0 C--N 1.295 -1.774 0 O-C-N 120.514 -1.366 . . . . 0.0 109.679 -179.314 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.58 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.8 m-80 -47.74 -28.29 2.41 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.437 -0.789 . . . . 0.0 110.366 -179.055 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.667 ' CB ' HD13 ' A' ' 23' ' ' LEU . 14.8 t80 -76.0 -57.6 3.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.616 -1.302 . . . . 0.0 109.797 179.566 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.591 ' SG ' ' CD2' ' A' ' 11' ' ' TYR . 34.0 t -54.13 -56.76 15.05 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.415 -177.949 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.569 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -41.93 -33.58 0.56 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.86 -1.15 . . . . 0.0 108.76 -178.693 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 37' ' ' PHE . . . -67.56 -49.11 64.79 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.191 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 38' ' ' CYS . 93.0 t -56.9 -63.76 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.396 0.617 . . . . 0.0 110.249 179.046 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.605 HG11 ' CB ' ' A' ' 11' ' ' TYR . 2.1 p -59.47 -22.73 23.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.504 -0.748 . . . . 0.0 111.799 -178.197 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.569 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -90.8 -17.74 26.08 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 120.348 -1.47 . . . . 0.0 108.451 179.084 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.9 ' O ' HG22 ' A' ' 47' ' ' THR . 16.7 p -102.73 29.55 5.27 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.907 -0.717 . . . . 0.0 109.476 179.807 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.46 ' CG ' ' O ' ' A' ' 44' ' ' SER . 1.4 p-10 45.1 53.84 7.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.183 -0.948 . . . . 0.0 109.103 -179.638 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 38.33 45.17 1.78 Allowed Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 179.958 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.9 HG22 ' O ' ' A' ' 44' ' ' SER . 11.1 t -110.48 -8.83 14.62 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.335 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.799 ' C ' HG23 ' A' ' 49' ' ' THR . 2.3 tp -81.71 -84.11 0.11 Allowed 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -179.837 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.799 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.2 p 79.81 171.62 0.16 Allowed 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.063 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.664 ' HB3' ' CZ ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -125.86 174.42 8.38 Favored 'General case' 0 C--N 1.292 -1.916 0 O-C-N 121.062 -1.024 . . . . 0.0 110.308 -178.633 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.652 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 0.2 OUTLIER -105.58 -35.13 7.54 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.591 . . . . . . . . 3 3 . 1 . 045 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.742 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 1.7 p80 -165.34 162.15 19.47 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-O 121.485 0.66 . . . . 0.0 109.55 -179.101 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.506 ' CD2' HD23 ' A' ' 23' ' ' LEU . 61.4 m-85 -78.54 177.48 8.53 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 108.975 179.154 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 76.03 -168.16 54.75 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 -179.949 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.83 141.96 30.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -1.153 . . . . 0.0 109.749 179.618 . . . . . . . . 2 2 . 1 . 045 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.606 ' HA ' ' HE2' ' A' ' 52' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.306 0.574 . . . . 0.0 109.609 . . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 47.13 34.71 3.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.344 -0.847 . . . . 0.0 109.779 179.984 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -80.38 153.63 28.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.241 -0.912 . . . . 0.0 109.566 179.823 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 4' ' ' VAL . 11.6 m -144.34 101.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.292 -0.88 . . . . 0.0 109.391 179.943 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -167.59 115.96 0.78 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.224 -0.922 . . . . 0.0 109.432 -179.903 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.48 130.73 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.281 -0.887 . . . . 0.0 109.242 -179.916 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -90.1 104.67 17.21 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.294 179.841 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 29.4 m -90.87 57.33 3.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.978 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.2 m -89.87 -20.35 23.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.358 -0.839 . . . . 0.0 108.897 179.762 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -91.4 16.7 9.67 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.279 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.988 ' HB3' HG11 ' A' ' 42' ' ' VAL . 17.5 m-85 -102.2 168.15 9.39 Favored Pre-proline 0 C--N 1.304 -1.39 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.542 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.92 ' HB3' HG21 ' A' ' 42' ' ' VAL . 34.9 Cg_endo -85.03 176.37 30.41 Favored 'Cis proline' 0 C--N 1.307 -1.658 0 C-N-CA 123.465 -1.473 . . . . 0.0 111.238 1.217 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 8.8 mttt -125.64 137.54 30.15 Favored Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 -179.881 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 34.8 Cg_endo -79.81 14.03 1.98 Allowed 'Trans proline' 0 C--N 1.312 -1.344 0 C-N-CA 122.575 2.183 . . . . 0.0 110.766 -179.286 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -161.48 124.0 3.05 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.624 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.468 ' O ' ' O ' ' A' ' 17' ' ' THR . 73.2 m -100.72 137.72 38.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.239 -0.913 . . . . 0.0 110.07 -179.324 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.468 ' O ' ' O ' ' A' ' 16' ' ' CYS . 1.0 OUTLIER -53.12 -174.68 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.395 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.5 pp -121.1 -10.23 9.05 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.793 -179.621 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.469 ' O ' ' O ' ' A' ' 18' ' ' LEU . 10.5 pm0 -57.3 -168.29 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.788 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.504 ' O ' ' CG ' ' A' ' 21' ' ' ARG . 6.9 t80 -136.45 129.2 30.77 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 118.63 -1.228 . . . . 0.0 111.19 179.89 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.577 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 2.8 mtm180 -161.25 79.27 2.19 Favored Pre-proline 0 C--N 1.294 -1.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.218 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 26.2 Cg_endo -64.97 116.61 3.93 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.233 1.955 . . . . 0.0 112.133 -177.288 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -108.81 125.82 52.37 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.432 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 41.8 t -78.91 165.87 23.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -178.953 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.69 172.26 20.97 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -179.18 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.487 ' OG ' ' OG1' ' A' ' 49' ' ' THR . 0.0 OUTLIER -66.04 -35.65 81.12 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.376 -1.073 . . . . 0.0 109.719 -179.099 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.571 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 3.6 p-10 -62.76 -11.55 18.4 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.096 -1.002 . . . . 0.0 108.915 179.361 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.571 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 7.4 t-20 85.69 30.34 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.457 0.646 . . . . 0.0 109.465 179.831 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' CB ' ' OD2' ' A' ' 27' ' ' ASP . 2.8 ttpt -114.71 143.29 45.29 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.481 -0.762 . . . . 0.0 109.087 179.749 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.474 ' N ' ' HG3' ' A' ' 29' ' ' LYS . 26.9 m -91.94 155.04 18.43 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.493 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.849 ' CE2' ' HB2' ' A' ' 40' ' ' ALA . 57.3 m-85 -123.56 124.48 42.92 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.826 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -34.25 -51.86 0.71 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 -177.669 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.0 p30 -154.73 -162.75 1.44 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.926 -1.338 . . . . 0.0 110.499 179.635 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.1 -42.45 93.99 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.574 -0.704 . . . . 0.0 111.628 -177.917 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.517 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 42.8 t -55.46 -49.7 71.8 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.247 -1.533 . . . . 0.0 109.275 -179.744 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -61.94 -53.62 53.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.814 -0.554 . . . . 0.0 110.68 -179.122 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.597 ' CE1' HD21 ' A' ' 48' ' ' LEU . 63.1 t80 -53.26 -48.08 68.56 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 122.402 1.096 . . . . 0.0 110.143 -179.215 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.634 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 40.7 m -64.58 -30.58 71.61 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.625 -179.477 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.617 ' HA ' HG22 ' A' ' 42' ' ' VAL . 10.5 m-80 -70.77 -22.36 62.39 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.98 -1.075 . . . . 0.0 108.528 179.296 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.849 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -82.51 -27.62 31.61 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.772 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.855 ' CG2' HD23 ' A' ' 48' ' ' LEU . 73.8 t -77.81 -31.95 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.128 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.988 HG11 ' HB3' ' A' ' 11' ' ' TYR . 21.5 m -86.42 -28.68 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.724 -0.61 . . . . 0.0 110.151 -179.431 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -91.99 -22.36 20.03 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.187 -0.946 . . . . 0.0 109.371 -179.586 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.667 ' O ' HG22 ' A' ' 47' ' ' THR . 26.2 p -89.88 10.36 24.08 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.709 -179.465 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 44' ' ' SER . 8.0 t30 74.47 11.24 4.07 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 108.654 -179.373 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.88 14.83 81.94 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 110.004 -1.238 . . . . 0.0 110.004 -179.827 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 44' ' ' SER . 9.7 t -80.15 -8.4 59.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -1.21 . . . . 0.0 108.857 179.127 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.855 HD23 ' CG2' ' A' ' 41' ' ' VAL . 0.3 OUTLIER -79.75 163.76 24.22 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.454 -0.779 . . . . 0.0 109.17 179.999 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.655 ' H ' HD12 ' A' ' 48' ' ' LEU . 40.0 p -147.71 126.55 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-O 121.953 0.882 . . . . 0.0 108.682 177.974 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 2.4 tp -58.5 125.19 22.32 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.334 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 9.5 t -83.22 -22.98 32.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.518 -0.739 . . . . 0.0 109.802 -179.753 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.562 ' CB ' ' O ' ' A' ' 51' ' ' SER . 10.8 p80 154.26 162.42 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.888 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -69.71 170.57 10.63 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 120.791 -1.193 . . . . 0.0 108.821 179.284 . . . . . . . . 1 1 . 1 . 046 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 78.27 -172.46 55.22 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.808 . . . . . . . . 2 2 . 1 . 046 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 56' ' ' CYS . 0.0 OUTLIER -90.78 150.04 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.056 -1.261 . . . . 0.0 109.313 179.118 . . . . . . . . 3 3 . 1 . 046 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.407 ' HA ' ' CE1' ' A' ' 52' ' ' HIS . 15.3 m . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.578 179.998 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.528 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.528 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 65.99 -160.84 0.26 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.246 -179.839 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.416 ' O ' HG13 ' A' ' 4' ' ' VAL . . . -107.82 130.87 54.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.5 -180.0 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.416 HG13 ' O ' ' A' ' 3' ' ' ALA . 4.8 m -153.1 93.37 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.398 -0.814 . . . . 0.0 109.285 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.6 122.63 0.63 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.268 -0.895 . . . . 0.0 109.369 -179.882 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 75.5 t -83.65 150.48 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.601 -179.835 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.463 ' OD1' ' OE1' ' A' ' 10' ' ' GLU . 12.1 t70 -60.86 151.84 28.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.243 -0.91 . . . . 0.0 109.092 179.772 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.489 ' SG ' ' HB ' ' A' ' 41' ' ' VAL . 1.6 t -150.58 16.44 0.8 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.087 -1.008 . . . . 0.0 110.011 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' HB3' ' OE2' ' A' ' 10' ' ' GLU . 2.4 t -90.37 10.21 25.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.177 -0.952 . . . . 0.0 109.313 179.488 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.48 ' OE2' ' HB3' ' A' ' 9' ' ' SER . 6.0 mp0 -124.66 -21.18 4.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.167 -0.958 . . . . 0.0 110.442 -179.618 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.637 ' CD2' ' HG3' ' A' ' 13' ' ' LYS . 91.4 m-85 -79.37 153.52 76.57 Favored Pre-proline 0 C--N 1.307 -1.257 0 O-C-N 120.832 -1.167 . . . . 0.0 109.178 -179.67 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 11' ' ' TYR . 40.6 Cg_endo -74.55 144.59 81.44 Favored 'Cis proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.232 -1.987 . . . . 0.0 111.344 1.514 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.637 ' HG3' ' CD2' ' A' ' 11' ' ' TYR . 0.1 OUTLIER -105.85 163.24 17.48 Favored Pre-proline 0 N--CA 1.493 1.688 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.692 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -76.28 13.69 1.28 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.426 2.084 . . . . 0.0 111.39 -179.75 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -177.17 130.72 0.17 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.153 -0.967 . . . . 0.0 109.725 179.947 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 17' ' ' THR . 90.5 m -93.76 152.54 18.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.925 . . . . 0.0 109.556 179.969 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 16' ' ' CYS . 0.4 OUTLIER -51.74 -176.85 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.229 -0.919 . . . . 0.0 108.987 179.648 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.708 ' H ' HD23 ' A' ' 18' ' ' LEU . 1.2 pt? -122.49 -35.69 3.05 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.027 -1.046 . . . . 0.0 109.612 179.811 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.54 ' N ' ' HG ' ' A' ' 18' ' ' LEU . 3.7 pm0 -53.13 137.98 32.48 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.429 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.507 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 11.1 t80 -86.88 127.61 35.04 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 122.258 1.028 . . . . 0.0 110.779 -178.462 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.611 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 7.2 mtm180 -160.61 85.31 1.91 Allowed Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.327 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.551 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 22.2 Cg_endo -64.8 117.94 4.98 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 C-N-CA 122.755 2.303 . . . . 0.0 112.998 -177.348 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.618 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -107.07 131.04 54.55 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 118.763 -1.175 . . . . 0.0 107.89 177.88 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.412 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 41.0 t -78.32 162.86 26.18 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.977 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -144.43 169.1 26.52 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.935 -1.602 . . . . 0.0 110.902 -178.084 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 48' ' ' LEU . 2.3 t -58.55 -19.07 34.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.603 -0.939 . . . . 0.0 110.32 -178.028 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.547 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 26.5 p-10 -61.24 -13.24 17.08 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.102 -0.999 . . . . 0.0 109.416 179.727 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 1.4 t-20 83.88 14.76 0.29 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.681 -0.637 . . . . 0.0 109.697 179.902 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -128.01 -166.36 1.61 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.278 -0.889 . . . . 0.0 109.296 179.464 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 31' ' ' TYR . 16.3 m -111.81 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.644 -0.66 . . . . 0.0 109.342 -179.898 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.715 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.7 m-85 -131.38 121.63 24.96 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.58 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -31.2 -52.9 0.28 Allowed Glycine 0 N--CA 1.496 2.649 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.264 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.611 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 52.3 p30 -157.89 -165.02 1.64 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.013 -1.286 . . . . 0.0 110.358 179.828 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.618 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.1 OUTLIER -53.66 -42.75 68.21 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.58 -0.7 . . . . 0.0 110.597 -178.485 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.453 ' HA ' ' CE2' ' A' ' 11' ' ' TYR . 50.7 t -62.2 -63.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.796 -1.19 . . . . 0.0 109.786 -179.844 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.581 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 15.9 m-80 -52.58 -23.69 6.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.115 -0.991 . . . . 0.0 110.211 -179.367 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' CE2' ' HB2' ' A' ' 50' ' ' LEU . 4.1 t80 -75.34 -67.08 0.69 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.871 -1.143 . . . . 0.0 110.457 -179.554 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' ' CD1' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -55.15 -46.66 75.71 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.796 -177.923 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.536 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 6.2 m-20 -44.09 -30.94 0.82 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 120.745 -1.222 . . . . 0.0 107.991 179.73 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.715 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -70.48 -49.5 47.84 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 177.537 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.878 HG22 HD23 ' A' ' 48' ' ' LEU . 76.8 t -54.02 -63.02 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 121.442 0.639 . . . . 0.0 110.216 178.945 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.538 HG21 ' O ' ' A' ' 11' ' ' TYR . 2.1 p -59.37 -22.61 23.12 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 O-C-N 121.408 -0.808 . . . . 0.0 111.086 -178.331 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.6 OUTLIER -92.21 -15.13 27.98 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.519 -1.363 . . . . 0.0 109.23 179.421 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.55 ' O ' HG22 ' A' ' 47' ' ' THR . 5.5 p -100.66 7.58 43.85 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.283 -0.885 . . . . 0.0 109.671 -179.685 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.7 t30 75.21 8.66 3.95 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.14 -0.975 . . . . 0.0 109.024 -179.579 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.26 19.78 63.93 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.831 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 44' ' ' SER . 14.5 t -91.7 -0.22 57.54 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.341 -1.094 . . . . 0.0 108.942 179.104 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.878 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -90.02 -70.32 0.67 Allowed 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.898 0.856 . . . . 0.0 109.276 -179.494 . . . . . . . . 3 3 . 1 . 047 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.781 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.7 p 83.37 154.33 0.1 Allowed 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 121.96 0.886 . . . . 0.0 109.579 -178.756 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.606 ' HB2' ' CE2' ' A' ' 37' ' ' PHE . 12.6 tp -72.82 126.01 28.9 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.384 -179.536 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.574 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 8.1 t -79.3 -24.17 43.03 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.165 -0.959 . . . . 0.0 108.874 179.444 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.574 ' CD2' ' O ' ' A' ' 51' ' ' SER . 17.1 p80 150.67 174.27 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.541 178.378 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -82.9 155.86 23.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.144 -0.973 . . . . 0.0 110.092 179.741 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.543 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 84.1 -174.18 50.82 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 109.69 -1.364 . . . . 0.0 109.69 -179.661 . . . . . . . . 2 2 . 1 . 047 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 1.6 mttt -90.24 146.38 24.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.054 -1.262 . . . . 0.0 109.008 179.249 . . . . . . . . 1 1 . 1 . 047 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.442 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.236 0.541 . . . . 0.0 109.556 . . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 61.85 -165.19 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.248 -0.908 . . . . 0.0 109.513 -179.949 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -134.86 156.79 48.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.569 179.944 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' A' ' 5' ' ' SER . 2.0 p -105.36 104.44 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.343 -0.848 . . . . 0.0 109.42 179.933 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 4' ' ' VAL . 61.1 p 178.37 139.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.323 -0.861 . . . . 0.0 109.485 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 30.0 t -80.4 134.0 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 0.0 109.297 179.879 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -76.64 133.84 39.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.137 -0.977 . . . . 0.0 109.278 -179.989 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 37.3 m -124.42 61.17 1.14 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 0.0 109.706 -179.828 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB3' ' OE1' ' A' ' 10' ' ' GLU . 1.4 t -90.19 -31.94 16.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.145 -0.972 . . . . 0.0 109.654 179.93 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 0.7 OUTLIER -81.48 0.94 35.56 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.373 -0.83 . . . . 0.0 109.307 179.792 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.928 ' HB3' HG11 ' A' ' 42' ' ' VAL . 65.5 m-85 -91.3 165.32 21.69 Favored Pre-proline 0 C--N 1.304 -1.411 0 O-C-N 121.413 -0.804 . . . . 0.0 108.876 -179.839 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.995 ' HB3' HG21 ' A' ' 42' ' ' VAL . 33.9 Cg_endo -84.58 152.0 59.9 Favored 'Cis proline' 0 C--N 1.306 -1.687 0 C-N-CA 123.366 -1.514 . . . . 0.0 111.162 0.715 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 14' ' ' PRO . 12.6 mttt -105.5 141.14 22.01 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.638 -0.664 . . . . 0.0 109.677 -179.485 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 13' ' ' LYS . 36.5 Cg_endo -80.5 14.11 2.08 Favored 'Trans proline' 0 C--N 1.312 -1.395 0 C-N-CA 122.464 2.11 . . . . 0.0 110.413 179.631 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.68 145.67 14.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.499 -0.751 . . . . 0.0 109.188 -179.985 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 60.4 m -123.76 152.71 41.87 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.107 -0.996 . . . . 0.0 109.955 -179.589 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.462 ' HB ' ' OE2' ' A' ' 19' ' ' GLU . 0.8 OUTLIER -61.7 -167.79 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.338 -0.851 . . . . 0.0 109.14 179.695 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' O ' ' O ' ' A' ' 19' ' ' GLU . 1.0 OUTLIER -125.08 -18.41 5.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.018 -1.051 . . . . 0.0 110.367 -179.664 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.467 ' O ' ' O ' ' A' ' 18' ' ' LEU . 7.3 pm0 -56.55 -167.41 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.285 0 O-C-N 120.891 -1.131 . . . . 0.0 108.246 179.591 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.576 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 8.9 t80 -135.73 130.35 34.04 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-O 122.401 1.096 . . . . 0.0 111.315 -179.833 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.591 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -160.81 79.0 2.35 Favored Pre-proline 0 C--N 1.295 -1.794 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.94 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.574 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 24.1 Cg_endo -64.47 114.85 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.432 2.088 . . . . 0.0 112.675 -176.995 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.631 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.4 OUTLIER -112.57 141.76 45.95 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.458 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.765 ' HB3' ' CD2' ' A' ' 52' ' ' HIS . 20.6 t -95.49 159.63 14.9 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 118.81 -1.156 . . . . 0.0 109.007 -179.565 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA3' HD11 ' A' ' 48' ' ' LEU . . . -129.58 172.08 20.03 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 120.255 -0.974 . . . . 0.0 111.321 -178.407 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.0 t -56.26 -38.31 70.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.664 -0.904 . . . . 0.0 111.458 -177.53 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.607 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.6 OUTLIER -52.08 -19.11 1.72 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.69 -1.256 . . . . 0.0 110.038 -179.276 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.607 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 4.2 t30 91.47 27.15 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.933 -0.48 . . . . 0.0 110.409 179.459 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.65 178.99 4.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.904 -1.122 . . . . 0.0 109.439 179.458 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.541 HG22 ' N ' ' A' ' 31' ' ' TYR . 41.7 m -107.15 162.37 13.93 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.537 -0.727 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.862 ' CE1' ' HB2' ' A' ' 40' ' ' ALA . 83.8 m-85 -127.74 121.09 29.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 179.027 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.576 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -33.93 -54.34 0.68 Allowed Glycine 0 N--CA 1.493 2.466 0 N-CA-C 110.419 -1.072 . . . . 0.0 110.419 -177.968 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.591 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 43.6 p30 -152.36 -167.88 2.89 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.038 -1.272 . . . . 0.0 109.991 179.114 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.8 -60.71 2.86 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.721 -0.792 . . . . 0.0 110.348 -178.518 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.487 ' N ' ' HE2' ' A' ' 34' ' ' LYS . 41.9 t -43.45 -62.97 0.92 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.802 -1.186 . . . . 0.0 110.432 -179.425 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -49.65 -34.25 17.78 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.179 -0.951 . . . . 0.0 110.315 -178.989 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.579 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 13.5 t80 -70.5 -60.05 2.49 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.31 1.052 . . . . 0.0 110.845 -179.002 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.87 ' O ' HG13 ' A' ' 42' ' ' VAL . 1.6 m -53.69 -30.77 45.09 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.711 -0.618 . . . . 0.0 110.18 -179.107 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.712 ' O ' HG22 ' A' ' 42' ' ' VAL . 1.6 m-80 -64.07 -39.15 93.44 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.106 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.862 ' HB2' ' CE1' ' A' ' 31' ' ' TYR . . . -67.34 -20.21 65.55 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.34 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.856 HG22 HD23 ' A' ' 48' ' ' LEU . 41.5 t -84.8 -31.88 7.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.824 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.995 HG21 ' HB3' ' A' ' 12' ' ' PRO . 2.7 m -82.28 -16.01 11.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.626 -0.671 . . . . 0.0 109.619 -179.679 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.656 ' HG2' ' HA ' ' A' ' 40' ' ' ALA . 0.0 OUTLIER -91.65 -32.35 15.5 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.885 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.811 ' O ' HG22 ' A' ' 47' ' ' THR . 60.0 p -86.56 10.14 16.33 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 120.101 -0.64 . . . . 0.0 109.802 -179.423 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.501 ' CB ' ' O ' ' A' ' 44' ' ' SER . 7.2 t30 75.05 7.35 4.21 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.142 -0.974 . . . . 0.0 108.858 -179.444 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' HG13 ' A' ' 41' ' ' VAL . . . 83.51 13.7 75.42 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.846 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.811 HG22 ' O ' ' A' ' 44' ' ' SER . 13.9 t -93.44 0.89 56.96 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -1.139 . . . . 0.0 108.995 179.128 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.856 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -80.06 -71.57 0.45 Allowed 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 122.036 0.922 . . . . 0.0 108.744 179.881 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.754 HG23 ' C ' ' A' ' 48' ' ' LEU . 1.4 p 79.62 152.02 0.12 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 122.384 1.088 . . . . 0.0 109.997 -179.505 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.608 ' HG ' ' N ' ' A' ' 51' ' ' SER . 0.4 OUTLIER -70.59 152.82 43.51 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.637 -179.734 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.608 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 2.6 p -99.38 -39.94 8.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 178.675 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.765 ' CD2' ' HB3' ' A' ' 24' ' ' CYS . 0.3 OUTLIER -176.85 163.97 2.31 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.23 179.972 . . . . . . . . 3 3 . 1 . 048 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -80.46 136.68 36.37 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.235 -0.915 . . . . 0.0 109.609 179.467 . . . . . . . . 1 1 . 1 . 048 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 22' ' ' PRO . . . 110.41 -167.64 12.73 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.798 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.61 151.72 23.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.132 -1.216 . . . . 0.0 108.97 179.243 . . . . . . . . 2 2 . 1 . 048 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 117.997 -1.001 . . . . 0.0 109.511 179.989 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.505 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 3.0 tp . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 1' ' ' LEU . . . 64.47 -163.01 0.27 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.284 -179.93 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -112.97 176.34 5.06 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 0.0 109.326 179.845 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.489 ' O ' ' CB ' ' A' ' 5' ' ' SER . 3.6 t -136.1 72.9 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.188 -0.945 . . . . 0.0 109.554 -179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.489 ' CB ' ' O ' ' A' ' 4' ' ' VAL . 0.6 OUTLIER 165.37 128.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 -179.973 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 15.9 t -84.89 150.92 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.231 -0.918 . . . . 0.0 109.233 179.938 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -107.85 121.65 45.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.937 . . . . 0.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 11' ' ' TYR . 16.8 m -102.19 62.87 0.88 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.326 179.982 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.35 -4.13 58.7 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.144 -0.972 . . . . 0.0 109.943 -179.542 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.1 pm0 -117.89 2.45 12.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.16 -0.963 . . . . 0.0 109.322 179.681 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.802 ' HB3' HG11 ' A' ' 42' ' ' VAL . 35.5 m-85 -85.54 165.38 35.91 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.434 -0.791 . . . . 0.0 109.782 -179.445 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.839 ' HB3' HG21 ' A' ' 42' ' ' VAL . 36.1 Cg_endo -88.13 169.42 36.99 Favored 'Cis proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.249 -1.563 . . . . 0.0 110.642 0.837 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.487 ' HD2' ' CE1' ' A' ' 11' ' ' TYR . 5.2 mtpt -122.55 143.67 40.38 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.337 -0.852 . . . . 0.0 108.765 -179.848 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.81 13.88 1.82 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.491 2.127 . . . . 0.0 110.582 -179.882 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -160.7 112.27 1.89 Allowed 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.636 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.3 m -81.02 143.28 32.62 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.242 -0.911 . . . . 0.0 109.837 -179.381 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.3 p -62.73 -163.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.317 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.915 ' N ' HD13 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -119.57 -15.9 8.93 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.987 -1.071 . . . . 0.0 109.636 179.836 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.804 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -47.92 123.46 6.16 Favored 'General case' 0 C--N 1.307 -1.253 0 O-C-N 121.016 -1.052 . . . . 0.0 108.477 179.417 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.491 ' O ' ' HG2' ' A' ' 21' ' ' ARG . 27.8 t80 -86.59 110.68 19.99 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-O 122.361 1.077 . . . . 0.0 110.376 -179.294 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 10.4 mtp180 -145.9 86.39 7.21 Favored Pre-proline 0 C--N 1.291 -1.968 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.306 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 31' ' ' TYR . 27.8 Cg_endo -67.33 104.19 0.87 Allowed 'Trans proline' 0 C--N 1.301 -1.951 0 C-N-CA 121.855 1.704 . . . . 0.0 111.596 -177.904 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.655 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.5 OUTLIER -101.82 120.58 40.6 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 178.639 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' SG ' ' N ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -78.82 -179.67 6.7 Favored 'General case' 0 C--N 1.295 -1.797 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.617 -178.867 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -149.74 165.27 29.63 Favored Glycine 0 N--CA 1.487 2.072 0 C-N-CA 119.198 -1.477 . . . . 0.0 112.222 -177.216 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.03 -33.04 74.84 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.761 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.61 ' O ' ' CB ' ' A' ' 28' ' ' ASN . 0.9 OUTLIER -50.65 -24.93 3.67 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.95 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.61 ' CB ' ' O ' ' A' ' 27' ' ' ASP . 31.1 t-20 96.33 37.78 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.026 179.57 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.448 ' O ' ' SG ' ' A' ' 24' ' ' CYS . 0.2 OUTLIER -136.88 -169.43 2.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.926 . . . . 0.0 109.663 179.591 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.457 ' HA ' ' HA ' ' A' ' 24' ' ' CYS . 91.8 m -127.39 158.92 36.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.64 -0.662 . . . . 0.0 109.345 -179.937 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.61 ' CG ' ' HA ' ' A' ' 37' ' ' PHE . 88.3 m-85 -132.51 105.9 7.52 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.378 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.472 ' C ' ' O ' ' A' ' 31' ' ' TYR . . . -27.78 -55.98 0.12 Allowed Glycine 0 N--CA 1.494 2.527 0 O-C-N 122.047 -0.408 . . . . 0.0 112.28 -177.789 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.6 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 51.1 p-10 -140.24 -171.02 3.1 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.608 -1.525 . . . . 0.0 110.627 -179.541 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.655 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 5.8 pttt -59.64 -30.77 68.96 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.777 -0.577 . . . . 0.0 110.55 -179.036 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.643 ' HA ' ' CE1' ' A' ' 11' ' ' TYR . 43.6 t -62.89 -74.12 0.1 Allowed 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.674 -1.266 . . . . 0.0 108.261 179.194 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.55 ' HA ' ' OD1' ' A' ' 39' ' ' ASN . 18.3 m-80 -39.37 -48.67 1.93 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.715 -0.616 . . . . 0.0 110.557 -179.975 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.61 ' HA ' ' CG ' ' A' ' 31' ' ' TYR . 74.1 t80 -55.13 -46.37 75.61 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.665 -1.272 . . . . 0.0 109.265 -179.508 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' HB3' ' CG ' ' A' ' 11' ' ' TYR . 27.3 m -59.83 -48.32 82.15 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.602 179.957 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.55 ' OD1' ' HA ' ' A' ' 36' ' ' ASN . 7.2 m120 -45.68 -30.02 1.44 Allowed 'General case' 0 N--CA 1.483 1.204 0 O-C-N 120.85 -1.156 . . . . 0.0 109.308 179.35 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.605 ' HB2' ' CE2' ' A' ' 31' ' ' TYR . . . -79.08 -40.16 31.92 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.314 -0.866 . . . . 0.0 109.137 179.992 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.993 HG22 HD23 ' A' ' 48' ' ' LEU . 58.1 t -69.88 -24.3 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.549 -0.719 . . . . 0.0 110.146 -179.821 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.839 HG21 ' HB3' ' A' ' 12' ' ' PRO . 30.1 m -91.94 -26.97 4.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.534 -179.182 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -91.29 -15.27 29.4 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.407 -0.808 . . . . 0.0 109.077 -179.931 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 45' ' ' ASN . 26.8 t -102.24 19.79 18.02 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.184 -0.947 . . . . 0.0 109.5 179.967 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.508 ' HB2' ' O ' ' A' ' 44' ' ' SER . 8.2 m120 65.31 18.58 11.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.454 -0.779 . . . . 0.0 109.044 -179.604 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.68 18.37 77.25 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.732 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.2 p -89.61 -10.02 47.52 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.486 -1.008 . . . . 0.0 108.784 179.401 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.993 HD23 HG22 ' A' ' 41' ' ' VAL . 0.0 OUTLIER -79.43 148.05 32.08 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.75 . . . . . . . . 3 3 . 1 . 049 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.578 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 30.1 p -123.07 139.98 53.5 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.888 0.852 . . . . 0.0 109.721 179.332 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD13 ' HB3' ' A' ' 23' ' ' LEU . 5.1 tp -61.21 130.16 44.85 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.696 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.586 ' O ' ' CD2' ' A' ' 52' ' ' HIS . 7.9 t -79.01 -22.95 44.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.741 -1.224 . . . . 0.0 109.241 -179.913 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.586 ' CD2' ' O ' ' A' ' 51' ' ' SER . 12.3 p80 154.1 164.78 0.01 OUTLIER 'General case' 0 C--N 1.288 -2.083 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.167 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -74.77 148.29 40.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.11 -0.993 . . . . 0.0 108.601 179.004 . . . . . . . . 1 1 . 1 . 049 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 22' ' ' PRO . . . 93.73 -179.31 38.46 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.325 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -82.97 168.4 17.05 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.964 -1.315 . . . . 0.0 109.017 178.821 . . . . . . . . 2 2 . 1 . 049 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.535 ' N ' ' SG ' ' A' ' 24' ' ' CYS . 30.7 m . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.687 -179.464 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.402 ' O ' HG13 ' A' ' 4' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.81 24.69 7.63 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.301 -0.874 . . . . 0.0 109.609 -179.966 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 57.11 88.21 0.05 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 0.0 109.288 179.959 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 1' ' ' LEU . 3.8 m -117.7 77.42 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.289 -0.882 . . . . 0.0 109.673 -179.717 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.3 m -146.48 163.88 34.28 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.399 179.79 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.4 t -137.77 149.37 25.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -83.9 117.25 23.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.285 -0.884 . . . . 0.0 109.274 179.894 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.3 m -128.19 37.36 4.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.142 -0.974 . . . . 0.0 109.894 -179.598 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -90.28 6.7 41.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.074 -1.016 . . . . 0.0 109.711 -179.859 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.419 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 24.1 mp0 -129.01 36.71 4.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.068 -1.02 . . . . 0.0 109.775 -179.76 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.967 ' HB3' HG11 ' A' ' 42' ' ' VAL . 24.3 m-85 -108.26 164.08 15.54 Favored Pre-proline 0 C--N 1.304 -1.384 0 O-C-N 121.212 -0.93 . . . . 0.0 108.541 179.969 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HA ' ' HB3' ' A' ' 11' ' ' TYR . 37.8 Cg_endo -77.7 -177.72 21.93 Favored 'Cis proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.967 -1.68 . . . . 0.0 111.684 2.232 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.636 ' HG3' ' CE2' ' A' ' 11' ' ' TYR . 4.4 mmmt -125.54 148.14 60.56 Favored Pre-proline 0 N--CA 1.489 1.481 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.616 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . 0.709 ' O ' ' HB2' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.73 14.01 1.55 Allowed 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.358 2.039 . . . . 0.0 111.409 -178.935 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.709 ' HB2' ' O ' ' A' ' 14' ' ' PRO . . . 163.62 165.48 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 109.688 179.746 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 49.9 t -140.43 160.0 40.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.34 -0.85 . . . . 0.0 109.699 179.877 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -58.48 -166.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.091 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 19' ' ' GLU . 3.0 pp -115.02 -24.37 8.62 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 120.86 -1.15 . . . . 0.0 109.57 179.605 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.544 ' O ' ' HG2' ' A' ' 19' ' ' GLU . 1.9 pt-20 -43.79 116.6 1.0 Allowed 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.412 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.561 ' CE1' ' O ' ' A' ' 32' ' ' GLY . 12.3 t80 -79.26 130.96 35.99 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-O 122.496 1.141 . . . . 0.0 111.325 -177.622 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -161.03 78.35 2.33 Favored Pre-proline 0 C--N 1.294 -1.811 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 179.315 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.573 ' O ' ' N ' ' A' ' 54' ' ' GLY . 22.2 Cg_endo -64.53 118.45 5.43 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.89 2.394 . . . . 0.0 112.898 -177.097 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.644 ' CD1' ' HA ' ' A' ' 34' ' ' LYS . 0.6 OUTLIER -106.67 131.58 53.65 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.779 178.478 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' N ' ' A' ' 25' ' ' GLY . 40.8 t -79.45 162.54 25.4 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 179.121 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' SG ' ' A' ' 24' ' ' CYS . . . -141.95 166.49 26.28 Favored Glycine 0 N--CA 1.487 2.046 0 C-N-CA 118.969 -1.586 . . . . 0.0 111.259 -178.054 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 t -55.74 -13.27 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.874 -0.78 . . . . 0.0 110.531 -178.729 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 4.0 p30 -75.01 5.94 4.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.819 -1.175 . . . . 0.0 109.427 179.236 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 27' ' ' ASP . 72.1 m-20 63.29 31.32 15.45 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.367 -0.833 . . . . 0.0 109.847 179.763 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -136.39 -168.26 2.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.227 -0.921 . . . . 0.0 109.429 179.659 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 31' ' ' TYR . 18.3 m -119.85 162.45 19.11 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.637 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.962 ' CZ ' ' HB2' ' A' ' 40' ' ' ALA . 12.8 m-85 -129.97 126.45 37.84 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 179.046 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.561 ' O ' ' CE1' ' A' ' 20' ' ' TYR . . . -35.27 -53.76 0.96 Allowed Glycine 0 N--CA 1.495 2.609 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -177.527 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.616 ' HA ' ' O ' ' A' ' 21' ' ' ARG . 47.6 p30 -157.54 -164.64 1.6 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.934 -1.333 . . . . 0.0 111.179 179.614 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.644 ' HA ' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -51.5 -47.49 63.22 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.662 -0.649 . . . . 0.0 112.31 -177.304 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.531 ' N ' ' HE3' ' A' ' 34' ' ' LYS . 5.2 m -63.54 -55.08 26.73 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.402 -1.436 . . . . 0.0 109.982 -178.62 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 19.4 m-80 -54.86 -27.87 45.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.105 -0.997 . . . . 0.0 110.027 -179.541 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 50' ' ' LEU . 29.0 t80 -74.03 -50.46 19.64 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.997 1.38 . . . . 0.0 109.401 179.639 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 13.5 m -60.56 -26.13 66.69 Favored 'General case' 0 C--N 1.278 -2.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 109.474 -179.257 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 19.7 m-20 -65.26 -34.22 77.85 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 178.927 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.962 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . . . -68.61 -39.13 80.99 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.819 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.627 HG22 HD23 ' A' ' 48' ' ' LEU . 86.5 t -65.11 -61.46 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.581 -0.699 . . . . 0.0 109.89 -179.727 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.967 HG11 ' HB3' ' A' ' 11' ' ' TYR . 14.1 p -59.28 -19.75 16.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -0.771 . . . . 0.0 110.7 -179.335 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -90.75 -22.52 21.04 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.6 -1.312 . . . . 0.0 107.909 178.981 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.821 ' O ' HG22 ' A' ' 47' ' ' THR . 0.9 OUTLIER -98.44 29.29 3.69 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.114 179.533 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.525 ' ND2' ' HB ' ' A' ' 47' ' ' THR . 6.0 p-10 44.34 53.82 6.59 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 45' ' ' ASN . . . 39.03 47.1 2.48 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 -179.31 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 44' ' ' SER . 6.5 t -111.53 -22.97 10.98 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.453 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.627 HD23 HG22 ' A' ' 41' ' ' VAL . 0.1 OUTLIER -79.64 150.88 30.84 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 178.999 . . . . . . . . 3 3 . 1 . 050 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.569 ' N ' ' HG ' ' A' ' 48' ' ' LEU . 31.2 p -125.02 138.14 54.22 Favored 'General case' 0 C--N 1.297 -1.715 0 O-C-N 121.074 -1.016 . . . . 0.0 109.41 179.621 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 10.3 tp -54.12 124.49 15.84 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.574 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.58 ' O ' ' CB ' ' A' ' 52' ' ' HIS . 8.4 t -78.0 -22.84 48.69 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.039 -1.038 . . . . 0.0 109.793 -178.867 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.58 ' CB ' ' O ' ' A' ' 51' ' ' SER . 12.9 p80 152.65 177.61 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.136 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 67.2 m-85 -87.62 160.95 17.96 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.194 -0.941 . . . . 0.0 109.427 179.653 . . . . . . . . 1 1 . 1 . 050 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.573 ' N ' ' O ' ' A' ' 22' ' ' PRO . . . 82.64 -170.43 50.18 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.11 -1.196 . . . . 0.0 110.11 -179.385 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 148.33 23.13 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.06 -1.259 . . . . 0.0 109.159 179.088 . . . . . . . . 2 2 . 1 . 050 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.457 ' SG ' ' NE2' ' A' ' 52' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.982 -1.008 . . . . 0.0 109.546 179.904 . . . . . . . . 2 2 . 1 stop_ save_